PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Sanz, FJ; Solana-Manrique, C; Lilao-Garzon, J; Brito-Casillas, Y; Munoz-Descalzo, S; Paricio, N				Sanz, Francisco Jose; Solana-Manrique, Cristina; Lilao-Garzon, Joaquin; Brito-Casillas, Yeray; Munoz-Descalzo, Silvia; Paricio, Nuria			Exploring the link between Parkinson's disease and type 2 diabetes mellitus in Drosophila	FASEB JOURNAL			English	Article						drosophila; high fat; sugar diet; mouse model; neurodegeneration; Parkinson's disease; type 2 diabetes mellitus	OXIDATIVE STRESS; DJ-1 MUTANTS; IN-VIVO; MODEL; DYSFUNCTION; HOMEOSTASIS; PATHWAY; OBESITY; CELLS	Parkinson's disease (PD) is the second most common neurodegenerative disease. Diabetes mellitus (DM) is a metabolic disease characterized by high levels of glucose in blood. Recent epidemiological studies have highlighted the link between both diseases; it is even considered that DM might be a risk factor for PD. To further investigate the likely relation of these diseases, we have used a Drosophila PD model based on inactivation of the DJ-1 beta gene (ortholog of human DJ-1), and diet-induced Drosophila and mouse type 2 DM (T2DM) models, together with human neuron-like cells. T2DM models were obtained by feeding flies with a high sugar-containing medium, and mice with a high fat diet. Our results showed that both fly models exhibit common phenotypes such as alterations in carbohydrate homeostasis, mitochondrial dysfunction or motor defects, among others. In addition, we demonstrated that T2DM might be a risk factor of developing PD since our diet-induced fly and mouse T2DM models present DA neuron dysfunction, a hallmark of PD. We also confirmed that neurodegeneration is caused by increased glucose levels, which has detrimental effects in human neuron-like cells by triggering apoptosis and leading to cell death. Besides, the observed phenotypes were exacerbated in DJ-1 beta mutants cultured in the high sugar medium, indicating that DJ-1 might have a role in carbohydrate homeostasis. Finally, we have confirmed that metformin, an antidiabetic drug, is a potential candidate for PD treatment and that it could prevent PD onset in T2DM model flies. This result supports antidiabetic compounds as promising PD therapeutics.	[Sanz, Francisco Jose; Solana-Manrique, Cristina; Paricio, Nuria] Univ Valencia, Fac CC Biol, Dept Genet, Dr Moliner 50, E-46100 Burjassot, Spain; [Sanz, Francisco Jose; Solana-Manrique, Cristina; Paricio, Nuria] Univ Valencia, Inst Univ Biotecnol & Biomed BIOTECMED, Burjassot, Spain; [Lilao-Garzon, Joaquin; Brito-Casillas, Yeray; Munoz-Descalzo, Silvia] Univ Las Palmas Gran Canaria ULPGC, Inst Univ Invest Biomed & Sanitarias IUIBS, Las Palmas Gran Canaria, Spain	University of Valencia; University of Valencia; Universidad de Las Palmas de Gran Canaria	Paricio, N (corresponding author), Univ Valencia, Fac CC Biol, Dept Genet, Dr Moliner 50, E-46100 Burjassot, Spain.	nuria.paricio@uv.es	Brito Casillas, Yeray/U-6954-2018; Paricio, Nuria/K-2184-2014	Brito Casillas, Yeray/0000-0002-0707-7444; Munoz-Descalzo, Silvia/0000-0003-0939-7721; Paricio, Nuria/0000-0001-7193-2532	University of Valencia (Programa de Acciones Especiales de Investigacion) [UV-INV-AE-1553209]; Agencia Canaria de Investigacion, Innovacion y Sociedad de la Informacion (ACIISI); ULPGC; ULPGC predoctoral program; ACIISI [CEI2019-02]; Programa de Ayudas a la Investigacion de la ULPGC; ACIISI; FEDER Funds [ProID2020010013]; ProjektDEAL	University of Valencia (Programa de Acciones Especiales de Investigacion); Agencia Canaria de Investigacion, Innovacion y Sociedad de la Informacion (ACIISI); ULPGC; ULPGC predoctoral program; ACIISI; Programa de Ayudas a la Investigacion de la ULPGC; ACIISI; FEDER Funds(European Commission); ProjektDEAL	We are grateful to Dr. Jongkyeong Chung and the Bloomington Drosophila Stock Center for providing fly stocks. Research at the NP lab is supported by the University of Valencia (Programa de Acciones Especiales de Investigacion, UV-INV-AE-1553209). SMD is supported by the "Viera y Clavijo" Program from the Agencia Canaria de Investigacion, Innovacion y Sociedad de la Informacion (ACIISI) and the ULPGC and JLG by the ULPGC predoctoral program. Research at the SMD lab is supported by the ACIISI (CEI2019-02), Programa de Ayudas a la Investigacion de la ULPGC, and ACIISI co-funded by FEDER Funds (ProID2020010013). Open access funding enabled and organized by ProjektDEAL.	Afentou N, 2019, MOV DISORD CLIN PRAC, V6, P282, DOI 10.1002/mdc3.12755; Alvarez-Rendon JP, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/1417528; Ambacher KK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046885; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Anandhan A, 2017, BRAIN RES BULL, V133, P12, DOI 10.1016/j.brainresbull.2017.03.009; Ariga H, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/683920; Ashcroft FM, 2017, CELL METAB, V26, P17, DOI 10.1016/j.cmet.2017.05.014; Athauda D, 2016, PARKINSONISM RELAT D, V32, P1, DOI 10.1016/j.parkreldis.2016.07.019; Bandres-Ciga S, 2020, NEUROBIOL DIS, V137, DOI 10.1016/j.nbd.2020.104782; Birse RT, 2010, CELL METAB, V12, P533, DOI 10.1016/j.cmet.2010.09.014; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Cao J, 2014, GENETICS, V197, P175, DOI 10.1534/genetics.113.160663; Casani S, 2013, FREE RADICAL BIO MED, V61, P151, DOI 10.1016/j.freeradbiomed.2013.03.021; Chai C, 2013, CURR GENOMICS, V14, P486, DOI 10.2174/1389202914666131210195808; Cheong JLY, 2020, J PARKINSON DIS, V10, P775, DOI 10.3233/JPD-191900; Cho SJ, 2019, BIOMOL THER, V27, P85, DOI 10.4062/biomolther.2018.202; Coulom H, 2004, J NEUROSCI, V24, P10993, DOI 10.1523/JNEUROSCI.2993-04.2004; Figlewicz DP, 1996, BRAIN RES, V736, P54, DOI 10.1016/S0006-8993(96)00727-5; Fiory F, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00868; Foray V, 2012, PHYSIOL ENTOMOL, V37, P295, DOI 10.1111/j.1365-3032.2012.00831.x; Galikova M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19071896; Gallegos S, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00059; Gonzalez-Rodriguez P, 2021, NATURE, V599, P650, DOI 10.1038/s41586-021-04059-0; Graham P, 2017, CURR TOP DEV BIOL, V121, P397, DOI 10.1016/bs.ctdb.2016.07.011; Han J, 2021, FRONT NUTR, V7, DOI 10.3389/fnut.2020.591161; Hassan A, 2020, CUREUS, V12, DOI 10.7759/cureus.9853; Hong CT, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9030740; Jain D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138535; Jain D, 2012, J MOL CELL BIOL, V4, P221, DOI 10.1093/jmcb/mjs025; Jang Y, 2017, EXP NEUROBIOL, V26, P104, DOI 10.5607/en.2017.26.2.104; Sanz FJ, 2017, FREE RADICAL BIO MED, V108, P683, DOI 10.1016/j.freeradbiomed.2017.04.364; Khan MAB, 2020, J EPIDEMIOL GLOB HEA, V10, P107, DOI 10.2991/jegh.k.191028.001; Kudryavtseva AV, 2016, ONCOTARGET, V7, P44879, DOI 10.18632/oncotarget.9821; Lavara-Culebras E, 2010, GENE, V462, P26, DOI 10.1016/j.gene.2010.04.009; Lavara-Culebras E, 2007, GENE, V400, P158, DOI 10.1016/j.gene.2007.06.013; Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002; Liguori F, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms222011295; Lilao-Garzon J, 2021, ADV EXP MED BIOL, V1307, P553, DOI 10.1007/5584_2020_536; Lu M, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyw047; Maiti P, 2017, TRANSL NEURODEGENER, V6, DOI 10.1186/s40035-017-0099-z; Matsumoto Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018292; McGurk L, 2015, GENETICS, V201, P377, DOI 10.1534/genetics.115.179457; Mencke P, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10020347; Meulener M, 2005, CURR BIOL, V15, P1572, DOI 10.1016/j.cub.2005.07.064; Molina-Mateo D, 2017, BBA-MOL BASIS DIS, V1863, P2882, DOI 10.1016/j.bbadis.2017.07.013; Mor DE, 2020, P NATL ACAD SCI USA, V117, P26438, DOI 10.1073/pnas.2009838117; Morris SNS, 2012, BBA-MOL BASIS DIS, V1822, P1230, DOI 10.1016/j.bbadis.2012.04.012; Munoz-Soriano V, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/520640; Murillo-Maldonado JM, 2011, DIABETES, V60, P1632, DOI 10.2337/db10-1288; Navarro JA, 2014, J NEUROCHEM, V131, P369, DOI 10.1111/jnc.12818; Park J, 2005, GENE, V361, P133, DOI 10.1016/j.gene.2005.06.040; Pasco MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036583; Paudel YN, 2020, PHARMACOL RES, V152, DOI 10.1016/j.phrs.2019.104593; Renaud J, 2018, NEUROBIOL AGING, V69, P117, DOI 10.1016/j.neurobiolaging.2018.05.010; Renaud J, 2014, NEUROTOX RES, V25, P110, DOI 10.1007/s12640-013-9439-7; Requejo-Aguilar R, 2015, BIOCHEM J, V467, P303, DOI 10.1042/BJ20141025; Rocha KMA., 2021, RES SOC DEV, V10, DOI [10.33448/rsd-v10i1.11673, DOI 10.33448/RSD-V10I1.11673]; Rose SJ, 2017, MOVEMENT DISORD, V32, P1694, DOI 10.1002/mds.27169; Sanz FJ., 2021, NEUROTHERAPEUTICS, V2021, P1; Sharma T, 2021, NEUROSCI LETT, V749, DOI 10.1016/j.neulet.2021.135754; Solana-Manrique Cristina, 2022, Cells, V11, DOI 10.3390/cells11030331; Solana-Manrique C, 2020, FREE RADICAL BIO MED, V158, P137, DOI 10.1016/j.freeradbiomed.2020.06.036; Sonninen TM, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71329-8; Standl E, 2019, EUR J PREV CARDIOL, V26, P7, DOI 10.1177/2047487319881021; Strobbe D, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00068; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; Teleman AA, 2012, EXP CLIN ENDOCR DIAB, V120, P184, DOI 10.1055/s-0032-1304566; Tysnes OB, 2017, J NEURAL TRANSM, V124, P901, DOI 10.1007/s00702-017-1686-y; Wu R, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2016.54; Xiong YL, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00228; Yasugi T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01754-9; Zhang XL, 2019, BRAIN RES BULL, V146, P228, DOI 10.1016/j.brainresbull.2019.01.007; Zhang Y, 2021, BMJ OPEN DIAB RES CA, V9, DOI 10.1136/bmjdrc-2021-002337	73	1	1	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2022	36	8							e22432	10.1096/fj.202200286R	http://dx.doi.org/10.1096/fj.202200286R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2M8OV	35766235	Green Published			2022-12-26	WOS:000817953200001
J	Pan, D; Yang, WW; Zeng, Y; Qin, HK; Xu, YT; Gui, YP; Fan, XS; Tian, G; Wu, YJ; Sun, HP; Ye, YT; Yang, SH; Zhou, JY; Guo, QL; Zhao, L				Pan, Di; Yang, Wanwan; Zeng, Yao; Qin, Hongkun; Xu, Yuting; Gui, Yanping; Fan, Xiangshan; Tian, Geng; Wu, Yujia; Sun, Haopeng; Ye, Yuting; Yang, Shihe; Zhou, Jieying; Guo, Qinglong; Zhao, Li			AKR1C3 regulated by NRF2/MAFG complex promotes proliferation via stabilizing PARP1 in hepatocellular carcinoma	ONCOGENE			English	Article							KETO REDUCTASE 1C3	Aldo-keto reductase family 1 member C3 (AKR1C3) serves as a contributor to numerous kinds of tumors, and its expression is elevated in patients with hepatocellular carcinoma (HCC). However, the biological function of AKR1C3 in HCC remains unclear. Here we investigated the role of AKR1C3 in liver carcinogenesis using in vitro and in vivo models. We determined that AKR1C3 is frequently increased in HCC tissues with poor prognosis. Genetically manipulated cells with AKR1C3 construction were examined to highlight the pro-tumoral growth of both wild-type AKR1C3 and mutant in vitro and in vivo. We observed promising treatment effects of AKR1C3 shRNA by intratumoral injection in mice. Mechanically, we demonstrated that the transcription factor heterodimer NRF2/MAFG was able to bind directly to AKR1C3 promoter to activate its transcription. Further, AKR1C3 stabilized PARP1 by decreasing its ubiquitination, which resulted in HCC cell proliferation and low sensitivity of Cisplatin. Moreover, we discovered that the tumorigenic role of AKR1C3 was non-catalytic dependent and the NRF2/MAFG-AKR1C3-PARP1 axis might be one of the important proliferation pathways in HCC. In conclusion, blockage of AKR1C3 expression provides potential therapeutic benefits against HCC.	[Pan, Di; Yang, Wanwan; Zeng, Yao; Qin, Hongkun; Xu, Yuting; Gui, Yanping; Tian, Geng; Wu, Yujia; Ye, Yuting; Yang, Shihe; Guo, Qinglong; Zhao, Li] China Pharmaceut Univ, Sch Basic Med & Clin Pharm, Dept Physiol, Nanjing 211198, Jiangsu, Peoples R China; [Pan, Di] Guizhou Med Univ, Sch Pharmaceut Sci, Key Lab Optimal Utilizat Nat Med Resources, Guiyang 550025, Guizhou, Peoples R China; [Fan, Xiangshan] Nanjing Univ, Sch Med, Dept Pathol, Nanjing Drum Tower Hosp, Nanjing 210000, Jiangsu, Peoples R China; [Sun, Haopeng] China Pharmaceut Univ, Dept Pharm, Nanjing 211198, Jiangsu, Peoples R China; [Zhou, Jieying] Florida Int Univ, Dept Chem & Biochem, Miami, FL 33199 USA; [Guo, Qinglong] China Pharmaceut Univ, Jiangsu Key Lab Carcinogenesis & Intervent, Nanjing 210009, Jiangsu, Peoples R China	China Pharmaceutical University; Guizhou Medical University; Nanjing University; China Pharmaceutical University; State University System of Florida; Florida International University; China Pharmaceutical University	Guo, QL; Zhao, L (corresponding author), China Pharmaceut Univ, Sch Basic Med & Clin Pharm, Dept Physiol, Nanjing 211198, Jiangsu, Peoples R China.; Guo, QL (corresponding author), China Pharmaceut Univ, Jiangsu Key Lab Carcinogenesis & Intervent, Nanjing 210009, Jiangsu, Peoples R China.	anticancer_drug@163.com; zhaoli@cpu.edu.cn	yang, wanwan/GZM-4650-2022	Tian, Geng/0000-0001-6320-6346; wu, wu yu jia/0000-0001-9542-273X; fan, xiangshan/0000-0003-4552-5858	Key Program of the National Science Foundation of China [81830105]; National Science Foundation of China [81773774]	Key Program of the National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Key Program of the National Science Foundation of China (81830105); the program of the National Science Foundation of China (81773774).	Bortolozzi R, 2018, BRIT J CANCER, V118, P985, DOI 10.1038/s41416-018-0014-0; Cao CG, 2020, J MED CHEM, V63, P11012, DOI 10.1021/acs.jmedchem.0c00821; Chaudhuri AR, 2017, NAT REV MOL CELL BIO, V18, P610, DOI 10.1038/nrm.2017.53; Curtin NJ, 2020, NAT REV DRUG DISCOV, V19, P711, DOI 10.1038/s41573-020-0076-6; Dong QZ, 2019, CANCER RES, V79, P819, DOI 10.1158/0008-5472.CAN-18-1273; Feng M, 2020, INNOVATION-AMSTERDAM, V1, DOI 10.1016/j.xinn.2020.100032; Gatti M, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.107985; Hirotsu Y, 2012, NUCLEIC ACIDS RES, V40, P10228, DOI 10.1093/nar/gks827; Hu ZH, 2021, ONCOGENE, V40, P647, DOI 10.1038/s41388-020-01551-1; Jackson VJ, 2012, ACTA CRYSTALLOGR F, V68, P409, DOI 10.1107/S1744309112009049; Katsuoka F, 2016, GENE, V586, P197, DOI 10.1016/j.gene.2016.03.058; Kim SY, 2021, ONCOGENE, V40, P4652, DOI 10.1038/s41388-021-01875-6; Ko HL, 2011, HEPATOLOGY, V54, P1190, DOI 10.1002/hep.24502; Rizner TL, 2020, PHARMACOL RES, V152, DOI 10.1016/j.phrs.2019.104446; Liu Y, 2020, J MED CHEM, V63, P11305, DOI 10.1021/acs.jmedchem.9b02138; Llovet JM, 2021, NAT REV DIS PRIMERS, V7, DOI 10.1038/s41572-020-00240-3; Mantel A, 2012, J INVEST DERMATOL, V132, P1103, DOI 10.1038/jid.2011.412; Matsunaga T, 2020, CHEM-BIOL INTERACT, V332, DOI 10.1016/j.cbi.2020.109295; Noordermeer SM, 2019, TRENDS CELL BIOL, V29, P820, DOI 10.1016/j.tcb.2019.07.008; Penning TM, 2019, ENDOCR REV, V40, P447, DOI 10.1210/er.2018-00089; Penning TM, 2019, MOL CELL ENDOCRINOL, V489, P82, DOI 10.1016/j.mce.2018.07.002; Penning TM, 2017, EXPERT OPIN THER PAT, V27, P1329, DOI 10.1080/13543776.2017.1379503; Penning TM, 2015, CHEM-BIOL INTERACT, V234, P236, DOI 10.1016/j.cbi.2014.09.024; Powell K, 2015, CLIN CANCER RES, V21, P2569, DOI 10.1158/1078-0432.CCR-14-2352; Rheinbay E, 2020, NATURE, V578, P102, DOI 10.1038/s41586-020-1965-x; Ricciotti E, 2021, CANCER RES, V81, P3751, DOI 10.1158/0008-5472.CAN-21-0758; Tang ZF, 2019, NUCLEIC ACIDS RES, V47, pW556, DOI 10.1093/nar/gkz430; Vallim TQD, 2015, CELL METAB, V21, P298, DOI 10.1016/j.cmet.2015.01.007; Velica P, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-121; Vera-Puente O, 2018, TRANSL RES, V200, P1, DOI 10.1016/j.trsl.2018.06.005; Wu T, 2014, FREE RADICAL BIO MED, V67, P69, DOI 10.1016/j.freeradbiomed.2013.10.806; Xie L, 2013, CANCER GENE THER, V20, P260, DOI 10.1038/cgt.2013.15; Zeng CM, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00119; Zhang L, 2019, NUCLEIC ACIDS RES, V47, P8502, DOI 10.1093/nar/gkz545; Zhao QY, 2019, CHEM COMMUN, V55, P369, DOI 10.1039/c8cc07813k; Zhao SF, 2019, ONCOL LETT, V18, P4515, DOI 10.3892/ol.2019.10802; Zhou QQ, 2021, CANCER RES, V81, P1361, DOI 10.1158/0008-5472.CAN-20-2480	37	1	1	9	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 29	2022	41	31					3846	3858		10.1038/s41388-022-02379-7	http://dx.doi.org/10.1038/s41388-022-02379-7		JUN 2022	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	3I9OZ	35773412				2022-12-26	WOS:000819316500001
J	Kinnebrew, E; Ochoa-Brito, JI; French, M; Mills-Novoa, M; Shoffner, E; Siegel, K				Kinnebrew, Eva; Ochoa-Brito, Jose I.; French, Matthew; Mills-Novoa, Megan; Shoffner, Elizabeth; Siegel, Katherine			Biases and limitations of Global Forest Change and author-generated land cover maps in detecting deforestation in the Amazon	PLOS ONE			English	Article							MADRE-DE-DIOS; ACCURACY ASSESSMENT; PROTECTED AREAS; TROPICAL FOREST; BUFFER ZONES; CONVERSION; FRONTIERS; DYNAMICS; DRIVERS; IMPACT	Studying land use change in protected areas (PAs) located in tropical forests is a major conservation priority due to high conservation value (e.g., species richness and carbon storage) here, coupled with generally high deforestation rates. Land use change researchers use a variety of land cover products to track deforestation trends, including maps they produce themselves and readily available products, such as the Global Forest Change (GFC) dataset. However, all land cover maps should be critically assessed for limitations and biases to accurately communicate and interpret results. In this study, we assess deforestation in PA complexes located in agricultural frontiers in the Amazon Basin. We studied three specific sites: Amboro and Carrasco National Parks in Bolivia, Jamanxim National Forest in Brazil, and Tambopata National Reserve and Bahuaja-Sonene National Park in Peru. Within and in 20km buffer areas around each complex, we generated land cover maps using composites of Landsat imagery and supervised classification, and compared deforestation trends to data from the GFC dataset. We then performed a dissimilarity analysis to explore the discrepancies between the two remote sensing products. Both the GFC and our supervised classification showed that deforestation rates were higher in the 20km buffer than inside the PAs and that Jamanxim National Forest had the highest deforestation rate of the PAs we studied. However, GFC maps showed consistently higher rates of deforestation than our maps. Through a dissimilarity analysis, we found that many of the inconsistencies between these datasets arise from different treatment of mixed pixels or different parameters in map creation (for example, GFC does not detect reforestation after 2012). We found that our maps underestimated deforestation while GFC overestimated deforestation, and that true deforestation rates likely fall between our two estimates. We encourage users to consider limitations and biases when using or interpreting our maps, which we make publicly available, and GFC's maps.	[Kinnebrew, Eva] Colorado State Univ, Dept Ecosyst Sci & Sustainabil, Ft Collins, CO 80523 USA; [Ochoa-Brito, Jose I.] Univ Calif Davis, Geog Grad Grp, Davis, CA USA; [Ochoa-Brito, Jose I.] Fdn EcoCiencia, Quito, Ecuador; [French, Matthew; Mills-Novoa, Megan] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA USA; [Mills-Novoa, Megan] Univ Calif Berkeley, Energy & Resources Grp, Berkeley, CA USA; [Shoffner, Elizabeth] Univ Washington, Dept Geog, Seattle, WA USA; [Siegel, Katherine] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO USA	Colorado State University; University of California System; University of California Davis; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Washington; University of Washington Seattle; University of Colorado System; University of Colorado Boulder	Kinnebrew, E (corresponding author), Colorado State Univ, Dept Ecosyst Sci & Sustainabil, Ft Collins, CO 80523 USA.	ekinnebr@uvm.edu		Kinnebrew, Eva/0000-0003-4766-5491	National Socio-Environmental Synthesis Center (SESYNC); National Science Foundation [DBI-1639145]	National Socio-Environmental Synthesis Center (SESYNC)(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Socio-Environmental Synthesis Center (SESYNC) under funding received from the National Science Foundation DBI-1639145 (EK, KS, MMN, ES, JOB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apan A, 2017, APPL GEOGR, V81, P32, DOI 10.1016/j.apgeog.2017.02.007; Asner GP, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa7dab; Asner GP, 2013, P NATL ACAD SCI USA, V110, P18454, DOI 10.1073/pnas.1318271110; Belgiu M, 2016, ISPRS J PHOTOGRAMM, V114, P24, DOI 10.1016/j.isprsjprs.2016.01.011; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman Leo, 2018, PACKAGE RANDOMFOREST; Brunson J.C., 2020, J OPEN SOURCE SOFTW, V5, P2017, DOI DOI 10.21105/JOSS.02017; Bullock EL, 2020, GLOBAL CHANGE BIOL, V26, P2956, DOI 10.1111/gcb.15029; Cabral AIR, 2018, APPL GEOGR, V100, P101, DOI 10.1016/j.apgeog.2018.10.003; Orihuela JC, 2017, FOREST POLICY ECON, V80, P52, DOI 10.1016/j.forpol.2017.03.010; Congalton RG, 2014, REMOTE SENS-BASEL, V6, P12070, DOI 10.3390/rs61212070; Roriz PAC, 2017, ENVIRON MANAGE, V60, P367, DOI 10.1007/s00267-017-0879-3; Cracknell AP, 1998, INT J REMOTE SENS, V19, P2025, DOI 10.1080/014311698214848; Cunningham D, 2019, FORESTS, V10, DOI 10.3390/f10100853; Curtis PG, 2018, SCIENCE, V361, P1108, DOI 10.1126/science.aau3445; De Marques AAB, 2015, ORYX, V49, P25, DOI 10.1017/S0030605314000726; Elias P., 2013, NAT CONSERV, V342, P850; Elmes A, 2014, REMOTE SENS LETT, V5, P882, DOI 10.1080/2150704X.2014.973080; Ewers RM, 2008, TRENDS ECOL EVOL, V23, P113, DOI 10.1016/j.tree.2007.11.008; Foga S, 2017, REMOTE SENS ENVIRON, V194, P379, DOI 10.1016/j.rse.2017.03.026; Friedl MA, 2002, REMOTE SENS ENVIRON, V83, P287, DOI 10.1016/S0034-4257(02)00078-0; Galiatsatos N, 2020, REMOTE SENS-BASEL, V12, DOI 10.3390/rs12111790; Gan LQ, 2019, INT GEOSCI REMOTE SE, P6302, DOI 10.1109/IGARSS.2019.8898641; Gaveau DLA, 2009, J BIOGEOGR, V36, P2165, DOI 10.1111/j.1365-2699.2009.02147.x; Giri C, 2005, REMOTE SENS ENVIRON, V94, P123, DOI 10.1016/j.rse.2004.09.005; Global Forest Watch, GLOB FOR WATCH; Gorelick N, 2017, REMOTE SENS ENVIRON, V202, P18, DOI 10.1016/j.rse.2017.06.031; Hansen M, 2014, SCIENCE, V344, DOI 10.1126/science.1248817; Hansen MC, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aax8574; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Heinrich VHA, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22050-1; Hengl T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169748; Joppa LN, 2011, P ROY SOC B-BIOL SCI, V278, P1633, DOI 10.1098/rspb.2010.1713; Joshi AR, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501675; Killeen TJ, 2007, AMBIO, V36, P600, DOI 10.1579/0044-7447(2007)36[600:TYOLCI]2.0.CO;2; Koltunov A, 2009, REMOTE SENS ENVIRON, V113, P2431, DOI 10.1016/j.rse.2009.07.005; Leroux SJ, 2013, CONSERV BIOL, V27, P166, DOI 10.1111/j.1523-1739.2012.01953.x; Linke J, 2017, REMOTE SENS ENVIRON, V188, P164, DOI 10.1016/j.rse.2016.10.040; LIU HQ, 1995, IEEE T GEOSCI REMOTE, V33, P457, DOI 10.1109/36.377946; Lui GV, 2016, ENVIRON RES, V147, P580, DOI 10.1016/j.envres.2015.11.008; Malhi Y, 2000, TRENDS ECOL EVOL, V15, P332, DOI 10.1016/S0169-5347(00)01906-6; Milodowski DT, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa7e1e; Molinaro CA., 2018, CASO FLORESTA NACL J; Muller R, 2012, REG ENVIRON CHANGE, V12, P445, DOI 10.1007/s10113-011-0259-0; Novotny R., 2010, Journal of Forest Science (Prague), V56, P381, DOI 10.17221/87/2009-JFS; Perez-Hoyos A, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9111118; Pinheiro TF, 2016, EARTH INTERACT, V20, DOI 10.1175/EI-D-15-0016.1; Planet Team, 2019, PLANET APPL PROGRAM; Pontius J., 2019, PACKAGE DIFFER METRI; Pontius RG, 2011, INT J REMOTE SENS, V32, P4407, DOI 10.1080/01431161.2011.552923; Powell RL, 2004, REMOTE SENS ENVIRON, V90, P221, DOI 10.1016/j.rse.2003.12.007; Sangermano F, 2012, LANDSCAPE ECOL, V27, P571, DOI 10.1007/s10980-012-9710-y; Sannier C, 2016, REMOTE SENS ENVIRON, V173, P326, DOI 10.1016/j.rse.2015.10.032; Schielein J, 2018, LAND USE POLICY, V76, P81, DOI 10.1016/j.landusepol.2018.04.052; Scullion JJ, 2014, BIOL CONSERV, V171, P247, DOI 10.1016/j.biocon.2014.01.036; Silva CHL, 2021, NAT ECOL EVOL, V5, P144, DOI 10.1038/s41559-020-01368-x; Silva CHL, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-00600-4; Silveira EMO, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10060808; Spracklen BD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143886; STORY M, 1986, PHOTOGRAMM ENG REM S, V52, P397; Swann ALS, 2015, AGR FOREST METEOROL, V214, P12, DOI 10.1016/j.agrformet.2015.07.006; Tropek R, 2014, SCIENCE, V344, DOI 10.1126/science.1248753; Tyukavina A, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601047; U.S. Geological Survey, LANDSAT 8 OLI; U.S. Geological Survey, LANDS 5 TM; U.S. Geological Survey, LANDS 7 ETM; UNEP-WCMC and IUCN, 2020, PROT PLAN WORLD DAT; van Gils HAMJ, 2006, AMBIO, V35, P81, DOI 10.1579/0044-7447(2006)35[81:WDCOTF]2.0.CO;2; van Vliet N, 2012, GLOBAL ENVIRON CHANG, V22, P418, DOI 10.1016/j.gloenvcha.2011.10.009; Verbesselt J, 2010, REMOTE SENS ENVIRON, V114, P106, DOI 10.1016/j.rse.2009.08.014; Weisse MJ, 2016, ENVIRON MANAGE, V58, P297, DOI 10.1007/s00267-016-0709-z; Yang YK, 2017, ISPRS J PHOTOGRAMM, V125, P156, DOI 10.1016/j.isprsjprs.2017.01.016	72	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7								10.1371/journal.pone.0268970	http://dx.doi.org/10.1371/journal.pone.0268970			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M3CI	35793333	gold, Green Published			2022-12-26	WOS:000835338100042
J	Tarry, H; Vezina, V; Bailey, J; Lopes, L				Tarry, Hammond; Vezina, Valerie; Bailey, Jacob; Lopes, Leah			Political orientation, moral foundations, and COVID-19 social distancing	PLOS ONE			English	Article								During the COVID-19 pandemic, governments have advocated numerous social distancing measures, and compliance with these has likely saved millions of lives globally. In an online sample drawn from the U.S. and Canada (N = 209), participants completed measures of political orientation, moral foundations, and COVID-19 social distancing attitudes and behaviours. A more left-wing political orientation, and greater endorsement of the individualizing moral foundations were significantly related to more positive social distancing attitudes, and greater self-reported compliance with relevant restrictions. A more right-wing political orientation, and greater endorsement of the binding and economic liberty foundations were associated with less positive attitudes and reduced compliance. In a series of mediation analyses, the relationships between political orientation and various social distancing measures were significantly mediated by variations in participants' moral foundations, particularly their endorsement of economic liberty and the individualizing foundations. Further data indicated that the perceived persuasiveness of messages based on each moral foundation advocating for continued social distancing was significantly related to both participants' moral values and their political orientation. Findings are discussed in terms of understanding politicized differences around social distancing as partly reflecting differential valuation of the moral foundations, and in creating effective public health messaging regarding compliance.	[Tarry, Hammond] Kwantlen Polytech Univ, Dept Psychol, Surrey, BC, Canada; [Vezina, Valerie] Kwantlen Polytech Univ, Dept Polit Sci, Surrey, BC, Canada; [Bailey, Jacob; Lopes, Leah] Kwantlen Polytech Univ, Surrey, BC, Canada		Tarry, H (corresponding author), Kwantlen Polytech Univ, Dept Psychol, Surrey, BC, Canada.	hammond.tarry@kpu.ca			Kwantlen Polytechnic University	Kwantlen Polytechnic University	Funding: For this study, HT and VV received a $8500CDN Faculty of Arts Excellence and Advancement Fund (FAEAF) grant from Kwantlen Polytechnic University, www.kpu.ca. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Abouk R, 2021, PUBLIC HEALTH REP, V136, P245, DOI 10.1177/0033354920976575; Amin AB, 2017, NAT HUM BEHAV, V1, P873, DOI 10.1038/s41562-017-0256-5; An L, 2021, PATIENT EDUC COUNS, V104, P1451, DOI 10.1016/j.pec.2020.11.027; Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5; Angus Reid Institute, 2020, COVID 19 COMPL ONE I; Anson IG, 2018, RES POLITICS, V5, DOI 10.1177/2053168018785483; Barrios JM, 2020, NATL BUREAU EC RES, DOI [10.3386/w27008, DOI 10.3386/W27008]; Berinsky AJ, 1999, AM J POLIT SCI, V43, P1209, DOI 10.2307/2991824; Bertrand M, 2001, AM ECON REV, V91, P67, DOI 10.1257/aer.91.2.67; Byrd N, 2021, COGNITION, V212, DOI 10.1016/j.cognition.2021.104649; CACIOPPO JT, 1983, J PERS SOC PSYCHOL, V45, P805, DOI 10.1037/0022-3514.45.4.805; CDC, 2020, COR DIS 2019 COVID 1; Centers for Disease Control and Prevention, 2022, COR DIS 2019 COVID 1; Chan EY, 2021, PERS INDIV DIFFER, V171, DOI 10.1016/j.paid.2020.110463; Chang L, 2009, PUBLIC OPIN QUART, V73, P641, DOI 10.1093/poq/nfp075; Christensen SR, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239693; Connors M, 2021, ANN INTERN MED, V174, P687, DOI 10.7326/M21-0111; Coroiu A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239795; Courtemanche C, 2020, HEALTH AFFAIR, V39, P1237, DOI 10.1377/hlthaff.2020.00608; Danchin A, 2020, ENVIRON MICROBIOL, V22, P2001, DOI 10.1111/1462-2920.15053; De Neys W., PREPRINT; Dehgani M, 2019, MORAL FDN DICT LINGU, DOI [10.17605/OSF.IO/EZN37, DOI 10.17605/OSF.IO/EZN37]; Diaz R, 2022, COGNITION EMOTION, V36, P120, DOI 10.1080/02699931.2021.1941783; Dickinson JL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163852; Duquette N., 2020, HEARD IMMUNITY EFFEC, DOI 10.2139/ssrn.3705504; Ekins E., 2020, POLL 62 AM SAY THEY; Emma Stuart, 2018, Arxiv, DOI arXiv:1810.08091; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Federico CM, 2013, POLIT PSYCHOL, V34, P589, DOI 10.1111/pops.12006; Feinberg M, 2019, SOC PERSONAL PSYCHOL, DOI 10.1111/spc3.12501; Feinberg M, 2015, PERS SOC PSYCHOL B, V41, P1665, DOI 10.1177/0146167215607842; Fernandez T.L., 2016, SCH ENG ED GRADUATE, DOI [10.18260/p.25751, DOI 10.18260/P.25751]; Field A.P., 2020, DISCOVERING STAT USI, V4th; Fontanet A, 2020, NAT REV IMMUNOL, V20, P583, DOI 10.1038/s41577-020-00451-5; Freeman D, 2022, PSYCHOL MED, V52, P251, DOI 10.1017/S0033291720001890; Fridman A, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0250123; Giroux M.E., HINDSIGHT BIAS COVID; Glogowsky U, 2020, ECONSTOR, DOI 10.2139/ssrn.3619845; Gollwitzer A, 2020, NAT HUM BEHAV, V4, P1186, DOI 10.1038/s41562-020-00977-7; Google, 2020, COVID 19 COMM MOB RE; Graham A., 2020, SOCIUS, V6, P1, DOI [10.1177/2378023120956815, DOI 10.1177/2378023120956815]; Graham J, 2011, J PERS SOC PSYCHOL, V101, P366, DOI 10.1037/a0021847; Graham J, 2009, J PERS SOC PSYCHOL, V96, P1029, DOI 10.1037/a0015141; Haidt J, 2004, DAEDALUS-US, V133, P55, DOI 10.1162/0011526042365555; Haidt J, 2010, PERSPECT PSYCHOL SCI, V5, P182, DOI 10.1177/1745691610362352; Hanel PHP, 2019, J PERS SOC PSYCHOL, V116, P541, DOI 10.1037/pspi0000154; Harper C. A, REANALYZING FACTOR S, DOI [10.31234/osf.io/p5fj8, DOI 10.31234/OSF.IO/P5FJ8]; Harper CA, 2021, INT J MENT HEALTH AD, V19, P1875, DOI 10.1007/s11469-020-00281-5; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Hopkins Johns., 2021, COVID 19 MAP; Horwell C., 2020, SHOULD WE WEAR FAC M; Iyer R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042366; Kai W, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241743; Kosinski M, 2015, AM PSYCHOL, V70, P543, DOI 10.1037/a0039210; Lazarus JV, 2020, NAT MED, V26, P1005, DOI 10.1038/s41591-020-0950-0; Lewnard JA, 2020, LANCET INFECT DIS, V20, P631, DOI 10.1016/S1473-3099(20)30190-0; Luttrell A, 2021, SOC PSYCHOL PERS SCI, V12, P946, DOI 10.1177/1948550620947853; Ambrose JM, 2021, ANTIBIOTICS-BASEL, V10, DOI 10.3390/antibiotics10050535; Marinthe G, 2020, BRIT J HEALTH PSYCH, V25, P957, DOI 10.1111/bjhp.12449; Matthews G, 2017, J PUBLIC HEALTH MAN, V23, P420, DOI 10.1097/PHH.0000000000000610; Norman P, 2020, BRIT J HEALTH PSYCH, V25, P1006, DOI 10.1111/bjhp.12474; Ontario Hospital Association, 2020, COMMUNICATIONS MEDIA; Pagliaro S, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248334; Pennycook G, 2020, PSYCHOL SCI, V31, P770, DOI 10.1177/0956797620939054; Pickup M, 2020, CAN J POLIT SCI, V53, P357, DOI 10.1017/S0008423920000463; Pink S., PREPRINT; Pivetti M, 2021, J PAC RIM PSYCHOL, V15, DOI 10.1177/18344909211039893; Plohl N, 2021, PSYCHOL HEALTH MED, V26, P1, DOI 10.1080/13548506.2020.1772988; Price G, 2021, SOC SCI QUART, V102, P2331, DOI 10.1111/ssqu.12988; Qian K, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235883; Rockey J., 2009, WHO IS LEFT WING WHO; Saez M, 2020, SCI TOTAL ENVIRON, V727, DOI 10.1016/j.scitotenv.2020.138761; Shahzad F, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18030896; Shatz I, 2017, SOC SCI COMPUT REV, V35, P537, DOI 10.1177/0894439316650163; Sheikh A, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.010348; Silver E, 2021, DEVIANT BEHAV, V42, P366, DOI 10.1080/01639625.2019.1678580; Stolerman D, 2020, POLIT PSYCHOL, V41, P439, DOI 10.1111/pops.12539; Strimling P, 2019, NAT HUM BEHAV, V3, P922, DOI 10.1038/s41562-019-0647-x; van Leeuwen F, 2012, EVOL HUM BEHAV, V33, P429, DOI 10.1016/j.evolhumbehav.2011.12.005; Wang DN, 2021, SOC WORK HEALTH CARE, V60, P240, DOI 10.1080/00981389.2020.1871157; Waytz A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12227-0; Weinberg JD, 2014, SOCIOL SCI, V1, P292, DOI 10.15195/v1.a19; Westfall J, 2015, PERSPECT PSYCHOL SCI, V10, P145, DOI 10.1177/1745691615569849; WHO, 2022, TRACKING SARS COV 2; Zaller JohnR., 1992, NATURE ORIGINS MASS	85	1	1	6	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	6							e0267136	10.1371/journal.pone.0267136	http://dx.doi.org/10.1371/journal.pone.0267136			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3F0KH	35749535	Green Published			2022-12-26	WOS:000830362700067
J	Daniele, LL; Han, JYS; Samuels, IS; Komirisetty, R; Mehta, N; McCord, JL; Yu, MZ; Wang, YK; Boesze-Battaglia, K; Bell, BA; Du, JH; Peachey, NS; Philp, NJ				Daniele, Lauren L.; Han, John Y. S.; Samuels, Ivy S.; Komirisetty, Ravikiran; Mehta, Nikhil; McCord, Jessica L.; Yu, Minzhong; Wang, Yekai; Boesze-Battaglia, Kathleen; Bell, Brent A.; Du, Jianhai; Peachey, Neal S.; Philp, Nancy J.			Glucose uptake by GLUT1 in photoreceptors is essential for outer segment renewal and rod photoreceptor survival	FASEB JOURNAL			English	Article						glucose depervation; GLUT1; photoreceptors; retina; rhodopsin; Slc2a1	TARGETED DISRUPTION; PROLINE OXIDASE; HOMEOBOX GENE; CONE DEATH; CELL FATE; METABOLISM; RHODOPSIN; RETINA; EXPRESSION; PIGMENT	Photoreceptors consume glucose supplied by the choriocapillaris to support phototransduction and outer segment (OS) renewal. Reduced glucose supply underlies photoreceptor cell death in inherited retinal degeneration and age-related retinal disease. We have previously shown that restricting glucose transport into the outer retina by conditional deletion of Slc2a1 encoding GLUT1 resulted in photoreceptor loss and impaired OS renewal. However, retinal neurons, glia, and the retinal pigment epithelium play specialized, synergistic roles in metabolite supply and exchange, and the cell-specific map of glucose uptake and utilization in the retina is incomplete. In these studies, we conditionally deleted Slc2a1 in a pan-retinal or rod-specific manner to better understand how glucose is utilized in the retina. Using non-invasive ocular imaging, electroretinography, and histochemical and biochemical analyses we show that genetic deletion of Slc2a1 from retinal neurons and Muller glia results in reduced OS growth and progressive rod but not cone photoreceptor cell death. Rhodopsin levels were severely decreased even at postnatal day 20 when OS length was relatively normal. Arrestin levels were not changed suggesting that glucose uptake is required to synthesize membrane glycoproteins. Rod-specific deletion of Slc2a1 resulted in similar changes in OS length and rod photoreceptor cell death. These studies demonstrate that glucose is an essential carbon source for rod photoreceptor cell OS maintenance and viability.	[Daniele, Lauren L.; Han, John Y. S.; Komirisetty, Ravikiran; Mehta, Nikhil; McCord, Jessica L.; Philp, Nancy J.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, 1020 Locust St, Philadelphia, PA 19107 USA; [Samuels, Ivy S.; Yu, Minzhong; Peachey, Neal S.] Cleveland Clin, Cole Eye Inst, Cleveland, OH 44106 USA; [Samuels, Ivy S.; Peachey, Neal S.] Louis Stokes Cleveland VA Med Ctr, Cleveland, OH USA; [Yu, Minzhong; Peachey, Neal S.] Case Western Reserve Univ, Dept Ophthalmol, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA; [Wang, Yekai; Du, Jianhai] West Virginia Univ, Dept Ophthalmol & Visual Sci, Morgantown, WV 26506 USA; [Wang, Yekai; Du, Jianhai] West Virginia Univ, Dept Biochem, Morgantown, WV 26506 USA; [Boesze-Battaglia, Kathleen] Univ Penn, Dept Basic & Translat Sci, Penn Dent Med, Philadelphia, PA 19104 USA; [Bell, Brent A.] Univ Penn, Dept Ophthalmol, Philadelphia, PA 19104 USA	Jefferson University; Cleveland Clinic Foundation; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Case Western Reserve University; Cleveland Clinic Foundation; West Virginia University; West Virginia University; University of Pennsylvania; University of Pennsylvania	Philp, NJ (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, 1020 Locust St, Philadelphia, PA 19107 USA.	nancy.philp@jefferson.edu	Peachey, Neal/G-5533-2010	Peachey, Neal/0000-0002-4419-7226; Philp, Nancy/0000-0001-7028-0448; Yu, Minzhong/0000-0002-3115-8930; Samuels, Ivy/0000-0003-1351-031X; Daniele, Lauren/0000-0002-9397-0342	HHS \ NIH \ National Eye Institute (NEI) [R01EY026525, R01EY12042, R01EY031324, R01EY032462, P30EY025585]; HHS \ NIH \ National Institute on Alcohol Abuse and Alcoholism (NIAAA) [T32AA007463]; Research to Prevent Blindness; U.S. Department of Veterans Affairs (VA) [I01BX002340, IK6-BX005233, I01BX005844]	HHS \ NIH \ National Eye Institute (NEI); HHS \ NIH \ National Institute on Alcohol Abuse and Alcoholism (NIAAA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); U.S. Department of Veterans Affairs (VA)(US Department of Veterans Affairs)	HHS | NIH | National Eye Institute (NEI), Grant/Award Number: R01EY026525(NJPandKBB), R01EY12042, R01EY031324, R01EY032462 and P30EY025585; HHS | NIH | National Institute on Alcohol Abuse and Alcoholism (NIAAA), Grant/Award Number: T32AA007463(JH); Research to Prevent Blindness (NSP); U.S. Department of Veterans Affairs (VA), Grant/Award Number: I01BX002340(NSP), IK6-BX005233(ISS) and I01BX005844(NSP)	Ait-Ali N, 2015, CELL, V161, P817, DOI 10.1016/j.cell.2015.03.023; AMES A, 1992, J NEUROSCI, V12, P4234; Bakall B, 2003, INVEST OPHTH VIS SCI, V44, P3622, DOI 10.1167/iovs.03-0030; Bell BA, 2019, EXP EYE RES, V185, DOI 10.1016/j.exer.2019.05.012; Bell BA, 2015, EXP EYE RES, V135, P192, DOI 10.1016/j.exer.2015.04.009; Bell BA, 2014, EXP EYE RES, V127, P280, DOI 10.1016/j.exer.2014.01.001; Bonezzi PJ, 2018, CURR EYE RES, V43, P666, DOI 10.1080/02713683.2018.1433859; Botta S, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.96560; CARTERDAWSON L, 1986, DEV BIOL, V116, P431, DOI 10.1016/0012-1606(86)90144-2; Chinchore Y, 2017, ELIFE, V6, DOI 10.7554/eLife.25946; Cunnane SC, 2020, NAT REV DRUG DISCOV, V19, P609, DOI 10.1038/s41573-020-0072-x; Daniele LL, 2011, VISION RES, V51, P447, DOI 10.1016/j.visres.2010.12.017; Daum JM, 2017, ELIFE, V6, DOI 10.7554/eLife.31437; Du JH, 2016, J BIOL CHEM, V291, P4698, DOI 10.1074/jbc.M115.698985; Du JH, 2013, P NATL ACAD SCI USA, V110, P18501, DOI 10.1073/pnas.1311193110; Duncan JL, 2003, INVEST OPHTH VIS SCI, V44, P826, DOI 10.1167/iovs.02-0438; Elhassan YS, 2019, CELL REP, V28, P1717, DOI 10.1016/j.celrep.2019.07.043; Fadl BR, 2020, MOL VIS, V26, P705; Flynn E, 2014, INVEST OPHTH VIS SCI, V55, P5643, DOI 10.1167/iovs.14-14136; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Gospe SM, 2010, J CELL SCI, V123, P3639, DOI 10.1242/jcs.072389; GOULD GW, 1991, BIOCHEMISTRY-US, V30, P5139, DOI 10.1021/bi00235a004; Gray S, 2002, J BIOL CHEM, V277, P34322, DOI 10.1074/jbc.M201304200; Grenell A, 2019, P NATL ACAD SCI USA, V116, P3530, DOI 10.1073/pnas.1812941116; Guo MC, 2022, FEBS J, V289, P2337, DOI 10.1111/febs.16177; Han JYS, 2020, FASEB J, V34, P5401, DOI 10.1096/fj.201902961R; Hancock CN, 2016, AMINO ACIDS, V48, P859, DOI 10.1007/s00726-015-2134-7; Hao YH, 2021, CELL, V184, P3573, DOI 10.1016/j.cell.2021.04.048; He JZ, 2021, FASEB J, V35, DOI 10.1096/fj.202101121R; Holoman NC, 2021, J NEUROSCI, V41, P3275, DOI 10.1523/JNEUROSCI.2010-20.2021; Hoxhaj G, 2019, SCIENCE, V363, P1088, DOI 10.1126/science.aau3903; Hsieh PN, 2019, ENDOCR REV, V40, P137, DOI 10.1210/er.2018-00151; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; Hurley JB, 2021, ANNU REV VIS SCI, V7, P665, DOI 10.1146/annurev-vision-100419-115156; Hurley JB, 2015, J NEUROSCI RES, V93, P1079, DOI 10.1002/jnr.23583; Joyal JS, 2016, NAT MED, V22, P439, DOI 10.1038/nm.4059; Kanow MA, 2017, ELIFE, V6, DOI 10.7554/eLife.28899; Koch SF, 2015, J CLIN INVEST, V125, P3704, DOI 10.1172/JCI82462; KOWALOFF EM, 1977, P NATL ACAD SCI USA, V74, P5368, DOI 10.1073/pnas.74.12.5368; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; Li B, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101672; McCann MR, 2021, METABOLITES, V11, DOI 10.3390/metabo11010051; Mehmel M, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061616; Montana CL, 2011, J BIOL CHEM, V286, P36921, DOI 10.1074/jbc.M111.279026; Murray AR, 2015, HUM MOL GENET, V24, P2709, DOI 10.1093/hmg/ddv031; Nandrot EE, 2004, J EXP MED, V200, P1539, DOI 10.1084/jem.20041447; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Nishida A, 2003, NAT NEUROSCI, V6, P1255, DOI 10.1038/nn1155; OBATA S, 1992, CELL TISSUE RES, V269, P39, DOI 10.1007/BF00384724; Okawa H, 2008, CURR BIOL, V18, P1917, DOI 10.1016/j.cub.2008.10.029; Otteson DC, 2004, INVEST OPHTH VIS SCI, V45, P2522, DOI 10.1167/iovs.04-0072; Palfi A, 2010, HUM GENE THER, V21, P311, DOI 10.1089/hum.2009.119; Pandhare J, 2009, J CELL BIOCHEM, V107, P759, DOI 10.1002/jcb.22174; Pang ZQ, 2020, METABOLITES, V10, DOI 10.3390/metabo10050186; Peng YR, 2019, CELL, V176, P1222, DOI 10.1016/j.cell.2019.01.004; Petit L, 2018, CELL REP, V23, P2629, DOI 10.1016/j.celrep.2018.04.111; POITRYYAMATE CL, 1995, J NEUROSCI, V15, P5179; Punzo C, 2009, NAT NEUROSCI, V12, P44, DOI 10.1038/nn.2234; Rajala A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64487-2; Rajala A, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0712-9; Rajala A, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0296-4; Sakurai K, 2007, J GEN PHYSIOL, V130, P21, DOI 10.1085/jgp.200609729; Salinas RY, 2017, J CELL BIOL, V216, P1489, DOI 10.1083/jcb.201608081; Samson M, 2009, DEV DYNAM, V238, P3218, DOI 10.1002/dvdy.22138; Sanz MM, 2007, NEUROSCIENCE, V145, P1120, DOI 10.1016/j.neuroscience.2006.12.034; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shen WY, 2021, GLIA, V69, P1966, DOI 10.1002/glia.24005; Shi G, 2007, J NEUROSCI, V27, P10084, DOI 10.1523/JNEUROSCI.2211-07.2007; Shin BC, 2018, J NEUROSCI, V38, P9579, DOI 10.1523/JNEUROSCI.0503-18.2018; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Swarup A, 2019, AM J PHYSIOL-CELL PH, V316, pC121, DOI 10.1152/ajpcell.00410.2018; Trachsel-Moncho L, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0855-8; Tran DH, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.012673; TURCO SJ, 1982, J BIOL CHEM, V257, P8674; Umino Y, 2006, P NATL ACAD SCI USA, V103, P19541, DOI 10.1073/pnas.0604478104; Viegas FO, 2021, FRONT MOL NEUROSCI, V14, DOI 10.3389/fnmol.2021.656000; Wagner E, 2000, DEV BIOL, V222, P460, DOI 10.1006/dbio.2000.9719; Wang L, 1997, ACTA PHYSIOL SCAND, V160, P75, DOI 10.1046/j.1365-201X.1997.00131.x; Wang LX, 2019, MOL NEURODEGENER, V14, DOI 10.1186/s13024-019-0305-9; Wang W, 2019, CELL REP, V28, P1323, DOI 10.1016/j.celrep.2019.06.093; Wang W, 2016, CELL REP, V15, P372, DOI 10.1016/j.celrep.2016.03.022; Watanabe T, 1999, BIOCHEM BIOPH RES CO, V256, P505, DOI 10.1006/bbrc.1999.0369; Weh E, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2638-2; Winkler BS, 2008, INVEST OPHTH VIS SCI, V49, P4613, DOI 10.1167/iovs.08-2004; WINKLER BS, 1981, J GEN PHYSIOL, V77, P667, DOI 10.1085/jgp.77.6.667; Winkler BS, 2000, INVEST OPHTH VIS SCI, V41, P3183; Xue YL, 2021, ELIFE, V10, DOI 10.7554/eLife.66240; Yam M, 2019, J BIOL CHEM, V294, P10278, DOI 10.1074/jbc.RA119.007983; Yamamoto J, 2004, J BIOL CHEM, V279, P16954, DOI 10.1074/jbc.M312079200; Young CD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023205; Yu C, 2020, TRENDS NEUROSCI, V43, P433, DOI 10.1016/j.tins.2020.03.012; Zhang R, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-03103-7; Zhang Y, 2019, J MOL CELL BIOL, V11, P1, DOI 10.1093/jmcb/mjy052	93	1	1	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2022	36	8							e22428	10.1096/fj.202200369R	http://dx.doi.org/10.1096/fj.202200369R			24	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2O2WK	35766190	hybrid, Green Published			2022-12-26	WOS:000818924600001
J	Fu, J; Zhang, XB; Zheng, HW; Yang, GB; Chen, Z; Yuan, GH				Fu, Jing; Zhang, Xiaobo; Zheng, Huiwen; Yang, Guobin; Chen, Zhi; Yuan, Guohua			A WWP2-PTEN-KLF5 signaling axis regulates odontoblast differentiation and dentinogenesis in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENTIN MATRIX PROTEIN-1; E3 UBIQUITIN LIGASE; IN-VITRO; PTEN; PROLIFERATION; WWP2; EXPRESSION; CELLS; PULP	WW domain-containing E3 Ubiquitin-protein ligase 2 (WWP2) has been found to positively regulate odontoblastic differentiation by monoubiquitinating the transcription factor Kruppel-like factor 5 (KLF5) in a cell culture system. However, the in vivo role of WWP2 in mouse teeth remains unknown. To explore this, here we generated Wwp2 knockout (Wwp2 KO) mice. We found that molars in Wwp2 KO mice exhibited thinner dentin, widened predentin, and reduced numbers of dentinal tubules. In addition, expression of the odontoblast differentiation markers Dspp and Dmp1 was decreased in the odontoblast layers of Wwp2 KO mice. These findings demonstrate that WWP2 may facilitate odontoblast differentiation and dentinogenesis. Furthermore, we show for the first time that phosphatase and tensin homolog (PTEN), a tumor suppressor, is expressed in dental papilla cells and odontoblasts of mouse molars and acts as a negative regulator of odontoblastic differentiation. Further investigation indicated that PTEN is targeted by WWP2 for degradation during odontoblastic differentiation. We demonstrate PTEN physically interacts with and inhibits the transcriptional activity of KLF5 on Dspp and Dmp1. Finally, we found WWP2 was able to suppress the interaction between PTEN and KLF5, which diminished the inhibition effect of PTEN on KLF5. Taken together, this study confirms the essential role of WWP2 and the WWP2-PTEN-KLF5 signaling axis in odontoblast differentiation and dentinogenesis in vivo.	[Fu, Jing; Zhang, Xiaobo; Zheng, Huiwen; Yang, Guobin; Chen, Zhi; Yuan, Guohua] Wuhan Univ, State Key Lab Breeding Base Basic Sci Stomatol, Wuhan, Peoples R China; [Fu, Jing; Zhang, Xiaobo; Zheng, Huiwen; Yang, Guobin; Chen, Zhi; Yuan, Guohua] Wuhan Univ, Sch & Hosp Stomatol, Key Lab Oral Biomed, Minist Educ, Wuhan, Peoples R China; [Fu, Jing; Zhang, Xiaobo; Zheng, Huiwen; Yuan, Guohua] Wuhan Univ, Frontier Sci Ctr Immunol & Metab, Wuhan, Peoples R China	Wuhan University; Wuhan University; Wuhan University	Yuan, GH (corresponding author), Wuhan Univ, State Key Lab Breeding Base Basic Sci Stomatol, Wuhan, Peoples R China.; Yuan, GH (corresponding author), Wuhan Univ, Sch & Hosp Stomatol, Key Lab Oral Biomed, Minist Educ, Wuhan, Peoples R China.; Yuan, GH (corresponding author), Wuhan Univ, Frontier Sci Ctr Immunol & Metab, Wuhan, Peoples R China.	yuanguohua@whu.edu.cn	Chen, Zhi/V-2214-2017	Chen, Zhi/0000-0003-2095-1324	National Natural Science Foundation of China [82170914]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Acknowledgments - This research was supported by grants from the National Natural Science Foundation of China (82170914 to Guo- hua Yuan) .	Ambrozkiewicz MC, 2018, NEURON, V100, P1097, DOI 10.1016/j.neuron.2018.10.008; Bleicher F, 2014, EXP CELL RES, V325, P65, DOI 10.1016/j.yexcr.2013.12.012; Butler W T, 1995, Connect Tissue Res, V33, P59, DOI 10.3109/03008209509016983; Cai BJ, 2019, EXP CELL RES, V385, DOI 10.1016/j.yexcr.2019.111647; Chen Z, 2017, SCI REP-UK, V7, DOI 10.1038/srep46746; Chen Z, 2009, ARCH ORAL BIOL, V54, P403, DOI 10.1016/j.archoralbio.2009.02.003; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Emerling BM, 2008, P NATL ACAD SCI USA, V105, P2622, DOI 10.1073/pnas.0706790105; Fang L, 2014, MOL CELL, V55, P537, DOI 10.1016/j.molcel.2014.06.018; Fu J, 2021, J DENT RES, V100, P432, DOI 10.1177/0022034520970866; Gibson MP, 2013, J BIOL CHEM, V288, P7204, DOI 10.1074/jbc.M112.445775; Goldberg Michel, 2011, Front Biosci (Elite Ed), V3, P711, DOI 10.2741/e281; Han N, 2017, INT ENDOD J, V50, P676, DOI 10.1111/iej.12672; Herhaus L, 2015, EMBO REP, V16, P1071, DOI 10.15252/embr.201540891; Ho J, 2020, CSH PERSPECT MED, V10, DOI 10.1101/cshperspect.a036079; Hopkins BD, 2014, TRENDS BIOCHEM SCI, V39, P183, DOI 10.1016/j.tibs.2014.02.006; Jo HS, 2012, EMBO J, V31, P817, DOI 10.1038/emboj.2011.443; Kero D, 2016, ORGANOGENESIS, V12, P152, DOI 10.1080/15476278.2016.1197460; Kim HS, 2017, J EXP MED, V214, P3381, DOI 10.1084/jem.20170523; Li HC, 2018, J BIOL CHEM, V293, P8886, DOI 10.1074/jbc.RA117.001060; Li RA, 2016, BLOOD, V128, P3052, DOI 10.1182/blood-2016-09-742502; Liu J, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2015.44; Liu Y, 2015, DEVELOPMENT, V142, P3374, DOI 10.1242/dev.127068; Lokody IB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129470; Lorenz S, 2018, BIOL CHEM, V399, P127, DOI 10.1515/hsz-2017-0184; Ma YY, 2021, DEVELOPMENT, V148, DOI 10.1242/dev.196360; Maddika S, 2011, NAT CELL BIOL, V13, P728, DOI 10.1038/ncb2240; Mayor R, 2013, DEVELOPMENT, V140, P2247, DOI 10.1242/dev.091751; Misra S, 2021, DNA REPAIR, V107, DOI 10.1016/j.dnarep.2021.103197; Nakamura Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1242; Rangiani A, 2012, INT J ORAL SCI, V4, P189, DOI 10.1038/ijos.2012.69; Rape M, 2018, NAT REV MOL CELL BIO, V19, P59, DOI 10.1038/nrm.2017.83; Song ZW, 2018, EXP CELL RES, V363, P179, DOI 10.1016/j.yexcr.2018.01.001; Sreenath T, 2003, J BIOL CHEM, V278, P24874, DOI 10.1074/jbc.M303908200; Sun F, 2011, NATURE, V480, P372, DOI 10.1038/nature10594; Wang K, 2020, BIOCHEM BIOPH RES CO, V521, P652, DOI 10.1016/j.bbrc.2019.10.179; Worby CA, 2014, ANNU REV BIOCHEM, V83, P641, DOI 10.1146/annurev-biochem-082411-113907; Xu HM, 2004, J BIOL CHEM, V279, P23495, DOI 10.1074/jbc.M400516200; Yang TF, 2018, DEV DYNAM, V247, P304, DOI [10.1002/dvdy.24605, 10.1002/DVDY.24605]; Yuan GH, 2017, SCI REP-UK, V7, DOI 10.1038/srep42449; Yuan GH, 2015, DEVELOPMENT, V142, P128, DOI 10.1242/dev.117887; Zhang H, 2019, CELL BIOSCI, V9, DOI 10.1186/s13578-019-0345-4; Zhu W, 2017, J BIOL CHEM, V292, P11178, DOI 10.1074/jbc.M116.772277	43	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2022	298	8							102220	10.1016/j.jbc.2022.102220	http://dx.doi.org/10.1016/j.jbc.2022.102220			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	4F0HN	35780838	Green Published, gold			2022-12-26	WOS:000848197700002
J	Meng, XJ; Yue, LX; Liu, A; Tao, WJ; Shi, L; Zhao, W; Wu, ZM; Zhang, Z; Wang, LC; Zhang, XL; Zhou, WJ				Meng, Xiaojing; Yue, Lingxiao; Liu, An; Tao, Wenjuan; Shi, Li; Zhao, Wan; Wu, Zhongmin; Zhang, Zhi; Wang, Liecheng; Zhang, Xulai; Zhou, Wenjie			Distinct basolateral amygdala excitatory inputs mediate the somatosensory and aversive-affective components of pain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULAR CORTEX; MEDIODORSAL THALAMUS; PREFRONTAL CORTEX; ANXIETY; BRAIN; RAT; IMPAIRMENT; EMOTION; LESION; TASTE	Pain is a multidimensional perception that includes unpleasant somatosensory and affective experiences; however, the underlying neural circuits that mediate different components of pain remain elusive. Although hyperactivity of basolateral amygdala glutamatergic (BLA(Glu)) neurons is required for the somatosensory and emotional processing of pain, the precise excitatory inputs to BLA(Glu) neurons and their roles in mediating different aspects of pain are unclear. Here, we identified two discrete glutamatergic neuronal circuits in male mice: a projection from the insular cortex glutamatergic (ICGlu) to BLA(Glu) neurons, which modulates both the somatosensory and affective components of pain, and a projection from the mediodorsal thalamic nucleus (MDGlu) to BLA(Glu) neurons, which modulates only the aversive-affective component of pain. Using whole-cell recording and fiber photometry, we found that neurons within the IC -> BLA and MD -> BLA pathways were activated in mice upon inflammatory pain induced by injection of complete Freund's adjuvant (CFA) into their paws. Optical inhibition of the ICGlu -> BLA pathway increased the nociceptive threshold and induced behavioral place preference in CFA mice. In contrast, optical inhibition of the MDGlu -> BLA pathway did not affect the nociceptive threshold but still induced place preference in CFA mice. In normal mice, optical activation of the ICGlu -> BLA pathway decreased the nociceptive threshold and induced place aversion, while optical activation of the MDGlu -> BLA pathway only evoked aversion. Taken together, our results demonstrate that discrete ICGlu -> BLA and MDGlu -> BLA pathways are involved in modulating different components of pain, provide insights into its circuit basis, and better our understanding of pain perception.	[Meng, Xiaojing; Shi, Li; Zhang, Xulai] Anhui Med Univ, Hefei Peoples Hosp 4, Anhui Mental Hlth Ctr, Affiliated Psychol Hosp, Hefei, Anhui, Peoples R China; [Yue, Lingxiao; Liu, An; Tao, Wenjuan; Wang, Liecheng] Anhui Med Univ, Sch Basic Med Sci, Dept Physiol, Hefei, Peoples R China; [Yue, Lingxiao] Anhui Med Coll, Dept Pathol, Hefei, Peoples R China; [Zhao, Wan] Univ Sci & Technol China, Div Life Sci & Med, Affiliated Hosp USTC 1, Dept Otolaryngol, Hefei, Anhui, Peoples R China; [Wu, Zhongmin] Taizhou Univ, Med Coll, Dept Anat, Taizhou, Peoples R China; [Zhang, Zhi; Zhou, Wenjie] Univ Sci & Technol China, CAS Key Lab Brain Funct & Dis, Hefei Natl Lab Phys Sci Microscale, Hefei, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical College; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Taizhou University; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Zhang, XL (corresponding author), Anhui Med Univ, Hefei Peoples Hosp 4, Anhui Mental Hlth Ctr, Affiliated Psychol Hosp, Hefei, Anhui, Peoples R China.; Wang, LC (corresponding author), Anhui Med Univ, Sch Basic Med Sci, Dept Physiol, Hefei, Peoples R China.; Zhou, WJ (corresponding author), Univ Sci & Technol China, CAS Key Lab Brain Funct & Dis, Hefei Natl Lab Phys Sci Microscale, Hefei, Peoples R China.	wangliecheng@ahmu.edu.cn; xulaizhang@ahmhcentre.com; zwj2850@ustc.edu.cn		wu zhong min, wu zhong min/0000-0003-2397-4476	National Natural Science Foundation of China [32000717, 81971236]; Natural Science Foundation of Anhui Province [KJ2020A0138]; China Postdoctoral Science Foundation [2020M682017]; University of Science and Technology of China Research Funds of the Double First-Class Initiative [YD3460002001]; Zhejiang Provincial Science and Technology Department of Public Welfare Technology Application Project [LGF20H090005]; Scientific research Foundation of Traditional Chinese Medicine of Zhejiang Province [2021ZA143]; Scientific and technological research project of Anhui Provincial Science and Technology Department [201904a07020009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Anhui Province(Natural Science Foundation of Anhui Province); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); University of Science and Technology of China Research Funds of the Double First-Class Initiative; Zhejiang Provincial Science and Technology Department of Public Welfare Technology Application Project; Scientific research Foundation of Traditional Chinese Medicine of Zhejiang Province; Scientific and technological research project of Anhui Provincial Science and Technology Department	This work was supported by the National Natural Science Foundation of China (32000717, 81971236), Natural Science Foundation of Anhui Province (2008085QC115), China Postdoctoral Science Foundation (2020M682017), University of Science and Technology of China Research Funds of the Double First-Class Initiative (YD3460002001), Zhejiang Provincial Science and Technology Department of Public Welfare Technology Application Project (LGF20H090005), Natural Science Foundation of Anhui Province (KJ2020A0138), Scientific research Foundation of Traditional Chinese Medicine of Zhejiang Province (2021ZA143), Scientific and technological research project of Anhui Provincial Science and Technology Department (201904a07020009).	Alonso-Matielo H, 2021, BRAIN RES, V1754, DOI 10.1016/j.brainres.2020.147237; Auvray M, 2010, NEUROSCI BIOBEHAV R, V34, P214, DOI 10.1016/j.neubiorev.2008.07.008; Berret E, 2019, SCIENCE, V364, P850, DOI 10.1126/science.aaw0474; Bravo L, 2012, ANESTHESIOLOGY, V117, P613, DOI 10.1097/ALN.0b013e3182657b3e; Bushnell MC, 2013, NAT REV NEUROSCI, V14, P502, DOI 10.1038/nrn3516; Cai YQ, 2018, J NEUROSCI, V38, P6340, DOI 10.1523/JNEUROSCI.2780-17.2018; Cardoso-Cruz H, 2013, PAIN, V154, P2397, DOI 10.1016/j.pain.2013.07.020; Chai SC, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-42; Chen J, 2013, NEUROSCI LETT, V541, P275, DOI 10.1016/j.neulet.2013.02.005; Ciocchi S, 2010, NATURE, V468, P277, DOI 10.1038/nature09559; Corder G, 2019, SCIENCE, V363, P276, DOI 10.1126/science.aap8586; CORNWALL J, 1988, NEUROSCIENCE, V24, P1035, DOI 10.1016/0306-4522(88)90085-1; Feinstein JS, 2013, CURR OPIN NEUROBIOL, V23, P304, DOI 10.1016/j.conb.2012.12.007; Felix-Ortiz AC, 2013, NEURON, V79, P658, DOI 10.1016/j.neuron.2013.06.016; Fields HL, 1999, PAIN, pS61, DOI 10.1016/S0304-3959(99)00139-6; Gandhi W, 2020, PAIN, V161, P300, DOI 10.1097/j.pain.0000000000001714; Gerrits MMJG, 2014, PAIN, V155, P53, DOI 10.1016/j.pain.2013.09.005; Gil-Lievana E, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-0862-z; Groh A, 2018, NEUROSCIENCE, V387, P58, DOI 10.1016/j.neuroscience.2017.09.042; Gu XS, 2012, BRAIN, V135, P2726, DOI 10.1093/brain/aws199; Huang JT, 2019, NAT NEUROSCI, V22, P1659, DOI 10.1038/s41593-019-0481-5; Huang TW, 2019, NATURE, V565, P86, DOI 10.1038/s41586-018-0793-8; Jhang J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05090-y; Ji GC, 2010, J NEUROSCI, V30, P5451, DOI 10.1523/JNEUROSCI.0225-10.2010; Jutzeler CR, 2016, SCI REP-UK, V6, DOI 10.1038/srep18534; Li Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10503; Li Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070921; Luongo L, 2013, NEUROPHARMACOLOGY, V66, P317, DOI 10.1016/j.neuropharm.2012.05.047; Maeoka H, 2015, J PAIN RES, V8, P431, DOI 10.2147/JPR.S86732; Mazzola L, 2009, PAIN, V146, P99, DOI 10.1016/j.pain.2009.07.014; Nagasaka K, 2020, EXP NEUROL, V323, DOI 10.1016/j.expneurol.2019.113096; Neugebauer V, 2004, NEUROSCIENTIST, V10, P221, DOI 10.1177/1073858403261077; Nieuwenhuys R, 2012, PROG BRAIN RES, V195, P123, DOI 10.1016/B978-0-444-53860-4.00007-6; Ostrowsky K, 2002, CEREB CORTEX, V12, P376, DOI 10.1093/cercor/12.4.376; Ouhaz Z, 2017, BRAIN STRUCT FUNCT, V222, P2527, DOI 10.1007/s00429-016-1354-2; Peng YQ, 2015, NATURE, V527, P512, DOI 10.1038/nature15763; Pogatzki EM, 2003, PAIN, V105, P97, DOI 10.1016/S0304-3959(03)00169-6; Raja SN, 2020, PAIN, V161, P1976, DOI 10.1097/j.pain.0000000000001939; Raver C, 2020, J NEUROSCI, V40, P3424, DOI 10.1523/JNEUROSCI.0075-20.2020; Ren WJ, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-93; RINALDI PC, 1991, J NEUROSURG, V74, P415, DOI 10.3171/jns.1991.74.3.0415; Rodriguez-Duran LF, 2017, NEUROBIOL LEARN MEM, V142, P85, DOI 10.1016/j.nlm.2016.12.014; Seymour B, 2012, BRAIN, V135, P316, DOI 10.1093/brain/aws005; Simons LE, 2014, HUM BRAIN MAPP, V35, P527, DOI 10.1002/hbm.22199; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Uematsu A, 2015, CEREB CORTEX, V25, P2719, DOI 10.1093/cercor/bhu069; Wang DQ, 2017, ELIFE, V6, DOI 10.7554/eLife.23045; Wang J., 2010, TECH REG ANESTH PAIN, V14, P59; Whitt JL, 2013, J NEUROSCI, V33, P3915, DOI 10.1523/JNEUROSCI.2639-12.2013; Yen Chen-Tung, 2013, Acta Anaesthesiol Taiwan, V51, P73, DOI 10.1016/j.aat.2013.06.011; Yiannakas A, 2021, CURR BIOL, V31, P2770, DOI 10.1016/j.cub.2021.04.010; Zhang MM, 2022, NEURON, V110, P1993, DOI 10.1016/j.neuron.2022.03.030; Zhang Z, 2011, NAT MED, V17, P1448, DOI 10.1038/nm.2442	53	1	1	7	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2022	298	8							102207	10.1016/j.jbc.2022.102207	http://dx.doi.org/10.1016/j.jbc.2022.102207			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3S2VB	35772494	Green Published, gold			2022-12-26	WOS:000839458000007
J	Liu, YQ; Luo, M; Shi, Y; Guo, Y; Zhang, H; Yang, KD; Li, TR; Yang, LQ; Liu, TT; Huang, B; Liu, Q; He, ZC; Zhang, XN; Wang, WY; Wang, S; Zeng, H; Niu, Q; Zhang, X; Cui, YH; Zhang, ZR; Bian, XW; Ping, YF				Liu, Yu-Qi; Luo, Min; Shi, Yu; Guo, Ying; Zhang, Hua; Yang, Kai-Di; Li, Tian-Ran; Yang, Liu-Qing; Liu, Ting-Ting; Huang, Bo; Liu, Qing; He, Zhi-Cheng; Zhang, Xiao-Ning; Wang, Wen-Ying; Wang, Shuai; Zeng, Hui; Niu, Qin; Zhang, Xia; Cui, You-Hong; Zhang, Zhi-Ren; Bian, Xiu-Wu; Ping, Yi-Fang			Dicer deficiency impairs proliferation but potentiates anti-tumoral effect of macrophages in glioblastoma	ONCOGENE			English	Article							MICRORNA; GLIOMA; INVASIVENESS; POLARIZATION	Glioblastoma is a lethal primary brain tumor with abundant immune-suppressive glioblastoma-associated macrophage (GAM) infiltration. Skewing immune suppressive GAMs towards an immune-activating phenotype represents a promising immunotherapeutic strategy against glioblastoma. Herein, we reported that genetic deletion of miRNA-processing enzyme Dicer in macrophages inhibited the growth of GL261 murine glioblastoma xenografts and prolonged survival of tumor-bearing mice. Single cell RNA sequencing (scRNA-seq) of the tumor-infiltrating immune cells revealed that Dicer deletion in macrophages reduced the proportion of cell-cycling GAM cluster and reprogramed the remaining GAMs towards a proinflammatory activation state (enhanced phagocytotic and IFN-producing signature). Dicer-deficient GAMs showed reduced level of cyclin-dependent kinases (CDK1 and CDK2) and increased expression of CDK inhibitor p27 Kip1, thus manifesting impaired proliferation. Dicer knockout enhanced phagocytotic activity of GAMs to eliminate GL261 tumor cells. Increased proinflammatory GAM clusters in macrophage Dicer-deficient mice actively interacted with tumor-infiltrating T cells and NK cells through TNF paracrine signaling to create a pro-inflammatory immune microenvironment for tumor cell elimination. Our work identifies the role of Dicer deletion in macrophages in generating an immune-activating microenvironment, which could be further developed as a potential immunotherapeutic strategy against glioblastoma.	[Liu, Yu-Qi; Luo, Min; Shi, Yu; Guo, Ying; Zhang, Hua; Yang, Kai-Di; Li, Tian-Ran; Yang, Liu-Qing; Liu, Qing; He, Zhi-Cheng; Zhang, Xiao-Ning; Wang, Wen-Ying; Wang, Shuai; Zeng, Hui; Niu, Qin; Zhang, Xia; Cui, You-Hong; Bian, Xiu-Wu; Ping, Yi-Fang] Third Mil Med Univ, Army Med Univ, Southwest Hosp, Inst Pathol, Chongqing 400038, Peoples R China; [Liu, Yu-Qi; Luo, Min; Shi, Yu; Guo, Ying; Zhang, Hua; Yang, Kai-Di; Li, Tian-Ran; Yang, Liu-Qing; Liu, Qing; He, Zhi-Cheng; Zhang, Xiao-Ning; Wang, Wen-Ying; Wang, Shuai; Zeng, Hui; Niu, Qin; Zhang, Xia; Cui, You-Hong; Bian, Xiu-Wu; Ping, Yi-Fang] Third Mil Med Univ, Army Med Univ, Southwest Hosp, Southwest Canc Ctr, Chongqing 400038, Peoples R China; [Liu, Yu-Qi; Luo, Min; Shi, Yu; Guo, Ying; Zhang, Hua; Yang, Kai-Di; Li, Tian-Ran; Yang, Liu-Qing; Liu, Qing; He, Zhi-Cheng; Zhang, Xiao-Ning; Wang, Wen-Ying; Wang, Shuai; Zeng, Hui; Niu, Qin; Zhang, Xia; Cui, You-Hong; Bian, Xiu-Wu; Ping, Yi-Fang] Minist Educ China, Key Lab Tumor Immunopathol, Chongqing 400038, Peoples R China; [Liu, Yu-Qi] Third Mil Med Univ, Army Med Univ, Xingiao Hosp, Army Hosp 953,Shigatse Branch, Shigatse 857000, Peoples R China; [Liu, Ting-Ting; Huang, Bo; Zhang, Zhi-Ren] Third Mil Med Univ, Army Med Univ, Inst Immunol, Chongqing 400038, Peoples R China	Army Medical University; Army Medical University; Ministry of Education, China; Army Medical University; Army Medical University	Bian, XW; Ping, YF (corresponding author), Third Mil Med Univ, Army Med Univ, Southwest Hosp, Inst Pathol, Chongqing 400038, Peoples R China.; Bian, XW; Ping, YF (corresponding author), Third Mil Med Univ, Army Med Univ, Southwest Hosp, Southwest Canc Ctr, Chongqing 400038, Peoples R China.; Bian, XW; Ping, YF (corresponding author), Minist Educ China, Key Lab Tumor Immunopathol, Chongqing 400038, Peoples R China.; Zhang, ZR (corresponding author), Third Mil Med Univ, Army Med Univ, Inst Immunol, Chongqing 400038, Peoples R China.	zhangzhiren@tmmu.edu.cn; bianxiuwu@263.net; pingyifang@126.com	Zhang, Xia/B-8152-2008; liu, ting/GZM-3326-2022	Zhang, Xia/0000-0002-9040-1486; liuqing, yang/0000-0002-9727-8580; Liu, Yuqi/0000-0002-5247-2152	National Natural Science Foundation of China [81821003, 81702940, 81922056]; National Key Research and Development Program of China [2016YFA0502201]; Science and Technology Innovation Project of Chongqing Science and Technology Commission, China [cstc2021yszx-jcyj0003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Science and Technology Innovation Project of Chongqing Science and Technology Commission, China	This research was supported by the National Natural Science Foundation of China under Grants [Nos. 81821003, 81702940 and 81922056], the National Key Research and Development Program of China (2016YFA0502201), and Science and Technology Innovation Project of Chongqing Science and Technology Commission, China (No. cstc2021yszx-jcyj0003).	Antonios JP, 2017, NEURO-ONCOLOGY, V19, P796, DOI 10.1093/neuonc/now287; Antunes ARP, 2021, NAT NEUROSCI, V24, P595, DOI 10.1038/s41593-020-00789-y; Baer C, 2016, NAT CELL BIOL, V18, P790, DOI 10.1038/ncb3371; Canfran-Duque A, 2017, EMBO MOL MED, V9, P1244, DOI 10.15252/emmm.201607492; Chen ZH, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01004; Cho YK, 2019, MOL METAB, V29, P86, DOI 10.1016/j.molmet.2019.08.015; Cloughesy TF, 2019, NAT MED, V25, P477, DOI 10.1038/s41591-018-0337-7; Di Leva G, 2014, ANNU REV PATHOL-MECH, V9, P287, DOI 10.1146/annurev-pathol-012513-104715; Dupont G, 2019, CLIN ANAT, V32, P117, DOI 10.1002/ca.23308; Feng MY, 2019, NAT REV CANCER, V19, P568, DOI 10.1038/s41568-019-0183-z; Frederico SC, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.672508; Gholamin S, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf2968; Grabowski MM, 2021, J NEURO-ONCOL, V151, P3, DOI 10.1007/s11060-020-03483-y; Gross TJ, 2014, J BIOL CHEM, V289, P12823, DOI 10.1074/jbc.M114.565473; Gutmann DH, 2019, NEURON, V104, P442, DOI 10.1016/j.neuron.2019.08.028; Horwitz SM, 2018, BLOOD, V131, P888, DOI 10.1182/blood-2017-08-802470; Jackson CM, 2019, NAT IMMUNOL, V20, P1100, DOI 10.1038/s41590-019-0433-y; Long QX, 2020, NAT MED, V26, P845, DOI 10.1038/s41591-020-0897-1; Ma PF, 2017, J HEPATOL, V67, P770, DOI 10.1016/j.jhep.2017.05.022; Mathsyaraja H, 2015, ONCOGENE, V34, P3651, DOI 10.1038/onc.2014.294; Omuro A, 2013, JAMA-J AM MED ASSOC, V310, P1842, DOI 10.1001/jama.2013.280319; Ostrom QT, 2018, JAMA ONCOL, V4, P1254, DOI 10.1001/jamaoncol.2018.1789; Perry JR, 2017, NEW ENGL J MED, V376, P1027, DOI 10.1056/NEJMoa1611977; Piao Y, 2016, NEURO-ONCOLOGY, V18, P1230, DOI 10.1093/neuonc/now030; Prosniak M, 2013, CLIN CANCER RES, V19, P3776, DOI 10.1158/1078-0432.CCR-12-1940; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Romani M, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00464; Ruckerl D, 2012, BLOOD, V120, P2307, DOI 10.1182/blood-2012-02-408252; Schalper KA, 2019, NAT MED, V25, P470, DOI 10.1038/s41591-018-0339-5; Shen C, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006259; Shi Y, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aah6816; Shi Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15080; Spigel DR, 2021, ANN ONCOL, V32, P631, DOI 10.1016/j.annonc.2021.01.071; Szulzewsky F, 2018, NEURO-ONCOLOGY, V20, P355, DOI 10.1093/neuonc/nox165; von Roemeling CA, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15129-8; Wang X, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1085-3; Wei YY, 2018, CIRCULATION, V138, P2007, DOI 10.1161/CIRCULATIONAHA.117.031589; Weiss T, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.abb2311; Wu KY, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01731; Xie F, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0892-z; Xun QJ, 2020, CURR MED CHEM, V27, P3944, DOI 10.2174/1573394715666190618121649; Zhang J, 2012, CARCINOGENESIS, V33, P312, DOI 10.1093/carcin/bgr289	42	0	0	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 22	2022	41	30					3791	3803		10.1038/s41388-022-02393-9	http://dx.doi.org/10.1038/s41388-022-02393-9		JUN 2022	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	3D1SP	35764885				2022-12-26	WOS:000817826700001
J	Andersen, EME; Wang, H; Khoo, JSH; Cerda, JF; Koder, RL				Andersen, Eskil M. E.; Wang, Hsin; Khoo, Joshua S. H.; Cerda, Jose F.; Koder, Ronald L.			Oxidation-reduction and photophysical properties of isomeric forms of Safranin	PLOS ONE			English	Article							LASER FLASH-PHOTOLYSIS; NMR; POLYMERIZATION; POTENTIALS; STATE; PROBE; CELL; DYE	Safranine O is widely used in the bioenergetics community as an indicator dye to determine membrane potentials and as an electron transfer mediator in potentiometric titrations. Here we show that two different commercial preparations of Safranine O contain less than sixty percent by weight of the title compound, with the rest primarily consisting of two closely related safranine isomers. All three major isomer components were isolated using reverse phase HPLC and their structures determined using mass spectrometry and two-dimensional NMR. These Safranines have two-electron midpoint potentials ranging from -272 to -315 mV vs. SHE. We have also investigated the absorption and fluorescence spectra of the compounds and found that they display distinct spectral and photophysical properties. While this mixture may aid in Safranine O's utility as a mediator compound, membrane potential measurements must take this range of dye potentials into account.	[Andersen, Eskil M. E.] CUNY City Coll, Dept Biochem, New York, NY USA; [Wang, Hsin] CUNY City Coll, Dept Chem, New York, NY USA; [Khoo, Joshua S. H.; Koder, Ronald L.] CUNY City Coll, Dept Phys, New York, NY 10031 USA; [Cerda, Jose F.] St Josephs Univ, Dept Chem, Philadelphia, PA 19131 USA; [Koder, Ronald L.] CUNY, Grad Ctr, Grad Program Phys, New York, NY 10017 USA; [Koder, Ronald L.] CUNY, Grad Ctr, Grad Program Biol, New York, NY 10017 USA; [Koder, Ronald L.] CUNY, Grad Ctr, Grad Program Chem & Biochem, New York, NY 10017 USA	City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System; City College of New York (CUNY); Saint Joseph's University; City University of New York (CUNY) System; City University of New York (CUNY) System; City University of New York (CUNY) System	Koder, RL (corresponding author), CUNY City Coll, Dept Phys, New York, NY 10031 USA.; Koder, RL (corresponding author), CUNY, Grad Ctr, Grad Program Phys, New York, NY 10017 USA.; Koder, RL (corresponding author), CUNY, Grad Ctr, Grad Program Chem & Biochem, New York, NY 10017 USA.	rkoder@ccny.cuny.edu		Koder, Ronald/0000-0003-0868-4972	New York State Energy Research and Development Authority (NYSERDA) [NYS115213]; NIH [S10OD018509, S10OD016432, P41GM066354]	New York State Energy Research and Development Authority (NYSERDA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a Grant from the New York State Energy Research and Development Authority (NYSERDA grant #NYS115213 to RLK). NIH grants S10OD018509, S10OD016432, and P41GM066354. URL: https://www.nyserda.ny.gov/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAX A, 1986, J AM CHEM SOC, V108, P2093, DOI 10.1021/ja00268a061; Bazzini P., 2008, PRACTICE MED CHEM, VFourth Edition, P319; Bertolotti SG, 1997, J PHOTOCH PHOTOBIO A, V103, P115, DOI 10.1016/S1010-6030(97)85300-2; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; Brisendine JM, 2013, ANAL BIOCHEM, V439, P1, DOI 10.1016/j.ab.2013.03.036; Broglia MF, 2005, J PHOTOCH PHOTOBIO A, V173, P115, DOI 10.1016/j.jphotochem.2005.01.010; Cao Y, 1999, TALANTA, V49, P377, DOI 10.1016/S0039-9140(98)00386-5; Cerda JF, 2008, ORG BIOMOL CHEM, V6, P2204, DOI 10.1039/b801952e; Cui DT, 2011, J PHYS CHEM B, V115, P7788, DOI 10.1021/jp202138d; Dutton P L, 1978, Methods Enzymol, V54, P411; Encinas MV, 1996, POLYMER, V37, P1395, DOI 10.1016/0032-3861(96)81137-2; Ensafi AA, 2002, MICROCHEM J, V72, P193, DOI 10.1016/S0026-265X(02)00035-8; FELLE H, 1980, BIOCHEMISTRY-US, V19, P3585, DOI 10.1021/bi00556a026; Figueira TR, 2012, METHODS MOL BIOL, V810, P103, DOI 10.1007/978-1-61779-382-0_7; Gerischer H., 1963, ANGEW CHEMIE, V75, P879, DOI [10.1002/ange.19630751838, DOI 10.1002/ANGE.19630751838]; Gomez ML, 2003, POLYMER, V44, P2875, DOI 10.1016/S0032-3861(03)00212-X; Hammett LP, 1937, J AM CHEM SOC, V59, P96, DOI 10.1021/ja01280a022; Hirsch JA., 1974, CONCEPTS THEORETICAL; Huang CZ, 1998, ANAL CHIM ACTA, V375, P89; HUTTUNEN MT, 1980, BIOCHIM BIOPHYS ACTA, V597, P274, DOI 10.1016/0005-2736(80)90105-4; Islam SDM, 1999, PHYS CHEM CHEM PHYS, V1, P3737; JAFFE HH, 1953, CHEM REV, V53, P191, DOI 10.1021/cr60165a003; JANA AK, 1988, ENERGY, V13, P161, DOI 10.1016/0360-5442(88)90041-2; Kiraly K, 1996, HISTOCHEM J, V28, P99, DOI 10.1007/BF02331414; Kock M, 2003, MAGN RESON CHEM, V41, P65, DOI 10.1002/mrc.1097; Koder RL, 2002, BIOCHEMISTRY-US, V41, P14197, DOI 10.1021/bi025805t; MASSEY V, 1991, FLAVINS AND FLAVOPROTEINS 1990, P59; MEITES L, 1948, ANAL CHEM, V20, P984, DOI 10.1021/ac60022a044; Nielander AC, 2019, ACS CATAL, V9, P5797, DOI 10.1021/acscatal.9b00358; Pearse AGE, 1984, J PATHOL, V143, P139, DOI [10.1002/path.1711430209, DOI 10.1002/PATH.1711430209]; Pierson LS, 2010, APPL MICROBIOL BIOT, V86, P1659, DOI 10.1007/s00253-010-2509-3; PREVITALI CM, 1994, MACROMOLECULES, V27, P7454, DOI 10.1021/ma00103a031; PRINCE RC, 1981, BIOCHIM BIOPHYS ACTA, V635, P132, DOI 10.1016/0005-2728(81)90014-1; Raju G, 2014, TETRAHEDRON LETT, V55, P2487, DOI 10.1016/j.tetlet.2014.03.010; Raju G, 2012, TETRAHEDRON LETT, V53, P1201, DOI 10.1016/j.tetlet.2011.12.028; SCHLEUCHER J, 1994, J BIOMOL NMR, V4, P301; SETTY OH, 1983, BIOPHYS J, V43, P371, DOI 10.1016/S0006-3495(83)84360-4; Sharma GD, 2003, MAT SCI ENG B-SOLID, V100, P13, DOI 10.1016/S0921-5107(02)00586-X; Zollinger H., 2003, COLOR CHEM SYNTHESES	39	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	6							e0265105	10.1371/journal.pone.0265105	http://dx.doi.org/10.1371/journal.pone.0265105			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3F0KH	35749430	Green Submitted, gold, Green Published			2022-12-26	WOS:000830362700090
J	Chu, NC; Wu, XL; Zhang, PY				Chu, Nan-Chen; Wu, Xiang-Li; Zhang, Ping-Yu			Spatiotemporal evolution characteristics of coordinated development of urbanization and ecological environment in eastern Russia-Perspectives from the 3D global trend and 2D plane analysis	PLOS ONE			English	Article							ECO-ENVIRONMENT	Under the background of "the Belt and Road" and "the economic corridor of China, Mongolia and Russia" initiatives, it has great value to study the temporal and spatial evolution characteristics of the coordinated development between the urbanization and ecological environment in eastern Russia (the Siberian Federal District and the Far East Federal District). In this paper, we studied the urbanization development level, eco-environment development level, and their coupling coordinated development degree during 2005-2018 in the eastern Russia from the perspectives of the 3D global trend and 2D plane analysis. First, combining with the Population-Economic-Sociology and Pressure-State-Response models, the urbanization development level and eco-environment development level were calculated by the comprehensive weighting method of entropy weight and variation coefficient for eastern Russia. Second, the coupling coordinated development degree of the urbanization development level and eco-environment development level was measured by the coupling coordination model for eastern Russia. Finally, the spatial differentiation of the urbanization development level, the eco-environment development level and their coupling coordinated development degree was performed respectively by the 3D global trend and 2D plane analysis using ArcGIS. The results are as following. First, the comprehensive urbanization development level of eastern Russia has increased from 2005 to 2018, and the economic urbanization is the main factor that affects the urbanization development in eastern Russia. The comprehensive eco-environment development level of eastern Russia has decreased from 2005 to 2018, and the eco-environment pressure is the main factor that affects the eco-environment development in eastern Russia. The coupling coordination degree of the urbanization development and eco-environment development has increased from 2005 to 2018. However, it is still in the uncoordinated stage. Second, from 2005 to 2018, the urbanization development level of the Siberian Federal District is higher than that of the Far East Federal District. The eco-environment development level of the Siberian Federal District is balanced to that of the Far East Federal District. The coupling coordination degree of the Siberian Federal District is higher than that of the Far East Federal District. Among the Siberian and Far East Federal Districts, most of the federal subjects belong to the uncoordinated stage of the urbanization development and the eco-environment development. Third, the urbanization development level, the eco-environment development level, and their coupling coordinated development level are all spatially imbalanced in the eastern Russia, which show the "High West, Low East" and "High Center, Low North and Low South" spatial pattern from the perspectives of the 3D global trend and 2D plane analysis. The areas with high levels are concentrated in the Novosibirsk Region, Altay Territory, Kemerovo Region, Krasnoyarsk Territory, and Irkutsk Region. The areas with low ones are mostly in the Republic of Altay and Chukotka Autonomous Area. Finally, we suggest policies and strategies that can boost the growth and development of the urbanization and the eco-environment in the Sino-Russian border areas.	[Chu, Nan-Chen; Wu, Xiang-Li] Harbin Normal Univ, Coll Geog Sci, Harbin, Peoples R China; [Zhang, Ping-Yu] Chinese Acad Sci, Northeast Inst Geog & Agroecol, Changchun, Peoples R China; [Zhang, Ping-Yu] Univ Chinese Acad Sci, Beijing, Peoples R China	Harbin Normal University; Chinese Academy of Sciences; Northeast Institute of Geography & Agroecology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wu, XL (corresponding author), Harbin Normal Univ, Coll Geog Sci, Harbin, Peoples R China.; Zhang, PY (corresponding author), Chinese Acad Sci, Northeast Inst Geog & Agroecol, Changchun, Peoples R China.; Zhang, PY (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.	jndxwxl@163.com; zhangpy@iga.ac.cn			National Natural Science Foundation of China [42101165, 42071162]; Heilongjiang Philosophy and Social Sciences Research Planning Project [21JLC201]; China Postdoctoral Science Foundation [2021M693817]; Heilongjiang Postdoctoral Science Foundation [21JLC201]; Ping-Yu Zhang Heilongjiang Philosophy and Social Sciences Research Planning Project [21JLC201]; Nan-Chen Chu China Postdoctoral Science Foundation [2021M693817]; Nan-Chen Chu Heilongjiang Postdoctoral Science Foundation [21JLC201];  [LBH-Z21067]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Heilongjiang Philosophy and Social Sciences Research Planning Project; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Heilongjiang Postdoctoral Science Foundation; Ping-Yu Zhang Heilongjiang Philosophy and Social Sciences Research Planning Project; Nan-Chen Chu China Postdoctoral Science Foundation; Nan-Chen Chu Heilongjiang Postdoctoral Science Foundation; 	This work is supported by the National Natural Science Foundation of China (No. 42101165; 42071162), Heilongjiang Philosophy and Social Sciences Research Planning Project (No. 21JLC201), China Postdoctoral Science Foundation (No. 2021M693817), and Heilongjiang Postdoctoral Science Foundation (No. LBH-Z21067). Author Contributions National Natural Science Foundation of China(No. 42101165) Recipient: Nan-Chen Chu National Natural Science Foundation of China(No. 42071162) Recipient: Ping-Yu Zhang Heilongjiang Philosophy and Social Sciences Research Planning Project (No. 21JLC201) Recipient: Nan-Chen Chu China Postdoctoral Science Foundation (No. 2021M693817) Recipient: Nan-Chen Chu Heilongjiang Postdoctoral Science Foundation (No. LBH-Z21067) Recipient: Nan-Chen Chu The funders have roles in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bityukova V. R., 2011, REGIONAL RES RUSSIA, V1, P394; Bityukova V.R, 2015, REGIONAL RES RUSSIA, V5, P367; [初楠臣 Chu Nanchen], 2018, [地理科学, Scientia Geographica Sinica], V38, P1069; Fang C L, 2009, REPORT CHINAS URBANI; Feng C.P, 2014, SHANGHAI URBAN PLANN, P72; Gao, 2014, RUSSIAN E EUR CENTRA, V1, P38; [郭付友 Guo Fuyou], 2021, [地理学报, Acta Geographica Sinica], V76, P726; [郭付友 Guo Fuyou], 2020, [地理科学, Scientia Geographica Sinica], V40, P200; [郭付友 Guo Fuyou], 2019, [地理研究, Geographical Research], V38, P2226; [黄金川 Huang Jinchuan], 2003, [地理研究, Geographical Research], V22, P211; Koshkin ES, 2019, J ASIA-PAC BIODIVERS, V12, P613, DOI 10.1016/j.japb.2019.07.002; Kuleshov VV., 2018, REG RES RUSS, V8, P345, DOI [10.1134/S2079970518040056, DOI 10.1134/S2079970518040056]; Li S., 2014, ECON GEOGR, V34, P42; Li YF, 2012, J ENVIRON MANAGE, V98, P127, DOI 10.1016/j.jenvman.2011.12.025; [梁龙武 Liang Longwu], 2019, [生态学报, Acta Ecologica Sinica], V39, P1212; [刘畅 Liu Chang], 2017, [中国人口·资源与环境, China Population Resources and Environment], V27, P155; [刘卫东 Liu Weidong], 2015, [地理科学进展, Progress in Geography], V34, P538; Lu D.D., 2017, SCI PRESS; Mishchuk S.N., 2013, REGIONAL RES RUSSIA, V3, P348; Shang Y, 2015, INT DATA INFORM, P50; Tan Jun-tao, 2015, Yingyong Shengtai Xuebao, V26, P3827; Vasilenko V, 2015, REG RES RUSS, V5, P378, DOI [10.1134/S2079970515040139, DOI 10.1134/S2079970515040139]; [王少剑 Wang Shaojian], 2015, [生态学报, Acta Ecologica Sinica], V35, P2244; Wang SJ, 2014, ECOL INDIC, V45, P171, DOI 10.1016/j.ecolind.2014.04.006; Wang X.F., 2011, AREAL RES DEV, V30, P54; Yu L., 2006, RUSS STUD, V2, P52; Zhou H.T, 2008, SIBERIAN STUDIES, P56; Zhuravel N.M., 2016, REGIONAL RES RUSSIA, V6, P193	28	1	1	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7								10.1371/journal.pone.0267272	http://dx.doi.org/10.1371/journal.pone.0267272			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M3CI	35793355	Green Published, gold			2022-12-26	WOS:000835338100006
J	Machalek, DAB; Vette, KM; Downes, M; Carlin, JBO; Nicholson, SB; Hirani, RF; Irving, DO; Gosbell, IB; Gidding, HF; Shilling, HM; Aung, E; Macartney, K; Kaldor, JM				Machalek, Dorothy A. B.; Vette, Kaitlyn M.; Downes, Marnie; Carlin, John B. O.; Nicholson, Suellen B.; Hirani, Rena F.; Irving, David O.; Gosbell, Iain B.; Gidding, Heather F.; Shilling, Hannah M.; Aung, Eithandee; Macartney, Kristine; Kaldor, John M.			Serological testing of blood donors to characterise the impact of COVID-19 in Melbourne, Australia, 2020	PLOS ONE			English	Article								Rapidly identifying and isolating people with acute SARS-CoV-2 infection has been a core strategy to contain COVID-19 in Australia, but a proportion of infections go undetected. We estimated SARS-CoV-2 specific antibody prevalence (seroprevalence) among blood donors in metropolitan Melbourne following a COVID-19 outbreak in the city between June and September 2020. The aim was to determine the extent of infection spread and whether seroprevalence varied demographically in proportion to reported cases of infection. The design involved stratified sampling of residual specimens from blood donors (aged 20-69 years) in three postcode groups defined by low (<3 cases/1,000 population), medium (3-7 cases/1,000 population) and high (>7 cases/1,000 population) COVID-19 incidence based on case notification data. All specimens were tested using the Wantai SARS-CoV-2 total antibody assay. Seroprevalence was estimated with adjustment for test sensitivity and specificity for the Melbourne metropolitan blood donor and residential populations, using multilevel regression and poststratification. Overall, 4,799 specimens were collected between 23 November and 17 December 2020. Seroprevalence for blood donors was 0.87% (90% credible interval: 0.25-1.49%). The highest estimates, of 1.13% (0.25-2.15%) and 1.11% (0.28-1.95%), respectively, were observed among donors living in the lowest socioeconomic areas (Quintiles 1 and 2) and lowest at 0.69% (0.14-1.39%) among donors living in the highest socioeconomic areas (Quintile 5). When extrapolated to the Melbourne residential population, overall seroprevalence was 0.90% (0.26-1.51%), with estimates by demography groups similar to those for the blood donors. The results suggest a lack of extensive community transmission and good COVID-19 case ascertainment based on routine testing during Victoria's second epidemic wave. Residual blood donor samples provide a practical epidemiological tool for estimating seroprevalence and information on population patterns of infection, against which the effectiveness of ongoing responses to the pandemic can be assessed.	[Machalek, Dorothy A. B.; Aung, Eithandee; Kaldor, John M.] Univ New South Wales, Kirby Inst, Sydney, Australia; [Machalek, Dorothy A. B.; Shilling, Hannah M.; Aung, Eithandee] Royal Womens Hosp, Ctr Womens Infect Dis, Melbourne, Australia; [Vette, Kaitlyn M.; Gidding, Heather F.; Macartney, Kristine] Natl Ctr Immunisat Res & Surveillance, Sydney, Australia; [Downes, Marnie; Carlin, John B. O.; Shilling, Hannah M.] Murdoch Childrens Res Inst, Melbourne, Australia; [Carlin, John B. O.] Univ Melbourne, Dept Paediat, Melbourne, Australia; [Carlin, John B. O.] Univ Melbourne, Sch Populat & Global Hlth, Melbourne, Australia; [Nicholson, Suellen B.] Royal Melbourne Hosp, Peter Doherty Inst Infect & Immun, Victorian Infect Dis Reference Lab, Melbourne, Australia; [Hirani, Rena F.; Irving, David O.; Gosbell, Iain B.] Australian Red Cross Lifeblood, Clin Serv & Res, Sydney, Australia; [Hirani, Rena F.] Macquarie Univ, Dept Mol Sci, Sydney, Australia; [Irving, David O.] Northern Sydney Local Hlth Dist, Kolling Inst, Women & Babies Res, Sydney, Australia; [Gosbell, Iain B.; Macartney, Kristine] Western Sydney Univ, Sch Med, Sydney, Australia; [Gidding, Heather F.] Univ Sydney, Fac Med & Hlth, Northern Clin Sch, Sydney, Australia	University of New South Wales Sydney; Kirby Institute; University of Sydney; Murdoch Children's Research Institute; University of Melbourne; University of Melbourne; Royal Melbourne Hospital; Victorian Infectious Diseases Reference Laboratory; Macquarie University; University of Sydney; Kolling Institute of Medical Research; Western Sydney University; University of Sydney	Machalek, DAB (corresponding author), Univ New South Wales, Kirby Inst, Sydney, Australia.; Machalek, DAB (corresponding author), Royal Womens Hosp, Ctr Womens Infect Dis, Melbourne, Australia.	dmachalek@kirby.unsw.edu.au		Gidding, Heather/0000-0001-7595-9281; Irving, David/0000-0003-2434-0686; Machalek, Dorothy/0000-0002-4101-8085	Victorian Government Department of Health; Snow Medical Foundation [CT28701/G207593]	Victorian Government Department of Health; Snow Medical Foundation	The study was supported by the Victorian Government Department of Health, and Snow Medical Foundation (CT28701/G207593). The Australian Government funds Australian Red Cross Lifeblood to provide blood, blood products and services to the Australian community. The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], NATL PLAN TRANSITION; [Anonymous], 2016, AUSTR BUREAU STAT RE; [Anonymous], MEDICAL J AUSTRAILA; Arora RK, 2020, LANCET INFECT DIS, V21, pE75, DOI 10.1016/S1473-3099(20)30631-9; Australian Bureau of Statistics, 2016, COUNT PERS PLAC US; Bouman JA, 2021, PLOS COMPUT BIOL, V17, DOI 10.1371/journal.pcbi.1008728; Burgdorf KS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169112; Chen XH, 2021, LANCET GLOB HEALTH, V9, pE598, DOI [10.1016/S2214-109X(21)00026-7, 10.1101/2020.09.11.20192773]; COVID-19 National Incident Room Surveillance Team, 2020, Commun Dis Intell (2018), V44, DOI 10.33321/cdi.2020.44.23; COVID-19 National Incident Room Surveillance Team, 2021, COMMUN DIS INTELL, P45, DOI [10.33321/cdi.2021.45.1, DOI 10.33321/CDI.2021.45.1]; Gelman A, 2020, J R STAT SOC C-APPL, V69, P1269, DOI 10.1111/rssc.12435; Gidding HF, 2021, MED J AUSTRALIA, V214, P179, DOI 10.5694/mja2.50940; Grant R, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-045425; Jones JM, 2021, JAMA-J AM MED ASSOC, V326, P1400, DOI 10.1001/jama.2021.15161; Karki S, 2021, TRANSFUSION, V61, P2855, DOI 10.1111/trf.16629; Marks G.N., 1999, MEASUREMENT SOCIOECO; Nicholson S, 2021, OPEN FORUM INFECT DI, V8, DOI 10.1093/ofid/ofab239; Patel EU, 2022, J INFECT DIS, V225, P1, DOI 10.1093/infdis/jiab517; Public Health England, 2021, WEEK 13 REP UP WEEK; Stone M, 2022, CLIN INFECT DIS, V74, P871, DOI 10.1093/cid/ciab537; The Victorian Government Department of Health, VICT COVID 19 DAT; Vette K., SEROPREVALENCE SARS; Vette Kaitlyn M, 2022, Open Forum Infect Dis, V9, pofac002, DOI 10.1093/ofid/ofac002; Whitaker HJ, 2021, J INFECTION, V83, P269, DOI 10.1016/j.jinf.2021.04.037	24	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7								10.1371/journal.pone.0265858	http://dx.doi.org/10.1371/journal.pone.0265858			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M3CI	35793307	gold, Green Published, Green Submitted			2022-12-26	WOS:000835338100047
J	Yasmin, T				Yasmin, Tahirah			In silico comprehensive analysis of coding and non-coding SNPs in human mTOR protein	PLOS ONE			English	Article							STABILITY CHANGES; MUTATIONAL ANALYSIS; CANCER; POLYMORPHISMS; PREDICTION; VARIANTS; GROWTH; IDENTIFICATION; ANNOTATION; PATTERNS	The mammalian/mechanistic target of rapamycin (mTOR) protein is an important growth regulator and has been linked with multiple diseases including cancer and diabetes. Non-synonymous mutations of this gene have already been found in patients with renal clear cell carcinoma, melanoma, and acute lymphoid leukemia among many others. Such mutations can potentially affect a protein's structure and hence its functions. In this study, therefore, the most deleterious SNPs of mTOR protein have been determined to identify potential biomarkers for various disease treatments. The aim is to generate a structured dataset of the mTOR gene's SNPs that may prove to be an asset for the identification and treatment of multiple diseases associated with the target gene. Both sequence and structure-based approaches were adopted and a wide variety of bioinformatics tools were applied to analyze the SNPs of mTOR protein. In total 11 nsSNPs have been filtered out of 2178 nsSNPs along with two non-coding variations. All of the nsSNPs were found to destabilize the protein structure and disrupt its function. While R619C, A1513D, and T1977R mutations were shown to alter C alpha distances and bond angles of the mTOR protein, L509Q, R619C and N2043S were predicted to disrupt the mTOR protein's interaction with NBS1 protein and FKBP1A/rapamycin complex. In addition, one of the non-coding SNPs was shown to alter miRNA binding sites. Characterizing nsSNPs and non-coding SNPs and their harmful effects on a protein's structure and functions will enable researchers to understand the critical impact of mutations on the molecular mechanisms of various diseases. This will ultimately lead to the identification of potential targets for disease diagnosis and therapeutic interventions.	[Yasmin, Tahirah] Univ Dhaka, Dept Biochem & Mol Biol, Dhaka, Bangladesh	University of Dhaka	Yasmin, T (corresponding author), Univ Dhaka, Dept Biochem & Mol Biol, Dhaka, Bangladesh.	tahirah.yasmin@du.ac.bd		Yasmin, Tahirah/0000-0002-8143-2993				Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Armon A, 2001, J MOL BIOL, V307, P447, DOI 10.1006/jmbi.2000.4474; Bhattacharya A, 2014, NUCLEIC ACIDS RES, V42, pD86, DOI 10.1093/nar/gkt1028; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Brookes AJ, 1999, GENE, V234, P177, DOI 10.1016/S0378-1119(99)00219-X; Bulusu KC, 2014, NUCLEIC ACIDS RES, V42, pD1040, DOI 10.1093/nar/gkt1182; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Capriotti E, 2006, BIOINFORMATICS, V22, P2729, DOI 10.1093/bioinformatics/btl423; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; Capriotti E, 2004, BIOINFORMATICS, V20, P63, DOI 10.1093/bioinformatics/bth928; Capriotti E, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S3-S2; Cheng JL, 2006, PROTEINS, V62, P1125, DOI 10.1002/prot.20810; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hecht M, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S8-S1; Hoadley KA, 2018, CELL, V173, P291, DOI 10.1016/j.cell.2018.03.022; Hunt SE, 2018, DATABASE-OXFORD, DOI [10.1093/database/bay119, 10.1186/1471-2164-11-293]; Husen P, 2019, TRANSPL P, V51, P1962, DOI 10.1016/j.transproceed.2019.03.027; Improta R, 2015, PROTEINS, V83, P1973, DOI 10.1002/prot.24876; Ittisoponpisan S, 2019, J MOL BIOL, V431, P2197, DOI 10.1016/j.jmb.2019.04.009; Jin ZN, 2016, ONCOTARGET, V7, P57464, DOI 10.18632/oncotarget.10805; Kamaraj B, 2016, J CELL BIOCHEM, V117, P2608, DOI 10.1002/jcb.25555; Kamaraj B, 2015, J BIOMOL STRUCT DYN, V33, P834, DOI 10.1080/07391102.2014.915762; Kamaraj B, 2014, CELL BIOCHEM BIOPHYS, V68, P97, DOI 10.1007/s12013-013-9697-2; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Klausen MS, 2019, PROTEINS, V87, P520, DOI 10.1002/prot.25674; Kumar A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003318; Kumar A, 2014, CELL BIOCHEM BIOPHYS, V68, P233, DOI 10.1007/s12013-013-9705-6; Kumar A, 2013, CELL BIOCHEM BIOPHYS, V67, P837, DOI 10.1007/s12013-013-9572-1; Kumar A, 2013, GENE, V519, P34, DOI 10.1016/j.gene.2013.01.056; Landrum MJ, 2018, NUCLEIC ACIDS RES, V46, pD1062, DOI 10.1093/nar/gkx1153; Li QX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071968; Liu JF, 2018, CELL, V173, P400, DOI 10.1016/j.cell.2018.02.052; Lopez-Ferrando V, 2017, NUCLEIC ACIDS RES, V45, pW222, DOI 10.1093/nar/gkx313; Messaoudi A, 2013, THEOR BIOL MED MODEL, V10, DOI 10.1186/1742-4682-10-22; Meyer MJ, 2016, HUM MUTAT, V37, P447, DOI 10.1002/humu.22963; Neufeld TP, 2010, CURR OPIN CELL BIOL, V22, P157, DOI 10.1016/j.ceb.2009.11.005; Pearce LR, 2007, BIOCHEM J, V405, P513, DOI 10.1042/BJ20070540; Pejaver V, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19669-x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pinero J, 2021, COMPUT STRUCT BIOTEC, V19, P2960, DOI 10.1016/j.csbj.2021.05.015; Rentzsch P, 2019, NUCLEIC ACIDS RES, V47, pD886, DOI 10.1093/nar/gky1016; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Rogers MF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11746-4; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Scaiola A, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc1251; Sherry ST, 1999, GENOME RES, V9, P677; Sim NL, 2012, NUCLEIC ACIDS RES, V40, pW452, DOI 10.1093/nar/gks539; Snel B, 2000, NUCLEIC ACIDS RES, V28, P3442, DOI 10.1093/nar/28.18.3442; Steinegger M, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-3019-7; Takei N, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00028; Vaser R, 2016, NAT PROTOC, V11, P1, DOI 10.1038/nprot.2015.123; Venselaar H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-548; Wang DL, 2020, NUCLEIC ACIDS RES, V48, pW140, DOI 10.1093/nar/gkaa275; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Xue WJ, 2018, J CANCER, V9, P1448, DOI 10.7150/jca.23566; Yates CM, 2014, J MOL BIOL, V426, P2692, DOI 10.1016/j.jmb.2014.04.026; Zehir A, 2017, NAT MED, V23, P703, DOI 10.1038/nm.4333; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhou HY, 2010, CURR PROTEIN PEPT SC, V11, P409, DOI 10.2174/138920310791824093; Zhu ML, 2013, J THORAC ONCOL, V8, P788, DOI 10.1097/JTO.0b013e31828916c6; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	68	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7								10.1371/journal.pone.0270919	http://dx.doi.org/10.1371/journal.pone.0270919			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M5FN	35788771	gold, Green Published			2022-12-26	WOS:000835487000033
J	Venkat, A; Tehrani, D; Taujale, R; Yeung, W; Gravel, N; Moremen, K; Kannan, N				Venkat, Aarya; Tehrani, Daniel; Taujale, Rahil; Yeung, Wayland; Gravel, Nathan; Moremen, Kelley; Kannan, Natarajan			Modularity of the hydrophobic core and evolution of functional diversity in fold A glycosyltransferases	GLYCOBIOLOGY			English	Meeting Abstract	Annual Meeting of the Society-for-Glycobiology (SPR)	OCT 02-05, 2022	Fernandina Beach, FL	Soc Glycobiol					[Venkat, Aarya; Tehrani, Daniel; Yeung, Wayland; Gravel, Nathan; Moremen, Kelley; Kannan, Natarajan] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Tehrani, Daniel; Moremen, Kelley] Complex Carboyhdrate Res Ctr, Athens, GA USA; [Taujale, Rahil; Yeung, Wayland; Gravel, Nathan; Kannan, Natarajan] Inst Bioinformat, Athens, GA USA	University System of Georgia; University of Georgia									0	0	0	1	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	OCT 31	2022	32	11				P060	992	992						1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology	5W9SZ	35780833	gold, Green Published			2022-12-26	WOS:000878249700069
J	Rahman, MM; Young, CKJ; Goffart, S; Pohjoismaki, JLO; Young, MJ				Rahman, Md Mostafijur; Young, Carolyn K. J.; Goffart, Steffi; Pohjoismaki, Jaakko L. O.; Young, Matthew J.			Heterozygous p.Y955C mutation in DNA polymerase gamma leads to alterations in bioenergetics, complex I subunit expression, and mtDNA replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN MITOCHONDRIAL-DNA; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; TRANSCRIPTION-FACTOR-A; SACCHAROMYCES-CEREVISIAE; NUCLEOSIDE ANALOGS; HELICASE TWINKLE; DISEASE VARIANT; TOXICITY; CELLS; POLG	In human cells, ATP is generated using oxidative phosphorylation machinery, which is inoperable without proteins encoded by mitochondrial DNA (mtDNA). The DNA polymerase gamma (Pol gamma) repairs and replicates the multicopy mtDNA genome in concert with additional factors. The Pol gamma catalytic subunit is encoded by the POLG gene, and mutations in this gene cause mtDNA genome instability and disease. Barriers to studying the molecular effects of disease mutations include scarcity of patient samples and a lack of available mutant models; therefore, we developed a human SJCRH30 myoblast cell line model with the most common autosomal dominant POLG mutation, c.2864A>G/p.Y955C, as individuals with this mutation can present with progressive skeletal muscle weakness. Using on-target sequencing, we detected a 50% conversion frequency of the mutation, confirming heterozygous Y955C substitution. We found mutated cells grew slowly in a glucose-containing medium and had reduced mitochondrial bioenergetics compared with the parental cell line. Furthermore, growing Y955C cells in a galactose-containing medium to obligate mitochondrial function enhanced these bioenergetic deficits. Also, we show complex I NDUFB8 and ND3 protein levels were decreased in the mutant cell line, and the maintenance of mtDNA was severely impaired (i.e., lower copy number, fewer nucleoids, and an accumulation of Y955C-specific replication intermediates). Finally, we show the mutant cells have increased sensitivity to the mitochondrial toxicant 2'-3'-dideoxycytidine. We expect this POLG Y955C cell line to be a robust system to identify new mitochondrial toxicants and therapeutics to treat mitochondrial dysfunction.	[Rahman, Md Mostafijur; Young, Carolyn K. J.; Young, Matthew J.] Southern Illinois Univ, Dept Biochem & Mol Biol, Sch Med, Carbondale, IL 62901 USA; [Goffart, Steffi; Pohjoismaki, Jaakko L. O.] Univ Eastern Finland, Dept Environm & Biol Sci, Joensuu, Finland	Southern Illinois University System; Southern Illinois University; University of Eastern Finland	Young, MJ (corresponding author), Southern Illinois Univ, Dept Biochem & Mol Biol, Sch Med, Carbondale, IL 62901 USA.	matthew.young@siu.edu	Rahman, Md Mostafijur/GPC-8781-2022	Rahman, Md Mostafijur/0000-0002-2857-0369; Young, Carolyn/0000-0001-9678-7327; Young, Matthew/0000-0002-5109-4719	National Institute of Environmental Health Sciences (NIEHS, National Institutes of Health) Pathway to Independence Award [5R00ES022638-04]; NIEHS, National Institutes of Health [1R15ES033394-01]; SIU School of Medicine; SIU Carbondale Doctoral Research Fellowship	National Institute of Environmental Health Sciences (NIEHS, National Institutes of Health) Pathway to Independence Award; NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); SIU School of Medicine; SIU Carbondale Doctoral Research Fellowship	This research was supported by a National Institute of Environmental Health Sciences (NIEHS, National Institutes of Health) Pathway to Independence Award to M. J. Y. (5R00ES022638-04), an NIEHS, National Institutes of Health R15 to M. J. Y. (1R15ES033394-01), start-up funds from SIU School of Medicine to M. J. Y, and by an SIU Carbondale Doctoral Research Fellowship to M. M. R. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ashley N, 2005, EXP CELL RES, V303, P432, DOI 10.1016/j.yexcr.2004.10.013; Atanassova N, 2011, HUM MOL GENET, V20, P1212, DOI 10.1093/hmg/ddq565; Bailey CM, 2009, ANTIMICROB AGENTS CH, V53, P2610, DOI 10.1128/AAC.01659-08; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219; Belmonte FR, 2016, SCI REP-UK, V6, DOI 10.1038/srep25186; Birkus G, 2002, ANTIMICROB AGENTS CH, V46, P716, DOI 10.1128/AAC.46.3.716-723.2002; Bjork JA, 2021, TOXICOL APPL PHARM, V433, DOI 10.1016/j.taap.2021.115783; Chaudhry A, 2020, AM J PHYSIOL-ENDOC M, V318, pE87, DOI 10.1152/ajpendo.00457.2019; Chen C, 2020, NEUROBIOL DIS, V134, DOI 10.1016/j.nbd.2019.104631; Chiappini F, 2009, CURR HIV RES, V7, P244, DOI 10.2174/157016209787581409; Ciesielska EJ, 2021, MITOCHONDRION, V61, P147, DOI 10.1016/j.mito.2021.09.010; Civitarese AE, 2010, CELL METAB, V11, P412, DOI 10.1016/j.cmet.2010.04.004; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; Clayton David A, 2014, Cold Spring Harb Protoc, V2014, DOI 10.1101/pdb.prot080002; Cohen BH, 2010, METHODS, V51, P364, DOI 10.1016/j.ymeth.2010.05.008; Divakaruni AS, 2014, METHOD ENZYMOL, V547, P309, DOI 10.1016/B978-0-12-801415-8.00016-3; Dong DW, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-677; Duong VN, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66153-z; Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004; Estep PA, 2011, BIOCHEMISTRY-US, V50, P6376, DOI 10.1021/bi200280r; Falabella M, 2019, CURR MED CHEM, V26, P2918, DOI 10.2174/0929867325666180228165527; Falkenberg M, 2020, CRIT REV BIOCHEM MOL, V55, P509, DOI 10.1080/10409238.2020.1818684; Farnum GA, 2014, BBA-BIOENERGETICS, V1837, P1113, DOI 10.1016/j.bbabio.2014.01.021; Fontana GA, 2020, NUCLEIC ACIDS RES, V48, P11244, DOI 10.1093/nar/gkaa804; Garcia-Gomez S, 2013, MOL CELL, V52, P541, DOI 10.1016/j.molcel.2013.09.025; Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359; Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805; Graziewicz MA, 2007, HUM MOL GENET, V16, P2729, DOI 10.1093/hmg/ddm227; Green M.R., 2012, MOL CLONING LAB MANU; Gustafson MA, 2020, DNA REPAIR, V93, DOI 10.1016/j.dnarep.2020.102916; Gustafsson CM, 2016, ANNU REV BIOCHEM, V85, P133, DOI 10.1146/annurev-biochem-060815-014402; He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067; Hyvarinen AK, 2007, NUCLEIC ACIDS RES, V35, P6458, DOI 10.1093/nar/gkm676; Ittisoponpisan S, 2019, J MOL BIOL, V431, P2197, DOI 10.1016/j.jmb.2019.04.009; Jemt E, 2015, NUCLEIC ACIDS RES, V43, P9262, DOI 10.1093/nar/gkv804; Jha Pooja, 2016, Curr Protoc Mouse Biol, V6, P1, DOI 10.1002/9780470942390.mo150182; Khurana L, 2019, METHOD ENZYMOL, V629, P307, DOI 10.1016/bs.mie.2019.05.053; Kikin O, 2006, NUCLEIC ACIDS RES, V34, pW676, DOI 10.1093/nar/gkl253; Kolesar JE, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1324; Ladner CL, 2004, ANAL BIOCHEM, V326, P13, DOI 10.1016/j.ab.2003.10.047; Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050; Lewis W, 2007, LAB INVEST, V87, P326, DOI 10.1038/labinvest.3700523; Li CF, 2021, AUTOPHAGY, V17, P948, DOI [10.1080/15548627.2020.1739447, 10.1145/3421766.3421867]; Li M, 2016, ANTIMICROB AGENTS CH, V60, P5608, DOI 10.1128/AAC.00976-16; Liang XQ, 2017, J BIOTECHNOL, V241, P136, DOI 10.1016/j.jbiotec.2016.11.011; Lobo-Jarne T, 2018, SEMIN CELL DEV BIOL, V76, P179, DOI 10.1016/j.semcdb.2017.07.021; Lujan SA, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02138-5; Maniura-Weber K, 2004, NUCLEIC ACIDS RES, V32, P6015, DOI 10.1093/nar/gkh921; Marroquin LD, 2007, TOXICOL SCI, V97, P539, DOI 10.1093/toxsci/kfm052; MARTIN JL, 1994, ANTIMICROB AGENTS CH, V38, P2743, DOI 10.1128/AAC.38.12.2743; Matic S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03552-x; MEDINA DJ, 1994, ANTIMICROB AGENTS CH, V38, P1824, DOI 10.1128/AAC.38.8.1824; Melkonian E. A., 2022, BIOCH ANAEROBIC GLYC; Mello DF, 2022, ENVIRON SCI TECHNOL, V56, P1113, DOI 10.1021/acs.est.1c05915; Morino K, 2012, DIABETES, V61, P877, DOI 10.2337/db11-1391; Nicholls TJ, 2018, MOL CELL, V69, P9, DOI 10.1016/j.molcel.2017.11.033; Nicholls TJ, 2014, HUM MOL GENET, V23, P6147, DOI 10.1093/hmg/ddu336; Niyazov DM, 2016, MOL SYNDROMOL, V7, P122, DOI 10.1159/000446586; Ohnstad HO, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-211; Pagnamenta AT, 2006, HUM REPROD, V21, P2467, DOI 10.1093/humrep/del076; Palin EJH, 2013, BRAIN, V136, P2379, DOI 10.1093/brain/awt160; Peeva V, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04131-w; Phillips AF, 2017, MOL CELL, V65, P527, DOI 10.1016/j.molcel.2016.12.014; Pohjoismaki JLO, 2006, NUCLEIC ACIDS RES, V34, P5815, DOI 10.1093/nar/gkl703; Pohjoismaki JLO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010426; Pohjoismaki JLO, 2009, J BIOL CHEM, V284, P21446, DOI 10.1074/jbc.M109.016600; Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200; Prasad R, 2017, DNA REPAIR, V60, P77, DOI 10.1016/j.dnarep.2017.10.011; Qian W, 2010, METHODS, V51, P452, DOI 10.1016/j.ymeth.2010.03.006; Rahman S, 2019, NAT REV NEUROL, V15, P40, DOI 10.1038/s41582-018-0101-0; Reyes A, 2009, METHODS MOL BIOL, V554, P15, DOI 10.1007/978-1-59745-521-3_2; ROBERTS WM, 1989, CANCER RES, V49, P5407; Rocher C, 2008, J BIOENERG BIOMEMBR, V40, P59, DOI 10.1007/s10863-008-9130-5; Saneto RP, 2010, DEV DISABIL RES REV, V16, P163, DOI 10.1002/ddrr.105; Schlieben LD, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.600079; Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275; Setzer B, 2005, ANTIVIR THER, V10, P327; Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409; Siibak T, 2017, HUM MOL GENET, V26, P2515, DOI 10.1093/hmg/ddx146; Singer VL, 1997, ANAL BIOCHEM, V249, P228, DOI 10.1006/abio.1997.2177; Singh B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140409; Stuart GR, 2006, HUM MOL GENET, V15, P363, DOI 10.1093/hmg/ddi454; Sufit A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165107; Sykora P, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00237-17; Szymanski MR, 2015, EMBO J, V34, P1959, DOI 10.15252/embj.201591520; Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222; TAPPER DP, 1981, J BIOL CHEM, V256, P5109; Torregrosa-Munumer R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45244-6; Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034; Wallace KB, 2022, TOXICOL APPL PHARM, V442, DOI 10.1016/j.taap.2022.116003; Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215; Wheeler Joel H, 2019, Curr Protoc Toxicol, V80, pe75, DOI 10.1002/cptx.75; Wisnovsky S, 2016, NAT CHEM BIOL, V12, P567, DOI [10.1038/NCHEMBIO.2102, 10.1038/nchembio.2102]; Xu YL, 2021, ANTIMICROB AGENTS CH, V65, DOI 10.1128/AAC.02237-20; Yamanaka H, 2007, J INFECT DIS, V195, P1419, DOI 10.1086/513872; Young CKJ, 2019, CELL CYCLE, V18, P476, DOI 10.1080/15384101.2019.1578133; Young CKJ, 2021, J BIOL CHEM, V296, DOI 10.1074/jbc.RA120.014885; Young MJ, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00074; Young MJ, 2016, CURR OPIN GENET DEV, V38, P52, DOI 10.1016/j.gde.2016.03.005; Young MJ, 2015, HUM MOL GENET, V24, P5184, DOI 10.1093/hmg/ddv240	101	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2022	298	8							102196	10.1016/j.jbc.2022.102196	http://dx.doi.org/10.1016/j.jbc.2022.102196			29	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3S2WH	35760101	gold, Green Published			2022-12-26	WOS:000839461200010
J	Stafford, P; Mitra, S; Debot, M; Lutz, P; Stem, A; Hadley, J; Hom, P; Schaid, TRR; Cohen, MJJ				Stafford, Preston; Mitra, Sanchayita; Debot, Margot; Lutz, Patrick; Stem, Arthur; Hadley, Jamie; Hom, Patrick; Schaid, Terry R. R.; Cohen, Mitchell J. J.			Astrocytes and pericytes attenuate severely injured patient plasma mediated expression of tight junction proteins in endothelial cells	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; CLAUDIN-5 EXPRESSION; DYSFUNCTION; ANGIOPOIETIN-2; ACTIVATION; OCCLUDIN; MARKER; ZO-1	Blood Brain Barrier (BBB) breakdown is a secondary form of brain injury which has yet to be fully elucidated mechanistically. Existing research suggests that breakdown of tight junction proteins between endothelial cells is a primary driver of increased BBB permeability following injury, and intercellular signaling between primary cells of the neurovascular unit: endothelial cells, astrocytes, and pericytes; contribute to tight junction restoration. To expound upon this body of research, we analyzed the effects of severely injured patient plasma on each of the cell types in monoculture and together in a triculture model for the transcriptional and translational expression of the tight junction proteins Claudins 3 and 5, (CLDN3, CLDN5) and Zona Occludens 1 (ZO-1). Conditioned media transfer studies were performed to illuminate the cell type responsible for differential tight junction expression. Our data show that incubation with 5% human ex vivo severely injured patient plasma is sufficient to produce a differential response in endothelial cell tight junction mRNA and protein expression. Endothelial cells in monoculture produced a significant increase of CLDN3 and CLDN5 mRNA expression, (3.98 and 3.51 fold increase vs. control respectively, p<0.01) and CLDN5 protein expression, (2.58 fold change vs. control, p<0.01), whereas in triculture, this increase was attenuated. Our triculture model and conditioned media experiments suggest that conditioned media from astrocytes and pericytes and a triculture of astrocytes, pericytes and endothelial cells are sufficient in attenuating the transcriptional increases of tight junction proteins CLDN3 and CLDN5 observed in endothelial monocultures following incubation with severely injured trauma plasma. This data suggests that inhibitory molecular signals from astrocytes and pericytes contributes to prolonged BBB breakdown following injury via tight junction transcriptional and translational downregulation of CLDN5.	[Stafford, Preston; Mitra, Sanchayita; Debot, Margot; Lutz, Patrick; Stem, Arthur; Hadley, Jamie; Hom, Patrick; Schaid, Terry R. R.; Cohen, Mitchell J. J.] Univ Colorado, Dept Surg, Div GITES, Anschutz Med Campus, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Cohen, MJJ (corresponding author), Univ Colorado, Dept Surg, Div GITES, Anschutz Med Campus, Aurora, CO 80045 USA.	Mitchell.cohen@cuanschutz.edu		Schaid, Terry/0000-0001-7183-0771; Stafford, Preston/0000-0003-4848-9979	National Heart, Lung and Blood Institute, NIH [TACTIC UM1-HL120877]	National Heart, Lung and Blood Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	MC Trans-agency Research Consortium for Trauma Induced Coagulopathy (TACTIC UM1-HL120877) from the National Heart, Lung and Blood Institute, NIH. https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-13-025.htmlThe funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alluri H, 2015, METAB BRAIN DIS, V30, P1093, DOI 10.1007/s11011-015-9651-7; Bai Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124362; Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; Beard RS, 2020, J CEREBR BLOOD F MET, V40, P374, DOI 10.1177/0271678X18817512; Beck H, 2000, AM J PATHOL, V157, P1473, DOI 10.1016/S0002-9440(10)64786-4; Beggs S, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-74; Berndt P, 2019, CELL MOL LIFE SCI, V76, P1987, DOI 10.1007/s00018-019-03030-7; Bhowmick S, 2019, EXP NEUROL, V317, P260, DOI 10.1016/j.expneurol.2019.03.014; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Camire RB, 2015, J NEUROIMMUNOL, V284, P57, DOI 10.1016/j.jneuroim.2015.05.008; Cohen MJ, 2010, J TRAUMA, V69, P31, DOI 10.1097/TA.0b013e3181e043fe; Coleman JR, 2019, SURGERY, V166, P1122, DOI 10.1016/j.surg.2019.07.014; Coyne CB, 2003, AM J PHYSIOL-LUNG C, V285, pL1166, DOI 10.1152/ajplung.00182.2003; Dias MC, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36731-3; Doherty CP, 2016, J NEUROPATH EXP NEUR, V75, P656, DOI 10.1093/jnen/nlw036; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Farell M, 2019, CLIN NEUROPATHOL, V38, P51, DOI 10.5414/NP301130; Faul M., TRAUMATIC BRAIN INJU; Ganter MT, 2008, ANN SURG, V247, P320, DOI 10.1097/SLA.0b013e318162d616; Gorina R, 2011, GLIA, V59, P242, DOI 10.1002/glia.21094; Greene C, 2018, MOL PSYCHIATR, V23, P2156, DOI 10.1038/mp.2017.156; Greene C, 2019, FLUIDS BARRIERS CNS, V16, DOI 10.1186/s12987-019-0123-z; Gu H, 2018, ARTERY RES, V23, P45, DOI 10.1016/j.artres.2018.07.004; Haseloff RF, 2015, SEMIN CELL DEV BIOL, V38, P16, DOI 10.1016/j.semcdb.2014.11.004; Hatherell K, 2011, J NEUROSCI METH, V199, P223, DOI 10.1016/j.jneumeth.2011.05.012; Helms HC, 2016, J CEREBR BLOOD F MET, V36, P862, DOI 10.1177/0271678X16630991; Hodgman EI, 2012, J TRAUMA ACUTE CARE, V72, P844, DOI 10.1097/TA.0b013e31824ef9d2; Honda M, 2006, CELL MOL NEUROBIOL, V26, P109, DOI 10.1007/s10571-006-9028-x; Ishrat T, 2010, EXP NEUROL, V226, P183, DOI 10.1016/j.expneurol.2010.08.023; Itoh M, 1999, J CELL BIOL, V147, P1351, DOI 10.1083/jcb.147.6.1351; Jiao HX, 2011, J MOL NEUROSCI, V44, P130, DOI 10.1007/s12031-011-9496-4; Kim M, 2016, J CLIN INVEST, V126, P3511, DOI 10.1172/JCI84871; Lazear HM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4304; Liebner S, 2000, ACTA NEUROPATHOL, V100, P323, DOI 10.1007/s004010000180; Milatz S, 2010, BBA-BIOMEMBRANES, V1798, P2048, DOI 10.1016/j.bbamem.2010.07.014; Morini MF, 2018, CIRC RES, V122, P231, DOI 10.1161/CIRCRESAHA.117.312392; Nag S, 2007, ACTA NEUROPATHOL, V114, P459, DOI 10.1007/s00401-007-0274-x; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Ohtsuki S, 2007, J CELL PHYSIOL, V210, P81, DOI 10.1002/jcp.20823; Paschoud S, 2007, MODERN PATHOL, V20, P947, DOI 10.1038/modpathol.3800835; Price L., 2016, TRANSLATIONAL RES TR; Quah S., 2016, INT ENCY PUBLIC HLTH; Rosa JM, 2021, BRIT J PHARMACOL, V178, P3395, DOI 10.1111/bph.15488; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; Steinemann A, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00016; Stone NL, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00230; Strbian D, 2008, NEUROSCIENCE, V153, P175, DOI 10.1016/j.neuroscience.2008.02.012; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thal SC, 2014, ARCH MED RES, V45, P698, DOI 10.1016/j.arcmed.2014.11.006; Vajtr D, 2009, PHYSIOL RES, V58, P263, DOI 10.33549/physiolres.931253; Wen JF, 2014, EXP THER MED, V8, P881, DOI 10.3892/etm.2014.1818; Winkler EA, 2011, NAT NEUROSCI, V14, P1398, DOI 10.1038/nn.2946; Yang CJ, 2019, AM J PHYSIOL-CELL PH, V316, pC135, DOI 10.1152/ajpcell.00136.2018; Zhao Z, 2015, CELL, V163, P1064, DOI 10.1016/j.cell.2015.10.067	54	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7								10.1371/journal.pone.0270817	http://dx.doi.org/10.1371/journal.pone.0270817			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M5FN	35789221	Green Published, gold			2022-12-26	WOS:000835487000029
J	Tan, SH; Li, RC; Vachula, RS; Tao, XY; Wen, MD; Liu, YZ; Dong, HY; Zhou, LT				Tan, Shuhui; Li, Rencheng; Vachula, Richard S.; Tao, Xinyue; Wen, Mengdan; Liu, Yizhi; Dong, Haiyan; Zhou, Lintong			Electron probe microanalysis of the elemental composition of phytoliths from woody bamboo species	PLOS ONE			English	Article							CARBON-ISOTOPE SIGNATURES; OCCLUDED CARBON; DENDROCALAMUS-RONGANENSIS; REPRESENTATIONAL BIAS; CHEMICAL-COMPOSITION; SILICA PHYTOLITHS; PLANT WATER; DISSOLUTION; GRASSES; OPAL	Electron probe microanalysis (EPMA) is promising for accurately determining elemental components in micro-areas of individual phytolith particles, interpreting compositional features and formation mechanisms of phytoliths in plants, identifying archeological and sedimental phytolith. However, the EPMA method of analyzing mounted slide phytoliths has not well been defined. In this study, we attempted different EPMA methods to determine the elemental compositions of phytoliths in mounted slides. Direct analysis of carbon (DAC) with other elements in phytolith could obtain abnormally high total values and carbon values. The method of carbon excluded in measuring elements (non-carbon analysis (NCA)) was feasible to obtain elemental compositions in phytolith. The NCA method was conducive to obtain the factual elemental compositions of an individual phytolith (morphotype) when the carbon content of phytolith was relatively low. The EPMA results of phytoliths from 20 bamboo species (three genera) showed that phytolith was dominantly composed of SiO2 but also included low contents of diverse other elements. The EPMA of phytoliths can provide the elemental composition of micro-areas of an individual phytolith particle. The elemental compositions of phytolith varied with their morphotypes, the genera and ecotype of bamboos. The EPMA of elemental compositions in phytoliths is a potential tool to study the formation mechanism of phytoliths, plant taxonomical identification, archaeological and paleoenvironmental reconstruction.	[Tan, Shuhui; Li, Rencheng; Tao, Xinyue; Wen, Mengdan; Liu, Yizhi; Dong, Haiyan; Zhou, Lintong] Guilin Univ Technol, Coll Earth Sci, Guilin, Peoples R China; [Li, Rencheng] Guangxi Key Lab Hidden Metall Ore Deposits Explor, Guilin, Peoples R China; [Vachula, Richard S.] Coll William & Mary, Dept Geol, Williamsburg, VA USA	Guilin University of Technology; William & Mary	Li, RC (corresponding author), Guilin Univ Technol, Coll Earth Sci, Guilin, Peoples R China.; Li, RC (corresponding author), Guangxi Key Lab Hidden Metall Ore Deposits Explor, Guilin, Peoples R China.	lirencheng98@gmail.com		Li, Rencheng/0000-0003-1435-2106	National Natural Science Foundation of China [41867058]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We are grateful to Wanyi Liang and Siming Zhao for help in EPMA experiments.	Alexandre A, 1997, PALAEOGEOGR PALAEOCL, V136, P213, DOI 10.1016/S0031-0182(97)00089-8; Alexandre A, 2016, BIOGEOSCIENCES, V13, P1693, DOI 10.5194/bg-13-1693-2016; Anala R, 2015, PADDY WATER ENVIRON, V13, P521, DOI 10.1007/s10333-014-0468-5; Ball T, 2016, J ARCHAEOL SCI, V68, P32, DOI 10.1016/j.jas.2015.08.010; Barboni D, 1999, PALAEOGEOGR PALAEOCL, V152, P87, DOI 10.1016/S0031-0182(99)00045-0; BARTOLI F, 1980, SOIL SCI SOC AM J, V44, P873, DOI 10.2136/sssaj1980.03615995004400040043x; BENNETT DM, 1980, ANN BOT-LONDON, V45, P541, DOI 10.1093/oxfordjournals.aob.a085858; Blecker SW, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2006GB002690; Bujan E, 2013, QUATERN INT, V287, P114, DOI 10.1016/j.quaint.2012.02.046; Bustin RM, 1996, INT J COAL GEOL, V32, P5, DOI 10.1016/S0166-5162(96)00028-6; Carnelli AL, 2002, AM J BOT, V89, P346, DOI 10.3732/ajb.89.2.346; Carter JA, 2009, QUATERN INT, V193, P20, DOI 10.1016/j.quaint.2007.11.013; Delplace G, 2020, SCI TOTAL ENVIRON, V712, DOI 10.1016/j.scitotenv.2019.135595; Du S, 2017, J MATER CIVIL ENG, V29, DOI 10.1061/(ASCE)MT.1943-5533.0001854; Elbaum R, 2009, QUATERN INT, V193, P11, DOI 10.1016/j.quaint.2007.07.006; Fenwick RSH, 2011, J ARCHAEOL SCI, V38, P2190, DOI 10.1016/j.jas.2011.03.016; FREDLUND GG, 1994, J BIOGEOGR, V21, P321, DOI 10.2307/2845533; Gao GZ, 2018, QUATERNARY RES, V90, P38, DOI 10.1017/qua.2018.5; Gierlinger N, 2008, PLANTA, V227, P969, DOI 10.1007/s00425-007-0671-3; Gu YS, 2016, J ARCHAEOL SCI, V68, P46, DOI 10.1016/j.jas.2015.08.003; Hart D., 2001, ELEMENTS OCCLUDED PH; HAYWARD DM, 1973, ANN BOT-LONDON, V37, P579, DOI 10.1093/oxfordjournals.aob.a084723; Hodson MJ, 2019, FRONT EARTH SC-SWITZ, V7, DOI 10.3389/feart.2019.00167; Hodson MJ, 2016, J ARCHAEOL SCI, V68, P62, DOI 10.1016/j.jas.2015.09.002; Hyland E, 2013, PALAEOGEOGR PALAEOCL, V374, P338, DOI 10.1016/j.palaeo.2013.01.026; Jakes KA, 1996, J ARCHAEOL SCI, V23, P149, DOI 10.1006/jasc.1996.0012; Kamenik J, 2013, ENVIRON CHEM LETT, V11, P189, DOI 10.1007/s10311-012-0396-9; KAUFMAN PB, 1969, SCIENCE, V166, P1015, DOI 10.1126/science.166.3908.1015; Krull ES, 2003, ORG GEOCHEM, V34, P1337, DOI 10.1016/S0146-6380(03)00100-1; Kumar S, 2017, NEW PHYTOL, V213, P791, DOI 10.1111/nph.14173; LANE SJ, 1994, AM MINERAL, V79, P745; [李仁成 Li Rencheng], 2020, [第四纪研究, Quaternary Sciences], V40, P283; Li RC, 2019, J PALEOLIMNOL, V61, P201, DOI 10.1007/s10933-018-0053-9; Li RC, 2017, REV PALAEOBOT PALYNO, V246, P62, DOI 10.1016/j.revpalbo.2017.06.006; Li RC, 2016, ORG GEOCHEM, V101, P72, DOI 10.1016/j.orggeochem.2016.08.012; [李仁成 Li Rencheng], 2013, [地球科学进展, Advance in Earth Sciences], V28, P1287; Li RC, 2010, J ARCHAEOL SCI, V37, P124, DOI 10.1016/j.jas.2009.09.022; Li ZM, 2020, GEODERMA, V360, DOI 10.1016/j.geoderma.2019.114037; Li ZM, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00529; Lu HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004448; Lu HY, 2003, DIVERS DISTRIB, V9, P73, DOI 10.1046/j.1472-4642.2003.00166.x; Madella M, 2009, QUATERN INT, V193, P32, DOI 10.1016/j.quaint.2007.06.012; McCune JL, 2013, PALAEOGEOGR PALAEOCL, V383, P59, DOI 10.1016/j.palaeo.2013.05.003; Motomura H, 2004, ANN BOT-LONDON, V93, P235, DOI 10.1093/aob/mch034; Nguyen HX, 2019, ARCH AGRON SOIL SCI, V65, P1354, DOI 10.1080/03650340.2018.1564908; Osterrieth M, 2009, QUATERN INT, V193, P70, DOI 10.1016/j.quaint.2007.09.002; Parr J, 2010, GLOBAL CHANGE BIOL, V16, P2661, DOI 10.1111/j.1365-2486.2009.02118.x; Parr JF, 2014, PLANT SOIL, V374, P45, DOI 10.1007/s11104-013-1847-1; Parr JF, 2011, PLANT SOIL, V342, P165, DOI 10.1007/s11104-010-0680-z; PERRY CC, 1987, J PLANT PHYSIOL, V126, P437, DOI 10.1016/S0176-1617(87)80028-7; Piperno D.R., 1998, SMITHSONIAN CONTRIBU, P1, DOI [10.5479/si.0081024X.85, DOI 10.5479/SI.0081024X.85]; Piperno DR, 1996, QUATERNARY RES, V45, P202, DOI 10.1006/qres.1996.0020; Piperno DR, 2003, SCIENCE, V299, P1054, DOI 10.1126/science.1080365; Reyerson PE, 2016, BIOGEOSCIENCES, V13, P1269, DOI 10.5194/bg-13-1269-2016; Santos GM, 2010, RADIOCARBON, V52, P113, DOI 10.1017/S0033822200045070; Shillito LM, 2009, SPECTROCHIM ACTA A, V73, P133, DOI 10.1016/j.saa.2009.02.004; Smith FA, 2004, PALAEOGEOGR PALAEOCL, V207, P277, DOI 10.1016/j.palaeo.2003.09.029; Song ZL, 2016, EARTH-SCI REV, V158, P19, DOI 10.1016/j.earscirev.2016.04.007; Tao XY, 2020, REV PALAEOBOT PALYNO, V272, DOI 10.1016/j.revpalbo.2019.104129; Tran TTT, 2019, J ENVIRON MANAGE, V249, DOI 10.1016/j.jenvman.2019.109423; Trinh TK, 2017, SOIL TILL RES, V171, P19, DOI 10.1016/j.still.2017.04.002; Tsutsui O, 2016, FLORA, V218, P44, DOI 10.1016/j.flora.2015.11.006; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; Wang Y, 1993, STUDY PHYTOLITH ITS; Wang Y., 1998, J OCEANOGR HUANGHAIB, V16, P33; Watling KM, 2011, SPECTROCHIM ACTA A, V80, P106, DOI 10.1016/j.saa.2011.03.002; Webb EA, 2000, GEOCHIM COSMOCHIM AC, V64, P767, DOI 10.1016/S0016-7037(99)00374-9; Wen MD, 2020, HOLOCENE, V30, P1567, DOI 10.1177/0959683620941086; Wu Y, 2014, J ARCHAEOL SCI, V49, P326, DOI 10.1016/j.jas.2014.06.001; Wu Y, 2014, APPL PHYS A-MATER, V114, P503, DOI 10.1007/s00339-013-7616-4; Yang J, 2014, CHINESE J ANAL CHEM, V42, P1389; Yin JH, 2014, SCI REP-UK, V4, DOI 10.1038/srep06511; Zancajo VMR, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01571; Zuo XX, 2014, PLANT SOIL, V374, P223, DOI 10.1007/s11104-013-1850-6	74	1	1	9	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7								10.1371/journal.pone.0270842	http://dx.doi.org/10.1371/journal.pone.0270842			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M5FN	35788203	gold, Green Published			2022-12-26	WOS:000835487000002
J	van Goor, HMR; van Loon, K; Breteler, MJM; Kalkman, C; Kaasjager, KAH				van Goor, Harriet M. R.; van Loon, Kim; Breteler, Martine J. M.; Kalkman, Cornelis; Kaasjager, Karin A. H.			Circadian patterns of heart rate, respiratory rate and skin temperature in hospitalized COVID-19 patients	PLOS ONE			English	Article							RHYTHMS; SLEEP; DETERIORATION; DISRUPTION; DELIRIUM; CLOCK; INDEX; LIGHT	RationaleVital signs follow circadian patterns in both healthy volunteers and critically ill patients, which seem to be influenced by disease severity in the latter. In this study we explored the existence of circadian patterns in heart rate, respiratory rate and skin temperature of hospitalized COVID-19 patients, and aimed to explore differences in circadian rhythm amplitude during patient deterioration. MethodsWe performed a retrospective study of COVID-19 patients admitted to the general ward of a tertiary hospital between April 2020 and March 2021. Patients were continuously monitored using a wireless sensor and fingertip pulse oximeter. Data was divided into three cohorts: patients who recovered, patients who developed respiratory insufficiency and patients who died. For each cohort, a population mean cosinor model was fitted to detect rhythmicity. To assess changes in amplitude, a mixed-effect cosinor model was fitted. ResultsA total of 429 patients were monitored. Rhythmicity was observed in heartrate for the recovery cohort (p<0.001), respiratory insufficiency cohort (p<0.001 and mortality cohort (p = 0.002). Respiratory rate showed rhythmicity in the recovery cohort (p<0.001), but not in the other cohorts (p = 0.18 and p = 0.51). Skin temperature also showed rhythmicity in the recovery cohort (p<0.001), but not in the other cohorts (p = 0.22 and p = 0.12). For respiratory insufficiency, only the amplitude of heart rate circadian pattern increased slightly the day before (1.2 (99%CI 0.16-2.2, p = 0.002)). In the mortality cohort, the amplitude of heart rate decreased (-1.5 (99%CI -2.6- -0.42, p<0.001)) and respiratory rate amplitude increased (0.72 (99%CI 0.27-1.3, p = 0.002) the days before death. ConclusionA circadian rhythm is present in heart rate of COVID-19 patients admitted to the general ward. For respiratory rate and skin temperature, rhythmicity was only found in patients who recover, but not in patients developing respiratory insufficiency or death. We found no consistent changes in circadian rhythm amplitude accompanying patient deterioration.	[van Goor, Harriet M. R.; Breteler, Martine J. M.; Kaasjager, Karin A. H.] Univ Med Ctr Utrecht, Dept Acute Internal Med, Utrecht, Netherlands; [van Loon, Kim; Breteler, Martine J. M.; Kalkman, Cornelis] Univ Med Ctr Utrecht, Dept Anesthesiol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	van Goor, HMR (corresponding author), Univ Med Ctr Utrecht, Dept Acute Internal Med, Utrecht, Netherlands.	h.m.r.vangoor-3@umcutrecht.nl						Baschieri F, 2019, AUTON NEUROSCI-BASIC, V217, P91, DOI 10.1016/j.autneu.2019.01.009; Bordag N, 2015, SCI REP-UK, V5, DOI 10.1038/srep15954; Born J, 1997, J IMMUNOL, V158, P4454; Bosco G, 2003, HIGH ALT MED BIOL, V4, P305, DOI 10.1089/152702903769192269; Brekke IJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210875; Chen T, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m1091, 10.1136/bmj.m1295]; Churpek MM, 2016, RESUSCITATION, V102, P1, DOI 10.1016/j.resuscitation.2016.02.005; Coiffard B, 2019, SHOCK, V52, P29, DOI 10.1097/SHK.0000000000001241; Cornelissen G, 2014, THEOR BIOL MED MODEL, V11, DOI 10.1186/1742-4682-11-16; Daou M, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.549908; Davidson S, 2021, CRIT CARE, V25, DOI 10.1186/s13054-021-03574-w; de Ree R, 2021, JAMIA OPEN, V4, DOI 10.1093/jamiaopen/ooab030; Deng JW, 2021, ANN NY ACAD SCI, V1486, P90, DOI 10.1111/nyas.14506; Eisenkraft A, 2021, J CLIN MED, V10, DOI 10.3390/jcm10184218; Ely EW, 2004, JAMA-J AM MED ASSOC, V291, P1753, DOI 10.1001/jama.291.14.1753; European Parliament, 2016, OFFICIAL J EUROPEAN, V59, P1; Griffin P, 2019, P NATL ACAD SCI USA, V116, P5102, DOI 10.1073/pnas.1812405116; Gubin DG, 2017, CHRONOBIOL INT, V34, P632, DOI 10.1080/07420528.2017.1288632; Helms J, 2020, NEW ENGL J MED, V382, P2268, DOI 10.1056/NEJMc2008597; Hirten RP, 2021, J MED INTERNET RES, V23, DOI 10.2196/26107; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Hou RX, 2021, BMC BIOINFORMATICS, V22, DOI 10.1186/s12859-021-04463-3; Idanpaan-Heikkila JE, 2001, B WORLD HEALTH ORGAN, V79, P279; KRAUCHI K, 1994, AM J PHYSIOL, V267, pR819, DOI 10.1152/ajpregu.1994.267.3.R819; Leenen JPL, 2020, J MED INTERNET RES, V22, DOI 10.2196/18636; Li JM, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.012388; Li YC, 2020, J MED VIROL, V92, P552, DOI 10.1002/jmv.25728; Maas MB, 2020, CRIT CARE MED, V48, pE1294, DOI 10.1097/CCM.0000000000004697; Maas MB, 2020, CRIT CARE MED, V48, P854, DOI 10.1097/CCM.0000000000004333; Madrid-Navarro CJ, 2015, CURR PHARM DESIGN, V21, P3453, DOI 10.2174/1381612821666150706105602; Mao L, 2020, JAMA NEUROL, V77, P683, DOI 10.1001/jamaneurol.2020.1127; Miyagi R, 2019, CHRONOBIOL INT, V36, P374, DOI 10.1080/07420528.2018.1550422; Mortola JP, 2004, EUR J APPL PHYSIOL, V91, P119, DOI 10.1007/s00421-003-0978-0; Papaioannou V, 2014, INTENS CARE MED EXP, V2, DOI 10.1186/2197-425X-2-18; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; Santos Mauro D, 2021, Front Digit Health, V3, P630273, DOI 10.3389/fdgth.2021.630273; Sarabia JA, 2008, PHYSIOL BEHAV, V95, P570, DOI 10.1016/j.physbeh.2008.08.005; Smolensky MH, 2016, CHRONOBIOL INT, V33, P1101, DOI 10.1080/07420528.2016.1184678; Spengler CM, 2000, J PHYSIOL-LONDON, V526, P683, DOI 10.1111/j.1469-7793.2000.00683.x; Tahkamo L, 2019, CHRONOBIOL INT, V36, P151, DOI 10.1080/07420528.2018.1527773; Tsai CL, 2022, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.800943; van Rossum MC, 2022, J CLIN MONIT COMPUT, V36, P407, DOI 10.1007/s10877-021-00666-4; Van Someren EJ, 2003, SLEEP BIOL RHYTHMS, V1, P55, DOI 10.1046/j.1446-9235.2003.00002.x; Vargas M, 2001, RESP PHYSIOL, V126, P233, DOI 10.1016/S0034-5687(01)00226-2; Vincent JL, 2018, EUR J ANAESTH, V35, P325, DOI 10.1097/EJA.0000000000000798; VITIELLO MV, 1986, NEUROBIOL AGING, V7, P97, DOI 10.1016/0197-4580(86)90146-6	46	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7							e0268065	10.1371/journal.pone.0268065	http://dx.doi.org/10.1371/journal.pone.0268065			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M2ZD	35797369	Green Published, gold			2022-12-26	WOS:000835328600012
J	Zheng, QZ; He, J; Qin, MS; Wu, X; Liu, TT; Huang, XL				Zheng, Qingzhou; He, Jun; Qin, Mengsheng; Wu, Xia; Liu, Tiantian; Huang, Xiaolin			Spatiotemporal variation of potential evapotranspiration and its dominant factors during 1970-2020 across the Sichuan-Chongqing region, China	PLOS ONE			English	Article							PAN EVAPORATION; RIVER-BASIN; PENMAN-MONTEITH; TREND; SENSITIVITY; VARIABLES; CLIMATE; PRECIPITATION; IMPACTS; WATER	Analyzing the primary factors of potential evapotranspiration (PET) dynamic is fundamental to accurately estimating crop yield, evaluating environmental impacts, and understanding water and carbon cycles. Previous studies have focused on regionally average regional PET and its dominant factors. Spatial distributions of PET trends and their main causes have not been fully investigated. The Mann-Kendall test was used to determine the significance of long-term trends in PET and five meteorological factors (net radiation, wind speed, air temperature, vapor pressure deficit, relative humidity) at 56 meteorological stations in the Sichuan-Chongqing region from 1970 to 2020. Furthermore, this present study combining and quantitatively illustrated sensitivities and contributions of the meteorological factors to change in annual and seasonal PET. There was a positive trend in PET for approximately 58%, 68%, 38%, 73% and 73% of all surveyed stations at annual, spring, summer, autumn and winter, respectively. Contribution analysis exhibited that the driving factors for the PET variation varied spatially and seasonally. For stations with an upward PET trend, vapor pressure deficit was a dominant factor at all time scales. For stations with a downward PET trend, annual changes in PET mainly resulted from decreased wind speed, as did changes in spring, autumn and winter; decreasing net radiation was the dominant factor in summer. The positive effect of the vapor pressure deficit offset the negative effects of wind speed and net radiation, leading to the increasing PET in this area as a whole. Sensitivity analysis showed that net radiation and relative humidity were the two most sensitive variables for PET, followed by vapor pressure deficit in this study area. Results from the two mathematical approaches were not perfect match, because the change magnitude of the meteorological factors is also responsible for the effects of meteorological factors on PET variation to some extent. However, conducting sensitivity and contribution analysis in this study can avoid the uncertainties from using a single method and provides detailed and well-understood information for interpreting the influence of global climate change on the water cycle and improving local water management.	[Zheng, Qingzhou; He, Jun; Liu, Tiantian] Chongqing Meteorol Bur, Chongqing, Peoples R China; [Qin, Mengsheng] Yangzhou Meteorol Bur, Yangzhou, Jiangsu, Peoples R China; [Wu, Xia] Baotou Meteorol Bur, Baotou, Peoples R China; [Huang, Xiaolin] Nanjing Univ Informat Sci & Technol, Nanjing, Peoples R China	Nanjing University of Information Science & Technology	He, J (corresponding author), Chongqing Meteorol Bur, Chongqing, Peoples R China.	geyanghe@163.com			Southwestern Regional Meteorological Center of China; Chongqing key scientific and technological project of Chongqing Meteorological Bureau [YWJSGG-202210]	Southwestern Regional Meteorological Center of China; Chongqing key scientific and technological project of Chongqing Meteorological Bureau	We acknowledge the China Meteorological Data Service Center (http://www.cma.gov.cn/) for providing daily weather observation data and the Computer Network Information Center (http://www.gscloud.cn/) for sharing the digital elevation model (DEM) and boundary of the Sichuan-Chongqing region.	Abtew W, 2011, HYDROL PROCESS, V25, P958, DOI 10.1002/hyp.7887; Allen R. G., 1998, FAO Irrigation and Drainage Paper; BEVEN K, 1979, J HYDROL, V44, P169, DOI 10.1016/0022-1694(79)90130-6; Blankenau PA, 2020, AGR WATER MANAGE, V242, DOI 10.1016/j.agwat.2020.106376; Chen DL, 2005, CLIM RES, V28, P123, DOI 10.3354/cr028123; Darshana, 2013, STOCH ENV RES RISK A, V27, P1407, DOI 10.1007/s00477-012-0677-7; Feng XY, 2020, SCI TOTAL ENVIRON, V726, DOI 10.1016/j.scitotenv.2020.138579; Gao G, 2012, STOCH ENV RES RISK A, V26, P655, DOI 10.1007/s00477-011-0525-1; Garrett TJ, 2006, NATURE, V440, P787, DOI 10.1038/nature04636; Guo JM, 2020, SUSTAIN CITIES SOC, V61, DOI 10.1016/j.scs.2020.102286; Han SJ, 2012, AGR FOREST METEOROL, V154, P44, DOI 10.1016/j.agrformet.2011.10.009; Hao L, 2015, HYDROL EARTH SYST SC, V19, P3319, DOI 10.5194/hess-19-3319-2015; Hao L, 2018, WATER RESOUR RES, V54, P6757, DOI 10.1029/2018WR023002; Huang X., 2021, GEOPHYS RES LETT; Irmak S, 2012, J HYDROL, V420, P228, DOI 10.1016/j.jhydrol.2011.12.006; Jhajharia D, 2012, HYDROL PROCESS, V26, P421, DOI 10.1002/hyp.8140; Jia YW, 2012, WATER RESOUR RES, V48, DOI 10.1029/2010WR009275; Jiang SS, 2021, ECOL INDIC, V121, DOI 10.1016/j.ecolind.2020.107193; Jiang SZ, 2019, AGR WATER MANAGE, V216, P365, DOI 10.1016/j.agwat.2019.02.014; KENDALL M. G., 1948, Rank correlation methods.; Lewis CS, 2014, J HYDROL, V510, P385, DOI 10.1016/j.jhydrol.2013.12.040; Li X, 2015, REMOTE SENS-BASEL, V7, P10917, DOI 10.3390/rs70810917; Lu JB, 2005, J AM WATER RESOUR AS, V41, P621, DOI 10.1111/j.1752-1688.2005.tb03759.x; Mann HB, 1945, ECONOMETRICA, V13, P245, DOI 10.2307/1907187; Monteith J L, 1965, Symp Soc Exp Biol, V19, P205; Moorhead J, 2015, J AM WATER RESOUR AS, V51, P1262, DOI 10.1111/1752-1688.12303; Newman B D., 2006, WATER RESOUR RES, V42; Nouri M, 2017, WATER RESOUR MANAG, V31, P2207, DOI 10.1007/s11269-017-1638-1; Peng F, 2015, ECOL ENG, V84, P653, DOI 10.1016/j.ecoleng.2015.09.069; Peng WF, 2019, J CLEAN PROD, V233, P353, DOI 10.1016/j.jclepro.2019.05.355; PENMAN HL, 1948, PROC R SOC LON SER-A, V193, P120, DOI 10.1098/rspa.1948.0037; Qin MS, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247278; Qin MS, 2019, J AM WATER RESOUR AS, V55, P189, DOI 10.1111/1752-1688.12714; Qin T, 2018, APPL GEOCHEM, V98, P448, DOI 10.1016/j.apgeochem.2018.10.009; Roderick ML, 2002, SCIENCE, V298, P1410; Ruirui Y., 2021, CLIMATIC ENV RES, V26, P413; Shan N, 2015, AGR FOREST METEOROL, V200, P322, DOI 10.1016/j.agrformet.2014.10.008; Shen YJ, 2010, HYDROL PROCESS, V24, P225, DOI 10.1002/hyp.7435; Sun G, 2012, ACSESS PUBL, P29, DOI 10.2136/2012.urban-rural.c3; Tang Y, 2021, J HYDROL, V598, DOI 10.1016/j.jhydrol.2021.126443; Vautard R, 2010, NAT GEOSCI, V3, P756, DOI [10.1038/ngeo979, 10.1038/NGEO979]; Wang H, 2020, EARTH SPACE SCI, V7, DOI 10.1029/2020EA001090; Xu CY, 2006, J HYDROL, V327, P81, DOI 10.1016/j.jhydrol.2005.11.029; Xu LH, 2015, HYDROL PROCESS, V29, P4846, DOI 10.1002/hyp.10541; Xu YP, 2014, J GEOPHYS RES-ATMOS, V119, P2174, DOI 10.1002/2013JD021245; Xu ZX, 2008, HYDROL PROCESS, V22, P3056, DOI 10.1002/hyp.6892; Yang C, 2020, SUSTAIN CITIES SOC, V61, DOI 10.1016/j.scs.2020.102271; Yang LinShan, 2014, Transactions of the Chinese Society of Agricultural Engineering, V30, P102; Yang XM, 2012, QUATERN INT, V263, P71, DOI 10.1016/j.quaint.2012.02.020; Yang YS, 2021, ATMOS ENVIRON, V262, DOI 10.1016/j.atmosenv.2021.118647; Yang Y, 2019, J HYDROL, V568, P147, DOI 10.1016/j.jhydrol.2018.10.069; Zhang S, 2017, J METEOROL RES-PRC, V31, P800, DOI 10.1007/s13351-017-6137-z; Zhang YL, 2004, THEOR APPL CLIMATOL, V78, P217, DOI 10.1007/s00704-003-0030-7; Zhang YH, 2019, J GEOPHYS RES-ATMOS, V124, P2643, DOI 10.1029/2018JD029834; Zhao N, 2015, IAHS-AISH P, V368, P287; Zhao RX, 2021, ECOL INDIC, V121, DOI 10.1016/j.ecolind.2020.107107; Zheng QZ, 2020, WATER-SUI, V12, DOI 10.3390/w12030645; Zheng XB, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034482; Zhou JJ, 2021, ECOL INDIC, V130, DOI 10.1016/j.ecolind.2021.108089; Zipper SC, 2017, GEOPHYS RES LETT, V44, P873, DOI 10.1002/2016GL072190; Zuo DP, 2012, HYDROL PROCESS, V26, P1149, DOI 10.1002/hyp.8206	61	0	0	7	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	6							e0268702	10.1371/journal.pone.0268702	http://dx.doi.org/10.1371/journal.pone.0268702			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3F0KH	35749445	gold, Green Published			2022-12-26	WOS:000830362700030
J	Pires, PGD; Torres, P; Soratto, TAT; Benetti, V; Hauptli, L; Wagner, G; Haese, DH; Pozzatti, CDH; Moraes, PDH				Pires, Paula Gabriela da Silva; Torres, Pedro; Teixeira Soratto, Tatiany Aparecida; Filho, Vilmar Benetti; Hauptli, Lucelia; Wagner, Glauber; Haese, Douglas H.; Pozzatti, Carolina D'avila H.; Moraes, Priscila de Oliveira H.			Comparison of functional-oil blend and anticoccidial antibiotics effects on performance and microbiota of broiler chickens challenged by coccidiosis	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; GROWTH PROMOTERS; CECAL MICROBIOTA; GUT MICROBIOTA; FED DIETS; MONENSIN; SUPPLEMENTATION; PRODUCTIVITY; MICROFLORA; STRATEGIES	This study aimed to compare the effects of different levels of cashew nutshell liquid (CNSL) and castor oil (CNSL-castor oil) with growth-promoting antibiotics associated with anticoccidials in broiler chickens challenged with coccidiosis. In this work, 2520 one-day-old male broiler chicks (Cobb) were randomly assigned to 84 pens, containing 30 birds each. The experimental design was completely randomized, with seven treatments: enramycin (8 ppm), virginiamycin (16.5 ppm), and tylosin (55 ppm); different doses of CNSL-castor oil (0.5, 0.75, and 1.00 kg/t); and a control diet (without additives). All treatments received semduramicin + nicarbazin (500 g/t; Aviax (R) Plus) from 0 to 28 d and monensin sodium (100 ppm; Elanco) from 29 to 35 days of age, when the feed was without antibiotics. The challenge was introduced at 14 days of age by inoculating broiler chickens with sporulated Eimeria tenella, Eimeria acervulina, and Eimeria maxima oocysts via oral gavage. In addition to performance parameters, intestinal contents were collected at 28 and 42 days of age for microbiota analysis by sequencing the 16s rRNA in V3 and V4 regions using the Illumina MiSeq platform. Taxonomy was assigned using the SILVA database (v. 138) with QIIME2 software (v. 2020.11). After one week of challenge, the broilers that received tylosin had a higher body weight gain (BWG) than those in the control group (p < 0.05), while the other treatments presented intermediate values. At 28 d, the BWG was lower for the control, CNSL-Castor oil 0.5 kg/t, enramycin, and virginiamycin treatments than that in the tylosin treatment. The inclusion of CNSL-Castor oil at concentrations of 0.75 and 1 kg/t acted as an intermediate treatment (p < 0.05). For alpha diversity, using the Shannon index, it was possible to observe the effect of age, with substantial diversity at 42 d. The Firmicutes phylum had the highest abundance, with values between 84.33% and 95.16% at 42 d. Tylosin showed better performance indices than other treatments. CNSL-castor oil treatments with concentrations of 0.75 and 1 kg/t showed similar results to those of enramycin and virginiamycin. Furthermore, CNSL-castor oil acted as a modulator of intestinal microbiota, reducing the abundance of pathogenic bacteria.	[Pires, Paula Gabriela da Silva; Moraes, Priscila de Oliveira H.] Adv Poultry Gut Sci, Florianopolis, SC, Brazil; [Torres, Pedro; Hauptli, Lucelia; Moraes, Priscila de Oliveira H.] Univ Fed Santa Catarina, Dept Anim Sci & Rural Dev, Florianopolis, SC, Brazil; [Teixeira Soratto, Tatiany Aparecida; Filho, Vilmar Benetti; Wagner, Glauber] Univ Fed Santa Catarina, Ctr Biol Sci, Lab Bioinformat, Florianopolis, SC, Brazil; [Haese, Douglas H.; Pozzatti, Carolina D'avila H.] Ctr Tecnol Anim Ltda, Domingos Martins, ES, Brazil	Universidade Federal de Santa Catarina (UFSC); Universidade Federal de Santa Catarina (UFSC)	Moraes, PDH (corresponding author), Adv Poultry Gut Sci, Florianopolis, SC, Brazil.; Moraes, PDH (corresponding author), Univ Fed Santa Catarina, Dept Anim Sci & Rural Dev, Florianopolis, SC, Brazil.	priscila.moraes@ufsc.br	Soratto, Tatiany/GXH-4572-2022; Benetti Filho, Vilmar/ABB-3536-2021	Soratto, Tatiany/0000-0001-6263-6432; Benetti Filho, Vilmar/0000-0003-0309-4877; Moraes, Priscila/0000-0001-6416-9436; Torres, Pedro/0000-0003-3026-6523				Banerjee S, 2018, MICROBIOL-SGM, V164, P142, DOI 10.1099/mic.0.000597; Blake DP, 2021, AVIAN PATHOL, V50, P209, DOI 10.1080/03079457.2021.1912288; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Bortoluzzi C, 2019, LIVEST SCI, V228, P187, DOI 10.1016/j.livsci.2019.09.001; Bortoluzzi C, 2018, FRONT SUSTAIN FOOD S, V2, DOI 10.3389/fsufs.2018.00072; Bozkurt M, 2016, POULTRY SCI, V95, P1858, DOI 10.3382/ps/pew077; Cardinal KM, 2019, POULTRY SCI, V98, P6659, DOI 10.3382/ps/pez536; Chapman HD, 2010, POULTRY SCI, V89, P1788, DOI 10.3382/ps.2010-00931; Chen HL, 2020, PARASITE VECTOR, V13, DOI 10.1186/s13071-020-3897-6; Choi JH, 2018, POULTRY SCI, V97, P970, DOI 10.3382/ps/pex360; Christensen HR, 2002, J IMMUNOL, V168, P171, DOI 10.4049/jimmunol.168.1.171; Chuang WY, 2021, ANIMALS-BASEL, V11, DOI 10.3390/ani11092550; Costa MC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171642; Danzeisen JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027949; Gaboriaud P, 2021, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.632556; Galli GM, 2020, MICROB PATHOGENESIS, V139, DOI 10.1016/j.micpath.2019.103916; Giannenas I, 2012, VET PARASITOL, V188, P31, DOI 10.1016/j.vetpar.2012.02.017; Hung CC, 2020, BRIT POULTRY SCI, V61, P465, DOI 10.1080/00071668.2020.1747598; Hussein SM, 2021, ITAL J ANIM SCI, V20, P1924, DOI 10.1080/1828051X.2021.1983479; JOHNSON J, 1970, EXP PARASITOL, V28, P30, DOI 10.1016/0014-4894(70)90063-9; Kers JG, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00235; Laxminarayan R, 2014, SCIENCE, V345, P1299, DOI 10.1126/science.1254163; Lu J, 2006, J APPL POULTRY RES, V15, P145, DOI 10.1093/japr/15.1.145; Lu MM, 2020, RES VET SCI, V132, P142, DOI 10.1016/j.rvsc.2020.05.013; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Moita VHC, 2021, ANIMALS-BASEL, V11, DOI 10.3390/ani11123351; Moraes PO, 2019, POULTRY SCI, V98, P5456, DOI 10.3382/ps/pez345; Moraes PO, 2019, ANIMAL, V13, P2190, DOI 10.1017/S1751731119000600; Murakami AE, 2014, ASIAN AUSTRAL J ANIM, V27, P981, DOI 10.5713/ajas.2013.13449; Niewold TA, 2007, POULTRY SCI, V86, P605, DOI 10.1093/ps/86.4.605; Noack S, 2019, PARASITOL RES, V118, P2009, DOI 10.1007/s00436-019-06343-5; Oksanen J, 2010, VEGAN COMMUNITY ECOL, V2; Orso C, 2021, POULTRY SCI, V100, DOI [10.1016/j.psj.2021.101388, 10.1016/j.psj.2020.12.066]; Pan D, 2014, GUT MICROBES, V5, P108, DOI 10.4161/gmic.26945; Parent E, 2020, POULTRY SCI, V99, P4303, DOI 10.1016/j.psj.2020.05.037; Robinson K, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7090282; Rostagno HS, 2017, U FEDERAL VICOSA DEP, P488; Sakomura N., 2016, METODOS PESQUISA NUT, P262; Salim HM, 2018, SCI PROGRESS-UK, V101, P52, DOI 10.3184/003685018X15173975498947; Stanley D, 2014, APPL MICROBIOL BIOT, V98, P4301, DOI 10.1007/s00253-014-5646-2; Sun H, 2013, POULTRY SCI, V92, P392, DOI 10.3382/ps.2012-02533; Torok VA, 2011, APPL ENVIRON MICROB, V77, P3380, DOI 10.1128/AEM.02300-10; Vieira AM, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-98549-w; Vieira AM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237118; WHO (WorldHealthOrganization), 2018, WHO FACT SHEETS; Wickham H, 2007, J STAT SOFTW, V21, P1; Wu SB, 2014, VET MICROBIOL, V169, P188, DOI 10.1016/j.vetmic.2014.01.007; Yi GF, 2005, POULTRY SCI, V84, P283, DOI 10.1093/ps/84.2.283; Zeitz JO, 2019, POULTRY SCI, V98, P287, DOI 10.3382/ps/pey345; Zhou BH, 2020, POULTRY SCI, V99, P1297, DOI 10.1016/j.psj.2019.10.073; Zhou ZY, 2017, EXP PARASITOL, V177, P73, DOI 10.1016/j.exppara.2017.04.007	51	0	0	6	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7								10.1371/journal.pone.0270350	http://dx.doi.org/10.1371/journal.pone.0270350			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M3CI	35793288	Green Published, gold			2022-12-26	WOS:000835338100034
J	Rezac, M; Tessler, S; Heneberg, P; Herrera, IMA; Glorikova, N; Forman, M; Rezacova, V; Kral, J				Rezac, Milan; Tessler, Steven; Heneberg, Petr; Herrera, Ivalu Macarena avila; Glorikova, Nela; Forman, Martin; Rezacova, Veronika; Kral, Jiri			Atypus karschi Donitz, 1887 (Araneae: Atypidae): An Asian purse-web spider established in Pennsylvania, USA	PLOS ONE			English	Article							INFRAORDER MYGALOMORPHAE ARANEAE; GENUS ATYPUS; NATURAL-HISTORY; CENTRAL-EUROPE; SPHODROS; KARYOTYPE; HETEROCHROMATIN; POPULATION; DISPERSAL; EVOLUTION	The mygalomorph spiders of the family Atypidae are among the most archaic spiders. The genus Atypus Latreille, 1804 occurs in Eurasia and northern Africa, with a single enigmatic species, Atypus snetsingeri Sarno, 1973, known only from a small area in southeastern Pennsylvania in eastern USA. A close relationship to European species could be assumed based on geographic proximity, but A. snetsingeri more closely resembled Asian species. This study was undertaken to learn more about the genetics of A. snetsingeri, its habitat requirements and natural history. Molecular markers (CO1 sequences) were compared to available data for other atypids and showed that A. snetsingeri is identical with A. karschi Donitz, 1887 native to East Asia. Natural history parameters in Pennsylvania were also similar in every respect to A. karschi in Japan, therefore, we propose that the spider is an introduced species and the specific epithet snetsingeri is relegated to a junior synonym of A. karschi. Cytogenetic analysis showed an X0 sex chromosome system (42 chromosomes in females, 41 in males) and we also detected nucleolus organizing regions and heterochromatin, the latter for the first time in the Atypoidea. In Pennsylvania the spider is found in a variety of habitats, from forests to suburban shrubbery, where the above-ground webs are usually attached vertically to trees, shrubs, or walls, although other webs are oriented horizontally near the ground. Prey include millipedes, snails, woodlice, carabid beetles and earthworms. Atypus karschi is the first known case of an introduced purse-web spider. It is rarely noticed but well-established within its range in southeastern Pennsylvania.	[Rezac, Milan; Glorikova, Nela; Rezacova, Veronika] Crop Res Inst, Prague, Czech Republic; [Tessler, Steven] Tyler Arboretum, Media, PA USA; [Heneberg, Petr] Charles Univ Prague, Fac Med 3, Prague, Czech Republic; [Herrera, Ivalu Macarena avila; Forman, Martin; Kral, Jiri] Charles Univ Prague, Prague, Czech Republic	Czech Crop Research Institute (CRI); Charles University Prague; Charles University Prague	Rezac, M (corresponding author), Crop Res Inst, Prague, Czech Republic.	rezac@vurv.cz	Řezáčová, Veronika/S-5801-2017; Ávila Herrera, Ivalú/GYU-9139-2022; Heneberg, Petr/C-1881-2012	Řezáčová, Veronika/0000-0002-1749-0355; Heneberg, Petr/0000-0002-0703-951X; Tessler, Steven/0000-0001-8989-7886	Ministry of Education, Youth and Sports of the Czech Republic [LTAUSA18171]; Ministry of Agriculture of the Czech Republic [MZe RO0418]; Charles University [92218]; Ministry of Education, Youth, and Sports of the Czech Republic [SVV260568, LTAUSA19142]	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Ministry of Agriculture of the Czech Republic(Ministry of Agriculture, Czech Republic); Charles University; Ministry of Education, Youth, and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	The study was supported by the Ministry of Education, Youth and Sports of the Czech Republic (project LTAUSA18171) and by the Ministry of Agriculture of the Czech Republic (project MZe RO0418). The chromosome part of this study was funded by the Charles University (project 92218) and Ministry of Education, Youth, and Sports of the Czech Republic (projects SVV260568 and LTAUSA19142).	Aoki T., 1983, Nanki Seibutu, V25, P43; Araujo D., 2020, WORLD SPIDER CYTOGEN; Herrera IMA, 2021, BMC ECOL EVOL, V21, DOI 10.1186/s12862-021-01750-8; Ayoub NA, 2007, MOL PHYLOGENET EVOL, V42, P394, DOI 10.1016/j.ympev.2006.07.018; BEATTY JA, 1986, J ARACHNOL, V14, P130; Bidegaray-Batista L, 2007, MOL ECOL, V16, P3198, DOI 10.1111/j.1365-294X.2007.03351.x; Bond JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038753; Bosenberg W., 1906, ABH SENCKENB NAT, V30, P93; Bristowe WilliamS., 1958, WORLD SPIDERS; British Arachnology Society, 2021, SPID HARV REC SCHEM; Buzatto BA, 2021, J COMP PHYSIOL A, V207, P279, DOI 10.1007/s00359-020-01459-x; Carmo-Fonseca M, 2000, NAT CELL BIOL, V2, pE107, DOI 10.1038/35014078; Chesney S., 2017, BOTANY; Clark M. S., 1996, Chromosomes: the complex code.; COYLE FA, 1985, J ARACHNOL, V13, P291; COYLE FA, 1983, J ARACHNOL, V11, P283; Dippenaar-Schoeman A.S., 1997, PLANT PROTECT RES; Donitz F. K. W., 1887, SITZUNGSBERICHTE GES, V1887, P8; Edwards GB, 1999, ENTOMOLOGY CIRCULAR; EDWARDS RL, 1990, J ARACHNOL, V18, P29; Enock F., 1885, T R ENTOMOL SOC LOND, V33, P389, DOI [10.1111/j.1365-2311.1885.tb00894.x, DOI 10.1111/J.1365-2311.1885.TB00894.X]; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Forman M, 2013, CYTOGENET GENOME RES, V141, P43, DOI 10.1159/000351041; Fujiwara A, 1998, CHROMOSOME RES, V6, P463, DOI 10.1023/A:1009200428369; Gertsch W.J., 1980, AM MUS NOVIT, V2704, P1; Guetg C, 2012, EPIGENETICS-US, V7, P811, DOI 10.4161/epi.21072; He AL, 2021, MITOCHONDRIAL DNA B, V6, P2523, DOI 10.1080/23802359.2021.1959443; Hedin M, 2006, MOL PHYLOGENET EVOL, V41, P454, DOI 10.1016/j.ympev.2006.05.017; Hedin M, 2019, PEERJ, V7, DOI 10.7717/peerj.6864; Heneberg P, 2013, ANTON LEEUW INT J G, V103, P713, DOI 10.1007/s10482-012-9853-5; iNaturalist, 2021, IM AT KARSCH; Information NCfB, 2022, LENV; Japan Society of Greater Philadelphia, 2021, SHOF HIST; Katsura K., 1975, Atypus, VNo. 64, P6; Kim J., 2019, KOREAN ARACHNOLOGY, V35, P1; Klein WM., 1995, GARDENS PHILADELPHIA; Korinkova Tereza, 2013, P159; Kral J, 2011, CYTOGENET GENOME RES, V133, P43, DOI 10.1159/000323497; Kral J, 2008, GENETICA, V134, P79, DOI 10.1007/s10709-007-9221-y; Kral J, 2013, BIOL J LINN SOC, V109, P377, DOI 10.1111/bij.12056; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Madsen K., 1989, ARNOLDIA, V49, P14; Mccook H. C., 1888, Proceedings of the Academy Philadelphia, P203; Mckenna-Foster A, 2011, J ARACHNOL, V39, P171, DOI 10.1636/P10-15.1; MILLER DA, 1976, EXP CELL RES, V101, P235, DOI 10.1016/0014-4827(76)90373-6; Miyashita Kazuyoshi, 1992, Acta Arachnologica, V41, P177, DOI 10.2476/asjaa.41.177; Moler PE, 2020, SOUTHEAST NAT, V19, P663, DOI 10.1656/058.019.0406; NATURESERVE, 2021, NATURESERVE EXPL; Nentwig W, SPIDERS EUROPE; Nentwig W, 2015, BIOL INVASIONS, V17, P2757, DOI 10.1007/s10530-015-0912-5; Norwood D., 2016, CHINA TRADE; O'Malley Michael, 1990, KEEPING WATCH A HIST; Platnick N.I., 2020, SPIDERS WORLD NATURA; Poteat WL., 1890, J ELISHA MITCH SCI S, V6, P132; Qiu JX, 2017, BIOL INVASIONS, V19, P73, DOI 10.1007/s10530-016-1264-5; R Core Team, 2020, R LANG ENV STAT COMP; RAVEN RJ, 1985, B AM MUS NAT HIST, V182, P1; Rehder A., 1946, ARNOLDIA, V6, P13; Rezac M, 2007, J BIOGEOGR, V34, P1016, DOI 10.1111/j.1365-2699.2006.01670.x; Rezac M, 2006, HEREDITAS, V143, P123; Rezac M, 2018, J INSECT CONSERV, V22, P135, DOI 10.1007/s10841-018-0048-x; Rezac M, 2018, INVERTEBR SYST, V32, P10, DOI 10.1071/IS16071; Rezac M, 2014, J INSECT CONSERV, V18, P523, DOI 10.1007/s10841-014-9668-y; Sait S., 1939, SAITO HO ON KAI MUSE, V18, P1; Sanmartin I, 2001, BIOL J LINN SOC, V73, P345, DOI 10.1006/bijl.2001.0542; SARNO P A, 1973, Entomological News, V84, P37; Sarudy B., 2020, COLONIAL EARLY AM GA; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwendinger P.J., 1989, Bulletin of the British Arachnological Society, V8, P89; SCHWENDINGER PJ, 1990, ZOOL SCR, V19, P353, DOI 10.1111/j.1463-6409.1990.tb00263.x; Sember A, 2020, GENES-BASEL, V11, DOI 10.3390/genes11080849; Srba M, 2012, J INSECT CONSERV, V16, P557, DOI 10.1007/s10841-011-9441-4; Stetson SP., 1949, PA MAG HIST BIOGR, V73, P26; Suzuki S., 1954, Journal of Science of the Hiroshima University Zoology, V15, P23; Tessler Mark A., 1994, HIST ISRAELI PALESTI; Wheeler WC, 2017, CLADISTICS, V33, P574, DOI 10.1111/cla.12182; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; World Spider Catalog, 2021, WORLD SPIDER CATALOG, DOI 10.24436/2; Yaginuma T., 1960, P1; Yih David, 2012, Arnoldia (Jamaica Plain), V69, P14; Zhu MS, 2006, ZOOTAXA, P1	82	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7							e0261695	10.1371/journal.pone.0261695	http://dx.doi.org/10.1371/journal.pone.0261695			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M2ZD	35797267	Green Published, Green Submitted, gold			2022-12-26	WOS:000835328600014
J	Schumacher, F; Edwards, MJ; Muhle, C; Carpinteiro, A; Wilson, GC; Wilker, B; Soddemann, M; Keitsch, S; Scherbaum, N; Muller, BW; Lang, UE; Linnemann, C; Kleuser, B; Muller, CP; Kornhuber, J; Gulbins, E				Schumacher, Fabian; Edwards, Michael J.; Muehle, Christiane; Carpinteiro, Alexander; Wilson, Greg C.; Wilker, Barbara; Soddemann, Matthias; Keitsch, Simone; Scherbaum, Norbert; Mueller, Bernhard W.; Lang, Undine E.; Linnemann, Christoph; Kleuser, Burkhard; Mueller, Christian P.; Kornhuber, Johannes; Gulbins, Erich			Ceramide levels in blood plasma correlate with major depressive disorder severity and its neutralization abrogates depressive behavior in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPASE-D; HIPPOCAMPAL NEUROGENESIS; STRESS; ACTIVATION; MECHANISMS; MODEL	Major depressive disorder (MDD) is a severe disease of unknown pathogenesis that will affect -10% of people during their lifetime. Therapy for MDD requires prolonged treatment and often fails, predicating a need for novel treatment strategies. Here, we report increased ceramide levels in the blood plasma of MDD patients and in murine stress-induced models of MDD. These blood plasma ceramide levels correlated with the severity of MDD in human patients and were independent of age, sex, or body mass index. In addition, intravenous injection of anti-ceramide antibodies or neutral ceramidase rapidly abrogated stress-induced MDD, and intravenous injection of blood plasma from mice with MDD induced depressionlike behavior in untreated mice, which was abrogated by ex vivo preincubation of the plasma with anti-ceramide antibodies or ceramidase. Mechanistically, we demonstrate that ceramide accumulated in endothelial cells of the hippocampus of stressed mice, evidenced by the quantitative measurement of ceramide in purified hippocampus endothelial cells. We found ceramide inhibited the activity of phospholipase D (PLD) in endothelial cells in vitro and in the hippocampus in vivo and thereby decreased phosphatidic acid in the hippocampus. Finally, we show intravenous injection of PLD or phosphatidic acid abrogated MDD, indicating the significance of this pathway in MDD pathogenesis. Our data indicate that ceramide controls PLD activity and phosphatidic acid formation in hippocampal endothelial cells and thereby mediates MDD. We propose that neutralization of plasma ceramide could represent a rapidacting targeted treatment for MDD.	[Schumacher, Fabian; Edwards, Michael J.; Carpinteiro, Alexander; Wilker, Barbara; Soddemann, Matthias; Keitsch, Simone; Gulbins, Erich] Univ Duisburg Essen, Univ Hosp Essen, Dept Mol Biol, Essen, Germany; [Schumacher, Fabian; Kleuser, Burkhard] Free Univ Berlin, Inst Pharm, Berlin, Germany; [Muehle, Christiane; Mueller, Christian P.; Kornhuber, Johannes] Friedrich Alexander Univ Erlangen Nuremberg, Univ Clin, Dept Psychiat & Psychotherapy, Erlangen, Germany; [Wilson, Greg C.] Univ Cincinnati, Coll Med, Dept Surg, Cincinnati, OH USA; [Scherbaum, Norbert; Mueller, Bernhard W.] Univ Duisburg Essen, LVR Hosp Essen, Dept Psychiat & Psychotherapy, Fac Med, Essen, Germany; [Mueller, Bernhard W.] Univ Wuppertal, Dept Psychol, Wuppertal, Germany; [Lang, Undine E.; Linnemann, Christoph] Univ Basel, Univ Psychiat Clin UPK, Dept Psychiat & Psychotherapy, Basel, Switzerland; [Mueller, Christian P.] Univ Sains Malaysia, Ctr Drug Res, Minden, Penang, Malaysia	University of Duisburg Essen; Free University of Berlin; University of Erlangen Nuremberg; University System of Ohio; University of Cincinnati; University of Duisburg Essen; University of Wuppertal; University of Basel; Universiti Sains Malaysia	Gulbins, E (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Dept Mol Biol, Essen, Germany.	erich.gulbins@uni-due.de	Muller, Bernhard W./D-9896-2011	Muller, Bernhard W./0000-0002-9573-1417; Schumacher, Fabian/0000-0001-8703-3275	DFG [GU 335/29-3, GU 335/32-2, KO 947/13-3, MU 2789/8-2]; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [270949263/GRK2162, 2162]	DFG(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG))	This study was supported by DFG grants GU 335/29-3 and GU 335/32-2 to E.G., KO 947/13-3 to J.K., and MU 2789/8-2 to C.P.M. C.M. is an associated fellow of the research training group 2162 funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)--270949263/GRK2162.	Abousalham A, 1997, J BIOL CHEM, V272, P1069, DOI 10.1074/jbc.272.2.1069; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI [10.1056/NEJMra073096, 10.1038/nrdp.2016.65]; Berman RM, 2000, BIOL PSYCHIAT, V47, P351, DOI 10.1016/S0006-3223(99)00230-9; Brink Christiaan B, 2006, Recent Pat CNS Drug Discov, V1, P29, DOI 10.2174/157488906775245327; Brunkhorst-Kanaan N, 2019, METABOLISM, V95, P65, DOI 10.1016/j.metabol.2019.04.002; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; De Miguel Z, 2021, NATURE, V600, P494, DOI 10.1038/s41586-021-04183-x; Demirkan A, 2013, J PSYCHIATR RES, V47, P357, DOI 10.1016/j.jpsychires.2012.11.001; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; Fan KQ, 2019, CELL, V179, P864, DOI 10.1016/j.cell.2019.10.001; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Filatova EV, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10061283; Frazer A, 2002, MOL PSYCHIATR, V7, pS23, DOI 10.1038/sj.mp.4001015; Gracia-Garcia P, 2011, J NEUROPSYCH CLIN N, V23, P215, DOI 10.1176/appi.neuropsych.23.2.215; Greaney JL, 2019, CIRC RES, V124, P564, DOI 10.1161/CIRCRESAHA.118.313764; Gulbins A, 2018, MOL PSYCHIATR, V23, P2324, DOI 10.1038/s41380-018-0090-9; Gulbins A, 2016, CELL PHYSIOL BIOCHEM, V39, P790, DOI 10.1159/000447789; Gulbins E, 2013, NAT MED, V19, P934, DOI 10.1038/nm.3214; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Horowitz AM, 2020, SCIENCE, V369, P167, DOI 10.1126/science.aaw2622; Howren MB, 2009, PSYCHOSOM MED, V71, P171, DOI 10.1097/PSY.0b013e3181907c1b; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Kryst J, 2020, EXPERT OPIN PHARMACO, V21, P9, DOI 10.1080/14656566.2019.1683161; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Lopez-Vilchez I, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.156; Lv H, 2021, CLIN CHIM ACTA, V518, P110, DOI 10.1016/j.cca.2021.03.014; Maes M, 1997, ACTA PSYCHIAT SCAND, V95, P212, DOI 10.1111/j.1600-0447.1997.tb09622.x; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Menard C, 2017, NAT NEUROSCI, V20, P1752, DOI 10.1038/s41593-017-0010-3; Moda-Sava RN, 2019, SCIENCE, V364, P147, DOI 10.1126/science.aat8078; Muhle C, 2019, J CLIN MED, V8, DOI 10.3390/jcm8060846; Oliveira TG, 2016, MOL PSYCHIATR, V21, P80, DOI 10.1038/mp.2015.14; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Schloss P, 2004, PHARMACOL THERAPEUT, V102, P47, DOI 10.1016/j.pharmthera.2004.02.001; Singh IN, 2001, BIOCHEMISTRY-US, V40, P11227, DOI 10.1021/bi010787l; Song C, 2009, J NEUROSCI, V29, P14, DOI 10.1523/JNEUROSCI.3569-08.2009; Tran DV, 2017, J ECT, V33, pE20, DOI 10.1097/YCT.0000000000000408; Venable ME, 1996, J BIOL CHEM, V271, P24800, DOI 10.1074/jbc.271.40.24800; Warner-Schmidt JL, 2006, HIPPOCAMPUS, V16, P239, DOI 10.1002/hipo.20156; Webb LM, 2010, MOL CELL BIOCHEM, V337, P153, DOI 10.1007/s11010-009-0294-z; WILLNER P, 1985, PSYCHOPHARMACOLOGY, V85, P387, DOI 10.1007/BF00429653; Wu SS, 2022, CELL MOL NEUROBIOL, V42, P2571, DOI 10.1007/s10571-021-01153-9; Yoshimura S, 1997, J NEUROCHEM, V69, P713; Zoicas I, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9051244	44	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2022	298	8							102185	10.1016/j.jbc.2022.102185	http://dx.doi.org/10.1016/j.jbc.2022.102185			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3S2VB	35753355	Green Published, gold			2022-12-26	WOS:000839458000006
J	Skurska, E; Szulc, B; Maszczak-Seneczko, D; Wiktor, M; Wiertelak, W; Makowiecka, A; Olczak, M				Skurska, Edyta; Szulc, Bozena; Maszczak-Seneczko, Dorota; Wiktor, Maciej; Wiertelak, Wojciech; Makowiecka, Aleksandra; Olczak, Mariusz			Incorporation of fucose into glycans independent of the GDP-fucose transporter SLC35C1 preferentially utilizes salvaged over de novo GDP-fucose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEFICIENCY TYPE-II; MANNOSE 4,6-DEHYDRATASE; CONGENITAL DISORDER; NUCLEOTIDE SUGARS; GOLGI-APPARATUS; O-FUCOSYLATION; ADHESION; GLYCOSYLATION; BIOSYNTHESIS; CLONING	Mutations in the SLC35C1 gene encoding the Golgi GDP-fucose transporter are known to cause leukocyte adhesion deficiency II. However, improvement of fucosylation in leukocyte adhesion deficiency II patients treated with exogenous fucose suggests the existence of an SLC35C1-independent route of GDP-fucose transport, which remains a mystery. To investigate this phenomenon, we developed and characterized a human cell-based model deficient in SLC35C1 activity. The resulting cells were cultured in the presence/absence of exogenous fucose and mannose, followed by examination of fucosylation potential and nucleotide sugar levels. We found that cells displayed low but detectable levels of fucosylation in the absence of SLC35C1. Strikingly, we show that defects in fucosylation were almost completely reversed upon treatment with millimolar concentrations of fucose. Furthermore, we show that even if fucose was supplemented at nanomolar concentrations, it was still incorporated into glycans by these knockout cells. We also found that the SLC35C1-independent transport preferentially utilized GDP-fucose from the salvage pathway over the de novo biogenesis pathway as a source of this substrate. Taken together, our results imply that the Golgi systems of GDP-fucose transport discriminate between substrate pools obtained from different metabolic pathways, which suggests a functional connection between nucleotide sugar transporters and nucleotide sugar synthases.	[Skurska, Edyta; Szulc, Bozena; Maszczak-Seneczko, Dorota; Wiktor, Maciej; Wiertelak, Wojciech; Makowiecka, Aleksandra; Olczak, Mariusz] Univ Wroclaw, Fac Biotechnol, Wroclaw, Poland; [Makowiecka, Aleksandra] Wroclaw Univ Sci & Technol, Dept Chem Biol & Bioimaging, Wroclaw, Poland	University of Wroclaw; Wroclaw University of Science & Technology	Olczak, M (corresponding author), Univ Wroclaw, Fac Biotechnol, Wroclaw, Poland.	mariusz.olczak@uwr.edu.pl		Szulc, Bozena/0000-0002-7782-9592; Wiertelak, Wojciech/0000-0002-6716-0696; Skurska, Edyta/0000-0002-8170-6616	National Science Centre (Cracow, Poland) [2016/21/B/NZ5/00144]	National Science Centre (Cracow, Poland)(National Science Centre, Poland)	This work is supported by the National Science Centre (Cracow, Poland), (grant no.: 2016/21/B/NZ5/00144; to M. O.).	Bazan B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207521; Cagdas D, 2014, J CLIN IMMUNOL, V34, P1009, DOI 10.1007/s10875-014-0091-7; CAPASSO JM, 1984, P NATL ACAD SCI-BIOL, V81, P7051, DOI 10.1073/pnas.81.22.7051; COATES SW, 1980, J BIOL CHEM, V255, P9225; Cooper N, 2020, CLIN IMMUNOL, V221, DOI 10.1016/j.clim.2020.108599; Dauber A, 2014, HUM MOL GENET, V23, P2880, DOI 10.1093/hmg/ddu001; ETZIONI A, 1992, NEW ENGL J MED, V327, P1789, DOI 10.1056/NEJM199212173272505; Gazit Y, 2010, J CLIN IMMUNOL, V30, P308, DOI 10.1007/s10875-009-9354-0; Hellbusch CC, 2007, J BIOL CHEM, V282, P10762, DOI 10.1074/jbc.M700314200; Helmus Y, 2006, BLOOD, V107, P3959, DOI 10.1182/blood-2005-08-3334; Hidalgo A, 2003, BLOOD, V101, P1705, DOI 10.1182/blood-2002-09-2840; Hullen A, 2021, J INHERIT METAB DIS, V44, P1441, DOI 10.1002/jimd.12426; Ishikawa HO, 2010, J BIOL CHEM, V285, P4122, DOI 10.1074/jbc.M109.016964; Kanda Y, 2007, J BIOTECHNOL, V130, P300, DOI 10.1016/j.jbiotec.2007.04.025; Karsan A, 1998, J CLIN INVEST, V101, P2438, DOI 10.1172/JCI905; Knapp KM, 2020, J HUM GENET, V65, P743, DOI 10.1038/s10038-020-0764-4; KORNFELD RH, 1966, BIOCHIM BIOPHYS ACTA, V117, P79, DOI 10.1016/0304-4165(66)90154-1; Kudelka MR, 2016, NAT METHODS, V13, P81, DOI [10.1038/NMETH.3675, 10.1038/nmeth.3675]; KUHN NJ, 1977, BIOCHEM J, V168, P423, DOI 10.1042/bj1680423; Liu TW, 2009, P NATL ACAD SCI USA, V106, P14581, DOI 10.1073/pnas.0903286106; Lu LC, 2010, J BIOL CHEM, V285, P36245, DOI 10.1074/jbc.M110.126003; Lubke T, 2001, NAT GENET, V28, P73, DOI 10.1038/88299; Luhn K, 2001, NAT GENET, V28, P69, DOI 10.1038/ng0501-69; Ma B, 2006, GLYCOBIOLOGY, V16, p158R, DOI 10.1093/glycob/cwl040; Marquardt T, 1999, BLOOD, V94, P3976, DOI 10.1182/blood.V94.12.3976.424k06_3976_3985; Maszczak-Seneczko D, 2011, GLYCOCONJUGATE J, V28, P481, DOI 10.1007/s10719-011-9348-z; Moriwaki K, 2007, GLYCOBIOLOGY, V17, P1311, DOI 10.1093/glycob/cwm094; Moriwaki K, 2010, WORLD J HEPATOL, V2, P151, DOI 10.4254/wjh.v2.i4.151; Nakajima K, 2010, GLYCOBIOLOGY, V20, P865, DOI 10.1093/glycob/cwq044; Olczak M, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0251805; Pareek V, 2021, MOL CELL, V81, P3775, DOI 10.1016/j.molcel.2021.08.030; Park SH, 1998, J BIOL CHEM, V273, P5685, DOI 10.1074/jbc.273.10.5685; Pastuszak I, 1998, J BIOL CHEM, V273, P30165, DOI 10.1074/jbc.273.46.30165; Rabina J, 2001, GLYCOCONJUGATE J, V18, P799, DOI 10.1023/A:1021107602535; Sosicka P., 2021, BIORXIV, DOI [10.1101/2021.11.03.467160, DOI 10.1101/2021.11.03.467160]; Sturla L, 2003, J BIOL CHEM, V278, P26727, DOI 10.1074/jbc.M304068200; Sullivan FX, 1998, J BIOL CHEM, V273, P8193, DOI 10.1074/jbc.273.14.8193; Szulc B, 2020, J BIOL CHEM, V295, P16445, DOI 10.1074/jbc.RA119.012362; Taylor SC, 2019, TRENDS BIOTECHNOL, V37, P761, DOI 10.1016/j.tibtech.2018.12.002; van de Vijver E, 2012, BLOOD CELL MOL DIS, V48, P53, DOI 10.1016/j.bcmd.2011.10.004; van Tol W., 2020, THESIS RADBOUD U NIJ; Varki A., 2015, ESSENTIALS GLYCOBIOL; WIESE TJ, 1994, J BIOL CHEM, V269, P22705; YURCHENCO PD, 1975, BIOCHEMISTRY-US, V14, P3107, DOI 10.1021/bi00685a011; YURCHENCO PD, 1977, BIOCHEMISTRY-US, V16, P944, DOI 10.1021/bi00624a021; Zhang YY, 2021, J INTEGR PLANT BIOL, V63, P865, DOI 10.1111/jipb.13050	46	2	2	5	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2022	298	8							102206	10.1016/j.jbc.2022.102206	http://dx.doi.org/10.1016/j.jbc.2022.102206			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3S2VB	35772493	Green Published, gold			2022-12-26	WOS:000839458000002
J	Sanguinetti, A; McIlvennie, C; Pritoni, MG; Schneider, SG				Sanguinetti, Angela; McIlvennie, Claire; Pritoni, Marco G.; Schneider, Susan G.			Two (or more) for one: Identifying classes of household energy- and water-saving measures to understand the potential for positive spillover	PLOS ONE			English	Article							ENVIRONMENTAL BEHAVIORS	A key component of behavior-based energy conservation programs is the identification of target behaviors. A common approach is to target behaviors with the greatest energy-saving potential. The concept of behavioral spillover introduces further considerations, namely that adoption of one energy-saving behavior may increase (or decrease) the likelihood of other energy-saving behaviors. This research aimed to identify and describe household energy- and water-saving measure classes within which positive spillover is likely to occur (e.g., adoption of energy-efficient appliances may correlate with adoption of water-efficient appliances), and explore demographic and psychographic predictors of each. Nearly 1,000 households in a California city were surveyed and asked to report whether they had adopted 75 different energy- and/or water-saving measures. Principal Component Analysis and Network Analysis based on correlations between adoption of these diverse measures revealed and characterized eight water-energy-saving measure classes: Water Conservation, Energy Conservation, Maintenance and Management, Efficient Appliance, Advanced Efficiency, Efficient Irrigation, Green Gardening, and Green Landscaping. Understanding these measure classes can help guide behavior-based energy program developers in selecting target behaviors and designing interventions.	[Sanguinetti, Angela] Univ Calif Davis, Ctr Water Energy Efficiency, Davis, CA 95616 USA; [McIlvennie, Claire] Univ Vermont, Rubenstein Sch Environm & Nat Resources, Burlington, VT USA; [Pritoni, Marco G.] Lawrence Berkeley Natl Lab, Berkeley, CA USA; [Schneider, Susan G.] Univ Pacific, Dept Psychol, Stockton, CA USA	University of California System; University of California Davis; University of Vermont; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of the Pacific	Sanguinetti, A (corresponding author), Univ Calif Davis, Ctr Water Energy Efficiency, Davis, CA 95616 USA.	asanguinetti@ucdavis.edu		Sanguinetti, Angela/0000-0002-9008-7175; Pritoni, Marco/0000-0003-4200-6905	California Department of Water Resources [4600011065]; (UC Davis Center for Water-Energy Efficiency)	California Department of Water Resources; (UC Davis Center for Water-Energy Efficiency)	This research was funded by the California Department of Water Resources (https://water.ca.gov/): Agreement Number 4600011065 (Principal Investigator Frank Loge, UC Davis Center for Water-Energy Efficiency) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, DRAWDOWN MOST COMPRE; Boudet HS, 2016, ENERG POLICY, V92, P444, DOI 10.1016/j.enpol.2016.02.033; Bratt C, 1999, ENVIRON BEHAV, V31, P28, DOI 10.1177/00139169921971985; Consortium for Energy Efficiency, 2018 BEH PROGR SUMM; Cooper J. O., 2019, APPL BEHAV ANAL, V3rd; Frankel D., 2013, SIZING POTENTIAL BEH; Gardner GT, 2008, ENVIRONMENT, V50, P12, DOI 10.3200/ENVT.50.5.12-25; Gatersleben B, 2002, ENVIRON BEHAV, V34, P335, DOI 10.1177/0013916502034003004; Jessoe K, 2017, E2E PROJECT WORKING; Karlin B, 2014, ENVIRON BEHAV, V46, P423, DOI 10.1177/0013916512467532; Kneebone S, 2018, J ENVIRON PSYCHOL, V55, P1, DOI 10.1016/j.jenvp.2017.10.007; Margetts EA, 2017, J ENVIRON PSYCHOL, V49, P30, DOI 10.1016/j.jenvp.2016.07.005; McKenzie-Mohr D., 2011, FOSTERING SUSTAINABL, Vthird; Nilsson A, 2017, ENVIRON EDUC RES, V23, P573, DOI 10.1080/13504622.2016.1250148; Osborne J.W., 2004, PRACT ASSESS RES EVA, V9, P9, DOI [10.7275/ktzq-jq66, DOI 10.7275/KTZQ-JQ66]; Peters J, 2013, PAVING WAY RICHER MI; Sanguinetti A, 2018, SMART WATER ENERGY S; Sanguinetti A, 2017, TRANSPORT RES D-TR E, V52, P73, DOI 10.1016/j.trd.2017.02.005; Steinhorst J, 2015, J ENVIRON PSYCHOL, V43, P125, DOI 10.1016/j.jenvp.2015.05.012; Stern PC, 2011, AM PSYCHOL, V66, P303, DOI 10.1037/a0023235; STOKES TF, 1989, BEHAV THER, V20, P337, DOI 10.1016/S0005-7894(89)80054-1; STOKES TF, 1977, J APPL BEHAV ANAL, V10, P349, DOI 10.1901/jaba.1977.10-349; Tabachnick B. G., 2001, USING MULTIVARIATE S; Thogersen J, 2003, J ENVIRON PSYCHOL, V23, P225, DOI 10.1016/S0272-4944(03)00018-5; Thogersen J., 2000, J CONSUM POLICY, V23, P285, DOI DOI 10.1023/A:1007122319675; Thogersen J, 2009, J CONSUM POLICY, V32, P141, DOI 10.1007/s10603-009-9101-1; Truelove HB, 2014, GLOBAL ENVIRON CHANG, V29, P127, DOI 10.1016/j.gloenvcha.2014.09.004; Whitmarsh L, 2010, J ENVIRON PSYCHOL, V30, P305, DOI 10.1016/j.jenvp.2010.01.003; Wynes S, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa7541	29	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7								10.1371/journal.pone.0268879	http://dx.doi.org/10.1371/journal.pone.0268879			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M5FN	35789329	Green Published, gold			2022-12-26	WOS:000835487000030
J	Januario, YC; Eden, J; de Oliveira, LS; De Pace, R; Tavares, LA; da Silva-Januario, ME; Apolloni, VB; Wilby, EL; Altmeyer, R; Burgos, PV; Correa, SAL; Gershlick, DC; daSilva, LLP				Januario, Yunan C.; Eden, Jessica; de Oliveira, Luan S.; De Pace, Raffaella; Tavares, Lucas A.; da Silva-Januario, Mara E.; Apolloni, Vinicius B.; Wilby, Elise L.; Altmeyer, Randolf; Burgos, Patricia, V; Correa, Sonia A. L.; Gershlick, David C.; daSilva, Luis L. P.			Clathrin adaptor AP-1-mediated Golgi export of amyloid precursor protein is crucial for the production of neurotoxic amyloid fragments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-BETA; SORTING SIGNALS; STRUCTURAL BASIS; CELL-SURFACE; BREFELDIN-A; DISEASE; APP; C99; RECOGNITION; ENDOSOMES	One of the hallmarks of Alzheimer's disease is the accumulation of toxic amyloid-beta (A beta) peptides in extracellular plaques. The direct precursor of A beta is the carboxyl-terminal fragment beta (or C99) of the amyloid precursor protein (APP). C99 is detected at elevated levels in Alzheimer's disease brains, and its intracellular accumulation has been linked to early neurotoxicity independently of A beta. Despite this, the causes of increased C99 levels are poorly understood. Here, we demonstrate that APP interacts with the clathrin vesicle adaptor AP-1 (adaptor protein 1), and we map the interaction sites on both proteins. Using quantitative kinetic trafficking assays, established cell lines and primary neurons, we also show that this interaction is required for the transport of APP from the trans-Golgi network to endosomes. In addition, disrupting AP-1-mediated transport of APP alters APP processing and degradation, ultimately leading to increased C99 production and A beta release. Our results indicate that AP-1 regulates the subcellular distribution of APP, altering its processing into neurotoxic fragments.	[Januario, Yunan C.; de Oliveira, Luan S.; Tavares, Lucas A.; da Silva-Januario, Mara E.; Apolloni, Vinicius B.; daSilva, Luis L. P.] Univ Sao Paulo, Ctr Virol Res, Ribeirao Preto, SP, Brazil; [Januario, Yunan C.; de Oliveira, Luan S.; Tavares, Lucas A.; da Silva-Januario, Mara E.; Apolloni, Vinicius B.; daSilva, Luis L. P.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Cell & Mol Biol, Ribeirao Preto, SP, Brazil; [Eden, Jessica; Wilby, Elise L.; Gershlick, David C.] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England; [de Oliveira, Luan S.; Correa, Sonia A. L.] Univ Bradford, Sch Pharm & Med Sci, Bradford, W Yorkshire, England; [De Pace, Raffaella] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Cell Biol & Neurobiol Branch, NIH, Bethesda, MD USA; [Altmeyer, Randolf] Univ Cambridgee, Dept Pure Math & Math Stat, Statslab, Cambridge, England; [Burgos, Patricia, V] Univ San Sebastian, Fac Med & Ciencia, Ctr Biol Celular & Biomed CEBICEM, Santiago, Chile; [Burgos, Patricia, V] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Ctr Aging & Regenerat CARE, Santiago, Chile; [Correa, Sonia A. L.] Manchester Metropolitan Univ, Fac Sci & Engn, Dept Life Sci, Manchester, Lancs, England	Universidade de Sao Paulo; Universidade de Sao Paulo; University of Cambridge; University of Bradford; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Cambridge; Universidad San Sebastian; Pontificia Universidad Catolica de Chile; Manchester Metropolitan University	daSilva, LLP (corresponding author), Univ Sao Paulo, Ctr Virol Res, Ribeirao Preto, SP, Brazil.; daSilva, LLP (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Cell & Mol Biol, Ribeirao Preto, SP, Brazil.; Gershlick, DC (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Cambridge, England.	dg553@cam.ac.uk; lldasilva@fmrp.usp.br	Tavares, Lucas Alves/ABG-2503-2020; Tavares, Lucas/GQH-4118-2022; Silva, Mara/HGC-4994-2022	Tavares, Lucas Alves/0000-0001-7883-1443; Tavares, Lucas/0000-0001-7883-1443; Silva, Mara/0000-0001-6375-4502; Eden, Jessica/0000-0002-3204-5583; Wilby, Elise/0000-0002-0608-6429; De Pace, Raffaella/0000-0002-8179-6869	Sao Paulo Research Foundation (FAPESP), Brazil [2018/00297-7]; Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo (FAEPA), Brazil; Sir Henry Dale Fellowship; Wellcome Trust/Royal Society, United Kingdom; Royal Society Research Grant, United Kingdom [RGS\R2\202082]; Financiamiento Basal [ANID/BASAL/ACE210009, ANID/BASAL/FB210008]; BBSRC Doctoral Training Partnership, United Kingdom [BB/M011194/1]; FAPESP, Brazil [2017/12022-0, 2019/08461-3, 2021/01182-1, 2017/18477-9, 2020/08831-2]; Wellcome Trust [200646/Z/16/Z]; European Erasmus+ Exchange Program [2018-1UK01-KA107-046991]; CNPq	Sao Paulo Research Foundation (FAPESP), Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo (FAEPA), Brazil; Sir Henry Dale Fellowship; Wellcome Trust/Royal Society, United Kingdom; Royal Society Research Grant, United Kingdom; Financiamiento Basal(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL); BBSRC Doctoral Training Partnership, United Kingdom; FAPESP, Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Wellcome Trust(Wellcome Trust); European Erasmus+ Exchange Program; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Sao Paulo Research Foundation (FAPESP), Brazil grant (grant no.: 2018/00297-7), Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo (FAEPA), Brazil grants (to L. L. P. d.). This work was also funded by a Sir Henry Dale Fellowship awarded to D. C. G. from the Wellcome Trust/Royal Society, United Kingdom (grant no.: 210481), as well as a Royal Society Research Grant, United Kingdom (grant no.: RGS\R2\202082), and by Financiamiento Basal (grant nos.: ANID/BASAL/ACE210009 and ANID/BASAL/FB210008 [to P. V. B.]). J. E. is funded by the BBSRC Doctoral Training Partnership, United Kingdom (grant no.: BB/M011194/1). Y. C. J., L. S. d. O., L. A. T., M. E. d. S.-J., and V. B. A. are funded by FAPESP, Brazil (grant nos.: 2017/12022-0, 2019/08461-3, 2021/01182-1, 2017/18477-9, and 2020/08831-2, respectively). SALC laboratory was supported by Wellcome Trust (grant no.: 200646/Z/16/Z). L. S. d. O. research placement at the University of Bradford in the UK was funded by the European Erasmus+ Exchange Program (grant no.: 2018-1UK01-KA107-046991). L. L. P. d. is the recipient of a longstanding investigator scholarship from CNPq.	Amorim NA, 2014, J BIOL CHEM, V289, P27744, DOI 10.1074/jbc.M114.560193; Boehm M, 2002, GENE, V286, P175, DOI 10.1016/S0378-1119(02)00422-5; Boncompain G, 2012, NAT METHODS, V9, P493, DOI [10.1038/NMETH.1928, 10.1038/nmeth.1928]; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bonifacino JS, 2014, J CELL BIOL, V204, P7, DOI 10.1083/jcb.201310021; Bourgeois A, 2018, NEUROBIOL AGING, V71, P21, DOI 10.1016/j.neurobiolaging.2018.06.038; Burgos PV, 2010, DEV CELL, V18, P425, DOI 10.1016/j.devcel.2010.01.015; Bustamante HA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083096; Caster AH, 2013, J BIOL CHEM, V288, P28567, DOI 10.1074/jbc.M113.481101; Chen Y, 2017, J CELL BIOL, V216, P4141, DOI 10.1083/jcb.201707172; Correa SAL, 2004, NEUROPHARMACOLOGY, V47, P475, DOI 10.1016/j.neuropharm.2004.04.021; DaSilva LLP, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0144-15.2016; de Carvalho JV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113691; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Eales KL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5701; Edbauer D, 2002, J BIOL CHEM, V277, P13389, DOI 10.1074/jbc.M111571200; El Ayadi A, 2012, P NATL ACAD SCI USA, V109, P13416, DOI 10.1073/pnas.1206786109; Farias GG, 2012, NEURON, V75, P810, DOI 10.1016/j.neuron.2012.07.007; FUJIWARA T, 1988, J BIOL CHEM, V263, P18545; Gonzalez AE, 2017, FASEB J, V31, P2446, DOI 10.1096/fj.201600713R; Guardia CM, 2018, CURR OPIN NEUROBIOL, V51, P103, DOI 10.1016/j.conb.2018.02.021; Guo XL, 2013, DEV CELL, V27, P353, DOI 10.1016/j.devcel.2013.10.006; HAASS C, 1994, J BIOL CHEM, V269, P17741; Heldwein EE, 2004, P NATL ACAD SCI USA, V101, P14108, DOI 10.1073/pnas.0406102101; Hung COY, 2018, CELL REP, V25, P3647, DOI 10.1016/j.celrep.2018.11.095; Huse JT, 2000, J BIOL CHEM, V275, P33729, DOI 10.1074/jbc.M004175200; Icking A, 2007, TRAFFIC, V8, P285, DOI 10.1111/j.1600-0854.2006.00526.x; IHARA Y, 1986, J BIOCHEM-TOKYO, V99, P1807, DOI 10.1093/oxfordjournals.jbchem.a135662; Jager S, 2009, J NEUROCHEM, V111, P1369, DOI 10.1111/j.1471-4159.2009.06420.x; Jia XF, 2012, NAT STRUCT MOL BIOL, V19, P701, DOI 10.1038/nsmb.2328; Jiang Y, 2010, P NATL ACAD SCI USA, V107, P1630, DOI 10.1073/pnas.0908953107; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; LAI A, 1995, J BIOL CHEM, V270, P3565, DOI 10.1074/jbc.270.8.3565; Lauritzen I, 2016, ACTA NEUROPATHOL, V132, P257, DOI 10.1007/s00401-016-1577-6; Lauritzen I, 2012, J NEUROSCI, V32, P16243, DOI 10.1523/JNEUROSCI.2775-12.2012; Lauritzen L, 2019, CURR ALZHEIMER RES, V16, P453, DOI 10.2174/1567205016666190325092841; Lie PPY, 2019, NEUROBIOL DIS, V122, P94, DOI 10.1016/j.nbd.2018.05.015; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Lu DC, 2000, NAT MED, V6, P397, DOI 10.1038/74656; Lu DC, 2003, J NEUROCHEM, V87, P733, DOI 10.1046/j.1471-4159.2003.02059.x; Mardones GA, 2013, J BIOL CHEM, V288, P9563, DOI 10.1074/jbc.M113.450775; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; MATLIN KS, 1983, CELL, V34, P233, DOI 10.1016/0092-8674(83)90154-X; Matrone C, 2008, P NATL ACAD SCI USA, V105, P13139, DOI 10.1073/pnas.0806133105; Matrone C, 2012, AGING CELL, V11, P1084, DOI 10.1111/acel.12009; Mattera R, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004107; Mattera R, 2011, J BIOL CHEM, V286, P2022, DOI 10.1074/jbc.M110.197178; Negredo PN, 2017, J CELL BIOL, V216, P2927, DOI 10.1083/jcb.201602058; Ohno H, 1999, FEBS LETT, V449, P215, DOI 10.1016/S0014-5793(99)00432-9; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; Prabhu Y, 2012, MOL BIOL CELL, V23, P2339, DOI 10.1091/mbc.E11-11-0944; Pulina MV, 2020, ALZHEIMERS DEMENT, V16, P273, DOI 10.1016/j.jalz.2019.09.002; Robinson MS, 2015, TRAFFIC, V16, P1210, DOI 10.1111/tra.12335; Ross BH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088147; Sanger A, 2019, J CELL SCI, V132, DOI 10.1242/jcs.222992; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Tan JZA, 2020, MOL BIOL CELL, V31, P27, DOI 10.1091/mbc.E19-09-0487; Tan JZA, 2019, BBA-BIOMEMBRANES, V1861, P697, DOI 10.1016/j.bbamem.2018.11.013; Tavares LA, 2020, J VIROL, V94, DOI 10.1128/JVI.02039-19; Tavares LA, 2017, J CELL SCI, V130, P429, DOI 10.1242/jcs.192104; Toh WH, 2018, MOL BIOL CELL, V29, P191, DOI 10.1091/mbc.E17-05-0270; Toh WH, 2017, TRAFFIC, V18, P159, DOI 10.1111/tra.12465; Traub LM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016790	66	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2022	298	8							102172	10.1016/j.jbc.2022.102172	http://dx.doi.org/10.1016/j.jbc.2022.102172			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	4F0HT	35753347	Green Published, gold, Green Accepted			2022-12-26	WOS:000848198300001
J	Fu, D; Su, C; Wang, WJ; Yuan, RY				Fu, Dong; Su, Chao; Wang, Wenjun; Yuan, Rongyao			Deep learning based lithology classification of drill core images	PLOS ONE			English	Article							NEURAL-NETWORK; IDENTIFICATION; PREDICTION; FACIES	Drill core lithology is an important indicator reflecting the geological conditions of the drilling area. Traditional lithology identification usually relies on manual visual inspection, which is time-consuming and professionally demanding. In recent years, the rapid development of convolutional neural networks has provided an innovative way for the automatic prediction of drill core images. In this work, a core dataset containing a total of 10 common lithology categories in underground engineering was constructed. ResNeSt-50 we adopted uses a strategy of combining channel-wise attention and multi-path network to achieve cross-channel feature correlations, which significantly improves the model accuracy without high model complexity. Transfer learning was used to initialize the model parameters, to extract the feature of core images more efficiently. The model achieved superior performance on testing images compared with other discussed CNN models, the average value of its Precision, Recall, F1- score for each category of lithology is 99.62%, 99.62%, and 99.59%, respectively, and the prediction accuracy is 99.60%. The test results show that the proposed method is optimal and effective for automatic lithology classification of borehole cores.	[Fu, Dong; Su, Chao; Wang, Wenjun; Yuan, Rongyao] Hohai Univ, Coll Water Conservancy & Hydropower Engn, Nanjing, Peoples R China	Hohai University	Su, C (corresponding author), Hohai Univ, Coll Water Conservancy & Hydropower Engn, Nanjing, Peoples R China.	csu_hhu@126.com	Fu, Dong/GQQ-4231-2022	Fu, Dong/0000-0001-5399-5935	National Natural Science Foundation of China [51579089]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Initials of the authors who received each award: C.S. Grant numbers awarded to each author: 51579089. The full name of each funder: National Natural Science Foundation of China. URL of each funder website: http://www.nsfc.gov.cn/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mudhafar WJ, 2017, J PET EXPLOR PROD TE, V7, P1023, DOI 10.1007/s13202-017-0360-0; Alzubaidi F, 2021, J PETROL SCI ENG, V197, DOI 10.1016/j.petrol.2020.107933; Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; Antariksa G, 2022, J PETROL SCI ENG, V208, DOI 10.1016/j.petrol.2021.109250; Bao YQ, 2019, STRUCT HEALTH MONIT, V18, P401, DOI 10.1177/1475921718757405; Baraboshkin EE, 2020, COMPUT GEOSCI-UK, V135, DOI 10.1016/j.cageo.2019.104330; Borsaru M, 2006, APPL RADIAT ISOTOPES, V64, P272, DOI 10.1016/j.apradiso.2005.07.012; Bradski G, 2000, DR DOBBS J, V25, P120; Chai H, 2009, APPL GEOPHYS, V6, P17, DOI 10.1007/s11770-009-0011-4; Deng CX, 2017, J GEOPHYS ENG, V14, P341, DOI 10.1088/1742-2140/aa5b5b; Deng J, 2009, PROC CVPR IEEE, P248, DOI 10.1109/CVPRW.2009.5206848; Dong YJ, 2020, CONSTR BUILD MATER, V253, DOI 10.1016/j.conbuildmat.2020.119185; [付光明 Fu Guangming], 2017, [地球物理学进展, Progress in Geophysiscs], V32, P26; Galdames FJ, 2017, INT J MINER PROCESS, V160, P47, DOI 10.1016/j.minpro.2017.01.008; Gu JX, 2018, PATTERN RECOGN, V77, P354, DOI 10.1016/j.patcog.2017.10.013; [郭清宏 Guo Qinghong], 2010, [中山大学学报. 自然科学版, Acta Scientiarum Naturalium Universitatis Sunyatseni], V49, P146; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Hu J, 2018, PROC CVPR IEEE, P7132, DOI [10.1109/CVPR.2018.00745, 10.1109/TPAMI.2019.2913372]; Huang G, 2017, PROC CVPR IEEE, P2261, DOI 10.1109/CVPR.2017.243; Jiang Y, 2017, 79 EAGE C EXHIBITION, P1, DOI [10.3997/2214-4609, DOI 10.3997/2214-4609]; Kingma DP., 2014, ADAM METHOD STOCHAST; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Li X, 2019, PROC CVPR IEEE, P510, DOI 10.1109/CVPR.2019.00060; [刘明军 LIU Mingjun], 2011, [煤田地质与勘探, Coal Geology & Exploration], V39, P8; Loshchilov I., 2017, ARXIV, DOI DOI 10.48550/ARXIV.1608.03983; Loshchilov I., 2017, ARXIV; Marmo R, 2005, COMPUT GEOSCI-UK, V31, P649, DOI 10.1016/j.cageo.2004.11.016; McCulloch Warren S., 1943, BULL MATH BIOPHYS, V5, P115, DOI 10.1007/BF02478259; Nanjo T., 2019, AB DHAB INT PETR EXH; Polat O, 2021, TURK J EARTH SCI, V30, P551, DOI 10.3906/yer-2007-19; Polat O, 2021, NEURAL COMPUT APPL, V33, P11531, DOI 10.1007/s00521-021-05849-3; Qin CJ, 2021, MECH SYST SIGNAL PR, V151, DOI 10.1016/j.ymssp.2020.107386; Sebtosheikh MA, 2015, J PETROL SCI ENG, V134, P143, DOI 10.1016/j.petrol.2015.08.001; Selvaraju RR, 2020, INT J COMPUT VISION, V128, P336, DOI 10.1007/s11263-019-01228-7; [单敬福 Shan Jingfu], 2015, [地球物理学进展, Progress in Geophysiscs], V30, P1257; Singh N, 2010, COMPUTAT GEOSCI, V14, P301, DOI 10.1007/s10596-009-9154-x; Szegedy C, 2016, PROC CVPR IEEE, P2818, DOI 10.1109/CVPR.2016.308; Szegedy C, 2015, PROC CVPR IEEE, P1, DOI 10.1109/CVPR.2015.7298594; Tan MX, 2019, PR MACH LEARN RES, V97; Tang LB, 2021, J ROCK MECH GEOTECH, V13, P1274, DOI 10.1016/j.jrmge.2021.08.006; Thomas A, 2011, FIRST BREAK, V29; Torrey L., 2010, HDB RES MACHINE LEAR, P242, DOI DOI 10.4018/978-1-60566-766-9.CH011; Valentin MB, 2019, J PETROL SCI ENG, V179, P474, DOI 10.1016/j.petrol.2019.04.030; van Rossum G., 1991, CWI Q, V4, P283; Wang WJ, 2021, AUTOMAT CONSTR, V128, DOI 10.1016/j.autcon.2021.103786; Xia MZ, 2010, ACTA PETROL SIN, V26, P2413; Xie SN, 2017, PROC CVPR IEEE, P5987, DOI 10.1109/CVPR.2017.634; Xu ZH, 2021, COMPUT GEOSCI-UK, V154, DOI 10.1016/j.cageo.2021.104799; [杨笑 Yang Xiao], 2019, [石油学报, Acta Petrolei Sinica], V40, P457; Yang Z, 2021, AUTOMAT CONSTR, V125, DOI 10.1016/j.autcon.2021.103612; Zhang A, 2021, ARXIV; Zhang H, 2020, ARXIV; Zhang Q.X., 2018, PROCEDIA ENG, V211, P441, DOI [10.1016/j.proeng.2017.12.034, DOI 10.1016/J.PROENG.2017.12.034]	55	1	1	28	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2022	17	7							e0270826	10.1371/journal.pone.0270826	http://dx.doi.org/10.1371/journal.pone.0270826			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4M3GX	35776744	Green Published, gold			2022-12-26	WOS:000853214500001
J	Ahat, E; Bui, S; Zhang, JC; Leprevost, FD; Sharkey, L; Reid, W; Nesvizhskii, AI; Paulson, HL; Wang, YZ				Ahat, Erpan; Bui, Sarah; Zhang, Jianchao; Leprevost, Felipe da Veiga; Sharkey, Lisa; Reid, Whitney; Nesvizhskii, Alexey I.; Paulson, Henry L.; Wang, Yanzhuang			GRASP55 regulates the unconventional secretion and aggregation of mutant huntingtin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; CEREBROSPINAL-FLUID; ALPHA-SYNUCLEIN; EXON-1 PROTEIN; AUTOPHAGY; STACKING; TAU; PROTEASOME; EXOCYTOSIS; PATHWAY	Recent studies demonstrated that the Golgi reassembly stacking proteins (GRASPs), especially GRASP55, regulate Golgi-independent unconventional secretion of certain cyto-solic and transmembrane cargoes; however, the underlying mechanism remains unknown. Here, we surveyed several neurodegenerative disease-related proteins, including mutant huntingtin (Htt-Q74), superoxide dismutase 1 (SOD1), tau, and TAR DNA-binding protein 43 (TDP-43), for unconventional secretion; our results show that Htt-Q74 is most robustly secreted in a GRASP55-dependent manner. Using Htt-Q74 as a model system, we demonstrate that unconventional secretion of Htt is GRASP55 and autophagy dependent and is enhanced under stress conditions such as starvation and endoplasmic reticulum stress. Mechanistically, we show that GRASP55 facilitates Htt secretion by tethering autophagosomes to lyso-somes to promote autophagosome maturation and subsequent lysosome secretion and by stabilizing p23/TMED10, a channel for translocation of cytoplasmic proteins into the lumen of the endoplasmic reticulum-Golgi intermediate compartment. Moreover, we found that GRASP55 levels are upregulated by various stresses to facilitate unconventional secretion, whereas inhibition of Htt-Q74 secretion by GRASP55 KO enhances Htt aggregation and toxicity. Finally, comprehensive secretomic analysis identified novel cytosolic cargoes secreted by the same unconventional pathway, including transgelin (TAGLN), multifunctional protein ADE2 (PAICS), and peroxiredoxin-1 (PRDX1). In conclusion, this study defines the pathway of GRASP55-mediated unconventional protein secretion and provides important insights into the progression of Hunting-ton's disease.	[Ahat, Erpan; Bui, Sarah; Zhang, Jianchao; Reid, Whitney; Wang, Yanzhuang] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Leprevost, Felipe da Veiga; Nesvizhskii, Alexey I.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA; [Sharkey, Lisa; Wang, Yanzhuang] Univ Michigan, Sch Med, Dept Neurol, Ann Arbor, MI 48109 USA; [Nesvizhskii, Alexey I.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Wang, YZ (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.; Wang, YZ (corresponding author), Univ Michigan, Sch Med, Dept Neurol, Ann Arbor, MI 48109 USA.	yzwang@umich.edu	Wang, Yanzhuang/AAE-5299-2019; Zhang, Jianchao/GZL-7527-2022; da Veiga Leprevost, Felipe/D-6905-2013	Wang, Yanzhuang/0000-0002-1864-7094; Zhang, Jianchao/0000-0002-3269-4639; da Veiga Leprevost, Felipe/0000-0002-8228-5374; , Whitney/0000-0003-0883-8812; Ahat, Erpan/0000-0002-4057-9120	National Institutes of Health [R35GM130331, R01NS102279]; Fast Forward Protein Folding Disease Initiative of the University of Michigan; University of Michigan Rackham Predoctoral Fellowship	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fast Forward Protein Folding Disease Initiative of the University of Michigan; University of Michigan Rackham Predoctoral Fellowship(University of Michigan System)	This work was supported by the National Institutes of Health grant (grant nos.: R35GM130331 and R01NS102279) and the Fast Forward Protein Folding Disease Initiative of the University of Michigan to Y. W., and a University of Michigan Rackham Predoctoral Fellowship to E. A. The content is solely the responsibility of the authors and does not necessarily represent the of fi cial views of the National Institutes of Health.	Ahat E, 2022, CELL MOL LIFE SCI, V79, DOI 10.1007/s00018-022-04223-3; Ahat E, 2019, MOL BIOL CELL, V30, P766, DOI 10.1091/mbc.E18-07-0462; Arbez N, 2017, J BIOL CHEM, V292, P19238, DOI 10.1074/jbc.M117.782300; Arrasate M, 2012, EXP NEUROL, V238, P1, DOI 10.1016/j.expneurol.2011.12.013; Barr FA, 1997, CELL, V91, P253, DOI 10.1016/S0092-8674(00)80407-9; Barr FA, 2001, J CELL BIOL, V155, P885, DOI 10.1083/jcb.200108102; Bates GP, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.5; Bekier ME, 2017, MOL BIOL CELL, V28, P2833, DOI 10.1091/mbc.E17-02-0112; Brandstaetter H, 2014, DIS MODEL MECH, V7, P1335, DOI 10.1242/dmm.017368; Bruns C, 2011, J CELL BIOL, V195, P979, DOI 10.1083/jcb.201106098; Caron NS, 2021, J NEUROSCI, V41, P780, DOI 10.1523/JNEUROSCI.1865-20.2020; Cerny J, 2004, EMBO REP, V5, P883, DOI 10.1038/sj.embor.7400243; Chen MC, 2017, P NATL ACAD SCI USA, V114, P4406, DOI 10.1073/pnas.1702237114; Cruz-Garcia D, 2017, J CELL BIOL, V216, P2691, DOI 10.1083/jcb.201704056; Dangoumau A, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.07.012; Dupont N, 2011, EMBO J, V30, P4701, DOI 10.1038/emboj.2011.398; Duran JM, 2010, J CELL BIOL, V188, P527, DOI 10.1083/jcb.200911154; Fodale V, 2017, J HUNTINGTONS DIS, V6, P349, DOI 10.3233/JHD-170269; Fu YH, 2017, NAT CHEM BIOL, V13, P1152, DOI 10.1038/nchembio.2461; Fujita Y, 2002, ACTA NEUROPATHOL, V103, P243, DOI 10.1007/s004010100461; Gee HY, 2011, CELL, V146, P746, DOI 10.1016/j.cell.2011.07.021; Gerson JE, 2020, HUM MOL GENET, V29, P2596, DOI 10.1093/hmg/ddaa152; Giuliani F, 2011, CURR OPIN CELL BIOL, V23, P498, DOI 10.1016/j.ceb.2011.04.005; Hegde RN, 2020, EMBO J, V39, DOI 10.15252/embj.2020104671; Heng MY, 2010, HUM MOL GENET, V19, P3702, DOI 10.1093/hmg/ddq285; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Kim J, 2016, TRAFFIC, V17, P733, DOI 10.1111/tra.12403; Kinseth MA, 2007, CELL, V130, P524, DOI 10.1016/j.cell.2007.06.029; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; Lee JG, 2016, NAT CELL BIOL, V18, P765, DOI 10.1038/ncb3372; Leitman J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090803; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; McAlary L, 2020, PROG MOL BIOL TRANSL, V175, P261, DOI 10.1016/bs.pmbts.2020.07.002; Mecocci P, 1998, ALZ DIS ASSOC DIS, V12, P211, DOI 10.1097/00002093-199809000-00015; Merezhko M, 2018, CELL REP, V25, P2027, DOI 10.1016/j.celrep.2018.10.078; Miller VM, 2005, J NEUROSCI, V25, P9152, DOI 10.1523/JNEUROSCI.3001-05.2005; Mizuno Y, 2001, ADV NEUROL, V86, P13; NISHIMURA Y, 1995, BIOL PHARM BULL, V18, P825; Noh SH, 2018, AUTOPHAGY, V14, P1761, DOI 10.1080/15548627.2018.1489479; Nuchel J, 2021, MOL CELL, V81, P3275, DOI 10.1016/j.molcel.2021.06.017; Rabouille C, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00001; Rui YN, 2015, NAT CELL BIOL, V17, P262, DOI 10.1038/ncb3101; Sathasivam K, 2013, P NATL ACAD SCI USA, V110, P2366, DOI 10.1073/pnas.1221891110; Saudou F, 2016, NEURON, V89, P910, DOI 10.1016/j.neuron.2016.02.003; Sbodio JI, 2018, P NATL ACAD SCI USA, V115, P780, DOI 10.1073/pnas.1717877115; Schotman H, 2008, DEV CELL, V14, P171, DOI 10.1016/j.devcel.2007.12.006; Tank EM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05049-z; Thompson LM, 2009, J CELL BIOL, V187, P1083, DOI 10.1083/jcb.200909067; Trajkovic K, 2017, J NEUROSCI, V37, P9000, DOI 10.1523/JNEUROSCI.0118-17.2017; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Umeda T, 2014, ACTA NEUROPATHOL, V127, P685, DOI 10.1007/s00401-014-1259-1; Villeneuve J, 2018, J CELL BIOL, V217, P649, DOI 10.1083/jcb.201705047; Wang YZ, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005330; Wang YZ, 2003, EMBO J, V22, P3279, DOI 10.1093/emboj/cdg317; Wild EJ, 2015, J CLIN INVEST, V125, P1979, DOI 10.1172/JCI80743; Winer L, 2013, JAMA NEUROL, V70, P201, DOI 10.1001/jamaneurol.2013.593; Xiang Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2669; Xiang Y, 2011, CELL TISSUE RES, V344, P365, DOI 10.1007/s00441-011-1166-x; Xiang Y, 2010, J CELL BIOL, V188, P237, DOI 10.1083/jcb.200907132; Zhang M, 2020, CELL, V181, P637, DOI 10.1016/j.cell.2020.03.031; Zhang XY, 2020, TRENDS BIOCHEM SCI, V45, P1065, DOI 10.1016/j.tibs.2020.08.001; Zhang XY, 2019, AUTOPHAGY, V15, P1787, DOI 10.1080/15548627.2019.1596480; Zhang XY, 2018, MOL CELL ONCOL, V5, DOI 10.1080/23723556.2018.1494948; Zhang XY, 2018, DEV CELL, V45, P245, DOI 10.1016/j.devcel.2018.03.023	65	1	1	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2022	298	8							102219	10.1016/j.jbc.2022.102219	http://dx.doi.org/10.1016/j.jbc.2022.102219			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	4F0HT	35780830	Green Published, gold, Green Submitted			2022-12-26	WOS:000848198300012
J	Katsyv, A; Mueller, V				Katsyv, Alexander; Mueller, Volker			A purified energy-converting hydrogenase from Thermoanaerobacter kivui demonstrates coupled H+-translocation and reduction in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ECH HYDROGENASE; FERREDOXIN OXIDOREDUCTASE; METHANOSARCINA-BARKERI; A(1)A(O)-ATP SYNTHASE; NIFE HYDROGENASES; REACTIVE PROTEIN; ATP SYNTHASE; PURIFICATION; COMPLEX; FORMATE	Energy-converting hydrogenases (Ech) are ancient, membrane-bound enzymes that use reduced ferredoxin (Fd) as an electron donor to reduce protons to molecular H-2. Experi-ments with whole cells, membranes and vesicle-fractions suggest that proton reduction is coupled to proton translocation across the cytoplasmatic membrane, but this has never been demonstrated with a purified enzyme. To this end, we pro-duced a His-tagged Ech complex in the thermophilic and anaerobic bacterium Thermoanaerobacter kivui. The enzyme could be purified by affinity chromatography from solubilized membranes with full retention of its eight subunits, as well as full retention of physiological activities, i.e., H-2-dependent Fd reduction and Fd(2-)-dependent H-2 production. We found the purified enzyme contained 34.2 +/- 12.2 mol of iron/mol of protein, in accordance with seven predicted [4Fe-4S]-clusters and one [Ni-Fe]-center. The pH and temperature optima were at 7 to 8 and 66 ?, respectively. Notably, we found that the enzymatic activity was inhibited by N,N'-dicyclohex-ylcarbodiimide, an agent known to bind ion-translocating glutamates or aspartates buried in the cytoplasmic membrane and thereby inhibiting ion transport. To demonstrate the function of the Ech complex in ion transport, we further established a procedure to incorporate the enzyme complex into liposomes in an active state. We show the enzyme did not require Na+ for activity and did not translocate Na-22(+) into the proteoliposomal lumen. In contrast, Ech activity led to the generation of a pH gradient and membrane potential across the proteoliposomal membrane, demonstrating that the Ech complex of T. kivui is a H+-translocating, H+-reducing enzyme.	[Katsyv, Alexander; Mueller, Volker] Goethe Univ Frankfurt, Inst Mol Biosci, Dept Mol Microbiol & Bioenerget, Frankfurt, Germany	Goethe University Frankfurt	Mueller, V (corresponding author), Goethe Univ Frankfurt, Inst Mol Biosci, Dept Mol Microbiol & Bioenerget, Frankfurt, Germany.	vmueller@bio.uni-frankfurt.de			Deutsche Forschungsgemeinschaft (DFG)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	We are grateful to the Deutsche Forschungsgemeinschaft (DFG) for financial support.	ALTENDORF K, 1975, FEBS LETT, V59, P268, DOI 10.1016/0014-5793(75)80390-5; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Basen M, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.02210-17; Bettenbrock K, 2014, ADV MICROB PHYSIOL, V64, P65, DOI 10.1016/B978-0-12-800143-1.00002-6; BLAMEY JM, 1993, BIOCHIM BIOPHYS ACTA, V1161, P19, DOI 10.1016/0167-4838(93)90190-3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brandt U, 2003, FEBS LETT, V545, P9, DOI 10.1016/S0014-5793(03)00387-9; BRYANT MP, 1972, AM J CLIN NUTR, V25, P1324; Ferguson SA, 2006, J BACTERIOL, V188, P5045, DOI 10.1128/JB.00128-06; FILLINGAME RH, 1975, J BACTERIOL, V124, P870, DOI 10.1128/JB.124.2.870-883.1975; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; Forzi L, 2005, FEBS J, V272, P4741, DOI 10.1111/j.1742-4658.2005.04889.x; Friedrich T, 2000, FEBS LETT, V479, P1, DOI 10.1016/S0014-5793(00)01867-6; Greening C, 2016, ISME J, V10, P761, DOI 10.1038/ismej.2015.153; Hedderich R, 2005, J MOL MICROB BIOTECH, V10, P92, DOI 10.1159/000091557; Hedderich R, 2004, J BIOENERG BIOMEMBR, V36, P65, DOI 10.1023/B:JOBB.0000019599.43969.33; HEIDER J, 1995, J BACTERIOL, V177, P4757, DOI 10.1128/jb.177.16.4757-4764.1995; HERMOLIN J, 1989, J BIOL CHEM, V264, P3896; Hess V, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1139; HUANG CS, 1983, BIOCHIM BIOPHYS ACTA, V722, P107, DOI 10.1016/0005-2728(83)90163-9; Hungate R.E., 1969, METHODS MICROBIOLO B, P117, DOI [DOI 10.1016/S0580-9517(08)70503-8, 10.1016/S0580-9517(08)70503-8]; Jain S, 2022, EXTREMOPHILES, V26, DOI 10.1007/s00792-021-01251-y; Katsyv A, 2021, EXTREMOPHILES, V25, P513, DOI 10.1007/s00792-021-01247-8; Katsyv A, 2021, FEBS OPEN BIO, V11, P1332, DOI 10.1002/2211-5463.13136; Kim YJ, 2010, NATURE, V467, P352, DOI 10.1038/nature09375; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAUBINGER W, 1988, BIOCHEMISTRY-US, V27, P7531, DOI 10.1021/bi00419a053; Lie TJ, 2012, P NATL ACAD SCI USA, V109, P15473, DOI 10.1073/pnas.1208779109; Lim JK, 2014, P NATL ACAD SCI USA, V111, P11497, DOI 10.1073/pnas.1407056111; Mayer F, 2015, J BIOL CHEM, V290, P6994, DOI 10.1074/jbc.M114.616862; Mayer F, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.411223; McDowall JS, 2014, P NATL ACAD SCI USA, V111, pE3948, DOI 10.1073/pnas.1407927111; McMillan DGG, 2011, J BIOL CHEM, V286, P39882, DOI 10.1074/jbc.M111.281675; McTernan PM, 2014, J BIOL CHEM, V289, P19364, DOI 10.1074/jbc.M114.567255; Meier T, 2006, J BACTERIOL, V188, P7759, DOI 10.1128/JB.00934-06; Meuer J, 1999, EUR J BIOCHEM, V265, P325, DOI 10.1046/j.1432-1327.1999.00738.x; Meuer J, 2002, P NATL ACAD SCI USA, V99, P5632, DOI 10.1073/pnas.072615499; Muller V, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02019; NAKOS G, 1971, BIOCHIM BIOPHYS ACTA, V227, P576, DOI 10.1016/0005-2744(71)90008-8; Oppinger C, 2022, INT MICROBIOL, V25, P75, DOI 10.1007/s10123-021-00190-0; PEZACKA E, 1984, P NATL ACAD SCI-BIOL, V81, P6261, DOI 10.1073/pnas.81.20.6261; Pisa KY, 2007, FEBS J, V274, P3928, DOI 10.1111/j.1742-4658.2007.05925.x; Ropke M, 2020, J AM CHEM SOC, V142, P21758, DOI 10.1021/jacs.0c09209; Ruth JC, 2021, CATALYSTS, V11, DOI 10.3390/catal11101197; Sapra R, 2000, J BACTERIOL, V182, P3423, DOI 10.1128/JB.182.12.3423-3428.2000; Sapra R, 2003, P NATL ACAD SCI USA, V100, P7545, DOI 10.1073/pnas.1331436100; Sargent F, 2016, ADV MICROB PHYSIOL, V68, P433, DOI 10.1016/bs.ampbs.2016.02.008; SAWERS G, 1994, ANTON LEEUW INT J G, V66, P57, DOI 10.1007/BF00871633; Sawers RG, 2005, BIOCHEM SOC T, V33, P42, DOI 10.1042/BST0330042; Schoelmerich MC, 2020, P NATL ACAD SCI USA, V117, P1167, DOI 10.1073/pnas.1914939117; Schoelmerich MC, 2020, CELL MOL LIFE SCI, V77, P1461, DOI 10.1007/s00018-019-03329-5; Schoelmerich MC, 2019, P NATL ACAD SCI USA, V116, P6329, DOI 10.1073/pnas.1818580116; SCHONHEIT P, 1978, FEBS LETT, V89, P219, DOI 10.1016/0014-5793(78)80221-X; Schuchmann K, 2014, NAT REV MICROBIOL, V12, P809, DOI 10.1038/nrmicro3365; Schuchmann K, 2012, J BIOL CHEM, V287, P31165, DOI 10.1074/jbc.M112.395038; Schwarz FM, 2020, MICROB BIOTECHNOL, V13, P2044, DOI 10.1111/1751-7915.13663; Shaw AJ, 2010, APPL ENVIRON MICROB, V76, P4713, DOI 10.1128/AEM.00402-10; Soboh B, 2004, MICROBIOL-SGM, V150, P2451, DOI 10.1099/mic.0.27159-0; SPRUTH M, 1995, BBA-BIOENERGETICS, V1229, P96, DOI 10.1016/0005-2728(94)00192-8; Toei M, 2013, J BIOL CHEM, V288, P25717, DOI 10.1074/jbc.M113.482455; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Vignais PM, 2004, CURR ISSUES MOL BIOL, V6, P159; Vignais PM, 2001, FEMS MICROBIOL REV, V25, P455, DOI 10.1111/j.1574-6976.2001.tb00587.x; Wang SN, 2013, J BACTERIOL, V195, P1267, DOI 10.1128/JB.02158-12; Weghoff MC, 2016, APPL ENVIRON MICROB, V82, P2312, DOI 10.1128/AEM.00122-16; Welte C, 2010, FEBS J, V277, P3396, DOI 10.1111/j.1742-4658.2010.07744.x; Welte C, 2010, J BACTERIOL, V192, P674, DOI 10.1128/JB.01307-09; Wittig I, 2007, ELECTROPHORESIS, V28, P3811, DOI 10.1002/elps.200700367; Wu CH, 2018, J BIOL CHEM, V293, P16687, DOI 10.1074/jbc.RA118.005092; Yu HJ, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100740; Yu HJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19697-7; Yu HJ, 2018, CELL, V173, P1636, DOI 10.1016/j.cell.2018.03.071; Zhu JP, 2016, NATURE, V536, P354, DOI 10.1038/nature19095	73	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2022	298	8							102216	10.1016/j.jbc.2022.102216	http://dx.doi.org/10.1016/j.jbc.2022.102216			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	4X0OB	35779632	Green Published, gold			2022-12-26	WOS:000860550600005
J	Li, T; Yan, B; Xiao, XJ; Zhou, L; Zhang, J; Yuan, Q; Shan, LT; Wu, HL; Efferth, T				Li, Ting; Yan, Bo; Xiao, Xiujuan; Zhou, Li; Zhang, Jin; Yuan, Qiang; Shan, Letian; Wu, Huiling; Efferth, Thomas			Onset of p53/NF-kappa B signaling crosstalk in human melanoma cells in response to anti-cancer theabrownin	FASEB JOURNAL			English	Article						crosstalk; DNA damage; melanoma; senescence; theabrownin; zebrafish	NF-KAPPA-B; DRINKING GREEN TEA; DNA-DAMAGE; SKIN-CANCER; BLACK TEA; P53; PROTECTION; POLY(ADP-RIBOSYL)ATION; PHOTOCARCINOGENESIS; CARCINOGENESIS	As a major tea component, theabrownin represents a promising anti-cancer candidate. However, its effect on the melanoma is unknown. To evaluate the in vitro and in vivo anti-melanoma efficacy of TB, we conducted cell viability, immunostaining, comet, and TUNEL assays on human A375 melanoma cells, and employed a zebrafish xenograft model of A375 cells. Real-time PCR (qPCR) and western blot were conducted to explore the molecular mechanisms of TB. In vitro, TB significantly inhibited the proliferation of A375 cells, and A375 cells showed the highest inhibitory rate among the other melanoma cell line (A875) and human dermal fibroblasts. TB triggered DNA damage and induced apoptosis of A375 cells and significantly inhibited the growth of A375 xenograft tumors in zebrafishes. Several key molecular events were activated by TB, including DNA damage-associated p53 and NF-kappa B pathways, through up-regulation of GADD45 alpha, gamma-H2A.X, phospho-ATM(p-ATM), phospho-ATR (p-ATR), phospho-p53 (p-p53), phospho-IKK alpha/beta (p-IKK alpha/beta), phospho-p65 (p-p65), etc. However, the TB-activated molecular events were counteracted by either knockdown of p53 or p65, and only dual knockdown of both p53 and p65 completed counteracted the anti-melanoma efficacy of TB. In conclusion, TB triggered DNA damage and thereby inhibited proliferation and induced cellular senescence and apoptosis of melanoma cells through mechanisms mediated by p53/NF-kappa B signaling crosstalk. This is the first report on the efficacy and mechanisms of TB on melanoma cells, making TB a promising candidate for anti-melanoma agent development.	[Li, Ting; Wu, Huiling] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Hangzhou, Peoples R China; [Li, Ting; Wu, Huiling] Zhejiang Univ, Dept Plast & Aesthet Ctr, Affiliated Hosp 1, Hangzhou, Peoples R China; [Yan, Bo; Xiao, Xiujuan; Yuan, Qiang] Zhejiang Chinese Med Univ, Coll Pharmaceut Sci, Hangzhou, Peoples R China; [Yan, Bo] Shangyu Biotechnol Co Ltd, Hangzhou Reg Cell Preparat Ctr, Cell Resource Bank, Hangzhou, Peoples R China; [Yan, Bo] Shangyu Biotechnol Co Ltd, Hangzhou Reg Cell Preparat Ctr, Integrated Cell Preparat Ctr Xiaoshan Dist, Hangzhou, Peoples R China; [Zhou, Li; Shan, Letian] Zhejiang Chinese Med Univ, Affiliated Hosp 1, Hangzhou, Peoples R China; [Zhang, Jin] Theabio Co Ltd, Hangzhou, Peoples R China; [Efferth, Thomas] Johannes Gutenberg Univ Mainz, Dept Pharmaceut Biol, Mainz, Germany	Zhejiang University; Zhejiang University; Zhejiang Chinese Medical University; Zhejiang Chinese Medical University; Johannes Gutenberg University of Mainz	Wu, HL (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Coll Med, Hangzhou, Peoples R China.; Shan, LT (corresponding author), Zhejiang Chinese Med Univ, Affiliated Hosp 1, Hangzhou, Peoples R China.	letian.shan@zcmu.edu.cn; zywhl@zju.edu.cn			National Natural Science Foundation of China (NSFC) [81774331, 81873049]; Zhejiang Provincial Natural Science Foundation of China (ZJNSF) [LY18H270004, LQ20H150008]; Zhejiang Provincial Basic Public Welfare Research Program [LGF22H150017]; Zhejiang Provincial Key Construction University Superiority Characteristic Discipline (Traditional Chinese Pharmacology) Opening Foundation of China [ZYX2018006]; Zhejiang Provincial Science and Technology Project of Traditional Chinese Medicine of China [2016ZZ011]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China (ZJNSF)(Natural Science Foundation of Zhejiang Province); Zhejiang Provincial Basic Public Welfare Research Program; Zhejiang Provincial Key Construction University Superiority Characteristic Discipline (Traditional Chinese Pharmacology) Opening Foundation of China; Zhejiang Provincial Science and Technology Project of Traditional Chinese Medicine of China	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81774331 and 81873049; Zhejiang Provincial Natural Science Foundation of China (ZJNSF), Grant/Award Number: LY18H270004 and LQ20H150008; Zhejiang Provincial Basic Public Welfare Research Program, Grant/Award Number: LGF22H150017; Zhejiang Provincial Key Construction University Superiority Characteristic Discipline (Traditional Chinese Pharmacology) Opening Foundation of China, Grant/Award Number: ZYX2018006; Zhejiang Provincial Science and Technology Project of Traditional Chinese Medicine of China, Grant/Award Number: 2016ZZ011	Abraham I, 2016, ALLERGY, V71, P593, DOI 10.1111/all.12815; Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Baliga MS, 2006, PHOTOCH PHOTOBIO SCI, V5, P243, DOI 10.1039/b505311k; Barnes PJ, 2019, AM J RESP CRIT CARE, V200, P556, DOI 10.1164/rccm.201810-1975TR; Bastian BC, 2014, ANNU REV PATHOL-MECH, V9, P239, DOI 10.1146/annurev-pathol-012513-104658; Bauer J, 2003, PIGM CELL RES, V16, P297, DOI 10.1034/j.1600-0749.2003.00047.x; Candido S, 2014, ONCOL REP, V31, P1079, DOI 10.3892/or.2014.2977; Carra G, 2020, CELL MOL LIFE SCI, V77, P4449, DOI 10.1007/s00018-020-03524-9; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Dimitriou F, 2018, CURR ONCOL REP, V20, DOI 10.1007/s11912-018-0732-8; Duan R, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/1057943; El-Deiry WS, 1998, SEMIN CANCER BIOL, V8, P345, DOI 10.1006/scbi.1998.0097; Gong JS, 2010, J FOOD SCI, V75, pH182, DOI 10.1111/j.1750-3841.2010.01675.x; Gordaliza M, 2007, CLIN TRANSL ONCOL, V9, P767, DOI 10.1007/s12094-007-0138-9; Guo L, 2020, ARCH BIOCHEM BIOPHYS, V692, DOI 10.1016/j.abb.2020.108519; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Han C, 1999, Wei Sheng Yan Jiu, V28, P343; Hawkes JE, 2016, SEMIN ONCOL, V43, P591, DOI 10.1053/j.seminoncol.2016.08.003; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hinz M, 2010, MOL CELL, V40, P63, DOI 10.1016/j.molcel.2010.09.008; Huang FJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12896-x; Huang MT, 1997, CANCER RES, V57, P2623; Imai K, 1997, PREV MED, V26, P769, DOI 10.1006/pmed.1997.0242; Jin WD, 2020, ONCOL REP, V44, P2621, DOI 10.3892/or.2020.7801; Jin WD, 2018, J CELL MOL MED, V22, P4423, DOI 10.1111/jcmm.13742; Katiyar Santosh K., 2003, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V3, P234, DOI 10.2174/1568008033340171; Katiyar S, 2007, J NUTR BIOCHEM, V18, P287, DOI 10.1016/j.jnutbio.2006.08.004; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kwon M, 2016, CELL CYCLE, V15, P3105, DOI 10.1080/15384101.2016.1235104; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Lowe JM, 2014, CANCER RES, V74, P2182, DOI 10.1158/0008-5472.CAN-13-1070; Mao XB, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20215249; Mortusewicz O, 2007, NUCLEIC ACIDS RES, V35, P7665, DOI 10.1093/nar/gkm933; Muruzabal D, 2021, ARCH TOXICOL, V95, P2825, DOI 10.1007/s00204-021-03102-3; Nakachi K, 1998, JPN J CANCER RES, V89, P254, DOI 10.1111/j.1349-7006.1998.tb00556.x; Ou HL, 2018, BLOOD, V131, P488, DOI 10.1182/blood-2017-07-746396; Perkins ND, 2004, TRENDS CELL BIOL, V14, P64, DOI 10.1016/j.tcb.2003.12.004; Record IR, 1998, MUTAT RES-FUND MOL M, V422, P191, DOI 10.1016/S0027-5107(98)00192-4; Record IR, 1998, NUTR CANCER, V32, P71, DOI 10.1080/01635589809514721; Rocha S, 2005, EMBO J, V24, P1157, DOI 10.1038/sj.emboj.7600608; Rosse T, 1998, NATURE, V391, P496, DOI 10.1038/35160; Russo AE, 2009, INT J ONCOL, V34, P1481, DOI 10.3892/ijo_00000277; Ryan KM, 2000, NATURE, V404, P892, DOI 10.1038/35009130; Shan ZG, 2021, OXID MED CELL LONGEV, V2021, DOI 10.1155/2021/6256618; Shirakami Y, 2018, MOLECULES, V23, DOI 10.3390/molecules23092284; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Smith J, 2010, ADV CANCER RES, V108, P73, DOI 10.1016/S0065.230X(10)08002.4; Tian LW, 2014, J AGR FOOD CHEM, V62, P12229, DOI 10.1021/jf5036959; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; WANG ZY, 1992, CANCER RES, V52, P6657; WANG ZY, 1994, CANCER RES, V54, P3428; WANG ZY, 1991, CARCINOGENESIS, V12, P1527, DOI 10.1093/carcin/12.8.1527; Wu CE, 2018, BRIT J CANCER, V118, P495, DOI 10.1038/bjc.2017.433; Wu EK, 2020, EUR J NUTR, V59, P1937, DOI 10.1007/s00394-019-02044-y; Wu FF, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00465; Wu ZH, 2007, J MOL MED, V85, P1187, DOI 10.1007/s00109-007-0227-9; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yakovlev AG, 2000, J BIOL CHEM, V275, P21302, DOI 10.1074/jbc.M001087200; Yang KM, 2018, CANCER EPIDEM BIOMAR, V27, P1115, DOI [10.1158/1055-9965.EPI-18-0243, 10.1158/1055-9965.epi-18-0243]; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yue XT, 2017, J MOL BIOL, V429, P1595, DOI 10.1016/j.jmb.2017.03.030; Zhou L, 2017, FRONT PHARMACOL, V8, P1, DOI 10.3389/fphar.2017.00075; Zhu K, 2021, CRIT REV FOOD SCI, V61, P1556, DOI 10.1080/10408398.2020.1762161	63	1	1	5	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2022	36	8							e22426	10.1096/fj.202200261R	http://dx.doi.org/10.1096/fj.202200261R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2P8PV	35779042				2022-12-26	WOS:000819996500001
J	Wang, CC; Lo, J; Geraghty, S; Yang, AWH				Wang, Carol Chunfeng; Lo, Johnny; Geraghty, Sadie; Yang, Angela Wei Hong			Effects of Tai Chi on the quality of life, mental wellbeing, and physical function of adults with chronic diseases: Protocol for a single-blind, two-armed, randomised controlled trial	PLOS ONE			English	Article							MCGILL PAIN QUESTIONNAIRE; FORM HEALTH SURVEY; VISUAL ANALOG; RELIABILITY; VALIDITY; SF-36; OUTCOMES	Introduction Quality of life (QoL), mental wellbeing, and physical function are often diminished among people with chronic disease. Tai Chi is a moderate form of exercise that may be effective in improving chronic disease management. This protocol paper outlines a trial to determine the therapeutic effects of a Tai Chi program on chronic disease management. Methods and analysis This study will be a pilot, interventional, single-blind, two-armed, randomised, parallel, and controlled trial involving a 12-week Tai Chi program for Australian adults. Forty people aged 18 years and older, diagnosed with one or more chronic disease from general community will be recruited. All participants will be randomised to either a 12-week Tai Chi program or a waiting list control group. The Tai Chi program will involve 12 weeks of group Tai Chi sessions, with 45 minutes per session, twice a week. The primary outcome will be QoL as measured by mean scores on the 12-item Short Form Health Survey (SF-12v2) and the EuroQoL (EQ-5D). The secondary outcomes will include anxiety as measured by mean score on the generalised anxiety disorder 7 (GAD-7) survey; depression as measured by mean score on the patient health questionnaire (PHQ-9); work productivity and activity assessment (WPAI:SHP); pain (if any) as measured by mean scores on the visual analogue scale (VAS) and the McGill pain questionnaire (MPQ). These primary and secondary outcomes will be self-administered via two online assessments prior to (T0) and post-intervention (T1). Objective measures as additional secondary outcomes, will also be carried out by the research team including flexibility as measured by the finger to floor distance (FFD); obesity as measured by mean scores on body mass index (BMI); vital signs (blood pressure, heart rate, respiratory rate, temperate, and oxygen saturation) as measured by a blood pressure monitor, tympanic, and pulse oximetry device, and these outcomes will be measured at T0 and T1 in the ECU Holistic Health Research Clinic. People diagnosed with pre-diabetes or diabetes, their glycosylated haemoglobin (HbA1C) and fasting (before breakfast) blood glucose level (BGL) will also be measured via test kits at T0 and T1 in the clinic. Linear mixed modelling will be conducted to assess changes in outcomes. Statistical significance will be set at an alpha level of 0.05 with a medium effect size. All analyses will be conducted using R version 4.1. Qualitative data will be analysed using template thematic analysis. Ethics and dissemination Ethical approval has been obtained from the Edith Cowan University (ECU) Human Research Ethics Committee (2021-03042-WANG). Research findings will be disseminated to the public, health professionals, researchers, and healthcare providers through conference presentations, lay summaries, and peer-reviewed publications. This study will provide an updated evidence on a safe, sustainable, and inexpensive non-pharmacological approach in the management of chronic disease, the number one burden of disease in Australia.	[Wang, Carol Chunfeng; Geraghty, Sadie] Univ Notre Dame Australia, Sch Nursing Midwifery Hlth Sci & Physiotherapy, Perth, WA, Australia; [Wang, Carol Chunfeng] Edith Cowan Univ, Sch Nursing & Midwifery, Perth, WA, Australia; [Lo, Johnny] Edith Cowan Univ, Sch Sci, Perth, WA, Australia; [Yang, Angela Wei Hong] RMIT Univ, Sch Hlth & Biomed Sci, Bundoora, Vic, Australia	University of Notre Dame Australia; Edith Cowan University; Edith Cowan University; Royal Melbourne Institute of Technology (RMIT)	Wang, CC (corresponding author), Univ Notre Dame Australia, Sch Nursing Midwifery Hlth Sci & Physiotherapy, Perth, WA, Australia.; Wang, CC (corresponding author), Edith Cowan Univ, Sch Nursing & Midwifery, Perth, WA, Australia.	carol.wang@nd.edu.au	Geraghty, Sadie/L-3029-2016	Geraghty, Sadie/0000-0001-6920-6013; Wang, Dr Carol Chunfeng/0000-0002-6672-7187				Australian Health Ministers' Advisory Council, 2017, NATL STRATEGIC FRAME; Brooks J, 2015, QUAL RES PSYCHOL, V12, P202, DOI 10.1080/14780887.2014.955224; Care RH, 12 ITEM SHORT FORM S; CARLSSON AM, 1983, PAIN, V16, P87, DOI 10.1016/0304-3959(83)90088-X; Chan AW, 2013, ANN INTERN MED, V158, P200, DOI 10.7326/0003-4819-158-3-201302050-00583; Diabetesaustralia, WHAT IS DIAB 2021; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Feng YS, 2021, QUAL LIFE RES, V30, P647, DOI 10.1007/s11136-020-02688-y; Foundation H, 2022, WHATS YOUR BMI; Gandek B, 1998, J CLIN EPIDEMIOL, V51, P1171, DOI 10.1016/S0895-4356(98)00109-7; Grafton KV, 2005, CLIN J PAIN, V21, P73, DOI 10.1097/00002508-200501000-00009; Hawker GA, 2011, ARTHRIT CARE RES, V63, pS240, DOI 10.1002/acr.20543; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; Janssen MF, 2013, QUAL LIFE RES, V22, P1717, DOI 10.1007/s11136-012-0322-4; Jenkinson C, 1997, J PUBLIC HEALTH MED, V19, P179, DOI 10.1093/oxfordjournals.pubmed.a024606; Jiang Y, 2013, J SPORT HEALTH SCI, V2, P204, DOI 10.1016/j.jshs.2013.03.008; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; Lough ME, 2015, HEMODYNAMIC MONITORI; Lowe B, 2004, MED CARE, V42, P1194, DOI 10.1097/00005650-200412000-00006; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; Ministry of Health. Chilean Government, 2018, DEVELOPER SURVEY RES; NHMRC, 2016, STATEMENT CONSUMER C; Oh B, 2010, ANN ONCOL, V21, P608, DOI 10.1093/annonc/mdp479; Painaustralia, 2021, PAINF FACTS; Preedy VR., 2010, HDB DIS BURDENS QUAL; PRICE DD, 1994, PAIN, V56, P217, DOI 10.1016/0304-3959(94)90097-3; Reilly M., 2018, WORK PRODUCTIVITY AC; REILLY MC, 1993, PHARMACOECONOMICS, V4, P353, DOI 10.2165/00019053-199304050-00006; Revicki DA, 2000, QUAL LIFE RES, V9, P887, DOI 10.1023/A:1008996223999; Strand LI, 2008, EUR J PAIN, V12, P917, DOI 10.1016/j.ejpain.2007.12.013; Wang CC, 2004, ARCH INTERN MED, V164, P493, DOI 10.1001/archinte.164.5.493; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Ware JE, 2000, SPINE, V25, P3130, DOI 10.1097/00007632-200012150-00008; WASSERTHEIL S, 1970, BIOMETRICS, V26, P588, DOI 10.2307/2529115; Wayne P, 2013, HARVARD MED SCH GUID; Wright KD, 2001, EUR J PAIN, V5, P279, DOI 10.1053/eujp.2001.0243; Yeh Gloria Y, 2008, Prev Cardiol, V11, P82	37	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2022	17	6							e0270212	10.1371/journal.pone.0270212	http://dx.doi.org/10.1371/journal.pone.0270212			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E6MG	35749413	gold, Green Published			2022-12-26	WOS:000847936900001
J	Appelt, S; Rohleder, AM; Jacob, D; Von Buttlar, H; Georgi, E; Mueller, K; Wernery, U; Kinne, J; Joseph, M; Jose, SV; Scholz, HC				Appelt, Sandra; Rohleder, Anna-Maria; Jacob, Daniela; Von Buttlar, Heiner; Georgi, Enrico; Mueller, Katharina; Wernery, Ulrich; Kinne, Joerg; Joseph, Marina; Jose, Shantymol V.; Scholz, Holger C.			Genetic diversity and spatial distribution of Burkholderia mallei by core genome-based multilocus sequence typing analysis	PLOS ONE			English	Article							GLANDERS; PSEUDOMALLEI; MELIOIDOSIS; INFECTION	Burkholderia mallei is the etiological agent of glanders, a highly contagious and often fatal disease in equids. Due to the high genetic clonality of B. mallei, high-resolution typing assays are necessary to differentiate between individual strains. Here we report on the development and validation of a robust and reproducible core genome-based Multi Locus Sequence Typing Assay (cgMLST) for B. mallei, which is based on 3328 gene targets and enables high-resolution typing at the strain level. The assay was validated using a set of 120 B. mallei genomes from public databases and 23 newly sequenced outbreak strains from in-house strain collections. In this cgMLST analysis, strains from different geographic regions were clearly distinguished by at least 70 allele differences, allowing spatial clustering while closely related and epidemiologically related strains were separated by only zero to three alleles. Neither the different sequencing technologies nor the assembly strategies had an influence on the cgMLST results. The developed cgMLST is highly robust, reproducible and can be used for outbreak investigations, source tracking and molecular characterization of new B. mallei isolates.	[Appelt, Sandra; Rohleder, Anna-Maria; Jacob, Daniela; Scholz, Holger C.] Robert Koch Inst, Ctr Biol Threats & Special Pathogens ZBS 2, Berlin, Germany; [Von Buttlar, Heiner; Georgi, Enrico; Mueller, Katharina; Scholz, Holger C.] Bundeswehr Inst Microbiol, Dept Bacteriol & Toxinol, Munich, Germany; [Wernery, Ulrich; Kinne, Joerg; Joseph, Marina; Jose, Shantymol V.] Cent Vet Res Lab, Dubai, U Arab Emirates	Robert Koch Institute; Bundeswehr Institute of Microbiology (IMB)	Scholz, HC (corresponding author), Robert Koch Inst, Ctr Biol Threats & Special Pathogens ZBS 2, Berlin, Germany.; Scholz, HC (corresponding author), Bundeswehr Inst Microbiol, Dept Bacteriol & Toxinol, Munich, Germany.	ScholzH@rki.de						Achtman M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002776; Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bernhards RC, 2017, ARCH MICROBIOL, V199, P277, DOI 10.1007/s00203-016-1303-8; Bochkareva OO, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5245-1; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P532; Currie BJ, 2009, EMERG INFECT DIS, V15, P169, DOI 10.3201/eid1502.081036; Dessau Ram Benny, 2008, Ugeskr Laeger, V170, P328; dos Santos EL, 2020, REV SOC BRAS MED TRO, V53, DOI 10.1590/0037-8682-0054-2020; Egan ES, 2005, MOL MICROBIOL, V56, P1129, DOI 10.1111/j.1365-2958.2005.04622.x; Elschner MC, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.01296-16; Elschner MC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214963; Francisco AP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-152; Girault G, 2018, INFECT GENET EVOL, V63, P1, DOI 10.1016/j.meegid.2018.05.004; Girault G., 2017, GENOME ANNOUNC, V5, DOI [10.1128/genomeA.00579-17, DOI 10.1128/GENOMEA.00579-17]; Godoy D, 2003, J CLIN MICROBIOL, V41, P2068, DOI 10.1128/JCM.41.5.2068-2079.2003; Hornstra H, 2009, EMERG INFECT DIS, V15, P2036, DOI 10.3201/eid1512.090738; Khan I, 2013, TRANSBOUND EMERG DIS, V60, P204, DOI 10.1111/j.1865-1682.2012.01342.x; Lailler R., 2016, J PROTEOMICS BIOINFO, V9, P1; Laroucau K, 2021, TRANSBOUND EMERG DIS, V68, P960, DOI 10.1111/tbed.13777; Lichtenegger S, 2021, J CLIN MICROBIOL, V59, DOI 10.1128/JCM.00093-21; Losada L, 2010, GENOME BIOL EVOL, V2, P102, DOI 10.1093/gbe/evq003; Malik P, 2012, VET ITAL, V48, P167; Miro E, 2020, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02961; Mota RA, 2010, BRAZ J MICROBIOL, V41, P146, DOI [10.1590/S1517-83822010000100021, 10.1590/S1517-838220100001000021]; Neubauer H., 1997, Revue Internationale des Services de Sante des Forces Armees, V70, P258; Neumann B, 2019, J CLIN MICROBIOL, V57, DOI [10.1128/JCM.01686-18, 10.1128/jcm.01686-18]; Nierman WC, 2004, P NATL ACAD SCI USA, V101, P14246, DOI 10.1073/pnas.0403306101; Norte AC, 2021, MICROORGANISMS, V9, DOI 10.3390/microorganisms9050933; Pearce ME, 2018, INT J FOOD MICROBIOL, V274, P1, DOI 10.1016/j.ijfoodmicro.2018.02.023; Pearson K, 1900, PHILOS MAG, V50, P157, DOI 10.1080/14786440009463897; Romero CM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-228; Sahl JW, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000074; Sankarasubramanian J, 2019, INFECT GENET EVOL, V67, P38, DOI 10.1016/j.meegid.2018.10.021; Savin C, 2019, MICROB GENOMICS, V5, DOI 10.1099/mgen.0.000301; Scholz HC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003195; Singha H, 2017, GENOME ANNOUNCEMENTS, V5, DOI [10.1128/genomeA.00063-17, 10.1128/genomea.00063-17]; Souvorov A, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1540-z; Trivedil UH, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00111; U'Ren JM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-23; Vale FF, 2015, SCI REP-UK, V5, DOI 10.1038/srep14333; Wernery U, 2011, EMERG INFECT DIS, V17, P1277, DOI 10.3201/eid1707.110222; Wirth T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000160; Wittig MB, 2006, DEUT TIERARZTL WOCH, V113, P323; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	45	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7								10.1371/journal.pone.0270499	http://dx.doi.org/10.1371/journal.pone.0270499			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M3CI	35793321	Green Published, gold			2022-12-26	WOS:000835338100011
J	Cho, S; Pandey, P; Hyun, JY; Marchenkova, T; Vitkalova, A; Petrov, T; Jeong, D; Lee, J; Kim, DY; Li, Y; Darman, Y; Min, MS; Kim, KS; Bardyuk, V; Lee, H				Cho, Sujoo; Pandey, Puneet; Hyun, Jee Yun; Marchenkova, Taisia; Vitkalova, Anna; Petrov, Timophey; Jeong, Daecheol; Lee, Jangmi; Kim, Dong Youn; Li, Ying; Darman, Yury; Min, Mi-Sook; Kim, Kyung Seok; Bardyuk, Victor; Lee, Hang			Efficient and cost-effective non-invasive population monitoring as a method to assess the genetic diversity of the last remaining population of Amur leopard (Panthera pardus orientalis) in the Russia Far East	PLOS ONE			English	Article							COMPUTER-PROGRAM; INDIVIDUAL IDENTIFICATION; PRIMORSKY KRAI; SIZE; CONSERVATION; TIGER; EXTINCTION; DNA; BOTTLENECK; SOUTHWEST	Small populations of the endangered species are more vulnerable to extinction and hence require periodic genetic monitoring to establish and revisit the conservation strategies. The Amur leopard is critically endangered with about 100 individuals in the wild. In this study, we developed a simple and cost-effective noninvasive genetic monitoring protocol for Amur leopards. Also, we investigated the impact of fecal sample's age, storage, and collection season on microsatellite genotyping success and data quality. We identified 89 leopard scats out of the 342 fecal samples collected from Land of the Leopard between 2014-2019. Microsatellite genotyping using 12 markers optimized in 3 multiplex PCR reactions reveals presence of at least 24 leopard individuals (18 males and 6 females). There was a significant difference in the success rate of genotyping depending on the time from feces deposition to collection (p = 0.014, Fisher's exact test), with better genotyping success for samples having <2 weeks of environmental exposure. Amur leopard genetic diversity was found low (H-o- 0.33, H-E- 0.35, and N-A- 2.57) with no visible population substructure and recent bottleneck signature. Although a historical bottleneck footprint was observed. Mitochondrial DNA diversity was also found low with two haplotypes differing by a point mutation reported in 1,769 bp of investigated sequence covering parts of cytochrome b gene (846 bp), NADH-5 gene (611 bp) and control region (312 bp). We recommend periodic genetic monitoring of wild Amur leopards following the proposed methodology to achieve cost effectiveness and efficiency.	[Cho, Sujoo; Pandey, Puneet; Hyun, Jee Yun; Jeong, Daecheol; Lee, Jangmi; Kim, Dong Youn; Li, Ying; Min, Mi-Sook; Lee, Hang] Seoul Natl Univ, Res Inst Vet Sci & Conservat Genome Resource Bank, Coll Vet Med, Seoul, South Korea; [Cho, Sujoo; Pandey, Puneet; Hyun, Jee Yun; Jeong, Daecheol; Lee, Jangmi; Kim, Dong Youn; Li, Ying; Min, Mi-Sook; Lee, Hang] Tiger & Leopard Conservat Fund Korea, Seoul, South Korea; [Pandey, Puneet] ENPROTEC India Fdn, Jaunpur, Uttar Pradesh, India; [Marchenkova, Taisia; Vitkalova, Anna; Petrov, Timophey; Bardyuk, Victor] Minist Nat Resources & Environm Russian Federat, Fed State Budgetary Inst Joint Directorate Kedrova, Vladivostok, Primorsky Krai, Russia; [Li, Ying] Yanbian Univ, Coll Geog & Ocean Sci, Jilin, Peoples R China; [Darman, Yury] WWF Russia, Amur Branch, Vladivostok, Primorsky Krai, Russia; [Kim, Kyung Seok] Iowa State Univ, Dept Nat Resource Ecol & Management, Ames, IA USA	Seoul National University (SNU); Yanbian University; World Wildlife Fund; Iowa State University	Pandey, P; Lee, H (corresponding author), Seoul Natl Univ, Res Inst Vet Sci & Conservat Genome Resource Bank, Coll Vet Med, Seoul, South Korea.; Pandey, P; Lee, H (corresponding author), Tiger & Leopard Conservat Fund Korea, Seoul, South Korea.; Pandey, P (corresponding author), ENPROTEC India Fdn, Jaunpur, Uttar Pradesh, India.; Bardyuk, V (corresponding author), Minist Nat Resources & Environm Russian Federat, Fed State Budgetary Inst Joint Directorate Kedrova, Vladivostok, Primorsky Krai, Russia.	puneet.pandey09@snu.ac.kr; director@leopard-land.ru; hanglee@snu.ac.kr	Darman, Yury/HGC-9072-2022	Marchenkova, Taisia/0000-0003-2857-6960; Kim, Dong Youn/0000-0002-2673-0445	Ministry of Environment of the Republic of Korea, Convention on Biological Diversity under Bio-Bridge Initiative [550-20190003]; Brain Korea-21 programme [5260-20190100, 5260-20200100, A0449-20200100, A0449-20210100]	Ministry of Environment of the Republic of Korea, Convention on Biological Diversity under Bio-Bridge Initiative; Brain Korea-21 programme(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported by the following. Ministry of Environment of the Republic of Korea, Convention on Biological Diversity under Bio-Bridge Initiative (550-20190003): SC, PP, JYH, DJ, JL, DYK, M-SM, HL, Brain Korea-21 programme (5260-20190100, 5260-20200100,A0449-20200100): SC, DJ, JL, Brain Korea-21 programme (A0449-20210100): SC. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	ABRAMOV V K, 1974, Byulleten' Moskovskogo Obshchestva Ispytatelei Prirody Otdel Biologicheskii, V79, P5; Aziz MA, 2017, GLOB ECOL CONSERV, V12, P272, DOI 10.1016/j.gecco.2017.09.002; Bayes M. K., 2000, Conservation Genetics, V1, P173, DOI 10.1023/A:1026595324974; Broseth H, 2010, BIOL CONSERV, V143, P113, DOI 10.1016/j.biocon.2009.09.012; CAUGHLEY G, 1994, J ANIM ECOL, V63, P215, DOI 10.2307/5542; Cornuet JM, 1996, GENETICS, V144, P2001; Creel S, 2003, MOL ECOL, V12, P2003, DOI 10.1046/j.1365-294X.2003.01868.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Gray TNE, 2012, J WILDLIFE MANAGE, V76, P163, DOI 10.1002/jwmg.230; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Frankham R, 1996, CONSERV BIOL, V10, P1500, DOI 10.1046/j.1523-1739.1996.10061500.x; Frankham R., 2002, INTRO CONSERVATION G, DOI 10.1017/CBO9780511808999; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Haig SM, 1998, ECOLOGY, V79, P413, DOI 10.1890/0012-9658(1998)079[0413:MCTC]2.0.CO;2; Henry P, 2009, MOL ECOL, V18, P3173, DOI 10.1111/j.1365-294X.2009.04266.x; Hyun JY, 2020, PEERJ, V8, DOI 10.7717/peerj.8900; Hyun JY., 2021, SCI REP-UK, V11, P1, DOI [10.1038/s41598-020-79139-8, DOI 10.1038/S41598-020-79139-8]; Jacobson AP, 2016, PEERJ, V4, DOI 10.7717/peerj.1974; Jhala YV, 2019, FRONT ECOL EVOL, V7, DOI 10.3389/fevo.2019.00312; Johnson CN, 1998, NATURE, V394, P272, DOI 10.1038/28385; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Kohn MH, 1999, P ROY SOC B-BIOL SCI, V266, P657, DOI 10.1098/rspb.1999.0686; Kretzschmar P, 2016, GLOB ECOL CONSERV, V6, P257, DOI 10.1016/j.gecco.2016.02.006; Kuhl HS, 2017, AM J PRIMATOL, V79, DOI 10.1002/ajp.22681; Lande R, 1998, RES POPUL ECOL, V40, P259, DOI 10.1007/BF02763457; Lopez JV, 1996, GENOMICS, V33, P229, DOI 10.1006/geno.1996.0188; Luikart G, 1998, CONSERV BIOL, V12, P228, DOI 10.1046/j.1523-1739.1998.96388.x; Lukarevskiy VS, 2019, BIOL BULL+, V46, P1146, DOI 10.1134/S1062359019090103; Matiukhina DS, 2016, NAT CONSERV RES, V1, P36, DOI 10.24189/ncr.2016.025; Maudet C, 2002, MOL ECOL, V11, P421, DOI 10.1046/j.0962-1083.2001.01451.x; Mengulluoglu D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216549; Mondol S, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-79; Mondol S, 2009, BIOL CONSERV, V142, P2350, DOI 10.1016/j.biocon.2009.05.014; Ning Y, 2022, ANIM CONSERV, V25, P521, DOI 10.1111/acv.12761; Nowell K, 1996, WILD CATS STATUS SUR; O'Grady JJ, 2006, BIOL CONSERV, V133, P42, DOI 10.1016/j.biocon.2006.05.016; Palsboll PJ, 1997, NATURE, V388, P767, DOI 10.1038/42005; Pandey P., 2016, INDIA J FORENSIC RES, V7, P1; Pandey P, 2018, CURR SCI INDIA, V114, P2368, DOI 10.18520/cs/v114/i11/2368-2373; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peery MZ, 2012, MOL ECOL, V21, P3403, DOI 10.1111/j.1365-294X.2012.05635.x; Pikunov D., 2009, DALNAUKA; Pikunov D, 2010, AMURSKII TIGR SEVERO, P334; Pikunov D., 2000, SURVEY FAR E LEOPARD; PIKUNOV DG, 1985, ZOOL ZH, V64, P897; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard JK, 2000, GENETICS, V155, P945; Prugh LR, 2005, MOL ECOL, V14, P1585, DOI 10.1111/j.1365-294X.2005.02533.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Rozhnov VV, 2013, BIOL BULL+, V40, P124, DOI 10.1134/S106235901302012X; Schwartz MK, 2007, TRENDS ECOL EVOL, V22, P25, DOI 10.1016/j.tree.2006.08.009; SHIELDS GF, 1991, EVOLUTION, V45, P218, DOI 10.1111/j.1558-5646.1991.tb05279.x; Sollmann R, 2013, BIOL CONSERV, V167, P242, DOI 10.1016/j.biocon.2013.08.003; Stein A. B., 2016, IUCN RED LIST THREAT; Sugimoto T, 2006, CONSERV GENET, V7, P799, DOI 10.1007/s10592-005-9071-z; Sugimoto T, 2014, CONSERV GENET, V15, P521, DOI 10.1007/s10592-013-0558-8; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; Uphyrkina O, 2002, J HERED, V93, P303, DOI 10.1093/jhered/93.5.303; Uphyrkina O, 2001, MOL ECOL, V10, P2617, DOI 10.1046/j.0962-1083.2001.01350.x; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vitkalova A., 2022, PHOTOMONITORING FAR; Vitkalova AV, 2016, NAT CONSERV RES, V1, P53, DOI 10.24189/ncr.2016.027; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; Wang TM, 2017, BIOL CONSERV, V210, P47, DOI 10.1016/j.biocon.2016.03.014; Yang L, 2016, ZOOKEYS, P143, DOI 10.3897/zookeys.592.6912	68	0	0	5	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7								10.1371/journal.pone.0270217	http://dx.doi.org/10.1371/journal.pone.0270217			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M3CI	35793341	Green Published, gold			2022-12-26	WOS:000835338100014
J	Pan, PC; Savidge, C; Amsellem, P; Hamilton, S				Pan, Po-ching; Savidge, Christine; Amsellem, Pierre; Hamilton, Stephanie			Comparison between propofol and alfaxalone anesthesia for the evaluation of laryngeal function in healthy dogs utilizing computerized software	PLOS ONE			English	Article							LARYNGOSCOPY; MOTION; PARALYSIS; DIAGNOSIS	Laryngeal paralysis is a well-documented cause of upper respiratory tract obstruction in canines. Diagnosis of laryngeal paralysis is usually made by visual evaluation of laryngeal motion whilst patients are under a light-plane of anesthesia. However, in human studies of laryngeal function evaluation, it has been shown that subjective scoring can lead to significant interobserver variance, which may cause false diagnosis. In this study, we propose to introduce a more objective method of assessing laryngeal function using GlotAnTools and Tracker software to directly measure laryngeal motion in anaesthetized patients. Additionally, two anesthetic agents, alfaxalone and propofol, were compared in this study to assess their relative effect on laryngeal motion and thus their suitability for use in this diagnostic process. This study was a two-stage, cross-over, 1:1 randomization, with two active treatment arms. Ten beagles (10-18 months, five males and five females) were exposed to both anesthetic agents and laryngeal motion was recorded using videoendoscopy. GlotAnTools and Tracker software were applied to the recorded images to measure glottal gap area (A) and length (L). A normalized measure of laryngeal function-computed as A/L-was created, representing the "elongatedness" of the rima glottidis. The glottal gap area was significantly reduced in dogs receiving alfaxalone. This study objectively establishes that alfaxalone impacted laryngeal motion significantly more than propofol and confirms the capability of these computational methods to detect differences in laryngeal motion.	[Pan, Po-ching; Savidge, Christine; Amsellem, Pierre; Hamilton, Stephanie] Univ Prince Edward Isl, Atlantic Vet Coll, Dept Compan Anim, Charlottetown, PE, Canada; [Pan, Po-ching] Cent Toronto Vet Referral Clin, York, ON, Canada; [Savidge, Christine] Tufts Vet Emergency Treatment & Specialties, Walpole, MA USA; [Amsellem, Pierre] Univ Minnesota, Vet Med Ctr, Dept Vet Clin Sci, Minneapolis, MN USA	University of Prince Edward Island; University of Minnesota System; University of Minnesota Twin Cities	Pan, PC (corresponding author), Univ Prince Edward Isl, Atlantic Vet Coll, Dept Compan Anim, Charlottetown, PE, Canada.	ppan@upei.ca		Pan, Po-ching/0000-0003-3382-6039				Ambros B, 2008, AM J VET RES, V69, P1391, DOI 10.2460/ajvr.69.11.1391; Amengual M, 2013, VET ANAESTH ANALG, V40, P115, DOI 10.1111/j.1467-2995.2012.00747.x; Broome C, 2000, AUST VET J, V78, P769, DOI 10.1111/j.1751-0813.2000.tb10449.x; Brown MB, 2019, VET SURG, V48, P70, DOI 10.1111/vsu.13110; BURBIDGE HM, 1995, BRIT VET J, V151, P71, DOI 10.1016/S0007-1935(05)80066-1; Chen G, 2014, COMPUT SPEECH LANG, V28, P1156, DOI 10.1016/j.csl.2013.11.006; Chen G, 2013, J ACOUST SOC AM, V133, P1656, DOI 10.1121/1.4789931; Estes C, 2017, LARYNGOSCOPE, V127, P2100, DOI 10.1002/lary.26570; Ettinger S.J., 2017, TXB VET INTERNAL MED; Gross ME, 2002, J AM ANIM HOSP ASSOC, V38, P503, DOI 10.5326/0380503; Jackson AM, 2004, VET SURG, V33, P102, DOI 10.1111/j.1532-950X.2004.04016.x; Macphail C., 2009, KIRKS CURRENT VET TH, P627; Monnet E, 2016, VET CLIN N AM-SMALL, V46, P709, DOI 10.1016/j.cvsm.2016.02.003; Muir W, 2008, VET ANAESTH ANALG, V35, P451, DOI 10.1111/j.1467-2995.2008.00406.x; Nelissen P, 2012, VET SURG, V41, P876, DOI 10.1111/j.1532-950X.2012.01030.x; Radkey DI, 2018, VET ANAESTH ANALG, V45, P241, DOI 10.1016/j.vaa.2017.08.014; Radlinsky MG, 2009, VET SURG, V38, P434, DOI 10.1111/j.1532-950X.2009.00506.x; Rosow DE, 2010, LARYNGOSCOPE, V120, P1376, DOI 10.1002/lary.20945; Smalle TM, 2017, VET ANAESTH ANALG, V44, P427, DOI 10.1016/j.vaa.2016.05.013; Smith MM, 2000, J AM ANIM HOSP ASSOC, V36, P383, DOI 10.5326/15473317-36-5-383; Tamura J, 2021, J VET MED SCI, V83, P73, DOI 10.1292/jvms.20-0407; Trapani G, 2000, CURR MED CHEM, V7, P249, DOI 10.2174/0929867003375335	22	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7								10.1371/journal.pone.0270812	http://dx.doi.org/10.1371/journal.pone.0270812			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M5FN	35789223	Green Published, gold			2022-12-26	WOS:000835487000027
J	Khondker, S; Kwiatek, JM; Han, GS; Carman, GM				Khondker, Shoily; Kwiatek, Joanna M.; Han, Gil -Soo; Carman, George M.			Glycogen synthase kinase homolog Rim11 regulates lipid synthesis through the phosphorylation of Pah1 phosphatidate phosphatase in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PUTATIVE PROTEIN-KINASE; SACCHAROMYCES-CEREVISIAE; PHOSPHOLIPID-SYNTHESIS; PHOSPHATIDYLSERINE SYNTHASE; GLOBAL ANALYSIS; MEDIATED REGULATION; MEMBRANE-PROTEINS; ORTHOLOGUE PAH1P; ACID PHOSPHATASE; CROSS-TALK	Pah1 phosphatidate (PA) phosphatase plays a major role in triacylglycerol synthesis in Saccharomyces cerevisiae by producing its precursor diacylglycerol and concurrently regulates de novo phospholipid synthesis by consuming its precursor PA. The function of Pah1 requires its membrane localization, which is controlled by its phosphorylation state. Pah1 is dephosphorylated by the Nem1-Spo7 protein phosphatase, whereas its phosphorylation occurs by multiple known and unknown protein kinases. In this work, we show that Rim11, a yeast homolog of mammalian glycogen synthase kinase-3 beta, is a protein kinase that phosphorylates Pah1 on serine (Ser12, Ser602, and Ser818) and threonine (Thr163, Thr164, Thr522) residues. Enzymological characterization of Rim11 showed that its K-m for Pah1 (0.4 mu M) is similar to those of other Pah1-phosphorylating protein kinases, but its K-m for ATP (30 mu M) is significantly higher than those of these same kinases. Furthermore, we demonstrate Rim11 phosphorylation of Pah1 does not require substrate prephosphorylation but was increased similar to 2-fold upon its prephosphorylation by the Pho85-Pho80 protein kinase. In addition, we show Rim11-phosphorylated Pah1 was a substrate for dephosphorylation by Nem1-Spo7. Finally, we demonstrate the Rim11 phosphorylation of Pah1 exerted an inhibitory effect on its PA phosphatase activity by reduction of its catalytic efficiency. Mutational analysis of the major phosphorylation sites (Thr163, Thr164, and Ser602) indicated that Rim11-mediated phosphorylation at these sites was required to ensure Nem1-Spo7-dependent localization of the enzyme to the membrane. Overall, these findings advance our understanding of the phosphorylation-mediated regulation of Pah1 function in lipid synthesis.	[Carman, George M.] Rutgers State Univ, Dept Food Sci, New Jersey Inst Food Nutr & Hlth, New Brunswick, NJ 08901 USA; Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, Rutgers Ctr Lipid Res, New Brunswick, NJ USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Carman, GM (corresponding author), Rutgers State Univ, Dept Food Sci, New Jersey Inst Food Nutr & Hlth, New Brunswick, NJ 08901 USA.	gcarman@rutgers.edu		Khondker, Shoily/0000-0002-3219-0932	National Institutes of Health [GM136128]; United States Public Health Service	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service)	Acknowledgments - We thank Peter Lobel for help in analyzing data from the LC-MS/MS determination of phosphorylation sites in Pah1. This work was supported, in whole or in part, by National Institutes of Health Grant GM136128 from the United States Public Health Service. The content is solely the responsibility of the authors and does not necessarily represent the of fi cial views of the National Institutes of Health.	Adeyo O, 2011, J CELL BIOL, V192, P1043, DOI 10.1083/jcb.201010111; Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Barbosa AD, 2015, MOL BIOL CELL, V26, P3641, DOI 10.1091/mbc.E15-03-0173; Beurel E, 2015, PHARMACOL THERAPEUT, V148, P114, DOI 10.1016/j.pharmthera.2014.11.016; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bodenmiller B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001182; BOWDISH KS, 1994, MOL CELL BIOL, V14, P7909, DOI 10.1128/MCB.14.12.7909; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Carman GM, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.100786; Carman GM, 2019, J LIPID RES, V60, P2, DOI 10.1194/jlr.S087452; Carman GM, 2019, J BIOL CHEM, V294, P1681, DOI 10.1074/jbc.TM118.004159; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; Carman GM, 2009, J LIPID RES, V50, pS69, DOI 10.1194/jlr.R800043-JLR200; Carman GM, 2009, J BIOL CHEM, V284, P2593, DOI 10.1074/jbc.R800059200; CARMAN GM, 1991, METHOD ENZYMOL, V197, P548; Chi A, 2007, P NATL ACAD SCI USA, V104, P2193, DOI 10.1073/pnas.0607084104; Choi HS, 2012, J BIOL CHEM, V287, P11290, DOI 10.1074/jbc.M112.346023; Choi HS, 2011, J BIOL CHEM, V286, P1486, DOI 10.1074/jbc.M110.155598; Choi HS, 2010, J BIOL CHEM, V285, P11526, DOI 10.1074/jbc.M110.100727; Corcoles-Saez I, 2016, BBA-MOL CELL BIOL L, V1861, P213, DOI 10.1016/j.bbalip.2015.12.014; Dey P, 2017, J LIPID RES, V58, P742, DOI 10.1194/jlr.M075036; Dubots E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104194; Fakas S, 2011, J BIOL CHEM, V286, P29074, DOI 10.1074/jbc.M111.258798; Fakas S, 2011, J BIOL CHEM, V286, P1464, DOI 10.1074/jbc.M110.194308; Gnad F, 2009, PROTEOMICS, V9, P4642, DOI 10.1002/pmic.200900144; Griffioen G, 2003, J BIOL CHEM, V278, P23460, DOI 10.1074/jbc.M210691200; Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P310, DOI 10.1074/mcp.M400219-MCP200; HAID A, 1983, METHOD ENZYMOL, V96, P192; Han GS, 2008, J BIOL CHEM, V283, P20433, DOI 10.1074/jbc.M802903200; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2017, J BIOL CHEM, V292, P13230, DOI 10.1074/jbc.M117.801720; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; HARDY TA, 1995, BIOCHEM BIOPH RES CO, V208, P728, DOI 10.1006/bbrc.1995.1398; Hassaninasab A, 2019, J BIOL CHEM, V294, P18256, DOI 10.1074/jbc.RA119.011314; Helbig AO, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-685; Henderson RJ, 1992, LIPID ANAL PRACTICAL, P65; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; HROMY JM, 1986, J BIOL CHEM, V261, P5572; Hsieh LS, 2016, J BIOL CHEM, V291, P9974, DOI 10.1074/jbc.M116.726588; Hsieh LS, 2015, J BIOL CHEM, V290, P11467, DOI 10.1074/jbc.M115.648659; HUGHES K, 1993, EMBO J, V12, P803, DOI 10.1002/j.1460-2075.1993.tb05715.x; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; IRIE K, 1993, MOL GEN GENET, V236, P283, DOI 10.1007/BF00277124; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jeffery DA, 2001, J MOL BIOL, V306, P997, DOI 10.1006/jmbi.2000.4417; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Karanasios E, 2013, MOL BIOL CELL, V24, P2124, DOI 10.1091/mbc.E13-01-0021; Karanasios E, 2010, P NATL ACAD SCI USA, V107, P17539, DOI 10.1073/pnas.1007974107; Kastaniotis AJ, 2004, MOL MICROBIOL, V53, P1407, DOI 10.1111/j.1365-2958.2004.04191.x; Khayyo VI, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15124-z; Khondker Shoily, 2022, Advances in Biological Regulation, V84, P100889, DOI 10.1016/j.jbior.2022.100889; Kwiatek JM, 2020, J LIPID RES, V61, P1232, DOI 10.1194/jlr.RA120000937; Kwiatek JM, 2020, BBA-MOL CELL BIOL L, V1865, DOI 10.1016/j.bbalip.2019.03.006; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lanz MC, 2021, EMBO REP, V22, DOI 10.15252/embr.202051121; Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j; LIN YP, 1989, J BIOL CHEM, V264, P8641; LIN YP, 1990, J BIOL CHEM, V265, P166; Lussier M, 1997, GENETICS, V147, P435; MACDONALD JIS, 1994, J BIOL CHEM, V269, P10529; MacGilvray ME, 2020, J PROTEOME RES, V19, P3405, DOI 10.1021/acs.jproteome.0c00253; Malathi K, 1997, MOL CELL BIOL, V17, P7230, DOI 10.1128/MCB.17.12.7230; MIMMS LT, 1981, BIOCHEMISTRY-US, V20, P833, DOI 10.1021/bi00507a028; MITCHELL AP, 1992, GENETICS, V131, P65; MORLOCK KR, 1988, J BACTERIOL, V170, P3561, DOI 10.1128/jb.170.8.3561-3566.1988; Nadra K, 2008, GENE DEV, V22, P1647, DOI 10.1101/gad.1638008; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Park Y, 2022, J BIOL CHEM, V298, DOI 10.1016/j.jbc.2022.101578; Park Y, 2017, J BIOL CHEM, V292, P19580, DOI 10.1074/jbc.M117.819375; Park Y, 2015, J BIOL CHEM, V290, P25382, DOI 10.1074/jbc.M115.680314; Pascual F, 2014, J BIOL CHEM, V289, P9811, DOI 10.1074/jbc.M114.550103; Pascual F, 2013, J BIOL CHEM, V288, P35781, DOI 10.1074/jbc.M113.525766; Pascual F, 2013, BBA-MOL CELL BIOL L, V1831, P514, DOI 10.1016/j.bbalip.2012.08.006; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002; PINTO WJ, 1992, J BACTERIOL, V174, P2565, DOI 10.1128/jb.174.8.2565-2574.1992; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Qie LX, 1997, J BIOL CHEM, V272, P16110, DOI 10.1074/jbc.272.26.16110; Rahman MA, 2018, FEBS J, V285, P1840, DOI 10.1111/febs.14448; Rose MD., 1990, METHODS YEAST GENETI; Rubin-Bejerano I, 2004, MOL CELL BIOL, V24, P6967, DOI 10.1128/MCB.24.16.6967-6979.2004; Ruiz C, 1999, YEAST, V15, P1001; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Sasser T, 2012, J BIOL CHEM, V287, P2221, DOI 10.1074/jbc.M111.317420; SHERO JH, 1991, GENE DEV, V5, P549, DOI 10.1101/gad.5.4.549; SIKORSKI RS, 1989, GENETICS, V122, P19; Siniossoglou S, 2000, J BIOL CHEM, V275, P19352, DOI 10.1074/jbc.M001314200; Siniossoglou S, 1998, EMBO J, V17, P6449, DOI 10.1093/emboj/17.22.6449; SMITH SW, 1957, J BIOL CHEM, V228, P915; Smolka MB, 2007, P NATL ACAD SCI USA, V104, P10364, DOI 10.1073/pnas.0701622104; Soto-Cardalda A, 2012, J BIOL CHEM, V287, P968, DOI 10.1074/jbc.M111.313130; Soufi B, 2009, MOL BIOSYST, V5, P1337, DOI 10.1039/b902256b; Soulard A, 2010, MOL BIOL CELL, V21, P3475, DOI 10.1091/mbc.E10-03-0182; Su WM, 2018, J BIOL CHEM, V293, P15801, DOI 10.1074/jbc.RA118.005348; Su WM, 2014, J BIOL CHEM, V289, P34699, DOI 10.1074/jbc.M114.614883; Su WM, 2014, J BIOL CHEM, V289, P18818, DOI 10.1074/jbc.M114.581462; Su WM, 2012, J BIOL CHEM, V287, P33364, DOI 10.1074/jbc.M112.402339; Swaney DL, 2013, NAT METHODS, V10, P676, DOI [10.1038/NMETH.2519, 10.1038/nmeth.2519]; Taus T, 2011, J PROTEOME RES, V10, P5354, DOI 10.1021/pr200611n; TAYLOR FR, 1979, BIOCHIM BIOPHYS ACTA, V575, P204, DOI 10.1016/0005-2760(79)90022-5; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Wiedmann S, 2008, DIABETES, V57, P209, DOI 10.2337/db07-0083; WIMMER C, 1992, EMBO J, V11, P5051, DOI 10.1002/j.1460-2075.1992.tb05612.x; Xu Z, 2012, J LIPID RES, V53, P522, DOI 10.1194/jlr.M022798; YANG WL, 1995, J BIOL CHEM, V270, P14983, DOI 10.1074/jbc.270.25.14983; Zeharia A, 2008, AM J HUM GENET, V83, P489, DOI 10.1016/j.ajhg.2008.09.002; Zhan XL, 2000, MOL BIOL CELL, V11, P663, DOI 10.1091/mbc.11.2.663; Zhang PX, 2014, CELL METAB, V20, P267, DOI 10.1016/j.cmet.2014.05.003; Zimmermann C, 2013, CELL REP, V5, P1036, DOI 10.1016/j.celrep.2013.10.024	113	1	1	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2022	298	8							102221	10.1016/j.jbc.2022.102221	http://dx.doi.org/10.1016/j.jbc.2022.102221			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	4X0OB	35780834	Green Published, gold			2022-12-26	WOS:000860550600009
J	Wang, YL; Li, CX; Zhang, JJ; Xu, XM; Fu, L; Xu, J; Zhu, H; Hu, Y; Li, CB; Wang, MJ; Wu, YJ; Zou, XJ; Liang, B				Wang, Yanli; Li, Chunxia; Zhang, Jingjing; Xu, Xiumei; Fu, Lin; Xu, Jie; Zhu, Hong; Hu, Ying; Li, Chengbin; Wang, Mengjie; Wu, Yingjie; Zou, Xiaoju; Liang, Bin			Polyunsaturated fatty acids promote the rapid fusion of lipid droplets in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHEROMONE BIOSYNTHESIS; ACYL-COENZYME; REVEALS; IDENTIFICATION; PEROXISOMES; LIPOGENESIS; METABOLISM; EXPANSION; BINDING; FAMILY	Lipid droplets (LDs) are intracellular organelles that dynamically regulate lipids and energy homeostasis in the cell. LDs can grow through either local lipid synthesis or LD fusion. However, how lipids involving in LD fusion for LD growth is largely unknown. Here, we show that genetic mutation of acox-3 (acyl-CoA oxidase), maoc-1 (enoyl-CoA hydratase), dhs-28 (3-hydroxylacyl-CoA dehydrogenase), and daf-22 (3-ketoacyl-CoA thiolase), all involved in the peroxisomal beta-oxidation pathway in Caenorhabditis elegans, led to rapid fusion of adjacent LDs to form giant LDs (gLDs). Mechanistically, we show that dysfunction of peroxisomal beta-oxidation results in the accumulation of long-chain fatty acid-CoA and phosphocho-line, which may activate the sterol-binding protein 1/sterol regulatory element-binding protein to promote gLD forma-tion. Furthermore, we found that inactivation of either FAT-2 (delta-12 desaturase) or FAT-3 and FAT-1 (delta-15 desaturase and delta-6 desaturase, respectively) to block the biosynthesis of polyunsaturated fatty acids (PUFAs) with three or more double bonds (n >= 3-PUFAs) fully repressed the formation of gLDs; in contrast, dietary supplementation of n >= 3-PUFAs or phosphocholine bearing these PUFAs led to recovery of the formation of gLDs in peroxisomal beta-oxidation-defective worms lacking PUFA biosynthesis. Thus, we conclude that n >= 3-PUFAs, distinct from other well-known lipids and proteins, promote rapid LD fusion leading to LD growth.	[Wang, Yanli; Li, Chunxia; Zhang, Jingjing; Xu, Xiumei; Fu, Lin; Zhu, Hong; Li, Chengbin; Wang, Mengjie; Liang, Bin] Yunnan Univ, Ctr Life Sci, Sch Life Sci, State Key Lab Conservat & Utilizat Bioresources, Kunming, Yunnan, Peoples R China; [Xu, Jie] Chinese Acad Sci, Kunming Inst Zool, Chinese Acad Sci & Yunnan Prov, Key Lab Anim Models Human Dis Mech, Kunming, Yunnan, Peoples R China; [Hu, Ying; Zou, Xiaoju] Yunnan Univ Chinese Med, Coll Chinese Mat Med, Kunming, Yunnan, Peoples R China; [Hu, Ying; Zou, Xiaoju] Yunnan Univ Chinese Med, Yunnan Key Lab Southern Med Utilizat, Kunming, Yunnan, Peoples R China; [Wu, Yingjie] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Prov Hosp, Sch Lab Anim, Jinan, Shandong, Peoples R China; [Wu, Yingjie] Shandong First Med Univ & Shandong Acad Med Sci, Sci & Technol Innovat Ctr, Shandong Lab Anim Ctr, Jinan, Shandong, Peoples R China; [Wu, Yingjie] Natl Ctr Genet Engn Anim Models Int Res, Inst Genome Engn Anim Models Human Dis, Liaoning Provence Key Lab Genome Engn Anim Models, Dalian, Liaoning, Peoples R China	Yunnan University; Chinese Academy of Sciences; Kunming Institute of Zoology; Yunnan University of Chinese Medicine; Yunnan University of Chinese Medicine; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong First Medical University & Shandong Academy of Medical Sciences	Liang, B (corresponding author), Yunnan Univ, Ctr Life Sci, Sch Life Sci, State Key Lab Conservat & Utilizat Bioresources, Kunming, Yunnan, Peoples R China.; Zou, XJ (corresponding author), Yunnan Univ Chinese Med, Coll Chinese Mat Med, Kunming, Yunnan, Peoples R China.; Zou, XJ (corresponding author), Yunnan Univ Chinese Med, Yunnan Key Lab Southern Med Utilizat, Kunming, Yunnan, Peoples R China.; Wu, YJ (corresponding author), Shandong First Med Univ & Shandong Acad Med Sci, Shandong Prov Hosp, Sch Lab Anim, Jinan, Shandong, Peoples R China.; Wu, YJ (corresponding author), Shandong First Med Univ & Shandong Acad Med Sci, Sci & Technol Innovat Ctr, Shandong Lab Anim Ctr, Jinan, Shandong, Peoples R China.; Wu, YJ (corresponding author), Natl Ctr Genet Engn Anim Models Int Res, Inst Genome Engn Anim Models Human Dis, Liaoning Provence Key Lab Genome Engn Anim Models, Dalian, Liaoning, Peoples R China.	yjwu@sdfmu.edu.cn; xiaojuzou@163.com; liangb73@ynu.edu.cn			National Natural Science Foundation of China [32160155, 31860323, 32071281, 32000818, 31600963, 91857113, U1702288, 31801001]; Ministry of Science and Technology of the People's Republic of China [2019FB046, 2019FY003021]; Yunnan Applied Basic Research Projects [202101AT070009, 2017KF004]; State Key Laboratory for Conservation and Utilization of Bio-Resources in Yunnan, Yunnan University;  [2018YFA0800700];  [2018YFA0800703];  [2019FB048]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); Yunnan Applied Basic Research Projects; State Key Laboratory for Conservation and Utilization of Bio-Resources in Yunnan, Yunnan University; ; ; 	We thank members of the C. L. Yang and M. T. Pu at Yunnan University for technical assistance and Metabo- Pro fi le Biotechnology Co, Ltd for lipid analysis. This work was supported by the National Natural Science Foundation of China (grant nos.: 32160155, 31860323, 32071281, 32000818, 31600963, 91857113, U1702288, and 31801001) , Ministry of Science and Technology of the People's Republic of China (grant nos.: 2018YFA0800700 and 2018YFA0800703) , the Yunnan Applied Basic Research Projects (grant nos.: 2019FB048, 2019FB046, 2019FY003021, and 202101AT070009) , and grant 2017KF004 from State Key Laboratory for Conservation and Utilization of Bio-Resources in Yunnan, Yunnan University.	Binns D, 2006, J CELL BIOL, V173, P719, DOI 10.1083/jcb.200511125; Brooks KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007545; Chen FJ, 2020, TRAFFIC, V21, P94, DOI 10.1111/tra.12717; Choudhary V, 2015, J CELL BIOL, V211, P261, DOI 10.1083/jcb.201505067; Dirkx R, 2005, HEPATOLOGY, V41, P868, DOI 10.1002/hep.20628; Fan CY, 1996, J BIOL CHEM, V271, P24698, DOI 10.1074/jbc.271.40.24698; Fan W, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006664; Fei WH, 2008, J CELL BIOL, V180, P473, DOI 10.1083/jcb.200711136; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Fujimoto Y, 2007, J LIPID RES, V48, P1280, DOI 10.1194/jlr.M700050-JLR200; Gong JY, 2011, J CELL BIOL, V195, P953, DOI 10.1083/jcb.201104142; Gross DA, 2011, P NATL ACAD SCI USA, V108, P19581, DOI 10.1073/pnas.1110817108; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Herzog K, 2018, J INHERIT METAB DIS, V41, P479, DOI 10.1007/s10545-017-0076-9; Herzog K, 2016, J LIPID RES, V57, P1447, DOI 10.1194/jlr.M067470; Huyghe S, 2006, BBA-MOL CELL BIOL L, V1761, P973, DOI 10.1016/j.bbalip.2006.04.006; Jacquier N, 2011, J CELL SCI, V124, P2424, DOI 10.1242/jcs.076836; Jeon TI, 2012, TRENDS ENDOCRIN MET, V23, P65, DOI 10.1016/j.tem.2011.10.004; Joo HJ, 2009, BIOCHEM J, V422, P61, DOI 10.1042/BJ20090513; Joshi AS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05277-3; Kniazeva M, 2004, PLOS BIOL, V2, P1446, DOI 10.1371/journal.pbio.0020257; Koynova R, 1998, BBA-REV BIOMEMBRANES, V1376, P91, DOI 10.1016/S0304-4157(98)00006-9; Krahmer N, 2011, CELL METAB, V14, P504, DOI 10.1016/j.cmet.2011.07.013; Kuerschner L, 2008, TRAFFIC, V9, P338, DOI 10.1111/j.1600-0854.2007.00689.x; Lam SM, 2020, SCI BULL, V65, P1840, DOI 10.1016/j.scib.2020.07.023; Lee HC, 2008, MOL BIOL CELL, V19, P1174, DOI 10.1091/mbc.E07-09-0893; Li SW, 2017, P NATL ACAD SCI USA, V114, P8841, DOI 10.1073/pnas.1704277114; Liang B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009869; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Mendel M, 2021, CELL, V184, P3125, DOI 10.1016/j.cell.2021.03.062; Murphy DJ, 1999, TRENDS BIOCHEM SCI, V24, P109, DOI 10.1016/S0968-0004(98)01349-8; Ohsaki Y, 2009, BBA-MOL CELL BIOL L, V1791, P399, DOI 10.1016/j.bbalip.2008.10.002; Olzmann JA, 2019, NAT REV MOL CELL BIO, V20, P137, DOI 10.1038/s41580-018-0085-z; Perez CL, 2008, CELL METAB, V8, P266, DOI 10.1016/j.cmet.2008.08.007; Shi X, 2013, J LIPID RES, V54, P2504, DOI 10.1194/jlr.M039669; Thazar-Poulot N, 2015, P NATL ACAD SCI USA, V112, P4158, DOI 10.1073/pnas.1403322112; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vrablik TL, 2015, BBA-MOL CELL BIOL L, V1851, P1337, DOI 10.1016/j.bbalip.2015.06.004; Walker AK, 2011, CELL, V147, P840, DOI 10.1016/j.cell.2011.09.045; Walther TC, 2017, ANNU REV CELL DEV BI, V33, P491, DOI 10.1146/annurev-cellbio-100616-060608; Wang HZ, 2016, GENETICS, V203, P241, DOI 10.1534/genetics.116.186742; Wang SH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05278-2; Watts JL, 2017, GENETICS, V207, P413, DOI 10.1534/genetics.117.300106; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799; Wilfling F, 2014, CURR OPIN CELL BIOL, V29, P39, DOI 10.1016/j.ceb.2014.03.008; Wilfling F, 2014, ELIFE, V3, DOI 10.7554/eLife.01607; Wilfling F, 2013, DEV CELL, V24, P384, DOI 10.1016/j.devcel.2013.01.013; Wu JY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03531-2; Xie K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51399-z; Yang FJ, 2006, NATURE, V442, P700, DOI 10.1038/nature04942; Yang L, 2012, J LIPID RES, V53, P1245, DOI 10.1194/jlr.R024117; Zhang JJ, 2017, J LIPID RES, V58, P1845, DOI 10.1194/jlr.M077198; Zhang P, 2012, MOL CELL PROTEOMICS, V11, P317, DOI 10.1074/mcp.M111.016345; Zhang SBO, 2010, P NATL ACAD SCI USA, V107, P4640, DOI 10.1073/pnas.0912308107; Zhang XX, 2016, P NATL ACAD SCI USA, V113, P10055, DOI 10.1073/pnas.1608262113; Zhang XX, 2015, P NATL ACAD SCI USA, V112, P3955, DOI 10.1073/pnas.1423951112	56	0	0	19	19	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2022	298	8							102179	10.1016/j.jbc.2022.102179	http://dx.doi.org/10.1016/j.jbc.2022.102179			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	4X0OB	35752365	Green Published, gold			2022-12-26	WOS:000860550600007
J	Zuo, ZB; Cui, HZ; Wang, MC; Huang, CX; Wu, J; Tao, CJ; Li, ZY; Yang, CL; Pan, K; Bao, JF; Liu, SR; Xu, AF				Zuo, Zhongbao; Cui, Huaizhong; Wang, Miaochan; Huang, Congxiang; Wu, Jing; Tao, Chengjing; Li, Zhaoyi; Yang, Chunli; Pan, Kenv; Bao, Jianfeng; Liu, Shourong; Xu, Aifang			Diagnostic of FibroTouch and six serological models in assessing the degree of liver fibrosis among patients with chronic hepatic disease: A single-center retrospective study	PLOS ONE			English	Article							CIRRHOSIS; INDEX; FIB-4	Background and aims The aim of this study was to evaluate the diagnostic value of FibroTouch and serological models on staging hepatic fibrosis in chronic liver diseases. Methods We recruited 850 patients undergoing liver biopsy and received FibroTouch test before or after liver biopsy within one week, blood was taken for the routine inspection before the operation within one week. The serological models were calculated by the blood results and routine clinical information. The diagnostic value of FibroTouch and six serological models was analyzed by receiver operating characteristic curve (ROC). Results Patients with severe liver fibrosis had significantly higher AST, ALT, GGT, RDW, ALP, and FT-LSM. The area under the receiver operating characteristic curve (AUROC) of FT-LSM for the liver diagnosis of S >= 2, S >= 3 and S = 4 was 0.75(95% confidence interval [CI]:0.72-0.78), 0.83(95% CI: 0.80-0.86), and 0.85 (95% CI: 0.81-0.89), respectively. The optimal cut-off of FT-LSM for diagnosing S >= 2, S >= 3 and S = 4 was 8.7, 10.7, and 12.3, respectively. Conclusions Our study showed the FibroTouch has a higher diagnostic value compared with the noninvasive serological models in staging the fibrosis stage. The cut-off of FibroTouch and five serological models (APRI, FIB-4, S-index, Forns, and PRP) increased with the severe of fibrosis stage.	[Zuo, Zhongbao; Cui, Huaizhong; Wang, Miaochan; Wu, Jing; Pan, Kenv; Xu, Aifang] Hangzhou Xixi Hosp, Dept Clin Lab, Hangzhou, Zhejiang, Peoples R China; [Huang, Congxiang] Hangzhou Xixi Hosp, Pathol Dept, Hangzhou, Zhejiang, Peoples R China; [Tao, Chengjing] Hangzhou Xixi Hosp, Dept Obstet & Gynecol, Hangzhou, Zhejiang, Peoples R China; [Li, Zhaoyi; Bao, Jianfeng] Hangzhou Xixi Hosp, Sci & Educ Dept, Hangzhou, Zhejiang, Peoples R China; [Yang, Chunli] 903rd Hosp PLA, Dept Clin Res, Hangzhou, Zhejiang, Peoples R China; [Liu, Shourong] Hangzhou Xixi Hosp, Dept Hepatol, Hangzhou, Zhejiang, Peoples R China		Xu, AF (corresponding author), Hangzhou Xixi Hosp, Dept Clin Lab, Hangzhou, Zhejiang, Peoples R China.	xingh@chinaaids.cn			Hangzhou agricultural and social development scientific research [20201203B179]; General projects of Hangzhou health science and technology plan [A20200157]	Hangzhou agricultural and social development scientific research; General projects of Hangzhou health science and technology plan	This research was funded by Hangzhou agricultural and social development scientific research (20201203B179) and General projects of Hangzhou health science and technology plan in 2020 (A20200157). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Castera L, 2019, GASTROENTEROLOGY, V156, P1264, DOI 10.1053/j.gastro.2018.12.036; Cheng JY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144425; Ding YY, 2019, SCAND J GASTROENTERO, V54, P81, DOI 10.1080/00365521.2018.1558786; Kolhe KM, 2019, BMJ OPEN GASTROENTER, V6, DOI 10.1136/bmjgast-2019-000288; Liu XD, 2012, WORLD J GASTROENTERO, V18, P2784, DOI 10.3748/wjg.v18.i22.2784; Ma XY, 2020, AM J PHYSIOL-ENDOC M, V318, pE817, DOI 10.1152/ajpendo.00427.2019; Mohan BP, 2019, GASTROINTEST ENDOSC, V89, P238, DOI [10.1016/j.gie.2018.10.018, 10.1016/j.gie.2018.10.036]; Qu Y, 2021, CLIN TRANSL GASTROEN, V12, DOI 10.14309/ctg.0000000000000323; Roth GA, 2018, LANCET, V392, P1736, DOI [10.1016/S0140-6736(18)32203-7, 10.1016/s0140-6736(18)32203-7]; Serra JT, 2020, HEPATIC MED-EVID RES, V12, P41, DOI 10.2147/HMER.S245455; Shiha G, 2017, HEPATOL INT, V11, P286, DOI 10.1007/s12072-017-9796-z; Smas M, 2019, POL ARCH INTERN MED; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Wang H, 2013, J VIRAL HEPATITIS, V20, pe3, DOI 10.1111/jvh.12010; Wang J, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000019201; Xiao J, 2019, J HEPATOL, V71, P212, DOI 10.1016/j.jhep.2019.03.004; Xing X, 2020, EXPERT REV GASTROENT, V14, P631, DOI 10.1080/17474124.2020.1779589; Xu YM, 2019, DIGEST LIVER DIS, V51, P1323, DOI 10.1016/j.dld.2019.02.009; Yang XZ, 2018, EUR REV MED PHARMACO, V22, P479, DOI 10.26355/eurrev_201801_14198; Zhou K, 2010, J GASTROEN HEPATOL, V25, P1569, DOI 10.1111/j.1440-1746.2010.06383.x	20	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2022	17	7							e0270512	10.1371/journal.pone.0270512	http://dx.doi.org/10.1371/journal.pone.0270512			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5M7ED	35776774	Green Published, gold			2022-12-26	WOS:000871259600001
J	Xia, LY; Xu, WY; Zhao, Y				Xia, Lin-Yu; Xu, Wei-Yun; Zhao, Yan			Effect of postmastectomy radiotherapy on T1-2N1M0 triple-negative breast cancer	PLOS ONE			English	Article							INTERNATIONAL EXPERT CONSENSUS; LYMPH-NODES; PRIMARY THERAPY; T1-T2; RECURRENCE; N1	Background The effect of postmastectomy radiotherapy (PMRT) on T1-2N1M0 triple-negative breast cancers (TNBC) remains unclear. The population-based study aimed to investigate the survival outcomes of T1-2N1M0 TNBC patients who underwent PMRT or not. Methods We selected 1743 patients with T1-2N1M0 TNBC who underwent mastectomy between 2010 and 2015 through the Surveillance, Epidemiology and End Results (SEER) database. After propensity score matching (PSM), the PMRT and no-PMRT groups consisted of 586 matched patients, respectively. The Kaplan-Meier method was applied to calculate breast cancer-specific survival (BCSS) and cox proportional hazard model was used to determine the prognostic factors of T1-2N1M0 TNBC. Results The 5-year BCSS for the PMRT and no-PMRT groups was 79.1% and 74.7%, respectively. Analysis showed that in patients with three nodes positive, radiotherapy could significantly improve BCSS (HR = 0.396, 95% CI = 0.175-0.900, P = 0.027), but it brought no significant advantage in BCSS in patients with one or two nodes positive (HR = 1.061, 95% CI = 0.725-1.552, P = 0.761; HR = 0.657, 95% CI = 0.405-1.065, P = 0.088). In addition, PMRT improves the BCSS in TNBC patients with T2 tumor concomitant with three positive lymph nodes (HR = 0.343, 95% CI = 0.132-0.890, P = 0.028). Conclusion TNBC patients with T2 tumor concomitant with three positive lymph nodes can benefit from PMRT.	[Xia, Lin-Yu] Chengdu Med Coll, Dept Thyroid & Breast Surg, Affiliated Hosp 1, Chengdu, Sichuan, Peoples R China; [Xu, Wei-Yun] Mianyang Cent Hosp, Dept Breast Surg, Mianyang, Sichuan, Peoples R China; [Zhao, Yan] Sichuan Mianyang 404 Hosp, Dept Breast Surg, Mianyang, Sichuan, Peoples R China	Chengdu Medical College	Xia, LY (corresponding author), Chengdu Med Coll, Dept Thyroid & Breast Surg, Affiliated Hosp 1, Chengdu, Sichuan, Peoples R China.	lylc1023@163.com						Bartsch R, 2017, MEMO-MAG EUR MED ONC, V10, P228, DOI 10.1007/s12254-017-0368-7; Bonsang-Kitzis H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144359; Cardoso F, 2019, ANN ONCOL, V30, P1194, DOI 10.1093/annonc/mdz173; Chen MS, 2020, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01551; Chen XX, 2013, ONCOLOGIST, V18, P141, DOI 10.1634/theoncologist.2012-0233; Coates AS, 2015, ANN ONCOL, V26, P1533, DOI 10.1093/annonc/mdv221; Cosar R, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-28; Curigliano G, 2017, ANN ONCOL, V28, P1700, DOI 10.1093/annonc/mdx308; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Gabos Z, 2010, BREAST CANCER RES TR, V124, P187, DOI 10.1007/s10549-010-1135-1; Harris JR, 2016, JAMA ONCOL, V2, P991, DOI 10.1001/jamaoncol.2016.0222; Huo DZ, 2015, ANN SURG ONCOL, V22, P4295, DOI 10.1245/s10434-015-4528-x; Kim J, 2017, RADIAT ONCOL J, V35, P227, DOI 10.3857/roj.2017.00101; Kim YJ, 2017, CANCER RES TREAT, V49, P927, DOI 10.4143/crt.2016.508; Li YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081765; McGale P, 2014, LANCET, V383, P2127, DOI 10.1016/S0140-6736(14)60488-8; Muhsen S, 2018, ANN SURG ONCOL, V25, P1912, DOI 10.1245/s10434-018-6422-9; Prat A, 2013, ONCOLOGIST, V18, P123, DOI 10.1634/theoncologist.2012-0397; Recht A, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.69.1188; Ribelles N, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3559; Sharma P, 2018, CURR TREAT OPTION ON, V19, DOI 10.1007/s11864-018-0539-8; Shen HH, 2016, TUMOR BIOL, V37, P6465, DOI 10.1007/s13277-015-4546-0; Taylor CW, 2015, CLIN ONCOL-UK, V27, P621, DOI 10.1016/j.clon.2015.06.007; Waks AG, 2019, JAMA-J AM MED ASSOC, V321, P288, DOI 10.1001/jama.2018.19323; Wang XY, 2020, ONCOL LETT, V19, P735, DOI 10.3892/ol.2019.11139; Wen G, 2016, J BREAST CANCER, V19, P176, DOI 10.4048/jbc.2016.19.2.176; Zhang Jie, 2019, Oncotarget, V10, P5245, DOI 10.18632/oncotarget.24703; Zhang L, 2020, BMC CANCER, V20, DOI 10.1186/s12885-020-07639-x; Zhu Q, 2018, CANCER TREAT REV, V68, P9, DOI 10.1016/j.ctrv.2018.03.008	29	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2022	17	6							e0270528	10.1371/journal.pone.0270528	http://dx.doi.org/10.1371/journal.pone.0270528			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6B8SK	35749525	Green Submitted, gold, Green Published			2022-12-26	WOS:000881596500001
J	Beraud, E; Bednarz, V; Otto, I; Golbuu, Y; Ferrier-Pages, C				Beraud, Eric; Bednarz, Vanessa; Otto, Ikelau; Golbuu, Yimnang; Ferrier-Pages, Christine			Plastics are a new threat to Palau's coral reefs	PLOS ONE			English	Article							MICROPLASTIC POLLUTION; MARINE-ENVIRONMENT; IDENTIFICATION METHODS; WATER; SEDIMENTS; DEBRIS; IMPACT; PARTICLES; SEA; ACCUMULATION	Plastic pollution of the oceans has long been an ongoing and growing problem. Single-use plastic (plastic bags and microbeads) is responsible for most of this pollution. In recent years, studies have highlighted the importance of the size of plastic particles, and the impact of this pollution source on the environment. We determined the concentration of small marine plastics in seawater, sediments and beach sand around a pristine reef area (Republic of Palau) using very simple tools (plankton net, sieves, organic matter degradation, density separation, Nile red fluorochrome). In this study, we succeeded in detecting microplastic (MPs) particles and microplastic fibers, but also nanoplastic (NPs). These three types of particles were found in all samples with a large heterogeneity, from 0.01 to 0.09 particles L-1 and 0.17 to 32.13 particles g-1 DW for MPs in seawater, sediments and sand, respectively. Even when NPs were identified, the amounts of NPs were underestimated and varied from 0.09 to 0.43 particles L-1 in seawater and from 1.08 to 71.02 particles g(-1) DW in sediment and sand, respectively. These variations could be attributed to the environmental characteristics of the different sites. This study shows that plastic pollution must be considered in environmental studies even in the most pristine locations. It also shows that NPs pollution is related to the amount of MPs found at the sites. To understand the effects of this plastic pollution, it is necessary that the next toxicological studies take into account the effects of this fraction that makes up the NPs.	[Beraud, Eric; Bednarz, Vanessa; Ferrier-Pages, Christine] Ctr Sci Monaco, Equipe Ecophysiol Corallienne, Monaco, Monaco; [Otto, Ikelau; Golbuu, Yimnang] PICRC Palau Int Coral Reef Ctr, Koror, Palau, Palau		Beraud, E (corresponding author), Ctr Sci Monaco, Equipe Ecophysiol Corallienne, Monaco, Monaco.	eberaud@centrescientifique.mc						Bakir A, 2020, MAR POLLUT BULL, V160, DOI 10.1016/j.marpolbul.2020.111572; Bergmann M, 2015, MARINE ANTHROPOGENIC LITTER, P1, DOI 10.1007/978-3-319-16510-3; Besley A, 2017, MAR POLLUT BULL, V114, P77, DOI 10.1016/j.marpolbul.2016.08.055; Besseling E, 2019, CRIT REV ENV SCI TEC, V49, P32, DOI 10.1080/10643389.2018.1531688; Bhattacharya P, 2010, J PHYS CHEM C, V114, P16556, DOI 10.1021/jp1054759; Boucher J., 2017, PRIMARY MICROPLASTIC, P1; Browne MA, 2011, ENVIRON SCI TECHNOL, V45, P9175, DOI 10.1021/es201811s; Carr SA, 2016, WATER RES, V91, P174, DOI 10.1016/j.watres.2016.01.002; Ceccarini A, 2018, ENVIRON SCI TECHNOL, V52, P5634, DOI 10.1021/acs.est.8b01487; Chapron L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33683-6; Choy CA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44117-2; Cole M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04528; Cole M, 2011, MAR POLLUT BULL, V62, P2588, DOI 10.1016/j.marpolbul.2011.09.025; Conkle JL, 2018, ENVIRON MANAGE, V61, P1, DOI 10.1007/s00267-017-0947-8; Coppock RL, 2017, ENVIRON POLLUT, V230, P829, DOI 10.1016/j.envpol.2017.07.017; Cox KD, 2019, ENVIRON SCI TECHNOL, V53, P7068, DOI 10.1021/acs.est.9b01517; Cozar A, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1600582; de Carvalho-Souza GF, 2018, MAR POLLUT BULL, V133, P464, DOI 10.1016/j.marpolbul.2018.05.049; Derraik JGB, 2002, MAR POLLUT BULL, V44, P842, DOI 10.1016/S0025-326X(02)00220-5; Driedger AGJ, 2015, J GREAT LAKES RES, V41, P9, DOI 10.1016/j.jglr.2014.12.020; Eerkes-Medrano D, 2015, WATER RES, V75, P63, DOI 10.1016/j.watres.2015.02.012; Erni-Cassola G, 2017, ENVIRON SCI TECHNOL, V51, P13641, DOI 10.1021/acs.est.7b04512; Free CM, 2014, MAR POLLUT BULL, V85, P156, DOI 10.1016/j.marpolbul.2014.06.001; Gall SC, 2015, MAR POLLUT BULL, V92, P170, DOI 10.1016/j.marpolbul.2014.12.041; Gigault J, 2018, ENVIRON POLLUT, V235, P1030, DOI 10.1016/j.envpol.2018.01.024; Graca B, 2017, ENVIRON SCI POLLUT R, V24, P7650, DOI 10.1007/s11356-017-8419-5; Hall NM, 2015, MAR BIOL, V162, P725, DOI 10.1007/s00227-015-2619-7; Hernandez LM, 2017, ENVIRON SCI TECH LET, V4, P280, DOI 10.1021/acs.estlett.7b00187; Holmes LA, 2012, ENVIRON POLLUT, V160, P42, DOI 10.1016/j.envpol.2011.08.052; Huang YJ, 2019, ENVIRON POLLUT, V255, DOI 10.1016/j.envpol.2019.113133; Huffer T, 2016, ENVIRON POLLUT, V214, P194, DOI 10.1016/j.envpol.2016.04.018; do Sul JAI, 2014, ENVIRON POLLUT, V185, P352, DOI 10.1016/j.envpol.2013.10.036; Jambeck JR, 2015, SCIENCE, V347, P768, DOI 10.1126/science.1260352; Kang JH, 2015, MAR POLLUT BULL, V96, P304, DOI 10.1016/j.marpolbul.2015.04.054; Kanhai LK, 2017, MAR POLLUT BULL, V115, P307, DOI 10.1016/j.marpolbul.2016.12.025; Karlsson TM, 2017, MAR POLLUT BULL, V122, P403, DOI 10.1016/j.marpolbul.2017.06.081; Kershaw P., 2019, GESAMP REP STUD; Kittinger JN, 2012, ECOL SOC, V17, DOI 10.5751/ES-05115-170417; Klein S, 2015, ENVIRON SCI TECHNOL, V49, P6070, DOI 10.1021/acs.est.5b00492; Koelmans AA, 2015, MARINE ANTHROPOGENIC LITTER, P309, DOI 10.1007/978-3-319-16510-3_11; Kooi M, 2017, ENVIRON SCI TECHNOL, V51, P7963, DOI 10.1021/acs.est.6b04702; Lamb JB, 2018, SCIENCE, V359, P460, DOI 10.1126/science.aar3320; Lavers JL, 2017, P NATL ACAD SCI USA, V114, P6052, DOI 10.1073/pnas.1619818114; Lee KW, 2013, ENVIRON SCI TECHNOL, V47, P11278, DOI 10.1021/es401932b; Leslie HA, 2017, ENVIRON INT, V101, P133, DOI 10.1016/j.envint.2017.01.018; Lusher A, 2015, MARINE ANTHROPOGENIC LITTER, P245, DOI 10.1007/978-3-319-16510-3_10; Lusher AL, 2014, MAR POLLUT BULL, V88, P325, DOI 10.1016/j.marpolbul.2014.08.023; Mathalon A, 2014, MAR POLLUT BULL, V81, P69, DOI 10.1016/j.marpolbul.2014.02.018; McCormick A, 2014, ENVIRON SCI TECHNOL, V48, P11863, DOI 10.1021/es503610r; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; Moore CJ, 2008, ENVIRON RES, V108, P131, DOI 10.1016/j.envres.2008.07.025; Moore CJ, 2002, MAR POLLUT BULL, V44, P1035, DOI 10.1016/S0025-326X(02)00150-9; Murphy F, 2016, ENVIRON SCI TECHNOL, V50, P5800, DOI 10.1021/acs.est.5b05416; Nie HY, 2019, SCI TOTAL ENVIRON, V696, DOI 10.1016/j.scitotenv.2019.134022; Portela LI, 2013, J COASTAL RES, P1188, DOI 10.2112/SI65-201.1; Qiu QX, 2016, ESTUAR COAST SHELF S, V176, P102, DOI 10.1016/j.ecss.2016.04.012; Ramos JAA, 2012, AQUAT BIOL, V17, P29, DOI 10.3354/ab00461; Reichert J, 2018, ENVIRON POLLUT, V237, P955, DOI 10.1016/j.envpol.2017.11.006; Rochman CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085433; Rochman CM, 2013, ENVIRON SCI TECHNOL, V47, P13976, DOI 10.1021/es403605f; Rochman CM, 2013, ENVIRON SCI TECHNOL, V47, P1646, DOI 10.1021/es303700s; Song YK, 2017, ENVIRON SCI TECHNOL, V51, P4368, DOI 10.1021/acs.est.6b06155; Song YK, 2015, MAR POLLUT BULL, V93, P202, DOI 10.1016/j.marpolbul.2015.01.015; Strungaru SA, 2019, TRAC-TREND ANAL CHEM, V110, P116, DOI 10.1016/j.trac.2018.10.025; Suhrhoff TJ, 2016, MAR POLLUT BULL, V102, P84, DOI 10.1016/j.marpolbul.2015.11.054; Sussarellu R, 2016, P NATL ACAD SCI USA, V113, P2430, DOI 10.1073/pnas.1519019113; Syakti AD, 2019, CHEMOSPHERE, V228, P528, DOI 10.1016/j.chemosphere.2019.04.156; Tan F, 2020, SCI TOTAL ENVIRON, V725, DOI 10.1016/j.scitotenv.2020.138383; Ter Halle A, 2017, ENVIRON SCI TECHNOL, V51, P13689, DOI 10.1021/acs.est.7b03667; Thiel M, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00238; Thompson RC, 2004, SCIENCE, V304, P838, DOI 10.1126/science.1094559; Van Cauwenberghe L, 2013, ENVIRON POLLUT, V182, P495, DOI 10.1016/j.envpol.2013.08.013; van Sebille E, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/12/124006; Wolanski E., 2007, CORAL REEFS PALAU, P238; Wright SL, 2013, ENVIRON POLLUT, V178, P483, DOI 10.1016/j.envpol.2013.02.031; Zarfl C, 2011, MAR POLLUT BULL, V62, P1589, DOI 10.1016/j.marpolbul.2011.02.040	76	0	0	7	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7								10.1371/journal.pone.0270237	http://dx.doi.org/10.1371/journal.pone.0270237			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M3CI	35793287	gold, Green Published			2022-12-26	WOS:000835338100040
J	Cox, A; Martini, A; Ghozlan, H; Moroose, RS; Zhu, X; Lee, EKY; Khaled, A; Barr, L; Alemany, C; Fanaian, N; Griffith, ER; Sause, R; Litherland, SA; Khaled, A				Cox, Amanda; Martini, Ana; Ghozlan, Heba; Moroose, Rebecca S.; Zhu, Xiang; Lee, Eunkyung; Khaled, Amr; Barr, Louis; Alemany, Carlos; Fanaian, Na'im; Griffith, Elizabeth R.; Sause, Ryan; Litherland, S. A.; Khaled, Annette			Chaperonin containing TCP1 as a marker for identification of circulating tumor cells in blood	PLOS ONE			English	Article							METASTATIC BREAST-CANCER; PERIPHERAL-BLOOD; PROGRESSION-FREE; EXPRESSION; CCT; SURVIVAL; COMPLEX; DIFFERENTIATION	Herein we report the use of Chaperonin-Containing TCP-1 (CCT or TRiC) as a marker to detect circulating tumor cells (CTCs) that are shed from tumors during oncogenesis. Most detection methods used in liquid biopsy approaches for enumeration of CTCs from blood, employ epithelial markers like cytokeratin (CK). However, such markers provide little information on the potential of these shed tumor cells, which are normally short-lived, to seed metastatic sites. To identify a marker that could go beyond enumeration and provide actionable data on CTCs, we evaluated CCT. CCT is a protein-folding complex composed of eight subunits. Previously, we found that expression of the second subunit (CCT2 or CCT beta) inversely correlated with cancer patient survival and was essential for tumorigenesis in mice, driving tumor-promoting processes like proliferation and anchorage-independent growth. In this study, we examined CCT2 expression in cancer compared to normal tissues and found statistically significant increases in tumors. Because not all blood samples from cancer patients contain detectable CTCs, we used the approach of spiking a known number of cancer cells into blood from healthy donors to test a liquid biopsy approach using CCT2 to distinguish rare cancer cells from the large number of non-cancer cells in blood. Using a clinically validated method for capturing CTCs, we evaluated detection of intracellular CCT2 staining for visualization of breast cancer and small cell lung (SCLC) cancer cells. We demonstrated that CCT2 staining could be incorporated into a CTC capture and staining protocol, providing biologically relevant information to improve detection of cancer cells shed in blood. These results were confirmed with a pilot study of blood from SCLC patients. Our studies demonstrate that detection of CCT2 could identify rare cancer cells in blood and has application in liquid biopsy approaches to enhance the use of minimally invasive methods for cancer diagnosis.	[Cox, Amanda; Martini, Ana; Ghozlan, Heba; Zhu, Xiang; Khaled, Annette] Univ Cent Florida, Burnett Sch Biomed Sci, Coll Med, Orlando, FL 32816 USA; [Moroose, Rebecca S.] Orlando Hlth Canc Inst, Orlando, FL 32806 USA; [Lee, Eunkyung] Univ Cent Florida, Coll Hlth Profess & Sci, Dept Hlth Sci, Orlando, FL 32816 USA; [Khaled, Amr] Orlando VA Med Ctr, Pathol & Lab Med, Orlando, FL 32803 USA; [Barr, Louis] AdventHealth Canc Inst, Surg Oncol, Orlando, FL 32804 USA; [Alemany, Carlos] AdventHealth Canc Inst, Oncol Hematol Clin Res, Orlando, FL 32804 USA; [Fanaian, Na'im] Cent Florida Pathol Associates, Orlando, FL 32803 USA; [Griffith, Elizabeth R.] AdventHealth Canc Inst, Clin Res, Orlando, FL 32804 USA; [Sause, Ryan] AdventHealth Heart Florida, Pathol, Orlando, FL 32804 USA; [Litherland, S. A.] AdventHealth Canc Inst, Translat Res, Orlando, FL 32804 USA	State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida; Adventist Health Services; AdventHealth; (AdventHealth) Central Florida Division; Central Florida Hospital - South; AdventHealth Orlando; Adventist Health Services; AdventHealth; (AdventHealth) Central Florida Division; Central Florida Hospital - South; AdventHealth Orlando; Adventist Health Services; AdventHealth; (AdventHealth) Central Florida Division; Central Florida Hospital - South; AdventHealth Orlando; Adventist Health Services; AdventHealth; (AdventHealth) Central Florida Division; Central Florida Hospital - South; AdventHealth Orlando	Khaled, A (corresponding author), Univ Cent Florida, Burnett Sch Biomed Sci, Coll Med, Orlando, FL 32816 USA.	annette.khaled@ucf.edu			Breast Cancer Research Foundation [BCRF-18-086]; Cathy Engelman Cancer Research Collaborative Fund	Breast Cancer Research Foundation; Cathy Engelman Cancer Research Collaborative Fund	Breast Cancer Research Foundation (https://www.bcrf.org) (BCRF-18-086) (ARK) and The Cathy Engelman Cancer Research Collaborative Fund (ARK). The funders and sponsors did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albakova Z, 2021, TRANSL ONCOL, V14, DOI 10.1016/j.tranon.2020.100995; Alix-Panabieres C, 2016, CANCER DISCOV, V6, P479, DOI 10.1158/2159-8290.CD-15-1483; Aswathy N, 2016, COMPUT BIOL CHEM, V64, P396, DOI 10.1016/j.compbiolchem.2016.09.002; Bassiouni R, 2016, CLIN CANCER RES, V22, P4366, DOI 10.1158/1078-0432.CCR-15-2502; Breuninger S, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00497; Camasses A, 2003, MOL CELL, V12, P87, DOI 10.1016/S1097-2765(03)00244-2; Carr AC, 2017, ONCOTARGET, V8, P110273, DOI 10.18632/oncotarget.22681; Chang YX, 2020, CANCERS, V12, DOI 10.3390/cancers12123865; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; de Bono JS, 2008, CLIN CANCER RES, V14, P6302, DOI 10.1158/1078-0432.CCR-08-0872; de Wit Sanne, 2018, Oncotarget, V9, P35705, DOI 10.18632/oncotarget.26298; de Wit S, 2018, CANCERS, V10, DOI 10.3390/cancers10100377; de Wit S, 2015, SCI REP-UK, V5, DOI 10.1038/srep12270; Dietz MS., 2021, BIORXIV, DOI [10.1038/s41598-021-93053-7, DOI 10.1038/S41598-021-93053-7]; El-Rehim DMA, 2004, J PATHOL, V203, P661, DOI 10.1002/path.1559; Fehm T, 2010, BREAST CANCER RES TR, V124, P403, DOI 10.1007/s10549-010-1163-x; Flores O, 2017, THERANOSTICS, V7, P2477, DOI 10.7150/thno.18879; Ghozlan H, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.663877; Guest ST, 2015, EXP CELL RES, V332, P223, DOI 10.1016/j.yexcr.2015.02.005; Hallal S, 2019, PROTEOMICS, V19, DOI 10.1002/pmic.201800157; Hayes DF, 2006, CLIN CANCER RES, V12, P4218, DOI 10.1158/1078-0432.CCR-05-2821; Hodgkinson CL, 2014, NAT MED, V20, P897, DOI 10.1038/nm.3600; Ilie M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111597; Jego G, 2013, CANCER LETT, V332, P275, DOI 10.1016/j.canlet.2010.10.014; Kasembeli M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001844; Khalil AA, 2011, BBA-REV CANCER, V1816, P89, DOI 10.1016/j.bbcan.2011.05.001; Korsching E, 2002, LAB INVEST, V82, P1525, DOI 10.1097/01.LAB.0000038508.86221.B3; Leitner A, 2012, STRUCTURE, V20, P814, DOI 10.1016/j.str.2012.03.007; Liu Q., 2020, MOL CLIN CHARACTERIZ; Liu YJ, 2020, CARCINOGENESIS, V41, P699, DOI 10.1093/carcin/bgz137; Lowes LE, 2014, JOVE-J VIS EXP, DOI 10.3791/51248; Macario Alberto J L, 2022, Semin Cancer Biol, V86, P26, DOI 10.1016/j.semcancer.2021.05.029; Mary Goldman B. C., 2019, BIORXIV, DOI [DOI 10.1101/326470, 10.1101/326470]; Meng SD, 2004, CLIN CANCER RES, V10, P8152, DOI 10.1158/1078-0432.CCR-04-1110; Rakha EA, 2007, HISTOPATHOLOGY, V50, P434, DOI 10.1111/j.1365-2559.2007.02638.x; Riethdorf S, 2007, CLIN CANCER RES, V13, P920, DOI 10.1158/1078-0432.CCR-06-1695; Rink M, 2012, EUR UROL, V61, P810, DOI 10.1016/j.eururo.2012.01.017; Roh SH, 2015, INT J MOL SCI, V16, P26706, DOI 10.3390/ijms161125975; Satelli A, 2017, ONCOTARGET, V8, P49329, DOI 10.18632/oncotarget.17632; Showalter AE, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-57602-w; Solimini NL, 2007, CELL, V130, P986, DOI 10.1016/j.cell.2007.09.007; Swennenhuis JF, 2016, EXPERT REV MOL DIAGN, V16, P1291, DOI 10.1080/14737159.2016.1255144; Veridex I., 2008, GUIDELINE USE OPTIMI; Won KA, 1998, MOL CELL BIOL, V18, P7584, DOI 10.1128/MCB.18.12.7584; Xiang Y, 2019, ENVIRON TOXICOL PHAR, V68, P141, DOI 10.1016/j.etap.2019.03.014; Yokota S, 2001, CELL STRESS CHAPERON, V6, P345, DOI 10.1379/1466-1268(2001)006<0345:IEOCCC>2.0.CO;2; Zeune L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186562; Zou Q, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-143	48	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	6							e0264651	10.1371/journal.pone.0264651	http://dx.doi.org/10.1371/journal.pone.0264651			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3F0KH	35749519	gold, Green Published			2022-12-26	WOS:000830362700089
J	Hardeman, AA; Han, YJ; Grushko, TA; Mueller, J; Gomez, MJ; Zheng, YL; Olopade, OI				Hardeman, Ashley A.; Han, Yoo Jane; Grushko, Tatyana A.; Mueller, Jeffrey; Gomez, Maria J.; Zheng, Yonglan; Olopade, Olufunmilayo I.			Subtype-specific expression of MELK is partly due to copy number alterations in breast cancer	PLOS ONE			English	Article							LEUCINE-ZIPPER KINASE; CELLS; GENE; INHIBITION; GROWTH	Maternal embryonic leucine-zipper kinase (MELK) regulates cell cycle progression and is highly expressed in many cancers. The molecular mechanism of MELK dysregulation has not been determined in aggressive forms of breast cancer, such as triple negative breast cancer (TNBC). To evaluate molecular markers of MELK aberrations in aggressive breast cancer, we assessed MELK gene amplification and expression in breast tumors. MELK mRNA expression is highly up-regulated in basal-like breast cancer (BLBC), the major molecular subtype of TNBC, compared to luminal or other subtypes of breast tumors. MELK copy number (CN) gains are significantly associated with BLBC, whereas no significant association of CpG site methylation or histone modifications with breast cancer subtypes was observed. Accordingly, the CN gains appear to contribute to an increase in MELK expression, with a significant correlation between mRNA expression and CN in breast tumors and cell lines. Furthermore, immunohistochemistry (IHC) assays revealed that both nuclear and cytoplasmic staining scores of MELK were significantly higher in invasive ductal carcinoma (IDC) tumors compared to ductal carcinoma in situ (DCIS) and normal breast tissues. Our data showed that upregulation of MELK in BLBC may be in part driven by CN gains, rather than epigenetic modifications, indicating a potential for overexpression and CN gains of MELK to be developed as a diagnostic and prognostic marker to identify patients who have more aggressive breast cancer.	[Hardeman, Ashley A.; Han, Yoo Jane; Grushko, Tatyana A.; Gomez, Maria J.; Zheng, Yonglan; Olopade, Olufunmilayo I.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Grushko, Tatyana A.] Abbott Mol Inc, Des Plaines, IL USA; [Mueller, Jeffrey] Univ Chicago, Dept Pathol, Chicago, IL USA	University of Chicago; University of Chicago	Han, YJ; Olopade, OI (corresponding author), Univ Chicago, Dept Med, Chicago, IL 60637 USA.	folopade@medicine.bsd.uchicago.edu; yjhan@medicine.bsd.uchicago.edu			National Cancer Institute [PA12-149, K12CA139160, CTSA-ITM CS UL1 RR024999]; Breast Cancer Research Foundation [BCRF20-071]; American Cancer Society; Entertainment Industry Foundation National Women's Cancer Research Alliance Program (EIF NWCRA)	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Breast Cancer Research Foundation; American Cancer Society(American Cancer Society); Entertainment Industry Foundation National Women's Cancer Research Alliance Program (EIF NWCRA)	This study was supported by grants from the National Cancer Institute PA12-149 (AH), K12CA139160 and CTSA-ITM CS UL1 RR024999 (TAG), Breast Cancer Research Foundation BCRF20-071 (OIO), American Cancer Society (OIO), and Entertainment Industry Foundation National Women's Cancer Research Alliance Program (EIF NWCRA) (OIO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alachkar H, 2014, ONCOTARGET, V5, P12371, DOI 10.18632/oncotarget.2642; Beke L, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150194; Cao LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070031; Chartrain I, 2013, BIOL OPEN, V2, P1037, DOI 10.1242/bio.20136080; Chung SY, 2012, ONCOTARGET, V3, P1629; Faggad A, 2009, MODERN PATHOL, V22, P579, DOI 10.1038/modpathol.2009.14; Franco HL, 2018, GENOME RES, V28, P159, DOI 10.1101/gr.226019.117; Ganguly R, 2015, CLIN TRANSL MED, V4, DOI 10.1186/s40169-014-0045-y; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gil M, 1997, GENE, V195, P295, DOI 10.1016/S0378-1119(97)00181-9; Grushko TA, 2002, CANCER RES, V62, P1481; Han YJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33629-y; Hebbard LW, 2010, CANCER RES, V70, P8863, DOI 10.1158/0008-5472.CAN-10-1295; Heyer BS, 1997, MOL REPROD DEV, V47, P148, DOI 10.1002/(SICI)1098-2795(199706)47:2&lt;148::AID-MRD4&gt;3.0.CO;2-M; Huo DZ, 2009, J CLIN ONCOL, V27, P4515, DOI 10.1200/JCO.2008.19.6873; Joshi K, 2013, STEM CELLS, V31, P1051, DOI 10.1002/stem.1358; Jung H, 2008, J BIOL CHEM, V283, P34541, DOI 10.1074/jbc.M807219200; Kato T, 2016, ONCOTARGET, V7, P17652, DOI 10.18632/oncotarget.7755; Kim SH, 2015, STEM CELL REP, V4, P226, DOI 10.1016/j.stemcr.2014.12.006; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Osterberg L, 2010, ANTICANCER RES, V30, P4451; Rakha EA, 2009, PATHOLOGY, V41, P40, DOI 10.1080/00313020802563510; Sarhadi VK, 2014, GENE CHROMOSOME CANC, V53, P579, DOI 10.1002/gcc.22168; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Speers C, 2016, CLIN CANCER RES, V22, P5864, DOI 10.1158/1078-0432.CCR-15-2711; Thike AA, 2010, MODERN PATHOL, V23, P123, DOI 10.1038/modpathol.2009.145; Vulsteke V, 2004, J BIOL CHEM, V279, P8642, DOI 10.1074/jbc.M311466200; Wang YB, 2014, ELIFE, V3, DOI 10.7554/eLife.01763	28	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	6							e0268693	10.1371/journal.pone.0268693	http://dx.doi.org/10.1371/journal.pone.0268693			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3F0KH	35749404	Green Published, gold			2022-12-26	WOS:000830362700084
J	Lu, GJ; Zhu, Z; Lu, YF; Shen, J; Yu, QL; Gao, L; Chen, W				Lu, Genjie; Zhu, Zhe; Lu, Yangfang; Shen, Jun; Yu, Qilin; Gao, Li; Chen, Wei			The influence of blood donation before pregnancy on neonatal birth weight	PLOS ONE			English	Article							IRON STATUS; DONORS; DEFICIENCY; OUTCOMES	ObjectiveTo evaluate the effect of blood donation before pregnancy on neonatal birth weight. MethodsA total of 14996 women with singleton pregnancies at full-term in Ningbo Medical Center Lihuili Hospital and Ningbo Women's and Children's Hospital from November 2019 to November 2020 were enrolled in this study. Detailed records of whole blood donation before pregnancy were obtained through Alipay software. The records were classified into three groups: nondonors, low-frequency donors and high-frequency donors according to the total numbers of blood donations in the 3-year period before pregnancy. The demographics and clinical information of the enrolled participants and their fetuses were collected from electronic medical records (EMRs). The effect of blood donations in the 3-year period before pregnancy on neonatal birth weight was analyzed. ResultsThere was no significant difference in neonatal birth weight among the three groups (P = 0.373). In line with this, there was no association between the number of blood donations in the 3-year period before pregnancy and neonatal birth weight (beta = 14.5; 95% confidence interval [CI]: -3.9, 31.4; P = 0.094) in the bootstrapped multivariate linear regression analysis models, adjusted for maternal age, number of pregnancies, number of deliveries, gestational age, mode of delivery, years of education and blood type in pregnant women. Compared to the nondonors, the risk of fetal macrosomia was higher in both low-frequency donors and all donors (OR: 1.539, 95% CI: 1.058, 2.134, P = 0.016; OR: 1.454, 95% CI: 1.033, 1.952, P = 0.021, respectively), in the bootstrapped binary logistic regression analysis models after adjusting for the variables mentioned above. ConclusionOur study showed that maternal blood donation in the 3-year period before pregnancy may not lead to a reduction in neonatal birth weight, but may be associated with the incidence of fetal macrosomia.	[Lu, Genjie; Yu, Qilin; Gao, Li; Chen, Wei] Ningbo Univ, Ningbo Med Ctr, Dept Blood Transfus, Lihuili Hosp, Ningbo, Peoples R China; [Zhu, Zhe] Univ Chinese Acad Sci, HwaMei Hosp, Dept Blood Transfus, Ningbo, Peoples R China; [Lu, Yangfang] Ningbo Univ, Ningbo Med Ctr, Dept Radiotherapy, Lihuili Hosp, Ningbo, Peoples R China; [Shen, Jun] Ningbo Univ, Ningbo Med Ctr, Dept Obstet, Lihuili Hosp, Ningbo, Peoples R China	Ningbo University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Ningbo University; Ningbo University	Chen, W (corresponding author), Ningbo Univ, Ningbo Med Ctr, Dept Blood Transfus, Lihuili Hosp, Ningbo, Peoples R China.	cw0031@163.com			Medical and Health Science and Technology Project of Zhejiang Province [2020KY864]	Medical and Health Science and Technology Project of Zhejiang Province	We thank Professor Jianping Ni for her help in our project. We thank Yisheng Zhang, PhD, for her guidance during the project as well as the study participants for their cooperation.	Adu P, 2021, TRANSFUS APHER SCI, V60, DOI 10.1016/j.transci.2020.103040; Alwan NA, 2015, BRIT J NUTR, V113, P1985, DOI 10.1017/S0007114515001166; Aizpurua AB, 2021, ESC HEART FAIL, V8, P1304, DOI 10.1002/ehf2.13204; Cable RG, 2011, TRANSFUSION, V51, P511, DOI 10.1111/j.1537-2995.2010.02865.x; Chasse M, 2020, TRANSFUS MED REV, V34, P117, DOI 10.1016/j.tmrv.2019.11.007; Ferrara P, 2020, MINERVA PEDIATR, V72, P508, DOI 10.23736/S0026-4946.16.04802-7; Germain M, 2016, TRANSFUSION, V56, P2760, DOI 10.1111/trf.13762; Goldman M, 2017, TRANSFUSION, V57, P564, DOI 10.1111/trf.13956; Hernandez-Martinez A, 2016, ARCH GYNECOL OBSTET, V293, P529, DOI 10.1007/s00404-015-3856-1; Hufnagel DH, 2021, J NATL COMPR CANC NE, V19, P513, DOI 10.6004/jnccn.2020.7638; Lee CK, 2013, TRANSFUSION, V53, P322, DOI 10.1111/j.1537-2995.2012.03788.x; Lobier M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220862; Rigas AS, 2019, TRANSFUSION, V59, P995, DOI 10.1111/trf.15072; Rigas AS, 2017, TRANSFUSION, V57, P2914, DOI 10.1111/trf.14364; Rigas AS, 2014, TRANSFUSION, V54, P789, DOI 10.1111/trf.12518; Rosli RRM, 2021, PEERJ, V9, DOI 10.7717/peerj.10527; Schotten N, 2016, BLOOD, V128, P2185, DOI 10.1182/blood-2016-04-709451; Sicinska E, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.504015; Srour MA, 2018, ANEMIA, V2018, DOI 10.1155/2018/9135625; Sweegers MG, 2020, TRIALS, V21, DOI 10.1186/s13063-020-04648-w; Timmer T, 2021, VOX SANG, V116, P755, DOI 10.1111/vox.13066; Unger EL, 2012, J NUTR, V142, P2040, DOI 10.3945/jn.112.162198; Vassallo RR, 2020, PEDIATRICS, V146, DOI 10.1542/peds.2019-3316; Vuk T, 2017, BLOOD TRANSFUS-ITALY, V15, P20, DOI 10.2450/2016.0101-16; Wojtaszek E, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.565135	25	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	6							e0269367	10.1371/journal.pone.0269367	http://dx.doi.org/10.1371/journal.pone.0269367			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3F0KH	35749434	Green Published, gold			2022-12-26	WOS:000830362700016
J	Nhamo, D; Duma, S; Ojewole, E; Chibanda, D; Cowan, F				Nhamo, Definate; Duma, Sinegugu; Ojewole, Elizabeth; Chibanda, Dixon; Cowan, Frances			Factors motivating female sex workers to initiate pre- exposure prophylaxis for HIV prevention in Zimbabwe	PLOS ONE			English	Article							PREEXPOSURE PROPHYLAXIS; ADHERENCE	BackgroundFemale sex workers (FSWs) have a 26 times greater chance of HIV infection compared to the women in the general population. The World Health Organization recommends pre-exposure prophylaxis (PrEP) for population groups with an HIV incidence of 3% or higher and FSWs in southern Africa fit this criteria. This study sought to understand factors that motivate FSWs to initiate PrEP, in Harare, Zimbabwe. MethodsWe purposively selected and recruited 20 FSWs to participate in the study in-order to gain an in-depth understanding of factors that motivate FSWs to initiate PrEP in Harare, Zimbabwe. We identified FSW who had been initiated on PrEP at a specialized clinic providing comprehensive sexual reproductive health (SRH) services for sex workers including HIV prevention options. We used a descriptive phenomenological approach to collect and analyze the data. Data was analyzed using Colaizzi's seven steps to analyze data. FindingsTwo broad themes were identified as intrinsic and extrinsic motivators. The two broad themes each have several sub-themes. The sub-themes under intrinsic motivation were (i) Self- protection from HIV infection and (ii) condoms bursting. Six sub-themes were identified as external motivators for initiating PrEP, these included (i) occupational risk associated with sex work, (ii) increased chance of offering unprotected sex as a motivator to initiate PrEP, (iii) positive encouragement from others (iv) need to take care of the children and (v) prior participation in HIV prevention research studies and (vi) Gender Based Violence. ConclusionsUnderstanding the factors that motivate FSWs to initiate PrEP is critical in developing contextually appropriate strategies to promote PrEP initiation and adherence strategies within specific and eligible populations for receiving PrEP according to the WHO guidelines (2015).	[Nhamo, Definate; Duma, Sinegugu] Univ KwaZulu Natal, Dept Nursing & Publ Hlth, Durban, South Africa; [Ojewole, Elizabeth] Univ KwaZulu Natal, Coll Hlth Sci, Discipline Pharmaceut Sci, Durban, South Africa; [Chibanda, Dixon] Univ Zimbabwe, Dept Psychiat, Harare, Zimbabwe; [Cowan, Frances] Ctr Sexual Hlth & HIV Res CeSHHAR Zimbabwe, Harare, Zimbabwe; [Cowan, Frances] Liverpool Sch Trop Med LSTM, Dept Int Publ Hlth, Liverpool, Lancashire, England	University of Kwazulu Natal; University of Kwazulu Natal; University of Zimbabwe; Liverpool School of Tropical Medicine	Nhamo, D (corresponding author), Univ KwaZulu Natal, Dept Nursing & Publ Hlth, Durban, South Africa.	defnh78@gmail.com		Nhamo, Definate/0000-0002-6058-5237; Cowan, Frances/0000-0003-3087-4422	DELTAS Africa Initiative [DEL-15-01]; New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust [DEL-15-01]; UK government; IREX	DELTAS Africa Initiative; New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust(Wellcome Trust); UK government; IREX	This work was supported through the DELTAS Africa Initiative [DEL-15-01]. The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA) and supported by the New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust [DEL-15-01] and the UK government. The views expressed in this publication are those of the author(s) and not necessarily those of AAS, NEPAD Agency, Wellcome Trust or the UK government. IREX funding through the UASP alumni small grants program is acknowledged for providing a platform for the development of this publication.	[Anonymous], 2015, GUIDELINE START ANTI; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Brooks RA, 2019, AIDS BEHAV, V23, P1964, DOI 10.1007/s10461-019-02397-9; Busza J, 2021, AIDS CARE, V33, P729, DOI 10.1080/09540121.2020.1832192; Chu M, 2020, J AM ASSOC NURSE PRA, V32, P423, DOI 10.1097/JXX.0000000000000282; Cowan FM, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25320; Cowan FM, 2018, LANCET HIV, V5, pE417, DOI 10.1016/S2352-3018(18)30111-5; Cowan FM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077080; Creswell J.W., 2009, RES DESIGN QUALITATI, DOI DOI 10.1007/S11252-005-3264-6; Creswell JW, 2000, THEOR PRACT, V39, P124, DOI 10.1207/s15430421tip3903_2; Duma SE, 2009, Curationis, V32, P52; Fowler FJ., 2013, SURV RES METHODS-GER, V5; Fusch PI, 2015, QUAL REP, V20, P1408; Giorgi A., 2009, DESCRIPTIVE PHENOMEN; Gombe MM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227632; Hargreaves JR, 2016, JAIDS-J ACQ IMM DEF, V72, pE1, DOI 10.1097/QAI.0000000000000920; Hargreaves JR, 2016, TRIALS, V17, DOI 10.1186/s13063-015-1095-1; Kinuthia J, 2020, LANCET HIV, V7, pE38, DOI 10.1016/S2352-3018(19)30335-2; Koechlin FM, 2017, AIDS BEHAV, V21, P1325, DOI 10.1007/s10461-016-1627-z; Lewis S, 2015, HEALTH PROMOT PRACT, V16, P473, DOI 10.1177/1524839915580941; Madrasi K, 2017, J CLIN PHARMACOL, V57, P606, DOI 10.1002/jcph.843; Medical Research Council of Zimbabwe, INF PART; Ngure K, 2016, AIDS PATIENT CARE ST, V30, P78, DOI 10.1089/apc.2015.0259; phia icap columbia, 2020, ZIMBABWE POPULATION; psycnet apa, 2009, DESCRIPTIVE PHENOMEN; Tranquillo Joseph, 2016, Surg Neurol Int, V7, pS197, DOI 10.4103/2152-7806.179231; Tufford L, 2012, QUAL SOC WORK, V11, P80, DOI 10.1177/1473325010368316; Ulin PR, 2012, QUALITATIVE METHODS; UNAIDS, 2021, CONFRONTING INEQUALI; van der Graaf R, 2021, JAMA-J AM MED ASSOC, V325, P1719, DOI 10.1001/jama.2021.0258; Ware NC, 2012, JAIDS-J ACQ IMM DEF, V59, P463, DOI 10.1097/QAI.0b013e31824a060b; Whitfield THF, 2018, AIDS BEHAV, V22, P3566, DOI 10.1007/s10461-018-2045-1; World Health Organization, 2013, CONSOLIDATED GUIDELI; World Health Organization, 2016, US ANT DRUGS TREAT P, P99; Zimmermann HML, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25389	35	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7							e0264470	10.1371/journal.pone.0264470	http://dx.doi.org/10.1371/journal.pone.0264470			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M2ZD	35797351	Green Accepted, Green Published, gold			2022-12-26	WOS:000835328600011
J	Ren, JY; Da, JL; Hu, NRS				Ren, Junyu; Da, Junlong; Hu, Narisu			Identification of COL1A1 associated with immune infiltration in brain lower grade glioma	PLOS ONE			English	Article							TUMOR; CANCER; METASTASIS; GENES	Brain low grade gliomas (LGG) often give serious clinical symptoms due to the invasion towards nervous system, affecting the life quality of patients. Collagen type I alpha 1(COL1A1) is the main component of type I collagen. Although there are many reports about abnormal expression of COL1A1 in various tumors, specific role and clinical significance of COL1A1 in LGG have not yet been elucidated. In this work, Tumor Immune Estimation Resource database was used for detecting the expression level of COL1A1 in cancer and normal tissues, and aimed to explore the relationship between COL1A1 and tumor immune infiltration. We applied Kaplan-Meier to analyze the role of COL1A1 in clinical prognosis. Univariate survival rate and multivariate Cox analysis were used to compare clinical characteristics and survival rate. The relativity between the expression of COL1A1 and the tumor microenvironment was evaluated using ESTIMATE algorithm. Finally, the relationship between expression level of COL1A1 and gene marker sets of immune cell infiltration was investigated via TIMER. According to TCGA, COL1A1 overexpression was correlated with overall survival (OS), progression free interval (PFI) and disease specific survival (DSS) of multiple tumors, especially in LGG. Multivariate analysis showed that COL1A1 expression was an independent prognostic factor for LGG. The expression of COL1A1 was positively correlated with the infiltration of CD4 + T and CD8 + T cells, neutrophils, macrophages and dendritic cells in LGG. In addition, there was a strong correlation between expression of COL1A1 and different immune marker sets in LGG. The results suggest that COL1A1 is related with tumor immune infiltration of LGG.	[Ren, Junyu; Hu, Narisu] Harbin Med Univ, Oral Implant Ctr, Affiliated Hosp 2, Harbin, Heilongjiang, Peoples R China; [Da, Junlong] Harbin Med Univ, Inst Hard Tissue Dev & Regenerat, Affiliated Hosp 2, Harbin, Heilongjiang, Peoples R China	Harbin Medical University; Harbin Medical University	Hu, NRS (corresponding author), Harbin Med Univ, Oral Implant Ctr, Affiliated Hosp 2, Harbin, Heilongjiang, Peoples R China.	hmuhunarisu@163.com			Natural Science Foundation of China [51972087]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We would like to thank The Second Affiliated Hospital of Harbin Medical University for their strong support and the constructive comments of the team members.	Azimi F, 2012, J CLIN ONCOL, V30, P2678, DOI 10.1200/JCO.2011.37.8539; Chandramohan V, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0614-0; Esfahani K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12628-1; Fan K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07124-9; Goldman MJ, 2020, NAT BIOTECHNOL, V38, P675, DOI 10.1038/s41587-020-0546-8; Gordon M., 2021, ADV FOREST PLOT USIN, V1; Haddad AF, 2022, NEUROSURG FOCUS, V52, DOI 10.3171/2021.11.FOCUS21587; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hayashi M, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-108; Hu HM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11962-y; Ibanez de Caceres I, 2006, CANCER RES, V66, P5021, DOI 10.1158/0008-5472.CAN-05-3365; Ilhan-Mutlu A, 2016, TUMOR BIOL, V37, P1173, DOI 10.1007/s13277-015-3790-7; Justus CR, 2015, INT J MOL SCI, V16, P11055, DOI 10.3390/ijms160511055; Kassambara A, SURVMINER DRAWING SU, P1; Kim HR, 2016, SCI REP-UK, V6, DOI 10.1038/srep36956; Leme-Kraus AA, 2017, J DENT RES, V96, P430, DOI 10.1177/0022034516680586; Li J, 2016, WORLD J SURG ONCOL, V14, DOI 10.1186/s12957-016-1056-5; Li MY, 2020, EXP CELL RES, V394, DOI 10.1016/j.yexcr.2020.112153; Li TW, 2017, CANCER RES, V77, pE108, DOI 10.1158/0008-5472.CAN-17-0307; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Lu JC, 2019, CANCER CELL INT, V19, DOI 10.1186/s12935-019-0972-1; Mustafa DAM, 2010, GENE REGUL SYST BIO, V4, P103, DOI 10.4137/GRSB.S4546; Nissen NI, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1110-6; Oleksiewicz U, 2017, J CANCER RES CLIN, V143, P1133, DOI 10.1007/s00432-017-2381-y; Pan YP, 2016, ONCOTARGET, V7, P2093, DOI 10.18632/oncotarget.6573; Panaroni C, 2009, BLOOD, V114, P459, DOI 10.1182/blood-2008-12-195859; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Ravelli A, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317695023; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Simon M.P., 2001, ATLAS GENET CYTOGENE, V5, P78; Sun CH, 2017, ONCOTARGET, V8, P70271, DOI 10.18632/oncotarget.20082; Sun S, 2018, INT J ONCOL, V53, P2542, DOI 10.3892/ijo.2018.4568; Swinnen FKR, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-88; Therneau T.M., 2014, SURVIVAL ANAL PUBLIS, V2, P3, DOI DOI 10.1038/S41525-021-00179-8; Tsao MS, 2017, ANN ONCOL, V28, P882, DOI 10.1093/annonc/mdx003; Villegas-Martinez I, 2016, PHARMACOGENET GENOM, V26, P126, DOI 10.1097/FPC.0000000000000199; Wang Q, 2018, BIOCHEM CELL BIOL, V96, P19, DOI 10.1139/bcb-2016-0254; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wu YH, 2014, ONCOGENE, V33, P3432, DOI 10.1038/onc.2013.307; Yang XF, 2021, ACTA RADIOL, V62, P1657, DOI 10.1177/0284185120973624; Yarchoan M, 2017, NEW ENGL J MED, V377, P2500, DOI 10.1056/NEJMc1713444; Yoshihara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3612; Zeke A, 2016, MICROBIOL MOL BIOL R, V80, P793, DOI 10.1128/MMBR.00043-14; Zhang LB, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52515-9; Zhang ZY, 2018, INT J ONCOL, V53, P1869, DOI 10.3892/ijo.2018.4536; Zhang ZY, 2018, MOL MED REP, V17, P5037, DOI 10.3892/mmr.2018.8533; Zhou Q, 2010, BLOOD, V116, P2484, DOI 10.1182/blood-2010-03-275446	47	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7								10.1371/journal.pone.0269533	http://dx.doi.org/10.1371/journal.pone.0269533			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M5FN	35789341	gold, Green Published			2022-12-26	WOS:000835487000003
J	Vohra, R; Hussain, A; Dudyala, AK; Pahareeya, J; Khan, W				Vohra, Rajan; Hussain, Abir; Dudyala, Anil Kumar; Pahareeya, Jankisharan; Khan, Wasiq			Multi-class classification algorithms for the diagnosis of anemia in an outpatient clinical setting	PLOS ONE			English	Article							HEALTH; DETERMINANTS	Anemia is one of the most pressing public health issues in the world with iron deficiency a major public health issue worldwide. The highest prevalence of anemia is in developing countries. The complete blood count is a blood test used to diagnose the prevalence of anemia. While earlier studies have framed the problem of diagnosis as a binary classification problem, this paper frames it as a multi class (three classes) classification problem with mild, moderate and severe classes. The three classes for the anemia classification (mild, moderate, severe) are so chosen as the world health organization (WHO) guidelines formalize this categorization based on the Haemoglobin (HGB) values of the chosen sample of patients in the Complete Blood Count (CBC) patient data set. Complete blood count test data was collected in an outpatient clinical setting in India. We used Feature selection with Majority voting to identify the key attributes in the input patient data set. In addition, since the original data set was imbalanced we used Synthetic Minority Oversampling Technique (SMOTE) to balance the data set. Four data sets including the original data set were used to perform the data experiments. Six standard machine learning algorithms were utilised to test our four data sets, performing multi class classification. Benchmarking these algorithms was performed and tabulated using both10 fold cross validation and hold out methods. The experimental results indicated that multilayer perceptron network was predominantly giving good recall values across mild and moderate class which are early and middle stages of the disease. With a good prediction model at early stages, medical intervention can provide preventive measure from further deterioration into severe stage or recommend the use of supplements to overcome this problem.	[Vohra, Rajan] Univ Bolton, Sch Creat Technol, Bolton, England; [Hussain, Abir] Univ Sharjah, Dept Elect Engn, Sharjah, U Arab Emirates; [Hussain, Abir; Khan, Wasiq] Liverpool John Moores Univ, Dept Comp Sci, Liverpool, England; [Dudyala, Anil Kumar] Natl Inst Technol Patna NIT Patna, Dept Comp Sci, Patna, India; [Pahareeya, Jankisharan] BSF Acad, Rustamji Inst Technol, Dept Informat Technol, Gwalior, India	University of Bolton; University of Sharjah; Liverpool John Moores University; University of Liverpool; National Institute of Technology (NIT System); National Institute of Technology Patna	Vohra, R (corresponding author), Univ Bolton, Sch Creat Technol, Bolton, England.	rv1res@bolton.ac.uk		Vohra, Rajan/0000-0002-5663-0963; Dudyala, Anil Kumar/0000-0001-6508-1129; Khan, Wasiq/0000-0002-7511-3873				Al-Asmari Salma, 2017, MANAGEMENT INFORM TE; Alghamdi M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179805; AmornratI WongsaI., 2018, INFORM HEALTH SOC CA, V43, P1; [Anonymous], 2019, PLOS ONE, V14; [Anonymous], WEKA 3 4 10JRE DATA; [Anonymous], 2021, COHENS KAPPA; Bates I, 2007, PLOS MED, V4, P1285, DOI 10.1371/journal.pmed.0040231; Ben Taieb S, 2014, INT J FORECASTING, V30, P382, DOI 10.1016/j.ijforecast.2013.07.005; Bienvenue K, 2015, 11 TH INT C MACHINE; Brabin B. J., 2001, J NUTR, V131, P6045; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Choi SB, 2014, COMPUT MATH METHOD M, V2014, DOI 10.1155/2014/618976; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cybenko G., 1989, Mathematics of Control, Signals, and Systems, V2, P303, DOI 10.1007/BF02551274; Ewusie JE, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-626; Guyon I., 2003, Journal of Machine Learning Research, V3, P1157, DOI 10.1162/153244303322753616; Hall M.A, 1999, CORRELATION BASED FE; Hsieh CH, 2011, SURGERY, V149, P87, DOI 10.1016/j.surg.2010.03.023; Jaiswal Manish, 2019, Recent Trends in Communication, Computing, and Electronics. Select Proceedings of IC3E 2018. Lecture Notes in Electrical Engineering (LNEE 524), P463, DOI 10.1007/978-981-13-2685-1_44; Khan JR, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-015-0536-z; Kleinbaum D. G., 2002, LOGISTIC REGRESSION; Kotsiantis SB, 2007, INFORM-J COMPUT INFO, V31, P249; Kumar Dudyala Anil, 2008, International Journal of Data Analysis Techniques and Strategies, V1, P4, DOI 10.1504/IJDATS.2008.020020; Laengsri V, 2019, BMC MED INFORM DECIS, V19, DOI 10.1186/s12911-019-0929-2; Lawson AB, 2006, STAT METHODS SPATIAL; Lewis R.J., 2000, ANN M SOC AC EM MED, V14; Lisboa PJG, 2002, NEURAL NETWORKS, V15, P11, DOI 10.1016/S0893-6080(01)00111-3; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Meng XH, 2013, KAOHSIUNG J MED SCI, V29, P93, DOI 10.1016/j.kjms.2012.08.016; Mengesha Misganaw Birhaneselassie, 2019, BMC Hematol, V19, P1, DOI 10.1186/s12878-018-0133-0; Cotta RMM, 2011, CAD SAUDE PUBLICA, V27, pS309, DOI 10.1590/S0102-311X2011001400017; Moody's Analytics, 2017, UNDERSTANDING HLTH C; Mutangadura GB, 2004, AGR ECON-BLACKWELL, V30, P170, DOI 10.1016/j.agecon.2003.11.006; Pahareeya J., 2014, INT J ADV RES COMPUT, V4, P295; Pahariya J. S., 2010, International Journal of Computer Information Systems and Industrial Management Applications, V2, P104; Pahariya J. S., 2009, Proceedings of the 2009 World Congress on Nature & Biologically Inspired Computing (NaBIC 2009), P849, DOI 10.1109/NABIC.2009.5393534; Quinlan JR., 1993, C45 PROGRAMS MACHINE; Rish I., 2001, IJCAI 2001 WORKSH EM, V3, P41, DOI DOI 10.1039/B104835J; Rosenblatt F., 1962, PRINCIPLES NEURODYNA, DOI 10.21236/AD0256582; Rumelhart D.E., 1986, PARALLEL DISTRIBUTED, V1; Sanap SA, 2011, LECT NOTES COMPUT SC, V7077, P113, DOI 10.1007/978-3-642-27242-4_14; Seligman B, 2018, SSM-POPUL HLTH, V4, P95, DOI 10.1016/j.ssmph.2017.11.008; Sow B, 2019, INFORM HEALTH SOC CA; Sow B., 2017, IEICE SWIM, V117, P13; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; von Seidlein L, 2012, CLIN INFECT DIS, V54, P1080, DOI 10.1093/cid/cis034; WALTER T, 1989, PEDIATRICS, V84, P7; Witten IH, 2011, MOR KAUF D, P1; Yu W, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-16; Zhao YJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174866	50	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7								10.1371/journal.pone.0269685	http://dx.doi.org/10.1371/journal.pone.0269685			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M3CI	35793343	Green Accepted, Green Published, gold			2022-12-26	WOS:000835338100016
J	Dhembla, C; Yadav, U; Kundu, S; Sundd, M				Dhembla, Chetna; Yadav, Usha; Kundu, Suman; Sundd, Monica			Lipoate protein ligase B primarily recognizes the C-8-phosphopantetheine arm of its donor substrate and weakly binds the acyl carrier protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPOIC ACID SYNTHESIS; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; LIPB; ENZYMES; LIPOYLATION; METABOLISM; MUTATIONS; PROCEEDS; CLONING	Lipoic acid is a sulfur-containing cofactor indispensable for the function of several metabolic enzymes. In microorganisms, lipoic acid can be salvaged from the surroundings by lipoate protein ligase A (LplA), an ATP-dependent enzyme. Alternatively, it can be synthesized by the sequential actions of lipoate protein ligase B (LipB) and lipoyl synthase (LipA). LipB takes up the octanoyl chain from C-8-acyl carrier protein (C-8-ACP), a byproduct of the type II fatty acid synthesis pathway, and transfers it to a conserved lysine of the lipoyl domain of a dehydrogenase. However, the molecular basis of its substrate recognition is still not fully understood. Using Escherichia coli LipB as a model enzyme, we show here that the octanoyltransferase mainly recognizes the 4'-phosphopantetheinetethered acyl-chain of its donor substrate and weakly binds the apo-acyl carrier protein. We demonstrate LipB can accept octanoate from its own ACP and noncognate ACPs, as well as C-8-CoA. Furthermore, our H-1 saturation transfer difference and P-31 NMR studies demonstrate the binding of adenosine, as well as the phosphopantetheine arm of CoA to LipB, akin to binding to LplA. Finally, we show a conserved 71 RGG 73 loop, analogous to the lipoate-binding loop of LplA, is required for full LipB activity. Collectively, our studies highlight commonalities between LipB and LplA in their mechanism of substrate recognition. This knowledge could be of significance in the treatment of mitochondrial fatty acid synthesis related disorders.	[Dhembla, Chetna; Kundu, Suman] Univ Delhi, Dept Biochem, South Campus, New Delhi, India; [Yadav, Usha; Sundd, Monica] Natl Inst Immunol, NMR Lab, New Delhi, India; [Kundu, Suman] Birla Inst Technol & Sci, KK Birla Goa Campus, Sancoale 403726, Goa, India	University of Delhi; Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Birla Institute of Technology & Science Pilani (BITS Pilani)	Sundd, M (corresponding author), Natl Inst Immunol, NMR Lab, New Delhi, India.	monicasundd@nii.ac.in			Lady Tata Foundation, India; University Grants Commission, India	Lady Tata Foundation, India; University Grants Commission, India(University Grants Commission, India)	Fellowship to C. D. from the Lady Tata Foundation, India, and U. Y. from the University Grants Commission, India is gratefully acknowledged.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Bartholow TG, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-01838-3; Bernardinelli E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179591; Brody S, 1997, FEBS LETT, V408, P217, DOI 10.1016/S0014-5793(97)00428-6; Cao XY, 2018, P NATL ACAD SCI USA, V115, pE7063, DOI 10.1073/pnas.1805862115; Cao XY, 2015, J BIOL CHEM, V290, P7280, DOI 10.1074/jbc.M114.626879; Christensen QH, 2010, BIOCHEMISTRY-US, V49, P10024, DOI 10.1021/bi101215f; Cronan JE, 2005, ADV MICROB PHYSIOL, V50, P103, DOI 10.1016/S0065-2911(05)50003-1; Cronan JE, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00510; Cronan JE, 2016, MICROBIOL MOL BIOL R, V80, P429, DOI 10.1128/MMBR.00073-15; Cronan JE, 2014, BIOCHEM J, V460, P157, DOI 10.1042/BJ20140239; Cronan JE, 2014, MOL MICROBIOL, V92, P217, DOI 10.1111/mmi.12558; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Frottin F, 2006, MOL CELL PROTEOMICS, V5, P2336, DOI 10.1074/mcp.M600225-MCP200; Fujiwara K, 2005, J BIOL CHEM, V280, P33645, DOI 10.1074/jbc.M505010200; Fujiwara K, 2010, J BIOL CHEM, V285, P9971, DOI 10.1074/jbc.M109.078717; Goddard D., 2008, SPARKY 3; Grzesiek S, 1996, NAT STRUCT BIOL, V3, P340, DOI 10.1038/nsb0496-340; Habarou F, 2017, AM J HUM GENET, V101, P283, DOI 10.1016/j.ajhg.2017.07.001; Hassan BH, 2011, J BIOL CHEM, V286, P8263, DOI 10.1074/jbc.M110.194191; Heimer G, 2016, AM J HUM GENET, V99, P1229, DOI 10.1016/j.ajhg.2016.09.021; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Iyer PP, 2001, J BACTERIOL, V183, P4244, DOI 10.1128/JB.183.14.4244-4250.2001; Jordan SW, 2003, J BACTERIOL, V185, P1582, DOI 10.1128/JB.185.5.1582-1589.2003; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kang J, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0463-x; Kim DJ, 2005, J BIOL CHEM, V280, P38081, DOI 10.1074/jbc.M507284200; Kim DJ, 2008, PROTEINS, V70, P1620, DOI 10.1002/prot.21843; KNOLL LJ, 1994, J BIOL CHEM, V269, P16348; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMBALOT RH, 1995, J BIOL CHEM, V270, P24658, DOI 10.1074/jbc.270.42.24658; Lambrechts RA, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201910488; Ma QJ, 2006, P NATL ACAD SCI USA, V103, P8662, DOI 10.1073/pnas.0510436103; Mandell DJ, 2007, J AM CHEM SOC, V129, P820, DOI 10.1021/ja063019w; MORRIS TW, 1995, J BACTERIOL, V177, P1; MORRIS TW, 1994, J BIOL CHEM, V269, P16091; Nair RR, 2018, J NEUROSCI, V38, P9781, DOI 10.1523/JNEUROSCI.3514-17.2018; Nair RR, 2017, HUM MOL GENET, V26, P2104, DOI 10.1093/hmg/ddx105; Narunsky A, 2020, P NATL ACAD SCI USA, V117, P4701, DOI 10.1073/pnas.1911349117; Nesbitt NM, 2005, PROTEIN EXPRES PURIF, V39, P269, DOI 10.1016/j.pep.2004.10.021; Nochi Z, 2020, PEDIATR RES, V88, P556, DOI 10.1038/s41390-020-0801-1; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pietikainen LP, 2021, BMC BIOL, V19, DOI 10.1186/s12915-021-00951-3; Posner MG, 2013, BIOCHEM J, V449, P415, DOI 10.1042/BJ20121150; Prince Josh P, 2021, Nat Commun, V12, P6721, DOI 10.1038/s41467-021-27107-9; Rowland EA, 2018, CURR OPIN CHEM BIOL, V42, P76, DOI 10.1016/j.cbpa.2017.11.003; Schaeffer ML, 2001, BBA-MOL CELL BIOL L, V1532, P67, DOI 10.1016/S1388-1981(01)00116-0; Spalding MD, 2010, MICROBIOL MOL BIOL R, V74, P200, DOI 10.1128/MMBR.00008-10; Sztain T, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2025597118; Tort F, 2016, J INHERIT METAB DIS, V39, P781, DOI 10.1007/s10545-016-9975-4; Wehbe Z, 2019, BBA-MOL CELL BIOL L, V1864, P1629, DOI 10.1016/j.bbalip.2019.07.012; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Woods AS, 2005, J PROTEOME RES, V4, P1397, DOI 10.1021/pr050077s; Zhao X, 2005, BIOCHEMISTRY-US, V44, P16737, DOI 10.1021/bi051865y; Zhao X, 2003, CHEM BIOL, V10, P1293, DOI 10.1016/j.chembiol.2003.11.016	56	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2022	298	8							102203	10.1016/j.jbc.2022.102203	http://dx.doi.org/10.1016/j.jbc.2022.102203			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3S2VB	35764173	Green Submitted, gold, Green Published			2022-12-26	WOS:000839458000009
J	Qi, F; Zhang, X; Wang, LK; Ren, CX; Zhao, XY; Luo, JY; Lu, D				Qi, Fang; Zhang, Xin; Wang, Likun; Ren, Caixia; Zhao, Xuyang; Luo, Jianyuan; Lu, Dan			E3 ubiquitin ligase NEURL3 promotes innate antiviral response through catalyzing K63-linked ubiquitination of IRF7	FASEB JOURNAL			English	Article						antiviral immune response; E3 ubiquitin ligase; IRF7; NEURL3; viral infection	INTERFERON; ACTIVATION; LUNG	Interferon regulatory factor 7 (IRF7), as the interferon-stimulated gene, maximally drives type I interferon (IFN) production. However, the mechanisms by which the biological function of IRF7 is regulated remain elusive. In this study, we found that IRF7 selectively interacted with the neuralized E3 ubiquitin-protein ligase 3 (NEURL3). In concomitant with IRF7 induction, NEURL3 is upregulated by NF-kappa B signaling in the late phase of viral infection. Moreover, NEURL3 augmented the host antiviral immune response through ubiquitinating IRF7. A mechanistic study revealed that NEURL3 triggered K63-linked poly-ubiquitination on IRF7 lysine 375, which in turn epigenetically enhanced the transcription of interferon-stimulated genes (ISGs) through disruption of the association of IRF7 with Histone Deacetylase 1 (HDAC1), consequently augmenting host antiviral immune response. Accordingly, Neurl3(-/-) mice produced less type I IFNs and exhibited increased susceptibility to viral infection. Taken together, our findings identify NEURL3 as an E3 ubiquitin ligase of IRF7 and shed new light on the positive regulation of IRF7 in host antiviral immune signaling.	[Qi, Fang; Zhang, Xin; Wang, Likun; Zhao, Xuyang; Lu, Dan] Peking Univ, Sch Basic Med Sci, Inst Syst Biomed, Beijing Key Lab Tumor Syst Biol,Hlth Sci Ctr, Beijing 100191, Peoples R China; [Ren, Caixia] Peking Univ, Dept Human Anat Histol & Embryol, Hlth Sci Ctr, Beijing, Peoples R China; [Luo, Jianyuan] Peking Univ, Dept Med Genet, Hlth Sci Ctr, Beijing, Peoples R China	Peking University; Peking University; Peking University	Lu, D (corresponding author), Peking Univ, Sch Basic Med Sci, Inst Syst Biomed, Beijing Key Lab Tumor Syst Biol,Hlth Sci Ctr, Beijing 100191, Peoples R China.	taotao@bjmu.edu.cn		Lu, Dan/0000-0002-3000-5094; Qi, Fang/0000-0001-9856-926X	Clinical Medicine Plus X-Young Scholars Project, Peking University [PKU2021LCXQ026]; National Natural Science Foundation of China [82022032, 81991505, 82171826]; Fundamental Research Funds for the Central Universities [BMU2018YJ003]	Clinical Medicine Plus X-Young Scholars Project, Peking University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	Clinical Medicine Plus X-Young Scholars Project, Peking University, Grant/Award Number: PKU2021LCXQ026; The National Natural Science Foundation of China, Grant/Award Number: 82022032, 81991505 and 82171826; Fundamental Research Funds for the Central Universities, Grant/Award Number: BMU2018YJ003	Carty M, 2021, BIOCHEM PHARMACOL, V183, DOI 10.1016/j.bcp.2020.114316; Chen HH, 2013, PROTEIN CELL, V4, P27, DOI 10.1007/s13238-012-2063-0; Glanz A, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13040575; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Hu Y, 2005, BIOCHEM BIOPH RES CO, V333, P253, DOI 10.1016/j.bbrc.2005.05.102; Jefferies CA, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00325; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Ling T, 2019, MOL IMMUNOL, V109, P116, DOI 10.1016/j.molimm.2019.02.019; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; Londhe VA, 2015, DEV DYNAM, V244, P827, DOI 10.1002/dvdy.24286; Lu D, 2020, NAT IMMUNOL, V21, P287, DOI 10.1038/s41590-019-0577-9; Mori M, 2004, J BIOL CHEM, V279, P9698, DOI 10.1074/jbc.M310616200; Negishi H, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a028423; Ning S, 2011, GENES IMMUN, V12, P399, DOI 10.1038/gene.2011.21; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Outlioua A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00853; Smith JB, 2002, AM J PHYSIOL-LUNG C, V283, pL636, DOI 10.1152/ajplung.00496.2001; Smith Jeffrey B, 2004, Proc Am Thorac Soc, V1, P275, DOI 10.1513/pats.200402-017MS; Tate JG, 2019, NUCLEIC ACIDS RES, V47, pD941, DOI 10.1093/nar/gky1015; Tracz M, 2021, CELL MOL BIOL LETT, V26, DOI 10.1186/s11658-020-00245-6; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Unterholzner L, 2013, IMMUNOBIOLOGY, V218, P1312, DOI 10.1016/j.imbio.2013.07.007; Xu WT, 2016, GENE, V592, P215, DOI 10.1016/j.gene.2016.07.062; Yu YX, 2010, IMMUNITY, V33, P863, DOI 10.1016/j.immuni.2010.11.027; Zhao YN, 2018, J VIROL, V92, DOI 10.1128/JVI.01123-18	25	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2022	36	8							e22409	10.1096/fj.202200316R	http://dx.doi.org/10.1096/fj.202200316R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2R5SN	35792897				2022-12-26	WOS:000821172000001
J	Tapio, J; Halmetoja, R; Dimova, EY; Maki, JM; Laitala, A; Walkinshaw, G; Myllyharju, J; Serpi, R; Koivunen, P				Tapio, Joona; Halmetoja, Riikka; Dimova, Elitsa Y.; Maki, Joni M.; Laitala, Anu; Walkinshaw, Gail; Myllyharju, Johanna; Serpi, Raisa; Koivunen, Peppi			Contribution of HIF-P4H isoenzyme inhibition to metabolism indicates major beneficial effects being conveyed by HIF-P4H-2 antagonism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID-METABOLISM; HYPOXIA; PROTECTS; GLUCOSE; OBESITY; DEFICIENCY; ATHEROSCLEROSIS; IDENTIFICATION; HOMEOSTASIS; MECHANISMS	Hypoxia-inducible factor (HIF) prolyl 4-hydroxylases (HIFP4Hs 1-3) are druggable targets in renal anemia, where panHIF-P4H inhibitors induce an erythropoietic response. Preclinical data suggest that HIF-P4Hs could also be therapeutic targets for treating metabolic dysfunction, although the contributions of HIF-P4H isoenzymes in various tissues to the metabolic phenotype are inadequately understood. Here, we used mouse lines that were gene-deficient for HIF-P4Hs 1 to 3 and two preclinical pan-HIF-P4H inhibitors to study the contributions of these isoenzymes to the anthropometric and metabolic outcome and HIF response. We show both inhibitors induced a HIF response in wildtype white adipose tissue (WAT), liver, and skeletal muscle and alleviated metabolic dysfunction during a 6-week treatment period, but they did not alter healthy metabolism. Our data indicate that HIF-P4H-1 contributed especially to skeletal muscle and WAT metabolism and that its loss lowered body weight and serum cholesterol levels upon aging. In addition, we found HIF-P4H-3 had effects on the liver and WAT and its loss increased body weight, adiposity, liver weight and triglyceride levels, WAT inflammation, and cholesterol levels and resulted in hyperglycemia and insulin resistance, especially during aging. Finally, we demonstrate HIF-P4H-2 affected all tissues studied; its inlevels and improved glucose tolerance. We found very few HIF target metabolic mRNAs were regulated by the inhibition of three isoenzymes, thus suggesting a potential for selective fications for the future development of HIF-P4H inhibitors for the treatment of metabolic diseases.	[Tapio, Joona; Halmetoja, Riikka; Dimova, Elitsa Y.; Maki, Joni M.; Laitala, Anu; Myllyharju, Johanna; Serpi, Raisa; Koivunen, Peppi] Univ Oulu, Fac Biochem & Mol Med, Oulu Ctr Cell Matrix Res, Bioctr Oulu, Oulu, Finland; [Walkinshaw, Gail] FibroGen Inc, San Francisco, CA USA; [Serpi, Raisa] Univ Oulu, Fac Med, Oulu, Finland; [Serpi, Raisa] Oulu Univ Hosp, Biobank Borealis Northern Finland, Oulu, Finland	University of Oulu; FibroGen; University of Oulu; University of Oulu	Koivunen, P (corresponding author), Univ Oulu, Fac Biochem & Mol Med, Oulu Ctr Cell Matrix Res, Bioctr Oulu, Oulu, Finland.	peppi.koivunen@oulu.fi		Tapio, Joona/0000-0002-9267-1586; Serpi, Raisa/0000-0002-8207-4673; Dimova, Elitsa/0000-0003-2745-8145; Laitala, Anu/0000-0002-9587-2025	Academy of Finland [266719, 308009, 296498]; Academy of Finland Center of Excellence [251314, 284605]; S. Juselius Foundation; Jane and Aatos Erkko Foundation	Academy of Finland(Academy of Finland); Academy of Finland Center of Excellence(Academy of Finland); S. Juselius Foundation; Jane and Aatos Erkko Foundation	This work was supported by Academy of Finland grants 266719 and 308009 (P. K.) , and 296498 (J. M.) , Academy of Finland Center of Excellence 2012 to 2017 grants 251314 and 284605 (J. M.) , and grants from the S. Juselius Foundation (P. K. and J. M.) and the Jane and Aatos Erkko Foundation (P. K. and J. M.) .	Amin RH, 2010, AM J PHYSIOL-ENDOC M, V298, pE28, DOI 10.1152/ajpendo.00446.2009; Aprelikova O, 2004, J CELL BIOCHEM, V92, P491, DOI 10.1002/jcb.20067; Aragones J, 2008, NAT GENET, V40, P170, DOI 10.1038/ng.2007.62; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bishop T, 2008, MOL CELL BIOL, V28, P3386, DOI 10.1128/MCB.02041-07; Bravo-Nuevo A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090031; Chen N, 2019, NEW ENGL J MED, V381, P1001, DOI 10.1056/NEJMoa1813599; Cockmann ME, 2019, ELIFE, V8, DOI 10.7554/eLife.46490; Demandt JAF, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.664258; Dhillon S, 2019, DRUGS, V79, P563, DOI 10.1007/s40265-019-01077-1; German NJ, 2016, MOL CELL, V63, P1006, DOI 10.1016/j.molcel.2016.08.014; Grundy SM, 2016, TRENDS CARDIOVAS MED, V26, P364, DOI 10.1016/j.tcm.2015.10.004; Hyvarinen J, 2010, J BIOL CHEM, V285, P13646, DOI 10.1074/jbc.M109.084855; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Karsikas S, 2016, J MOL MED, V94, P301, DOI 10.1007/s00109-015-1349-0; Kile M, 2021, INT UROL NEPHROL, V53, P283, DOI 10.1007/s11255-020-02584-x; Klop B, 2013, NUTRIENTS, V5, P1218, DOI 10.3390/nu5041218; Koivunen P, 2018, TRENDS MOL MED, V24, P1021, DOI 10.1016/j.molmed.2018.10.004; Laitakari A, 2020, J MOL MED, V98, P719, DOI 10.1007/s00109-020-01903-0; Laitakari A, 2020, FASEB J, V34, P5590, DOI 10.1096/fj.201902331R; Laitakari A, 2019, REDOX BIOL, V22, DOI 10.1016/j.redox.2019.101145; Laitala A, 2012, BLOOD, V120, P3336, DOI 10.1182/blood-2012-07-441824; Liu H, 2016, BIOCHEM BIOPH RES CO, V473, P99, DOI 10.1016/j.bbrc.2016.03.058; Liu QD, 2012, J CLIN INVEST, V122, P4635, DOI 10.1172/JCI63924; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Marlatt KL, 2020, INT J OBESITY, V44, P744, DOI 10.1038/s41366-019-0422-0; Marsch E, 2016, EUR HEART J, V37, P2993, DOI 10.1093/eurheartj/ehw156; Matsuura H, 2013, CIRCULATION, V127, P2078, DOI 10.1161/CIRCULATIONAHA.113.001742; Metzen E, 2005, BIOCHEM J, V387, P711, DOI 10.1042/BJ20041736; Myllyharju J, 2013, BIOL CHEM, V394, P435, DOI 10.1515/hsz-2012-0328; Petersen MC, 2018, PHYSIOL REV, V98, P2133, DOI 10.1152/physrev.00063.2017; Rahtu-Korpela L, 2014, DIABETES, V63, P3324, DOI 10.2337/db14-0472; Rodriguez J, 2018, CELL REP, V24, P1316, DOI 10.1016/j.celrep.2018.06.108; Saito H, 2019, LAB INVEST, V99, P1217, DOI 10.1038/s41374-019-0239-4; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Sugahara M, 2020, J AM SOC NEPHROL, V31, P560, DOI 10.1681/ASN.2019060582; Taniguchi CM, 2013, NAT MED, V19, P1325, DOI 10.1038/nm.3294; Ullah K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17376-0; Voss JD, 2013, INT J OBESITY, V37, P1407, DOI 10.1038/ijo.2013.5; Woolcott OO, 2015, ENDOCR REV, V36, P149, DOI 10.1210/er.2014-1063; Yin W, 2012, J LIPID RES, V53, P51, DOI 10.1194/jlr.M019927	43	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2022	298	8							102222	10.1016/j.jbc.2022.102222	http://dx.doi.org/10.1016/j.jbc.2022.102222			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	4X0OB	35787374	Green Published, gold			2022-12-26	WOS:000860550600004
J	Achila, OO; Abrhaley, F; Kesete, Y; Tesfaldet, F; Alazar, F; Fisshaye, L; Gebremeskel, L; Mehari, R; Andemichael, D				Achila, Oliver Okoth; Abrhaley, Feven; Kesete, Yafet; Tesfaldet, Feven; Alazar, Filmon; Fisshaye, Lidya; Gebremeskel, Lidya; Mehari, Rodas; Andemichael, Danait			Dyslipidemia and associated risk factors among HIV/AIDS patients on HAART in Asmara, Eritrea	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; MYOCARDIAL-INFARCTION; HIV-INFECTION; SERUM-LIPIDS; ADULTS; ABNORMALITIES; CHOLESTEROL; POPULATION; DISEASE	Background Though the initiation of Highly Active Antiretroviral Therapy (HAART) has led to decreased HIV/AIDS related mortality, the regimen has been reported to be associated with lipid toxicities. Baseline data on such disturbances are required to induce countrywide interventional HIV/AIDS programs. The aim of this study was to determine the frequency and risks of dyslipidemia in HIV patients on HAART medication in Eritrea. Methods A cross sectional study was conducted on HIV/AIDS patients in two national referral hospitals in Asmara, Eritrea. A structured questionnaire was used to collect demographic data and blood sample was taken for analyses of lipid profile tests. Data was analyzed using chi-square test, Post Hoc and logistic regression in SPSS software. Results The study included 382 participants of whom 256(67%) were females. Their median age, CD4+ T cell count (cell/microliter) and duration of HAART (years) was 45(IQR: 38-51), 434(IQR: 294-583) & 5(IQR: 3-5) respectively. The prevalence of dyslipidemia was 331(86.6%). Increased Low Density Lipoprotein-C (LDL-C) 213(55.8%) was the predominant abnormality. Abacavir was significantly related with highest means of triglycerides (TG) (228.17 193.81) and lowest means of High Density Lipoprotein (HDL-C) (46.94 +/- 12.02). Females had substantially higher proportions of TG (aOR = 2.89, 95% CI: 1.65-5.05) and TC/HDL ratio (aOR = 2.33, 95% CI: 1.40-3.87) and low HDL-C (aOR = 2.16, 95% CI: 1.34-3.48). Increased age was related with increased pro-atherogenic lipid parameters. High LDL-C was more infrequent in non-smokers (aOR = 0.028, 95% CI: 0.12-0.69). Conclusion The study showed a high prevalence of dyslipidemia in HIV-patients receiving HAART in Eritrea. Sex, age and smoking practice were among key factors associated with dyslipidemia. The necessity to assess lipid profiles and other cardiovascular risk factors before initiation of HAART treatment and continuous monitoring during therapy is mandatory.	[Achila, Oliver Okoth] Orotta Coll Med & Hlth Sci, Asmera, Eritrea; [Abrhaley, Feven; Kesete, Yafet; Tesfaldet, Feven; Alazar, Filmon; Fisshaye, Lidya; Gebremeskel, Lidya; Mehari, Rodas; Andemichael, Danait] Asmara Coll Hlth Sci, Asmera, Eritrea; [Abrhaley, Feven] Natl Hlth Lab, Asmera, Eritrea; [Kesete, Yafet] Nakfa Hosp, Nakfa, Eritrea; [Tesfaldet, Feven] Afabet Hosp, Afabet, Eritrea; [Alazar, Filmon] Ghindae Zonal Referral Hosp, Ghindae, Eritrea; [Fisshaye, Lidya] Halibet Natl Referral Hosp, Asmera, Eritrea; [Fisshaye, Lidya] Keren Zonal Referral Hosp, Keren, Eritrea; [Mehari, Rodas] Agordot Hosp, Agordot, Eritrea		Kesete, Y (corresponding author), Asmara Coll Hlth Sci, Asmera, Eritrea.; Kesete, Y (corresponding author), Nakfa Hosp, Nakfa, Eritrea.	yafuyafa@gmail.com		Kesete, Yafet/0000-0003-4569-3544				Armstrong C, 2011, JAIDS-J ACQ IMM DEF, V57, P141, DOI 10.1097/QAI.0b013e318219a3d1; Assmann G, 1998, EUR HEART J, V19, pA2; Brown TT, 2005, ARCH INTERN MED, V165, P1179, DOI 10.1001/archinte.165.10.1179; Carr A, 1998, AIDS, V12, pF51, DOI 10.1097/00002030-199807000-00003; Carroll MD, 2005, JAMA-J AM MED ASSOC, V294, P1773, DOI 10.1001/jama.294.14.1773; Ceccato MGB, 2011, BRAZ J MED BIOL RES, V44, P1177, DOI [10.1590/S0100-879X2011007500129, 10.1590/S0100-879X2011001100015]; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Dickson S.N., 2015, BMC CARDIOVASC DISOR; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Enanoria WTA, 2004, LANCET INFECT DIS, V4, P414, DOI 10.1016/S1473-3099(04)01057-6; Estrada V, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-36; Feeney Eoin R, 2011, Open Cardiovasc Med J, V5, P49, DOI 10.2174/1874192401105010049; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Friis-Moller N, 2003, NEW ENGL J MED, V349, P1993, DOI 10.1056/NEJMoa030218; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; George JA, 2009, AIDS RES HUM RETROV, V25, P771, DOI 10.1089/aid.2008.0308; Gsponer T, 2012, AIDS, V26, P57, DOI 10.1097/QAD.0b013e32834e1b5f; Hadigan C, 2001, CLIN INFECT DIS, V32, P130, DOI 10.1086/317541; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; Heath KV, 2002, INT J EPIDEMIOL, V31, P1016, DOI 10.1093/ije/31.5.1016; Luetkemeyer Anne F, 2011, Top Antivir Med, V19, P58; Mamary EM, 2002, AIDS PATIENT CARE ST, V16, P39, DOI 10.1089/108729102753429389; Mary-Krause M, 2003, AIDS, V17, P2479, DOI 10.1097/00002030-200311210-00010; Menezes CN, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-244; Nyblade L, 2003, DISENTANGLING HIV AI; Padmapriyadarsini C, 2011, CLIN INFECT DIS, V52, P540, DOI 10.1093/cid/ciq195; Passalaris JD, 2000, CLIN INFECT DIS, V31, P787; Riddler SA, 2003, JAMA-J AM MED ASSOC, V289, P2978, DOI 10.1001/jama.289.22.2978; Samaras K, 2008, J ANTIMICROB CHEMOTH, V61, P238, DOI 10.1093/jac/dkm475; Smith KY, 2009, AIDS, V23, P1547, DOI 10.1097/QAD.0b013e32832cbcc2; Tadewos A, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-31; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190; Valentino L, 2022, RSF-RUS SAGE J SOC S, V8, P89, DOI [10.18311/ti/2021/v28i1/24809, 10.1097/QAD.0000000000003368, 10.1016/j.vaccine.2022.07.056, 10.7758/RSF.2022.8.7.05]; van Griensven J, 2010, T ROY SOC TROP MED H, V104, P148, DOI 10.1016/j.trstmh.2009.07.009; WHO, 2020, KEY FACTS HIV 2020; World Health Organization, 2006, ANT THER HIV INF AD; Yinzhong S., MEDICINE, V94	37	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2022	17	7							e0270838	10.1371/journal.pone.0270838	http://dx.doi.org/10.1371/journal.pone.0270838			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6E4KA	35776747	gold, Green Published			2022-12-26	WOS:000883348200001
J	Cagetti, MG; Bonta, G; Lara, JS; Campus, G				Cagetti, Maria Grazia; Bonta, Giuliana; Lara, Juan Sebastian; Campus, Guglielmo			Caries risk assessment using different Cariogram models. A comparative study about concordance in different populations-Adults and children	PLOS ONE			English	Article							ORAL-HEALTH; SCHOOLCHILDREN; VALIDITY; PROGRAM	This methodological survey aimed to verify whether there is concordance among several Cariogram different risk models at different thresholds, comparing both children and adult populations and how each risk/protective factor weight on the overall caries risk profile. Three groups' data (two in children and one in adults) were obtained from previous studies, while a fourth, in young adults, was ad hoc enrolled. Different caries risk levels were assessed: a) three risk categories with two different thresholds as: "low risk" = 61-100% or 81-100% chance to avoid caries, "moderate risk" = 41-60% or 21-80% and "high risk" = 0-40% or 0-20%, named model 1 and 2; b) four risk categories with two different thresholds as: "low risk" = 61-100% or 76-100%, "moderate/low risk" = 41-60% or 51-75%; "moderate/high risk" = 21-40% or 26-50% and "high risk" = 0-20% or 0-25%, model 3 and 4; c) five risk categories as: "very low risk" = 81-100%; "low risk" = 61-80% "moderate risk" = 41-60%; "high risk" = 21-40% and "very high risk" = 0-20%, model 5. Concordance of the different Cariogram risk categories among the four groups was calculated using Cohen's kappa. The weight of the association between all Cariogram models toward the Cariogram risk variables was evaluated by ordinal logistic regression models. Considering Cariogram model 1 and 2, Cohen's Kappa values ranged from 0.40 (SE = 0.07) for the young adult group to 0.71 (SE = 0.05) for the adult one. Cohen's Kappa values ranged from 0.14 (SE = 0.03 p<0.01) for the adult group to 0.62 (SE = 0.02) for the two groups of children in models 3 and 4. Statistically significant associations were found for all Cariogram risk variables excepting Fluoride program in models 4 and 5 and the overall risk on children's samples. Caries experience showed a quite variable weight in the different models in both adult groups. In the regression analyses, adult groups' convergence was not always achievable since variations in associations between caries risk and different risk variables were narrower compared to other samples. Significant differences in caries risk stratification using different thresholds stands out from data analysis; consequently, risk assessments need to be carefully considered due to the risk of misleadingly choosing preventive and research actions.	[Cagetti, Maria Grazia; Bonta, Giuliana] Univ Milan, Dept Biomed Surg & Dent Sci, Milan, Italy; [Lara, Juan Sebastian] Indiana Univ, Dept Cariol Operat Dent & Dent Publ Hlth, Sch Dent, Indianapolis, IN USA; [Campus, Guglielmo] Univ Bern, Dept Restorat Prevent & Pediat Dent, Bern, Switzerland; [Campus, Guglielmo] Univ Sassari, Sch Dent, Dept Surg Micro Surg & Med Sci, Sassari, Italy; [Campus, Guglielmo] Sechenov Univ, Dept Pediat Prevent Dent & Orthodont, Sch Dent, Moscow, Russia	University of Milan; Indiana University System; Indiana University-Purdue University Indianapolis; University of Bern; University of Sassari; Sechenov First Moscow State Medical University	Campus, G (corresponding author), Univ Bern, Dept Restorat Prevent & Pediat Dent, Bern, Switzerland.; Campus, G (corresponding author), Univ Sassari, Sch Dent, Dept Surg Micro Surg & Med Sci, Sassari, Italy.; Campus, G (corresponding author), Sechenov Univ, Dept Pediat Prevent Dent & Orthodont, Sch Dent, Moscow, Russia.	guglielmo.campus@zmk.unibe.ch						Bratthall D, 2005, COMMUNITY DENT ORAL, V33, P256, DOI 10.1111/j.1600-0528.2005.00233.x; Bratthall D., 2004, MALMO; Cagetti MG, 2018, BMC ORAL HEALTH, V18, DOI 10.1186/s12903-018-0585-4; Campus G, 2007, CARIES RES, V41, P512, DOI 10.1159/000110884; Campus G, 2012, CARIES RES, V46, P16, DOI 10.1159/000334932; Campus G, 2009, ACTA ODONTOL SCAND, V67, P146, DOI 10.1080/00016350902740498; Carta G, 2015, BRAZ ORAL RES, V29, DOI 10.1590/1807-3107BOR-2015.vol29.0126; Castiglia Paolo, 2007, Oral Health Prev Dent, V5, P255; Chang J, 2014, SPEC CARE DENT, V34, P201, DOI 10.1111/scd.12047; Fadel H, 2011, ACTA ODONTOL SCAND, V69, P118, DOI 10.3109/00016357.2010.538718; Giacaman RA, 2013, BRAZ ORAL RES, V27, P7, DOI 10.1590/S1806-83242013000100002; Halasa-Rappel YA, 2019, J AM DENT ASSOC, V150, P91, DOI 10.1016/j.adaj.2018.11.011; Jamieson LM, 2004, COMMUNITY DENT ORAL, V32, P49, DOI 10.1111/j.1600-0528.2004.00126.x; Kriegler K, 2021, CLIN CASE REP, V9, DOI 10.1002/ccr3.4751; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Martignon S, 2021, BRAZ ORAL RES, V35, DOI 10.1590/1807-3107bor-2021.vol35.0053; Petersson GH, 2003, ACTA ODONTOL SCAND, V61, P164, DOI 10.1080/00016350310002261; Petersson GH, 2002, CARIES RES, V36, P327, DOI 10.1159/000065963; Pitts N B, 2004, J Dent Res, V83 Spec No C, pC43; Riley JL, 2011, COMMUNITY DENT ORAL, V39, P564, DOI 10.1111/j.1600-0528.2011.00626.x; Ruiz Miravet Ana, 2007, Med Oral Patol Oral Cir Bucal, V12, pE412; Schwendicke F, 2020, CLIN ORAL INVEST, V24, P3315, DOI 10.1007/s00784-020-03431-0; Splieth CH, 2020, CARIES RES, V54, P297, DOI 10.1159/000507692; Su NC, 2021, J DENT, V110, DOI 10.1016/j.jdent.2021.103664; Sundell AL, 2015, BMC ORAL HEALTH, V15, DOI 10.1186/s12903-015-0067-x; Tellez M, 2013, COMMUNITY DENT ORAL, V41, P67, DOI 10.1111/cdoe.12003; Trottini M, 2020, CARIES RES, V54, P258, DOI 10.1159/000507276; Twetman S, 2005, DIABETIC MED, V22, P312, DOI 10.1111/j.1464-5491.2005.01419.x; Zukanovic Amila, 2013, Acta Med Acad, V42, P198, DOI 10.5644/ama2006-124.87	29	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	6							e0264945	10.1371/journal.pone.0264945	http://dx.doi.org/10.1371/journal.pone.0264945			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3F0KH	35749436	Green Published, gold			2022-12-26	WOS:000830362700066
J	Huang, YJ; Wang, PM; Tang, KS; Chen, CJ; Huang, YH; Tiao, MM				Huang, Yu-Jyun; Wang, Pei-Ming; Tang, Kuo-Shu; Chen, Chih-Jen; Huang, Ying-Hsien; Tiao, Mao-Meng			Butyrate ameliorates maternal high-fat diet-induced fetal liver cellular apoptosis	PLOS ONE			English	Article							INSULIN-RESISTANCE; GUT MICROBIOTA; PROPIONIC-ACID; MALONDIALDEHYDE MDA; OXIDATIVE STRESS; IMPACT; ACTIVATION; NUTRITION; HEALTH; DAMAGE	A maternal high-fat diet (HFD) can impact the offspring's development of liver steatosis, with fetal development in utero being a crucial period. Therefore, this study investigated the mechanism and whether butyrate can rescue liver injury caused by maternal HFD in the fetus. Pregnant female Sprague Dawley rats were randomly divided into two groups, prenatal HFD (58% fat) exposure or normal control diet (4.5% fat). The HFD group was fed an HFD 7 weeks before mating and during gestation until sacrifice at gestation 21 days. After confirmation of mating, the other HFD group was supplemented with sodium butyrate (HFSB). The results showed that maternal liver histology showed lipid accumulation with steatosis and shortened ileum villi in HFD, which was ameliorated in the HFSB group (P<0.05). There was increased fetal liver and ileum TUNEL staining and IL-6 expression with increased fetal liver TNF-alpha and malondialdehyde expression in the HFD group (P<0.05), which decreased in the HFSB group (P<0.05). The fetal liver expression of phospho-AKT/AKT and GPX1 decreased in the HFD group but increased in the HFSB group (P<0.05). In conclusion that oxidative stress with inflammation and apoptosis plays a vital role after maternal HFD in the fetus liver that can be ameliorated with butyrate supplementation.	[Huang, Yu-Jyun; Tang, Kuo-Shu; Chen, Chih-Jen; Huang, Ying-Hsien; Tiao, Mao-Meng] Chang Gung Univ Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Pediat, Kaohsiung, Taiwan; [Wang, Pei-Ming] Chang Gung Univ Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Family Med, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Tiao, MM (corresponding author), Chang Gung Univ Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Pediat, Kaohsiung, Taiwan.	tmm@cgmh.org.tw		Tiao, Mao-Meng/0000-0002-0338-3495	Chang Gung Memorial Hospital, Taiwan [CMRPG8J0881, CMRPG8J0882]	Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital)	The authors thank Editage for English editing and Mr. Yao-Ming Chou for the support of the experimental process consultation. We appreciated the Biostatistics Center, Kaohsiung Chang Gung Memorial Hospital for statistics work.	Al-Daihan S, 2015, INT J MOL CELL MED, V4, P188; Arabshahi HA, 2021, POULTRY SCI, V100, DOI 10.1016/j.psj.2021.101066; Atiba AS, 2016, ETHIOP J HEALTH SCI, V26, P479, DOI 10.4314/ejhs.v26i5.10; BRASS EP, 1986, BIOCHEM J, V236, P131, DOI 10.1042/bj2360131; Brumbaugh DE, 2014, PEDIATR RES, V75, P140, DOI 10.1038/pr.2013.193; Catalano PM, 2009, DIABETES CARE, V32, P1076, DOI 10.2337/dc08-2077; Chriett S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36941-9; Dawood MAO, 2021, ECOTOX ENVIRON SAFE, V220, DOI 10.1016/j.ecoenv.2021.112412; Dornas W, 2019, PHARMACOL RES, V141, P418, DOI 10.1016/j.phrs.2019.01.026; GLASGOW AM, 1976, PEDIATR RES, V10, P683, DOI 10.1203/00006450-197610070-00010; Gohir W, 2015, PEDIATR RES, V77, P196, DOI 10.1038/pr.2014.169; Grant WF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017261; Harada N, 2004, J SURG RES, V121, P159, DOI 10.1016/j.jss.2004.04.016; Haugen AC, 2015, J DEV ORIG HLTH DIS, V6, P55, DOI 10.1017/S2040174414000580; Heerwagen MJR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067791; Huang YH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030369; Huang YM, 2021, HELICOBACTER, V26, DOI 10.1111/hel.12785; Jiang M, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00665; Kislal S, 2020, PRENATAL DIAG, V40, P1109, DOI 10.1002/pd.5784; Klurfeld David M., 1999, Frontiers in Bioscience, V4, pD299, DOI 10.2741/klurfeld; Kozyrskyj AL, 2016, J DEV ORIG HLTH DIS, V7, P25, DOI 10.1017/S2040174415001269; Kuo WT, 2021, GASTROENTEROLOGY, V161, P1924, DOI 10.1053/j.gastro.2021.08.047; Lee SY, 2015, HEPATOLOGY, V62, P135, DOI 10.1002/hep.27804; Lee S, 2020, NUTRIENTS, V12, DOI 10.3390/nu12113524; Lee S, 2018, J NUTR, V148, P209, DOI 10.1093/jn/nxx027; Li L, 2019, J CELL BIOCHEM, V120, P2370, DOI 10.1002/jcb.27565; Li S, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/4234061; Li YJ, 2020, EXP THER MED, V19, P3521, DOI 10.3892/etm.2020.8625; Liu H, 2018, ADV NUTR, V9, P21, DOI 10.1093/advances/nmx009; Mateos R, 2005, J CHROMATOGR B, V827, P76, DOI 10.1016/j.jchromb.2005.06.035; McCurdy CE, 2009, J CLIN INVEST, V119, P323, DOI 10.1172/JCI32661; Parente LB, 2008, CLIN NUTR, V27, P623, DOI 10.1016/j.clnu.2008.05.005; Pirozzi C, 2020, FASEB J, V34, P676, DOI 10.1096/fj.201900927RR; Raso GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068626; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Samy Waleed, 2011, Arab J Gastroenterol, V12, P80, DOI 10.1016/j.ajg.2011.04.008; Sangild PT, 2006, EXP BIOL MED, V231, P1695, DOI 10.1177/153537020623101106; Sun B, 2018, J AGR FOOD CHEM, V66, P7633, DOI 10.1021/acs.jafc.8b01189; Suzuki T, 2011, J BIOL CHEM, V286, P31263, DOI 10.1074/jbc.M111.238147; Tang WX, 2012, ARTIF ORGANS, V36, pE39, DOI 10.1111/j.1525-1594.2011.01417.x; Tiao MM, 2018, LIPIDS HEALTH DIS, V17, DOI 10.1186/s12944-018-0824-3; Tsai TA, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082780; Varghese F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096801; Wieckowska A, 2008, AM J GASTROENTEROL, V103, P1372, DOI 10.1111/j.1572-0241.2007.01774.x; Xie Y, 2020, MOL MED REP, V21, P1133, DOI 10.3892/mmr.2020.10932; Zheng J, 2016, MICROBIOLOGYOPEN, V5, P296, DOI 10.1002/mbo3.328; Zhou D, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0183-1; Zhou D, 2017, WORLD J GASTROENTERO, V23, P60, DOI 10.3748/wjg.v23.i1.60; Zhou LS, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00876	49	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7								10.1371/journal.pone.0270657	http://dx.doi.org/10.1371/journal.pone.0270657			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M3CI	35793323	gold, Green Published			2022-12-26	WOS:000835338100015
J	Lin, HF; Zrelli, H; Mohamed, NHA; Li, YH; Alam, MM; Guo, W; Khan, YA				Lin, Haofeng; Zrelli, Houyem; Mohamed, Noha Hassan abd Algalil; Li, Yonghui; Alam, Mohammad Mahtab; Guo, Wei; Khan, Yousaf Ali			The impact of agricultural water salvation investment on economics development: Evidence from Eastern China	PLOS ONE			English	Article							GROWTH	Agricultural water salvation is the lifeblood of the national economy and is of great significance to the high-quality development of the region. In order to maximize the economic assistances of agricultural water salvation investment, this article focuses on panel data from 2005 to 2019 in 14 provinces in Eastern China, this research constructs an economic development evaluation index system from five dimensions: innovative development, coordinated development, green development, open development and shared development, and uses dynamic panel model to explore the influence relationship and path of Eastern Agricultural water salvation investment on economic development. The results represent that: there is a significant non-linear effect between agricultural water salvation investment and economic growth, showing an inverted U-shaped relationship. Which means that with the expansion of agricultural water salvation investment; economic growth has risen first and then declined. At present, the impact of agricultural water salvation investment in the Eastern region on economic development is in the promotion stage of positive and sustained growth. The recommendation of this research will help the state control in the amount of agricultural water salvation investment in the Eastern region, improve the efficiency of agricultural water salvation investment, and provide support in decision making.	[Lin, Haofeng] Lishui Univ, Sch Business, Lishui, Zhejiang, Peoples R China; [Lin, Haofeng] Lishui Univ, Liangshan Inst, Lishui, Zhejiang, Peoples R China; [Zrelli, Houyem] Majmaah Univ, Coll Sci & Humanities Alghat, Dept Business Adm, Al Majmaah, Saudi Arabia; [Mohamed, Noha Hassan abd Algalil] Majmaah Univ, Coll Sci & Humanities Remah, Dept Business Adm, Al Majmaah, Saudi Arabia; [Li, Yonghui] Zhejiang Agr & Forestry Univ, Jiyang Coll, Zhuji, Zhejiang, Peoples R China; [Alam, Mohammad Mahtab] King Khalid Univ, Coll Appl Med Sci, Dept Basic Med Sci, Abha, Saudi Arabia; [Guo, Wei] Guangdong Univ Finance, Sch Credit Management, Guangzhou, Peoples R China; [Khan, Yousaf Ali] Hazara Univ, Dept Math & Stat, Mansehra, Khyber Pakhtunk, Pakistan	Lishui University; Lishui University; Majmaah University; Majmaah University; Zhejiang A&F University; King Khalid University; Guangdong University of Finance; Hazara University	Li, YH (corresponding author), Zhejiang Agr & Forestry Univ, Jiyang Coll, Zhuji, Zhejiang, Peoples R China.; Khan, YA (corresponding author), Hazara Univ, Dept Math & Stat, Mansehra, Khyber Pakhtunk, Pakistan.	sara6859@126.com; yousaf_hu@yahoo.com	li, yong/HDN-3885-2022; ALAM, MOHAMMAD MAHTAB/AAQ-4375-2020; Khan, Yousaf Ali/GYA-4160-2022		General Research Project Khalid University [R.G.P.2/160/43]	General Research Project Khalid University	This research was funded by General Research Project Khalid University, grant number R.G.P.2/160/43. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An ZS, 2014, DEV PALEOENVIRON RES, V16, P491, DOI 10.1007/978-94-007-7817-7_6; Aryal G, 2018, J ENTREP PUBLIC POLI, V7, P357, DOI 10.1108/JEPP-D-18-00026; Blackwell Brian G., 2000, Reviews in Fisheries Science, V8, P1, DOI 10.1080/10641260091129161; Blagojevic A, 2020, SYMMETRY-BASEL, V12, DOI 10.3390/sym12091479; Cai F, 2002, CHINA ECON REV, V13, P197, DOI 10.1016/S1043-951X(02)00072-X; Chen PY, 2019, EXPERT SYST APPL, V136, P33, DOI 10.1016/j.eswa.2019.06.035; Chen YY, 2005, CORROS SCI, V47, P2257, DOI 10.1016/j.corsci.2004.11.008; Elyachar J, 2002, PUBLIC CULTURE, V14, P493, DOI 10.1215/08992363-14-3-493; Fazakas L., 2020, PRO, V4, P31; Huang J., 2004, CHINAS GREAT EC TRAN; HUANG JK, 1995, AM J AGR ECON, V77, P853, DOI 10.2307/1243808; iovic M., 2020, DECIS MAKING, V3, P149, DOI DOI 10.31181/DMAME2003149Z; Jiang J, 2005, MAT SCI ENG B-SOLID, V117, P334, DOI 10.1016/j.mseb.2005.01.002; Jin SQ, 2010, J PROD ANAL, V33, P191, DOI 10.1007/s11123-009-0145-7; Ke WJ, 2015, J MATER CHEM A, V3, P17971, DOI 10.1039/c5ta04313a; KOHLER NE, 1995, FISH B-NOAA, V93, P412; Koutinas M., 2005, J CHEM-NY; Lin YH, 2005, J PHYS CHEM B, V109, P14410, DOI 10.1021/jp0514675; Lohmar Bryan T., 2003, INVESTMENT CONFLICTS; Molle F, 2020, WIRES WATER, V7, DOI 10.1002/wat2.1395; Mukhametzyanov I., 2018, DECIS MAK APPL MANAG, V1, P51, DOI [10.31181/dmame1802050m, DOI 10.31181/DMAME1802050M]; Mukhametzyanov I., 2021, DECIS MAKING, V4, P76; Mukhametzyanov I. Z., 2018, IZ NORM METHOD NORMA; Mukhametzyanov I. Z., 2019, P 25 INT C MULT CRIT, P96; Mukhametzyanov I.Z., 2021, INT J INFORM TECHNOL; Mukhametzyanov IZ, 2020, INT J INF TECH DECIS, V19, P1389, DOI 10.1142/S0219622020500327; Nagachevska T.V., 2014, FINANCING MECH INVES, V159; National Bureau of Statistics of China, 2004, CHIN STAT YB 2004; Naughton B, 1995, CHINA QUART, P1083; [NBS] National Bureau of Statistics of China, 2005, CHINA ENERGY STAT YB; Nkamleu GB, 2020, AFR J AGRIC RESOUR E, V15, P302; Salarpouri A, 2018, IRAN J FISH SCI, V17, P313, DOI 10.22092/IJFS.2018.115488; Sparre P., 1998, FAO FISH TECH PAP; Wang YB, 2005, FISHERIES SCI, V71, P1036, DOI 10.1111/j.1444-2906.2005.01061.x; Wang YG, 2002, IND ENG CHEM RES, V41, P2910, DOI 10.1021/ie000739h; World Bank, 1997, WORLD DEV REP STAT C; Xu Y., 2015, J FOOD SCI TECH MYS, V52, P2878; Zhang Q.H., 2007, FISHERY RESOURCES TH; Zhao Q., 2020, AGR SYST, V94, P189	39	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7								10.1371/journal.pone.0267627	http://dx.doi.org/10.1371/journal.pone.0267627			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M3CI	35793363	gold, Green Published			2022-12-26	WOS:000835338100020
J	Mogessie, HM; Gebeyehu, MA; Kenbaw, MG; Tadesse, TA				Mogessie, Hailye Mamo; Gebeyehu, Mulugeta Adugnew; Kenbaw, Mitaw Girma; Tadesse, Tesfaye Assefa			Diabetic health literacy and associated factors among diabetes mellitus patients on follow up at public hospitals, Bale Zone, South East Ethiopia, 2021	PLOS ONE			English	Article								ObjectiveThis study was aimed to assess diabetic health literacy and associated factors among adult diabetic patients in public hospitals, Bale Zone, Southeast Ethiopia. MethodsA hospital-based cross-sectional study was conducted among 402 diabetic patients in three public hospitals and the samples were selected using simple random sampling technique. The comprehensive functional, communicative, and critical health literacy questionnaire was used to measure diabetic health literacy. Descriptive statistics and Ordinary logistic regression analyses were conducted, and a P-value of < 0.05 was considered to declare a result as statistically significant. ResultA total of 402 diabetic patients were involved in the study. Of all respondents, 41.8%, 27.9%, and 30.3% had low, moderate, and high diabetic health literacy respectively. Educational status; can't read and write (AOR = 0.085;95% CI: 0.03,0.26), can read and write (AOR = 0.10; 95% CI: 0.04,0.30), primary school (AOR = 0.25; 95% CI: 0.09,0.67), secondary school (AOR = 0.37; 95% CI: 0.14,0.99), duration of onset <= 5 years (AOR = 2.05; 95% CI:1.09,4.19), being not member of DM association (AOR = 0.43; 95% CI: 0.26,0.73), having <= 3 diabetes mellitus information sources (AOR = 0.15; 95% CI: 0.03,0.77), social support; poor (AOR = 0.40;95% CI: 0.21,0.79), and moderate (AOR = 0.50; 95% CI: 0.28,0.92) were significantly associated with diabetic health literacy. ConclusionA substantial number of diabetic patients had low diabetic health literacy. Educational status, Sources of diabetic information, Member of DM association, and social support were significantly and positively associated with diabetic health literacy. But, duration of diabetes onset was negatively associated with diabetic health literacy of respondents. So, we recommend providing readable and picturized printed materials, and diabetic patient education to be considered.	[Mogessie, Hailye Mamo; Gebeyehu, Mulugeta Adugnew; Tadesse, Tesfaye Assefa] Madda Walabu Univ, Goba Referral Hosp, Sch Hlth Sci, Dept Nursing, Goba, Ethiopia; [Kenbaw, Mitaw Girma] Wollo Univ, Sch Hlth Sci, Dept Nursing, Dessie, Ethiopia		Mogessie, HM (corresponding author), Madda Walabu Univ, Goba Referral Hosp, Sch Hlth Sci, Dept Nursing, Goba, Ethiopia.	hibuzie2123@gmail.com		Mamo, Hailye/0000-0001-6713-743X				Abdullah A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216402; Alidosti M., 2019, J HEALTH LITERACY, V3, P36; Bishu KGJ.C., 2019, OBESITY MED, V15, P100, DOI [10.1016/j.obmed.2019.100132, DOI 10.1016/J.OBMED.2019.100132]; Hussein SH, 2018, DIABETES RES CLIN PR, V141, P118, DOI 10.1016/j.diabres.2018.04.033; International Diabetes Federation,, 2019, IDF DIABETES ATLAS; Kocalevent Ruya-Daniela, 2018, BMC Psychol, V6, P31, DOI 10.1186/s40359-018-0249-9; Lee EH, 2018, INT J NURS STUD, V88, P1, DOI 10.1016/j.ijnurstu.2018.08.002; Liu HY, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15081711; Mamo Y, 2019, BMC ENDOCR DISORD, V19, DOI 10.1186/s12902-019-0421-0; Mehzabin Refat., 2019, J MED, V20, P19; Mengiste M, 2021, DIABET METAB SYND OB, V14, P2155, DOI 10.2147/DMSO.S289905; Mohammadi Zahra, 2015, Med J Islam Repub Iran, V29, P230; Mukanoheli V., 2020, RWANDA J MED HLTH SC, V3, P49; Noroozi M., 2019, J HEALTH LITERACY, V4, P43; Radwan M, 2018, THER ADV ENDOCRINOL, V9, P3, DOI 10.1177/2042018817742070; Salimi M., 2017, INT J HEALTH STUD, V3, P14; Singh SG, 2017, Int J Nurs Sci, V4, P266, DOI 10.1016/j.ijnss.2017.06.004; Tefera YG, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231291; WHO, 2016, GLOB REP PSOR; Xu Xin Yi, 2018, Health Lit Res Pract, V2, pe67, DOI 10.3928/24748307-20180313-01	20	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7							e0270161	10.1371/journal.pone.0270161	http://dx.doi.org/10.1371/journal.pone.0270161			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M2ZD	35797276	Green Published, gold			2022-12-26	WOS:000835328600017
J	Scheffler, RJ; Bratton, BP; Gitai, Z				Scheffler, Robert J.; Bratton, Benjamin P.; Gitai, Zemer			Pseudomonas aeruginosa clinical blood isolates display significant phenotypic variability	PLOS ONE			English	Article							BIOFILM RESISTANCE; VIRULENCE FACTORS; IV PILI; PATHOGENESIS; PERFORMANCE; ADAPTATION; MECHANISMS; IMAGE	Pseudomonas aeruginosa is a significant threat in healthcare settings where it deploys a wide host of virulence factors to cause disease. Many virulence-related phenotypes such as pyocyanin production, biofilm formation, and twitching motility have been implicated in causing disease in a number of hosts. In this study, we investigate these three virulence factors in a collection of 22 clinical strains isolated from blood stream infections. Despite the fact that all 22 strains caused disease and came from the same body site of different patients, they show significant variability in assays for each of the three specific phenotypes examined. There was no significant correlation between the strength of the three phenotypes across our collection, suggesting that they can be independently modulated. Furthermore, strains deficient in each of the virulence-associated phenotypes examined could be identified. To understand the genetic basis of this variability we sequenced the genomes of the 22 strains. We found that the majority of genes responsible for pyocyanin production, biofilm formation, and twitching motility were highly conserved among the strains despite their phenotypic variability, suggesting that the phenotypic variability is likely due to regulatory changes. Our findings thus demonstrate that no one lab-assayed phenotype of pyocyanin production, biofilm production, and twitching motility is necessary for a P. aeruginosa strain to cause blood stream infection and that additional factors may be needed to fully predict what strains will lead to specific human diseases.	[Scheffler, Robert J.; Bratton, Benjamin P.; Gitai, Zemer] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Scheffler, Robert J.] Carnegie Inst Sci, Dept Embryol, Baltimore, MD USA; [Bratton, Benjamin P.] Vanderbilt Univ, Dept Pathol Immunol & Microbiol, Med Ctr, Nashville, TN USA; [Bratton, Benjamin P.] Vanderbilt Inst Infect Immunol & Inflammat, Nashville, TN USA	Princeton University; Carnegie Institution for Science; Vanderbilt University	Gitai, Z (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	zgitai@princeton.edu		Vrla, Geoffrey/0000-0002-4474-7259	NIH [DP1AI124669, T32 GM007388]; National Science Foundation [NSF PHY-1734030]; VUMC DSP	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); VUMC DSP	Funding was provided in part by NIH (DP1AI124669: Z.G., B.P.B., and R.J.S., T32 GM007388: R.J.S.). Additional funding provided by the National Science Foundation (NSF PHY-1734030: B.P.B.), and VUMC DSP (B.P.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JP, 2021, TRENDS MICROBIOL, V29, P621, DOI 10.1016/j.tim.2020.12.002; Allen JP, 2020, P NATL ACAD SCI USA, V117, P6811, DOI 10.1073/pnas.1919198117; Allen RC, 2014, NAT REV MICROBIOL, V12, P300, DOI 10.1038/nrmicro3232; Ballok AE, 2013, J BACTERIOL, V195, P4013, DOI 10.1128/JB.00339-13; Beasley KL, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240351; Bjarnsholt T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010115; Bucior I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002616; Burrows LL, 2012, ANNU REV MICROBIOL, V66, P493, DOI 10.1146/annurev-micro-092611-150055; Chadha J, 2022, MICROB BIOTECHNOL, V15, P1695, DOI 10.1111/1751-7915.13981; Chang CY, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02671; Clark ST, 2015, SCI REP-UK, V5, DOI 10.1038/srep10932; Cornforth DM, 2020, MBIO, V11, DOI 10.1128/mBio.03042-19; Criscuolo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-210; Cullen L, 2015, PATHOGENS, V4, P66, DOI 10.3390/pathogens4010066; Darch SE, 2018, P NATL ACAD SCI USA, V115, P4779, DOI 10.1073/pnas.1719317115; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; Di Domenico EG, 2021, MICROBIOL SPECTR, V9, DOI 10.1128/Spectrum.00550-21; Feinbaum RL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002813; Gellatly SL, 2013, PATHOG DIS, V67, P159, DOI 10.1111/2049-632X.12033; Gonzalez MR, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00039; Grosso-Becerra MV, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-318; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gupte A, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0253259; Hall S, 2016, TOXINS, V8, DOI 10.3390/toxins8080236; Hickey C, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00357; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kruczek C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149229; Lau GW, 2004, INFECT IMMUN, V72, P4275, DOI 10.1128/IAI.72.7.4275-4278.2004; Lee DG, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r90; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; Mahajan-Miklos S, 1999, CELL, V96, P47, DOI 10.1016/S0092-8674(00)80958-7; McCarthy KL, 2018, MICROB PATHOGENESIS, V119, P81, DOI 10.1016/j.micpath.2018.03.062; Merritt Judith H, 2005, Curr Protoc Microbiol, VChapter 1, DOI 10.1002/9780471729259.mc01b01s00; Mulcahy LR, 2014, MICROB ECOL, V68, P1, DOI 10.1007/s00248-013-0297-x; Newman JN., 2022, INVASION DIVERSITY P; O'Loughlin CT, 2013, P NATL ACAD SCI USA, V110, P17981, DOI 10.1073/pnas.1316981110; O'Toole GA, 2011, JOVE-J VIS EXP, DOI 10.3791/2437; Persat A, 2015, P NATL ACAD SCI USA, V112, P7563, DOI 10.1073/pnas.1502025112; Pincus NB, 2020, MBIO, V11, DOI 10.1128/mBio.01527-20; Rasko DA, 2010, NAT REV DRUG DISCOV, V9, P117, DOI 10.1038/nrd3013; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Sanfilippo JE, 2019, NAT MICROBIOL, V4, P1274, DOI 10.1038/s41564-019-0455-0; Schaber JA, 2004, J MED MICROBIOL, V53, P841, DOI 10.1099/jmm.0.45617-0; Schick A, 2018, P NATL ACAD SCI USA, V115, P10714, DOI 10.1073/pnas.1721270115; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Siryaporn A, 2014, P NATL ACAD SCI USA, V111, P16860, DOI 10.1073/pnas.1415712111; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Turner KH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004518; van 't Wout EFA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004946; Vrla GD, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008867; Wang K, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170029; Warrier A, 2021, FUTURE MICROBIOL, V16, P1003, DOI 10.2217/fmb-2020-0301; Wick RR, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005595; Williams P, 2009, CURR OPIN MICROBIOL, V12, P182, DOI 10.1016/j.mib.2009.01.005; Winsor GL, 2009, NUCLEIC ACIDS RES, V37, pD483, DOI 10.1093/nar/gkn861	58	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7								10.1371/journal.pone.0270576	http://dx.doi.org/10.1371/journal.pone.0270576			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M3CI	35793311	Green Published, gold			2022-12-26	WOS:000835338100010
J	Dedukh, D; Riumin, S; Kolenda, K; Chmielewska, M; Rozenblut-Koscisty, B; Kazmierczak, MV; Ogielska, MV; Krasikova, AV				Dedukh, Dmitrij; Riumin, Sergey; Kolenda, Krzysztof; Chmielewska, Magdalena; Rozenblut-Koscisty, Beata; Kazmierczak, Mikolaj V.; Ogielska, Maria V.; Krasikova, Alla V.			Maintenance of pure hybridogenetic water frog populations: Genotypic variability in progeny of diploid and triploid parents	PLOS ONE			English	Article							PELOPHYLAX-ESCULENTUS COMPLEX; ALL-HYBRID POPULATIONS; RANA-ESCULENTA; GENOME ELIMINATION; GENETIC DIVERSITY; AMPHIBIA; DNA; REPRODUCTION; EVOLUTION; PATTERNS	An intriguing outcome of hybridisation is the emergence of clonally and hemiclonally reproducing hybrids, that can sustain, reproduce, and lead to the emergence of polyploid forms. However, the maintenance of diploid and polyploid hybrid complexes in natural populations remains unresolved. We selected water frogs from the Pelophylax esculentus complex to study how diploid and triploid hybrids, which reproduce hemiclonally via hybridogenesis, are maintained in natural populations. During gametogenesis in diploid hybrids, one of the parental genomes is eliminated, and the remaining genome is endoreplicated. In triploid hybrids, the single-copy genome is typically eliminated, while genome endoreplication does not occur. To investigate how diploid and triploid hybrid frogs reproduce in populations without parental species, we crossed these hybrid animals from two separate pure hybrid populations located in Poland. Using cytogenetic analysis of tadpoles that emerged from the crosses, we established which gametes were produced by parental hybrids. The majority of hybrid females and hybrid males produced one type of gamete with the P. ridibundus genome. However, in both studied populations, approximately half of the diploid and triploid hybrids simultaneously produced gametes with different genome compositions and ploidy levels, specifically, the P. ridibundus and P. lessonae genomes, as well as diploid gametes with genomes of both parental species. Triploid hybrid males and females mostly produced haploid gametes with the P. lessonae genome; however, gametes with the P. ridibundus genome have also been observed. These results suggest that not all hybrids follow the classical hybridogenetic reproduction program and reveal a significant level of alterations in the gametogenesis pathways. In addition, we found a variable survival rate of particular progeny genotypes when we crossed hybrid females with different males suggesting the important role of postzygotic barriers on the maintenance of pure hybrid systems. We suggest that the observed variability in produced gametes and the different survival rate of the progeny with certain genotypes is crucial for the existence of pure hybrid systems.	[Dedukh, Dmitrij; Riumin, Sergey; Krasikova, Alla V.] St Petersburg State Univ, Dept Cytol & Histol, St Petersburg, Russia; [Riumin, Sergey] Pavlov First St Petersburg State Med Univ, Raisa Gorbacheva ?em Res Inst Pediat Oncol Hematol, St Petersburg, Russia; [Kolenda, Krzysztof; Chmielewska, Magdalena; Rozenblut-Koscisty, Beata; Kazmierczak, Mikolaj V.; Ogielska, Maria V.] Univ Wroclaw, Fac Biol Sci, Dept Evolutionary Biol & Conservat Vertebrates, Amphibian Biol Grp, Wroclaw, Poland	Saint Petersburg State University; Pavlov First Saint Petersburg State Medical University; University of Wroclaw	Krasikova, AV (corresponding author), St Petersburg State Univ, Dept Cytol & Histol, St Petersburg, Russia.	a.krasikova@spbu.ru	Krasikova, Alla/E-4767-2011; Dedukh, Dmitrij/H-8403-2013	Krasikova, Alla/0000-0002-6571-5328; Dedukh, Dmitrij/0000-0002-1152-813X; Kolenda, Krzysztof/0000-0001-8683-9867	Russian Science Foundation [20-74-00030, NCN 2012/07/B/NZ3/02563]; D.D. Russian Science Foundation [20-74-00030]; M.O. Polish National Science Centre [NCN 2012/07/B/NZ3/02563]	Russian Science Foundation(Russian Science Foundation (RSF)); D.D. Russian Science Foundation(Russian Science Foundation (RSF)); M.O. Polish National Science Centre	D.D. Russian Science Foundation (https://rscf.ru/en/) ? 20-74-00030 M.O. Polish National Science Centre (https://www.ncn.gov.pl/ en) no.NCN 2012/07/B/NZ3/02563 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott R, 2013, J EVOLUTION BIOL, V26, P229, DOI 10.1111/j.1420-9101.2012.02599.x; Abbott RJ, 2010, TAXON, V59, P1375, DOI 10.1002/tax.595005; Alves MJ, 2001, GENETICA, V111, P375, DOI 10.1023/A:1013783029921; Alves MJ, 1998, MOL BIOL EVOL, V15, P1233, DOI 10.1093/oxfordjournals.molbev.a025852; Arioli M, 2010, MOL ECOL, V19, P1814, DOI 10.1111/j.1365-294X.2010.04603.x; ARNOLD ML, 1995, TRENDS ECOL EVOL, V10, P67, DOI 10.1016/S0169-5347(00)88979-X; Baack EJ, 2007, CURR OPIN GENET DEV, V17, P513, DOI 10.1016/j.gde.2007.09.001; BERGER L, 1973, Journal of Herpetology, V7, P1, DOI 10.2307/1562822; BERGER L, 1988, P ACAD NAT SCI PHILA, V140, P202; Berger L., 1968, Acta Zoologica Cracoviensia, V13, P301; BERGER L, 1976, Annales Zoologici (Warsaw), V33, P201; Berger L., 1988, Archiv fuer Naturschutz und Landschaftsforschung, V28, P265; Berger L., 1971, ZOOL POLONIAE, V21, P345; Berger Leszek, 1994, Amphibia-Reptilia, V15, P408, DOI 10.1163/156853894X00452; Biriuk OV, 2016, J ZOOL SYST EVOL RES, V54, P215, DOI 10.1111/jzs.12132; Borkin Leo J., 2004, Russian Journal of Herpetology, V11, P203; BUCCI S, 1990, J EXP ZOOL, V255, P37, DOI 10.1002/jez.1402550107; Chapman MA, 2007, EVOLUTION, V61, P1773, DOI 10.1111/j.1558-5646.2007.00134.x; Chmielewska M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26168-z; Christiansen DG, 2005, EVOLUTION, V59, P1348; Christiansen Ditte G., 2010, BMC Ecology, V10, P14, DOI 10.1186/1472-6785-10-14; Christiansen DG, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-135; Christiansen DG, 2009, EVOLUTION, V63, P1754, DOI 10.1111/j.1558-5646.2009.00673.x; Coyne J.A., 2004, SPECIATION; Coyne JA, 1998, PHILOS T ROY SOC B, V353, P287, DOI 10.1098/rstb.1998.0210; Dawley R. M, 1989, EVOLUTION ECOLOGY UN; Dedukh D, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64977-3; Dedukh D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224759; Dedukh D, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-1063-3; Dedukh D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123304; Dedukh D, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-26; Dolezalkova M, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0408-z; Dolezalkova-Kastankova M, 2018, BIOL SEX DIFFER, V9, DOI 10.1186/s13293-018-0172-z; GRAF JD, 1979, EXPERIENTIA, V35, P1574, DOI 10.1007/BF01953200; Graf Jean-Daniel, 1989, New York State Museum Bulletin, V466, P289; Guex GD, 2002, EVOLUTION, V56, P1036; Gunther R., 1979, Mitteilungen aus dem Zoologischen Museum in Berlin, V55, P35; HEPPICH S, 1982, THEOR APPL GENET, V61, P101, DOI 10.1007/BF00273874; Hermaniuk A, 2013, HERPETOLOGICA, V69, P36, DOI 10.1655/HERPETOLOGICA-D-12-00037; Hoffmann A, 2015, MOL ECOL, V24, P4371, DOI 10.1111/mec.13325; Jacob C, 2007, STRUCTURE DYNAMICS P; Kierzkowski P, 2011, ANN ZOOL FENN, V48, P56, DOI 10.5735/086.048.0106; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Mikulicek Peter, 2001, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Zoologische Reihe, V77, P59; Svinin AO, 2021, J ZOOL SYST EVOL RES, V59, P646, DOI 10.1111/jzs.12447; Plu┬tner J., 2005, WESTPALAARKTISCHEN W; Pruvost NBM, 2013, ECOL EVOL, V3, P2933, DOI 10.1002/ece3.687; RAGGHIANTI M, 1995, CHROMOSOME RES, V3, P497, DOI 10.1007/BF00713965; Ragghianti M, 2007, GENET RES, V89, P39, DOI 10.1017/S0016672307008610; Rybacki Mariusz, 1994, Zoologica Poloniae, V39, P345; Rybacki Mariusz, 2001, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Zoologische Reihe, V77, P51; Rybacki Mariusz, 1994, Zoologica Poloniae, V39, P331; Schmeller DS, 2004, ANN ZOOL FENN, V41, P681; Schon I, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P1; Som C, 2006, EVOL ECOL RES, V8, P1235; Stenberg P, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P63, DOI 10.1007/978-90-481-2770-2_4; Stock M, 2021, PHILOS T R SOC B, V376, DOI 10.1098/rstb.2020.0103; Stock M, 2012, P ROY SOC B-BIOL SCI, V279, P1293, DOI 10.1098/rspb.2011.1738; TUNNER HG, 1981, NATURWISSENSCHAFTEN, V68, P207, DOI 10.1007/BF01047207; TUNNER HG, 1973, NATURWISSENSCHAFTEN, V60, P481; UZZELL T, 1975, P ACAD NAT SCI PHILA, V127, P81; UZZELL T, 1976, P ACAD NAT SCI PHILA, V128, P147; VINOGRADOV AE, 1990, GENOME, V33, P619, DOI 10.1139/g90-092; VINOGRADOV AE, 1991, HEREDITAS, V114, P245, DOI 10.1111/j.1601-5223.1991.tb00331.x	64	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7								10.1371/journal.pone.0268574	http://dx.doi.org/10.1371/journal.pone.0268574			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M3CI	35793279	gold, Green Published			2022-12-26	WOS:000835338100043
J	Mtui, DT; Ogutu, JO; Okick, RE; Newmark, WD				Mtui, Devolent T.; Ogutu, Joseph O.; Okick, Raymond E.; Newmark, William D.			Elevational distribution of montane Afrotropical butterflies is influenced by seasonality and habitat structure	PLOS ONE			English	Article							GEOMETRID MOTHS LEPIDOPTERA; SPECIES RICHNESS; EVOLUTIONARY RESPONSES; DIVERSITY; PATTERNS; GRADIENTS; NYMPHALIDAE; ASSEMBLAGES; SATYRINAE; ABUNDANCE	Determinants of elevational distribution of butterfly species richness and abundance in the tropics are poorly understood. Here we assess the combined effects, both additive and interactive, of seasonality and habitat structure on the elevational distribution of butterflies in the Uluguru Mountains, Tanzania. We sampled butterflies along a 1100 m elevational gradient that extended from 1540 to 2639 m using a time-constrained fixed-area method during the short to long rains and long to short rains transitions, and in habitat structure classified as closed or open. We used semi-parametric generalized linear mixed models to assess the relation between butterfly species richness or abundance, and seasonality, habitat structure, family and elevation. For all species combined, species richness declined with elevation in both open and closed habitats during the long to short rains transition. During the short to long rains transition, species richness displayed a mid-elevation peak across habitats. Among the three focal families (Nymphalidae, Papilionidae and Pieridae) similar patterns in the elevational distribution of species richness were observed. Species abundance declined or remained stable with elevation across seasons and habitat structure; the exception being species abundance in open habitat during the short to long rain transition and increased slightly with elevation. Abundance by family did not vary significantly by habitat structure or season. Our results indicate that seasonality and habitat structure shape species richness and abundance of butterflies along an elevational gradient in the Uluguru Mountains. These patterns are important for informing conservation actions because temperature as well as annual and seasonal variation in precipitation are predicted to increase in East Africa as a result of climate change, important determinants of seasonality, while habitat disturbance may increase due to a projected doubling in Tanzania's population over the next 27 years.	[Mtui, Devolent T.; Okick, Raymond E.] Tanzania Wildlife Res Inst, Arusha, Tanzania; [Ogutu, Joseph O.] Univ Hohenheim, Inst Crop Sci, Biostat Unit, Stuttgart, Germany; [Newmark, William D.] Univ Utah, Nat Hist Museum Utah, Salt Lake City, UT USA	University Hohenheim; Utah System of Higher Education; University of Utah	Mtui, DT (corresponding author), Tanzania Wildlife Res Inst, Arusha, Tanzania.	deovolentem@gmail.com		Newmark, William/0000-0002-0359-9763	JRS Biodiversity Foundation [60708_TAWIRI]; Deutsche Forschungsgemeinschaft DFG [257734638]	JRS Biodiversity Foundation; Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG))	We thank C. Congdon and S. Colins at the African Butterfly Research Institute for their assistance with species identification; E. Lewis and L. Leblanc at the University of Idaho, Department of Entomology, Plant Pathology and Nematology for hosting D. Mtui in the William F. Barr Entomological Museum during her sabbatical; L. Waits, T. Osborn, F. Gerbert and P. Ranke for their generous assistance with R; G. Massawe, K. Ntiniwa, P. Kalenga, T. Venance, S. Bernard and O. Mwakabejela for their assistance in the field; M. Mwita and M. Pallanore for their assistance with database design and management; D. Wanna for logistics support, and the Tanzania Wildlife Research Institute, Tanzania Commission for Science and Technology, and the Uluguru Nature Reserve Authority for permission to conduct the study.	Acharya BK, 2015, ECOL RES, V30, P909, DOI 10.1007/s11284-015-1292-0; Axmacher JC, 2008, TROP ZOOL, V21, P243; Axmacher JC, 2009, J BIOGEOGR, V36, P337, DOI 10.1111/j.1365-2699.2008.01997.x; Bartzke GS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202814; Basset Y, 2013, INSECT CONSERV DIVER, V6, P223, DOI 10.1111/j.1752-4598.2012.00205.x; Beck J, 2017, GLOBAL ECOL BIOGEOGR, V26, P412, DOI 10.1111/geb.12548; Brehm G, 2003, DIVERS DISTRIB, V9, P351, DOI 10.1046/j.1472-4642.2003.00023.x; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Brown JH, 2001, GLOBAL ECOL BIOGEOGR, V10, P101, DOI 10.1046/j.1466-822x.2001.00228.x; Caldas A, 2003, BIOL CONSERV, V110, P211, DOI 10.1016/S0006-3207(02)00190-8; Chao A, 2016, WILEY STATSREF STAT, DOI [10.1002/9780470015902.a0026329, DOI 10.1002/9780470015902.A0026329]; Chen IC, 2011, GLOBAL ECOL BIOGEOGR, V20, P34, DOI 10.1111/j.1466-8238.2010.00594.x; Chen IC, 2009, P NATL ACAD SCI USA, V106, P1479, DOI 10.1073/pnas.0809320106; Dewan S., 2021, FRONT BIOGEOGR, V13, P1, DOI [10.21425/F5FBG49643, DOI 10.21425/F5FBG49643]; Fine PVA, 2015, ANNU REV ECOL EVOL S, V46, P369, DOI 10.1146/annurev-ecolsys-112414-054102; Funk C, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.66; Grotan V, 2014, ECOGRAPHY, V37, P509, DOI 10.1111/ecog.00635; Grotan V, 2012, J ANIM ECOL, V81, P714, DOI 10.1111/j.1365-2656.2011.01950.x; Habel J.C., 2018, Animal Conservation, V21, P405, DOI 10.1111/acv.12408; Haber WA., 2004, BIODIVERS CONSERV, P99, DOI [10.1525/california/9780520223097.003.0008, DOI 10.1525/CALIFORNIA/9780520223097.003.0008]; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Hill JK, 2003, J TROP ECOL, V19, P35, DOI 10.1017/S0266467403003055; Hsiung AC, 2018, BIOL REV, V93, P2049, DOI 10.1111/brv.12435; Janzen D.H., 1988, Orion, V7, P38; Janzen Daniel H., 1993, P448; JANZEN DH, 1987, INSECT SCI APPL, V8, P489, DOI 10.1017/S1742758400022530; Kenward MG, 2009, COMPUT STAT DATA AN, V53, P2583, DOI 10.1016/j.csda.2008.12.013; Kielland J., 1990, BUTTERFLIES TANZANIA; Kuussaari M, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0413; LEMMON PAUL E., 1956, FOREST SCI, V2, P314; Lomolino MV, 2001, GLOBAL ECOL BIOGEOGR, V10, P3, DOI 10.1046/j.1466-822x.2001.00229.x; Lovett J.C., 1993, BIOGEOGRAPHY ECOLOGY; Maicher V, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-78659-7; Maicher V, 2020, J BIOGEOGR, V47, P342, DOI 10.1111/jbi.13740; Maicher V, 2018, ECOL EVOL, V8, P12761, DOI 10.1002/ece3.4704; Martins DJ., 2017, BUTTERFLIES E AFRICA; MCCAIN C. M., 2010, ENCY LIFE SCI, DOI [DOI 10.1002/9780470015902.A0022548, 10.1002/9780470015902.a0022548]; MCCOY ED, 1990, OIKOS, V58, P313, DOI 10.2307/3545222; Mittermeier R.A., 2011, BIODIVERSITY HOTSPOT, V1st ed., P3; Molina-Martinez A, 2013, J INSECT CONSERV, V17, P1169, DOI 10.1007/s10841-013-9598-0; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Neate-Clegg MHC, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248712; Neate-Clegg MHC, 2021, GLOBAL CHANGE BIOL, V27, P2254, DOI 10.1111/gcb.15567; Newmark W. D., 2002, CONSERVING BIODIVERS; Newmark WD, 2018, BIODIVERS CONSERV, V27, P1387, DOI 10.1007/s10531-018-1498-x; Nyafwono M, 2015, BIODIVERS CONSERV, V24, P1473, DOI 10.1007/s10531-015-0870-3; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Peters MK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13736; Pocs T., 1976, BOISSIERA, V24, P477; Pyrcz TW, 2009, NEOTROP ENTOMOL, V38, P716, DOI 10.1590/S1519-566X2009000600003; Pyrcz TW, 2002, GLOBAL ECOL BIOGEOGR, V11, P211, DOI 10.1046/j.1466-822X.2002.00285.x; RAHBEK C, 1995, ECOGRAPHY, V18, P200, DOI 10.1111/j.1600-0587.1995.tb00341.x; Rahbek C, 1997, AM NAT, V149, P875, DOI 10.1086/286028; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rydon A, 1964, J Lepid Soc, V18, P51; SAS Institute, 2002, SAS SYST WIND VERS 9; Schmitt T, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-94274-6; Sheldon KS, 2019, ANNU REV ECOL EVOL S, V50, P303, DOI 10.1146/annurev-ecolsys-110218-025005; TERBORGH J, 1977, ECOLOGY, V58, P1007, DOI 10.2307/1936921; TERBORGH J, 1985, ECOLOGY, V66, P1237, DOI 10.2307/1939177; TERBORGH J, 1975, ECOLOGY, V56, P562, DOI 10.2307/1935491; United Nations D.o.E.a.S.A. Population Division, 2019, WORLD POPULATION PRO; Valtonen A, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00338.1; Wiens JJ, 2007, P ROY SOC B-BIOL SCI, V274, P919, DOI 10.1098/rspb.2006.0301; WOLFINGER R, 1993, J STAT COMPUT SIM, V48, P233, DOI 10.1080/00949659308811554	66	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7								10.1371/journal.pone.0270769	http://dx.doi.org/10.1371/journal.pone.0270769			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M5FN	35789332	gold, Green Published			2022-12-26	WOS:000835487000009
J	Shimada, K; Nohara, M; Shinozaki, F; Tatsuda, M; Watanabe, T; Kamei, A; Abe, K				Shimada, Kousuke; Nohara, Masakatsu; Shinozaki, Fumika; Tatsuda, Midori; Watanabe, Takayuki; Kamei, Asuka; Abe, Keiko			The effects of compression load to the trunk on lipid metabolism in an inactive phase	PLOS ONE			English	Article							RECOVERY; PRESSURE	The effects of compression load to a specific body part, e.g. leg, arm, or trunk, evoke many functions and are applied in various fields including clinical medicine, sports, and general health care. Nevertheless, little is known about the functional mechanism of compression load, especially regarding its effects on metabolic function. We investigated the effects of compression load to the trunk on the metabolism. We designed adjustable compression clothes for mice and attached them to ten-week-old C57BL/6N male mice in a controlled environment. The mice were divided into compression and no-compression groups, the latter only wearing the clothes without added compression. The evoked metabolic changes were evaluated using indirect calorimetry and transcriptomics with liver tissue to investigate the mechanism of the metabolic changes induced by the compression load. The results indicated decreases in body weight gain, food intake, and respiratory exchange ratio in the compression group compared to the no-compression group, but these effects were limited in the "light period" which was an inactive phase for mice. As a result of the transcriptome analysis after eight hours of compression load to the trunk, several DEGs, e.g., Cpt1A, Hmgcr, were classified into functional categories relating to carbohydrate metabolism, lipid metabolism, or immune response. Lipid metabolism impacts included suppression of fatty acid synthesis and activation of lipolysis and cholesterol synthesis in the compression group. Taken together, our results showed that activation of lipid metabolism processes in an inactive phase was induced by the compression load to the trunk.	[Shimada, Kousuke; Nohara, Masakatsu; Shinozaki, Fumika; Kamei, Asuka; Abe, Keiko] Kanagawa Inst Ind Sci & Technol, Grp Food Funct Assessment, Kawasaki, Kanagawa, Japan; [Tatsuda, Midori; Watanabe, Takayuki] DIANA Co Ltd, Shibuya Ku, Tokyo, Japan; [Abe, Keiko] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo, Japan	Kanagawa Academy Science & Technology; University of Tokyo	Shimada, K; Kamei, A; Abe, K (corresponding author), Kanagawa Inst Ind Sci & Technol, Grp Food Funct Assessment, Kawasaki, Kanagawa, Japan.; Abe, K (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo, Japan.	kousuke.s0223@gmail.com; kamei@kistec.jp; aka7308@mail.ecc.u-tokyo.ac.jp	Kamei, Asuka/GXH-4934-2022		DIANA Co.,Ltd.; JSPS KAKENHI [15H05346, 16K12734, 18K05514, 19K14047]	DIANA Co.,Ltd.; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was funded by DIANA Co.,Ltd. and this study was also supported by a research grant from JSPS KAKENHI Grant Numbers 15H05346 (to A. K.), 16K12734 (to K. S.), 18K05514 (to A. K.), 19K14047 (to K. S.).	Baumgartner A, 2016, BRIT J DERMATOL, V174, P1061, DOI 10.1111/bjd.14289; Bringard A, 2006, J SPORT MED PHYS FIT, V46, P548; Coban PT, 2019, TURK GOGUS KALP DAMA, V27, P49, DOI 10.5606/tgkdc.dergisi.2019.16867; Hill J, 2017, INT J SPORT PHYSIOL, V12, P1078, DOI 10.1123/ijspp.2016-0380; Hill J, 2014, BRIT J SPORT MED, V48, P1340, DOI 10.1136/bjsports-2013-092456; Huang CY, 2012, TISSUE ENG PT A, V18, P2106, DOI [10.1089/ten.TEA.2012.0064, 10.1089/ten.tea.2012.0064]; Kapasa ER, 2017, J FUNCT BIOMATER, V8, DOI 10.3390/jfb8040042; Li TR, 2016, CELL MOL BIOL, V62, P102, DOI 10.14715/cmb/2016.62.12.18; Liu J, 2009, ANN BIOMED ENG, V37, P794, DOI 10.1007/s10439-009-9638-9; Lopera C, 2017, LYMPHAT RES BIOL, V15, P235, DOI 10.1089/lrb.2017.0001; Mizuno S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00834; Peckett AJ, 2011, METABOLISM, V60, P1500, DOI 10.1016/j.metabol.2011.06.012; Perrey S., 2009, ENG SPORT, V7, P319; Rubin J, 2006, GENE, V367, P1, DOI 10.1016/j.gene.2005.10.028; Saito T, 2007, BIOCHEM BIOPH RES CO, V357, P371, DOI 10.1016/j.bbrc.2007.03.169; Samotrueva MA, 2019, B EXP BIOL MED+, V166, P754, DOI 10.1007/s10517-019-04434-y; Scheer R, 2017, J LYMPHOEDEMA, V12; Smale BA, 2018, EUR J SPORT SCI, V18, P315, DOI 10.1080/17461391.2017.1413139; Turner CH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.268pt3; Zinner C, 2017, EUR J SPORT SCI, V17, P1304, DOI 10.1080/17461391.2017.1380707	20	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7								10.1371/journal.pone.0270705	http://dx.doi.org/10.1371/journal.pone.0270705			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M3CI	35793326	gold, Green Published			2022-12-26	WOS:000835338100029
J	Sugue, MF; Burdur, AN; Ringel, MT; Drager, G; Bruser, T				Sugue, Michael-Frederick; Burdur, Ali Nazmi; Ringel, Michael T.; Draeger, Gerald; Brueser, Thomas			PvdM of fluorescent pseudomonads is required for the oxidation of ferribactin by PvdP in periplasmic pyoverdine maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN RENAL DIPEPTIDASE; ELECTROPHORETIC TRANSFER; ALKALINE-PHOSPHATASE; POLYACRYLAMIDE-GELS; PROTEIN SECRETION; MEMBRANE; SIDEROPHORE; IRON; NITROCELLULOSE; IDENTIFICATION	Fluorescent pseudomonads such as Pseudomonas aeruginosa or Pseudomonas fluorescens produce pyoverdine siderophores that ensure iron-supply in iron-limited environments. After its synthesis in the cytoplasm, the nonfluorescent pyoverdine precursor ferribactin is exported into the periplasm, where the enzymes PvdQ, PvdP, PvdO, PvdN, and PtaA are responsible for fluorophore maturation and tailoring steps. While the roles of all these enzymes are clear, little is known about the role of PvdM, a human renal dipeptidase-related protein that is predicted to be periplasmic and that is essential for pyoverdine biogenesis. Here, we reveal the subcellular localization and functional role of PvdM. Using the model organism P. fluorescens, we show that PvdM is anchored to the periplasmic side of the cytoplasmic membrane, where it is indispensable for the activity of the tyrosinase PvdP. While PvdM does not share the metallopeptidase function of renal dipeptidase, it still has the corresponding peptide-binding site. The substrate of PvdP, deacylated ferribactin, is secreted by a Delta pvdM mutant strain, indicating that PvdM prevents loss of this periplasmic biosynthesis intermediate into the medium by ensuring the efficient transfer of ferribactin to PvdP in vivo. We propose that PvdM belongs to a new dipeptidase-related protein subfamily with inactivated Zn(2+ )coordination sites, members of which are usually genetically linked to TonB-dependent uptake systems and often associated with periplasmic FAD-dependent oxidoreductases related to D-amino acid oxidases. We suggest that these proteins are necessary for selective binding, exposure, or transfer of specific D- and L-amino acid-containing peptides and other periplasmic biomolecules in manifold pathways.	[Sugue, Michael-Frederick; Burdur, Ali Nazmi; Ringel, Michael T.; Brueser, Thomas] Leibniz Univ Hannover, Inst Microbiol, Hannover, Germany; [Draeger, Gerald] Leibniz Univ Hannover, Inst Organ Chem, Hannover, Germany	Leibniz University Hannover; Leibniz University Hannover	Bruser, T (corresponding author), Leibniz Univ Hannover, Inst Microbiol, Hannover, Germany.	brueser@ifmb.uni-hannover.de		Bruser, Thomas/0000-0002-5889-8306	German Research Foundation (DFG) [BR 2285/7-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by grant BR 2285/7-1 of the German Research Foundation (DFG) to T. B.	ADACHI H, 1990, J BIOL CHEM, V265, P15341; ADACHI H, 1993, BIOCHIM BIOPHYS ACTA, V1163, P42, DOI 10.1016/0167-4838(93)90276-W; [Anonymous], 2021, PYMOL MOL GRAPHICS S; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Berrisford JM, 2016, BBA-BIOENERGETICS, V1857, P892, DOI 10.1016/j.bbabio.2016.01.012; Blum M, 2021, NUCLEIC ACIDS RES, V49, pD344, DOI 10.1093/nar/gkaa977; Braun P, 1999, BIOCHEMISTRY-US, V38, P9778, DOI 10.1021/bi990923a; BRICKMAN E, 1975, J MOL BIOL, V96, P307, DOI 10.1016/0022-2836(75)90350-2; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CAMPBELL BJ, 1988, BIOCHIM BIOPHYS ACTA, V956, P110, DOI 10.1016/0167-4838(88)90256-7; Chu BC, 2010, BIOMETALS, V23, P601, DOI 10.1007/s10534-010-9361-x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cummings JA, 2010, BIOCHEMISTRY-US, V49, P611, DOI 10.1021/bi901935y; CUNNINGHAM RP, 1989, BIOCHEMISTRY-US, V28, P4450, DOI 10.1021/bi00436a049; Draper RC, 2011, MOL MICROBIOL, V82, P1444, DOI 10.1111/j.1365-2958.2011.07901.x; Henriquez T, 2019, ENV MICROBIOL REP, V11, P98, DOI 10.1111/1758-2229.12708; HOFFMAN CS, 1985, P NATL ACAD SCI USA, V82, P5107, DOI 10.1073/pnas.82.15.5107; Hoffmann L, 2021, APPL MICROBIOL BIOT, V105, P247, DOI 10.1007/s00253-020-11034-8; Ize B, 2014, METHODS MOL BIOL, V1149, P185, DOI 10.1007/978-1-4939-0473-0_15; Keynan S, 1997, BIOCHEM J, V326, P47, DOI 10.1042/bj3260047; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamont IL, 2002, P NATL ACAD SCI USA, V99, P7072, DOI 10.1073/pnas.092016999; Lemoine F, 2019, NUCLEIC ACIDS RES, V47, pW260, DOI 10.1093/nar/gkz303; Maqbool A, 2015, BIOCHEM SOC T, V43, P1011, DOI 10.1042/BST20150135; Marelja Z, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00050; Romero AM, 2021, MICROORGANISMS, V9, DOI 10.3390/microorganisms9051058; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Meyer JM, 1997, MICROBIOL-UK, V143, P35, DOI 10.1099/00221287-143-1-35; Nadal-Jimenez P, 2014, J BACTERIOL, V196, P2681, DOI 10.1128/JB.01376-13; Natale P, 2008, BBA-BIOMEMBRANES, V1778, P1735, DOI 10.1016/j.bbamem.2007.07.015; Nitanai Y, 2002, J MOL BIOL, V321, P177, DOI 10.1016/S0022-2836(02)00632-0; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Poppe J, 2018, J BIOL CHEM, V293, P14926, DOI 10.1074/jbc.RA118.002560; Porcelli I, 2002, BIOCHEMISTRY-US, V41, P13690, DOI 10.1021/bi026142i; Richter S, 2005, J BIOL CHEM, V280, P42723, DOI 10.1074/jbc.M509570200; Ringel MT, 2018, MICROB CELL, V5, P424, DOI 10.15698/mic2018.10.649; Ringel MT, 2018, J BIOL CHEM, V293, P2330, DOI 10.1074/jbc.RA117.000121; Ringel MT, 2017, J BIOL CHEM, V292, P18660, DOI 10.1074/jbc.M117.812545; Ringel MT, 2016, J BIOL CHEM, V291, P23929, DOI 10.1074/jbc.M116.755611; Rose RW, 2002, MOL MICROBIOL, V45, P943, DOI 10.1046/j.1365-2958.2002.03090.x; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Stefansson A, 2007, ENVIRON SCI TECHNOL, V41, P6117, DOI 10.1021/es070174h; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vansuyt G, 2007, MOL PLANT MICROBE IN, V20, P441, DOI 10.1094/MPMI-20-4-0441; WENDENBAUM S, 1983, TETRAHEDRON LETT, V24, P4877, DOI 10.1016/S0040-4039(00)94031-0; Winsor GL, 2016, NUCLEIC ACIDS RES, V44, pD646, DOI 10.1093/nar/gkv1227	46	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2022	298	8							102201	10.1016/j.jbc.2022.102201	http://dx.doi.org/10.1016/j.jbc.2022.102201			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3S2VB	35764171	Green Published, gold			2022-12-26	WOS:000839458000012
J	Tillo, M; Lamanna, WC; Dwyer, CA; Sandoval, DR; Pessentheiner, AR; Al-Azzam, N; Sarrazin, S; Gonzales, JC; Kan, SH; Andreyev, AY; Schultheis, N; Thacker, BE; Glass, CA; Dickson, PI; Wang, RY; Selleck, SB; Esko, JD; Gordts, PLSM				Tillo, Miguel; Lamanna, William C.; Dwyer, Chrissa A.; Sandoval, Daniel R.; Pessentheiner, Ariane R.; Al-Azzam, Norah; Sarrazin, Stephane; Gonzales, Jon C.; Kan, Shih-Hsin; Andreyev, Alexander Y.; Schultheis, Nicholas; Thacker, Bryan E.; Glass, Charles A.; Dickson, Patricia I.; Wang, Raymond Y.; Selleck, Scott B.; Esko, Jeffrey D.; Gordts, Philip L. S. M.			Impaired mitophagy in Sanfilippo a mice causes hypertriglyceridemia and brown adipose tissue activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; LIPID-METABOLISM; HUNTERS SYNDROME; CLEARANCE; AUTOPHAGY; DISORDERS; PATHOLOGY; MODEL; IIIA	Lysosomal storage diseases result in various developmental and physiological complications, including cachexia. To study the causes for the negative energy balance associated with cachexia, we assessed the impact of sulfamidase deficiency and heparan sulfate storage on energy homeostasis and metabolism in a mouse model of type IIIa mucopolysaccharidosis (MPS IIIa, Sanfilippo A syndrome). At 12-weeks of age, MPS IIIa mice exhibited fasting and postprandial hypertriglyceridemia compared with wildtype mice, with a reduction of white and brown adipose tissues. Par-titioning of dietary [H-3]triolein showed a marked increase in in-testinal uptake and secretion, whereas hepatic production and clearance of triglyceride-rich lipoproteins did not differ from wildtype controls. Uptake of dietary triolein was also elevated in brown adipose tissue (BAT), and notable increases in beige adi-pose tissue occurred, resulting in hyperthermia, hyperphagia, hyperdipsia, and increased energy expenditure. Furthermore, fasted MPS IIIa mice remained hyperthermic when subjected to low temperature but became cachexic and profoundly hypo-thermic when treated with a lipolytic inhibitor. We demonstrated that the reliance on increased lipid fueling of BAT was driven by a reduced ability to generate energy from stored lipids within the depot. These alterations arose from impaired autophagosome- lysosome fusion, resulting in increased mitochondria content in beige and BAT. Finally, we show that increased mitochondria content in BAT and postprandial dyslipidemia was partially reversed upon 5-week treatment with recombinant sulfamidase. We hypothesize that increased BAT activity and persistent in-creases in energy demand in MPS IIIa mice contribute to the negative energy balance observed in patients with MPS IIIa.	[Tillo, Miguel; Pessentheiner, Ariane R.; Al-Azzam, Norah; Gordts, Philip L. S. M.] Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA; [Lamanna, William C.; Dwyer, Chrissa A.; Sandoval, Daniel R.; Sarrazin, Stephane; Gonzales, Jon C.; Esko, Jeffrey D.; Gordts, Philip L. S. M.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Sandoval, Daniel R.; Gonzales, Jon C.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA USA; [Kan, Shih-Hsin] UCLA, Lundquist Inst Biomed Innovat Harbor, Med Ctr, Torrance, CA USA; [Kan, Shih-Hsin] CHOC Childrens Hosp Orange Cty, Orange, CA USA; [Andreyev, Alexander Y.; Dickson, Patricia I.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA USA; [Schultheis, Nicholas; Selleck, Scott B.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA USA; [Thacker, Bryan E.; Glass, Charles A.] TEGA Therapeut Inc, San Diego, CA USA; [Dickson, Patricia I.] Washington Univ, Dept Pediat, St Louis, MO USA; [Wang, Raymond Y.] Div Metab Disorders, Orange, CA USA; [Wang, Raymond Y.] Univ Calif Irvine, Sch Med, Dept Pediat, Irvine, CA USA; [Esko, Jeffrey D.; Gordts, Philip L. S. M.] Univ Calif San Diego, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Los Angeles; University of California System; University of California San Diego; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Washington University (WUSTL); University of California System; University of California Irvine; University of California System; University of California San Diego	Gordts, PLSM (corresponding author), Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA.; Esko, JD; Gordts, PLSM (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.; Esko, JD; Gordts, PLSM (corresponding author), Univ Calif San Diego, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA.	jesko@health.ucsd.edu; pgordts@health.ucsd.edu	Kan, Shih-hsin/GLT-3129-2022; Wang, Raymond Yu Jeang/CAJ-3535-2022	Kan, Shih-hsin/0000-0003-0209-4963; Andreyev, Alexander Y./0000-0002-9246-9943; Wang, Raymond/0000-0001-6494-7613	Ruth L. Kirschstein NRSA [DK085905, F31HL977212]; McNair Scholarship; T32 fellowship in the UCLA Medical Genetics Training Program [GM008243]; National Mucopoly-saccharidosis Society; NIH [P30 DK063491, GM33063, P01 HL107150]; European Community FP7 Award [PIOF-GA-2010-273994]; Cure San Filippo Foundation	Ruth L. Kirschstein NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McNair Scholarship; T32 fellowship in the UCLA Medical Genetics Training Program; National Mucopoly-saccharidosis Society; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Community FP7 Award; Cure San Filippo Foundation	This work was supported by Ruth L. Kirschstein NRSA DK085905 (to W. C. L) and F31HL977212 (to J. C. G.) , a McNair Scholarship (to N. A.-A.) , a T32 fellowship in the UCLA Medical Genetics Training Program (GM008243) (to S.-H. K.) , a grant from the National Mucopoly-saccharidosis Society, NIH grant GM33063 and P01 HL107150 (to J. D. E.) , a European Community FP7 Award PIOF-GA-2010-273994, NIH grant P30 DK063491 (to P. L. S. M. G.) , and a Cure San Filippo Foundation grant (S. B. S. and J. D. E.) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ADEBAHR G, 1985, Z RECHTSMED, V95, P197; Altshuler-Keylin S, 2016, CELL METAB, V24, P402, DOI 10.1016/j.cmet.2016.08.002; Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Beesley CE, 2009, MOL GENET METAB, V96, P218, DOI 10.1016/j.ymgme.2008.12.002; Beijer E, 2012, ONCOL REV, V6, P88, DOI 10.4081/oncol.2012.e11; Bhaumik M, 1999, GLYCOBIOLOGY, V9, P1389, DOI 10.1093/glycob/9.12.1389; Bik-Multanowski M, 2016, MOL GENET METAB REP, V6, P5, DOI 10.1016/j.ymgmr.2015.12.002; Bishop JR, 2008, CURR OPIN LIPIDOL, V19, P307, DOI 10.1097/MOL.0b013e3282feec2d; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Carmean CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067807; CLEARY MA, 1993, ARCH DIS CHILD, V69, P403, DOI 10.1136/adc.69.3.403; Deng YP, 2012, HEPATOLOGY, V55, P277, DOI 10.1002/hep.24626; Drucker DJ, 2022, MOL METAB, V57, DOI 10.1016/j.molmet.2021.101351; Duan K., 2022, STAR PROTOC, V3; Dwyer CA, 2017, SCI REP-UK, V7, DOI 10.1038/srep46576; Foley EM, 2010, PROG MOL BIOL TRANSL, V93, P213, DOI 10.1016/S1877-1173(10)93010-X; Fu HY, 2017, METAB BRAIN DIS, V32, P1403, DOI 10.1007/s11011-017-0009-1; Gonzales JC, 2013, J CLIN INVEST, V123, P2742, DOI 10.1172/JCI67398; Gordts PLSM, 2016, J CLIN INVEST, V126, P2855, DOI 10.1172/JCI86610; Gordts PLSM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038330; Hussain MM, 2014, CURR OPIN LIPIDOL, V25, P200, DOI 10.1097/MOL.0000000000000084; Jolly RD, 2007, VET PATHOL, V44, P569, DOI 10.1354/vp.44-5-569; Kaur J, 2015, NAT REV MOL CELL BIO, V16, P461, DOI 10.1038/nrm4024; Kir S, 2014, NATURE, V513, P100, DOI 10.1038/nature13528; Kowalewski B, 2015, HUM MOL GENET, V24, P1856, DOI 10.1093/hmg/ddu603; Kurt I, 2014, CLIN CHIM ACTA, V431, P250, DOI 10.1016/j.cca.2014.02.012; Langford-Smith A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025717; Levy E, 2015, J LIPID RES, V56, P945, DOI 10.1194/jlr.R052415; Lewis GF, 2015, ENDOCR REV, V36, P131, DOI 10.1210/er.2014-1062; Moog U, 2007, AM J MED GENET C, V145C, P293, DOI 10.1002/ajmg.c.30142; Neufeld EF, 2001, MUCOPOLYSACCHARIDOSE, P3421, DOI DOI 10.1036/OMMBID.165; Pawaskar DK, 2013, CANCER CHEMOTH PHARM, V71, P1219, DOI 10.1007/s00280-013-2116-y; Petruzzelli M, 2014, CELL METAB, V20, P433, DOI 10.1016/j.cmet.2014.06.011; Putri M, 2015, BIOCHEM BIOPH RES CO, V457, P520, DOI 10.1016/j.bbrc.2014.12.124; Rozaklis T, 2011, EXP NEUROL, V230, P123, DOI 10.1016/j.expneurol.2011.04.004; Sarrazin S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004952; Sass F, 2021, MOL METAB, V47, DOI 10.1016/j.molmet.2021.101173; Settembre C, 2008, AUTOPHAGY, V4, P113, DOI 10.4161/auto.5227; Settembre C, 2008, HUM MOL GENET, V17, P119, DOI 10.1093/hmg/ddm289; Settembre C, 2014, TRENDS CELL BIOL, V24, P743, DOI 10.1016/j.tcb.2014.06.006; Woloszynek JC, 2007, J BIOL CHEM, V282, P35765, DOI 10.1074/jbc.M705124200; Woloszynek JC, 2009, J BIOL CHEM, V284, P29684, DOI 10.1074/jbc.M109.020818; Xu D, 2014, ANNU REV BIOCHEM, V83, P129, DOI 10.1146/annurev-biochem-060713-035314; YOUNG ID, 1983, DEV MED CHILD NEUROL, V25, P481; YOUNG ID, 1982, J MED GENET, V19, P408, DOI 10.1136/jmg.19.6.408; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018	47	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2022	298	8							102159	10.1016/j.jbc.2022.102159	http://dx.doi.org/10.1016/j.jbc.2022.102159			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	4X0OB	35750212	gold, Green Published			2022-12-26	WOS:000860550600010
J	Thammavong, P; Boyer, S; Luangamath, P; Phommavanh, N; Vungkyly, V; Nilaxay, S; Lakeomany, K; Brey, P; Grandadam, M; Marcombe, S				Thammavong, Phoutmany; Boyer, Sebastien; Luangamath, Phonesavanh; Phommavanh, Nothasine; Vungkyly, Vaekey; Nilaxay, Somphat; Lakeomany, Khaithong; Brey, Paul; Grandadam, Marc; Marcombe, Sebastien			Small-scale field assessment against the dengue vector Aedes aegypti using the auto-dissemination approach in an urban area of Vientiane, Lao PDR	PLOS ONE			English	Article							IN2CARE(R) MOSQUITO TRAP; PYRIPROXYFEN AUTODISSEMINATION; BEAUVERIA-BASSIANA; ALBOPICTUS; DEPLOYMENT; EFFICACY; SPINOSAD; GROWTH	Background In Lao PDR, dengue fever is the most important vector borne disease and vector control remains the principal method to fight against Aedes aegypti the primary transmitter mosquito species. Vector control management programs need new strategies in addition to conventional larviciding and adulticiding interventions in the country. In this study, we examined the In2Care (R) Mosquito Trap's efficacy using insecticide auto-dissemination strategy. The insecticide pyriproxyfen, present in powder form inside the trap station, contaminates the body of gravid female mosquitoes visiting the traps and is later on disseminated via the mosquitoes in breeding sites surrounding the traps. We tested the attractiveness of the Traps, their efficacy to reduce the larval and adult abundance, and the impact on emergence rates. Specifically, we tested if the servicing interval of the In2Care (R) Mosquito Trap could be extended to 12 weeks. Methods Two black plastic ovitrap buckets and two BG (R) sentinel traps were placed in the premises of the Science campus of Vientiane Capital located in an urban area to measure weekly the larval and adult relative abundance of Aedes mosquitoes from 2017 to 2019. Twenty-five In2Care (R) Mosquito Traps were evenly distributed in this area and two studies of 12 weeks were implemented during January and April 2018 and, July to October 2018 (dry and rainy season, respectively). Every 2 weeks, water samples from 5 In2Care (R) Traps were randomly selected and tested at the laboratory with Ae. aegypti larvae to measure the larval and pupal mortality. The relative abundance of Aedes mosquitoes in the BG traps (R) with the presence of In2Care (R) Traps in 2018, was compared with the surveillance results obtained in 2017 and 2019 without In2Care (R) Traps. Every week, water samples from the ovitrap buckets were tested for Emergence Inhibition (EI). Results The In2Care (R) Traps were very attractive to gravid Ae. aegypti mosquitoes specifically during the rainy seasons with 96% of the traps colonized with larvae/pupae within four weeks. The bioassays showed 100% mortality in the water samples from the traps during the twelve weeks studies showing the good efficacy over time of the pyriproxyfen without additional servicing in the 12 week period. In addition, the larvicide was successfully disseminated into the ovitrap buckets placed in the treated area where 100% of EI during all weeks of intervention was measured. There was no significant effect of the treatment on adult abundance reduction in the treated area, probably due to recolonization of adult mosquitoes surrounding the field experiment. Conclusions The observed potential of the In2Care (R) Mosquito Trap using the auto-dissemination strategy could lead to the use of this new tool in combination with conventional control methods against Dengue vectors in urban tropical areas. Large scale field trials should be implemented in Lao PDR to prove its efficacy for Public Health programs.	[Thammavong, Phoutmany; Luangamath, Phonesavanh; Phommavanh, Nothasine; Vungkyly, Vaekey; Nilaxay, Somphat; Lakeomany, Khaithong; Brey, Paul; Grandadam, Marc; Marcombe, Sebastien] Inst Pasteur Lao PDR, Med Entomol & Biol Dis Vectors, Minist Hlth, Viangchan, Laos; [Boyer, Sebastien] Inst Pasteur Cambodge, Med & Vet Entomol Unit, Phnom Penh, Cambodia	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia	Marcombe, S (corresponding author), Inst Pasteur Lao PDR, Med Entomol & Biol Dis Vectors, Minist Hlth, Viangchan, Laos.	sebastienmarcombe@gmail.com			ECOMORE 2 project; AFD (Agence Francaise pour le Developpement) [CZZ 2146 01]	ECOMORE 2 project; AFD (Agence Francaise pour le Developpement)	MG received the award. The study was supported by the ECOMORE 2 project and financially supported by AFD (Agence Franaise pour le Developpement, https://www.afd.fr/fr) grant n CZZ 2146 01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad-Franch F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002213; Abad-Franch F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003702; Buckner EA, 2021, J AM MOSQUITO CONTR, V37, P242, DOI 10.2987/21-7038; Buckner EA, 2017, J AM MOSQUITO CONTR, V33, P193, DOI 10.2987/17-6642R.1; Caputo B, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001793; Chandel K, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005235; Darbro JM, 2012, AM J TROP MED HYG, V86, P656, DOI 10.4269/ajtmh.2012.11-0455; Darriet F, 2005, J AM MOSQUITO CONTR, V21, P495, DOI 10.2987/8756-971X(2006)21[495:SANLAI]2.0.CO;2; Darriet F, 2006, J MED ENTOMOL, V43, P1190, DOI 10.1603/0022-2585(2006)43[1190:LEOPAS]2.0.CO;2; Darriet F, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-88; Devine GJ, 2009, P NATL ACAD SCI USA, V106, P11530, DOI 10.1073/pnas.0901369106; Fargues J, 1997, MYCOLOGIA, V89, P383, DOI 10.2307/3761032; Garcia KKS, 2020, PARASITE VECTOR, V13, DOI 10.1186/s13071-020-04221-z; Gaugler R, 2012, MED VET ENTOMOL, V26, P37, DOI 10.1111/j.1365-2915.2011.00970.x; Geden CJ, 2012, J MED ENTOMOL, V49, P606, DOI 10.1603/ME11226; Itoh T., 1995, UTILIZATION BLOOD FE, V36, P243; Itoh Takaaki, 1993, Tropical Medicine, V35, P259; Kawada Hitoshi, 1993, Japanese Journal of Sanitary Zoology, V44, P349; Lao M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115569; Mains JW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003406; Marcombe S, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007852; Marcombe S, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3187-8; Marcombe S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101992; Ohba S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067045; Snetselaar J, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-200; Su TY, 2020, J AM MOSQUITO CONTR, V36, P167, DOI 10.2987/20-6929.1; Suman DS, 2014, ACTA TROP, V135, P96, DOI 10.1016/j.actatropica.2014.03.026; Suman DS, 2013, J MED ENTOMOL, V50, P1261, DOI 10.1603/ME13068; Tangena JAA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206387; Unlu I, 2020, J MED ENTOMOL, V57, P1120, DOI 10.1093/jme/tjaa011; Unlu I, 2018, J MED ENTOMOL, V55, P472, DOI 10.1093/jme/tjx216; Unlu I, 2014, T ROY SOC TROP MED H, V108, P699, DOI 10.1093/trstmh/tru139; WHO, 2019, DENG SIT UPD; Williams T, 2003, BIOCONTROL SCI TECHN, V13, P459, DOI 10.1080/0958315031000140956	34	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2022	17	7							e0270987	10.1371/journal.pone.0270987	http://dx.doi.org/10.1371/journal.pone.0270987			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6E4KA	35776762	Green Published, gold			2022-12-26	WOS:000883348200011
J	Cattafesta, M; Petarli, GB; Zandonade, E; Bezerra, OMDA; de Abreu, SMR; Salaroli, LB				Cattafesta, Monica; Petarli, Glenda Blaser; Zandonade, Eliana; Bezerra, Olivia Maria de Paula Alves; de Abreu, Sandra Marlene Ribeiro; Salaroli, Luciane Bresciani			Prevalence and determinants of obesity and abdominal obesity among rural workers in Southeastern Brazil	PLOS ONE			English	Article							DIETARY PATTERNS; RISK-FACTORS; FARMERS; ADULTS; OVERWEIGHT/OBESITY; HYPERTENSION; ASSOCIATION; POPULATION; TRANSITION; EPIDEMIC	The objectives of this study were to assess the nutritional status of rural workers from a municipality in Southeastern Brazil and estimate the association of sociodemographic, labor, lifestyle, and dietary pattern factors with obesity and abdominal obesity of men and women of this rural area. This is a cross-sectional, epidemiological study of 740 farmers (51.5%, n = 381 males; 48.5%, n = 359 females). The sociodemographic, labor, lifestyle and dietary patterns determinants were assessed. Food intake data were obtained by applying three 24-hour recalls and dietary patterns were determined by Principal Component Analysis with Varimax orthogonal rotation. Poisson regression with robust variance stratified by sex was applied. The general prevalence of overweight status was 31.5% (95% CI 28.2-34.8%), 19.7% of obesity (95% CI 16.8-22.6%) and 31.5% of abdominal obesity (95% CI 28.2-34.8%), with higher rates in women (P < 0.001). Men of higher socioeconomic class had a 2.3 times higher prevalence of obesity (95% CI 1.08-4.90). In addition, the shorter travel time to purchase food increased the prevalence of abdominal obesity in males. For women, the older the age group, the greater the general and central obesity. A lower adherence to traditional dietary patterns (approximately PR [prevalence ratio] 1.6 for general obesity and PR 1.3 for abdominal obesity) and a greater number of places to buy food were associated with higher rates of obesity in women. Finally, women farmers with a higher workload had a 20% lower prevalence of central obesity (PR 0.80; 95% CI 0.65-0.97). Such findings demonstrate that obesity must be an issue in the health care of remote and rural populations. There is a need to promote healthier environments that respect traditional food culture through multiple approaches that consider the heterogeneity of rural areas and the differences between sexes.	[Cattafesta, Monica; Petarli, Glenda Blaser; Zandonade, Eliana; Salaroli, Luciane Bresciani] Univ Fed Espirito Santo, Grad Program Collect Hlth, Vitoria, ES, Brazil; [Bezerra, Olivia Maria de Paula Alves] Univ Fed Ouro Preto, Dept Family Med Mental & Collect Hlth, Ouro Preto, MG, Brazil; [de Abreu, Sandra Marlene Ribeiro] Univ Porto, Univ Porto FADEUP, Fac Sports, Res Ctr Phys Act Hlth & Leisure CIAFEL,Lab Integra, Porto, Portugal; [de Abreu, Sandra Marlene Ribeiro] Univ Porto, Fac Sports, Res Ctr Phys Act Hlth & Leisure, Porto, Portugal	Universidade Federal do Espirito Santo; Universidade Federal de Ouro Preto; Universidade do Porto; Universidade do Porto	Salaroli, LB (corresponding author), Univ Fed Espirito Santo, Grad Program Collect Hlth, Vitoria, ES, Brazil.	lucianebresciani@gmail.com		Cattafesta, Monica/0000-0002-8973-622X	Research and Innovation Support Foundation of Espirito Santo (FAPES) [05/2015]	Research and Innovation Support Foundation of Espirito Santo (FAPES)	This research was funded by Research and Innovation Support Foundation of Espirito Santo (FAPES), URL: https://fapes.es.gov.br/with grant number FAPES/CNPq/Decit -SCTIE-MS/SESA n degrees 05/2015 -PPSUS (Research Program for Brazilian Health Unic System) received by LBS.	ABEP - ASSOCIACAO BRASILEIRA DE EMPRESAS DE PESQUISA, 2014, CRIT CLASS EC BRAS; Abeywickrama HM, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17010150; [Anonymous], 2015, PESQ NAC SAUD 2013 C; Bicalho Paula Gonçalves, 2010, Rev. Saúde Pública, V44, P884, DOI 10.1590/S0034-89102010005000023; Bixby H, 2019, NATURE, V569, P260, DOI 10.1038/s41586-019-1171-x; BRASIL, 2005, DIARIO OFICIAL UNIAO; Brumby S, 2013, J RURAL HEALTH, V29, P311, DOI 10.1111/jrh.12001; Caballero B, 2007, EPIDEMIOL REV, V29, P1, DOI 10.1093/epirev/mxm012; Canella DS, 2020, PUBLIC HEALTH NUTR, V23, pS29, DOI 10.1017/S136898001900274X; Carvalho E.O., 2011, 101 NC SA DE COLETIV, V16, P179, DOI [10.1590/S1413-81232011000100021, DOI 10.1590/S1413-81232011000100021]; Caspard H, 2018, DIABETES OBES METAB, V20, P667, DOI 10.1111/dom.13143; Cattafesta M., 2019, 101 NC SA DE COLETIV, V24, P3909, DOI [10.1590/1413-812320182410.31342017, DOI 10.1590/1413-812320182410.31342017]; Cattafesta M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240756; Cattafesta M, 2020, NUTR J, V19, DOI 10.1186/s12937-020-00542-y; Chen Y, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2006-9; Choi D, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.013471; Coutinho Leticia M S, 2008, Rev. Saúde Pública, V42, P992, DOI 10.1590/S0034-89102008000600003; da Luz TC, 2020, CIENC SAUDE COLETIVA, V25, P3919, DOI 10.1590/1413-812320202510.36022018; Selem SSD, 2014, J ACAD NUTR DIET, V114, P1216, DOI 10.1016/j.jand.2014.01.007; de Oliveira VH, 2014, ECON HUM BIOL, V15, P67, DOI 10.1016/j.ehb.2014.07.001; Donham KJ, 2019, J AGROMEDICINE, V24, P228, DOI [10.1080/1059924x.2019.1591316, 10.1080/1059924X.2019.1591316]; Dorner T, 2004, SOZ PRAVENTIV MED, V49, P243, DOI 10.1007/s00038-004-3120-0; Egger G, 1997, BRIT MED J, V315, P477, DOI 10.1136/bmj.315.7106.477; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; Fernandes MP, 2018, REV SAUDE PUBL, V52, DOI [10.11606/S1518-8787.2018052000267, 10.11606/s1518-8787.2018052000267]; Ferreira Arthur Pate de Souza, 2019, Rev. bras. epidemiol., V22, pe190024, DOI 10.1590/1980-549720190024; de Almeida TLF, 2021, FRONT NUTR, V8, DOI 10.3389/fnut.2021.671377; Finco FDBA FincoMVA., 2017, NFS J, V9, P1, DOI [10.1016/j.nfs.2017.08.001, DOI 10.1016/J.NFS.2017.08.001]; Rodrigues LPF, 2016, ECOL FOOD NUTR, V55, P365, DOI 10.1080/03670244.2016.1188090; Galeano AV.., 2017, PRODUCAO AGRICOLA MU; Haab RS., 2012, REV BRAS MED FAM COM, V7, P90, DOI [10.5712/rbmfc7(23)237, DOI 10.5712/RBMFC7(23)237]; Hill JL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1051; Hunter GR, 1997, MED SCI SPORT EXER, V29, P362, DOI 10.1097/00005768-199703000-00011; Instituto Brasileiro de Geografia e Estatistica., 2006, CENS AGR 2006; Instituto Brasileiro de Geografia e Estatistica (IBGE), 2020, PESQUISA NACL AMOSTR; Instituto Brasileiro de Geografia e Estatistica IBGE, 2010, PESQ ORC FAM 2008 20; Isara AR, 2015, PAN AFR MED J, V20, DOI 10.11604/pamj.2015.20.103.5619; Justo GF, 2012, RURAL REMOTE HEALTH, V12; Kapelios CJ, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4053-x; Karmakar N., 2019, CHRISMED J HLTH RES, V6, P23, DOI [10.4103/cjhr.cjhr_6_18, DOI 10.4103/CJHR.CJHR_6_18]; Kirunda BE, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2506-7; Lenardson JD, 2015, CURR OBES REP, V4, P46, DOI 10.1007/s13679-014-0136-5; Lima R de S., 2016, ESTUDOS SOCIOCULTURA, P59; Little Matthew, 2016, BMC Obes, V3, P12, DOI 10.1186/s40608-016-0091-7; Lucan SC, 2012, CHILD OBES, V8, P484, DOI 10.1089/chi.2012.0063; Lukacs A, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7839-1; Martins-Silva Thais, 2019, Rev. bras. epidemiol., V22, pe190049, DOI 10.1590/1980-549720190049; Martins-Silva T, 2018, REV SAUDE PUBL, V52, DOI [10.11606/S1518-8787.2018052000264, 10.11606/s1518-8787.2018052000264]; Meshram II, 2016, BRIT J NUTR, V115, P1265, DOI 10.1017/S0007114516000039; Monasterio LM., 2006, MUNICH PERS REPEC AR, V1118, P1; Moniruzzaman M, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-016-4003-z; Mu M, 2017, IRAN J PUBLIC HEALTH, V46, P869; Neuman M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099327; Nogueira VC.., 2019, 101 NC SA DE COLETIV, V24, P761, DOI [10.1590/1413-81232018243.03362017, DOI 10.1590/1413-81232018243.03362017]; NORGAN NG, 1988, ERGONOMICS, V31, P1493, DOI 10.1080/00140138808966796; Nucleo de Estudos e Pesquisas em Alimentacao (NEPA). Universidade Estadual de Campinas (UNICAMP), 2011, TABELA BRASILEIRA CO, V4; Nusser SM, 1996, J AM STAT ASSOC, V91, P1440, DOI 10.2307/2291570; Olinto M.T.A., 2007, EPIDEMIOLOGIA NUTR, P213; Oliveira Ernesto P. de, 2006, Arq Bras Endocrinol Metab, V50, P456, DOI 10.1590/S0004-27302006000300008; Park S, 2019, NEUROTOXICOLOGY, V70, P12, DOI 10.1016/j.neuro.2018.10.007; Paula Costa DVde., DIFERENCAS CONSUMO A; Pei LL, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1503-1; Petarli GB, 2022, J MENT HEALTH, DOI 10.1080/09638237.2022.2069701; Petarli GB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225416; Pickett W, 2015, PREV MED, V70, P59, DOI 10.1016/j.ypmed.2014.11.012; Pimenta AM., 2011, 101 NC SA DE COLETIV, V16, P3297, DOI [10.1590/S1413-81232011000800029, DOI 10.1590/S1413-81232011000800029]; Pinho Claudia Porto Sabino, 2013, Cad Saude Publica, V29, P313, DOI 10.1590/S0102-311X2013000200018; Poobalan A, 2016, CURR OBES REP, V5, P2, DOI 10.1007/s13679-016-0187-x; Popkin BM, 2019, NATURE, V569, P200, DOI 10.1038/d41586-019-01182-x; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Wagner KJP, 2019, J EPIDEMIOL COMMUN H, V73, P544, DOI 10.1136/jech-2018-211664; Ramolefhe G. T., 2015, African Journal of Food, Agriculture, Nutrition and Development, V15, P10455; Reinaldo EDF, 2015, INTERCIENCIA, V40, P8; Rezagholizadeh F, 2017, NUTR RES, V41, P1, DOI 10.1016/j.nutres.2017.01.006; de Castro IRR, 2017, CAD SAUDE PUBLICA, V33, DOI [10.1590/0102-311x00100017, 10.1590/0102-311X00100017]; Robles B, 2014, PREV MED, V67, pS34, DOI 10.1016/j.ypmed.2014.02.016; Roman G, 2019, ACTA ENDOCRINOL-BUCH, V15, P86, DOI 10.4183/aeb.2019.86; Said-Mohamed R, 2018, ANN HUM BIOL, V45, P123, DOI 10.1080/03014460.2018.1442497; Salaroli LB.., 2019, FATORES RISCO DOENCA, P32; Salaroli LB, 2020, CLINICS, V75, DOI 10.6061/clinics/2020/e1603; Shyam S, 2020, PUBLIC HEALTH NUTR, V23, P319, DOI 10.1017/S1368980019001861; Sichieri R, 2008, CAD SAUDE PUBLICA, V24, pS209, DOI 10.1590/S0102-311X2008001400002; Sichieri R, 2010, BRIT J NUTR, V103, P1534, DOI 10.1017/S0007114509993448; Siddiquee T, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2193-4; Silva DA, 2008, ARQ BRAS ENDOCRINOL, V52, P489, DOI 10.1590/S0004-27302008000300009; Silva NRda.., 2018, DEMETRA ALIMENT NUTR, V13, P925, DOI [10.12957/demetra.2018.34989, DOI 10.12957/DEMETRA.2018.34989]; Sterling SR, 2017, PREV CHRONIC DIS, V14, DOI 10.5888/pcd14.160595; Stevens GA, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-22; Stuetz W, 2019, NUTRIENTS, V11, DOI 10.3390/nu11051025; Swinburn BA, 2019, LANCET, V393, P791, DOI 10.1016/S0140-6736(18)32822-8; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Tagliari IA., 2016, J HUM GROWTH DEV, V26, P67, DOI [10.7322/jhgd.113723, DOI 10.7322/JHGD.113723]; Tateyama Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208176; Triches Rozane Marcia, 2015, Cuad. Desarro. Rural, V12, P55, DOI 10.11144/Javeriana.cdr12-75.asac; Tripathy JP, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3489-8; van Doorn D, 2017, J AGROMEDICINE, V22, P264, DOI 10.1080/1059924X.2017.1318728; Vandevijvere S, 2015, B WORLD HEALTH ORGAN, V93, P446, DOI 10.2471/BLT.14.150565; Velasquez-Melendez G, 2007, SAO PAULO MED J, V125, P155, DOI 10.1590/S1516-31802007000300006; Wang Y, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5577-4; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; WHO, 2011, WORLD REPORT ON DISABILITY, P1; WHO Consultation, 2000, WHO TECH REP SER, V894, P1; Willett W., 2012, NUTR EPIDEMIOLOGY; Witeck GA, 2010, SCI MED, V20, P282	104	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7							e0270233	10.1371/journal.pone.0270233	http://dx.doi.org/10.1371/journal.pone.0270233			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M2ZD	35797372	Green Published, gold			2022-12-26	WOS:000835328600021
J	Lovering, JR; Swain, M; Blomqvist, L; Hernandez, R				Lovering, Jessica R.; Swain, Marian; Blomqvist, Linus; Hernandez, Rebecca			Land-use intensity of electricity production and tomorrow's energy landscape	PLOS ONE			English	Article							RENEWABLE ENERGY; SOLAR-ENERGY; USE REQUIREMENTS; IMPACTS; BIODIVERSITY; GENERATION; WATER; COUNTRIES; WILDLIFE; HABITAT	Eq 1: Direct land use intensity Eq 2: Indirect land use intensity (applicable energy systems: coal, natural gas, biomass, nuclear) The global energy system has a relatively small land footprint at present, comprising just 0.4% of ice-free land. This pales in comparison to agricultural land use- 30-38% of ice-free land-yet future low-carbon energy systems that shift to more extensive technologies could dramatically alter landscapes around the globe. The challenge is more acute given the projected doubling of global energy consumption by 2050 and widespread electrification of transportation and industry. Yet unlike greenhouse gas emissions, land use intensity of energy has been rarely studied in a rigorous way. Here we calculate land-use intensity of energy (LUIE) for real-world sites across all major sources of electricity, integrating data from published literature, databases, and original data collection. We find a range of LUIE that span four orders of magnitude, from nuclear with 7.1 ha/TWh/y to dedicated biomass at 58,000 ha/TWh/y. By applying these LUIE results to the future electricity portfolios of ten energy scenarios, we conclude that land use could become a significant constraint on deep decarbonization of the power system, yet low-carbon, land-efficient options are available. Eq 4: Direct area definitions (applicable energy systems: natural gas, wind) Eq 3: Total land use intensity	[Lovering, Jessica R.] Univ Michigan, Fastest Path Zero Initiat, Ann Arbor, MI 48109 USA; [Swain, Marian] Breakthrough Inst, Oakland, CA USA; [Blomqvist, Linus] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA USA; [Hernandez, Rebecca] Univ Calif Berkeley, Energy & Resources Grp, Berkeley, CA USA; [Hernandez, Rebecca] Lawrence Berkeley Natl Lab, Climate & Carbon Sci Program, Earth Sci Div, Berkeley, CA USA; [Hernandez, Rebecca] Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA USA; [Hernandez, Rebecca] Univ Calif Davis, John Muir Inst Environm, Wild Energy Initiat, Davis, CA USA	University of Michigan System; University of Michigan; University of California System; University of California Santa Barbara; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Davis; University of California System; University of California Davis	Lovering, JR (corresponding author), Univ Michigan, Fastest Path Zero Initiat, Ann Arbor, MI 48109 USA.	lovering@umich.edu		Swain, Marian/0000-0002-8087-8686; Lovering, Jessica/0000-0003-3797-774X	USDA National Institute of Food and Agriculture Hatch Project [1010512]; Department of Land, Air and Water Resources at UC Davis; UC President's Postdoctoral Fellowship	USDA National Institute of Food and Agriculture Hatch Project; Department of Land, Air and Water Resources at UC Davis; UC President's Postdoctoral Fellowship	R.R.H. received funding for this project from the USDA National Institute of Food and Agriculture Hatch Project 1010512, the Department of Land, Air and Water Resources at UC Davis, and the UC President's Postdoctoral Fellowship. https://nifa.usda.gov/grants https://www.lawr.ucdavis.edu/https://ppfp.ucop.edu/info/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abt RC, 2010, BIOMASS BIOENERG, V34, P1679, DOI 10.1016/j.biombioe.2010.05.007; American S, 2009, SCI AM S A PATH SUST, P1; Angel S, 2011, PROG PLANN, V75, P53, DOI 10.1016/j.progress.2011.04.001; [Anonymous], **DATA OBJECT**, DOI 10.5281/zenodo.4613099; Arent D, 2014, APPL ENERG, V123, P368, DOI 10.1016/j.apenergy.2013.12.022; Bertani R, 2005, GEOTHERMICS, V34, P651, DOI 10.1016/j.geothermics.2005.09.005; Bondarkov MD, 2011, HEALTH PHYS, V101, P442, DOI 10.1097/HP.0b013e318229df28; Boyce MS, 2011, ENERGY DEV WILDLIFE, pix; BP, 2018, BP STAT REV WORLD EN; Brook BW, 2012, ENERG POLICY, V42, P4, DOI 10.1016/j.enpol.2011.11.041; Bryce R, 2011, POWER HUNGRY MYTHS G; Cagle AE, SUSTAINABILITY-BASEL, V12; Capellan-Perez I, 2017, RENEW SUST ENERG REV, V77, P760, DOI 10.1016/j.rser.2017.03.137; Conkling TJ, 2022, ROY SOC OPEN SCI, V9, DOI 10.1098/rsos.211558; Copeland Holly E., 2011, P7; Dale S., 2021, STAT REV WORLD EN; Denholm P, LAND USE REQUIREMENT; Denholm P, 2008, ENERG POLICY, V36, P3531, DOI 10.1016/j.enpol.2008.05.035; Deryabina TG, 2015, CURR BIOL, V25, pR824, DOI 10.1016/j.cub.2015.08.017; Dijkman TJ, 2010, RENEW SUST ENERG REV, V14, P3148, DOI 10.1016/j.rser.2010.07.029; DOE,, 1983, EN TECHN CHAR HDB EN; Doesburg SM, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006142, 10.1371/journal.pone.0006802]; EIA (Energy Information Administration), 2015, EIA EL DAT NOW INCL; Eliasson B, 2003, INTEGRATED ASSESSMEN; Finch WI, URANIUM ITS IMPACT N; Fthenakis V, 2009, RENEW SUST ENERG REV, V13, P1465, DOI 10.1016/j.rser.2008.09.017; Gagnon Pieter, 2016, NRELTP6A2065298; Gasparatos A, 2017, RENEW SUST ENERG REV, V70, P161, DOI 10.1016/j.rser.2016.08.030; Gates DM, 1985, ENERGY ECOLOGY; Giordono LS, 2018, ENERGY RES SOC SCI, V43, P119, DOI 10.1016/j.erss.2018.05.016; Greenpeace International European Renewable Energy Council Council GWE, 2012, EN REV SUST WORLD EN; Grodsky SM, 2021, BIOL CONSERV, V263, DOI 10.1016/j.biocon.2021.109336; Guo YH, 2022, ENERG CONVERS MANAGE, V255, DOI 10.1016/j.enconman.2022.115319; Hadjerioua B., 2012, ASSESSMENT ENERGY PO, DOI [10.2172/1039957, DOI 10.2172/1039957]; Harries J, 1997, NUCL ENG DES, V176, P15, DOI 10.1016/S0029-5493(96)01337-4; Hernandez RR, 2019, NAT SUSTAIN, V2, P560, DOI 10.1038/s41893-019-0309-z; Hernandez RR, 2015, P NATL ACAD SCI USA, V112, P13579, DOI 10.1073/pnas.1517656112; Hernandez RR, 2015, NAT CLIM CHANGE, V5, P353, DOI 10.1038/nclimate2556; Hernandez RR, RENEW SUST ENERG REV; Hertwich EG, 2015, P NATL ACAD SCI USA, V112, P6277, DOI 10.1073/pnas.1312753111; Horner RM, 2013, LIFE CYCLE LAND USE; Hurford AP, 2013, ENVIRON SCI POLICY, V38, P1; IEA, 2015, TECHN ROADM HYDR FUE, DOI [10.1007/SpringerReference_7300, DOI 10.1007/SPRINGERREFERENCE_7300]; IEA, 2017, ENERGY TECHNOLOGY PE, DOI DOI 10.1787/ENERGY_TECH-2017-EN; IEA: Directorate of Global Energy Economics, 2014, WORLD EN OUTL 2014, P726, DOI [10.1787/weo-2014-en, DOI 10.1787/WEO-2014-EN]; International Commission on Large Dams, 2022, WORLD REG DAMS REG M; Jacobson MZ, 2017, JOULE, V1, P108, DOI 10.1016/j.joule.2017.07.005; Jacobson MZ, 2011, ENERG POLICY, V39, P1154, DOI 10.1016/j.enpol.2010.11.040; Jacobson MZ, 2009, ENERG ENVIRON SCI, V2, P148, DOI 10.1039/b809990c; Jenkins JD, 2021, JOULE, V5, P2755, DOI 10.1016/j.joule.2021.10.016; Johansson TB, 2012, GLOBAL ENERGY ASSESS; Jones IL, 2014, ECOL EVOL, V4, P79, DOI 10.1002/ece3.884; Jordaan SM, 2017, NAT ENERGY, V2, DOI 10.1038/s41560-017-0004-0; Jordaan SM, 2010, LAND USE FOOTPRINT E; Kareiva PM, 2012, P NATL ACAD SCI USA, V109, P5553, DOI 10.1073/pnas.1203263109; Keoleian GA, 2005, CRIT REV PLANT SCI, V24, P385, DOI 10.1080/07352680500316334; Khan MR, 2021, J PHYS D APPL PHYS, V54, DOI 10.1088/1361-6463/abfce5; Kiesecker JM, 2010, FRONT ECOL ENVIRON, V8, P261, DOI 10.1890/090005; Kumar A, 2003, BIOMASS BIOENERG, V24, P445, DOI 10.1016/S0961-9534(02)00149-6; Lambin EF, 2011, P NATL ACAD SCI USA, V108, P3465, DOI 10.1073/pnas.1100480108; Lee K, 2013, NUCL ENG DES, V254, P129, DOI 10.1016/j.nucengdes.2012.09.011; MacKay DJC, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2011.0431; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Millennium Ecosystem Assessment, 2005, ECOSYSTEMS HUMAN WEL; Mudd GM, 2011, COMPILATION URANIUM, V41; Northrup JM, 2013, ECOL LETT, V16, P112, DOI 10.1111/ele.12009; Oakleaf JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138334; OECD/NEA,, 2014, UR 2014 RES PROD DEM; Ong S, 2013, LAND USE REQUIREMENT, P1, DOI DOI 10.2172/1086349; Pimentel D, 2002, BIOSCIENCE, V52, P1111, DOI 10.1641/0006-3568(2002)052[1111:RECAPI]2.0.CO;2; Schlomer S., 2014, CLIMATE CHANGE 2014; Schneider E, 2013, ENERG ECON, V40, P911, DOI 10.1016/j.eneco.2013.08.006; Searchinger T, 2015, AVOIDING BIOENERGY C; Skone TJ, 2014, LIFE CYCLE ANAL NATU; Smil V., 2015, POWER DENSITY KEY UN; Smil V, 2010, POWER DENSITY PRIM 1; Smith J, BUILT ENV WIND TURBI; Smith P, 2010, PHILOS T R SOC B, V365, P2941, DOI 10.1098/rstb.2010.0127; Solar Energy Industries Association,, 2015, MAJ SOL PROJ US OP U; Spitzley D V, 2005, LIFE CYCLE ENV EC AS; Trainor AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162269; U.S. Energy Information Administration,, 860 EIA; U.S. Energy Information Administration,, 923 EIA; Vo TTE, 2021, ENERGIES, V14, DOI 10.3390/en14216988; World Health Organization, 2015, POW PLANT ONL DAT; World Nuclear Association,, 2016, FUKUSHIMA ACCIDENT; World Wildlife Fund,, 2011, EN REP 100 REN EN 20; Wu GC, 2015, ENVIRON SCI TECHNOL, V49, P2013, DOI 10.1021/es502979v; Ziv G, 2012, P NATL ACAD SCI USA, V109, P5609, DOI 10.1073/pnas.1201423109	89	0	0	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7								10.1371/journal.pone.0270155	http://dx.doi.org/10.1371/journal.pone.0270155			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M3CI	35793381	Green Published, gold			2022-12-26	WOS:000835338100037
J	Qureshi, A; Sulaiman, SAS; Kumar, N; Qureshi, PAAA				Qureshi, Ali; Syed Sulaiman, Syed Azhar; Kumar, Narendar; Qureshi, Pir Abdul Ahad Aziz			Knowledge, perception, and fear among the global population towards newly evoked variant Omicron (B.1.1.529)	PLOS ONE			English	Article							COVID-19	Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-1), notoriously known as COVID-19, emerged in 2019 and was responsible for causing acute respiratory collapse. Moreover, in September 2020, new variant cases of severe acute respiratory syndrome coronavirus 2 were reported in the United Kingdom, with many patients and deaths. This study aimed to see knowledge, perception, and fear among the global population towards a new variant of severe acute respiratory syndrome coronavirus 2, known as Omicron (B.1.1.529). This online cross-sectional global study was conducted during the emergence of the B.1.1.529 variant, also known as the Omicron variant. The survey was carried out from 2(nd) December 2021 to 3(rd) January 2022. The descriptive analysis was presented as frequencies (N), percentages (%), and mean +/- standard deviation (m +/- SD). The association between dependent and categorical independent variables was determined using the Chi-square test (x2). Statistical analysis was performed by using SPSS version 23. Of 353 respondents, approximately 61% were females. One hundred fifty-four respondents were in the age group of 18-27 years. The average age was 31.53 +/- 10.3 (mean +/- SD). The majority of respondents (43.9%) were from Indonesia. The mean knowledge score about the Omicron variant was 3.18 +/- 1.14. Our study suggests that people have some knowledge about the new variant, Omicron (B.1.1.529). Besides, there was a significant association (p = 0.05) for the perception of the fatality rate of Omicron among the respondents from different countries. However, there is still an ample research gap in enlightening people about this infection (B.1.1.529).	[Qureshi, Ali; Syed Sulaiman, Syed Azhar; Kumar, Narendar] USM, Sch Pharmaceut Sci, Dept Clin Pharm, George Town, Malaysia; [Qureshi, Ali; Kumar, Narendar] Univ Sindh Jamshoro, Fac Pharm, Jamshoro, Pakistan; [Qureshi, Pir Abdul Ahad Aziz] Syed Abdullah Shah Inst Med Sci, Dept Radiol, Sindh, Pakistan	Universiti Sains Malaysia; University of Sindh	Sulaiman, SAS (corresponding author), USM, Sch Pharmaceut Sci, Dept Clin Pharm, George Town, Malaysia.	sazhar@usm.my	Kumar, Narendar/AAF-9404-2021	Kumar, Narendar/0000-0002-2648-3915; syed sulaiman, syed azhar/0000-0001-5535-2802				Abdelhafiz AS, 2020, J COMMUN HEALTH, V45, P881, DOI 10.1007/s10900-020-00827-7; Akter R, 2021, ENVIRON SCI POLLUT R, V28, P68071, DOI 10.1007/s11356-021-16809-8; Al-Hatamleh MAI, 2021, EUR J PHARMACOL, V896, DOI 10.1016/j.ejphar.2021.173930; Bourgonje AR, 2020, J PATHOL, V251, P228, DOI 10.1002/path.5471; Cao Y, 2021, NUMER LINEAR ALGEBR, V28, DOI [10.1038/s41586-021-04385-3, 10.1002/nla.2362]; Chakraborty C, 2021, ANN MED SURG, V66, DOI 10.1016/j.amsu.2021.102428; Control ECfDPa, 2021, THREAT ASS BRIEF EM; Duong D, 2021, CAN MED ASSOC J, V193, pE1059, DOI 10.1503/cmaj.1095949; Duong D, 2021, CAN MED ASSOC J, V193, pE141, DOI 10.1503/cmaj.1095915; Ferraz MVF, 2021, CHEM COMMUN, V57, P6094, DOI 10.1039/d1cc01747k; Fourati S, 2021, EMERG INFECT DIS, V27, P1540, DOI 10.3201/eid2705.210324; Guo SX, 2021, INT J BIOL SCI, V17, P1476, DOI 10.7150/ijbs.59137; Hanson, 2021, CLASS OM B1 1 529 SA, P2021; Harvey WT, 2021, NAT REV MICROBIOL, V19, P409, DOI 10.1038/s41579-021-00573-0; Karthika C, 2021, ENVIRON SCI POLLUT R, V28, P64951, DOI 10.1007/s11356-021-16654-9; Khandia R, 2022, ENVIRON RES, V209, DOI 10.1016/j.envres.2022.112816; Krause PR, 2021, NEW ENGL J MED, V385, P179, DOI 10.1056/NEJMsr2105280; Kumar N, 2021, J RES PHARM, V25, P881, DOI 10.29228/jrp.84; Lee K, 2009, GLOB INST, P1; Letko M, 2020, NAT MICROBIOL, V5, P562, DOI [10.1038/s41564-020-0688-y, 10.1101/2020.01.22.915660]; Madhi SA., 2022, MEDRXIV; Mohd Hanafiah K., 2020, PUBLIC KNOWLEDGE PER, V35, P201, DOI DOI 10.31124/ADVANCE.12102816.V1; Muhammad S., 2021, J PHARM RES INT, V32, P30; Muhammad S, 2021, J RES PHARM, V25, P937, DOI 10.29228/jrp.90; Organization; WH, 2021, WEEKLY EPIDEMIOLOGIC; Organization WH, 2021, ADV PUBL COR DIS COV; Ozer E., 2021, MEDRXIV, DOI [10.1101/2021.04.09.21255206, DOI 10.1101/2021.04.09.21255206]; Panzera Y, 2021, MICROBIOL RESOUR ANN, V10, DOI 10.1128/MRA.00410-21; Prevention CfDCa, 2022, OM VAR WHAT YOU NEED; Ramanathan M, 2021, LANCET INFECT DIS, V21, P1070, DOI 10.1016/S1473-3099(21)00262-0; Romano CM, 2021, REV INST MED TROP SP, V63, DOI [10.1590/S1678-9946202163036, 10.1590/s1678-9946202163036]; Sabino EC, 2021, LANCET, V397, P452, DOI 10.1016/S0140-6736(21)00183-5; Temsah M-H., 2021, MEDRXIV; Thiagarajan K, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1124; Vaidyanathan G, 2021, NATURE, V593, P321, DOI 10.1038/d41586-021-01274-7; Yue ST, 2021, J COMMUN HEALTH, V46, P286, DOI 10.1007/s10900-020-00877-x	36	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7								10.1371/journal.pone.0270761	http://dx.doi.org/10.1371/journal.pone.0270761			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M3CI	35793377	Green Published, gold			2022-12-26	WOS:000835338100048
J	Son, KY; Shin, DW; Lee, JE; Kim, SH; Yun, JM; Cho, B				Son, Ki Young; Shin, Dong Wook; Lee, Ji Eun; Kim, Sang Hyuck; Yun, Jae Moon; Cho, Belong			Association between timed up and go test and future incidence of disability: A nationwide representative longitudinal study in Korea	PLOS ONE			English	Article							BODY-MASS INDEX; GAIT SPEED; HANDGRIP STRENGTH; HEALTH DISPARITIES; MORTALITY; WOMEN; ADULTS; PERFORMANCE; BEHAVIORS; PATTERNS	Although previous studies examined the association between mobility and disability, they have used either subjective measure disability such as activity of daily living or instrumental activity of daily living or indirect measure such as long-term care service use with small size of participants. This study aimed to examine the association between timed up and go (TUG) test and disability incidence with national disability registration data in Korea longitudinally, by using a national representative sample. We used the National Health Insurance Service-National Health Screening Cohort (NHIS-HEALS) database of National Health Information Database. The NHIS-HEALS dataset includes disability information of National Screening Programme participants, including registration date and type of disability, which is merged from Korean National Disability Registry (KNDR). We used Cox proportional hazard models to evaluate the association between TUG and disability incidence. We constructed three models with different levels of adjustment; Model 3 was a fully adjusted model. We conducted subgroup analysis according to the risk factors for disability. The study population comprised 81,473 participants; 86 of them were newly registered to KNDR, which were observed during a mean follow-up of 4.1 +/- 2.6 (maximum, 8.9) years. For 334,200.9 person-year (PY) follow-up, the disability incidence rate was 0.208 per 1,000 PY. Disability incidence was significantly higher in participants with abnormal TUG results than in those with normal TUG results. (adjusted hazard ratio [aHR] 1.600, 95% confidence interval [CI] 1.036-2.472). In subgroup analysis, the disability incidence increased in participants of normal cognition, without obesity or without cardiovascular (CV) disease. Increased incidence in disability was noted in participants with abnormal TUG results. The increase was more evident for participants with normal cognition, without obesity or CV disease.	[Son, Ki Young] Asan Med Ctr, Dept Family Med, Seoul, South Korea; [Shin, Dong Wook] Sungkyunkwan Univ, Support Care Ctr, Samsung Med Ctr, Dept Family Med,Sch Med, Seoul, South Korea; [Shin, Dong Wook] Sungkyunkwan Univ, Ctr Clin Epidemiol, SAIHST, Seoul, South Korea; [Lee, Ji Eun; Yun, Jae Moon; Cho, Belong] Seoul Natl Univ Hosp, Dept Family Med, Seoul, South Korea; [Lee, Ji Eun; Yun, Jae Moon; Cho, Belong] Seoul Natl Univ Hosp, Hlth Promot Ctr, Seoul, South Korea; [Kim, Sang Hyuck] Bumin Hosp, Dept Family Med, Seoul, South Korea; [Cho, Belong] Seoul Natl Univ, Coll Med, Inst Aging, Seoul, South Korea	University of Ulsan; Asan Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Son, KY (corresponding author), Asan Med Ctr, Dept Family Med, Seoul, South Korea.	mdsky75@gmail.com		Son, Ki Young/0000-0003-1262-100X	KYS; Hanmi Group, Seoul, Korea [0620140890 (2013-2607)]	KYS; Hanmi Group, Seoul, Korea	KYS awarded a grant from the Hanmi Group [0620140890 (2013-2607)], Seoul, Korea. The funder had no role in the design or conduct of the study.	Al Snih S, 2002, J AM GERIATR SOC, V50, P1250, DOI 10.1046/j.1532-5415.2002.50312.x; Artaud F, 2015, J AM GERIATR SOC, V63, P1129, DOI 10.1111/jgs.13442; Becker H, 2008, PUBLIC HEALTH NURS, V25, P526, DOI 10.1111/j.1525-1446.2008.00739.x; Bertoli S, 2006, NUTR METAB CARDIOVAS, V16, P100, DOI 10.1016/j.numecd.2005.05.007; Blaum CS, 2005, DIABETIC MED, V22, P543, DOI 10.1111/j.1464-5491.2005.01457.x; Brach JS, 2007, J GERONTOL A-BIOL, V62, P983, DOI 10.1093/gerona/62.9.983; Brawarsky P, 2002, TOB CONTROL, V11, pII29; Centers for Disease Control and Prevention (CDC), 1998, MMWR Morb Mortal Wkly Rep, V47, P853; Chainani V, 2016, INT J CARDIOL, V215, P487, DOI 10.1016/j.ijcard.2016.04.068; Cho M. J., 1999, J KOREAN NEUROPSYCHI, V38, P48; Chun SH, 2017, ARCH GERONTOL GERIAT, V68, P174, DOI 10.1016/j.archger.2016.10.008; Diab ME, 2004, ARCH PHYS MED REHAB, V85, P749, DOI 10.1016/j.apmr.2003.06.028; Donoghue OA, 2014, ARCH PHYS MED REHAB, V95, P1954, DOI 10.1016/j.apmr.2014.06.008; Ekstrom H, 2011, J AGING HEALTH, V23, P1379, DOI 10.1177/0898264311418504; Ferraro KF, 2002, AM J PUBLIC HEALTH, V92, P834, DOI 10.2105/AJPH.92.5.834; Guralnik JM, 2000, J GERONTOL A-BIOL, V55, pM221, DOI 10.1093/gerona/55.4.M221; Havercamp SM, 2004, PUBLIC HEALTH REP, V119, P418, DOI 10.1016/j.phr.2004.05.006; Huang WNW, 2010, J AM GERIATR SOC, V58, P844, DOI 10.1111/j.1532-5415.2010.02820.x; Huisman MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086863; Iezzoni LI, 2000, AM J PUBLIC HEALTH, V90, P955, DOI 10.2105/AJPH.90.6.955; Jones GC, 2004, FAM COMMUNITY HEALTH, V27, P22, DOI 10.1097/00003727-200401000-00004; Jones GC, 2008, DISABIL REHABIL, V30, P901, DOI 10.1080/09638280701800392; Kim HS, 2012, J KOREAN MED SCI, V27, pS70, DOI 10.3346/jkms.2012.27.S.S70; 양동원, 2002, [Journal of the Korean Neurological Association, 대한신경과학회지], V20, P135; Kuo HK, 2007, GERONTOLOGY, V53, P102, DOI 10.1159/000096792; Lee JE, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e25; Ling CHY, 2010, CAN MED ASSOC J, V182, P429, DOI 10.1503/cmaj.091278; Makizako H, 2017, PHYS THER, V97, P417, DOI 10.2522/ptj.20150665; Mansson NO, 1996, INT J EPIDEMIOL, V25, P80, DOI 10.1093/ije/25.1.80; National Rehabilitation Center, 2018, 2016 STAT DIS HLTH; Nosek MA, 1997, ARCH PHYS MED REHAB, V78, pS39, DOI 10.1016/S0003-9993(97)90220-3; Perera S, 2016, J GERONTOL A-BIOL, V71, P63, DOI 10.1093/gerona/glv126; Ramirez A, 2005, AM J PUBLIC HEALTH, V95, P2057, DOI 10.2105/AJPH.2005.066118; Rantanen T, 2003, J AM GERIATR SOC, V51, P636, DOI 10.1034/j.1600-0579.2003.00207.x; Rimmer JH, 1999, MED SCI SPORT EXER, V31, P613, DOI 10.1097/00005768-199904000-00020; Seong SC, 2017, INT J EPIDEMIOL, V46, P799, DOI 10.1093/ije/dyw253; Smith EM, 2009, ARCH PHYS MED REHAB, V90, P1127, DOI 10.1016/j.apmr.2008.09.578	37	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7								10.1371/journal.pone.0270808	http://dx.doi.org/10.1371/journal.pone.0270808			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M5FN	35789342	Green Published, gold			2022-12-26	WOS:000835487000012
J	Saffi, GT; Wang, CA; Mangialardi, EM; Vacher, J; Botelho, RJ; Salmena, L				Saffi, Golam T.; Wang, Cheng An; Mangialardi, Emily M.; Vacher, Jean; Botelho, Roberto J.; Salmena, Leonardo			Inhibition of lipid kinase PIKfyve reveals a role for phosphatase Inpp4b in the regulation of PI(3)P-mediated lysosome dynamics through VPS34 activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL; BIOGENESIS; PROTEIN; FUSION; FLUX	Lysosome membranes contain diverse phosphoinositide (PtdIns) lipids that coordinate lysosome function and dynamics. The PtdIns repertoire on lysosomes is tightly regulated by the actions of diverse PtdIns kinases and phosphatases; however, specific roles for PtdIns in lysosomal functions and dynamics are currently unclear and require further investigation. It was previously shown that PIKfyve, a lipid kinase that synthesizes PtdIns(3,5)P-2 from PtdIns(3)P, controls lysosome "fusion-fission" cycle dynamics, autophagosome turnover, and endocytic cargo delivery. Furthermore, INPP4B, a PtdIns 4-phosphatase that hydrolyzes PtdIns(3,4)P-2 to form PtdIns(3) P, is emerging as a cancer-associated protein with roles in lysosomal biogenesis and other lysosomal functions. Here, we investigated the consequences of disrupting PIKfyve function in Inpp4b-deficient mouse embryonic fibroblasts. Through confocal fluorescence imaging, we observed the formation of massively enlarged lysosomes, accompanied by exacerbated reduction of endocytic trafficking, disrupted lysosome fusion-fission dynamics, and inhibition of autophagy. Finally, HPLC scintillation quantification of H-3-myo-inositol labeled PtdIns and PtdIns immunofluorescence staining, we observed that lysosomal PtdIns(3)P levels were significantly elevated in Inpp4b-deficient cells due to the hyperactivation of phosphatidylinositol 3-kinase catalytic subunit VPS34 enzymatic activity. In conclusion, our study identifies a novel signaling axis that maintains normal lysosomal homeostasis and dynamics, which includes the catalytic functions of Inpp4b, PIKfyve, and VPS34.	[Saffi, Golam T.; Wang, Cheng An; Mangialardi, Emily M.; Salmena, Leonardo] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada; [Vacher, Jean] Univ Montreal, Inst Rech Clin Montreal IRCM, Dept Med, Montreal, PQ, Canada; [Botelho, Roberto J.] Ryerson Univ, Dept Chem & Biol, Toronto, ON, Canada; [Salmena, Leonardo] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada	University of Toronto; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Toronto Metropolitan University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Salmena, L (corresponding author), Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada.; Salmena, L (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada.	leonardo.salmena@utoronto.ca	Botelho, Roberto/B-9145-2013	Botelho, Roberto/0000-0002-7820-0999; Vacher, Jean/0000-0002-4560-3476	Tier II Canada Research Chair (CRC); Human Frontier Career Development Program (HFSP) Award; Natural Sciences and Engineering Council of Canada [RGPIN2020-04343]; Canada Research Chairs Program [950-232333]; Ryerson University; CIHR [123343]	Tier II Canada Research Chair (CRC); Human Frontier Career Development Program (HFSP) Award; Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs Program(Canada Research Chairs); Ryerson University; CIHR(Canadian Institutes of Health Research (CIHR))	L. S. is the recipient of a Tier II Canada Research Chair (CRC) and was supported through the Human Frontier Career Development Program (HFSP) Award. R. J. B contributions to this work was funded by Natural Sciences and Engineering Council of Canada (Discovery Grant RGPIN2020-04343), the Canada Research Chairs Program (950-232333), and contributions from Ryerson University. This work was supported in part by funds from CIHR (MOP#123343) awarded to J. V.	A.Fountain, 2019, bioRxiv, DOI 10.1101/705491; Bago R, 2014, BIOCHEM J, V463, P413, DOI 10.1042/BJ20140889; Baluska F, 2004, J EXP BOT, V55, P463, DOI 10.1093/jxb/erh042; Bissig C, 2017, TRAFFIC, V18, P747, DOI 10.1111/tra.12525; Bright NA, 2005, CURR BIOL, V15, P360, DOI 10.1016/j.cub.2005.01.049; Bright NA, 2016, CURR BIOL, V26, P2233, DOI 10.1016/j.cub.2016.06.046; Brijmohan AS, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00034; Chaurra A, 2011, APPL SPECTROSC, V65, P20, DOI 10.1366/10-06095; Choy CH, 2018, J CELL SCI, V131, DOI 10.1242/jcs.213587; Dayam RM, 2015, TRAFFIC, V16, P1010, DOI 10.1111/tra.12303; de Campos CB, 2020, HAEMATOLOGICA, V105, P1641, DOI 10.3324/haematol.2019.222729; Duclos S, 2003, J CELL SCI, V116, P907, DOI 10.1242/jcs.00259; Dyson Jennifer M, 2012, Subcell Biochem, V58, P215, DOI 10.1007/978-94-007-3012-0_7; Ebner M, 2019, BIOCHEM SOC T, V47, P1173, DOI 10.1042/BST20190158; Gayle S, 2017, BLOOD, V129, P1768, DOI 10.1182/blood-2016-09-736892; Giridharan S. S. P., 2021, BIORXIV, DOI [10.1101/2021.05.25.445615, DOI 10.1101/2021.05.25.445615]; Giridharan SSP, 2022, ELIFE, V11, DOI [10.7554/eLife.69709, 10.7554/eLife.69709.sa0, 10.7554/eLife.69709.sa1, 10.7554/eLife.69709.sa2]; Gray MA, 2016, CURR BIOL, V26, P1955, DOI 10.1016/j.cub.2016.05.070; Hansen TE, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-39; Hessvik NP, 2016, CELL MOL LIFE SCI, V73, P4717, DOI 10.1007/s00018-016-2309-8; Ho CY, 2012, TRAFFIC, V13, P1, DOI 10.1111/j.1600-0854.2011.01246.x; Hong Z, 2017, J CELL BIOL, V216, P4217, DOI 10.1083/jcb.201611073; Ikonomov OC, 2015, BBA-MOL CELL RES, V1853, P1240, DOI 10.1016/j.bbamcr.2015.01.008; Inpanathan S, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00113; J. F. Woolley, 2022, bioRxiv, DOI 10.1101/2021.03.25.437029; Jeschke A, 2018, MOL BIOL CELL, V29, P452, DOI 10.1091/mbc.E17-07-0464; Kim S, 2020, BMB REP, V53, P241, DOI 10.5483/BMBRep.2020.53.5.046; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204; Lamming DW, 2019, TRAFFIC, V20, P27, DOI 10.1111/tra.12617; Law F, 2017, J CELL SCI, V130, P2007, DOI 10.1242/jcs.194746; Liu H, 2020, CANCER DISCOV, V10, P1226, DOI 10.1158/2159-8290.CD-19-1262; Luzio JP, 2000, J CELL SCI, V113, P1515; Marat AL, 2017, SCIENCE, V356, P968, DOI 10.1126/science.aaf8310; Martin S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060152; Marwaha R, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2571; McCartney AJ, 2014, BIOESSAYS, V36, P52, DOI 10.1002/bies.201300012; Mironova YA, 2016, ELIFE, V5, DOI 10.7554/eLife.13023; Munson MJ, 2015, EMBO J, V34, P2272, DOI 10.15252/embj.201590992; N'Diaye EN, 2009, EMBO REP, V10, P173, DOI 10.1038/embor.2008.238; Qiao YY, 2021, NAT CANCER, V2, P978, DOI 10.1038/s43018-021-00237-1; Rodgers SJ, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23241-6; Runwal G, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46657-z; Saffi GT, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0259313; Saffi GT, 2019, TRENDS CELL BIOL, V29, P635, DOI 10.1016/j.tcb.2019.05.003; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Sasaki T, 2009, PROG LIPID RES, V48, P307, DOI 10.1016/j.plipres.2009.06.001; Savini M, 2019, TRENDS CELL BIOL, V29, P876, DOI 10.1016/j.tcb.2019.08.008; Sbrissa D, 1999, J BIOL CHEM, V274, P21589, DOI 10.1074/jbc.274.31.21589; Sbrissa D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204532; Settembre C, 2014, TRENDS CELL BIOL, V24, P743, DOI 10.1016/j.tcb.2014.06.006; Sharma G, 2019, AUTOPHAGY, V15, P1694, DOI 10.1080/15548627.2019.1586257; Zhang JB, 2018, AUTOPHAGY, V14, P1043, DOI 10.1080/15548627.2018.1447290; Zhang XJ, 2013, ACTA PHARMACOL SIN, V34, P595, DOI 10.1038/aps.2012.184; Zhang YL, 2012, EMBO J, V31, P3442, DOI 10.1038/emboj.2012.200; Zhu SY, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.667750	56	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2022	298	8							102187	10.1016/j.jbc.2022.102187	http://dx.doi.org/10.1016/j.jbc.2022.102187			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3S2WH	35760104	gold, Green Published			2022-12-26	WOS:000839461200007
J	Darvishi, A; Sadeghipour, P; Darrudi, A; Daroudi, R				Darvishi, Ali; Sadeghipour, Parham; Darrudi, Alireza; Daroudi, Rajabali			Cost-utility analysis of Cryoballoon ablation versus Radiofrequency ablation in the treatment of paroxysmal atrial fibrillation in Iran	PLOS ONE			English	Article							CATHETER ABLATION; MANAGEMENT	Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia (Calkins H, et al. 2012). There are various methods to treat AF of which Ablation is one of the most effective. We aimed to assess the cost-utility of Cryoballoon ablation (CBA) compared to Radiofrequency ablation (RFA) to treat patients with paroxysmal AF in Iran. A cost-utility analysis was done using a decision-analytic model based on a lifetime Markov structure which was drawn considering the nature of interventions and the natural progress of the disease. Costs data were extracted from medical records of 47 patients of Shahid Rajaie Cardiovascular Medical Center in Tehran in 2019. Parameters and variables such as transition probabilities, risks related to side effects, mortality rates, and utility values were extracted from the available evidence. Deterministic and probabilistic sensitivity analysis was also done. TreeAge pro-2020 software was used in all stages of analysis. In the base case analysis, the CBA strategy was associated with higher cost and effectiveness than RFA, and the incremental cost-effectiveness ratio was $11,223 per Quality-adjusted life year (QALY), which compared to Iran's GDP per capita as Willingness to pay threshold, CBA was not cost-effective. On the other hand, considering twice the GDP per capita as a threshold, CBA was cost-effective. Probabilistic sensitivity analysis confirmed the findings of base case analysis, showed that RFA was cost-effective and the probability of cost-effectiveness was 59%. One-way sensitivity analysis showed that the results of the study have the highest sensitivity to changes in the RFA cost variable. Results of sensitivity analysis showed that the cost-effectiveness results were not robust and are sensitive to changes in variables changes. Primary results showed that CBA compared to RFA is not cost-effective in the treatment of AF considering one GDP per capita. But the sensitivity analysis results showed considerable sensitivity to changes of the ablation costs variable.	[Darvishi, Ali] Univ Tehran Med Sci, Endocrinol & Metab Populat Sci Inst, Chron Dis Res Ctr, Tehran, Iran; [Darvishi, Ali; Darrudi, Alireza; Daroudi, Rajabali] Univ Tehran Med Sci, Sch Publ Hlth, Dept Hlth Management & Econ, Tehran, Iran; [Sadeghipour, Parham] Iran Univ Med Sci, Cardiovasc Intervent Res Ctr, Rajaie Cardiovasc Med & Res Ctr, Tehran, Iran	Tehran University of Medical Sciences; Tehran University of Medical Sciences; Iran University of Medical Sciences	Daroudi, R (corresponding author), Univ Tehran Med Sci, Sch Publ Hlth, Dept Hlth Management & Econ, Tehran, Iran.	rdaroudi@yahoo.com		Daroudi, Rajabali/0000-0002-0487-4114				Calkins H, 2012, EUROPACE, V14, P528, DOI 10.1093/europace/eus027; Cappato R, 2005, CIRCULATION, V111, P1100, DOI 10.1161/01.CIR.0000157153.30978.67; Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119; Colilla S, 2013, AM J CARDIOL, V112, P1142, DOI 10.1016/j.amjcard.2013.05.063; Excellence NIfHaC, 2013, GUID METH TECHN APPR; Flaker GC, 2010, CIRC-CARDIOVASC QUAL, V3, P277, DOI 10.1161/CIRCOUTCOMES.109.884171; Fortuni F, 2020, AM J CARDIOL, V125, P1170, DOI 10.1016/j.amjcard.2020.01.016; Friberg J, 2003, EPIDEMIOLOGY, V14, P666, DOI 10.1097/01.ede.0000091649.26364.c0; Garg Jalaj, 2016, J Atr Fibrillation, V9, P1429, DOI 10.4022/jafib.1429; Husereau D, 2022, VALUE HEALTH, V25, P10, DOI 10.1016/j.jval.2021.10.008; January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI [10.1161/CIR.0000000000000041, 10.1016/j.jacc.2014.03.022, 10.1161/CIR.0000000000000142, 10.1016/j.jacc.2014.03.021]; Jones L., 2004, HLTH TECHNOLOGY ASSE, V8, piii, DOI [10.3310/hta8380, DOI 10.3310/HTA8380]; Kazibwe J, 2022, VALUE HEALTH, V25, P385, DOI 10.1016/j.jval.2021.08.014; Kuck KH, 2016, EUR HEART J, V37, P2858, DOI 10.1093/eurheartj/ehw285; Kuck KH, 2016, NEW ENGL J MED, V374, P2235, DOI 10.1056/NEJMoa1602014; Linhart M, 2009, J CARDIOVASC ELECTR, V20, P1343, DOI 10.1111/j.1540-8167.2009.01560.x; Marzona I, 2012, CAN MED ASSOC J, V184, pE329, DOI 10.1503/cmaj.111173; Ming J, 2019, VALUE HEALTH, V22, P863, DOI 10.1016/j.jval.2019.02.001; Murray Marie-Isabel, 2018, J Atr Fibrillation, V11, P2069, DOI 10.4022/jafib.2069; Novbakht H, 2020, J EDUC HEALTH PROMOT, V9, DOI 10.4103/jehp.jehp_8_19; Nyong J, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012088.pub2; Organization WH, 2016, LIF TABL LIF TABL CO; Packer DL, 2013, J AM COLL CARDIOL, V61, P1713, DOI 10.1016/j.jacc.2012.11.064; Reynolds MR, 2014, EUROPACE, V16, P652, DOI 10.1093/europace/eut380; Schmidt M, 2014, J CARDIOVASC ELECTR, V25, P1, DOI 10.1111/jce.12267; Sun XR, 2019, CLIN THER, V41, P78, DOI 10.1016/j.clinthera.2018.11.008; Thrall G, 2006, AM J MED, V119, DOI 10.1016/jamjmed.2005.10.057; Wang TJ, 2003, CIRCULATION, V107, P2920, DOI 10.1161/01.CIR.0000072767.89944.6E; Wilber DJ, 2010, JAMA-J AM MED ASSOC, V303, P333, DOI 10.1001/jama.2009.2029; Xu JX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090323; Zhou Zi-qiang, 2004, Zhonghua Nei Ke Za Zhi, V43, P491	31	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7								10.1371/journal.pone.0270642	http://dx.doi.org/10.1371/journal.pone.0270642			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M3CI	35793364	gold, Green Published			2022-12-26	WOS:000835338100050
J	Xu, H; Jin, J; Chen, Y; Wu, GQ; Zhu, H; Wang, Q; Wang, J; Li, SG; Grigore, FN; Ma, J; Chen, CC; Lan, Q; Li, M				Xu, Hui; Jin, Jing; Chen, Ying; Wu, Guoqing; Zhu, Hua; Wang, Qing; Wang, Ji; Li, Shenggang; Grigore, Florina-Nicoleta; Ma, Jun; Chen, Clark C.; Lan, Qing; Li, Ming			GBP3 promotes glioblastoma resistance to temozolomide by enhancing DNA damage repair	ONCOGENE			English	Article							CENTRAL-NERVOUS-SYSTEM; BREAST-CANCER; STING PATHWAY; NRF2; INFLAMMATION; ACTIVATION; PROTEINS; ADAPTER; HEALTH; GLIOMA	Glioblastoma is the most common malignant brain cancer with dismal survival and prognosis. Temozolomide (TMZ) is a first-line chemotherapeutic agent for glioblastoma, but the emergence of drug resistance limits its anti-tumor activity. We previously discovered that the interferon inducible guanylate binding protein 3 (GBP3) is highly elevated and promotes tumorigenicity of glioblastoma. Here, we show that TMZ treatment significantly upregulates the expression of GBP3 and stimulator of interferon genes (STING), both of which increase TMZ-induced DNA damage repair and reduce cell apoptosis of glioblastoma cells. Mechanistically, relying on its N-terminal GTPase domain, GBP3 physically interacts with STING to stabilize STING protein levels, which in turn induces expression of p62 (Sequestosome 1), nuclear factor erythroid 2 like 2 (NFE2L2, NRF2), and O6-methlyguanine-DNA-methyltransferase (MGMT), leading to the resistance to TMZ treatment. Reducing GBP3 levels by RNA interference in glioblastoma cells markedly increases the sensitivity to TMZ treatment in vitro and in murine glioblastoma models. Clinically, GBP3 expression is high and positively correlated with STING, NRF2, p62, and MGMT expression in human glioblastoma tumors, and is associated with poor outcomes. These findings provide novel insight into TMZ resistance and suggest that GBP3 may represent a novel potential target for the treatment of glioblastoma.	[Xu, Hui; Jin, Jing; Chen, Ying; Wu, Guoqing; Wang, Qing; Wang, Ji; Li, Shenggang; Lan, Qing] Soochow Univ, Affiliated Hosp 2, Dept Neurosurg, Suzhou 215004, Jiangsu, Peoples R China; [Xu, Hui; Lan, Qing] Soochow Univ, Inst Neurosci, Jiangsu Key Lab Neuropsychiat Dis, Suzhou 215004, Jiangsu, Peoples R China; [Zhu, Hua] China Med Univ, Hosp 1, Dept Pediat, Shenyang 110122, Liaoning, Peoples R China; [Grigore, Florina-Nicoleta; Ma, Jun; Chen, Clark C.; Li, Ming] Univ Minnesota, Dept Neurosurg, Minneapolis, MN 55455 USA	Soochow University - China; Soochow University - China; China Medical University; University of Minnesota System; University of Minnesota Twin Cities	Lan, Q (corresponding author), Soochow Univ, Affiliated Hosp 2, Dept Neurosurg, Suzhou 215004, Jiangsu, Peoples R China.; Lan, Q (corresponding author), Soochow Univ, Inst Neurosci, Jiangsu Key Lab Neuropsychiat Dis, Suzhou 215004, Jiangsu, Peoples R China.; Li, M (corresponding author), Univ Minnesota, Dept Neurosurg, Minneapolis, MN 55455 USA.	szlq006@163.com; m2li@umn.edu	Ma, Jun/ADU-1664-2022	Ma, Jun/0000-0003-0427-8205	National Natural Science Foundation of China [81572480]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Key Laboratory of Minimally Invasive Neurosurgery of Suzhou [SZ2021262]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; Key Laboratory of Minimally Invasive Neurosurgery of Suzhou	This work was supported by grants from the National Natural Science Foundation of China (81572480), the Priority Academic Program Development of Jiangsu Higher Education Institutions, and the Key Laboratory of Minimally Invasive Neurosurgery of Suzhou (SZ2021262).	Cheng LF, 2020, INT J ONCOL, V57, P858, DOI 10.3892/ijo.2020.5086; Cheng ZL, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0198-7; Cong ZX, 2014, J NEURO-ONCOL, V116, P41, DOI 10.1007/s11060-013-1260-x; de la Vega MR, 2018, CANCER CELL, V34, P21, DOI 10.1016/j.ccell.2018.03.022; Deng DN, 2019, CANCER CELL INT, V19, DOI 10.1186/s12935-019-1004-x; Duan ZF, 2006, CANCER CHEMOTH PHARM, V57, P25, DOI 10.1007/s00280-005-0026-3; Dunphy G, 2018, MOL CELL, V71, P745, DOI 10.1016/j.molcel.2018.07.034; Fukumoto M, 2014, CANCER SCI, V105, P1351, DOI 10.1111/cas.12489; Godoy P, 2014, BREAST CANCER-TOKYO, V21, P491, DOI 10.1007/s12282-012-0404-8; Guimaraes DP, 2009, INT J CANCER, V124, P272, DOI 10.1002/ijc.23944; Hombach-Klonisch S, 2018, PHARMACOL THERAPEUT, V184, P13, DOI 10.1016/j.pharmthera.2017.10.017; Kitange GJ, 2009, NEURO-ONCOLOGY, V11, P281, DOI 10.1215/15228517-2008-090; Kwon J, 2020, CANCER DISCOV, V10, P26, DOI 10.1158/2159-8290.CD-19-0761; Li M, 2017, ONCOTARGET, V8, P55319, DOI 10.18632/oncotarget.19429; Li M, 2011, J EXP MED, V208, P2657, DOI 10.1084/jem.20111102; Li T, 2018, J EXP MED, V215, P1287, DOI 10.1084/jem.20180139; Liu JH, 2020, J EXP CLIN CANC RES, V39, DOI 10.1186/s13046-020-01641-8; Liu YX, 2007, P NATL ACAD SCI USA, V104, P5205, DOI 10.1073/pnas.0700898104; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Ma LN, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0517-y; Moscat J, 2016, CELL, V167, P606, DOI 10.1016/j.cell.2016.09.030; Nordmann A, 2012, FASEB J, V26, P1290, DOI 10.1096/fj.11-189886; Ostrom Quinn T, 2019, Neuro Oncol, V21, pv1, DOI 10.1093/neuonc/noz150; Paranjpe A, 2016, J BIOMED RES, V30, P393, DOI 10.7555/JBR.30.20160040; Pilla-Moffett D, 2016, J MOL BIOL, V428, P3495, DOI 10.1016/j.jmb.2016.04.032; Polonen P, 2019, ONCOGENE, V38, P7473, DOI 10.1038/s41388-019-0956-6; Prabakaran T, 2018, EMBO J, V37, DOI 10.15252/embj.201797858; Quintero M, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3726-2; Rocha CRR, 2016, ONCOTARGET, V7, P48081, DOI 10.18632/oncotarget.10129; Reislander T, 2020, MOL CELL, V80, P21, DOI 10.1016/j.molcel.2020.07.026; Ryoo IG, 2018, REDOX BIOL, V17, P246, DOI 10.1016/j.redox.2018.04.015; Singh A, 2016, ACS CHEM BIOL, V11, P3214, DOI 10.1021/acschembio.6b00651; Storozynsky Q, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21228877; Tretina K, 2019, J EXP MED, V216, P482, DOI 10.1084/jem.20182031; Vashi N, 2021, TRENDS BIOCHEM SCI, V46, P446, DOI 10.1016/j.tibs.2020.12.010; Wang J, 2020, J CELL BIOCHEM, V121, P1250, DOI 10.1002/jcb.29358; Wu JF, 2019, BIOCHEM BIOPH RES CO, V518, P698, DOI 10.1016/j.bbrc.2019.08.113; Xia TL, 2016, CELL REP, V14, P282, DOI 10.1016/j.celrep.2015.12.029; Xu H, 2018, BIOCHEM BIOPH RES CO, V495, P446, DOI 10.1016/j.bbrc.2017.11.050; Yu SY, 2020, ONCOGENE, V39, P5042, DOI 10.1038/s41388-020-1348-7; Yu XT, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-03492-3; Zhang Q, 2019, CELL DEATH DIFFER, V26, P2300, DOI 10.1038/s41418-019-0303-z; Zhao J, 2020, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01494; Zheng JY, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01250-1	44	0	0	5	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 29	2022	41	31					3876	3885		10.1038/s41388-022-02397-5	http://dx.doi.org/10.1038/s41388-022-02397-5		JUL 2022	10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	3I9OZ	35780181				2022-12-26	WOS:000819907600003
J	Mehrabian, M; Wang, XZ; Eid, S; Yan, BQ; Grinberg, M; Siegner, M; Sackmann, C; Sulman, M; Zhao, W; Williams, D; Schmitt-Ulms, G				Mehrabian, Mohadeseh; Wang, Xinzhu; Eid, Shehab; Yan, Bei Qi; Grinberg, Mark; Siegner, Murdock; Sackmann, Christopher; Sulman, Muhammad; Zhao, Wenda; Williams, Declan; Schmitt-Ulms, Gerold			Cardiac glycoside-mediated turnover of Na, K-ATPases as a rational approach to reducing cell surface levels of the cellular prion protein	PLOS ONE			English	Article							SITE-DIRECTED MUTAGENESIS; BETA-SUBUNIT ISOFORMS; WILD-TYPE; EXPRESSING ALPHA-1; CATHEPSIN-B; IN-VITRO; NA,K-ATPASE; BRAIN; OUABAIN; DISEASE	It is widely anticipated that a reduction of brain levels of the cellular prion protein (PrPC) can prolong survival in a group of neurodegenerative diseases known as prion diseases. To date, efforts to decrease steady-state PrPC levels by targeting this protein directly with small molecule drug-like compounds have largely been unsuccessful. Recently, we reported Na,K-ATPases to reside in immediate proximity to PrPC in the brain, unlocking an opportunity for an indirect PrPC targeting approach that capitalizes on the availability of potent cardiac glycosides (CGs). Here, we report that exposure of human co-cultures of neurons and astrocytes to non-toxic nanomolar levels of CGs causes profound reductions in PrPC levels. The mechanism of action underpinning this outcome relies primarily on a subset of CGs engaging the ATP1A1 isoform, one of three alpha subunits of Na,K-ATPases expressed in brain cells. Upon CG docking to ATP1A1, the ligand receptor complex, and PrPC along with it, is internalized by the cell. Subsequently, PrPC is channeled to the lysosomal compartment where it is digested in a manner that can be rescued by silencing the cysteine protease cathepsin B. These data signify that the repurposing of CGs may be beneficial for the treatment of prion disorders.	[Mehrabian, Mohadeseh; Wang, Xinzhu; Eid, Shehab; Yan, Bei Qi; Grinberg, Mark; Siegner, Murdock; Sackmann, Christopher; Sulman, Muhammad; Zhao, Wenda; Williams, Declan; Schmitt-Ulms, Gerold] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Krembil Discovery Ctr, Toronto, ON, Canada; [Mehrabian, Mohadeseh; Wang, Xinzhu; Eid, Shehab; Yan, Bei Qi; Siegner, Murdock; Zhao, Wenda; Schmitt-Ulms, Gerold] Univ Toronto, Dept Lab Med Pathobiol, Toronto, ON, Canada	University of Toronto; University of Toronto	Schmitt-Ulms, G (corresponding author), Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Krembil Discovery Ctr, Toronto, ON, Canada.; Schmitt-Ulms, G (corresponding author), Univ Toronto, Dept Lab Med Pathobiol, Toronto, ON, Canada.	g.schmittulms@utoronto.ca		Sackmann, Christopher/0000-0002-1273-6731; Williams, Declan/0000-0002-6754-1624	Krembil Foundation; Borden Rosiak family; Arnold Irwin family	Krembil Foundation; Borden Rosiak family; Arnold Irwin family	This work would not have been possible without generous support by the Krembil Foundation, the Borden Rosiak family, and the Arnold Irwin family. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar PD, 2004, NEURON, V43, P169, DOI 10.1016/j.neuron.2004.06.028; Arshad H, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.101073; Azarias G, 2013, J BIOL CHEM, V288, P2734, DOI 10.1074/jbc.M112.425785; Bai Y, 2016, PHYSIOL GENOMICS, V48, P739, DOI 10.1152/physiolgenomics.00042.2016; Ballmer BA, 2017, J BIOL CHEM, V292, P8356, DOI [10.1074/jbc.M116.773283, 10.1074/jbc.m116.773283]; Barcroft LC, 2004, MECH DEVELOP, V121, P417, DOI 10.1016/j.mod.2004.04.005; Batrakova EV, 2001, J PHARMACOL EXP THER, V296, P551; Benestad SL, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-87; Bennett CF, 2019, ANNU REV MED, V70, P307, DOI 10.1146/annurev-med-041217-010829; Beuschlein F, 2013, NAT GENET, V45, P440, DOI 10.1038/ng.2550; Blanco G, 2005, SEMIN NEPHROL, V25, P292, DOI 10.1016/j.semnephrol.2005.03.004; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; BUELER H, 1994, MOL MED, V1, P19; CAMERON R, 1994, MOL BRAIN RES, V21, P333, DOI 10.1016/0169-328X(94)90264-X; Cherniavsky-Lev M, 2014, J BIOL CHEM, V289, P1049, DOI 10.1074/jbc.M113.517003; Clausen MV, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00371; Dalskov SM, 2005, NEUROCHEM INT, V46, P489, DOI 10.1016/j.neuint.2004.11.010; De Fusco M, 2003, NAT GENET, V33, P192, DOI 10.1038/ng1081; Donato R, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-36; Dunn DE, 2011, J NEUROCHEM, V119, P805, DOI 10.1111/j.1471-4159.2011.07439.x; Ehle Michael, 2011, Crit Pathw Cardiol, V10, P93, DOI 10.1097/HPC.0b013e318221e7dd; Einholm AP, 2010, J BIOL CHEM, V285, P26245, DOI 10.1074/jbc.M110.123976; FLASCH H, 1976, ARZNEIMITTEL-FORSCH, V26, P1213; FORD AR, 1979, BRIT J CLIN PHARMACO, V8, P115, DOI 10.1111/j.1365-2125.1979.tb05809.x; Ghodrati F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26685-x; Habeck M, 2016, J BIOL CHEM, V291, P23159, DOI 10.1074/jbc.M116.751735; Hachiya N, 2011, NEUROSCI LETT, V490, P150, DOI 10.1016/j.neulet.2010.12.046; HERRERA VLM, 1987, J CELL BIOL, V105, P1855, DOI 10.1083/jcb.105.4.1855; Hsu A, 2018, J MOL NEUROSCI, V65, P420, DOI 10.1007/s12031-018-1110-6; Karapetyan YE, 2013, P NATL ACAD SCI USA, V110, P7044, DOI 10.1073/pnas.1303510110; Katz A, 2010, J BIOL CHEM, V285, P19582, DOI 10.1074/jbc.M110.119248; Kim YH, 2015, NAT PROTOC, V10, P985, DOI 10.1038/nprot.2015.065; Korneenko TV, 2016, SCI REP-UK, V6, DOI 10.1038/srep22395; KUHLMANN J, 1979, N-S ARCH PHARMACOL, V307, P65, DOI 10.1007/BF00506553; Lassuthova P, 2018, AM J HUM GENET, V102, P505, DOI 10.1016/j.ajhg.2018.01.023; Lecuona E, 1996, BRAIN RES BULL, V40, P167, DOI 10.1016/0361-9230(96)00042-1; Lev MC, 2015, AM J PHYSIOL-CELL PH, V309, pC126, DOI 10.1152/ajpcell.00089.2015; Lewis PA, 2006, BIOCHEM J, V395, P443, DOI 10.1042/BJ20051677; Liu LJ, 2006, AM J PHYSIOL-CELL PH, V291, pC569, DOI 10.1152/ajpcell.00002.2006; Liu LJ, 2011, BIOCHEMISTRY-US, V50, P8664, DOI 10.1021/bi2009008; LUCCHESI PA, 1991, J BIOL CHEM, V266, P9327; Luhr KM, 2004, NEUROREPORT, V15, P1663, DOI 10.1097/01.wnr.0000134931.81690.34; Ma JY, 2001, P NATL ACAD SCI USA, V98, P14955, DOI 10.1073/pnas.011578098; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Mallucci GR, 2007, NEURON, V53, P325, DOI 10.1016/j.neuron.2007.01.005; Martin-Vasallo P, 2000, GLIA, V31, P206, DOI 10.1002/1098-1136(200009)31:3<206::AID-GLIA20>3.0.CO;2-1; Mayer U, 1996, BRIT J PHARMACOL, V119, P1038, DOI 10.1111/j.1476-5381.1996.tb15775.x; Mays CE, 2014, J CLIN INVEST, V124, P847, DOI 10.1172/JCI72241; Mazur C, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.129240; Minikel EV, 2020, NUCLEIC ACIDS RES, V48, P10615, DOI 10.1093/nar/gkaa616; Minikel EV, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad5169; Morrill GA, 2012, STEROIDS, V77, P1160, DOI 10.1016/j.steroids.2012.04.012; Moseley AE, 2003, J BIOL CHEM, V278, P5317, DOI 10.1074/jbc.M211315200; Moseley AE, 2007, J NEUROSCI, V27, P616, DOI 10.1523/JNEUROSCI.4464-06.2007; Murata K, 2020, J COMP NEUROL, V528, P2654, DOI 10.1002/cne.24924; Naslavsky N, 1997, J BIOL CHEM, V272, P6324, DOI 10.1074/jbc.272.10.6324; Ni Dan, 2002, J Exp Ther Oncol, V2, P278, DOI 10.1046/j.1359-4117.2002.01052.x; Polyakova O, 2009, EUR BIOPHYS J BIOPHY, V38, P209, DOI 10.1007/s00249-008-0371-3; PRICE EM, 1988, BIOCHEMISTRY-US, V27, P8400, DOI 10.1021/bi00422a016; PRICE EM, 1990, J BIOL CHEM, V265, P6638; Rankovic Z, 2017, J MED CHEM, V60, P5943, DOI 10.1021/acs.jmedchem.6b01469; Richt JA, 2007, NAT BIOTECHNOL, V25, P132, DOI 10.1038/nbt1271; SAILER A, 1994, CELL, V77, P967, DOI 10.1016/0092-8674(94)90436-7; Schinkel AH, 1996, J CLIN INVEST, V97, P2517, DOI 10.1172/JCI118699; Schinkel AH, 1997, P NATL ACAD SCI USA, V94, P4028, DOI 10.1073/pnas.94.8.4028; Schmalzing G, 1997, P NATL ACAD SCI USA, V94, P1136, DOI 10.1073/pnas.94.4.1136; Schmitt-Ulms G, 2004, NAT BIOTECHNOL, V22, P724, DOI 10.1038/nbt969; SHYNG SL, 1993, J BIOL CHEM, V268, P15922; Silber BM, 2014, BIOORGAN MED CHEM, V22, P1960, DOI 10.1016/j.bmc.2014.01.001; Sundaram SM, 2019, NEUROCHEM INT, V128, P163, DOI 10.1016/j.neuint.2019.04.009; Sweadner KJ, 2019, NEUROL-GENET, V5, DOI 10.1212/NXG.0000000000000303; Taskar KS, 2017, J CENT NERV SYST DIS, V9, DOI 10.1177/1179573517693596; TOBIN T, 1972, BIOCHIM BIOPHYS ACTA, V274, P551, DOI 10.1016/0005-2736(72)90201-5; Tokhtaeva E, 2012, J BIOL CHEM, V287, P26115, DOI 10.1074/jbc.M112.370734; Wang JKT, 2006, P NATL ACAD SCI USA, V103, P10461, DOI 10.1073/pnas.0600930103; Wang XZ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52543-5; Wansapura AN, 2011, AM J PHYSIOL-HEART C, V300, pH347, DOI 10.1152/ajpheart.00625.2010; WATTS AG, 1991, P NATL ACAD SCI USA, V88, P7425, DOI 10.1073/pnas.88.16.7425; Weigand KM, 2014, CHEM RES TOXICOL, V27, P2082, DOI 10.1021/tx500290k; Welker P., 2006, ROLE LIPID RAFTS MEM, DOI [10.1152/ajpregu.00166.2006 17082358, DOI 10.1152/AJPREGU.00166.200617082358]; Williams D, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0258682; Xiang W, 2004, J VIROL, V78, P11051, DOI 10.1128/JVI.78.20.11051-11060.2004; Yadati T, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9071679; Yedidia Y, 2001, EMBO J, V20, P5383, DOI 10.1093/emboj/20.19.5383; Zhang YH, 2003, J GEN VIROL, V84, P2279, DOI 10.1099/vir.0.19153-0	85	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2022	17	7							e0270915	10.1371/journal.pone.0270915	http://dx.doi.org/10.1371/journal.pone.0270915			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6E4KA	35776750	gold, Green Published			2022-12-26	WOS:000883348200008
J	Wang, XH; Wu, QW; Li, LL; Wang, P; Wang, Y; Wei, WF; Ma, XJ; Shu, J; Zhang, K; Ma, DM				Wang, Xinhong; Wu, Qingwen; Li, Lulu; Wang, Peng; Wang, Yue; Wei, Weifeng; Ma, Xiaojun; Shu, Jing; Zhang, Kai; Ma, Dongming			Determination of quality markers for quality control of Zanthoxylum nitidum using ultra-performance liquid chromatography coupled with near infrared spectroscopy	PLOS ONE			English	Article							RAPID IDENTIFICATION; ALKALOIDS	With the increasing demand for quality control in the traditional Chinese medicine industry, there is a need for the development of quality markers and a quick, non-destructive technique for the discrimination of related species. In our previous study, ultra-performance liquid chromatography (UPLC) was used for the simultaneous determination of five compounds, including three alkaloids (nitidine chloride, chelerythrine, and magnoflorine), one flavonoid (aurantiamarin), and one lignan (sesamin). In this study, the simultaneous quantification of the above-mentioned compounds could be used to discriminate the powders of roots from those of stems. To further test the reliability of the five compounds, seventy-two batches of wild and seventy-five batches of cultivated Zanthoxylum nitidum samples collected from Guangdong, Guangxi, and Fujian provinces in China were analyzed by UPLC and near-infrared spectroscopy (NIRS). In general, the quantitative results of UPLC were consistent with those of NIRS, and cultivated Z. nitidum has similar major bioactive compounds as the wild one, as supported by principal component analysis. Consequently, these five major bioactive compounds are suggested as potential quality markers. In addition, the NIRS method with discriminant analysis successfully differentiated Z. nitidum from three related species (Z. avicennae, Z. scandens and Toddalia asiatica) of the Rutaceae family. In summary, this study provides a method for the rapid identification of Z. nitidum and discrimination of root and stem powders, and suggests five compounds as quality markers for the evaluation of Z. nitidum.	[Wang, Xinhong; Li, Lulu; Wang, Peng; Ma, Xiaojun; Shu, Jing; Zhang, Kai] Shandong Agr & Engn Univ, Coll Forestry Engn, Jinan, Shandong, Peoples R China; [Wu, Qingwen; Ma, Dongming] Guangzhou Univ Chinese Med, Res Ctr Chinese Herbal Resource Sci & Engn, Guangzhou, Guangdong, Peoples R China; [Wang, Yue] Shandong Acad Agr Sci, Jinan, Shandong, Peoples R China; [Wei, Weifeng] China Resources Sanjiu Med Pharmaceut Co Ltd, Shenzhen, Guangdong, Peoples R China	Shandong Agriculture & Engineering University; Guangzhou University of Chinese Medicine; Shandong Academy of Agricultural Sciences; China Resources Group	Ma, DM (corresponding author), Guangzhou Univ Chinese Med, Res Ctr Chinese Herbal Resource Sci & Engn, Guangzhou, Guangdong, Peoples R China.	madm@gzucm.edu.cn		Wang, Xinhong/0000-0002-8979-1472; Ma, Dongming/0000-0003-4612-0756; Qingwen, Wu/0000-0003-2269-0519	Shandong agriculture and engineering university [31720007]; Guangdong Pearl River Talents Plan [2017GC010368]	Shandong agriculture and engineering university; Guangdong Pearl River Talents Plan	We are grateful for financial support of the doctor fund of Shandong agriculture and engineering university (31720007) and Guangdong Pearl River Talents Plan (2017GC010368).	Bec KB, 2021, J PHARMACEUT BIOMED, V193, DOI 10.1016/j.jpba.2020.113686; Bhattacharya S, 2009, ASIAN J PHARM CLIN R, V2, P30; Bogomolov A, 2018, FRONT CHEM, V6, DOI 10.3389/fchem.2018.00388; Chan CO, 2007, ANAL CHIM ACTA, V592, P121, DOI 10.1016/j.aca.2007.04.016; Chen Wei-xuan, 2015, Zhong Yao Cai, V38, P2358; Ciurczak E W, 1986, SPECTROSCOPY-US, V1, P36; Cui Y, 2020, J CANCER, V11, P1250, DOI 10.7150/jca.37890; [冯洁 Feng Jie], 2011, [中药药理与临床, Pharmacology and Clinics of Chinese Materia Medica], V27, P60; Han BX, 2014, PHARMACOGN MAG, V10, P353, DOI 10.4103/0973-1296.137378; Huang HB, 2008, J FOOD ENG, V87, P303, DOI 10.1016/j.jfoodeng.2007.12.022; [黄依玲 Huang Yiling], 2013, [中药药理与临床, Pharmacology and Clinics of Chinese Materia Medica], V29, P103; Huck CW, 2005, ANAL CHIM ACTA, V538, P195, DOI 10.1016/j.aca.2005.01.064; Kudo M, 2000, J PHARM PHARMACOL, V52, P1271, DOI 10.1211/0022357001777252; Li M, 2017, FOOD CONTROL, V73, P1334, DOI 10.1016/j.foodcont.2016.10.054; Li WL, 2012, VIB SPECTROSC, V62, P159, DOI 10.1016/j.vibspec.2012.07.005; Lu Q, 2020, J ETHNOPHARMACOL, V260, DOI 10.1016/j.jep.2020.112946; Meng Y, 2015, J ANAL METHODS CHEM, V2015, DOI 10.1155/2015/752162; MOODY JO, 1984, PLANTA MED, V50, P101, DOI 10.1055/s-2007-969634; N.P. Commission, 2020, PHARMACOPOEIA PEOPLE, P166; Nguyen QA, 2002, Z NATURFORSCH C, V57, P986; Nicolai BM, 2007, POSTHARVEST BIOL TEC, V46, P99, DOI 10.1016/j.postharvbio.2007.06.024; Peng Z H, 2018, PHARM TODAY, V28, P500; Qiao JW, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13293-0; Qin FF, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00359; Qu HB, 2004, CHINESE J ANAL CHEM, V32, P477; Rinnan A, 2009, TRAC-TREND ANAL CHEM, V28, P1201, DOI 10.1016/j.trac.2009.07.007; Shen T, 2020, MOLECULES, V25, DOI 10.3390/molecules25061442; Wang XH, 2020, IND CROP PROD, V150, DOI 10.1016/j.indcrop.2020.112345; Yan H, 2021, SPECTROCHIM ACTA A, V249, DOI 10.1016/j.saa.2020.119344; Yan SM, 2014, J ANAL METHODS CHEM, V2014, DOI 10.1155/2014/704971; Yang GH, 2008, CHEM BIODIVERS, V5, P1718, DOI 10.1002/cbdv.200890160; Zeng Z, 2021, SAUDI PHARM J, V29, P781, DOI 10.1016/j.jsps.2021.05.003; Zhang S, 2001, Zhong Yao Cai, V24, P649; Ziegel E R, 2004, TECHNOMETRICS, V46, P108, DOI [10.1198/004017004000000167, DOI 10.1198/004017004000000167]; Zou WB, 2018, FRONT CHEM, V6, DOI 10.3389/fchem.2018.00184	35	0	0	11	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2022	17	6							e0270315	10.1371/journal.pone.0270315	http://dx.doi.org/10.1371/journal.pone.0270315			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6I0VV	35749476	gold, Green Published			2022-12-26	WOS:000885846600001
J	Amede, PO; Adedire, E; Usman, A; Ameh, CA; Umar, FS; Umeokonkwo, CD; Balogun, MS				Amede, Peter Okpeh; Adedire, Elizabeth; Usman, Aishat; Ameh, Celestine Attah; Umar, Faruk Saleh; Umeokonkwo, Chukwuma David; Balogun, Muhammad Shakir			Drug-susceptible tuberculosis treatment outcomes and its associated factors among inmates in prison settings in Bauchi State, Nigeria, 2014-2018	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; AGE	Tuberculosis (TB) is a contagious disease and its transmissibility is increased in congregate settings. TB incidence rates are five-to-fifty times higher among inmates in prison settings than the general population which has a direct impact on the outcome of TB treatment. There is paucity of information on TB treatment outcomes and its associated factors in Nigerian prison settings. We therefore assessed TB treatment outcomes among inmates in prison settings in Bauchi State, Nigeria. We conducted a retrospective data analysis of inmates with TB in the five-main prison settings in Bauchi State. We extracted socio-demographic, clinical and treatment outcome characteristics from TB treatment register of inmates treated for TB between January 2014 and December 2018, using a checklist. We calculated the TB treatment success rate (TSR) and explored the relationship between the TSR and socio-demographic and clinical characteristics. Related variables were modelled in multiple logistic regression to identify factors associated with TSR at 5% level of significance. All 216 inmates were male with mean (SD) age of 37.6 +/- 11.4 years. Seventy-six (35.2%) were cured, 61 (28.2%) completed treatment, 65 (30.1%) were transferred-out without evaluation and 14 (6.5%) died. Overall TSR was 72.9%. Factors associated with successful-treatment-outcome were age, weight, imprisonment duration and HIV status. The results indicate that inmates who are 20-29 years are at least ten times more likely to be successful (aOR = 10.5; 95%CI: 3.2-35.1) than inmates who are 55 years or older. Inmates who are 30-39 years are about four times more likely to be successful than inmates who are 55 years or older (aOR = 4.2; 95% CI: 1.3-13.1). In general, the younger an inmate, the more successful he is. Inmates with pretreatment-weight; 55kg or more are 13 times more likely to be successful (aOR = 13.3; 95%CI: 6.0-29.6) than inmates with weight below 55kg. Inmates who were imprisoned for 2 years or less are about three times more likely to be successful (aOR = 2.6; 95%CI: 1.3-5.4) than inmates who were imprisoned for more than 2 years and HIV negative inmates were three times more likely to succeed (aOR = 3.3; 95%CI:1.4-7.8) than inmates who were HIV positive. We recommended that to improve TB treatment outcome among inmates; age, duration-of-imprisonment, weight and TB/HIV co-infection should be the major consideration during pretreatment, psychological and nutritional counselling and a tracking-system be developed by the authority to follow-up inmates transferred-out to other health facilities to ensure they complete the treatment and outcomes evaluated.	[Amede, Peter Okpeh] Nigeria Field Epidemiol & Lab Training Program, Abuja, Federal Capital, Nigeria; [Adedire, Elizabeth; Usman, Aishat; Ameh, Celestine Attah; Balogun, Muhammad Shakir] African Field Epidemiol Network Nigeria, Abuja, Federal Capital, Nigeria; [Umar, Faruk Saleh; Umeokonkwo, Chukwuma David] Bauchi State Command, Nigerian Correct Serv, Abuja, Federal Capital, Nigeria; [Umeokonkwo, Chukwuma David] Alex Ekwueme Fed Univ Teaching Hosp, Dept Community Med, Abakaliki, Ebonyi, Nigeria		Amede, PO (corresponding author), Nigeria Field Epidemiol & Lab Training Program, Abuja, Federal Capital, Nigeria.	perosports05@gmail.com	Adedire, Elizabeth/HDM-6344-2022; Umeokonkwo, Chukwuma David/U-7112-2019	Umeokonkwo, Chukwuma David/0000-0002-0050-2874; Amede, Peter/0000-0002-9200-0379				Adane K, 2018, BMC PULM MED, V18, DOI 10.1186/s12890-018-0600-1; [Anonymous], 2017, WORLD PRIS BRIEF WOR, P1; Ayala G, 2016, REV PANAM SALUD PUBL, V39, P38; Barbour V, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000383; Baussano I, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000381; Berihun YA, 2018, ETHIOP J HEALTH SCI, V28, P347, DOI 10.4314/ejhs.v28i3.13; Biruk MYB, 2016, ADV PUBLIC HEAL, V2016, P1, DOI 10. 1155/2016/850462932.; Dara M, 2015, INT J INFECT DIS, V32, P111, DOI 10.1016/j.ijid.2014.12.029; Ejeta E, 2015, J INFECT DEV COUNTR, V9, P752, DOI 10.3855/jidc.5963; Eurosurveillance editorial team, 2013, Euro Surveill, V18, P20455; Fatiregun AA, 2009, ANN AFR MED, V8, P100, DOI 10.4103/1596-3519.56237; Getahun B, 2013, BRAZ J INFECT DIS, V17, P521, DOI 10.1016/j.bjid.2012.12.010; Hamusse SD, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25382; Institute for Crime Justice Policy Research, 2018, WORLD PRIS BRIEF WOR, P1; Jordan TS, 2010, INT J TUBERC LUNG D, V14, P683; Karo B, 2015, EUROSURVEILLANCE, V20, P18, DOI 10.2807/1560-7917.ES.2015.20.49.30087; Minion J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053466; Mnisi T., 2013, Southern African Journal of Epidemiology & Infection, V28, P96; Muluye AB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206227; National Tuberculosis and Leprosy Control Programme (Nigeria), 2014, NAT TUB LEPR BUR ULC, P1; Ncube RT, 2017, PUBLIC HEALTH ACTION, V7, P212, DOI 10.5588/pha.17.0024; O'Grady J, 2011, EUR RESPIR J, V38, P752, DOI 10.1183/09031936.00041211; O'Grady J, 2011, SAMJ S AFR MED J, V101, P107, DOI 10.7196/SAMJ.4629; Orr P, 2011, INT J CIRCUMPOL HEAL, V70, P113, DOI 10.3402/ijch.v70i2.17809; Park K., 2015, PARKS TXB PREVENTIVE, V23rd; Reid MJA, 2019, LANCET, V393, P1331, DOI 10.1016/S0140-6736(19)30024-8; Reid SE., 2012, J INFECT DIS, P205; Schwitters A, 2014, INT J TUBERC LUNG D, V18, P781, DOI 10.5588/ijtld.13.0934; Singano V, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08841-z; Todrys KW, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001215; Todrys KW, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-8; Tola HH, 2015, IRAN J PUBLIC HEALTH, V44, P1; Ukwaja KN, 2015, INT J TUBERC LUNG D, V19, P295, DOI 10.5588/ijtld.14.0494; Ukwaja KN, 2013, PAN AFR MED J, V16, DOI 10.11604/pamj.2013.16.11.680; United Nations Office on Drugs and Crime (UNODC), 2018, CRIM JUST SER, P11; Vesosky B, 2005, IMMUNOL REV, V205, P229, DOI 10.1111/j.0105-2896.2005.00257.x; WHO, 2017, GLOB TUB REP 2017; WHO, 2017, WHO TECHN REP SER; World Health Organization, 2020, BALTIMORE HLTH NEWS, VXLIX, P8; World Health Organization, 2016, GLOB TUB REP; World Health Organization (WHO), 2018, TB BURD REP 2018, V63, P476	41	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7								10.1371/journal.pone.0270819	http://dx.doi.org/10.1371/journal.pone.0270819			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M5FN	35789216	Green Published, gold			2022-12-26	WOS:000835487000031
J	Perossi, J; Koenigkam-Santos, M; Perossi, L; dos Santos, DO; Simoni, LHD; de Souza, HCD; Gastaldi, AC				Perossi, Jessica; Koenigkam-Santos, Marcel; Perossi, Larissa; dos Santos, Daniele Oliveira; Simoni, Leticia Helena de Souza; de Souza, Hugo Celso Dutra; Gastaldi, Ada Clarice			Correlation among clinical, functional and morphological indexes of the respiratory system in non-cystic fibrosis bronchiectasis patients	PLOS ONE			English	Article							FORCED OSCILLATION TECHNIQUE; IMPULSE OSCILLOMETRY; RESISTANCE; REACTANCE	BackgroundNon-cystic fibrosis bronchiectasis (NCFB) is a heterogeneous disease, which assessment and severity can't be defined by one particular instrument but using a multidimensional score. Thus, in additional to traditional methods, alternative tools have been developed to assist these patients' evaluation. ObjectiveTo correlate functional and morphological indexes with severity and dyspnea in NCFB patients, focusing on the correlation between the impulse oscillometry system (IOS) and the quantitative analysis of computed tomography (CT). MethodsClinically stable NCFB patients, between 18 and 80 years old were submitted to clinical, functional and morphological evaluations assessed by Bronchiectasis Severity Index (BSI) and Medical Research Council (MRC) scale; spirometry and IOS; and subjective and quantitative Chest CT scans analysis, respectively. ResultsThis study included 38 patients. The best correlations obtained between functional and morphological airway indexes were: resistance at 5 Hz-R5 and the normalized thickness of bronchial walls-Pi10 (r = 0.57), and the mean forced expiratory flow (FEF25-75%) and CT score (r = -0.39). BSI as well as MRC showed higher correlations with the quantitative automated analysis of CT (BSI and Pi10: r = 0.41; MRC and Pi10: r = 0.35) than with subjective CT score (BSI and CT score: r = 0.41; MRC and CT score: r = 0.15); and moderate and weak correlations were obtained on both functional airway indexes (BSI and peripheral airways resistance - R5-R20: r = 0.53; BSI and forced expiratory volume at the first second-FEV1: R = -0,64; MRC and R5-R20: r = 0.42; and MRC and VEF1: r = -0.45). ConclusionIn NCFB patients, compartmentalized methods for assessing the respiratory system (IOS and the automated quantitative CT analysis) have a good correlation with severity and dyspnea.	[Perossi, Jessica; Perossi, Larissa; dos Santos, Daniele Oliveira; Simoni, Leticia Helena de Souza; de Souza, Hugo Celso Dutra; Gastaldi, Ada Clarice] Ribeirao Preto Med Sch, Dept Hlth Sci, Grad Program Funct Performance, Ribeirao Preto, SP, Brazil; [Koenigkam-Santos, Marcel] Ribeirao Preto Med Sch, Dept Med Imaging Hematol & Clin Oncol, Ribeirao Preto, SP, Brazil		Gastaldi, AC (corresponding author), Ribeirao Preto Med Sch, Dept Hlth Sci, Grad Program Funct Performance, Ribeirao Preto, SP, Brazil.	ada@fmrp.usp.br	Santos, Marcel Koenigkam/B-8177-2013; Souza, Hugo/C-5818-2012	Santos, Marcel Koenigkam/0000-0002-7160-4691; Souza, Hugo/0000-0002-0009-0005; Gastaldi, Ada/0000-0001-9845-3611	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brazil (CAPES) [88887.461810/2019-00]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-Brazil (FAPESP) [2018/07178-3]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brazil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-Brazil (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Jessica Perossi received a sponsorship given by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brazil (CAPES)-Grant code/Process number: 88887.461810/2019-00 and by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-Brazil (FAPESP)-Grant code/Process number: 2018/07178-3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker AF, 2002, NEW ENGL J MED, V346, P1383, DOI 10.1056/NEJMra012519; BHALLA M, 1991, RADIOLOGY, V179, P783, DOI 10.1148/radiology.179.3.2027992; Brashier B, 2015, BREATHE, V11, P57, DOI 10.1183/20734735.020514; Chalmers JD, 2014, AM J RESP CRIT CARE, V189, P576, DOI 10.1164/rccm.201309-1575OC; CRAPO RO, 1981, AM REV RESPIR DIS, V123, P659; de Albuquerque CG, 2015, J BRAS PNEUMOL, V41, P422, DOI 10.1590/S1806-37132015000004517; Dionisio GH, 2018, RESP CARE, V63, P565, DOI 10.4187/respcare.05471; Edwards EA, 2004, EUR RESPIR J, V24, P538, DOI 10.1183/09031936.04.00142903; FAHY JV, 1992, AM REV RESPIR DIS, V146, P1430, DOI 10.1164/ajrccm/146.6.1430; Gastaldi AC, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001845; Goeminne P, 2010, POSTGRAD MED J, V86, P493, DOI 10.1136/pgmj.2009.091041; Guan WJ, 2016, RESP CARE, V61, P1513, DOI 10.4187/respcare.04710; Kauczor HU, 2011, J THORAC IMAG, V26, P290, DOI 10.1097/RTI.0b013e3182277113; Kim C, 2012, TUBERC RESPIR DIS, V73, P249, DOI 10.4046/trd.2012.73.5.249; Kovelis Demetria, 2008, J. bras. pneumol., V34, P1008; Martinez-Garcia MA, 2017, INT J CHRONIC OBSTR, V12, P275, DOI 10.2147/COPD.S121943; Martinez-Garcia MA, 2014, EUR RESPIR J, V43, P1357, DOI 10.1183/09031936.00026313; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; O'Donnell AE, 2008, CHEST, V134, P815, DOI 10.1378/chest.08-0776; Oostveen E, 2003, EUR RESPIR J, V22, P1026, DOI 10.1183/09031936.03.00089403; Oppenheimer BW, 2012, SURG OBES RELAT DIS, V8, P582, DOI 10.1016/j.soard.2011.08.004; Paredi P, 2010, THORAX, V65, P263, DOI 10.1136/thx.2009.120790; Pasteur MC, 2010, THORAX, V65, pI1, DOI 10.1136/thx.2010.136119; Pasteur MC, 2000, AM J RESP CRIT CARE, V162, P1277, DOI 10.1164/ajrccm.162.4.9906120; REIFF DB, 1995, AM J ROENTGENOL, V165, P261, DOI 10.2214/ajr.165.2.7618537; Santos Marcel Koenigkam, 2016, Radiol Bras, V49, P351, DOI 10.1590/0100-3984.2015.0145; Wada Danilo Tadao, 2017, Radiol Bras, V50, P351, DOI 10.1590/0100-3984.2016.0163; Weinheimer O, 2008, IEEE T MED IMAGING, V27, P64, DOI 10.1109/TMI.2007.902798; Wielputz MO, 2013, J THORAC IMAG, V28, P104, DOI 10.1097/RTI.0b013e3182765785	29	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7								10.1371/journal.pone.0269897	http://dx.doi.org/10.1371/journal.pone.0269897			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M3CI	35793286	gold, Green Published			2022-12-26	WOS:000835338100001
J	Ryu, SI; Park, YH; Kim, J; Huh, I; Chang, SJ; Jang, SN; Noh, EY				Ryu, So Im; Park, Yeon-Hwan; Kim, Jinhyun; Huh, Iksoo; Chang, Sun Ju; Jang, Soong-Nang; Noh, Eun-Young			Impact of COVID-19 on the social relationships and mental health of older adults living alone: A two-year prospective cohort study	PLOS ONE			English	Article							RISK-FACTORS; LONELINESS; DEPRESSION; METAANALYSIS; ASSOCIATION; COMMUNITY; MORTALITY; SUICIDE; SERVICE; LIFE	BackgroundOwing to the COVID-19 outbreak, older adults living alone, who can only connect socially outside their homes, are at risk of social isolation and poor mental health. This study aimed to identify the changes, before and after COVID-19, by sex and age, in social relationships (social activity, social network, and social support) and mental health (depression and suicide ideation) among older adults living alone. MethodsThis is a prospective cohort study of community-dwelling older adults who were at least 65 years old and living alone in South Korea. The study was conducted during 2018-2020 with 2,291 participants (795, 771, and 725 for the 1st to 3rd waves, respectively). The data were collected via face-to-face interviews. A generalized linear mixed modeling framework was used to test for changes over three years. ResultsSocial activity was reduced after the COVID-19, with an interaction effect of sex: older women (odds ratio [OR], 0.19; 95% confidence interval [CI], 0.15-0.23; p < .001) showed greater reduction than older men (OR, 0.50; 95% CI, 0.34-0.75; p < .001). Interaction with neighbors also reduced after the pandemic, but there was no significant evidence of interaction effects. Interaction with family members increased in both sexes during the pandemic, with the interaction effect of sex: older women (OR, 1.40; 95% CI, 1.11-1.76; p = .004) showed greater increase than men (OR, 1.55; 95% CI, 1.13-2.14; p = .007). Social support increased in both sexes during the pandemic, but there was no significant evidence of interaction effects. Depression and suicide ideation showed no significant differences before and after the pandemic. ConclusionsThe findings provide health administrators and health providers with explorative insights into the impact of the COVID-19 on social relationships and mental health among older adults living alone and can guide further studies of interventions considering specific properties of social relationships.	[Ryu, So Im; Park, Yeon-Hwan; Kim, Jinhyun; Huh, Iksoo; Chang, Sun Ju] Seoul Natl Univ, Res Inst Nursing Sci, Coll Nursing, Seoul, South Korea; [Park, Yeon-Hwan; Kim, Jinhyun; Huh, Iksoo; Chang, Sun Ju; Noh, Eun-Young] Seoul Natl Univ, Coll Nursing, Seoul, South Korea; [Jang, Soong-Nang] Chung Ang Univ, Red Cross Coll Nursing, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Chung Ang University	Park, YH (corresponding author), Seoul Natl Univ, Res Inst Nursing Sci, Coll Nursing, Seoul, South Korea.; Park, YH (corresponding author), Seoul Natl Univ, Coll Nursing, Seoul, South Korea.	hanipyh@snu.ac.kr		Noh, Eun-Young/0000-0002-4573-6877; Park, Yeon-Hwan/0000-0002-5236-6683; Huh, Iksoo/0000-0003-2472-9501	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health and Welfare, Republic of Korea [HI18C1284]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health and Welfare, Republic of Korea	We would like to acknowledge the S* Public Health Center and its officers, especially Director Munghee Park, Head Manager Kyungwon Park, and Manager Taeyang Choi for their help in recruiting and collecting data for three years. We also thank all older adults living alone who participated in this study.	Almeida OP, 2012, BRIT J PSYCHIAT, V201, P466, DOI 10.1192/bjp.bp.112.110130; Amagasa S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175392; Barber SJ, 2021, J GERONTOL B-PSYCHOL, V76, pE17, DOI 10.1093/geronb/gbaa068; Barlow MA, 2015, HEALTH PSYCHOL, V34, P870, DOI 10.1037/hea0000182; Cohen S, 2004, AM PSYCHOL, V59, P676, DOI 10.1037/0003-066X.59.8.676; Conejero I, 2018, CLIN INTERV AGING, V13, P691, DOI 10.2147/CIA.S130670; Donnelly EA, 2010, GERONTOLOGIST, V50, P158, DOI 10.1093/geront/gnp103; Ettman CK, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.19686; Evans IEM, 2019, J ALZHEIMERS DIS, V70, pS119, DOI 10.3233/JAD-180501; Fields EC, 2022, AGING MENT HEALTH, V26, P2071, DOI 10.1080/13607863.2021.2010183; Fingerman KL, 2021, J GERONTOL B-PSYCHOL, V76, pE116, DOI 10.1093/geronb/gbaa200; Heaney C.A., 2008, HLTH BEHAV HLTH ED T, V4, P189, DOI DOI 10.1177/109019818501200106; Holt-Lunstad J, 2015, PERSPECT PSYCHOL SCI, V10, P227, DOI 10.1177/1745691614568352; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Holwerda TJ, 2014, J NEUROL NEUROSUR PS, V85, P135, DOI 10.1136/jnnp-2012-302755; House J. S., 1987, SOCIOL FORUM, V2, P135, DOI 10.1007/bf01107897; Hu XY, 2012, INT J PSYCHIAT MED, V43, P19, DOI 10.2190/PM.43.1.b; Santini ZI, 2015, J AFFECT DISORDERS, V175, P53, DOI 10.1016/j.jad.2014.12.049; Jang SN, 2020, ANN GERIATR MED RES, V24, P229, DOI 10.4235/agmr.20.0096; Jeon GS, 2012, ANN GERIATR MED RES, V16, P84, DOI 10.4235/jkgs.2012.16.2.84; Joo Chae Lin, 2019, Korean Journal of Family Practice, V9, P247, DOI 10.21215/kjfp.2019.9.3.247; Kee BS, 1996, J KOREAN NEUROPSYCHI, V35, P298; Killgore WDS, 2020, PSYCHIAT RES, V293, DOI 10.1016/j.psychres.2020.113390; Ko H, 2019, ARCH GERONTOL GERIAT, V83, P239, DOI 10.1016/j.archger.2019.05.009; Korea Institute for Health and Social Affairs, 2018, 2017 SURV LIV COND W; Kuiper JS, 2016, INT J EPIDEMIOL, V45, P1169, DOI 10.1093/ije/dyw089; Lee HS, 2016, ASIAN NURS RES, V10, P182, DOI 10.1016/j.anr.2016.06.003; Lee H, 2021, CLIN INFECT DIS, V73, pE132, DOI 10.1093/cid/ciaa672; Ministry of Health and Welfare, 2020, IMS M NOV COR PRES P; Mitchell Pamela H, 2003, J Cardiopulm Rehabil, V23, P398, DOI 10.1097/00008483-200311000-00001; Noh EY, 2021, GERIATR NURS, V42, P1488, DOI 10.1016/j.gerinurse.2021.10.006; Oksuzyan A., 2018, DEMOGRAPHIC PERSPECT, P65, DOI DOI 10.1007/978-3-319-72356-3_5; Pirkis J, 2021, LANCET PSYCHIAT, V8, P579, DOI 10.1016/S2215-0366(21)00091-2; Purcell B, 2012, AM J GERIAT PSYCHIAT, V20, P717, DOI 10.1097/JGP.0b013e31822ccd79; Reher D.S., 2020, COVID 19 PANDEMIC AG, DOI [10.31235/OSF.IO/BFVXT, DOI 10.31235/OSF.IO/BFVXT, 10.31235/osf.io/bfvxt]; Reher D, 2018, POPUL DEV REV, V44, P427, DOI 10.1111/padr.12149; Sakurai R, 2019, J AM MED DIR ASSOC, V20, P1438, DOI 10.1016/j.jamda.2019.02.021; Santini ZI, 2020, LANCET PUBLIC HEALTH, V5, pE62, DOI 10.1016/S2468-2667(19)30230-0; Santomauro DF, 2021, LANCET, V398, P1700, DOI 10.1016/S0140-6736(21)02143-7; Seong H, 2021, INT J INFECT DIS, V104, P742, DOI 10.1016/j.ijid.2021.02.004; Shankar A, 2011, HEALTH PSYCHOL, V30, P377, DOI 10.1037/a0022826; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Sher L, 2020, QJM-INT J MED, V113, P707, DOI 10.1093/qjmed/hcaa202; Smith KJ, 2019, AGEING SOC, V39, P1709, DOI 10.1017/S0144686X18000132; Stahl ST, 2017, AGING MENT HEALTH, V21, P1065, DOI 10.1080/13607863.2016.1191060; Statistics Korea, 2019, POPULATION PROJECTIO; Steptoe A, 2013, P NATL ACAD SCI USA, V110, P5797, DOI 10.1073/pnas.1219686110; Valtorta NK, 2016, HEART, V102, P1009, DOI 10.1136/heartjnl-2015-308790; Wand APF, 2020, INT PSYCHOGERIATR, V32, P1225, DOI 10.1017/S1041610220000770; Westergren A, 2014, J NUTR HEALTH AGING, V18, P905, DOI 10.1007/s12603-014-0469-5; Won S, 2020, ASIAN SOC WORK POLIC, V14, P61, DOI 10.1111/aswp.12193; World Health Organization, 2020, MENT HLTH OLD AD; Yi YM, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18020825	53	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7								10.1371/journal.pone.0270260	http://dx.doi.org/10.1371/journal.pone.0270260			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M3CI	35793334	Green Published, gold			2022-12-26	WOS:000835338100021
J	Tsukidate, D; Takashima, K; Sasaki, S; Miyashita, S; Kaneko, T; Takahashi, H; Ando, S				Tsukidate, Daiki; Takashima, Keisuke; Sasaki, Shota; Miyashita, Shuhei; Kaneko, Toshiro; Takahashi, Hideki; Ando, Sugihiro			Activation of plant immunity by exposure to dinitrogen pentoxide gas generated from air using plasma technology	PLOS ONE			English	Article							SALICYLIC-ACID; NITRIC-OXIDE; BOTRYTIS-CINEREA; CELL-DEATH; RESISTANCE; DEFENSE; OZONE; MECHANISMS; PROTEINS; ETHYLENE	Reactive nitrogen species (RNS) play an important role in plant immunity as signaling factors. We previously developed a plasma technology to partially convert air molecules into dinitrogen pentoxide (N2O5), an RNS whose physiological action is poorly understood. To reveal the function of N2O5 gas in plant immunity, Arabidopsis thaliana was exposed to plasma-generated N2O5 gas once (20 s) per day for 3 days, and inoculated with Botrytis cinerea, Pseudomonas syringae pv. tomato DC3000 (Pst), or cucumber mosaic virus strain yellow (CMV(Y)) at 24 h after the final N2O5 gas exposure. Lesion size with B. cinerea infection was significantly (P < 0.05) reduced by exposure to N2O5 gas. Propagation of CMV(Y) was suppressed in plants exposed to N2O5 gas compared with plants exposed to the air control. However, proliferation of Pst in the N2O5-gas-exposed plants was almost the same as in the air control plants. These results suggested that N2O5 gas exposure could control plant disease depending on the type of pathogen. Furthermore, changes in gene expression at 24 h after the final N2O5 gas exposure were analyzed by RNA-Seq. Based on the gene ontology analysis, jasmonic acid and ethylene signaling pathways were activated by exposure of Arabidopsis plants to N2O5 gas. A time course experiment with qRT-PCR revealed that the mRNA expression of the transcription factor genes, WRKY25, WRKY26, WRKY33, and genes for tryptophan metabolic enzymes, CYP71A12, CYP71A13, PEN2, and PAD3, was transiently induced by exposure to N2O5 gas once for 20 s peaking at 1-3 h post-exposure. However, the expression of PDF1.2 was enhanced beginning from 6 h after exposure and its high expression was maintained until 24-48 h later. Thus, enhanced tryptophan metabolism leading to the synthesis of antimicrobial substances such as camalexin and antimicrobial peptides might have contributed to the N2O5-gas-induced disease resistance.	[Tsukidate, Daiki; Miyashita, Shuhei; Takahashi, Hideki; Ando, Sugihiro] Tohoku Univ, Grad Sch Agr Sci, Sendai, Miyagi, Japan; [Takashima, Keisuke; Sasaki, Shota; Kaneko, Toshiro] Tohoku Univ, Grad Sch Engn, Sendai, Miyagi, Japan	Tohoku University; Tohoku University	Ando, S (corresponding author), Tohoku Univ, Grad Sch Agr Sci, Sendai, Miyagi, Japan.	sugihiro.ando.a2@tohoku.ac.jp		Ando, Sugihiro/0000-0003-0189-5064; Takashima, Keisuke/0000-0002-8037-5210	Tohoku University Research Program "Frontier Research in Duo" (FRiD); Japan Society for the Promotion of Science KAKENHI [15K07307, 20K06045, 26292022]; Ministry of Education, Culture, Science, Sports and Technology of Japan [16H06429, 16K21723, 16H06435]; Japan Society for the Promotion of Science Core-to-Core Program (Advanced Research Networks)	Tohoku University Research Program "Frontier Research in Duo" (FRiD); Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Science, Sports and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science Core-to-Core Program (Advanced Research Networks)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was financially supported in part by Tohoku University Research Program "Frontier Research in Duo" (FRiD) (https://w3.tohoku.ac.jp/frid-en/); by the Japan Society for the Promotion of Science KAKENHI (grant numbers 15K07307, 20K06045, and 26292022) (https://www.jsps.go.jp/english/e-grants/index.html); by grants for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Science, Sports and Technology of Japan (grant numbers 16H06429, 16K21723, and 16H06435) (https://www.jsps.go.jp/j-grantsinaid/34_new_scientific/), and by the Japan Society for the Promotion of Science Core-to-Core Program (Advanced Research Networks) entitled "Establishment of International Agricultural Immunology Research Core for a Quantum Improvement in Food Safety" (https://www.jsps.go.jp/english/e-c2c/index.html).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuQamar S, 2017, CRIT REV BIOTECHNOL, V37, P262, DOI 10.1080/07388551.2016.1271767; Adhikari B, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.00077; Ando S, 2021, MOL PLANT PATHOL, V22, P19, DOI 10.1111/mpp.13005; Ando S, 2014, PHYSIOL MOL PLANT P, V85, P8, DOI 10.1016/j.pmpp.2013.11.001; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Baxter A, 2014, J EXP BOT, V65, P1229, DOI 10.1093/jxb/ert375; Bellin D, 2013, MOL PLANT MICROBE IN, V26, P271, DOI 10.1094/MPMI-09-12-0214-CR; Bilgin DD, 2008, MOL PLANT MICROBE IN, V21, P1297, DOI 10.1094/MPMI-21-10-1297; Birkenbihl RP, 2012, PLANT PHYSIOL, V159, P266, DOI 10.1104/pp.111.192641; Choi HW, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005518; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; Galib M, 2021, SCIENCE, V371, P921, DOI 10.1126/science.abd7716; Gaupels F, 2011, CURR OPIN PLANT BIOL, V14, P707, DOI 10.1016/j.pbi.2011.07.005; Gimenez-Ibanez S, 2010, MICROBES INFECT, V12, P428, DOI 10.1016/j.micinf.2010.03.002; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Hou SG, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00646; Howlader P, 2020, INT J BIOL MACROMOL, V164, P4054, DOI 10.1016/j.ijbiomac.2020.09.026; Jain P, 2018, FUNCT PLANT BIOL, V45, P70, DOI [10.1071/FP16279, 10.1071/fp16279]; Jia XC, 2018, MOL PLANT MICROBE IN, V31, P1271, DOI [10.1094/MPMI-03-18-0071-R, 10.1094/mpmi-03-18-0071-r]; Kaneko T, 2022, JPN J APPL PHYS, V61, DOI 10.35848/1347-4065/ac25dc; Kangasjarvi J, 2005, PLANT CELL ENVIRON, V28, P1021, DOI 10.1111/j.1365-3040.2005.01325.x; Kasten D, 2016, J EXP BOT, V67, P6337, DOI 10.1093/jxb/erw401; Kumar P, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0253878; Kumar P, 2021, BMC PLANT BIOL, V21, DOI 10.1186/s12870-021-03113-3; Kumar P, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52479-w; Li SJ, 2011, PLANTA, V233, P1237, DOI 10.1007/s00425-011-1375-2; Lim SY, 2011, ANTIOXID REDOX SIGN, V15, P2235, DOI 10.1089/ars.2010.3641; Liu SA, 2015, ELIFE, V4, DOI 10.7554/eLife.07295; Lotze MT, 2007, IMMUNOL REV, V220, P60, DOI 10.1111/j.1600-065X.2007.00579.x; Lu RF, 2020, RICE, V13, DOI 10.1186/s12284-020-00382-8; Lykogianni M, 2021, SCI TOTAL ENVIRON, V795, DOI 10.1016/j.scitotenv.2021.148625; Mayer D, 2018, PLANT PHYSIOL, V178, P468, DOI 10.1104/pp.18.00704; Misra NN, 2016, TRENDS FOOD SCI TECH, V55, P39, DOI 10.1016/j.tifs.2016.07.001; Mur LAJ, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00288; Mur LAJ, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00215; Narusaka M, 2013, PLANT BIOTECHNOL-NAR, V30, P89, DOI 10.5511/plantbiotechnology.12.1226a; Nomura K, 2005, CURR OPIN PLANT BIOL, V8, P361, DOI 10.1016/j.pbi.2005.05.005; Pertea M, 2016, NAT PROTOC, V11, P1650, DOI 10.1038/nprot.2016.095; Pieterse CMJ, 2012, ANNU REV CELL DEV BI, V28, P489, DOI 10.1146/annurev-cellbio-092910-154055; Rao MV, 2002, PLANT J, V32, P447, DOI 10.1046/j.1365-313X.2002.01434.x; Rao MV, 2000, PLANT MOL BIOL, V44, P345, DOI 10.1023/A:1026548726807; Reeves PH, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002506; Ross A, 2016, PLANT METHODS, V12, DOI 10.1186/s13007-016-0149-z; Sasaki S, 2021, IND ENG CHEM RES, V60, P798, DOI 10.1021/acs.iecr.0c04915; Song FM, 2001, MOL PLANT MICROBE IN, V14, P1458, DOI 10.1094/MPMI.2001.14.12.1458; Takahashi H, 2002, PLANT J, V32, P655, DOI 10.1046/j.1365-313X.2002.01453.x; TAKAHASHI H, 1994, PLANT J, V6, P369, DOI 10.1046/j.1365-313X.1994.06030369.x; TAKAHASHI H, 1993, MOL PLANT MICROBE IN, V6, P182, DOI 10.1094/MPMI-6-182; Takashima K, 2017, PLASMA SOURCES SCI T, V26, DOI 10.1088/1361-6595/aa7082; Tendero C, 2006, SPECTROCHIM ACTA B, V61, P2, DOI 10.1016/j.sab.2005.10.003; Venereau E, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00422; Wendehenne D, 2014, CURR OPIN PLANT BIOL, V20, P127, DOI 10.1016/j.pbi.2014.05.012; Wohlgemuth H, 2002, PLANT CELL ENVIRON, V25, P717, DOI 10.1046/j.1365-3040.2002.00859.x; YALPANI N, 1994, PLANTA, V193, P372, DOI 10.1007/BF00201815; Yang J, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01349; Yu MD, 2014, NEW PHYTOL, V202, P1142, DOI 10.1111/nph.12739; Ziegler K, 2020, REDOX BIOL, V37, DOI 10.1016/j.redox.2020.101581	57	0	0	6	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	6							e0269863	10.1371/journal.pone.0269863	http://dx.doi.org/10.1371/journal.pone.0269863			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3N5VQ	35749435	Green Published, gold			2022-12-26	WOS:000836216500002
J	Zeng, YJ; Yin, L; Zhou, JL; Zeng, RY; Xiao, Y; Black, AR; Hu, T; Singh, PK; Yin, F; Batra, SK; Yu, F; Chen, YH; Dong, JX				Zeng, Yongji; Yin, Ling; Zhou, Jiuli; Zeng, Renya; Xiao, Yi; Black, Adrian R.; Hu, Tuo; Singh, Pankaj K.; Yin, Feng; Batra, Surinder K.; Yu, Fang; Chen, Yuanhong; Dong, Jixin			MARK2 regulates chemotherapeutic responses through class IIa HDAC-YAP axis in pancreatic cancer	ONCOGENE			English	Article							HISTONE DEACETYLASE INHIBITORS; HIPPO PATHWAY; MITOTIC PHOSPHORYLATION; NAB-PACLITAXEL; SIZE-CONTROL; MITOSIS; KINASE; GROWTH; GEMCITABINE; HOMEOSTASIS	Despite paclitaxel's wide use in cancer treatment, patient response rate is still low and drug resistance is a major clinical obstacle. Through a Phos-tag-based kinome-wide screen, we identified MARK2 as a critical regulator for paclitaxel chemosensitivity in PDAC. We show that MARK2 is phosphorylated by CDK1 in response to antitubulin chemotherapeutics and in unperturbed mitosis. Phosphorylation is essential for MARK2 in regulating mitotic progression and paclitaxel cytotoxicity in PDAC cells. Mechanistically, our findings also suggest that MARK2 controls paclitaxel chemosensitivity by regulating class IIa HDACs. MARK2 directly phosphorylates HDAC4 specifically during antitubulin treatment. Phosphorylated HDAC4 promotes YAP activation and controls expression of YAP target genes induced by paclitaxel. Importantly, combination of HDAC inhibition and paclitaxel overcomes chemoresistance in organoid culture and preclinical PDAC animal models. The expression levels of MARK2, HDACs, and YAP are upregulated and positively correlated in PDAC patients. Inhibition of MARK2 or class IIa HDACs potentiates paclitaxel cytotoxicity by inducing mitotic abnormalities in PDAC cells. Together, our findings identify the MARK2-HDAC axis as a druggable target for overcoming chemoresistance in PDAC.	[Zeng, Yongji; Yin, Ling; Zhou, Jiuli; Zeng, Renya; Xiao, Yi; Black, Adrian R.; Hu, Tuo; Singh, Pankaj K.; Chen, Yuanhong; Dong, Jixin] Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Yin, Feng] Univ Missouri, Dept Pathol & Anat Sci, Columbia, MO USA; [Batra, Surinder K.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE USA; [Yu, Fang] Univ Nebraska Med Ctr, Coll Publ Hlth, Dept Biostat, Omaha, NE USA; [Zhou, Jiuli] Tongji Univ, Shanghai East Hosp, Sch Med, Dept Oncol, Shanghai, Peoples R China	University of Nebraska System; University of Nebraska Medical Center; University of Missouri System; University of Missouri Columbia; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Tongji University	Dong, JX (corresponding author), Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA.	dongj@unmc.edu	Hu, Tuo/HDM-3005-2022; Yin, Ling/AAD-8990-2022	Hu, Tuo/0000-0001-7069-1466; Yin, Ling/0000-0003-1606-2620; Zeng, Yongji/0000-0002-1184-1900; Singh, Pankaj/0000-0001-8903-0131; Batra, Surinder K./0000-0001-9470-9317	Fred & Pamela Buffett Cancer Center Support Grant [P30 CA036727]; National Institutes of Health (NIH) [R01 GM109066]	Fred & Pamela Buffett Cancer Center Support Grant; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Dr. Xiao-long Yang (Queens University) for the TetO-shCDK1 HeLa cell line. All fluorescence images were acquired by a Zeiss LSM 800 microscope and processed with accompanying software at the Advanced Microscopy Core at the University of Nebraska Medical Center. Research in the Dong laboratory is supported by Fred & Pamela Buffett Cancer Center Support Grant (P30 CA036727) and R01 GM109066 from the the National Institutes of Health (NIH). We are very grateful to Dr. Joyce Solheim for critical reading and comments on the paper.	Adamska Aleksandra, 2018, Advances in Biological Regulation, V68, P77, DOI 10.1016/j.jbior.2017.11.007; Ahrari S, 2017, ARCH BIOCHEM BIOPHYS, V630, P66, DOI 10.1016/j.abb.2017.07.002; Arash EH, 2017, EMBO REP, V18, P420, DOI 10.15252/embr.201642455; Aylon Y, 2006, GENE DEV, V20, P2687, DOI 10.1101/gad.1447006; BAGRODIA S, 1991, NATURE, V349, P172, DOI 10.1038/349172a0; Beghini A, 2003, ONCOGENE, V22, P2581, DOI 10.1038/sj.onc.1206336; Boj SF, 2015, CELL, V160, P324, DOI 10.1016/j.cell.2014.12.021; Chen XC, 2016, CELL SIGNAL, V28, P1826, DOI 10.1016/j.cellsig.2016.08.013; Chen XC, 2016, J BIOL CHEM, V291, P14761, DOI 10.1074/jbc.M116.722751; Conroy T, 2018, NEW ENGL J MED, V379, P2395, DOI 10.1056/NEJMoa1809775; Dequiedt F, 2006, MOL CELL BIOL, V26, P7086, DOI 10.1128/MCB.00231-06; Dietrich CS, 2010, GYNECOL ONCOL, V116, P126, DOI 10.1016/j.ygyno.2009.09.039; Dominguez-Brauer C, 2015, MOL CELL, V60, P524, DOI 10.1016/j.molcel.2015.11.006; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dowdy SC, 2006, MOL CANCER THER, V5, P2767, DOI 10.1158/1535-7163.MCT-06-0209; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Duong-Ly Krisna C, 2013, Curr Protoc Pharmacol, VChapter 2, DOI 10.1002/0471141755.ph0209s60; Fu V, 2017, CURR OPIN CELL BIOL, V49, P99, DOI 10.1016/j.ceb.2017.12.012; Goodwin JM, 2014, MOL CELL, V55, P436, DOI 10.1016/j.molcel.2014.06.021; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Henriques AC, 2019, CANCER LETT, V440, P64, DOI 10.1016/j.canlet.2018.10.005; Hessmann E, 2017, GUT, V66, P168, DOI 10.1136/gutjnl-2016-312539; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Huang HL, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001620; Hubaux R, 2015, INT J CANCER, V137, P2072, DOI 10.1002/ijc.29577; Jackson JR, 2007, NAT REV CANCER, V7, P107, DOI 10.1038/nrc2049; Janssen A, 2011, ONCOGENE, V30, P2799, DOI 10.1038/onc.2011.30; Jenardhanan P, 2014, MOL BIOSYST, V10, P1845, DOI 10.1039/c3mb70591a; Kato T, 2001, NEOPLASIA, V3, P4, DOI 10.1038/sj.neo.7900132; Kiyokawa N, 1997, J BIOL CHEM, V272, P18656, DOI 10.1074/jbc.272.30.18656; Koutsounas I, 2013, WORLD J GASTROENTERO, V19, P1173, DOI 10.3748/wjg.v19.i8.1173; Kwan J, 2016, GENE DEV, V30, P2696, DOI 10.1101/gad.284539.116; Lee KM, 2005, LAB INVEST, V85, P1003, DOI 10.1038/labinvest.3700298; Lens SMA, 2003, EMBO J, V22, P2934, DOI 10.1093/emboj/cdg307; Ma A, 2001, MOL BIOL CELL, V12, P1; Ma WW, 2013, CLIN CANCER RES, V19, P5572, DOI 10.1158/1078-0432.CCR-13-1356; Magnani I, 2011, ANAL CELL PATHOL, V34, P319, DOI [10.1155/2011/206756, 10.3233/ACP-2011-0031]; Maugeri-Sacca M, 2018, PHARMACOL THERAPEUT, V186, P60, DOI 10.1016/j.pharmthera.2017.12.011; Mohseni M, 2014, NAT CELL BIOL, V16, P108, DOI 10.1038/ncb2884; Mokhtari RB, 2017, ONCOTARGET, V8, P38022, DOI 10.18632/oncotarget.16723; Natalia MA., 2018, CELLS MICRORNA, V7, P54, DOI [10.2174/2211536606666171024160244, DOI 10.2174/2211536606666171024160244]; Ni X, 2015, ONCOL LETT, V9, P515, DOI 10.3892/ol.2014.2714; Nigg Erich A., 1993, Trends in Cell Biology, V3, P296, DOI 10.1016/0962-8924(93)90011-O; Pardo OE, 2016, EMBO REP, V17, P570, DOI 10.15252/embr.201540970; Qiu Wanglong, 2013, Methods Mol Biol, V980, P215, DOI 10.1007/978-1-62703-287-2_11; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Robinson DR, 2000, ONCOGENE, V19, P5548, DOI 10.1038/sj.onc.1203957; Roche J, 2016, EUR J MED CHEM, V121, P451, DOI 10.1016/j.ejmech.2016.05.047; Sarantis P, 2020, WORLD J GASTRO ONCOL, V12, DOI 10.4251/wjgo.v12.i2.173; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sild M, 2019, MOL PSYCHIATR, V24, P1425, DOI 10.1038/s41380-019-0366-8; Sinn M, 2017, J CLIN ONCOL, V35, P3330, DOI 10.1200/JCO.2017.72.6463; Stauffer S, 2019, J CELL SCI, V132, DOI 10.1242/jcs.236000; Stauffer S, 2017, CELL SIGNAL, V39, P74, DOI 10.1016/j.cellsig.2017.08.001; Suraweera A, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00092; Tang EI, 2013, J ENDOCRINOL, V217, pR13, DOI 10.1530/JOE-12-0586; Torres MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080580; Tsai HC, 2014, BBA-MOL CELL RES, V1843, P846, DOI 10.1016/j.bbamcr.2014.01.007; Varelas X, 2014, DEVELOPMENT, V141, P1614, DOI 10.1242/dev.102376; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Von Hoff DD, 2011, J CLIN ONCOL, V29, P4548, DOI 10.1200/JCO.2011.36.5742; Wanek J, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103128; Wang AH, 2000, MOL CELL BIOL, V20, P6904, DOI 10.1128/MCB.20.18.6904-6912.2000; Wang L, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.328; Wang Z, 2018, CELL SIGNAL, V52, P137, DOI 10.1016/j.cellsig.2018.09.007; Wang ZK, 2014, EPIGENOMICS-UK, V6, P139, DOI 10.2217/epi.13.73; Weaver BA, 2014, MOL BIOL CELL, V25, P2677, DOI 10.1091/mbc.E14-04-0916; Woodring PJ, 2005, J BIOL CHEM, V280, P10318, DOI 10.1074/jbc.M410658200; Xiao L, 2011, J BIOL CHEM, V286, P7788, DOI 10.1074/jbc.M110.173468; Yang CPH, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081733; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Zasadil LM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007965; Zhang L, 2015, MOL CELL BIOL, V35, P1350, DOI 10.1128/MCB.00102-15; Zhang L, 2012, J BIOL CHEM, V287, P34069, DOI 10.1074/jbc.M112.385518; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao YL, 2015, ONCOTARGET, V6, P21906, DOI 10.18632/oncotarget.4259; Zhou JL, 2018, P NATL ACAD SCI USA, V115, pE6760, DOI 10.1073/pnas.1800621115	79	0	0	4	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 29	2022	41	31					3859	3875		10.1038/s41388-022-02399-3	http://dx.doi.org/10.1038/s41388-022-02399-3		JUL 2022	17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	3I9OZ	35780183	Green Submitted			2022-12-26	WOS:000819907600002
J	Li, YJ; Yang, Q; Chen, H; Yang, XT; Han, JR; Yao, XJ; Wei, XJ; Si, JY; Yao, HL; Liu, HL; Wan, LX; Yang, HS; Wang, YM; Bao, DK				Li, Yujia; Yang, Qi; Chen, Hui; Yang, Xiaotian; Han, Jingru; Yao, Xiaojuan; Wei, Xiajie; Si, Jiaoyang; Yao, Huanling; Liu, Hongliang; Wan, Lixin; Yang, Hushan; Wang, Yanming; Bao, Dengke			TFAM downregulation promotes autophagy and ESCC survival through mtDNA stress-mediated STING pathway	ONCOGENE			English	Article								The dynamics of mitochondrial biogenesis regulation is critical in maintaining cellular homeostasis for immune regulation and tumor prevention. Here, we report that mitochondrial biogenesis disruption through TFAM reduction significantly impairs mitochondrial function, induces autophagy, and promotes esophageal squamous cell carcinoma (ESCC) growth. We found that TFAM protein reduction promotes mitochondrial DNA (mtDNA) release into the cytosol, induces cytosolic mtDNA stress, subsequently activates the cGAS-STING signaling pathway, thereby stimulating autophagy and ESCC growth. STING depletion or mtDNA degradation by DNase I abrogates mtDNA stress response, attenuates autophagy, and decreases the growth of TFAM depleted cells. In addition, autophagy inhibitor also ameliorates mitochondrial dysfunction-induced activation of the cGAS-STING signaling pathway and ESCC growth. In conclusion, our results indicate that mtDNA stress induced by mitochondria biogenesis perturbation activates the cGAS-STING pathway and autophagy to promote ESCC growth, revealing an underappreciated therapeutic strategy for ESCC. [GRAPHICS] .	[Li, Yujia; Yang, Qi; Chen, Hui; Yang, Xiaotian; Han, Jingru; Yao, Xiaojuan; Wei, Xiajie; Si, Jiaoyang; Liu, Hongliang; Bao, Dengke] Henan Univ, Sch Pharm, Lab Canc Biomarkers & Liquid Biopsy, Kaifeng 475004, Henan, Peoples R China; [Li, Yujia; Yang, Qi; Yao, Huanling; Wang, Yanming] Henan Univ, Sch Life Sci, Kaifeng 475004, Henan, Peoples R China; [Wan, Lixin; Bao, Dengke] Henan Univ, Nanyang Cent Hosp, Nanyang 473000, Henan, Peoples R China; [Yang, Hushan] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Dept Med Oncol, Philadelphia, PA 19107 USA	Henan University; Henan University; Henan University; Jefferson University	Bao, DK (corresponding author), Henan Univ, Sch Pharm, Lab Canc Biomarkers & Liquid Biopsy, Kaifeng 475004, Henan, Peoples R China.; Wang, YM (corresponding author), Henan Univ, Sch Life Sci, Kaifeng 475004, Henan, Peoples R China.; Bao, DK (corresponding author), Henan Univ, Nanyang Cent Hosp, Nanyang 473000, Henan, Peoples R China.; Yang, HS (corresponding author), Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Dept Med Oncol, Philadelphia, PA 19107 USA.	hushan.yang@jefferson.edu; yanmingwang@henu.edu.cn; bdkmydy12004@126.com	wan, li/GRY-7634-2022		China Postdoctoral Science Foundation [2020M682286, 2021T140180]; Young Core Instructor of Henan [2021GGJS027]; Henan University	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Young Core Instructor of Henan; Henan University	Project funded by China Postdoctoral Science Foundation (NO. 2020M682286, 2021T140180) to DB, the Young Core Instructor of Henan (NO. 2021GGJS027) to DB. Thanks for startup fund from Henan University to YW and DB.		0	0	0	9	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 22	2022	41	30					3735	3746		10.1038/s41388-022-02365-z	http://dx.doi.org/10.1038/s41388-022-02365-z		JUN 2022	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	3D1SP	35750756				2022-12-26	WOS:000815475400001
J	Ebrie, AM; Woldeyohanis, M; Abafita, BJ; Ali, SA; Zemedkun, A; Yimer, Y; Ashebir, Z; Mohammed, S				Ebrie, Ayub Mohammed; Woldeyohanis, Misrak; Abafita, Bedru Jemal; Ali, Siraj Ahmed; Zemedkun, Abebayehu; Yimer, Yusuf; Ashebir, Zewetir; Mohammed, Salih			Hemodynamic and analgesic effect of intrathecal fentanyl with bupivacaine in patients undergoing elective cesarean section; a prospective cohort study	PLOS ONE			English	Article							LOW-DOSE BUPIVACAINE; SPINAL-ANESTHESIA; DELIVERY; EFFICACY; BLOCK	BackgroundSpinal anesthesia with bupivacaine has side effects such as hypotension, respiratory depression, vomiting, and shivering. The side effects are dose-dependent, therefore different approaches have been attempted to avoid spinal-induced complications including lowering the dose of local anesthetic and mixing it with additives like Neuraxial opioids. ObjectiveTo compare the Hemodynamic and analgesic effects of intrathecal fentanyl as an adjuvant with low and conventional doses of bupivacaine in patients undergoing elective cesarean section under spinal anesthesia. MethodologyAn institutional-based prospective cohort study was conducted on 90 patients. Data was collected with chart review, intraoperative observation, and postoperatively patient interview. Data was entered into EPI INFO and transport to SPSS version 23 for analysis of variables using one-way ANOVA, Kruskal Wallis H rank test, and chi-square. ResultHypotension but not bradycardia, was significantly frequent in a conventional dose of bupivacaine alone (CB) group and a conventional dose of bupivacaine with fentanyl (CBF) groups than that of the lower dose of bupivacaine with fentanyl (LBF) groups. Duration of analgesia was significantly longer in LBF (248 +/- 35.6 minutes) and in CBF groups (260.3 +/- 40.3 minutes) than in CB group (167.10 +/- 31.45 minutes). Time for the first analgesic request was significantly later in LBF (304 +/- 47.8 minutes) and CBF (294.6 +/- 99.5 minutes) groups than that in CB group (177 +/- 25.88 minutes). ConclusionThe Lower dose of bupivacaine is associated with less risk of hypotension and faster recovery. Adding fentanyl with the lower dose of bupivacaine in spinal anesthesia for cesarean section could provide comparable anesthesia with the lower risk of hypotension and longer postoperative analgesia.	[Ebrie, Ayub Mohammed; Abafita, Bedru Jemal; Ali, Siraj Ahmed; Zemedkun, Abebayehu] Dilla Univ Coll Med & Hlth Sci, Dept Anesthesiolo, Dilla, Ethiopia; [Woldeyohanis, Misrak; Ashebir, Zewetir] Addis Ababa Univ Coll Hlth Sci, Addis Ababa, Ethiopia; [Yimer, Yusuf; Mohammed, Salih] Wollo Univ, Coll Hlth Sci & Med, Dept Anesthesiol, Dessie, Ethiopia	Dilla University	Ali, SA (corresponding author), Dilla Univ Coll Med & Hlth Sci, Dept Anesthesiolo, Dilla, Ethiopia.	srjmyn@gmail.com	Jemal, Bedru/AAX-4086-2020; ABAFITA, BEDRU JEMAL/GRR-2273-2022	Jemal, Bedru/0000-0002-4194-4724; ABAFITA, BEDRU JEMAL/0000-0002-4194-4724; Ashebir, Zewetir/0000-0001-6615-4078				Abate SM, 2019, SAUDI J ANAESTH, V13, P340, DOI 10.4103/sja.SJA_17_19; Abebe FE, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-015-0114-8; Ali Hassan Mohamed, 2019, Anesth Essays Res, V13, P663, DOI 10.4103/aer.AER_131_19; Arzola C, 2011, BRIT J ANAESTH, V107, P308, DOI 10.1093/bja/aer200; Begum A., 2010, PAK J MED HLTH SCI, V4, P3; BenDavid B, 1997, ANESTH ANALG, V85, P560, DOI 10.1097/00000539-199709000-00014; Biswas B, 2002, INDIAN J ANAESTH, V46, P469; Bogra Jaishri, 2005, BMC Anesthesiol, V5, P5; Central Statistical Agency-CSA/Ethiopia ICF, 2017, ETH DEM HLTH SURV 20; Chavan G., 2014, INT J HEALTHCARE BIO, V2, P67; Choi DH, 2000, REGION ANESTH PAIN M, V25, P240, DOI 10.1016/S1098-7339(00)90005-1; Cowan CM, 2002, BRIT J ANAESTH, V89, P452; Farzi Farnoush, 2017, Anesth Pain Med, V7, pe12738, DOI 10.5812/aapm.12738; Gauchan S, 2014, Nepal Med Coll J, V16, P5; Hamber EA, 1999, REGION ANESTH PAIN M, V24, P255; Khezri MB, 2014, PAIN RES TREAT, V2014, DOI 10.1155/2014/513628; Khezri Marzieh-Beigom, 2012, Acta Anaesthesiol Taiwan, V50, P19, DOI 10.1016/j.aat.2012.03.001; Lee YY, 2005, EUR J ANAESTH, V22, P899, DOI 10.1017/S0265021505001523; Mebazaa Mhamed S., 2010, Middle East Journal of Anesthesiology, V20, P673; Mercier FJ, 2012, CURR OPIN ANESTHESIO, V25, P286, DOI 10.1097/ACO.0b013e3283530dab; Ousley R, 2012, ANAESTHESIA, V67, P1356, DOI 10.1111/anae.12034; Palmer SK, 2000, REGIONAL ANALGESIA IN OBSTETRICS, P3; Seyedhejazi M, 2007, PAK J MED SCI, V23, P747; Shashikala TK, 2014, J EVOL MED DENT SCI-, V3, P8980, DOI 10.14260/jemds/2014/3156; Stewart A, 2010, ANESTH ANALG, V111, P1230, DOI 10.1213/ANE.0b013e3181f2eae1; Venkata HG, 2015, SAUDI J ANAESTH, V9, P122, DOI 10.4103/1658-354X.152827; Yesuf KA., 2017, J ANESTH CRIT CARE O, V7, P00278	27	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7							e0268318	10.1371/journal.pone.0268318	http://dx.doi.org/10.1371/journal.pone.0268318			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M2ZD	35797265	Green Published, gold			2022-12-26	WOS:000835328600015
J	Passafiume, J; Glover, N; Crecelius, A; Chaudhari, AMW				Passafiume, Joseph; Glover, Nelson; Crecelius, Anne; Chaudhari, Ajit M. W.			The influence of receiving real-time visual feedback on breathing during treadmill running to exhaustion	PLOS ONE			English	Article							RESPIRATORY INDUCTANCE PLETHYSMOGRAPHY; PERCEIVED EXERTION; EXERCISE; VALIDATION; CAFFEINE; VENTILATION; CALIBRATION; INGESTION; RESPONSES; VALIDITY	Breathing plays a vital role in everyday life, and specifically during exercise it provides working muscles with the oxygen necessary for optimal performance. Respiratory inductance plethysmography (RIP) monitors breathing through elastic belts around the chest and abdomen, with efficient breathing defined by synchronous chest and abdomen movement. This study examined if providing runners with visual feedback through RIP could increase breathing efficiency and thereby time to exhaustion. Thirteen recreational runners (8F, 5M) ran to exhaustion on an inclined treadmill on two days, with visual feedback provided on one randomly chosen day. Phase angle was calculated as a measure of thoraco-abdominal coordination. Time to exhaustion was not significantly increased when visual feedback was provided (p = 1). Phase angle was not significantly predicted by visual feedback (p = 0.667). Six participants improved phase angle when visual feedback was provided, four of whom increased time to exhaustion. Four participants improved phase angle by 9 degrees or more, three of whom increased time to exhaustion. Participants who improved phase angle with visual feedback highlight that improving phase angle could increase time to exhaustion. Greater familiarization with breathing techniques and visual feedback and a different paradigm to induce running fatigue are needed to support future studies of breathing in runners.	[Passafiume, Joseph; Glover, Nelson; Chaudhari, Ajit M. W.] Ohio State Univ, Dept Mech & Aerosp Engn, Columbus, OH 43210 USA; [Crecelius, Anne] Univ Dayton, Dept Hlth & Sport Sci, Dayton, OH USA; [Chaudhari, Ajit M. W.] Ohio State Univ, Sch Hlth & Rehabil Sci, Columbus, OH USA; [Chaudhari, Ajit M. W.] Ohio State Univ, Sports Med Res Inst, Columbus, OH USA	University System of Ohio; Ohio State University; University of Dayton; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Passafiume, J (corresponding author), Ohio State Univ, Dept Mech & Aerosp Engn, Columbus, OH 43210 USA.	passafiume.6@osu.edu						Albertus Y, 2005, MED SCI SPORT EXER, V37, P461, DOI 10.1249/01.MSS.0000155700.72702.76; Amann M, 2012, EXP PHYSIOL, V97, P311, DOI 10.1113/expphysiol.2011.058800; Backhouse SH, 2011, APPETITE, V57, P247, DOI 10.1016/j.appet.2011.05.304; Bahensky P, 2021, J CLIN MED, V10, DOI 10.3390/jcm10163514; Bassett DR, 2000, MED SCI SPORT EXER, V32, P70, DOI 10.1097/00005768-200001000-00012; Bell DG, 1998, EUR J APPL PHYSIOL O, V77, P427, DOI 10.1007/s004210050355; Bernardi E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174927; BROOKS GA, 1986, MED SCI SPORT EXER, V18, P360, DOI 10.1249/00005768-198606000-00019; Carry PY, 1997, CHEST, V111, P910, DOI 10.1378/chest.111.4.910; Chitkara DK, 2006, AM J GASTROENTEROL, V101, P2449, DOI 10.1111/j.1572-0241.2006.00801.x; Clarenbach CF, 2005, CHEST, V128, P1282, DOI 10.1378/chest.128.3.1282; Denadai BS, 1998, BRAZ J MED BIOL RES, V31, P581, DOI 10.1590/S0100-879X1998000400017; Duncker DJ, 2008, PHYSIOL REV, V88, P1009, DOI 10.1152/physrev.00045.2006; Fraga C, 2017, CLIN PHYSIOL FUNCT I, V37, P17, DOI 10.1111/cpf.12261; Gu F, 2017, PERVASIVE MOB COMPUT, V42, P498, DOI 10.1016/j.pmcj.2017.06.015; HAMMER J, 1995, PEDIATR PULM, V19, P167, DOI 10.1002/ppul.1950190305; Harbour E, 2021, SENSORS-BASEL, V21, DOI 10.3390/s21165606; Heyde C, 2014, MED SCI SPORT EXER, V46, P488, DOI 10.1249/MSS.0000000000000130; Johnson ML, 2004, METHOD ENZYMOL, V384, P130; Kent L, 2009, RESP PHYSIOL NEUROBI, V167, P162, DOI 10.1016/j.resp.2009.03.013; Kravitz L., 2002, IDEA HLTH FITNESS SO, V20, P40; Martarelli D, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep169; Matsumoto T, 2011, RESP PHYSIOL NEUROBI, V178, P275, DOI 10.1016/j.resp.2011.06.025; MAUGHAN RJ, 1983, EUR J APPL PHYSIOL O, V52, P80, DOI 10.1007/BF00429030; Mayer OH, 2003, CHEST, V124, P1812, DOI 10.1378/chest.124.5.1812; Murata M, 2020, J CARDIOL, V76, P521, DOI 10.1016/j.jjcc.2020.06.001; Rahman T, 2017, J MED DEVICES, V11, DOI 10.1115/1.4035546; SACKNER MA, 1989, J APPL PHYSIOL, V66, P410, DOI 10.1152/jappl.1989.66.1.410; Seppanen TM, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-97; SIVAN Y, 1991, PEDIATR PULM, V11, P141, DOI 10.1002/ppul.1950110211; STICK SM, 1992, PEDIATR PULM, V14, P187, DOI 10.1002/ppul.1950140308; STRADLING JR, 1985, B EUR PHYSIOPATH RES, V21, P317; Swanson R., 2009, SLEEP DIAGNOSIS THER, V4, P24; Taboga P, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229035; Utter AC, 1999, EUR J APPL PHYSIOL O, V80, P92, DOI 10.1007/s004210050563; Valsted F.M., 2017, P 29 AUSTR C COMP HU, P275, DOI 10.1145/3152771.3152801; Van Middelkoop M, 2008, SCAND J MED SCI SPOR, V18, P140, DOI 10.1111/j.1600-0838.2007.00683.x; Vink R, 2021, GEOJOURNAL, V86, P963, DOI 10.1007/s10708-019-10104-3; Vitacca M, 1998, EUR RESPIR J, V11, P408, DOI 10.1183/09031936.98.11020408; VivoSense Inc, 2018, VIVOSENSE US MAN COM; WASSERMAN K, 1978, NEW ENGL J MED, V298, P780, DOI 10.1056/NEJM197804062981408; Witt JD, 2006, RESP PHYSIOL NEUROBI, V154, P389, DOI 10.1016/j.resp.2006.01.010	42	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7							e0270335	10.1371/journal.pone.0270335	http://dx.doi.org/10.1371/journal.pone.0270335			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M2ZD	35797373	Green Published, gold			2022-12-26	WOS:000835328600002
J	Sereda, AD; Kazakova, AS; Namsrayn, SG; Vlasov, ME; Kolbasov, DV				Sereda, Alexey D.; Kazakova, Anna S.; Namsrayn, Sanzhi G.; Vlasov, Mikhail E.; Kolbasov, Denis V.			The attenuated ASFV strains MK-200 and FK-32/135 as possible models for investigation of protective immunity by ASFV infection	PLOS ONE			English	Article							AFRICAN-SWINE-FEVER; DOMESTIC PIGS; VIRUS; ISOLATE; IDENTIFICATION; CHALLENGE; P72	African swine fever (ASF) is an infectious disease of domestic and wild pigs of all breeds and ages, with the acute form of the disease being characterized by high fever, hemorrhages in the reticuloendothelial system and a high mortality rate. Registered safe and efficacious ASF vaccines are not available. The development of experimental ASF vaccines, particularly live attenuated, have considerably intensified in the last years. There is much variability in experimental approaches undertaken by laboratories attempting to develop first generation vaccines, rendering it difficult to interpret and make comparisons across trials. ASF virus (ASFV) genotyping does not fully correlate with available cross-protection data and may be of limited value in predicting cross-protective vaccine efficacy. Recently, ASFV strains were assigned to a respective nine groups by seroimmunotype (from I to IX): in vivo the grouping is based on results of cross protection of pigs survived after their infection with a virulent strain (bioassay), while in vitro this grouping is based on hemadsorption inhibition assay (HADIA) data. Here we demonstrate the antigenic and protective properties of two attenuated ASFV strains MK200 and FK-32/135. Pronounced differences in the HADIA and in immunological test in animals allow us to consider them and the corresponding reference virulent strains of the ASFV of Mozambique-78 (seroimmunotype III, genotype V) and France-32 (seroimmunotype IV, genotype I) as useful models for studying the mechanisms of protective immunity and evaluation of the candidate vaccines.	[Sereda, Alexey D.; Kazakova, Anna S.; Namsrayn, Sanzhi G.; Vlasov, Mikhail E.; Kolbasov, Denis V.] Fed Res Ctr Virol & Microbiol FRCVM, Volginsky, Russia		Sereda, AD; Kazakova, AS (corresponding author), Fed Res Ctr Virol & Microbiol FRCVM, Volginsky, Russia.	sereda-56@mail.ru; annakazakova85@gmail.com		Namsrayn, Sanzhi/0000-0003-1116-090X	Ministry of Science and Higher Education of the Russian Federation [0451-2019-0005]	Ministry of Science and Higher Education of the Russian Federation	We are thankful to Almaz R. Imatdinov for the technical assistance.	Abrams CC, 2013, VIROLOGY, V443, P99, DOI 10.1016/j.virol.2013.04.028; [Anonymous], RUL SAMPL PATH MAT B; Ashmarin IP., 1975, RAPID METHODS STAT P, V2nd Edition, P76; Balyshev V., 1995, VIRAL DIS ANIMALS, P230; Bastos ADS, 2003, ARCH VIROL, V148, P693, DOI 10.1007/s00705-002-0946-8; Blome S, 2013, VIRUS RES, V173, P122, DOI 10.1016/j.virusres.2012.10.026; Boinas FS, 2004, J GEN VIROL, V85, P2177, DOI 10.1099/vir.0.80058-0; Correia S, 2013, VIRUS RES, V173, P87, DOI 10.1016/j.virusres.2012.10.013; Dixon LK, 2004, VET IMMUNOL IMMUNOP, V100, P117, DOI 10.1016/j.vetimm.2004.04.002; Gallardo C, 2015, TRANSBOUND EMERG DIS, V62, P612, DOI 10.1111/tbed.12431; Gallardo C, 2009, VIRUS GENES, V38, P85, DOI 10.1007/s11262-008-0293-2; Gallardo C, 2018, VACCINE, V36, P2694, DOI 10.1016/j.vaccine.2018.03.040; Jori F, 2013, VIRUS RES, V173, P212, DOI 10.1016/j.virusres.2012.10.005; King K, 2011, VACCINE, V29, P4593, DOI 10.1016/j.vaccine.2011.04.052; Korennoy FI, 2017, TRANSBOUND EMERG DIS, V64, P1858, DOI 10.1111/tbed.12583; Lacasta A, 2015, VET RES, V46, DOI 10.1186/s13567-015-0275-z; Leitao A, 2001, J GEN VIROL, V82, P513, DOI 10.1099/0022-1317-82-3-513; Lucas A., 1967, COLLECTION MONOGRAPH; MALMQUIST WA, 1963, AM J VET RES, V24, P450; MALMQUIST WA, 1960, AM J VET RES, V21, P104; Malogolovkin A, 2015, J GEN VIROL, V96, P866, DOI [10.1099/jgv.0.000490, 10.1099/jgv.0.000024]; Malogolovkin A., 2020, EMERGING TRANSBOUNDA, P27, DOI 10.1007/978-981-15-0402-0_2; Malogolovkin A, 2015, EMERG INFECT DIS, V21, P312, DOI 10.3201/eid2102.140649; Mulumba-Mfumu LK, 2016, TRANSBOUND EMERG DIS, V63, pE323, DOI 10.1111/tbed.12303; National Research Council (US) Committee, 2011, GUIDE CARE USE LAB A, DOI [DOI 10.17226/12910, 10.17226/12910]; Nix RJ, 2006, ARCH VIROL, V151, P2475, DOI 10.1007/s00705-006-0794-z; OIE ASF, 2019, MANUAL DIAGNOSTIC TE, V8th; PINI A, 1974, VET REC, V94, P2, DOI 10.1136/vr.94.1.2; Pini A., 1977, THESIS U PRETORIA; Rock DL, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13050943; Ruiz-Gonzalvo F, 1983, AFRICAN SWINE FEVER, P2066; Sanchez-Botija C., 1977, LAB MANUAL DIAGNOSIS, V133, P6; Sanchez-Cordon PJ, 2017, ANTIVIR RES, V138, P1, DOI 10.1016/j.antiviral.2016.11.021; Sang H, 2020, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.00084; Sanna G, 2017, TRANSBOUND EMERG DIS, V64, P1280, DOI 10.1111/tbed.12504; Sereda AD, 2011, VOP VIRUSOL+, V56, P38; SEREDA AD, 1992, VOP VIRUSOL+, V37, P168; Sereda AD, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9040274; Sereda AD, 2018, SLOV VET RES, V55, P141, DOI 10.26873/SVR-454-2018; Tran HTT, 2021, ACTA VET-BEOGRAD, V71, P98, DOI 10.2478/acve-2021-0007; VIGARIO JD, 1974, ARCH GES VIRUSFORSCH, V45, P272, DOI 10.1007/BF01249690; VIGARIO JD, 1970, ARCH GES VIRUSFORSCH, V31, P387, DOI 10.1007/BF01253773; Vishnyakov IF., 1991, VETERINARIYA, V4, P28	43	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7							e0270641	10.1371/journal.pone.0270641	http://dx.doi.org/10.1371/journal.pone.0270641			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M2ZD	35797376	Green Published, gold			2022-12-26	WOS:000835328600023
J	Vilimek, D; Kubicek, J; Golian, M; Jaros, R; Kahankova, R; Hanzlikova, P; Barvik, D; Krestanova, A; Penhaker, M; Cerny, M; Prokop, O; Buzga, M; Tang, YM				Vilimek, Dominik; Kubicek, Jan; Golian, Milos; Jaros, Rene; Kahankova, Radana; Hanzlikova, Pavla; Barvik, Daniel; Krestanova, Alice; Penhaker, Marek; Cerny, Martin; Prokop, Ondrej; Buzga, Marek; Tang, Yiming			Comparative analysis of wavelet transform filtering systems for noise reduction in ultrasound images	PLOS ONE			English	Article							REMOVAL	Wavelet transform (WT) is a commonly used method for noise suppression and feature extraction from biomedical images. The selection of WT system settings significantly affects the efficiency of denoising procedure. This comparative study analyzed the efficacy of the proposed WT system on real 292 ultrasound images from several areas of interest. The study investigates the performance of the system for different scaling functions of two basic wavelet bases, Daubechies and Symlets, and their efficiency on images artificially corrupted by three kinds of noise. To evaluate our extensive analysis, we used objective metrics, namely structural similarity index (SSIM), correlation coefficient, mean squared error (MSE), peak signal-to-noise ratio (PSNR) and universal image quality index (Q-index). Moreover, this study includes clinical insights on selected filtration outcomes provided by clinical experts. The results show that the efficiency of the filtration strongly depends on the specific wavelet system setting, type of ultrasound data, and the noise present. The findings presented may provide a useful guideline for researchers, software developers, and clinical professionals to obtain high quality images.	[Vilimek, Dominik; Kubicek, Jan; Jaros, Rene; Kahankova, Radana; Barvik, Daniel; Krestanova, Alice; Penhaker, Marek; Cerny, Martin] VSB Tech Univ Ostrava, Fac Elect Engn & Comp Sci, Dept Cybernet & Biomed Engn, Ostrava, Czech Republic; [Golian, Milos; Buzga, Marek] Univ Ostrava, Human Mot Diagnost Ctr, Dept Human Movement Studies, Ostrava, Czech Republic; [Hanzlikova, Pavla] Univ Ostrava, Fac Med, Dept Imaging Method, Ostrava, Czech Republic; [Prokop, Ondrej] MEDIN as, Nove Mesto Na Morave, Czech Republic; [Buzga, Marek] Univ Ostrava, Fac Med, Dept Physiol & Pathophysiol, Ostrava, Czech Republic	Technical University of Ostrava; University Hospital Ostrava; University of Ostrava; University of Ostrava; University of Ostrava	Kahankova, R (corresponding author), VSB Tech Univ Ostrava, Fac Elect Engn & Comp Sci, Dept Cybernet & Biomed Engn, Ostrava, Czech Republic.	radana.kahankova@vsb.cz	Barvik, Daniel/AAO-3930-2020; Vilímek, Dominik/AFA-9182-2022; Jaros, Rene/ABG-1067-2020	Barvik, Daniel/0000-0001-7699-8792; Vilímek, Dominik/0000-0003-3781-1280; Jaros, Rene/0000-0003-3346-6467	project entitled Innovative Therapeutic Methods of Musculoskeletal System in Accident Surgery within the Operational Programme Research [CZ.02.1.01/0.0/0.0/17_049/0008441]; Ministry of Education of the Czech Republic [SP2022/34, SV4502261/SP2022/98]	project entitled Innovative Therapeutic Methods of Musculoskeletal System in Accident Surgery within the Operational Programme Research; Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	M.C. received funding from project entitled Innovative Therapeutic Methods of Musculoskeletal System in Accident Surgery within the Operational Programme Research, No. CZ.02.1.01/0.0/0.0/17_049/0008441, R.K. received funding from Ministry of Education of the Czech Republic under Project SP2022/34 and M.P. received funding from Ministry of Education of the Czech Republic under Project SV4502261/SP2022/98 Biomedical Engineering Systems XVIII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo F, 2013, MEASUREMENT, V46, P2447, DOI 10.1016/j.measurement.2013.04.064; Alla Takam Clemence, 2020, Informatics in Medicine Unlocked, V19, P222, DOI 10.1016/j.imu.2020.100335; Andria G, 2012, MEASUREMENT, V45, P1792, DOI 10.1016/j.measurement.2012.04.005; Andria G, 2013, IEEE T INSTRUM MEAS, V62, P2270, DOI 10.1109/TIM.2013.2255978; Arnal J, 2020, ADV ENG SOFTW, V148, DOI 10.1016/j.advengsoft.2020.102867; Bargsten L, 2020, INT J COMPUT ASS RAD, V15, P1427, DOI 10.1007/s11548-020-02203-1; Birge L, 1997, FESTSCHRIFT L LECAM, P55; Buffarini L, 2020, OPT LASER ENG, V129, DOI 10.1016/j.optlaseng.2020.106084; Chang Y, 2020, IEEE T INSTRUM MEAS, V69, P2707, DOI 10.1109/TIM.2019.2925881; Choi H, 2020, SYMMETRY-BASEL, V12, DOI 10.3390/sym12060938; Thanh DNH, 2019, INFORM-J COMPUT INFO, V43, P151, DOI 10.31449/inf.v43i2.2179; Devakumari D, 2020, ADV INTELL SYST COMP, V1108, P109, DOI 10.1007/978-3-030-37218-7_13; Dong GF, 2021, IEEE ACCESS, V9, P28272, DOI 10.1109/ACCESS.2021.3059003; DONOHO DL, 1994, BIOMETRIKA, V81, P425, DOI 10.1093/biomet/81.3.425; Duarte-Salazar CA, 2020, IEEE ACCESS, V8, P15983, DOI 10.1109/ACCESS.2020.2967178; Egmont-Petersen M, 2000, IEEE T BIO-MED ENG, V47, P941, DOI 10.1109/10.846689; Gai S, 2018, DIGIT SIGNAL PROCESS, V72, P192, DOI 10.1016/j.dsp.2017.10.006; Gueziri HE, 2020, MED IMAGE ANAL, V65, DOI 10.1016/j.media.2020.101769; Han SY, 2020, ULTRASONIC IMAGING, V42, P57, DOI 10.1177/0161734619900147; Hore Alain, 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P2366, DOI 10.1109/ICPR.2010.579; Karunharan KA., 2019, INT J PHARM RES, V11, DOI [10.31838/ijpr/2019.11.01.092, DOI 10.31838/IJPR/2019.11.01.092]; Kokil P, 2020, COMPUT METH PROG BIO, V194, DOI 10.1016/j.cmpb.2020.105477; Kollem Sreedhar, 2019, International Journal of Machine Learning and Computing, V9, P288, DOI 10.18178/ijmlc.2019.9.3.800; Kumar M, 2020, CURR MED IMAGING, V16, P278, DOI 10.2174/1573405614666180801113345; Leal AS, 2019, MEASUREMENT, V140, P572, DOI 10.1016/j.measurement.2019.03.050; Leveque L, 2021, PHYS MED BIOL, V66, DOI 10.1088/1361-6560/ac1157; Li HY, 2017, BIOMED ENG ONLINE, V16, DOI 10.1186/s12938-017-0336-9; Li L, 2020, MEASUREMENT, V152, DOI 10.1016/j.measurement.2019.107367; Loizou CP, 2014, COMPUT METH PROG BIO, V114, DOI 10.1016/j.cmpb.2014.01.018; LOUPAS T, 1989, IEEE T CIRCUITS SYST, V36, P129, DOI 10.1109/31.16577; Mason A, 2020, IEEE T MED IMAGING, V39, P1064, DOI 10.1109/TMI.2019.2930338; Mei FY, 2020, COMPUT METH PROG BIO, V196, DOI 10.1016/j.cmpb.2020.105670; Mei KQ, 2020, IEEE T IMAGE PROCESS, V29, P2845, DOI 10.1109/TIP.2019.2953361; Mishra D, 2018, INT C PATT RECOG, P3802, DOI 10.1109/ICPR.2018.8545031; Mittal D, 2010, MED BIOL ENG COMPUT, V48, P1281, DOI 10.1007/s11517-010-0650-x; Mugasa H, 2020, PATTERN RECOGN LETT, V131, P463, DOI 10.1016/j.patrec.2020.02.009; Nagaraj Y., 2018, COMPUTER VISION PATT, V841, P424; Nayak R, 2019, PHYS MED BIOL, V64, DOI 10.1088/1361-6560/ab5879; Nisha SS, 2020, INT J IMAGE GRAPH, V20, DOI 10.1142/S0219467820500254; Ozkul MC, 2019, ULTRASONIC IMAGING, V41, P368, DOI 10.1177/0161734619865961; Prasath VBS, 2017, INFORMATICA-LITHUAN, V28, P505, DOI 10.15388/Informatica.2017.141; Puyo L, 2020, BIOMED OPT EXPRESS, V11, P3274, DOI 10.1364/BOE.392699; Randhawa SK, 2019, MULTIDIM SYST SIGN P, V30, P1545, DOI 10.1007/s11045-018-0616-y; Rani VMK, 2020, MULTIMED TOOLS APPL, V79, P16967, DOI 10.1007/s11042-019-7487-6; Rezatofighi SH, 2009, ICDIP 2009: INTERNATIONAL CONFERENCE ON DIGITAL IMAGE PROCESSING, PROCEEDINGS, P107, DOI 10.1109/ICDIP.2009.19; Sagheer SVM, 2020, BIOMED SIGNAL PROCES, V61, DOI 10.1016/j.bspc.2020.102036; Sara U., 2019, JOUR COMP COMMU, V07, P8, DOI [10.4236/jcc.2019.73002, DOI 10.4236/JCC.2019.73002]; Setiadi DIM, 2021, MULTIMED TOOLS APPL, V80, P8423, DOI 10.1007/s11042-020-10035-z; Sheehan MP, 2019, EUR SIGNAL PR CONF; Sofuni A, 2020, J MED ULTRASON, V47, P359, DOI 10.1007/s10396-019-00968-w; Taneja H., 2018, PROCEDIA COMPUTER SC, V132, P643, DOI [10.1016/j.procs.2018.05.063, DOI 10.1016/J.PROCS.2018.05.063]; Wang Z, 2002, IEEE SIGNAL PROC LET, V9, P81, DOI 10.1109/97.995823; Xu Haohao, 2018, Annu Int Conf IEEE Eng Med Biol Soc, V2018, P874, DOI 10.1109/EMBC.2018.8512314; Yu YJ, 2002, IEEE T IMAGE PROCESS, V11, P1260, DOI 10.1109/TIP.2002.804279; Zhang K, 2018, IEEE T IMAGE PROCESS, V27, P4608, DOI 10.1109/TIP.2018.2839891; Zhang NY, 2020, BIOMED ENG ONLINE, V19, DOI 10.1186/s12938-020-00778-z	57	1	1	9	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7							e0270745	10.1371/journal.pone.0270745	http://dx.doi.org/10.1371/journal.pone.0270745			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M2ZD	35797331	Green Published, gold			2022-12-26	WOS:000835328600005
J	DuBose, MB; Sartawi, T; Sawatzky, TM; Causey, CP; Rehman, FK; Knuckley, B				DuBose, Mollie B.; Sartawi, Tala; Sawatzky, Tina M.; Causey, Corey P.; Rehman, Fatima Khwaja; Knuckley, Bryan			A peptoid-based inhibitor of protein arginine methyltransferase 1 (PRMT1) induces apoptosis and autophagy in cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-SPECIFICITY; IN-VIVO; METHYLATION; PERMEABILITY; DISTINCT; PEPTIDE; BINDING; FAMILY; ASSAY	Protein arginine methyltransferases (PRMTs) are S-adenosylmethionine-dependent enzymes that transfer a methyl group to arginine residues within proteins, most notably histones. The nine characterized PRMT family members are divided into three types depending on the resulting methylated product: asymmetric dimethylarginine (Type I PRMT), symmetric dimethylarginine (Type II PRMT), or monomethylated arginine (Type III PRMT). In some cancers, the resulting product can lead to either increased or decreased transcription of cancer-related genes, suggesting PRMT family members may be valid therapeutic targets. Traditionally, peptide-based compounds have been employed to target this family of enzymes, which has resulted in multiple tool and lead compounds being developed. However, peptide-based therapeutics suffer from poor stability and short half-lives, as proteases can render them useless by hydrolytic degradation. Conversely, peptoids, which are peptide-mimetics composed of N-substituted glycine monomers, are less susceptible to hydrolysis, resulting in improved stability and longer half-lives. Herein, we report the development of a bioavailable, peptoid-based PRMT1 inhibitor that induces cell death in MDA468 and HCT116 cancer cell lines while not exhibiting any significant impact on non-tumorigenic HepaRG or normal human mammary epithelial cells. Furthermore, the inhibitor described herein appears to induce both apoptosis and autophagy, suggesting it may be a less toxic cytostatic agent. In conclusion, we propose this peptoid-based inhibitor has significant anticancer and therapeutic potential by reducing cell viability, growth, and size in breast and colon cancer. Further experimentation will help determine the mechanism of action and downstream effects of this compound.	[DuBose, Mollie B.; Sawatzky, Tina M.; Causey, Corey P.; Knuckley, Bryan] Univ North Florida, Dept Chem, Jacksonville, FL 32224 USA; [Sartawi, Tala; Rehman, Fatima Khwaja] Univ North Florida, Dept Biol, Jacksonville, FL USA	State University System of Florida; University of North Florida; State University System of Florida; University of North Florida	Knuckley, B (corresponding author), Univ North Florida, Dept Chem, Jacksonville, FL 32224 USA.	bryan.knuckley@unf.edu		Knuckley, Bryan/0000-0002-6751-3762; Rehman, Fatima/0000-0001-7941-4107; Brekker, Mollie/0000-0002-2603-1089	University of North Florida (UNF) College of Arts and Sciences (COAS) Dean's Leadership Fellowship grant; UNF startup funds	University of North Florida (UNF) College of Arts and Sciences (COAS) Dean's Leadership Fellowship grant; UNF startup funds	This work was supported by the University of North Florida (UNF) College of Arts and Sciences (COAS) Dean's Leadership Fellowship grant and UNF startup funds.	Baldwin R Mitchell, 2014, World J Biol Chem, V5, P115, DOI 10.4331/wjbc.v5.i2.115; Baldwin RM, 2012, CELL CYCLE, V11, P4597, DOI 10.4161/cc.22871; Bedford MT, 2007, J CELL SCI, V120, P4243, DOI 10.1242/jcs.019885; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bicker KL, 2020, CHEM COMMUN, V56, P11158, DOI 10.1039/d0cc04704j; Bicker KL, 2011, MOL BIOSYST, V7, P48, DOI 10.1039/c0mb00015a; Blanc RS, 2017, MOL CELL, V65, P8, DOI 10.1016/j.molcel.2016.11.003; Boriack-Sjodin PA, 2016, BIOCHEMISTRY-US, V55, P1557, DOI 10.1021/acs.biochem.5b01129; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Cheng SS, 2020, J HEMATOL ONCOL, V13, DOI 10.1186/s13045-020-00850-0; Culf AS, 2010, MOLECULES, V15, P5282, DOI 10.3390/molecules15085282; Di Lorenzo A, 2011, FEBS LETT, V585, P2024, DOI 10.1016/j.febslet.2010.11.010; Eram MS, 2016, ACS CHEM BIOL, V11, P772, DOI 10.1021/acschembio.5b00839; Fedoriw A, 2019, CANCER CELL, V36, P100, DOI 10.1016/j.ccell.2019.05.014; Gao YY, 2016, SCI REP-UK, V6, DOI 10.1038/srep19874; Gary JD, 1998, PROG NUCLEIC ACID RE, V61, P65, DOI 10.1016/S0079-6603(08)60825-9; Green RM, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.106048; Guccione E, 2019, NAT REV MOL CELL BIO, V20, P642, DOI 10.1038/s41580-019-0155-x; Nguyen HC, 2015, ACS COMB SCI, V17, P500, DOI 10.1021/acscombsci.5b00070; Herrmann F, 2009, J CELL SCI, V122, P667, DOI 10.1242/jcs.039933; Janisiak J, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22158023; Jarrold J, 2019, TRENDS MOL MED, V25, P993, DOI 10.1016/j.molmed.2019.05.007; Kwon YU, 2007, J AM CHEM SOC, V129, P1508, DOI 10.1021/ja0668623; Lee YH, 2009, MOL ENDOCRINOL, V23, P425, DOI 10.1210/me.2008-0380; Levengood MR, 2009, CHEMBIOCHEM, V10, P911, DOI 10.1002/cbic.200800752; Lim HS, 2007, J AM CHEM SOC, V129, P7750, DOI 10.1021/ja072027p; Liu LM, 2019, CANCER RES, V79, P2865, DOI 10.1158/0008-5472.CAN-18-3211; Mann SA, 2020, BIOCHEM J, V477, P2971, DOI 10.1042/BCJ20200534; Mann SA, 2019, BIOORGAN MED CHEM, V27, P224, DOI 10.1016/j.bmc.2018.12.001; Mathioudaki K, 2008, BRIT J CANCER, V99, P2094, DOI 10.1038/sj.bjc.6604807; Obianyo O, 2010, CHEMBIOCHEM, V11, P1219, DOI 10.1002/cbic.201000209; OLIVER MH, 1989, J CELL SCI, V92, P513; Osborne TC, 2007, BIOCHEMISTRY-US, V46, P13370, DOI 10.1021/bi701558t; Pal S, 2007, J CELL PHYSIOL, V213, P306, DOI 10.1002/jcp.21180; Pal S, 2007, EMBO J, V26, P3558, DOI 10.1038/sj.emboj.7601794; Raveendra BL, 2013, CHEM BIOL, V20, P351, DOI 10.1016/j.chembiol.2012.12.009; Schwochert J, 2015, ORG LETT, V17, P2928, DOI 10.1021/acs.orglett.5b01162; Tsapras P, 2017, CELL DEATH DIFFER, V24, P1369, DOI 10.1038/cdd.2017.43; Vhuiyan M, 2013, FUTURE MED CHEM, V5, P2199, DOI 10.4155/fmc.13.184; Wang L, 2022, SIGNAL TRANSDUCT TAR, V7, DOI 10.1038/s41392-022-00904-4; Wolf SS, 2009, CELL MOL LIFE SCI, V66, P2109, DOI 10.1007/s00018-009-0010-x; Wu Q, 2021, NAT REV DRUG DISCOV, V20, P509, DOI 10.1038/s41573-021-00159-8; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409; Yoshimatsu M, 2011, INT J CANCER, V128, P562, DOI 10.1002/ijc.25366; Yu ZB, 2009, MOL CELL BIOL, V29, P2982, DOI 10.1128/MCB.00042-09; Zhang BL, 2017, TOXICOL APPL PHARM, V336, P1, DOI 10.1016/j.taap.2017.10.002; Zhang YR, 2020, METHODS, V175, P24, DOI 10.1016/j.ymeth.2019.08.003; Zhao X, 2008, GENE DEV, V22, P640, DOI 10.1101/gad.1632608; Zhao Y, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1595-0; ZUCKERMANN RN, 1992, J AM CHEM SOC, V114, P10646, DOI 10.1021/ja00052a076	50	0	0	8	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2022	298	8							102205	10.1016/j.jbc.2022.102205	http://dx.doi.org/10.1016/j.jbc.2022.102205			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3S2WH	35764172	gold, Green Published			2022-12-26	WOS:000839461200008
J	Mirbaha, H; Chen, DL; Mullapudi, V; Terpack, SJ; White, CL; Joachimiak, LA; Diamond, MI				Mirbaha, Hilda; Chen, Dailu; Mullapudi, Vishruth; Terpack, Sandi Jo; White, Charles L.; Joachimiak, Lukasz A.; Diamond, Marc, I			Seed-competent tau monomer initiates pathology in a tauopathy mouse model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TAU; MICROTUBULE; PHOSPHORYLATION; PROPAGATION; MICE	Tau aggregation into ordered assemblies causes neurodegenerative tauopathies. We previously reported that tau monomer exists in either inert (M-i) or seed-competent (M-s) conformational ensembles and that M-s encodes strains, that is, unique, self-replicating, biologically active assemblies. It is unknown if disease begins with M-s formation followed by fibril assembly or if M-s derives from fibrils and is therefore an epiphenomenon. Here, we studied a tauopathy mouse model (PS19) that expresses full-length mutant human (1N4R) tau (P301S). Insoluble tau seeding activity appeared at 2 months of age and insoluble tau protein assemblies by immunoblot at 3 months. Tau monomer from mice aged 1 to 6 weeks, purified using size-exclusion chromatography, contained soluble seeding activity at 4 weeks, before insoluble material or larger assemblies were observed, with assemblies ranging from n = 1 to 3 tau units. By 5 to 6 weeks, large soluble assemblies had formed. This indicated that the first detectable pathological forms of tau were in fact M-s. We next examined post-translational modifications of tau monomer from 1 to 6 weeks. We detected no phosphorylation unique to M-s in PS19 or human Alzheimer's disease brains. We conclude that tauopathy begins with formation of the M-s monomer, whose activity is phosphorylation independent. M-s then self assembles to form oligomers before it forms insoluble fibrils. The conversion of tau monomer from M-i to M-s thus constitutes the first detectable step in the initiation of tauopathy in this mouse model, with obvious implications for the origins of tauopathy in humans.	[Mirbaha, Hilda; Chen, Dailu; Mullapudi, Vishruth; Terpack, Sandi Jo; White, Charles L.; Joachimiak, Lukasz A.; Diamond, Marc, I] Univ Texas Southwestern Med Ctr Dallas, Ctr Alzheimers & Neurodegenerat Dis, Peter ODonnell Jr Brain Inst, Dallas, TX 75390 USA; [Mirbaha, Hilda; White, Charles L.] Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Diamond, MI (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Ctr Alzheimers & Neurodegenerat Dis, Peter ODonnell Jr Brain Inst, Dallas, TX 75390 USA.	marc.diamond@utsouthwestern.edu	White, Charles L/AAJ-1858-2021	White, Charles L/0000-0002-3870-2804; Mullapudi, Vishruth/0000-0002-5346-4242; Joachimiak, Lukasz/0000-0003-3061-5850	Aging Mind Foundation; Glick Family Foundation; Cure Alzheimer's Foundation; NIH [1RF1AG065407, 1R01AG059689, 1R56AG061847]; BrightFocus; CurePSP	Aging Mind Foundation; Glick Family Foundation; Cure Alzheimer's Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BrightFocus(BrightFocus Foundation); CurePSP	Research was supported by Aging Mind Foundation (M. I. D.); Glick Family Foundation (M. I. D.); Cure Alzheimer's Foundation (M. I. D.); NIH 1RF1AG065407 (M. I. D., L. A. J.); 1R01AG059689 (M. I. D.), 1R56AG061847 (M. I. D.); BrightFocus (L. A. J.); CurePSP (L. A. J.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ambadipudi S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00480-0; BIERNAT J, 1992, EMBO J, V11, P1593, DOI 10.1002/j.1460-2075.1992.tb05204.x; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Chen DL, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10355-1; Clavaguera F, 2013, P NATL ACAD SCI USA, V110, P9535, DOI 10.1073/pnas.1301175110; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; CLEVELAND DW, 1977, J MOL BIOL, V116, P227, DOI 10.1016/0022-2836(77)90214-5; Frost B, 2009, PRION, V3, P74, DOI 10.4161/pri.3.2.8754; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Frost B, 2009, J BIOL CHEM, V284, P3546, DOI 10.1074/jbc.M805627200; Furman JL, 2015, JOVE-J VIS EXP, DOI 10.3791/53205; GOEDERT M, 1992, FEBS LETT, V312, P95, DOI 10.1016/0014-5793(92)81418-L; Gotz J, 2001, J BIOL CHEM, V276, P529, DOI 10.1074/jbc.M006531200; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Holmes BB, 2014, P NATL ACAD SCI USA, V111, pE4376, DOI 10.1073/pnas.1411649111; Hou ZQ, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-93093-z; IHARA Y, 1986, J BIOCHEM-TOKYO, V99, P1807, DOI 10.1093/oxfordjournals.jbchem.a135662; IQBAL K, 1986, LANCET, V2, P421; Kaufman SK, 2016, NEURON, V92, P796, DOI 10.1016/j.neuron.2016.09.055; Kontaxi C, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00056; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Mirbaha H, 2018, ELIFE, V7, DOI 10.7554/eLife.36584; Mirbaha H, 2015, J BIOL CHEM, V290, P14893, DOI 10.1074/jbc.M115.652693; Nachman E, 2020, J BIOL CHEM, V295, P9676, DOI 10.1074/jbc.RA120.013478; Sanders DW, 2016, NEURON, V89, P433, DOI 10.1016/j.neuron.2016.01.026; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; Sharma AM, 2018, ELIFE, V7, DOI 10.7554/eLife.37813.001; Vaquer-Alicea J, 2021, ACTA NEUROPATHOL, V142, P57, DOI 10.1007/s00401-021-02301-7; Wegmann S, 2019, ADV EXP MED BIOL, V1184, P341, DOI 10.1007/978-981-32-9358-8_25; Wegmann S, 2018, EMBO J, V37, DOI 10.15252/embj.201798049; WITMAN GB, 1976, P NATL ACAD SCI USA, V73, P4070, DOI 10.1073/pnas.73.11.4070; Yanamandra K, 2013, NEURON, V80, P402, DOI 10.1016/j.neuron.2013.07.046; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zhang XM, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002183	34	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2022	298	8							102163	10.1016/j.jbc.2022.102163	http://dx.doi.org/10.1016/j.jbc.2022.102163			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3S2VB	35750209	Green Published, gold			2022-12-26	WOS:000839458000003
J	Radka, CD; Miller, DJ; Frank, MW; Rock, CO				Radka, Christopher D.; Miller, Darcie J.; Frank, Matthew W.; Rock, Charles O.			Biochemical characterization of the first step in sulfonolipid biosynthesis in Alistipes finegoldii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE PALMITOYLTRANSFERASE; 8-AMINO-7-OXONONANOATE SYNTHASE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; OUTER-MEMBRANE; BACTERIUM; INTERMEDIATE; MECHANISM; ACID; SULFOBACIN	Sulfonolipids are unusual lipids found in the outer membranes of Gram-negative bacteria in the phylum Bacteroidetes. Sulfonolipid and its deacylated derivative, capnine, are sulfur analogs of ceramide-1-phosphate and sphingosine-1-phosphate, respectively; thus, sulfonolipid biosynthesis is postulated to be similar to the sphingolipid biosynthetic pathway. Here, we identify the first enzyme in sulfonolipid synthesis in Alistipes finegoldii as the product of the alfi_1224 gene, cysteate acyl-acyl carrier protein (ACP) transferase (SulA). We show SulA catalyzes the condensation of acyl-ACP and cysteate (3-sulfo-alanine) to form 3-ketocapnine. Acyl-CoA is a poor substrate. We show SulA has a bound pyridoxal phosphate (PLP) cofactor that undergoes a spectral redshift in the presence of cysteate, consistent with the transition of the lysine-aldimine complex to a substrate-aldimine complex. Furthermore, the SulA crystal structure shows the same prototypical fold found in bacterial serine palmitoyltransferases (Spts), enveloping the PLP cofactor bound to Lys251. We observed the SulA and Spt active sites are identical except for Lys281 in SulA, which is an alanine in Spt. Additionally, SulA(K281A) is catalytically inactive but binds cysteate and forms the external aldimine normally, highlighting the structural role of the Lys281 side chain in walling off the active site from bulk solvent. Finally, the electropositive groove on the protein surface adjacent to the active site entrance provides a landing pad for the electronegative acyl-ACP surface. Taken together, these data identify the substrates, products, and mechanism of SulA, the PLP-dependent condensing enzyme that catalyzes the first step in sulfonolipid synthesis in a gut commensal bacterium.	[Radka, Christopher D.; Frank, Matthew W.; Rock, Charles O.] St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA; [Miller, Darcie J.] St Jude Childrens Res Hosp, Dept Struct Biol, 332 N Lauderdale St, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	Radka, CD (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA.	christopher.radka@stjude.org	Radka, Christopher D./AGX-1090-2022; Rock, Charles/N-2256-2018	Radka, Christopher D./0000-0002-6037-7710; Rock, Charles/0000-0001-8648-4189	National Institutes of Health, United States [1K99AI166116, GM034496]	National Institutes of Health, United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health, United States grants 1K99AI166116 (C. D. R.) and GM034496 (C. O. R.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABBANAT DR, 1986, NATURE, V324, P367, DOI 10.1038/324367a0; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Alegado RA, 2012, ELIFE, V1, DOI 10.7554/eLife.00013; Anders H, 2014, INT J SYST EVOL MICR, V64, P1264, DOI 10.1099/ijs.0.057463-0; ANDERSON MS, 1993, J BIOL CHEM, V268, P19858; ANDERSON R, 1979, BIOCHIM BIOPHYS ACTA, V573, P557, DOI 10.1016/0005-2760(79)90230-3; ANDERSON R, 1975, BIOCHIM BIOPHYS ACTA, V409, P259, DOI 10.1016/0005-2760(75)90160-5; Astner I, 2005, EMBO J, V24, P3166, DOI 10.1038/sj.emboj.7600792; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baronio M, 2010, J LIPID RES, V51, P1878, DOI 10.1194/jlr.M004804; Batrakov SG, 1998, BBA-LIPID LIPID MET, V1391, P79, DOI 10.1016/S0005-2760(97)00165-3; Batrakov SG, 2000, BBA-MOL CELL BIOL L, V1484, P225, DOI 10.1016/S1388-1981(00)00011-1; Chaudhari PN, 2009, APPL BIOCHEM BIOTECH, V158, P231, DOI 10.1007/s12010-008-8417-7; Chun SW, 2019, SYNLETT, V30, P1269, DOI 10.1055/s-0037-1611755; Corcelli A, 2004, APPL ENVIRON MICROB, V70, P6678, DOI 10.1128/AEM.70.11.6678-6685.2004; DeLano W. L., 2002, PYMOL MOL GRAPHICS S; Dziarski R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146162; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GILMORE DF, 1989, BIOCHEM BIOPH RES CO, V160, P535, DOI 10.1016/0006-291X(89)92465-0; GODCHAUX W, 1980, J BACTERIOL, V144, P592, DOI 10.1128/JB.144.2.592-602.1980; GODCHAUX W, 1983, J BACTERIOL, V153, P1238, DOI 10.1128/JB.153.3.1238-1246.1983; GODCHAUX W, 1988, ARCH MICROBIOL, V150, P42, DOI 10.1007/BF00409716; GODCHAUX W, 1991, J BACTERIOL, V173, P7607, DOI 10.1128/jb.173.23.7607-7614.1991; GODCHAUX W, 1990, J BACTERIOL, V172, P1250, DOI 10.1128/jb.172.3.1250-1255.1990; Hou LK, 2022, ACS CHEM BIOL, V17, P1197, DOI 10.1021/acschembio.2c00141; Hunter GA, 1999, BIOCHEMISTRY-US, V38, P3711, DOI 10.1021/bi982390w; Ikushiro H, 2008, J BIOL CHEM, V283, P7542, DOI 10.1074/jbc.M706874200; Ikushiro H, 2009, J BIOCHEM, V146, P549, DOI 10.1093/jb/mvp100; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kerbarh O, 2006, CHEM COMMUN, P60, DOI 10.1039/b511837a; Lee MT, 2022, J LIPID RES, V63, DOI 10.1016/j.jlr.2022.100236; Lima SF, 2022, GASTROENTEROLOGY, V162, P166, DOI 10.1053/j.gastro.2021.09.061; Liu YB, 2022, BIOCHEMISTRY-US, DOI 10.1021/acs.biochem.2c00102; Lowther J, 2010, MOL BIOSYST, V6, P1682, DOI 10.1039/c003743e; Maeda J, 2010, INT J MOL MED, V26, P751, DOI 10.3892/ijmm_00000522; McIntosh CM, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0474-8; Olea-Ozuna RJ, 2021, ENVIRON MICROBIOL, V23, DOI 10.1111/1462-2920.15280; Paiardini A, 2004, PROTEIN SCI, V13, P2992, DOI 10.1110/ps.04938104; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; PITTA TP, 1989, J BACTERIOL, V171, P952, DOI 10.1128/jb.171.2.952-957.1989; Radka CD, 2020, J BIOL CHEM, V295, P7635, DOI 10.1074/jbc.RA120.013336; Radka CD, 2020, MOL MICROBIOL, V113, P807, DOI 10.1111/mmi.14445; Radka CD, 2017, ACTA CRYSTALLOGR D, V73, P921, DOI 10.1107/S2059798317015236; Raman MCC, 2009, J BIOL CHEM, V284, P17328, DOI 10.1074/jbc.M109.008680; Schmidt A, 2001, BIOCHEMISTRY-US, V40, P5151, DOI 10.1021/bi002204y; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schuck P., 2015, BASIC PRINCIPLES ANA; Skubak P, 2004, ACTA CRYSTALLOGR D, V60, P2196, DOI 10.1107/S0907444904019079; SMITH CA, 1988, BIOCHEM EDUC, V16, P104, DOI 10.1016/0307-4412(88)90075-1; Stankeviciute G, 2022, NAT CHEM BIOL, V18, P305, DOI 10.1038/s41589-021-00948-7; Sukocheva OA, 2020, ADV PROTEIN CHEM STR, V120, P123, DOI 10.1016/bs.apcsb.2019.11.003; Vences-Guzman MA, 2021, ENVIRON MICROBIOL, V23, P2448, DOI 10.1111/1462-2920.15445; Walker A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10369-z; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Webster SP, 2000, BIOCHEMISTRY-US, V39, P516, DOI 10.1021/bi991620j; Whaley SG, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.101434; WHITE RH, 1984, J BACTERIOL, V159, P42, DOI 10.1128/JB.159.1.42-46.1984; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Woznica A, 2016, P NATL ACAD SCI USA, V113, P7894, DOI 10.1073/pnas.1605015113; Yao JW, 2015, J BIOL CHEM, V290, P22163, DOI 10.1074/jbc.M115.671008; Yard BA, 2007, J MOL BIOL, V370, P870, DOI 10.1016/j.jmb.2007.04.086; Zhao HY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126420; Zhao Huaying, 2013, Curr Protoc Protein Sci, VChapter 20, DOI 10.1002/0471140864.ps2012s71	63	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2022	298	8							102195	10.1016/j.jbc.2022.102195	http://dx.doi.org/10.1016/j.jbc.2022.102195			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3S2VB	35760102	gold, Green Published			2022-12-26	WOS:000839458000011
J	Tarantino, D; Walker, C; Weekes, D; Pemberton, H; Davidson, K; Torga, G; Frankum, J; Mendes-Pereira, AM; Prince, C; Ferro, R; Brough, R; Pettitt, SJ; Lord, CJ; Grigoriadis, A; Tutt, ANJ				Tarantino, Dalia; Walker, Callum; Weekes, Daniel; Pemberton, Helen; Davidson, Kathryn; Torga, Gonzalo; Frankum, Jessica; Mendes-Pereira, Ana M.; Prince, Cynthia; Ferro, Riccardo; Brough, Rachel; Pettitt, Stephen J.; Lord, Christopher J.; Grigoriadis, Anita; Tutt, Andrew N. J.			Functional screening reveals HORMAD1-driven gene dependencies associated with translesion synthesis and replication stress tolerance	ONCOGENE			English	Article							DNA-POLYMERASES; BREAST-CANCER; EXPRESSION; INHIBITOR; MUTATIONS; BRCANESS; TUMORS	HORMAD1 expression is usually restricted to germline cells, but it becomes mis-expressed in epithelial cells in similar to 60% of triple-negative breast cancers (TNBCs), where it is associated with elevated genomic instability (1). HORMAD1 expression in TNBC is bimodal with HORMAD1-positive TNBC representing a biologically distinct disease group. Identification of HORMAD1-driven genetic dependencies may uncover novel therapies for this disease group. To study HORMAD1-driven genetic dependencies, we generated a SUM159 cell line model with doxycycline-inducible HORMAD1 that replicated genomic instability phenotypes seen in HORMAD1-positive TNBC (1). Using small interfering RNA screens, we identified candidate genes whose depletion selectively inhibited the cellular growth of HORMAD1-expressing cells. We validated five genes (ATR, BRIP1, POLH, TDP1 and XRCC1), depletion of which led to reduced cellular growth or clonogenic survival in cells expressing HORMAD1. In addition to the translesion synthesis (TLS) polymerase POLH, we identified a HORMAD1-driven dependency upon additional TLS polymerases, namely POLK, REV1, REV3L and REV7. Our data confirms that out-of-context somatic expression of HORMAD1 can lead to genomic instability and reveals that HORMAD1 expression induces dependencies upon replication stress tolerance pathways, such as translesion synthesis. Our data also suggest that HORMAD1 expression could be a patient selection biomarker for agents targeting replication stress.	[Tarantino, Dalia; Weekes, Daniel; Mendes-Pereira, Ana M.; Prince, Cynthia; Ferro, Riccardo; Grigoriadis, Anita; Tutt, Andrew N. J.] Kings Coll London, Breast Canc Now Res Unit, London, England; [Tarantino, Dalia; Weekes, Daniel; Mendes-Pereira, Ana M.; Prince, Cynthia; Ferro, Riccardo; Grigoriadis, Anita; Tutt, Andrew N. J.] Kings Coll London, Fac Life Sci & Med, Sch Canc & Pharmaceut Sci, Kings Hlth Partners AHSC, London, England; [Walker, Callum; Weekes, Daniel; Pemberton, Helen; Davidson, Kathryn; Torga, Gonzalo; Frankum, Jessica; Brough, Rachel; Pettitt, Stephen J.; Lord, Christopher J.; Tutt, Andrew N. J.] Inst Canc Res, Breast Canc Now Toby Robins Res Ctr, London, England; [Pemberton, Helen; Frankum, Jessica; Brough, Rachel; Pettitt, Stephen J.; Lord, Christopher J.] Inst Canc Res, CRUK Gene Funct Lab, London, England	University of London; King's College London; King's Health Partners; University of London; King's College London; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Tutt, ANJ (corresponding author), Kings Coll London, Breast Canc Now Res Unit, London, England.; Tutt, ANJ (corresponding author), Kings Coll London, Fac Life Sci & Med, Sch Canc & Pharmaceut Sci, Kings Hlth Partners AHSC, London, England.; Tutt, ANJ (corresponding author), Inst Canc Res, Breast Canc Now Toby Robins Res Ctr, London, England.	Andrew.Tutt@icr.ac.uk		Torga, Gonzalo/0000-0002-6401-5127; Tutt, Andrew/0000-0001-8715-2901; Grigoriadis, Anita/0000-0003-3434-201X	Programme Grants from Breast Cancer Now; Cancer Research UK; National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust; NIHR Royal Marsden Hospital Biomedical Research Centre	Programme Grants from Breast Cancer Now; Cancer Research UK(Cancer Research UK); National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust; NIHR Royal Marsden Hospital Biomedical Research Centre	This work was funded by Programme Grants from Breast Cancer Now as part of Programme Funding to the Breast Cancer Now Toby Robins Research Centre and by funding from Cancer Research UK, the National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and the NIHR Royal Marsden Hospital Biomedical Research Centre to Prof. Andrew Tutt. We thank King's College London Genomic Core Facility for supporting the RT-qPCR data acquisition and analysis. We thank the Nikon Imaging Centre (KCL) for access to and assistance with the microscope facilities. We thank Sorapun Utting, Melanie Ferrao and Caroline Carey for technical and administrative assistance. We thank Dr. Rebecca Marlow for providing training in immunofluorescence image processing. We thank Dr. Tencho Tenev for providing assistance with the design and optimisation of the CRISPR-Cas9 based gene editing experiments. We thank Dr. Olivia Rossanese and the Cancer Therapeutics Unit (ICR) for kindly providing laboratory space for conducting part of the experimental work.	Bradbury A, 2020, PHARMACOL THERAPEUT, V207, DOI 10.1016/j.pharmthera.2019.107450; Brough R, 2011, CANCER DISCOV, V1, P260, DOI 10.1158/2159-8290.CD-11-0107; Campbell J, 2016, CELL REP, V14, P2490, DOI 10.1016/j.celrep.2016.02.023; Campeau PM, 2008, HUM GENET, V124, P31, DOI 10.1007/s00439-008-0529-1; Chen B, 2019, CANCER MANAG RES, V11, P179, DOI 10.2147/CMAR.S187151; Daniel K, 2011, NAT CELL BIOL, V13, P599, DOI 10.1038/ncb2213; Foulkes WD, 2003, J NATL CANCER I, V95, P1482, DOI 10.1093/jnci/djg050; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gao YZ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33601-w; Il'ina IV, 2020, MOLECULES, V25, DOI 10.3390/molecules25153496; Jones SE, 2017, CANCER RES, V77, P7014, DOI 10.1158/0008-5472.CAN-17-2056; Ketkar A, 2019, ACS CHEM BIOL, V14, P1337, DOI 10.1021/acschembio.9b00304; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Liu K, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2736-1; Lord CJ, 2016, NAT REV CANCER, V16, P110, DOI 10.1038/nrc.2015.21; Lord CJ, 2008, DNA REPAIR, V7, P2010, DOI 10.1016/j.dnarep.2008.08.014; Matros E, 2005, BREAST CANCER RES TR, V91, P179, DOI 10.1007/s10549-004-7603-8; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Menolfi D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07798-3; Nichols BA, 2018, CANCER RES, V78, P6196, DOI 10.1158/0008-5472.CAN-18-1377; Pommier Y, 2014, DNA REPAIR, V19, P114, DOI 10.1016/j.dnarep.2014.03.020; Rakha EA, 2008, HUM PATHOL, V39, P857, DOI 10.1016/j.humpath.2007.10.011; Reis-Filho JS, 2008, HISTOPATHOLOGY, V52, P108, DOI 10.1111/j.1365-2559.2007.02889.x; Ryan CJ, 2018, TRENDS CANCER, V4, P671, DOI 10.1016/j.trecan.2018.08.003; Saal LH, 2008, NAT GENET, V40, P102, DOI 10.1038/ng.2007.39; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; Schmid P, 2018, NEW ENGL J MED, V379, P2108, DOI 10.1056/NEJMoa1809615; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Temprine K, 2020, SCI SIGNAL, V13, DOI 10.1126/scisignal.aau1453; Tonzi P, 2018, ELIFE, V7, DOI 10.7554/eLife.41426; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Tutt ANJ, 2021, NEW ENGL J MED, V384, P2394, DOI 10.1056/NEJMoa2105215; Wang Xian, 2018, Oncotarget, V9, P30115, DOI 10.18632/oncotarget.25728; Watkins J, 2015, CANCER DISCOV, V5, P488, DOI 10.1158/2159-8290.CD-14-1092; Wojtaszek JL, 2019, CELL, V178, P152, DOI 10.1016/j.cell.2019.05.028; Yamanaka K, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006842; Yang W, 2018, ANNU REV BIOCHEM, V87, P239, DOI 10.1146/annurev-biochem-062917-012405; Zafar MK, 2018, BIOCHEMISTRY-US, V57, P1262, DOI 10.1021/acs.biochem.7b01176; Zhang J, 2016, GENES-BASEL, V7, DOI 10.3390/genes7080051	40	0	0	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 5	2022	41	32					3969	3977		10.1038/s41388-022-02369-9	http://dx.doi.org/10.1038/s41388-022-02369-9		JUN 2022	9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	3O2GY	35768547	hybrid, Green Published			2022-12-26	WOS:000818607200001
J	Alajlan, AA; Mukhtar, LE; Almussallam, AS; Alnuqaydan, AM; Albakiri, NS; Almutari, TF; Bin Shehail, KM; Aldawsari, FS; Alajel, SM				Alajlan, Abdullah A.; Mukhtar, Lenah E.; Almussallam, Adnan S.; Alnuqaydan, Abdullah M.; Albakiri, Nasser S.; Almutari, Turki F.; Bin Shehail, Khalid M.; Aldawsari, Fahad S.; Alajel, Sulaiman M.			Assessment of disinfectant efficacy in reducing microbial growth	PLOS ONE			English	Article							SECONDARY INFECTIONS; RESISTANCE; HEALTH; CHLORHEXIDINE; SUBSTRATE; GENES; SKIN	The incidence of hospital- and community-acquired infections has been dramatically increased worldwide. Accordingly, hands hygiene and the use of disinfectants have been increased leading to the expansion in hand sanitizers production to meet public demand. This study was conducted to assess the efficiency of common disinfectants in the market of Riyadh, Saudi Arabia in inhibiting the microbial growth during the time of Coronavirus disease 2019 (COVID-19) pandemic. Five bacterial strains of commonly hospital-acquired infections (Pseudomonas aeruginosa, Escherichia coli, Salmonella enteritidis, Staphylococcus aureus, and Enterococcus faecalis) (ATCC reference strains and clinical isolates) were examined for their susceptibility against 18 disinfectants collected from the Saudi market. The tested 18 disinfectants were broadly clustered into different groups based on their active chemical composition as following: 12 products contained alcohol, 2 products had chlorhexidine, 3 products contained mixed concentration of alcohol/chlorhexidine and 1 product had a mixture of chlorhexidine/Hexamidine/Chlorocresol. By measuring the minimum inhibitory concentration (MIC) and the minimum bactericidal concentration (MBC), our results revealed that all the 18 disinfectants have reduced the microbial growth of all the tested strains. Generally, the MICs and the MBCs for the clinical strains are higher than those of the reference strains. Taken together, our findings showed that all tested products have high disinfectants' killing rate against microbes of different origins, which suggest the high quality of these disinfectants and the good surveillance practice by the local authorities in Saudi Arabia.	[Alajlan, Abdullah A.] Saudi Food & Drug Author SFDA, Execut Dept Reference Labs, Reference Lab Microbiol,Res & Labs Sect, Microbial Identificat Div, Riyadh, Saudi Arabia; [Mukhtar, Lenah E.] Saudi Food & Drug Author SFDA, Antimicrobial Resistance Div, Reference Lab Microbiol, Execut Dept Reference Labs,Res & Labs Sect, Riyadh, Saudi Arabia; [Almussallam, Adnan S.; Aldawsari, Fahad S.] Saudi Food & Drug Author SFDA, Execut Dept Reference Labs, Drug & Cosmet Reference Lab, Res & Labs Sect, Riyadh, Saudi Arabia; [Alnuqaydan, Abdullah M.] Qassim Univ, Coll Appl Med Sci, Dept Med Biotechnol, Buraydah, Saudi Arabia; [Albakiri, Nasser S.; Almutari, Turki F.; Bin Shehail, Khalid M.] Saudi Food & Drug Author SFDA, Execut Dept Lab, Drug & Cosmet Control Lab, Res & Labs Sect, Riyadh, Saudi Arabia; [Alajel, Sulaiman M.] Saudi Food & Drug Author SFDA, Execut Dept Reference Labs, Reference Lab Microbiol, Res & Labs Sect, Riyadh, Saudi Arabia	Qassim University	Alajel, SM (corresponding author), Saudi Food & Drug Author SFDA, Execut Dept Reference Labs, Reference Lab Microbiol, Res & Labs Sect, Riyadh, Saudi Arabia.	SMOtibi@sfda.gov.sa		Mukhtar, Lenah/0000-0002-8174-3062; Alajel, Sulaiman/0000-0002-8840-6931				Althani AA, 2016, J CELL PHYSIOL, V231, P1688, DOI 10.1002/jcp.25284; Ansari MIA, 2003, FOOD BIOPROD PROCESS, V81, P57, DOI 10.1205/096030803765208670; Berardi A, 2020, INT J PHARMACEUT, V584, DOI 10.1016/j.ijpharm.2020.119431; Burton M, 2011, INT J ENV RES PUB HE, V8, P97, DOI 10.3390/ijerph8010097; BUSH LW, 1986, J CLIN MICROBIOL, V24, P343, DOI 10.1128/JCM.24.3.343-348.1986; Chojnacki M, 2021, MSPHERE, V6, DOI 10.1128/mSphere.00062-21; Di Muzio M, 2015, ANN IG MED PREV COMU, V27, P485, DOI 10.7416/ai.2015.2035; Ekizoglu M, 2016, TURK J MED SCI, V46, P903, DOI 10.3906/sag-1503-140; Fiorillo L, 2019, GELS-BASEL, V5, DOI 10.3390/gels5020031; Gold NA., 2021, STATPEARLS INTERNET; Haseeb R, 2016, MATERIALS, V9, DOI 10.3390/ma9060452; Ishma T., 2019, INT J SCI REP, V5, P355, DOI [10.18203/issn.2454-2156.IntJSciRep20195300, DOI 10.18203/ISSN.2454-2156.INTJSCIREP20195300]; Jain Vardhaman Mulchand, 2016, Dent Res J (Isfahan), V13, P424; Kakroo P., 2020, IJSRED, V3; Kim M, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.01201-18; Kratzel A, 2020, EMERG INFECT DIS, V26, P1592, DOI 10.3201/eid2607.200915; Larson EL, 2012, AM J INFECT CONTROL, V40, P806, DOI 10.1016/j.ajic.2011.10.016; Lee K, 2009, GLOB INST, P1; LEELAPORN A, 1994, J MED MICROBIOL, V40, P214, DOI 10.1099/00222615-40-3-214; LITTLEJOHN TG, 1991, GENE, V101, P59, DOI 10.1016/0378-1119(91)90224-Y; LITTLEJOHN TG, 1992, FEMS MICROBIOL LETT, V95, P259; Mahmood A, 2020, SCI TOTAL ENVIRON, V742, DOI 10.1016/j.scitotenv.2020.140561; Malherbe Helene, 2013, Sante Publique, V25 Suppl 1, P57; Manaye G, 2021, INFECT DRUG RESIST, V14, P547, DOI [10.2147/IDR.S288652, 10.2147/IDR.S288852]; McDonnell G, 2001, CLIN MICROBIOL REV, V14, P227; Menegueti MG, 2019, ANTIMICROB RESIST IN, V8, DOI 10.1186/s13756-019-0553-z; Mondal S., 2004, ANTISEPTIC, V101, P55; Monegro AF., 2021, STATPEARLS; Oke MA., 2013, IFE J SCI, V15, P111; Pasquini C, 2020, MICROCHEM J, V159, DOI 10.1016/j.microc.2020.105421; Peleg AY, 2010, NEW ENGL J MED, V362, P1804, DOI 10.1056/NEJMra0904124; Rabenau HF, 2005, J HOSP INFECT, V61, P107, DOI 10.1016/j.jhin.2004.12.023; Ramasethu Jayashree, 2017, Matern Health Neonatol Perinatol, V3, P5, DOI 10.1186/s40748-017-0043-3; Reena Rajkumari B., 2015, INT J PHARM BIO SCI, V6, P984, DOI DOI 10.3390/IJERPH17093326; Reynolds SA, 2006, EMERG INFECT DIS, V12, P527, DOI 10.3201/eid1203.050955; Ripa M, 2021, CLIN MICROBIOL INFEC, V27, P451, DOI 10.1016/j.cmi.2020.10.021; RUSSELL AD, 1986, INFECTION, V14, P212, DOI 10.1007/BF01644264; Sanford JA, 2013, SEMIN IMMUNOL, V25, P370, DOI 10.1016/j.smim.2013.09.005; Sarani H., 2018, MED SURG NURS J, V7, DOI [10.5812/msnj.85962, DOI 10.5812/MSNJ.85962]; Schug AR, 2020, VET MICROBIOL, V248, DOI 10.1016/j.vetmic.2020.108791; Siddharta A, 2017, J INFECT DIS, V215, P902, DOI 10.1093/infdis/jix046; Suchomel M, 2013, J HOSP INFECT, V83, P284, DOI 10.1016/j.jhin.2012.11.030; Suchomel M, 2017, ANTIMICROB RESIST IN, V6, DOI 10.1186/s13756-017-0229-5; Taheri Nona, 2016, Oman Med J, V31, P426, DOI 10.5001/omj.2016.86; Tasnia A, 2018, S J MICROBIOL, V8, P10, DOI [10.3329/sjm.v8i1.42431, DOI 10.3329/SJM.V8I1.42431]; Tri-Country Health Care, 2018, GROSS HAND HYG OTH G; US Food and Drug Administration (US FDA) Guidance, 2020, TEMP POL PREP CERT A; Wakshlak RBK, 2019, ACS OMEGA, V4, P20868, DOI 10.1021/acsomega.9b00297; Wang J, 2020, CELLULOSE, V27, P3651, DOI 10.1007/s10570-020-03062-4; West AM, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-018-0340-2; World Health Organisation, 2009, WHO GUID HAND HYG HL; Zhang HC, 2020, EMERG MICROBES INFEC, V9, P1958, DOI 10.1080/22221751.2020.1812437; Zhang M, 2011, J HOSP INFECT, V78, P113, DOI 10.1016/j.jhin.2011.02.018; Zmantar Tarek, 2011, BMC Res Notes, V4, P453, DOI 10.1186/1756-0500-4-453	54	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	6							e0269850	10.1371/journal.pone.0269850	http://dx.doi.org/10.1371/journal.pone.0269850			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3N5VQ	35759454	Green Published, gold			2022-12-26	WOS:000836216500001
J	Aliyo, A; Jibril, A				Aliyo, Alqeer; Jibril, Abdurezak			Assessment of anemia and associated risk factors among children under-five years old in the West Guji Zone, southern Ethiopia: Hospital-based cross-sectional study	PLOS ONE			English	Article							PREVALENCE; AGE	BackgroundAnemia adversely affects children's mental, physical and social development, particularly in Africa. In the early stages of life, it leads to severe negative consequences on the cognitive, growth and development of children. ObjectiveThis study aimed to assess anemia and associated risk factors among children under-five years old in the West Guji Zone, southern Ethiopia, from October to November 2020. MethodA hospital-based quantitative cross-sectional study was conducted at Bule Hora General Hospital, Southern Ethiopia. A convenience sampling technique was used to include 375 under-five children enrolled in the study. The pretested structure questionnaire was used to collect socioeconomic and demographic characteristics of study individuals after taking appropriate written informed consent. Then, a venous blood sample was collected from each child and analyzed for hemoglobin determination using a Midray BC 3000 Plus machine. Binary logistic regression models were used to identify associated factors of anemia. A p-value <= 0.05 was considered statistically significant. ResultThe overall prevalence of anemia among under-five children was 13.2% (50) [95% CI = 5.2-21.2%]. Among anemic children under-five years of age, 12% (6) had mild anemia, 32% (16) had moderate anemia and 56% (28) had severe anemia. In this study, anemia was significantly associated with a history of intestinal protozoan infection [AOR = 2.55, 95% CI = 1.28-10.42], malaria infection [AOR = 5.01, 95% CI = 0.18-11.44] and soil-transmitted helminths infection [AOR = 6.39, 95% CI = 1.75-29.08]. ConclusionThe prevalence of anemia among under-five children was found to be low in the study area; however, the majority of anemic children were in a severe stage. It could be managed by preventing malaria infection, intestinal protozoa and soil-transmitted helminthic infection.	[Aliyo, Alqeer] Bule Hora Univ, Dept Med Lab Sci, Bule Hora, Ethiopia; [Jibril, Abdurezak] Bule Hora Univ, Dept Nursing, Bule Hora, Ethiopia		Aliyo, A (corresponding author), Bule Hora Univ, Dept Med Lab Sci, Bule Hora, Ethiopia.	alker438@gmail.com	Aliyo, Alqeer/AHA-5990-2022	Aliyo, Alqeer/0000-0001-7301-5332				Abdisa B., 2016, INT J DEV RES, V8, P14652; Ahmed RA., 2017, INT BLOOD RES REV, V7, P1; Alderman H., 2001, DEMOGR RES, V5, P79; Allen LH, 2001, J NUTR, V131, p581S, DOI 10.1093/jn/131.2.581S; Birhanu M, 2018, ETHIOP J HEALTH SCI, V28, P259, DOI 10.4314/ejhs.v28i3.3; Brabin BJ, 2001, J NUTR, V131, p636S, DOI 10.1093/jn/131.2.636S; Central Statistical Agency & ICF, 2017, ETH DEM HLTH SURV 20; Santos Rosemary Ferreira dos, 2011, Rev. Bras. Hematol. Hemoter., V33, P100, DOI 10.5581/1516-8484.20110028; Enawgaw Bamlaku, 2019, EJIFCC, V30, P35; Gao WL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062883; Gebereselassie Y, 2020, ANEMIA, V2020, DOI 10.1155/2020/7580104; Gebreweld A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218961; Getaneh Z, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190151; Kebede D, 2021, BMC PEDIATR, V21, DOI 10.1186/s12887-021-03011-5; Knowledge SUCCESS, AN PREV CAUS CONS; Kratz A, 2004, NEW ENGL J MED, V351, P1548, DOI 10.1056/NEJMcpc049016; Longanbach S, 2016, RODAKS HEMATOLOGY CL, P208; Mahmoud H, 2014, SUDANESE J PUB HEAL, V9, P33; Mainasara A., 2017, IBRR, V7, P1; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Muoneke VU, 2012, INDIAN PEDIATR, V49, P119, DOI 10.1007/s13312-012-0026-4; Novaes Taiane Gonçalves, 2017, Rev. paul. pediatr., V35, P281, DOI 10.1590/1984-0462/;2017;35;3;00008; Oladeinde BH, 2012, IRAN J PARASITOL, V7, P31; Parbey PA, 2019, ANEMIA, V2019, DOI 10.1155/2019/2139717; Semedo RML, 2014, J HEALTH POPUL NUTR, V32, P646; Simbauranga Rehema H, 2015, BMC Hematol, V15, P13, DOI 10.1186/s12878-015-0033-5; Uthman E., 2009, UNDERSTANDING ANEMIA; Woldie H, 2015, J NUTR METAB, V2015, DOI 10.1155/2015/928632; World Health Organization, 2015, GLOBAL PREVALENCE AN	29	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7								10.1371/journal.pone.0270853	http://dx.doi.org/10.1371/journal.pone.0270853			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M5FN	35789228	Green Published, gold			2022-12-26	WOS:000835487000021
J	Umunnakwe, CN; Makatini, ZN; Maphanga, M; Mdunyelwa, A; Mlambo, KM; Manyaka, P; Nijhuis, M; Wensing, A; Tempelman, HA				Umunnakwe, Chijioke N.; Makatini, Zinhle N.; Maphanga, Mathapelo; Mdunyelwa, Anele; Mlambo, Khamusi M.; Manyaka, Puseletso; Nijhuis, Monique; Wensing, Annemarie; Tempelman, Hugo A.			Evaluation of a commercial SARS-CoV-2 multiplex PCR genotyping assay for variant identification in resource-scarce settings	PLOS ONE			English	Article							SCREENING ASSAYS	The rapid emergence and spread of numerous severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants across the globe underscores the crucial need for continuous SARS-CoV-2 surveillance to ensure that potentially more pathogenic variants are detected early and contained. Whole genome sequencing (WGS) is currently the gold standard for COVID-19 surveillance; however, it remains cost-prohibitive and requires specialized technical skills. To increase surveillance capacity, especially in resource-scarce settings, supplementary methods that are cost- and time-effective are needed. Real-time multiplex PCR genotyping assays offer an economical and fast solution for screening circulating and emerging variants while simultaneously complementing existing WGS approaches. In this study we evaluated the Allplex (TM) SARS-CoV-2 Variants II multiplex real-time PCR genotyping assay, Seegene (South Korea), and implemented it in retrospectively characterizing circulating SARS-CoV-2 variants in a rural South African setting between April and October 2021, prior to the emergence of the Omicron variant in South Africa. The Allplex (TM) SARS-CoV-2 Variants II real-time PCR assay demonstrated perfect concordance with whole-genome sequencing in detecting Beta and Delta variants and exhibited high specificity, sensitivity and reproducibility. Implementation of the assay in characterization of SARS-CoV-2 variants between April and October 2021 in a rural South African setting revealed a rapid shift from the Beta to the Delta variant between April and June. All specimens successfully genotyped in April were Beta variants and the Delta variant was not detected until May. By June, 78% of samples genotyped were Delta variants and in July >95% of all genotyped samples were Delta variants. The Delta variant continued to predominate through to the end of our analysis in October 2021. Taken together, a commercial SARS-CoV-2 variant genotyping assay detected the rapid rate at which the Delta variant displaced the Beta variant in Limpopo, an under-monitored province in South Africa. Such assays provide a quick and cost-effective method of monitoring circulating variants and should be used to complement genomic sequencing for COVID-19 surveillance especially in resource-scarce settings.	[Umunnakwe, Chijioke N.; Maphanga, Mathapelo; Mdunyelwa, Anele; Mlambo, Khamusi M.; Manyaka, Puseletso; Tempelman, Hugo A.] Ndlovu Res Ctr & Labs, Dennilton, Limpopo, South Africa; [Umunnakwe, Chijioke N.; Makatini, Zinhle N.; Nijhuis, Monique; Wensing, Annemarie; Tempelman, Hugo A.] Ndlovu Res Consortium, Dennilton, Limpopo, South Africa; [Makatini, Zinhle N.] Univ Witwatersrand, Fac Hlth Sci, Dept Virol, Johannesburg, South Africa; [Nijhuis, Monique; Wensing, Annemarie] Univ Med Ctr Utrecht UMCU, Dept Med Microbiol, Virol, Utrecht, Netherlands; [Nijhuis, Monique] Univ Witwatersrand, Fac Hlth Sci, HIV Pathogenesis Res Unit, Johannesburg, South Africa; [Wensing, Annemarie; Tempelman, Hugo A.] Univ Witwatersrand, Wits Reprod Hlth & HIV Inst Wits RHI, Johannesburg, South Africa	University of Witwatersrand; Utrecht University; Utrecht University Medical Center; University of Witwatersrand; University of Witwatersrand	Umunnakwe, CN (corresponding author), Ndlovu Res Ctr & Labs, Dennilton, Limpopo, South Africa.; Umunnakwe, CN (corresponding author), Ndlovu Res Consortium, Dennilton, Limpopo, South Africa.	cumunnakwe@ndlovu.com						A. D.Smith, 2020, bioRxiv, DOI 10.1101/2020.09.04.283077; Angulo J, 2022, FRONT MED-LAUSANNE, V9, DOI 10.3389/fmed.2022.841073; [Anonymous], NATL COVID 19 DAILY; [Anonymous], SARS COV 2 GENOMIC S; [Anonymous], 2022, REP WEEKL DEATHS S A; [Anonymous], COVID 19 DAILY CASES; Boudet A, 2021, DIAGNOSTICS, V11, DOI 10.3390/diagnostics11071241; Brown CM, 2021, MMWR-MORBID MORTAL W, V70, P1059, DOI 10.15585/mmwr.mm7031e2; Camp JV, 2021, J CLIN VIROL, V141, DOI 10.1016/j.jcv.2021.104905; Caza M, 2021, J CLIN VIROL, V144, DOI 10.1016/j.jcv.2021.104996; De Oliveira Tulio, UPDATE DELTA OTHER V; De Pace V., 2022, MICROORGANISMS, V10, P306, DOI DOI 10.3390/MICROORGANISMS10020306; Fabiani M, 2022, VACCINES-BASEL, V10, DOI 10.3390/vaccines10030483; Hasan MR, 2021, INT J INFECT DIS, V112, P52, DOI 10.1016/j.ijid.2021.09.006; Johnson R, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-05110-4; Jung C, 2022, J VIROL, V96, DOI 10.1128/jvi.02077-21; Karim SSA, 2021, LANCET, V398, P2126, DOI 10.1016/S0140-6736(21)02758-6; Kirby T, 2021, LANCET RESP MED, V9, pE20, DOI 10.1016/S2213-2600(21)00005-9; Konings F, 2021, NAT MICROBIOL, V6, P821, DOI 10.1038/s41564-021-00932-w; Koyama T, 2020, B WORLD HEALTH ORGAN, V98, P495, DOI 10.2471/BLT.20.253591; Lim HJ, 2021, DIAGNOSTICS, V11, DOI 10.3390/diagnostics11061084; Migueres M, 2021, J CLIN VIROL, V143, DOI 10.1016/j.jcv.2021.104969; Msomi N, 2020, LANCET MICROBE, V1, pE229, DOI 10.1016/S2666-5247(20)30116-6; Nielsen MC, 2022, J MOL DIAGN, V24, P455, DOI 10.1016/j.jmoldx.2022.02.001; Pillay S, 2020, GENES-BASEL, V11, DOI 10.3390/genes11080949; Quick J., 2020, PROTOCOLSIO, DOI [10.17504/protocols.io.bbmuik6w.https://doi.org/10.17504/protocols.io.bbmuik6w, DOI 10.17504/PROTOCOLS.IO.BBMUIK6W.HTTPS://DOI.ORG/10.17504/PROTOCOLS.IO.BBMUIK6W]; Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066; R Core Team, 2021, R LANG ENV STAT; Tegally H, 2021, NAT MED, V27, P440, DOI 10.1038/s41591-021-01255-3; Viana R, 2022, NATURE, V603, P679, DOI 10.1038/s41586-022-04411-y; Vogels CBF, 2021, PLOS BIOL, V19, DOI 10.1371/journal.pbio.3001236; Wang HN, 2021, J CLIN MICROBIOL, V59, DOI 10.1128/JCM.00859-21; WHO, 2022, TRACKING SARS COV 2; Wilkinson Eduan, 2021, Science, V374, P423, DOI 10.1126/science.abj4336; Yaniv K, 2021, WATER RES, V207, DOI 10.1016/j.watres.2021.117808	35	2	2	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	6							e0269071	10.1371/journal.pone.0269071	http://dx.doi.org/10.1371/journal.pone.0269071			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3F0KH	35749403	gold, Green Published			2022-12-26	WOS:000830362700037
J	Aita, R; Aldea, D; Hassan, S; Hur, J; Pellon-Cardenas, O; Cohen, E; Chen, L; Shroyer, N; Christakos, S; Verzi, MP; Fleet, JC				Aita, Rohit; Aldea, Dennis; Hassan, Sohaib; Hur, Joseph; Pellon-Cardenas, Oscar; Cohen, Evan; Chen, Lei; Shroyer, Noah; Christakos, Sylvia; Verzi, Michael P.; Fleet, James C.			Genomic analysis of 1,25-dihydroxyvitamin D-3 action in mouse intestine reveals compartment and segment-specific gene regulatory effects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-D-RECEPTOR; TARGET GENES; TRANSCRIPTION FACTORS; CALCIUM-ABSORPTION; KNOCKOUT MICE; EXPRESSION; RAT; DIFFERENTIATION; ENTEROCYTES; METABOLISM	1,25-dihydroxyvitamin D (VD) regulates intestinal calcium absorption in the small intestine (SI) and also reduces risk of colonic inflammation and cancer. However, the intestine compartment-specific target genes of VD signaling are unknown. Here, we examined VD action across three functional compartments of the intestine using RNA-seq to measure VD -induced changes in gene expression and Chromatin Immunoprecipitation with next generation sequencing to measure vitamin D receptor (VDR) genomic binding. We found that VD regulated the expression of 55 shared transcripts in the SI crypt, SI villi, and in the colon, including Cyp24a1, S100g, Trpv6, and Slc30a10. Other VD-regulated transcripts were unique to the SI crypt (162 up, 210 down), villi (199 up, 63 down), or colon (102 up, 28 down), but this did not correlate with mRNA levels of the VDR. Furthermore, bioinformatic analysis identified unique VD-regulated biological functions in each compartment. VDR-binding sites were found in 70% of upregulated genes from the colon and SI villi but were less common in upregulated genes from the SI crypt and among downregulated genes, suggesting some transcript-level VD effects are likely indirect. Consistent with this, we show that VD regulated the expression of other transcription factors and their downstream targets. Finally, we demonstrate that compartment-specific VD-mediated gene expression was associated with compartment-specific VDR-binding sites (< 30% of targets) and enrichment of intestinal transcription factor-binding motifs within VDR-binding peaks. Taken together, our data reveal unique spatial patterns of VD action in the intestine and suggest novel mechanisms that could account for compartment-specific functions of this hormone.	[Aita, Rohit; Aldea, Dennis; Hassan, Sohaib; Hur, Joseph; Pellon-Cardenas, Oscar; Cohen, Evan; Chen, Lei; Verzi, Michael P.] Rutgers State Univ, Human Genet Inst New Jersey, Rutgers Canc Inst New Jersey, Inst Food Nutr & Hlth,Dept Genet,EOHSI, New Brunswick, NJ 08901 USA; [Shroyer, Noah] Baylor Coll Med, Dept Med, Sect Gastroenterol & Hepatol, Houston, TX USA; [Christakos, Sylvia] Rutgers State Univ, New Jersey Med Sch, Dept Microbiol Biochem & Mol Genet, Newark, NJ 07103 USA; [Fleet, James C.] Univ Texas, Dept Nutr Sci, Austin, TX 78705 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Baylor College of Medicine; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Texas System; University of Texas Austin	Verzi, MP (corresponding author), Rutgers State Univ, Human Genet Inst New Jersey, Rutgers Canc Inst New Jersey, Inst Food Nutr & Hlth,Dept Genet,EOHSI, New Brunswick, NJ 08901 USA.; Christakos, S (corresponding author), Rutgers State Univ, New Jersey Med Sch, Dept Microbiol Biochem & Mol Genet, Newark, NJ 07103 USA.; Fleet, JC (corresponding author), Univ Texas, Dept Nutr Sci, Austin, TX 78705 USA.	christak@njms.rutgers.edu; Verzi@biology.rutgers.edu; james.fleet@austin.utexas.edu		Hassan, Sohaib/0000-0002-1313-0387; Chen, Lei/0000-0001-7812-508X; Aita, Rohit/0000-0001-5524-9717; Aldea, Dennis/0000-0002-0809-6030	National Institutes of Diabetes and Digestive and Kidney Diseases [R01 DK112365]	National Institutes of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding and additional information - This work was supported by a multi -PI award from the National Institutes of Diabetes and Digestive and Kidney Diseases (R01 DK112365) to S. C., M. P. V., and J. C. F. The content is solely the responsibility of the authors and does not necessarily represent the of fi cial views of the National Institutes of Health.	Beuling E, 2011, GASTROENTEROLOGY, V140, P1219, DOI 10.1053/j.gastro.2011.01.033; Beyaz S, 2021, CELL STEM CELL, V28, P598, DOI 10.1016/j.stem.2021.03.001; Cartwright JA, 2018, J VET INTERN MED, V32, P764, DOI 10.1111/jvim.15052; Chatterjee I, 2021, J CROHNS COLITIS, V15, P1720, DOI 10.1093/ecco-jcc/jjab044; Chatterji P, 2018, TRENDS MOL MED, V24, P490, DOI 10.1016/j.molmed.2018.03.008; Chen L, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.179432; Christakos S, 2021, JBMR PLUS, V5, DOI 10.1002/jbm4.10554; COLSTON KW, 1994, GUT, V35, P1219, DOI 10.1136/gut.35.9.1219; Corcoran SE, 2016, J CLIN INVEST, V126, P3699, DOI 10.1172/JCI84431; Costales-Carrera A, 2020, CANCERS, V12, DOI 10.3390/cancers12082302; da Silva TC, 2016, J STEROID BIOCHEM, V163, P77, DOI 10.1016/j.jsbmb.2016.04.006; DELUCA HF, 1982, FED PROC, V41, P66; Dhawan P, 2017, ENDOCRINOLOGY, V158, P3792, DOI 10.1210/en.2017-00258; Dwivedi PP, 2000, J BIOL CHEM, V275, P47, DOI 10.1074/jbc.275.1.47; Dye DE, 2009, CELL MOL LIFE SCI, V66, P681, DOI 10.1007/s00018-009-8645-1; Fernandez-Barral A, 2020, FEBS J, V287, P53, DOI 10.1111/febs.14998; Ferrer-Mayorga G, 2019, J STEROID BIOCHEM, V185, P1, DOI 10.1016/j.jsbmb.2018.07.002; Fleet JC, 2022, J BIOL CHEM, V298, DOI 10.1016/j.jbc.2022.101616; Fleet JC, 2017, MOL CELL ENDOCRINOL, V453, P36, DOI 10.1016/j.mce.2017.04.008; Fleet James C., 1993, American Journal of Physiology, V264, pG1037; Fritz A, 2019, BASIC CLIN PHARMACOL, V124, P245, DOI 10.1111/bcpt.13137; Fujita H, 2008, MOL BIOL CELL, V19, P1912, DOI 10.1091/mbc.E07-09-0973; Giordano Attianese Greta M P, 2015, Nucl Recept Signal, V13, pe001, DOI 10.1621/nrs.13001; Guengerich FP, 2021, J BIOL CHEM, V296, DOI 10.1074/jbc.RA120.016855; Harusato A, 2009, J PHYSIOL PHARMACOL, V60, P149; Hennigar SR, 2022, J NUTR BIOCHEM, V101, DOI 10.1016/j.jnutbio.2021.108927; Jiang H, 2020, J STEROID BIOCHEM, V198, DOI 10.1016/j.jsbmb.2019.105574; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Kong J, 2008, AM J PHYSIOL-GASTR L, V294, pG208, DOI 10.1152/ajpgi.00398.2007; Kutuzova GD, 2007, TOXICOL APPL PHARM, V218, P37, DOI 10.1016/j.taap.2006.10.005; Lee SM, 2015, J BIOL CHEM, V290, P18199, DOI 10.1074/jbc.M115.665794; Lee SM, 2014, ENDOCRINOLOGY, V155, P2064, DOI 10.1210/en.2014-1107; Li DL, 2016, GASTROENTEROLOGY, V151, P724, DOI 10.1053/j.gastro.2016.06.051; Li SS, 2021, MOL CELL BIOL, V41, DOI 10.1128/MCB.00372-20; Lin JH, 1999, PHARMACOL REV, V51, P135; Lu XL, 2012, J MOL ENDOCRINOL, V48, P1, DOI 10.1530/JME-11-0132; Luu W, 2015, J LIPID RES, V56, P888, DOI 10.1194/jlr.M056986; McConnell BB, 2008, GASTROENTEROLOGY, V134, P1007, DOI 10.1053/j.gastro.2008.01.013; Morteau Olivier, 2000, Archivum Immunologiae et Therapiae Experimentalis, V48, P473; Nandan MO, 2015, STEM CELL RES, V14, P10, DOI 10.1016/j.scr.2014.10.008; Ohashi W, 2019, DIGEST DIS SCI, V64, P2404, DOI 10.1007/s10620-019-05561-2; Pan CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023157; Park S, 2016, ACTA PHARM SIN B, V6, P475, DOI 10.1016/j.apsb.2016.07.004; Pattanaungkul S, 2000, J CLIN ENDOCR METAB, V85, P4023, DOI 10.1210/jc.85.11.4023; Peregrina K, 2015, CARCINOGENESIS, V36, P25, DOI 10.1093/carcin/bgu221; Pike JW, 2017, ENDOCRIN METAB CLIN, V46, P815, DOI 10.1016/j.ecl.2017.07.001; Prakash Chandra, 2015, Nucl Receptor Res, V2; Reynolds CJ, 2019, J STEROID BIOCHEM, V186, P56, DOI 10.1016/j.jsbmb.2018.09.009; San Roman AK, 2015, J BIOL CHEM, V290, P1850, DOI 10.1074/jbc.M114.620211; Song YR, 2003, ENDOCRINOLOGY, V144, P3885, DOI 10.1210/en.2003-0314; Van Cromphaut SJ, 2001, P NATL ACAD SCI USA, V98, P13324, DOI 10.1073/pnas.231474698; Vierstra J, 2014, SCIENCE, V346, P1007, DOI 10.1126/science.1246426; WALTERS JRF, 1987, AM J PHYSIOL, V252, pG170, DOI 10.1152/ajpgi.1987.252.2.G170; Wang F, 2017, ENDOCRINOLOGY, V158, P1951, DOI 10.1210/en.2016-1913; Wang QD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019882; Wang ZC, 2012, MOL PHARMACOL, V81, P498, DOI 10.1124/mol.111.076356; Wilfinger J, 2014, J NUTR BIOCHEM, V25, P875, DOI 10.1016/j.jnutbio.2014.04.002; Wood RJ, 1998, ENDOCRINOLOGY, V139, P3843, DOI 10.1210/en.139.9.3843; Wood RJ, 2004, PHYSIOL GENOMICS, V17, P122, DOI 10.1152/physiolgenomics.00002.2003; WU JCY, 1992, DIFFERENTIATION, V51, P195, DOI 10.1111/j.1432-0436.1992.tb00696.x; Xue G, 2021, AM J PHYSIOL-GASTR L, V320, pG837, DOI 10.1152/ajpgi.00061.2021; Xue YB, 2009, GASTROENTEROLOGY, V136, P1317, DOI 10.1053/j.gastro.2008.12.051; Yamada S, 2001, AM J PHYSIOL-GASTR L, V281, pG229, DOI 10.1152/ajpgi.2001.281.1.G229; Zhao HW, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-57; Zhou CC, 2006, J CLIN INVEST, V116, P1703, DOI 10.1172/JCI27793; Zhou Q, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15089	66	1	1	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2022	298	8							102213	10.1016/j.jbc.2022.102213	http://dx.doi.org/10.1016/j.jbc.2022.102213			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	4F0HN	35779631	gold, Green Published			2022-12-26	WOS:000848197700010
J	Chandrasekera, P; Perfetto, M; Lu, CY; Zhuo, MH; Bahudhanapati, H; Li, JJ; Chen, WC; Kulkarni, P; Christian, L; Liu, J; Yien, YY; Yu, CD; Wei, S				Chandrasekera, Pathirennehelage; Perfetto, Mark; Lu, Congyu; Zhuo, Minghui; Bahudhanapati, Harinath; Li, Jiejing; Chen, Wei-Chih; Kulkarni, Pallavi; Christian, Laura; Liu, Jun; Yien, Yvette Y.; Yu, Chundong; Wei, Shuo			Metalloprotease ADAM9 cleaves ephrin-B ligands and differentially regulates Wnt and mTOR signaling downstream of Akt kinase in colorectal cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3; BETA-CATENIN; TUMOR-SUPPRESSOR; COLON-CANCER; WNT/BETA-CATENIN; NEURAL CREST; PATHWAY; APC; PHOSPHORYLATION; ACTIVATION	Ephrin-B signaling has been implicated in many normal and pathological processes, including neural crest development and tumor metastasis. We showed previously that proteolysis of ephrin-B ligands by the disintegrin metalloprotease ADAM13 is necessary for canonical Wnt signal activation and neural crest induction in Xenopus, but it was unclear if these mechanisms are conserved in mammals. Here, we report that mammalian ADAM9 cleaves ephrin-B1 and ephrin-B2 and can substitute for Xenopus ADAM13 to induce the neural crest. We found that ADAM9 expression is elevated in human colorectal cancer (CRC) tissues and that knockdown (KD) of ADAM9 inhibits the migration and invasion of SW620 and HCT116 CRC cells by reducing the activity of Akt kinase, which is antagonized by ephrin-Bs. Akt is a signaling node that activates multiple downstream pathways, including the Wnt and mTOR pathways, both of which can promote CRC cell migration/invasion. Surprisingly, we also found that KD of ADAM9 downregulates Wnt signaling but has negligible effects on mTOR signaling in SW620 cells; in contrast, mTOR activity is suppressed while Wnt signaling remains unaffected by ADAM9 KD in HCT116 cells. These results suggest that mammalian ADAM9 cleaves ephrin-Bs to derepress Akt and promote CRC migration and invasion; however, the signaling pathways regulators.	[Chandrasekera, Pathirennehelage; Perfetto, Mark; Lu, Congyu; Kulkarni, Pallavi; Yien, Yvette Y.; Wei, Shuo] Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA; [Perfetto, Mark; Bahudhanapati, Harinath; Li, Jiejing; Chen, Wei-Chih; Christian, Laura] West Virginia Univ, Dept Biol, Morgantown, WV USA; [Perfetto, Mark; Yien, Yvette Y.] Univ Pittsburgh, Pittsburgh Heart Lung & Blood Vasc Med Inst, Pittsburgh, PA USA; [Perfetto, Mark; Yien, Yvette Y.] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; [Zhuo, Minghui; Yu, Chundong] Xiamen Univ, Innovat Ctr Cell Biol, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen, Peoples R China; [Li, Jiejing] Kunming Univ Sci & Technol, Affiliated Hosp KUMST, Med Sch, Dept Clin Lab, Kunming, Peoples R China; [Liu, Jun] West Virginia Univ, Dept Biochem, Sch Med, Morgantown, WV USA; [Liu, Jun] West Virginia Univ, Canc Inst, Sch Med, Morgantown, WV USA	University of Delaware; West Virginia University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Xiamen University; Kunming University of Science & Technology; West Virginia University; West Virginia University	Wei, S (corresponding author), Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA.	swei@udel.edu		Lu, Congyu/0000-0003-2651-6251	National Institutes of Health [R01 GM114105, R01 DE029802, P20 GM104316, U54 GM104941, R35 GM133560]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding and additional information - This work was supported by the National Institutes of Health (R01 GM114105, R01 DE029802, P20 GM104316, and U54 GM104941 to S. W., and R35 GM133560 to Y. Y. Y.) . The content is solely the responsibility of the authors and does not necessarily represent the of fi cial views of the National Institutes of Health.	Ahmed D, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.35; Anderson EC, 2010, GASTROENTEROLOGY, V139, P718, DOI 10.1053/j.gastro.2010.07.012; Anderton M, 2021, CANCERS, V13, DOI 10.3390/cancers13020206; Atapattu L, 2014, CELL ADHES MIGR, V8, P294, DOI 10.4161/19336918.2014.970026; Barriga EH, 2015, DEVELOPMENT, V142, P1555, DOI 10.1242/dev.121590; Batlle E, 2005, NATURE, V435, P1126, DOI 10.1038/nature03626; Betters E, 2018, DEV BIOL, V444, pS181, DOI 10.1016/j.ydbio.2018.06.012; Brandt M, 2018, CELL METAB, V27, P118, DOI 10.1016/j.cmet.2017.11.006; Brantley-Sieders DM, 2012, SEMIN CELL DEV BIOL, V23, P102, DOI 10.1016/j.semcdb.2011.10.014; Brown JS, 2017, PHARMACOL THERAPEUT, V172, P101, DOI 10.1016/j.pharmthera.2016.12.001; Cancer Genome Atlas Network, 2012, NATURE, V487, P330, DOI [10.1038/nature11252, DOI 10.1038/NATURE11252]; Chan TA, 2002, P NATL ACAD SCI USA, V99, P8265, DOI 10.1073/pnas.082240999; Chou CW, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21207790; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Ding VW, 2000, J BIOL CHEM, V275, P32475, DOI 10.1074/jbc.M005342200; Faller WJ, 2015, NATURE, V517, P497, DOI 10.1038/nature13896; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Fukumoto S, 2001, J BIOL CHEM, V276, P17479, DOI 10.1074/jbc.C000880200; GRODEN J, 1995, CANCER RES, V55, P1531; Hattori M, 2000, SCIENCE, V289, P1360, DOI 10.1126/science.289.5483.1360; Herath NI, 2012, EUR J CANCER, V48, P753, DOI 10.1016/j.ejca.2011.07.003; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; Hwang YS, 2017, GENESIS, V55, DOI 10.1002/dvg.23002; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Izumi Y, 1998, EMBO J, V17, P7260, DOI 10.1093/emboj/17.24.7260; Jagle S, 2014, P NATL ACAD SCI USA, V111, P4886, DOI 10.1073/pnas.1314523111; Janes PW, 2005, CELL, V123, P291, DOI 10.1016/j.cell.2005.08.014; Jansen VM, 2016, CLIN CANCER RES, V22, P2599, DOI 10.1158/1078-0432.CCR-16-0100; Ji YJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4516; Kohn AD, 1996, J BIOL CHEM, V271, P21920, DOI 10.1074/jbc.271.36.21920; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Koshikawa N, 2015, CANCER RES, V75, P3327, DOI 10.1158/0008-5472.CAN-14-2798; Lagares D, 2017, NAT MED, V23, P1405, DOI 10.1038/nm.4419; Li G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1675; Li JJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47665-9; Li JJ, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.158154; Lichtenthaler SF, 2018, EMBO J, V37, DOI 10.15252/embj.201899456; Lisabeth EM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009159; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu RH, 2015, CLIN CANCER RES, V21, P854, DOI 10.1158/1078-0432.CCR-14-1740; Lu QJ, 2015, ONCOL LETT, V10, P277, DOI 10.3892/ol.2015.3228; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Mathot L, 2017, CANCER RES, V77, P1730, DOI 10.1158/0008-5472.CAN-16-1921; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Naito AT, 2005, CIRC RES, V97, P144, DOI 10.1161/01.RES.0000175241.92285.f8; Ng SS, 2009, J BIOL CHEM, V284, P35308, DOI 10.1074/jbc.M109.078261; Nie XB, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.01341; Nusse R, 2017, CELL, V169, P985, DOI 10.1016/j.cell.2017.05.016; Oria VO, 2018, CELL MOL LIFE SCI, V75, P2291, DOI 10.1007/s00018-018-2796-x; Park Y, 2017, CELL REP, V19, P1083, DOI 10.1016/j.celrep.2017.04.042; Perfetto M, 2021, DEVELOPMENT, V148, DOI 10.1242/dev.184341; Persad Amit, 2016, Genes Cancer, V7, P368, DOI 10.18632/genesandcancer.128; Pon YL, 2008, CANCER RES, V68, P6524, DOI 10.1158/0008-5472.CAN-07-6302; Prossomariti A, 2020, CELL MOL GASTROENTER, V10, P491, DOI 10.1016/j.jcmgh.2020.04.007; Saha N, 2019, CANCER LETT, V467, P50, DOI 10.1016/j.canlet.2019.10.003; Saha N, 2018, INT J BIOCHEM CELL B, V105, P123, DOI 10.1016/j.biocel.2018.10.006; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Sharma M, 2002, J BIOL CHEM, V277, P30935, DOI 10.1074/jbc.M201919200; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Song MQ, 2019, CANCER RES, V79, P1019, DOI 10.1158/0008-5472.CAN-18-2738; Sparks AB, 1998, CANCER RES, V58, P1130; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; Stamos JL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a007898; Taylor H, 2017, CURR BIOL, V27, pR90, DOI 10.1016/j.cub.2017.01.003; Valvezan AJ, 2014, DIS MODEL MECH, V7, P63, DOI 10.1242/dmm.012625; Valvezan AJ, 2012, J BIOL CHEM, V287, P3823, DOI 10.1074/jbc.M111.323337; Voloshanenko O, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3610; Wei S, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P1086, DOI 10.1016/B978-0-12-382219-2.00248-9; Wei S, 2012, DEV BIOL, V363, P147, DOI 10.1016/j.ydbio.2011.12.031; Wei S, 2010, DEV CELL, V19, P345, DOI 10.1016/j.devcel.2010.07.012; Weskamp G, 2002, MOL CELL BIOL, V22, P1537, DOI 10.1128/MCB.22.5.1537-1544.2002; Yang J, 2006, J BIOL CHEM, V281, P17751, DOI 10.1074/jbc.M600831200; Zadka L, 2018, NEOPLASMA, V65, P823, DOI 10.4149/neo_2018_171220N832; Zhou HY, 2011, CURR PROTEIN PEPT SC, V12, P30; Zhou R, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00214	78	0	0	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2022	298	8							102225	10.1016/j.jbc.2022.102225	http://dx.doi.org/10.1016/j.jbc.2022.102225			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	4F0HT	35780836	gold, Green Published			2022-12-26	WOS:000848198300007
J	Haworth, AS; Hodges, SL; Capatina, AL; Isom, LL; Baumann, CG; Brackenbury, WJ				Haworth, Alexander S.; Hodges, Samantha L.; Capatina, Alina L.; Isom, Lori L.; Baumann, Christoph G.; Brackenbury, William J.			Subcellular dynamics and functional activity of the cleaved intracellular domain of the Na+ channel beta 1 subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; GATED SODIUM-CHANNELS; BREAST-CANCER CELLS; GAMMA-SECRETASE; MOLECULAR DETERMINANTS; EXTRACELLULAR DOMAIN; PROTEOLYTIC RELEASE; NEURITE OUTGROWTH; ADHESION MOLECULE; PLASMA-MEMBRANE	The voltage-gated Na+ channel beta 1 subunit, encoded by SCN1B, regulates cell surface expression and gating of alpha subunits and participates in cell adhesion. beta 1 is cleaved by alpha/beta and gamma-secretases, releasing an extracellular domain and intracellular domain (ICD), respectively. Abnormal SCN1B expression/function is linked to pathologies including epilepsy, cardiac arrhythmia, and cancer. In this study, we sought to determine the effect of secretase cleavage on beta 1 function in breast cancer cells. Using a series of GFP-tagged beta 1 constructs, we show that beta 1-GFP is mainly retained intracellularly, particularly in the endoplasmic reticulum and endolysosomal pathway, and accumulates in the nucleus. Reduction in endosomal beta 1-GFP levels occurred following gamma-secretase inhibition, implicating endosomes and/or the preceding plasma membrane as important sites for secretase processing. Using live-cell imaging, we also report beta 1ICD-GFP accumulation in the nucleus. Furthermore, beta 1-GFP and beta 1ICD-GFP both increased Na+ current, whereas beta 1STOP-GFP, which lacks the ICD, did not, thus highlighting that the beta 1-ICD is necessary and sufficient to increase Na+ current measured at the plasma membrane. Importantly, although the endogenous Na+ current expressed in MDA-MB-231 cells is tetrodotoxin (TTX)-resistant (carried by Na(v)1.5), the Na+ current increased by beta 1-GFP or beta 1ICD-GFP was TTX-sensitive. Finally, we found beta 1-GFP increased mRNA levels of the TTX-sensitive a subunits SCN1A/Na(v)1.1 and SCN9A/Na(v)1.7. Taken together, this work suggests that the beta 1-ICD is a critical regulator of alpha subunit function in cancer cells. Our data further highlight that gamma-secretase may play a key role in regulating beta 1 function in breast cancer.	[Haworth, Alexander S.; Capatina, Alina L.; Baumann, Christoph G.; Brackenbury, William J.] Univ York, Dept Biol, York, N Yorkshire, England; [Haworth, Alexander S.; Capatina, Alina L.; Baumann, Christoph G.; Brackenbury, William J.] Univ York, York Biomed Res Inst, York, N Yorkshire, England; [Hodges, Samantha L.; Isom, Lori L.] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA	University of York - UK; University of York - UK; University of Michigan System; University of Michigan	Brackenbury, WJ (corresponding author), Univ York, Dept Biol, York, N Yorkshire, England.; Brackenbury, WJ (corresponding author), Univ York, York Biomed Res Inst, York, N Yorkshire, England.	william.brackenbury@york.ac.uk	; Brackenbury, William/D-8029-2014	Baumann, Christoph George/0000-0002-8818-972X; Brackenbury, William/0000-0001-6882-3351	BBSRC Doctoral Training Partnership in "Mechanistic Biology and its Strategic Application" [BB/M011151/1]; BBSRC White Rose Doctoral Training Partnership Grant [BB/J014443/1]; NIH [R37 NS076752]; University of Michigan Postdoctoral Pioneer Program Fellowship	BBSRC Doctoral Training Partnership in "Mechanistic Biology and its Strategic Application"(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC White Rose Doctoral Training Partnership Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Postdoctoral Pioneer Program Fellowship	This work was supported by a studentship from the BBSRC Doctoral Training Partnership in "Mechanistic Biology and its Strategic Application" Grant BB/M011151/1 to A. S. H., C. G. B., and W. J. B. by a studentship from the BBSRC White Rose Doctoral Training Partnership Grant BB/J014443/1 to A. L. C. and W. J. B. by NIH R37 NS076752 to L. L. I. and by a University of Michigan Postdoctoral Pioneer Program Fellowship to S. L. H. The content is solely the responsibility of the authors and does not necessarily represent the additional views of the National Institutes of Health.	Aeby A, 2019, ANN CLIN TRANSL NEUR, V6, P2354, DOI 10.1002/acn3.50921; Altier C, 2011, NAT NEUROSCI, V14, P173, DOI 10.1038/nn.2712; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Area-Gomez E, 2009, AM J PATHOL, V175, P1810, DOI 10.2353/ajpath.2009.090219; ARMSTRONG CM, 1977, J GEN PHYSIOL, V70, P567, DOI 10.1085/jgp.70.5.567; Bon E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13648; Bouza AA, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.141776; Bouza AA, 2020, J BIOL CHEM, V295, P10380, DOI 10.1074/jbc.RA120.013978; Bouza AA, 2018, HANDB EXP PHARMACOL, V246, P423, DOI 10.1007/164_2017_48; Brackenbury WJ, 2008, J NEUROSCI, V28, P3246, DOI 10.1523/JNEUROSCI.5446-07.2008; Brackenbury WJ, 2007, BREAST CANCER RES TR, V101, P149, DOI 10.1007/s10549-006-9281-1; Brackenbury WJ, 2013, P NATL ACAD SCI USA, V110, P1089, DOI 10.1073/pnas.1208767110; Brackenbury WJ, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00053; Brackenbury WJ, 2010, P NATL ACAD SCI USA, V107, P2283, DOI 10.1073/pnas.0909434107; Catterall WA, 2014, EXP PHYSIOL, V99, P35, DOI 10.1113/expphysiol.2013.071969; Chahine M, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00070; Chen CL, 2004, J NEUROSCI, V24, P4030, DOI 10.1523/JNEUROSCI.4139-03.2004; Chioni AM, 2009, INT J BIOCHEM CELL B, V41, P1216, DOI 10.1016/j.biocel.2008.11.001; Chyung JH, 2005, J BIOL CHEM, V280, P4383, DOI 10.1074/jbc.M409272200; Davis TH, 2004, J BIOL CHEM, V279, P51424, DOI 10.1074/jbc.M410830200; Djamgoz MBA, 2019, CANCERS, V11, DOI 10.3390/cancers11111675; Dulsat G, 2017, BIOL CELL, V109, P273, DOI 10.1111/boc.201600085; Fraser SP, 2005, CLIN CANCER RES, V11, P5381, DOI 10.1158/1078-0432.CCR-05-0327; Han JX, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2347; Hille B., 1992, IONIC CHANNELS EXCIT; ISOM LL, 1995, J BIOL CHEM, V270, P3306, DOI 10.1074/jbc.270.7.3306; ISOM LL, 1992, SCIENCE, V256, P839, DOI 10.1126/science.1375395; Kaplan DI, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a022814; Kazarinova-Noyes K, 2001, J NEUROSCI, V21, P7517, DOI 10.1523/JNEUROSCI.21-19-07517.2001; Kim DY, 2007, NAT CELL BIOL, V9, P755, DOI 10.1038/ncb1602; Kim DY, 2005, J BIOL CHEM, V280, P23251, DOI 10.1074/jbc.M412938200; Kimberly WT, 2001, J BIOL CHEM, V276, P40288, DOI 10.1074/jbc.C100447200; Kimura N, 2001, BRAIN RES, V922, P30, DOI 10.1016/S0006-8993(01)03146-8; Korner J, 2018, J PHYSIOL-LONDON, V596, P2433, DOI 10.1113/JP275905; Laedermann CJ, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00137; Li S, 2016, SCI REP-UK, V6, DOI 10.1038/srep39320; Lopez-Charcas O, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102270; Lopez-Santiago Luis F, 2007, J Mol Cell Cardiol, V43, P636, DOI 10.1016/j.yjmcc.2007.07.062; Lopez-Santiago LF, 2006, J NEUROSCI, V26, P7984, DOI 10.1523/JNEUROSCI.2211-06.2006; Lopez-Santiago LF, 2011, J BIOL CHEM, V286, P22913, DOI 10.1074/jbc.M111.242370; Makita N, 1996, J NEUROSCI, V16, P7117; Malhotra JD, 2000, J BIOL CHEM, V275, P11383, DOI 10.1074/jbc.275.15.11383; Malhotra JD, 2002, J BIOL CHEM, V277, P26681, DOI 10.1074/jbc.M202354200; Malhotra JD, 2001, CIRCULATION, V103, P1303; Maroni M, 2019, PFLUG ARCH EUR J PHY, V471, P1481, DOI 10.1007/s00424-019-02324-w; Mauthe M, 2018, AUTOPHAGY, V14, P1435, DOI 10.1080/15548627.2018.1474314; McCormick KA, 1999, J BIOL CHEM, V274, P32638, DOI 10.1074/jbc.274.46.32638; McCormick KA, 1998, J BIOL CHEM, V273, P3954, DOI 10.1074/jbc.273.7.3954; McEwen DP, 2004, J BIOL CHEM, V279, P52744, DOI 10.1074/jbc.M405990200; Meadows L, 2001, J NEUROCHEM, V76, P1871, DOI 10.1046/j.1471-4159.2001.00192.x; Medeiros-Domingo A, 2007, CIRCULATION, V116, P134, DOI 10.1161/CIRCULATIONAHA.106.659086; Miyazaki H, 2007, BIOCHEM BIOPH RES CO, V361, P43, DOI 10.1016/j.bbrc.2007.06.170; Mojica SA, 2015, MOL BIOL CELL, V26, P1918, DOI 10.1091/mbc.E14-11-1530; Morgan K, 2000, P NATL ACAD SCI USA, V97, P2308, DOI 10.1073/pnas.030362197; Nelson M, 2014, INT J CANCER, V135, P2338, DOI 10.1002/ijc.28890; Okamoto I, 2001, J CELL BIOL, V155, P755, DOI 10.1083/jcb.200108159; Pan XJ, 2018, SCIENCE, V362, DOI 10.1126/science.aau2486; Pasternak SH, 2003, J BIOL CHEM, V278, P26687, DOI 10.1074/jbc.M304009200; Patino GA, 2011, J NEUROSCI, V31, P14577, DOI 10.1523/JNEUROSCI.0361-11.2011; Phair RD, 2004, METHOD ENZYMOL, V375, P393; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; Ramos-Mondragon R, 2022, JCI INSIGHT, V7, DOI 10.1172/jci.insight.152050; Ran Y, 2017, EMBO MOL MED, V9, P950, DOI 10.15252/emmm.201607265; Rivaud MR, 2020, CARDIOVASC RES, V116, P1557, DOI 10.1093/cvr/cvaa082; Rofe AP, 2017, MICROBIOLOGYOPEN, V6, DOI 10.1002/mbo3.416; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Seibel NM, 2007, ANAL BIOCHEM, V368, P95, DOI 10.1016/j.ab.2007.05.025; Spampanato J, 2004, J NEUROSCI, V24, P10022, DOI 10.1523/JNEUROSCI.2034-04.2004; Tam JHK, 2014, MOL BRAIN, V7, DOI 10.1186/s13041-014-0054-1; Timney BL, 2016, J CELL BIOL, V215, P57, DOI 10.1083/jcb.201601004; Vasquez-Del Carpio R, 2011, MOL CELL BIOL, V31, P1396, DOI 10.1128/MCB.00360-10; Veeraraghavan R, 2018, ELIFE, V7, DOI 10.7554/eLife.37610; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Watanabe H, 2008, J CLIN INVEST, V118, P2260, DOI [10.1172/JC133891, 10.1172/JCI33891]; Watanabe H, 2009, CIRC-ARRHYTHMIA ELEC, V2, P268, DOI 10.1161/CIRCEP.108.779181; Wong HK, 2005, J BIOL CHEM, V280, P23009, DOI 10.1074/jbc.M414648200; Xia WM, 1998, BIOCHEMISTRY-US, V37, P16465, DOI 10.1021/bi9816195; Xiao ZC, 1999, J BIOL CHEM, V274, P26511, DOI 10.1074/jbc.274.37.26511; Yan Z, 2017, CELL, V170, P470, DOI 10.1016/j.cell.2017.06.039; Yang EK, 2001, J BIOL CHEM, V276, P4839, DOI 10.1074/jbc.M004768200; Yang M, 2020, J CELL PHYSIOL, V235, P3950, DOI 10.1002/jcp.29290; Yang M, 2012, BREAST CANCER RES TR, V134, P603, DOI 10.1007/s10549-012-2102-9; Zhang JM, 1998, J BIOL CHEM, V273, P12436, DOI 10.1074/jbc.273.20.12436; Zhu WD, 2017, J GEN PHYSIOL, V149, P813, DOI 10.1085/jgp.201711802	86	0	0	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2022	298	8							102174	10.1016/j.jbc.2022.102174	http://dx.doi.org/10.1016/j.jbc.2022.102174			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3S2WH	35752364	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000839461200006
J	Zhang, XQ; Zhou, WQ; Niu, YY; Zhu, SY; Zhang, YY; Li, XG; Yu, C				Zhang, Xiaoqin; Zhou, Wenqian; Niu, Yangyang; Zhu, Saiya; Zhang, Yingying; Li, Xiaogang; Yu, Chen			Lysyl oxidase promotes renal fibrosis via accelerating collagen cross-link driving by beta-arrestin/ERK/STAT3 pathway	FASEB JOURNAL			English	Article						ERK; STAT3; LOX; renal fibrosis; STAT3-pY705; beta-arrestin pathway	BETA-ARRESTIN; SIGNALING PATHWAYS; ACTIVATION; ERK; PACKAGE; ROLES	Lysyl oxidase (LOX) is a copper-dependent monoamine oxidase whose primary function is the covalent cross-linking of collagen in the extracellular matrix (ECM). Evidence has shown that LOX is associated with cancer and some fibrotic conditions. We recently found that serum LOX is a potential diagnostic biomarker for renal fibrosis, but the mechanism by which LOX is regulated and contributes to renal fibrosis remains unknown. The current study demonstrates the following: (1) LOX expression was increased in fibrotic kidneys including ischemia-reperfusion injury-(IRI-), unilateral ureteral obstruction-(UUO-), and folic acid- (FA-) induced fibrotic kidneys as well as in the paraffin-embedded sections of human kidneys from the patients with renal fibrosis. (2) The increasing deposition and cross-linking of collagen induced by LOX was observed in IRI-, UUO- and FA-kidneys. (3) LOX was regulated by the beta-arrestin-ERK-STAT3 pathway in renal fibrosis. STAT3 was the downstream of AT1R-beta-arrestin-ERK, ERK entered the nucleus and activated STAT3-pY705 but not STAT3-pS727. (4) STAT3 nuclear subtranslocation and binding to the LOX promoter may be responsible for the upregulation of LOX expression. (5) Pharmacologic inhibition of LOX with BAPN in vivo inhibited the upregulation of LOX, decreased collagen over cross-linking and ameliorated renal fibrosis after ischemic injury. Collectively, these observations suggest that LOX plays an essential role in the development of renal fibrosis by catalyzing collagen over cross-linking. Thus, strategies targeting LOX could be a new avenue in developing therapeutics against renal fibrosis.	[Zhang, Xiaoqin; Zhou, Wenqian; Niu, Yangyang; Zhu, Saiya; Zhang, Yingying; Yu, Chen] Tongji Univ, Shanghai Tongji Hosp, Dept Nephrol, Sch Med, 389 Xincun Rd, Shanghai 200065, Peoples R China; [Li, Xiaogang] Mayo Clin, Dept Internal Med, Rochester, MN USA; [Li, Xiaogang] Mayo Clin, Dpartment Biochem & Mol Biol, Rochester, MN USA	Tongji University; Mayo Clinic; Mayo Clinic	Yu, C (corresponding author), Tongji Univ, Shanghai Tongji Hosp, Dept Nephrol, Sch Med, 389 Xincun Rd, Shanghai 200065, Peoples R China.	yuchen@tongji.edu.cn			Foundation for the National Institutes of Health (FNIH) [R01 DK 129241, R01 DK126662]; National Natural Science Foundation of China (NSFC) [82170696, 81873609]	Foundation for the National Institutes of Health (FNIH); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	Foundation for the National Institutes of Health (FNIH), Grant/Award Number: R01 DK 129241 and R01 DK126662; National Natural Science Foundation of China (NSFC), Grant/Award Number: 82170696 and 81873609	Adam O, 2011, J MOL CELL CARDIOL, V50, P678, DOI 10.1016/j.yjmcc.2010.12.019; Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Barker HE, 2012, NAT REV CANCER, V12, P540, DOI 10.1038/nrc3319; Bologna Z, 2017, BIOMOL THER, V25, P12, DOI 10.4062/biomolther.2016.165; Canelon SP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166392; Chen LJ, 2019, J DRUG TARGET, V27, P790, DOI 10.1080/1061186X.2018.1550649; Chung JK, 1997, MOL CELL BIOL, V17, P6508, DOI 10.1128/MCB.17.11.6508; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; Cox TR, 2013, CANCER RES, V73, P1721, DOI 10.1158/0008-5472.CAN-12-2233; Cox TR, 2011, DIS MODEL MECH, V4, P165, DOI 10.1242/dmm.004077; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Dewire SM, 2008, J BIOL CHEM, V283, P10611, DOI 10.1074/jbc.M710515200; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eberson LS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124013; Eishingdrelo H, 2015, J BIOMOL SCREEN, V20, P341, DOI 10.1177/1087057114557233; Gu YJ, 2015, ACTA PHARMACOL SIN, V36, P1277, DOI 10.1038/aps.2015.74; He Weichun, 2015, Curr Pathobiol Rep, V3, P183; Jean-Charles PY, 2017, J CARDIOVASC PHARM, V70, P142, DOI 10.1097/FJC.0000000000000482; Klepfish M, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00480; Kumari S, 2017, INDIAN J CLIN BIOCHE, V32, P134, DOI 10.1007/s12291-016-0576-7; Li J, 2013, P NATL ACAD SCI USA, V110, P7395, DOI 10.1073/pnas.1221608110; Li LX, 2017, J CLIN INVEST, V127, P2751, DOI 10.1172/JCI90921; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu SB, 2016, FASEB J, V30, P1599, DOI 10.1096/fj.14-268425; Luttrell LM, 2003, J MOL ENDOCRINOL, V30, P117, DOI 10.1677/jme.0.0300117; Luttrell Louis M., 2006, V332, P3; Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Miana M, 2015, DIS MODEL MECH, V8, P543, DOI 10.1242/dmm.020107; Nguyen XX, 2021, AM J PHYSIOL-LUNG C, V320, pL29, DOI 10.1152/ajplung.00173.2020; Niu YY, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2404-5; Papachroni KK, 2010, J CELL MOL MED, V14, P2460, DOI 10.1111/j.1582-4934.2009.00841.x; Peterson YK, 2017, PHARMACOL REV, V69, P256, DOI 10.1124/pr.116.013367; Qi Qian-Rong, 2014, World J Biol Chem, V5, P231, DOI 10.4331/wjbc.v5.i2.231; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saatci O, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16199-4; Smith-Mungo LI, 1998, MATRIX BIOL, V16, P387, DOI 10.1016/S0945-053X(98)90012-9; Sun Y, 2002, J BIOL CHEM, V277, P49212, DOI 10.1074/jbc.M207294200; Tan L, 2018, J MED CHEM, V61, P9841, DOI 10.1021/acs.jmedchem.8b00435; TANG SS, 1989, CONNECT TISSUE RES, V19, P93, DOI 10.3109/03008208909016817; Tilley DG, 2011, CIRC RES, V109, P217, DOI 10.1161/CIRCRESAHA.110.231225; Wang TH, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010062; Wang YD, 2017, AM J PHYSIOL-RENAL, V313, pF1, DOI 10.1152/ajprenal.00588.2016; Wuest M, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0609-9; Xia J, 2016, J INTEGR MED-JIM, V14, P165, DOI 10.1016/S2095-4964(16)60256-X; Xu HY, 2018, J MOL MED, V96, P97, DOI 10.1007/s00109-017-1606-5; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhang CY, 2017, IMMUNOL CELL BIOL, V95, P943, DOI 10.1038/icb.2017.73; Zhang XQ, 2020, AM J NEPHROL, V51, P907, DOI 10.1159/000509381; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6	50	0	0	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2022	36	8							e22427	10.1096/fj.202200573R	http://dx.doi.org/10.1096/fj.202200573R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2R5OB	35792886	Green Published			2022-12-26	WOS:000821160400001
J	Bunting, SR; Feinstein, BA; Calabrese, SK; Hazra, A; Sheth, NK; Chen, AF; Garber, SS				Bunting, Samuel R.; Feinstein, Brian A.; Calabrese, Sarah K.; Hazra, Aniruddha; Sheth, Neeral K.; Chen, Alex F.; Garber, Sarah S.			Assumptions about patients seeking PrEP: Exploring the effects of patient and sexual partner race and gender identity and the moderating role of implicit racism	PLOS ONE			English	Article							HIV PREEXPOSURE PROPHYLAXIS; BLACK-MEN; UNITED-STATES; RACIAL/ETHNIC BIAS; EXPLICIT ATTITUDES; RISK COMPENSATION; BISEXUAL MEN; HEALTH; PREVENTION; INFECTION	Introduction Daily pre-exposure prophylaxis (PrEP) for HIV-prevention is an essential component of national plans to end the HIV epidemic. Despite its well-documented safety and effectiveness, PrEP prescription has not met the public health need. Significant disparities between White and Black people exist with respect to PrEP prescription, as do disparities between men and women. One factor contributing to these disparities is clinicians' assumptions about patients seeking PrEP. Methods The present study sought to investigate medical students' assumptions about patients seeking PrEP (anticipated increased condomless sex, extra-relational sex, and adherence to PrEP), and assumed HIV risk when presenting with their sexual partner. We systematically varied the race (Black or White) and gender (man or woman) of a fictional patient and their sexual partner. All were in serodifferent relationships including men who have sex with men (MSM), women (MSW), and women who have sex with men (WSM). Participants also completed an implicit association test measuring implicit racism against Black people. We evaluated the moderation effects of patient and partner race on assumptions as well as the moderated moderation effects of implicit racism. Results A total of 1,472 students participated. For MSM patients, having a Black partner was associated with higher assumed patient non-adherence to PrEP compared to a White partner, however a White partner was associated with higher assumed HIV risk. For MSW patients, a White male patient was viewed as being more likely to engage in more extra-relational sex compared to a Black male patient. For WSM patients, White women were assumed to be more likely to have condomless and extra-relational sex, be nonadherent to PrEP, and were at higher HIV risk. Overall, implicit racism was not related to negative assumptions about Black patients as compared to White patients based on patient/partner race. Discussion Medical education about PrEP for HIV prevention must ensure future health professionals understand the full range of patients who are at risk for HIV, as well as how implicit racial biases may affect assumptions about patients in serodifferent couples seeking PrEP for HIV prevention. As gatekeepers for PrEP prescription, clinicians' assumptions about patients seeking PrEP represent a barrier to access. Consistent with prior research, we identified minimal effects of race and implicit racism in an experimental setting.	[Bunting, Samuel R.] Univ Chicago Med, Dept Psychiat & Behav Neurosci, Chicago, IL 60637 USA; [Feinstein, Brian A.] Rosalind Franklin Univ, Dept Psychol, Coll Hlth Profess, N Chicago, IL USA; [Calabrese, Sarah K.] George Washington Univ, Dept Psychol & Brain Sci, Washington, DC USA; [Hazra, Aniruddha] Univ Chicago Med, Sect Infect Dis & Global Hlth, Dept Med, Chicago, IL USA; [Sheth, Neeral K.] Rush Univ, Dept Psychiat & Behav Sci, Med Ctr, Chicago, IL USA; [Chen, Alex F.] Rosalind Franklin Univ, Chicago Med Sch, N Chicago, IL USA; [Garber, Sarah S.] Rosalind Franklin Univ, Dept Pharmaceut Sci, Coll Pharm, N Chicago, IL USA	Rosalind Franklin University Medical & Science; George Washington University; Rush University; Chicago Medical School; Rosalind Franklin University Medical & Science; Rosalind Franklin University Medical & Science	Bunting, SR (corresponding author), Univ Chicago Med, Dept Psychiat & Behav Neurosci, Chicago, IL 60637 USA.	Samuel.Bunting@uchospitals.edu		Chen, Alex/0000-0002-8857-4214	Gilead Sciences [IN-US-412-9042]; National Institute on Drug Abuse [K08DA045575]	Gilead Sciences(Gilead Sciences); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported with unrestricted research funding from Gilead Sciences under award number IN-US-412-9042 (PI: Garber, Co-I: Bunting). Brian Feinstein's time was supported by a grant from the National Institute on Drug Abuse (K08DA045575). The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies. The funders had no input on study design, implementation, data analysis, interpretation of results, drafting of the report, or the decision of where to submit the report for publication. There was no additional external funding received for this study.	Adams LM, 2016, AIDS CARE, V28, P1154, DOI 10.1080/09540121.2016.1153595; Andreychik MR, 2012, J EXP SOC PSYCHOL, V48, P1082, DOI 10.1016/j.jesp.2012.05.006; [Anonymous], 2018, HIV PREVENTION PILL; Auerbach JD, 2015, AIDS PATIENT CARE ST, V29, P102, DOI 10.1089/apc.2014.0142; Bakhai Neha, 2016, MedEdPORTAL, V12, P10520, DOI 10.15766/mep_2374-8265.10520; Bar-Anan Y., 2021, MINNOJS FILE LIB; Bar-Anan Y., 2020, RUNNING PROJECT IMPL; Becasen JS, 2019, AM J PUBLIC HEALTH, V109, pE1, DOI 10.2105/AJPH.2018.304727; Bi Stephanie, 2020, MedEdPORTAL, V16, P10970, DOI 10.15766/mep_2374-8265.10970; Blair Irene V, 2011, Perm J, V15, P71; Blumenthal Jill, 2014, Virtual Mentor, V16, P909, DOI 10.1001/virtualmentor.2014.16.11.stas1-1411; Bolin JH, 2014, J EDUC MEAS, V51, P335, DOI 10.1111/jedm.12050; Bowleg L., 2017, PALGRAVE HDB CRITICA, P507, DOI DOI 10.1057/978-1-137-51018-1_25; Bradley E, 2019, J WOMENS HEALTH, V28, P1272, DOI 10.1089/jwh.2018.7353; Brooks RA, 2020, J URBAN HEALTH, V97, P679, DOI 10.1007/s11524-019-00371-3; Brooks RA, 2012, AIDS PATIENT CARE ST, V26, P87, DOI 10.1089/apc.2011.0283; Bunting SR, 2021, PREV MED REP, V24, DOI 10.1016/j.pmedr.2021.101590; Bunting SR, 2021, SEX TRANSM DIS, V48, P959, DOI 10.1097/OLQ.0000000000001488; Bunting SR, 2020, J GEN INTERN MED, V35, P2873, DOI 10.1007/s11606-020-05736-y; Calabrese SK, 2020, CURR HIV-AIDS REP, V17, P579, DOI 10.1007/s11904-020-00533-y; Calabrese SK, 2019, JAIDS-J ACQ IMM DEF, V81, P395, DOI 10.1097/QAI.0000000000002042; Calabrese SK, 2018, AIDS BEHAV, V22, P1122, DOI 10.1007/s10461-017-1979-z; Calabrese SK, 2018, ARCH SEX BEHAV, V47, P143, DOI 10.1007/s10508-016-0911-3; Calabrese SK, 2014, AIDS BEHAV, V18, P226, DOI 10.1007/s10461-013-0675-x; Calabrese SK., 2021, AIDS BEHAV; Centers for Disease Control and Prevention, 2019, TERMINOLOGY; Chapman EN, 2013, J GEN INTERN MED, V28, P1504, DOI 10.1007/s11606-013-2441-1; Charlesworth TES, 2019, PSYCHOL SCI, V30, P174, DOI 10.1177/0956797618813087; Chou R, 2019, JAMA-J AM MED ASSOC, V321, P2214, DOI 10.1001/jama.2019.2591; Cooper-Patrick L, 1999, JAMA-J AM MED ASSOC, V282, P583, DOI 10.1001/jama.282.6.583; Dehon E, 2017, ACAD EMERG MED, V24, P895, DOI 10.1111/acem.13214; Dovidio JF, 2008, SOC SCI MED, V67, P478, DOI 10.1016/j.socscimed.2008.03.019; Eaton Lisa A, 2007, Curr HIV/AIDS Rep, V4, P165, DOI 10.1007/s11904-007-0024-7; Eaton LA, 2017, PREV SCI, V18, P505, DOI 10.1007/s11121-017-0756-6; El-Bassel N, 2010, JAIDS-J ACQ IMM DEF, V55, pS98, DOI 10.1097/QAI.0b013e3181fbf407; Farthing H, 2019, INT J STD AIDS, V30, P147, DOI 10.1177/0956462418799174; Finlayson T, 2019, MMWR-MORBID MORTAL W, V68, P597, DOI 10.15585/mmwr.mm6827a1; Fitch L, 2018, HIV RES PREVENTION C; FitzGerald C, 2019, BMC PSYCHOL, V7, DOI 10.1186/s40359-019-0299-7; FitzGerald C, 2017, BMC MED ETHICS, V18, DOI 10.1186/s12910-017-0179-8; Fonner VA, 2016, AIDS, V30, P1973, DOI 10.1097/QAD.0000000000001145; Freeborn K, 2018, J CLIN NURS, V27, P3254, DOI 10.1111/jocn.13990; Frost DM, 2017, J HEALTH SOC BEHAV, V58, P455, DOI 10.1177/0022146517736754; Furukawa NW, 2020, AM J PREV MED, V59, pE79, DOI 10.1016/j.amepre.2020.02.010; Givens SMB, 2005, MEDIA PSYCHOL, V7, P87, DOI 10.1207/S1532785XMEP0701_5; Golub SA, 2018, CURR HIV-AIDS REP, V15, P190, DOI 10.1007/s11904-018-0385-0; Goodreau SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050522; Goparaju Lakshmi, 2017, J AIDS Clin Res, V8, DOI 10.4172/2155-6113.1000730; Green AR, 2007, J GEN INTERN MED, V22, P1231, DOI 10.1007/s11606-007-0258-5; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Grov C, 2021, J SEX RES, V58, P891, DOI 10.1080/00224499.2021.1936440; Grov C, 2018, AIDS BEHAV, V22, P2743, DOI 10.1007/s10461-018-2084-7; Hagey Jill M, 2020, MedEdPORTAL, V16, P11001, DOI 10.15766/mep_2374-8265.11001; Hall WJ, 2015, AM J PUBLIC HEALTH, V105, pE60, DOI 10.2105/AJPH.2015.302903; Hammack PL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202806; Hayes AF, 2017, BEHAV RES THER, V98, P39, DOI 10.1016/j.brat.2016.11.001; Health Resources and Services Administration, END HIV EP PLAN AM; Hess KL, 2017, ANN EPIDEMIOL, V27, P238, DOI 10.1016/j.annepidem.2017.02.003; Hodges-Mameletzis I, 2019, DRUGS, V79, P1263, DOI 10.1007/s40265-019-01143-8; Huang YLA, 2018, MMWR-MORBID MORTAL W, V67, P1147, DOI 10.15585/mmwr.mm6741a3; Hull SJ, 2021, JAIDS-J ACQ IMM DEF, V88, P165, DOI 10.1097/QAI.0000000000002750; Kahle EM, 2020, AIDS BEHAV, V24, P2169, DOI 10.1007/s10461-020-02782-9; Kanny D, 2019, MMWR-MORBID MORTAL W, V68, P801, DOI 10.15585/mmwr.mm6837a2; Kennedy M B, 1995, J Am Med Womens Assoc (1972), V50, P103; Krakower DS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132398; Lee R., 2014, MEDEDPORTAL, V10; Levy ME, 2014, AIDS BEHAV, V18, P972, DOI 10.1007/s10461-014-0719-x; Ma DS, 2015, BEHAV RES METHODS, V47, P1122, DOI 10.3758/s13428-014-0532-5; Maina IW, 2018, SOC SCI MED, V199, P219, DOI 10.1016/j.socscimed.2017.05.009; Major B, 2013, HEALTH PSYCHOL, V32, P514, DOI 10.1037/a0030358; Mayer KH, 2020, ADV THER, V37, P1778, DOI 10.1007/s12325-020-01295-0; Mayer KH, 2018, JAIDS-J ACQ IMM DEF, V77, P119, DOI 10.1097/QAI.0000000000001579; Mayfield Jacob J, 2017, MedEdPORTAL, V13, P10634, DOI 10.15766/mep_2374-8265.10634; Mimiaga MJ, 2014, ARCH SEX BEHAV, V43, P99, DOI 10.1007/s10508-013-0208-8; Morris M, 2019, BMC MED EDUC, V19, DOI 10.1186/s12909-019-1727-3; Morris MC, 2020, MED SCI EDUC, V30, P123, DOI 10.1007/s40670-020-00930-3; Newcomb ME, 2018, JAIDS-J ACQ IMM DEF, V77, P358, DOI 10.1097/QAI.0000000000001604; O'Keefe DJ, 2003, COMMUN THEOR, V13, P251, DOI 10.1111/j.1468-2885.2003.tb00292.x; Oswald FL, 2013, J PERS SOC PSYCHOL, V105, P171, DOI 10.1037/a0032734; Owens C, 2020, AIDS EDUC PREV, V32, P51, DOI 10.1521/aeap.2020.32.1.51; Parish SJ, 2007, J SEX MED, V4, P259, DOI 10.1111/j.1743-6109.2007.00430.x; Patel AS, 2019, JAIDS-J ACQ IMM DEF, V80, P527, DOI 10.1097/QAI.0000000000001950; Philbin MM, 2016, AIDS PATIENT CARE ST, V30, P282, DOI 10.1089/apc.2016.0037; Pleuhs B, 2020, AIDS PATIENT CARE ST, V34, P111, DOI 10.1089/apc.2019.0189; Poteat T, 2016, JAIDS-J ACQ IMM DEF, V72, pS210, DOI 10.1097/QAI.0000000000001087; Purcell DW, 2014, ARCH SEX BEHAV, V43, P35, DOI 10.1007/s10508-013-0205-y; Quinn K, 2019, SOC SCI MED, V232, P86, DOI 10.1016/j.socscimed.2019.04.042; Quinn K, 2019, AIDS BEHAV, V23, P1951, DOI 10.1007/s10461-018-2375-z; Riddell J, 2018, JAMA-J AM MED ASSOC, V319, P1261, DOI 10.1001/jama.2018.1917; Rosengren-Hovee AL, 2021, AIDS BEHAV, V25, P2054, DOI 10.1007/s10461-020-03135-2; Rosenthal L, 2019, J SOC PERS RELAT, V36, P3408, DOI 10.1177/0265407518822785; Rosenthal L, 2016, PSYCHOL WOMEN QUART, V40, P414, DOI 10.1177/0361684315627459; Rosenthal L, 2015, J FAM PSYCHOL, V29, P818, DOI 10.1037/fam0000116; Sabin JA, 2008, MED CARE, V46, P678, DOI 10.1097/MLR.0b013e3181653d58; Sabin JA, 2015, AM J PUBLIC HEALTH, V105, P1831, DOI 10.2105/AJPH.2015.302631; Sabin JA, 2012, AM J PUBLIC HEALTH, V102, P988, DOI 10.2105/AJPH.2011.300621; Shindel AW, 2016, J SEX MED, V13, P1013, DOI 10.1016/j.jsxm.2016.04.069; Siegler AJ, 2020, ANN EPIDEMIOL, V45, P24, DOI 10.1016/j.annepidem.2020.03.013; Siegler AJ, 2018, ANN EPIDEMIOL, V28, P841, DOI 10.1016/j.annepidem.2018.06.005; Skolnik AA, 2020, J GEN INTERN MED, V35, P832, DOI 10.1007/s11606-019-05475-9; Smith DK, 2018, ANN EPIDEMIOL, V28, P850, DOI 10.1016/j.annepidem.2018.05.003; Sophus AI, 2019, AIDS BEHAV, V23, P1749, DOI 10.1007/s10461-018-2305-0; Starks TJ, 2019, PREV SCI, V20, P157, DOI 10.1007/s11121-018-0892-7; Stephenson R, 2022, AIDS BEHAV, V26, P361, DOI 10.1007/s10461-021-03389-4; Stumbar Sarah E, 2018, MedEdPORTAL, V14, P10772, DOI 10.15766/mep_2374-8265.10772; Sukhera J, 2019, PERSPECT MED EDUC, V8, P267, DOI 10.1007/s40037-019-00533-8; Sullivan PS, 2018, ANN EPIDEMIOL, V28, P833, DOI 10.1016/j.annepidem.2018.06.009; Sullivan PS, 2009, AIDS, V23, P1153, DOI 10.1097/QAD.0b013e32832baa34; Talley AE, 2010, AIDS BEHAV, V14, P72, DOI 10.1007/s10461-008-9493-y; Tan JY, 2018, AIDS PATIENT CARE ST, V32, P459, DOI 10.1089/apc.2018.0131; Tellalian D, 2013, AIDS PATIENT CARE ST, V27, P553, DOI 10.1089/apc.2013.0173; Thomann M, 2018, CULT HEALTH SEX, V20, P772, DOI 10.1080/13691058.2017.1380230; Traeger MW, 2018, CLIN INFECT DIS, V67, P676, DOI 10.1093/cid/ciy182; US Public Health Service, 2017, PREEXP PROPH PREV HI, DOI DOI 10.1016/S0040-4039(01)91800-3; US Public Health Service, 2018, PREEXP PROPH PREV HI; van Ryn M, 2003, AM J PUBLIC HEALTH, V93, P248, DOI 10.2105/AJPH.93.2.248; Williams DR, 2013, AM BEHAV SCI, V57, P1152, DOI 10.1177/0002764213487340	118	1	1	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2022	17	7							e0270861	10.1371/journal.pone.0270861	http://dx.doi.org/10.1371/journal.pone.0270861			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6E4KA	35776746	Green Published, gold			2022-12-26	WOS:000883348200002
J	Fang, C; Zhou, W; Liu, XG; Ren, HX; Wu, JJ				Fang, Cheng; Zhou, Wei; Liu, Xinguo; Ren, Hongxiang; Wu, Jianjun			Towards an uncertainty evaluation model for marine track considering local sampling cloud and sample information	PLOS ONE			English	Article							EXTENDED AHP METHODOLOGY; FUZZY-AHP; SHIP; SELECTION; SYSTEM	To evaluate the practical ability of crews during the navigation of an inward-port single ship, a track evaluation model was developed on a planar forward normal cloud chart under sample information based on the forward normal and the backward normal cloud generator. Since the track sampling cloud may be too divergent, a track belt division method based on the contributions of normal cloud drops was proposed. Combining the track evaluation model with the track belt division method, a comprehensive track evaluation scheme of the local sampling cloud based on sampling information was established. The results of an example of M.V. DAQING 257 unloaded into Dalian Port demonstrated the effectiveness of the model and showed its consistency with expert evaluation results based on subjective information. The proposed uncertainty evaluation model provides a new approach for intelligent evaluation under sample information.	[Fang, Cheng; Liu, Xinguo] Zhejiang Univ, Coll Comp Sci & Technol, Hangzhou, Peoples R China; [Fang, Cheng] Zhejiang Sci Res Inst Transport, Hangzhou, Peoples R China; [Zhou, Wei] Zhejiang Univ Technol, Coll Informat Engn, Hangzhou, Peoples R China; [Fang, Cheng; Zhou, Wei] Zhejiang Inst Commun, Coll Marine, Hangzhou, Peoples R China; [Ren, Hongxiang] Dalian Maritime Univ, Avigat Coll, Dalian, Peoples R China; [Wu, Jianjun] Shanghai Maritime Univ, Merchant Marine Coll, Shanghai, Peoples R China	Zhejiang University; Zhejiang University of Technology; Dalian Maritime University; Shanghai Maritime University	Wu, JJ (corresponding author), Shanghai Maritime Univ, Merchant Marine Coll, Shanghai, Peoples R China.	jjwu@shmtu.edu.cn			Zhejiang Provincial Natural Science Foundation of China [LGG18E090001]; Zhejiang Provincial Postdoctoral Research Project [225846]; Open Re-search Project of the State Key Laboratory of Industrial Control Technology, Zhejiang University, China [ICT2021B16]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Zhejiang Provincial Postdoctoral Research Project; Open Re-search Project of the State Key Laboratory of Industrial Control Technology, Zhejiang University, China	We appreciate the data support from the Fujian Maritime Safety Administration (MSA), China.	Alarcin F, 2014, J MAR ENG TECHNOL, V13, P3; Besikci EB, 2016, OCEAN ENG, V121, P392, DOI 10.1016/j.oceaneng.2016.05.031; Celik M, 2009, EXPERT SYST APPL, V36, P190, DOI 10.1016/j.eswa.2007.09.004; Chen Hao, 2015, Journal of Chinese Computer Systems, V36, P544; Chen L., 2011, J CHONGQING JIAOTONG, V30, P1049; Chen Lining, 2012, Navigation of China, V35, P1; Ezgi C, 2014, INT J REFRIG, V48, P153, DOI 10.1016/j.ijrefrig.2014.08.016; [方诚 Fang Cheng], 2016, [大连海事大学学报, Journal of Dalian Maritime University], V42, P35; [房希旺 Fang Xiwang], 2013, [大连海事大学学报, Journal of Dalian Maritime University], V39, P31; Gou Jin, 2010, Journal of Software, V5, P288, DOI 10.4304/jsw.5.3.288-295; Jiang SQ, 2013, APPL MECH MATER, V321-324, P1788, DOI 10.4028/www.scientific.net/AMM.321-324.1788; Jiang X., 2016, AUTOMATIC EVALUATION; Jiang X., 2015, SCI TECHNOLOGY ENG, V15, P250; Kobayashi H., 1998, J JAPAN I NAVIGATION, V98, P161, DOI [10.9749/jin.98.161, DOI 10.9749/JIN.98.161]; Li D.Y., 1995, COMPUT RES DEV, V32, P16; Li D.Y., 2005, ENG SCI, V3, P18; Liu Jingjing, 2015, Journal of Chongqing University of Posts and Telecommunication (Natural Science Edition), V27, P735, DOI 10.3979/j.issn.1673-825X.2015.06.005; Luo Z., 2007, J FRONTIERS COMPUTER, V1, P234; Nakamura S., 1993, NAVIGATION-US, V118, P39; Nguyen H, 2009, POL MARIT RES, V16, P78, DOI 10.2478/v10012-008-0014-8; Priadi AA, 2012, APPL MECH MATER, V209-211, P959, DOI 10.4028/www.scientific.net/AMM.209-211.959; Ren H., 2016, J CHONGQING JIAOTONG, V35, P146; Sakaguchi Y, 1996, NAVIGATION-US, V127, P10; Ugurlu O, 2015, INT J IND ERGONOM, V47, P132, DOI 10.1016/j.ergon.2015.01.013; Wang D., 2017, SHIP OCEAN ENG, P191; [王德龙 Wang Delong], 2015, [中国航海, Journal of Navigation of China], V38, P44; [王德龙 Wang Delong], 2014, [大连海事大学学报, Journal of Dalian Maritime University], V40, P27; Xu CL, 2014, FUND INFORM, V133, P55, DOI 10.3233/FI-2014-1062; [杨晓 Yang Xiao], 2015, [大连海事大学学报, Journal of Dalian Maritime University], V41, P40; Ye L., 2017, SHIP OCEAN ENG, V46, P180; [于少伟 Yu Shaowei], 2011, [系统工程理论与实践, Systems Engineering-Theory & Practice], V31, P2021; Yung Xiao, 2013, Navigation of China, V36, P28; [张光卫 Zhang Guangwei], 2007, [北京航空航天大学学报, Journal of Beijing University of Aeronautics and Astronautics], V33, P486; [张巧芬 Zhang Qiaofen], 2014, [哈尔滨工程大学学报, Journal of Harbin Engineering University], V35, P725; Zhanjiang, 2011, SHIP ELECT ENG, V31, P119; Zhao Z, 2013, INT J ANTENN PROPAG, V2013, DOI 10.1155/2013/698370; Zhe Xu, 2013, Journal of Networks, V8, P2556, DOI 10.4304/jnw.8.11.2556-2563; [周建文 Zhou Jianwen], 2014, [中国航海, Journal of Navigation of China], V37, P1	38	0	0	5	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	6							e0269184	10.1371/journal.pone.0269184	http://dx.doi.org/10.1371/journal.pone.0269184			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3F0KH	35749408	Green Published, gold			2022-12-26	WOS:000830362700048
J	Galardi, JW; Bela, VN; Jeffery, N; He, XY; Glasser, E; Loerch, S; Jenkins, JL; Pulvino, MJ; Boutz, PL; Kielkopf, CL				Galardi, Justin W.; Bela, Victoria N.; Jeffery, Nazish; He, Xueyang; Glasser, Eliezra; Loerch, Sarah; Jenkins, Jermaine L.; Pulvino, Mary J.; Boutz, Paul L.; Kielkopf, Clara L.			A UHM-ULM interface with unusual structural features contributes to U2AF2 and SF3B1 association for pre-mRNA splicing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; N-TERMINAL DOMAIN; U2 SNRNP; ACTIVATED SPLICEOSOME; DETAINED INTRONS; BRANCH SITE; BINDING; RECOGNITION; SF1; U2AF(65)	During spliceosome assembly, the 3' splice site is recognized by sequential U2AF2 complexes, first with Splicing Factor 1 (SF1) and second by the SF3B1 subunit of the U2 small nuclear ribonuclear protein particle. The U2AF2-SF1 interface is well characterized, comprising a U2AF homology motif (UHM) of U2AF2 bound to a U2AF ligand motif (ULM) of SF1. However, the structure of the U2AF2-SF3B1 interface and its importance for pre-mRNA splicing are unknown. To address this knowledge gap, we determined the crystal structure of the U2AF2 UHM bound to a SF3B1 ULM site at 1.8-angstrom resolution. We discovered a distinctive trajectory of the SF3B1 ULM across the U2AF2 UHM surface, which differs from prior UHM/ULM structures and is expected to modulate the orientations of the full-length proteins. We established that the binding affinity of the U2AF2 UHM for the cocrystallized SF3B1 ULM rivals that of a nearly full-length U2AF2 protein for an N-terminal SF3B1 region. An additional SF3B6 subunit had no detectable effect on the U2AF2-SF3B1 binding affinities. We further showed that key residues at the U2AF2 UHM-SF3B1 ULM interface contribute to coimmunoprecipitation of the splicing factors. Moreover, disrupting the U2AF2-SF3B1 interface changed splicing of representative human transcripts. From analysis of genome-wide data, we found that many of the splice sites coregulated by U2AF2 and SF3B1 differ from those coregulated by U2AF2 and SF1. Taken together, these findings support distinct structural and functional roles for the U2AF2-SF1 and U2AF2-SF3B1 complexes during the pre-mRNA splicing process.	[Galardi, Justin W.; Bela, Victoria N.; Jeffery, Nazish; He, Xueyang; Glasser, Eliezra; Loerch, Sarah; Jenkins, Jermaine L.; Pulvino, Mary J.; Boutz, Paul L.; Kielkopf, Clara L.] Univ Rochester, Ctr RNA Biol, Dept Biochem & Biophys, Sch Med & Dent, Rochester, NY 14627 USA; [Loerch, Sarah] UC Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA	University of Rochester; University of California System; University of California Santa Cruz	Kielkopf, CL (corresponding author), Univ Rochester, Ctr RNA Biol, Dept Biochem & Biophys, Sch Med & Dent, Rochester, NY 14627 USA.	clara_kielkopf@urmc.rochester.edu		PULVINO-RODRIGUEZ, MARY/0000-0001-9874-3088; Loerch, Sarah/0000-0002-1731-516X	National Institutes of Health (NIH) [R01 GM070503, R01 GM141544, T32 GM135134]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding and additional information-This study was supported by National Institutes of Health (NIH) grants R01 GM070503 to C. L. K., R01 GM141544 to P. L. B., and T32 GM135134 supported J. W. G. The content of this article is solely the responsibility of the au-thors and does not necessarily represent the official views of the National Institutes of Health.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Afonine PV, 2015, ACTA CRYSTALLOGR D, V71, P646, DOI 10.1107/S1399004714028132; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Agafonov DE, 2011, MOL CELL BIOL, V31, P2667, DOI 10.1128/MCB.05266-11; Agrawa AA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10950; Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bai R, 2018, SCIENCE, V360, P1423, DOI 10.1126/science.aau0325; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; BENNETT M, 1992, GENE DEV, V6, P1986, DOI 10.1101/gad.6.10.1986; Berglund JA, 1998, GENE DEV, V12, P858, DOI 10.1101/gad.12.6.858; Bertram K, 2017, CELL, V170, P701, DOI 10.1016/j.cell.2017.07.011; Boutz PL, 2015, GENE DEV, V29, P63, DOI 10.1101/gad.247361.114; Braun CJ, 2017, CANCER CELL, V32, P411, DOI 10.1016/j.ccell.2017.08.018; Bunkoczi G, 2013, ACTA CRYSTALLOGR D, V69, P2276, DOI 10.1107/S0907444913022750; Cass DM, 2006, BIOCHEMISTRY-US, V45, P10092, DOI 10.1021/bi060429o; Chatrikhi R, 2021, CELL CHEM BIOL, V28, P1145, DOI 10.1016/j.chembiol.2021.02.007; Chatrikhi R, 2016, BIOPHYS J, V111, P2570, DOI 10.1016/j.bpj.2016.11.007; Chen L, 2017, NUCLEIC ACIDS RES, V45, P2051, DOI 10.1093/nar/gkw860; Corioni M, 2011, NUCLEIC ACIDS RES, V39, P1868, DOI 10.1093/nar/gkq1042; Corsini L, 2007, NAT STRUCT MOL BIOL, V14, P620, DOI 10.1038/nsmb1260; Darman RB, 2015, CELL REP, V13, P1033, DOI 10.1016/j.celrep.2015.09.053; Das BK, 1999, MOL CELL BIOL, V19, P6796; Davis CA, 2018, NUCLEIC ACIDS RES, V46, pD794, DOI 10.1093/nar/gkx1081; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fu XD, 2014, NAT REV GENET, V15, P689, DOI 10.1038/nrg3778; Fukumura K, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24879-y; Gozani O, 1998, MOL CELL BIOL, V18, P4752, DOI 10.1128/MCB.18.8.4752; Gozani O, 1996, GENE DEV, V10, P233, DOI 10.1101/gad.10.2.233; Guth S, 2000, J BIOL CHEM, V275, P38059, DOI 10.1074/jbc.M001483200; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Haselbach D, 2018, CELL, V172, P454, DOI 10.1016/j.cell.2018.01.010; Hastings ML, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000538; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kielkopf CL, 2001, CELL, V106, P595, DOI 10.1016/S0092-8674(01)00480-9; Kralovicova J, 2004, HUM MOL GENET, V13, P3189, DOI 10.1093/hmg/ddh334; Li XN, 2019, NATURE, V573, P375, DOI 10.1038/s41586-019-1523-6; Loerch S, 2019, J BIOL CHEM, V294, P2892, DOI 10.1074/jbc.RA118.006764; Loerch S, 2016, RNA, V22, P1795, DOI 10.1261/rna.057950.116; Loerch S, 2014, J BIOL CHEM, V289, P17325, DOI 10.1074/jbc.M114.558825; Mackereth CD, 2011, NATURE, V475, P408, DOI 10.1038/nature10171; Maji D, 2020, J BIOL CHEM, V295, P17148, DOI 10.1074/jbc.RA120.015339; Matera AG, 2014, NAT REV MOL CELL BIO, V15, P108, DOI 10.1038/nrm3742; Miller HB, 2011, RNA, V17, P665, DOI 10.1261/rna.2462011; Obeng EA, 2016, CANCER CELL, V30, P404, DOI 10.1016/j.ccell.2016.08.006; Pacheco TR, 2006, MOL CELL BIOL, V26, P8183, DOI 10.1128/MCB.00350-06; Plaschka C, 2017, NATURE, V546, P617, DOI 10.1038/nature22799; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; R Core Team, 2021, R LANGUAGE ENV STAT; Rain JC, 1998, RNA, V4, P551, DOI 10.1017/S1355838298980335; Rimel JK, 2020, GENE DEV, V34, P1452, DOI 10.1101/gad.341545.120; RUSKIN B, 1988, CELL, V52, P207, DOI 10.1016/0092-8674(88)90509-0; Shao CW, 2014, NAT STRUCT MOL BIOL, V21, P997, DOI 10.1038/nsmb.2906; Shi YG, 2017, NAT REV MOL CELL BIO, V18, P655, DOI 10.1038/nrm.2017.86; Soltis SM, 2008, ACTA CRYSTALLOGR D, V64, P1210, DOI 10.1107/S0907444908030564; Spadaccini R, 2006, RNA, V12, P410, DOI 10.1261/rna.2271406; Tanackovic G, 2005, MOL BIOL CELL, V16, P1366, DOI 10.1091/mbc.E04-11-1034; Thickman KR, 2006, J MOL BIOL, V356, P664, DOI 10.1016/j.jmb.2005.11.067; Van Nostrand EL, 2020, NATURE, V583, P711, DOI 10.1038/s41586-020-2077-3; Wang WH, 2013, STRUCTURE, V21, P197, DOI 10.1016/j.str.2012.10.020; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu SP, 1999, NATURE, V402, P832, DOI 10.1038/45590; Yan CY, 2016, SCIENCE, V353, P904, DOI 10.1126/science.aag0291; ZAMORE PD, 1989, P NATL ACAD SCI USA, V86, P9243, DOI 10.1073/pnas.86.23.9243; Zarnack K, 2013, CELL, V152, P453, DOI 10.1016/j.cell.2012.12.023; Zhang XF, 2018, CELL RES, V28, P307, DOI 10.1038/cr.2018.14; Zhang Y, 2013, NUCLEIC ACIDS RES, V41, P1343, DOI 10.1093/nar/gks1097	69	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	298	8							102224	10.1016/j.jbc.2022.102224	http://dx.doi.org/10.1016/j.jbc.2022.102224			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5R8XW	35780835	Green Published, gold			2022-12-26	WOS:000874789500007
J	Gupta, P; Jindal, A; Ahuja, G; Jayadeva; Sengupta, D				Gupta, Prashant; Jindal, Aashi; Ahuja, Gaurav; Jayadeva; Sengupta, Debarka			A new deep learning technique reveals the exclusive functional contributions of individual cancer mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONE-CARBON METABOLISM; BROWSER	Cancers are caused by genomic alterations that may be inherited, induced by environmental carcinogens, or caused due to random replication errors. Postinduction of carcinogenicity, mutations further propagate and drastically alter the cancer genomes. Although a subset of driver mutations has been identified and characterized to date, most cancer-related somatic mutations are indistinguishable from germline variants or other noncancerous somatic mutations. Thus, such overlap impedes appreciation of many deleterious but previously uncharacterized somatic mutations. The major bottleneck arises due to patient-to-patient variability in mutational profiles, making it difficult to associate specific mutations with a given disease outcome. Here, we describe a newly developed technique Continuous Representation of Codon Switches (CRCS), a deep learning-based method that allows us to generate numerical vector representations of mutations, thereby enabling numerous machine learning-based tasks. We demonstrate three major applications of CRCS; first, we show how CRCS can help detect cancer-related somatic mutations in the absence of matched normal samples, which has applications in cell-free DNA-based assessment of tumor mutation burden. Second, the proposed approach also enables identification and exploration of driver genes; our analyses implicate DMD, RSK4, OFD1, WDR44, and AFF2 as potential cancer drivers. Finally, we used CRCS to score individual mutations in a tumor sample, which was found to be predictive of patient survival in bladder urothelial carcinoma, hepatocellular carcinoma, and lung adenocarcinoma. Taken together, we propose CRCS as a valuable computational tool for analysis of the functional significance of individual cancer mutations.	[Gupta, Prashant; Jindal, Aashi; Jayadeva] Indian Inst Technol Delhi IIT D, Dept Elect Engn, Delhi, India; [Ahuja, Gaurav; Sengupta, Debarka] Indraprastha Inst Informat Technol Delhi IIIT D, Dept Computat Biol, Delhi, India; [Jayadeva] Indian Inst Technol Delhi IIT D, Yardi Sch Artificial Intelligence, Delhi, India; [Sengupta, Debarka] Indraprastha Inst Informat Technol Delhi IIIT D, Dept Comp Sci & Engn, Delhi, India; [Sengupta, Debarka] Indraprastha Inst Informat Technol Delhi IIIT D, Ctr Artificial Intelligence, Delhi, India	Indraprastha Institute of Information Technology Delhi; Indraprastha Institute of Information Technology Delhi; Indraprastha Institute of Information Technology Delhi	Jayadeva (corresponding author), Indian Inst Technol Delhi IIT D, Dept Elect Engn, Delhi, India.; Sengupta, D (corresponding author), Indraprastha Inst Informat Technol Delhi IIIT D, Dept Computat Biol, Delhi, India.; Jayadeva (corresponding author), Indian Inst Technol Delhi IIT D, Yardi Sch Artificial Intelligence, Delhi, India.; Sengupta, D (corresponding author), Indraprastha Inst Informat Technol Delhi IIIT D, Dept Comp Sci & Engn, Delhi, India.; Sengupta, D (corresponding author), Indraprastha Inst Informat Technol Delhi IIIT D, Ctr Artificial Intelligence, Delhi, India.	jayadeva@ee.iitd.ac.in; debarka@iiitd.ac.in		Gupta, Prashant/0000-0003-4211-9125	INSPIRE Faculty Grant [DST/INSPIRE/04/2015/003068]; Department of Science and Technology (DST)	INSPIRE Faculty Grant; Department of Science and Technology (DST)(Department of Science & Technology (India))	This work is partially supported by the INSPIRE Faculty Grant [DST/INSPIRE/04/2015/003068] awarded to D. S. by the Department of Science and Technology (DST), Govt. of India.	Abramowicz A, 2018, J APPL GENET, V59, P253, DOI 10.1007/s13353-018-0444-7; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alexandrov LB, 2020, NATURE, V578, P94, DOI 10.1038/s41586-020-1943-3; Alfarouk KO, 2020, METABOLITES, V10, DOI 10.3390/metabo10070285; Asgari E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141287; Auer PL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0138-2; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chakravarty D, 2017, JCO PRECIS ONCOL, V1; Chang C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176231; Chen XX, 2021, BMC CANCER, V21, DOI 10.1186/s12885-021-08372-9; Christian Szegedy, 2015, Arxiv, DOI arXiv:1502.03167; Church DN, 2013, HUM MOL GENET, V22, P2820, DOI 10.1093/hmg/ddt131; Fabbri L, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20061336; Fancello L, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0647-4; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Garcia-Nieto PE, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1919-5; GARCIAFERNANDEZ J, 1994, NATURE, V370, P563, DOI 10.1038/370563a0; Gaspar TB, 2018, GENES-BASEL, V9, DOI 10.3390/genes9050241; Gonzalez-Perez A, 2013, NAT METHODS, V10, P1081, DOI [10.1038/NMETH.2642, 10.1038/nmeth.2642]; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Greg Corrado, 2013, Arxiv, DOI arXiv:1301.3781; Hofree M, 2013, NAT METHODS, V10, P1108, DOI [10.1038/NMETH.2651, 10.1038/nmeth.2651]; Jiao XD, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm-20-3807; Jin L, 2019, ONCOL LETT, V17, P4213, DOI 10.3892/ol.2019.10112; Jones L, 2021, CELL ONCOL, V44, P19, DOI 10.1007/s13402-020-00572-y; Kaneko S, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar5598; Karczewski KJ, 2019, BIORXIV, DOI [10.1101/531210, DOI 10.1101/531210]; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Khan T, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.592455; Kim S, 2018, BMC MED GENOMICS, V11, DOI 10.1186/s12920-018-0349-7; Kingma DP., 2014, ADAM METHOD STOCHAST; Kundra R, 2021, JCO CLIN CANCER INFO, V5, P221, DOI 10.1200/CCI.20.00108; Kurdistani SK, 2007, BRIT J CANCER, V97, P1, DOI 10.1038/sj.bjc.6603844; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li JY, 2020, LIPIDS HEALTH DIS, V19, DOI 10.1186/s12944-020-01390-9; Li M, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0073-5; Li MY, 2020, J CLIN INVEST, V130, P4301, DOI 10.1172/JCI134930; Liu Jun, 2004, Hepatobiliary Pancreat Dis Int, V3, P110; Luo P, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00013; Malnic B, 2004, P NATL ACAD SCI USA, V101, P2584, DOI 10.1073/pnas.0307882100; Massari F, 2016, CANCER TREAT REV, V45, P46, DOI 10.1016/j.ctrv.2016.03.005; McFarland CD, 2017, CANCER RES, V77, P4763, DOI 10.1158/0008-5472.CAN-15-3283-T; Milanese JS, 2021, GENOM PROTEOM BIOINF, V19, P973, DOI 10.1016/j.gpb.2020.06.009; Momozawa Y, 2021, J HUM GENET, V66, P11, DOI 10.1038/s10038-020-00845-2; Moore LE, 2007, INT J CANCER, V120, P2452, DOI 10.1002/ijc.22565; Newman AC, 2017, BRIT J CANCER, V116, P1499, DOI 10.1038/bjc.2017.118; Patrick Ng, 2017, Arxiv, DOI arXiv:1701.06279; Polak P, 2017, NAT GENET, V49, P1476, DOI 10.1038/ng.3934; Priestley P, 2019, NATURE, V575, P210, DOI 10.1038/s41586-019-1689-y; Quang D, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw226; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Reynaud E., 2010, NAT ED, V3, P28; Richter F, 2020, NAT GENET, V52, P769, DOI 10.1038/s41588-020-0652-z; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Roberts SA, 2012, MOL CELL, V46, P424, DOI 10.1016/j.molcel.2012.03.030; Sangster AG, 2022, PLOS ONE, V17, DOI 10.1371/journal.pone.0259992; Schuster M, 1997, IEEE T SIGNAL PROCES, V45, P2673, DOI 10.1109/78.650093; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; SIDRANSKY D, 1992, NEW ENGL J MED, V326, P737, DOI 10.1056/NEJM199203123261104; Sun JX, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1005965; Tamborero D, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0531-8; Tang ZM, 2013, NATURE, V502, P254, DOI 10.1038/nature12606; Tate JG, 2019, NUCLEIC ACIDS RES, V47, pD941, DOI 10.1093/nar/gky1015; Tomasetti C, 2017, SCIENCE, V355, P1330, DOI 10.1126/science.aaf9011; Vaser R, 2016, NAT PROTOC, V11, P1, DOI 10.1038/nprot.2015.123; Walia V, 2019, DEV CELL, V50, P229, DOI 10.1016/j.devcel.2019.05.022; Walker DR, 1999, ONCOGENE, V18, P211, DOI 10.1038/sj.onc.1202298; Warren IA, 2014, GENOME BIOL EVOL, V6, P1790, DOI 10.1093/gbe/evu131; Wu S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05467-z; Yang Z., 2016, P 2016 C N AM CHAPTE, P1480; Zhou J, 2015, NAT METHODS, V12, P931, DOI [10.1038/NMETH.3547, 10.1038/nmeth.3547]; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6	73	0	0	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2022	298	8							102177	10.1016/j.jbc.2022.102177	http://dx.doi.org/10.1016/j.jbc.2022.102177			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3S2WH	35753349	gold, Green Published			2022-12-26	WOS:000839461200011
J	Dayekh, AY; Naseridine, M; Dakroub, F; Olleik, A				Dayekh, Alaa Yehya; Naseridine, Mohammad; Dakroub, Fatima; Olleik, Adel			Impact, obstacles and boundaries of patient partnership: A qualitative interventional study in Lebanon	PLOS ONE			English	Article							KNOWLEDGE	The patient as partner approach is a modern left-to-right markmodel of patient engagement that integrates the patients' knowledge and skills into managing their own health. This study aims to evaluate the benefits and barriers of patient partnership in a healthcare setting. It is a qualitative and interventional study that implemented a patient and family partnership committee (PFPC) at a Lebanese hospital during the COVID-19 pandemic. A purposeful guided approach was used for sampling, and data was collected by structured questionnaire left-to-right markinterviews. Seven PFPC team dynamics building blocks were generated: transparency, support, motivation, comfortable communication, mutual understanding, equity in positions and empowerment to participate. Both the patient partners (94%) and healthcare professionals (90%) were satisfied with the PFPC experience. The majority of the healthcare professionals (HP) reported a noticeable change in the quality improvement process (QIP) (89%) and approved to standardize the PFPC (93%). The patient partnership benefits were clear, and the PFPC was perceived positively by both patient partners (PP) and HP. PP experienced distress relief (37%), gained ideas (41%) and felt that their opinion was heard (27%) after PFPC participation. PP reported benefits to hospitalized patients, including respect and care (63%) and patient satisfaction (20%). The main challenges for PFPC implementation were time availability and conflicts. Lessons from patient partnership can be utilized to improve the patient care policies in the Lebanese healthcare system. Moreover, developing countries can benefit from the patient partnership approach in their healthcare settings.	[Dayekh, Alaa Yehya; Naseridine, Mohammad; Dakroub, Fatima] Lebanese Univ, Fac Sci, Beirut, Lebanon; [Dayekh, Alaa Yehya] St George Hosp, Qual Improvement Dept, Beirut, Lebanon; [Naseridine, Mohammad; Olleik, Adel] Gates Grp Soc Sarl, Beirut, Lebanon	Lebanese University	Dayekh, AY; Naseridine, M (corresponding author), Lebanese Univ, Fac Sci, Beirut, Lebanon.; Dayekh, AY (corresponding author), St George Hosp, Qual Improvement Dept, Beirut, Lebanon.; Naseridine, M (corresponding author), Gates Grp Soc Sarl, Beirut, Lebanon.	alaadayekh@hotmail.com; Mohamad.nassereddine@ul.edu.lb		Dakroub, Fatima/0000-0002-7432-0977; Dayekh, Alaa/0000-0002-1522-2592				Ammar DW., NATL HOSP ACCREDITAT, P161; Black A, 2018, J HEALTH SERV RES PO, V23, P158, DOI 10.1177/1355819618762960; Canadian Institute for Health Information, 2016, ENG PAT PAT SAF A CA; Fu Y, 2016, INT J NURS STUD, V59, P197, DOI 10.1016/j.ijnurstu.2016.04.009; Fumagalli LP, 2015, HEALTH POLICY, V119, P384, DOI 10.1016/j.healthpol.2014.10.017; Grogan A, 2012, HAEMOPHILIA, V18, P875, DOI 10.1111/j.1365-2516.2012.02885.x; Hain D, 2011, J AM ACAD NURSE PRAC, V23, P351, DOI 10.1111/j.1745-7599.2011.00619.x; Harrison MB, 2012, WORLDV EVID-BASED NU, V9, P49, DOI 10.1111/j.1741-6787.2011.00231.x; Longtin Y, 2010, MAYO CLIN PROC, V85, P53, DOI 10.4065/mcp.2009.0248; Moody-Williams J., 2020, JOURNEY PATIENT CENT, DOI [10.1007/978-3-030-26311-9, DOI 10.1007/978-3-030-26311-9]; Morgan D., 2008, SAGE ENCY QUALITATIV, P816, DOI 10.4135/9781412963909; Pomey M., 2015, PATIENT EXP J, V2, P29, DOI [10.35680/2372-0247.1064, DOI 10.35680/2372-0247.1064]; Pomey MP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122499; Pomey MP., 2019, PATIENT ENGAGEMENT P, DOI [10.1007/978-3-030-14101-1, DOI 10.1007/978-3-030-14101-1]; Vahdat S, 2014, IRAN RED CRESCENT ME, V16, DOI 10.5812/ircmj.12454; weldon david, 2013, HEALTHC ORG AR PLANN; WHO, 2009, AFR PARTN PAT SAF WO; World Alliance for Patient Safety, 2005, GLOB PAT SAF CHALL 2; ZEITHAML VA, 1988, J MARKETING, V52, P2, DOI 10.2307/1251446	19	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7							e0270654	10.1371/journal.pone.0270654	http://dx.doi.org/10.1371/journal.pone.0270654			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M2ZD	35797381	Green Published, gold			2022-12-26	WOS:000835328600003
J	Viola, IM; Gao, Z; Smith, J				Viola, Ignazio Maria; Gao, Zhi; Smith, James			Use of streamnormal forces within an array of tidal power harvesters	PLOS ONE			English	Article							FREE-SURFACE; TURBINE; FLOW; EFFICIENCY; LIMIT	Tidal energy is a renewable and promising energy source. Turbines are deployed under water in marine channels where there is a fast tidal current. The first arrays have only recently been deployed and there is no consensus yet on the optimal array design. In this paper, we explore whether the maximum harvestable power can be increased by using harvesters or flow deflectors that exert a side force in the streamnormal direction to oppose the expansion of the streamtube. The power harvesting and the side force exertion are modelled with sink terms in the two-dimensional Reynolds-averaged Navier-Stokes equations. We found that the power limit increases linearly with the side force, and it should be exerted from the upstream side edges of the array. We conclude that future arrays might not be made only of turbines that harvest power, but also of deflectors such as vertical wings of size comparable to a turbine. The promising results of this theoretical study may direct new research on the use of deflectors to maximise the power harvested by tidal arrays.	[Viola, Ignazio Maria; Gao, Zhi; Smith, James] Univ Edinburgh, Sch Engn, Inst Energy Syst, Edinburgh, Midlothian, Scotland	University of Edinburgh	Viola, IM (corresponding author), Univ Edinburgh, Sch Engn, Inst Energy Syst, Edinburgh, Midlothian, Scotland.	i.m.viola@ed.ac.uk			UK Engineering and Physical Sciences Research Council (EPSRC) [EP/V009443/1]	UK Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	IMV received funds from the UK Engineering and Physical Sciences Research Council (EPSRC) through the grant number EP/V009443/1 (https://gow.epsrc.ukri.org/NGBOViewGrant.aspx?GrantRef=EP/V009443/1).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock TAA, 2021, ANNU REV FLUID MECH, V53, P287, DOI 10.1146/annurev-fluid-010719-060207; Adcock TAA, 2013, P ROY SOC A-MATH PHY, V469, DOI 10.1098/rspa.2013.0072; Betz A, 1929, NATURWISSENSCHAFTEN, V17, P160, DOI 10.1007/BF01506436; Betz A., 1920, Z GESAMTE TURBINENWE, V20; Bontempo R, 2020, APPL ENERG, V280, DOI 10.1016/j.apenergy.2020.115867; Bontempo R, 2013, J FLUID MECH, V728, P163, DOI 10.1017/jfm.2013.257; Cochrane C, 2021, WHAT IS VALUE INNOVA; CONWAY JT, 1995, J FLUID MECH, V297, P327, DOI 10.1017/S0022112095003120; Cooke SC, 2016, RENEW ENERG, V97, P284, DOI 10.1016/j.renene.2016.05.087; Dehtyriov D., 2021, Journal of Fluid Mechanics, V927, DOI 10.1017/jfm.2021.766; Draper S, 2014, J FLUID MECH, V739, P72, DOI 10.1017/jfm.2013.593; Garrett C, 2007, J FLUID MECH, V588, P243, DOI 10.1017/S0022112007007781; Gupta V, 2017, J FLUID MECH, V825, P651, DOI 10.1017/jfm.2017.399; Joukowski N., 1906, P PHYS SECT NAT SCI, V13, P12; Kanya B, 2018, WIND ENERGY SCI, V3, P919, DOI 10.5194/wes-3-919-2018; Lanchester FW., 1907, AERODYNAMICS CONSTIT; Nishino T, 2013, J FLUID MECH, V730, P220, DOI 10.1017/jfm.2013.340; Nishino T, 2012, J FLUID MECH, V708, P596, DOI 10.1017/jfm.2012.349; Nunes MM, 2020, RENEW SUST ENERG REV, V133, DOI 10.1016/j.rser.2020.110075; Tartari F, 2017, EUR J MECH B-FLUID, V65, P350, DOI 10.1016/j.euromechflu.2017.06.003; Vennell R, 2013, RENEW ENERG, V55, P277, DOI 10.1016/j.renene.2012.12.016; Vennell R, 2010, J FLUID MECH, V663, P253, DOI 10.1017/S0022112010003502; Viola IM, 2013, INT J NUMER METH FL, V72, P1146, DOI 10.1002/fld.3780; Viola IM, 2021, OCEAN ENG, V239, DOI 10.1016/j.oceaneng.2021.109749; Vogel CR, 2016, RENEW ENERG, V88, P317, DOI 10.1016/j.renene.2015.11.050; Whelan JI, 2009, J FLUID MECH, V624, P281, DOI 10.1017/S0022112009005916	26	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7								10.1371/journal.pone.0270578	http://dx.doi.org/10.1371/journal.pone.0270578			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M3CI	35793320	Green Published, gold			2022-12-26	WOS:000835338100012
J	Shen, C; Nayak, A; Neitzel, LR; Yang, F; Li, B; Williams, CH; Hong, CC; Ahmed, Y; Lee, ET; Robbins, DJ				Shen, Chen; Nayak, Anmada; Neitzel, Leif R.; Yang, Fan; Li, Bin; Williams, Charles H.; Hong, Charles C.; Ahmed, Yashi; Lee, Ethan; Robbins, David J.			The Casein kinase 1 alpha agonist pyrvinium attenuates Wnt-mediated CK1 alpha degradation via interaction with the E3 ubiquitin ligase component Cereblon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; LENALIDOMIDE; TARGET; CRBN; PROMOTES; COMPLEX; IKAROS	The Cullin-RING ligase 4 E3 ubiquitin ligase component Cereblon (CRBN) is a well-established target for a class of small molecules termed immunomodulatory drugs (IMiDs). These drugs drive CRBN to modulate the degradation of a number of neosubstrates required for the growth of multiple cancers. Whereas the mechanism underlying the activation of CRBN by IMiDs is well described, the normal physiological regulation of CRBN is poorly understood. We recently showed that CRBN is activated following exposure to Wnt ligands and subsequently mediates the degradation of a subset of physiological substrates. Among the Wnt-dependent substrates of CRBN is Casein kinase 1 alpha (CK1 alpha), a known negative regulator of Wnt signaling. Wnt-mediated degradation of CK1 alpha occurs via its association with CRBN at a known IMiD binding pocket. Herein, we demonstrate that a small-molecule CK1 alpha agonist, pyrvinium, directly prevents the Wnt-dependent interaction of CRBN with CK1 alpha, attenuating the consequent CK1 alpha degradation. We further show that pyrvinium disrupts the ability of CRBN to interact with CK1 alpha at the IMiD binding pocket within the CRBN-CK1 alpha complex. Of note, this function of pyrvinium is independent of its previously reported ability to enhance CK1 alpha kinase activity. Furthermore, we also demonstrate that pyrvinium attenuates CRBN-induced Wnt pathway activation in vivo. Collectively, these results reveal a novel dual mechanism through which pyrvinium inhibits Wnt signaling by both attenuating the CRBN-mediated destabilization of CK1 alpha and activating CK1 alpha kinase activity.	[Shen, Chen; Nayak, Anmada; Yang, Fan; Robbins, David J.] Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20057 USA; [Shen, Chen; Nayak, Anmada; Yang, Fan; Li, Bin] Univ Miami, Miller Sch Med, DeWitt Daughtry Family Dept Surg, Mol Oncol Program, Miami, FL USA; [Neitzel, Leif R.; Williams, Charles H.; Hong, Charles C.] Univ Maryland, Dept Med, Baltimore, MD USA; [Ahmed, Yashi] Dartmouth Coll, Norris Cotton Canc Ctr, Geisel Sch Med, Dept Mol & Syst Biol, New Hampshire, OH USA; [Lee, Ethan] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN USA	Georgetown University; University of Miami; University System of Maryland; University of Maryland Baltimore; Norris Cotton Cancer Center; Vanderbilt University	Robbins, DJ (corresponding author), Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20057 USA.	dr956@georgetown.edu	; Williams, Charles/H-2351-2015	Hong, Charles/0000-0002-0424-8252; Williams, Charles/0000-0002-0331-5652	National Institutes of Health [R01CA219189, R35GM122516, R01GM121421, R01GM122222, R35GM136233, R01CA244188, R01GM118557]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding and additional information-This work was supported by the National Institutes of Health grants: R01CA219189 (to D. J. R.) , R35GM122516 (to E. L.) , R01GM121421, R01GM122222, and R35GM136233 (to Y. A.) , R01CA244188 (to D. J. R., E. L., and Y. A.) , and R01GM118557 (to C. C. H.) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302; Ando H, 2019, ISCIENCE, V15, P95, DOI 10.1016/j.isci.2019.04.007; Asatsuma-Okumura T, 2019, NAT CHEM BIOL, V15, P1077, DOI 10.1038/s41589-019-0366-7; Budini M, 2009, J CELL BIOCHEM, V106, P399, DOI 10.1002/jcb.22019; Cheong JK, 2015, J CLIN INVEST, V125, P1401, DOI 10.1172/JCI78018; Donovan KA, 2018, ELIFE, V7, DOI 10.7554/eLife.38430; Fischer ES, 2014, NATURE, V512, P49, DOI 10.1038/nature13527; Gandhi AK, 2014, BRIT J HAEMATOL, V164, P811, DOI 10.1111/bjh.12708; Gao SB, 2020, BIOMARK RES, V8, DOI 10.1186/s40364-020-0182-y; Ito T, 2021, CELL CHEM BIOL, V28, P987, DOI 10.1016/j.chembiol.2021.04.012; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Kronke J, 2015, NATURE, V523, P183, DOI 10.1038/nature14610; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; Li B, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aak9916; Li B, 2014, CANCER RES, V74, P4811, DOI 10.1158/0008-5472.CAN-14-0317; Li B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101969; Li LF, 2020, MOL THER-ONCOLYTICS, V18, P215, DOI 10.1016/j.omto.2020.06.013; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Lu G, 2014, SCIENCE, V343, P305, DOI 10.1126/science.1244917; Lu J, 2015, CHEM BIOL, V22, P755, DOI 10.1016/j.chembiol.2015.05.009; Matyskiela ME, 2016, NATURE, V535, P252, DOI 10.1038/nature18611; Momtazi-borojeni AA, 2018, J CELL PHYSIOL, V233, P2871, DOI 10.1002/jcp.26006; Neitzel LR, 2019, MECH DEVELOP, V156, P20, DOI 10.1016/j.mod.2019.03.002; Petzold G, 2016, NATURE, V532, P127, DOI 10.1038/nature16979; Schatoff EM, 2017, CURR COLORECT CANC R, V13, P101, DOI 10.1007/s11888-017-0354-9; Shen C, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-25634-z; Shen C, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21165940; Shen C, 2019, BIOCHEMISTRY-US, V58, P5102, DOI 10.1021/acs.biochem.9b00891; Stamos JL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a007898; Nguyen TV, 2017, P NATL ACAD SCI USA, V114, P3565, DOI 10.1073/pnas.1700949114; Thorne CA, 2010, NAT CHEM BIOL, V6, P829, DOI 10.1038/NCHEMBIO.453; Tochigi T, 2020, BLOOD, V135, P2146, DOI 10.1182/blood.2019003749; van de Water S, 2001, DEVELOPMENT, V128, P3877; Wu K, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2007328118; Yamamoto J, 2020, NAT CHEM BIOL, V16, P1208, DOI 10.1038/s41589-020-0645-3; Yang J, 2018, J BIOL CHEM, V293, P10141, DOI 10.1074/jbc.RA118.002246; Yim DGR, 2013, CELL RES, V23, P737, DOI 10.1038/cr.2013.51; Zorn JA, 2010, NAT CHEM BIOL, V6, P179, DOI 10.1038/NCHEMBIO.318	38	0	0	5	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2022	298	8							102227	10.1016/j.jbc.2022.102227	http://dx.doi.org/10.1016/j.jbc.2022.102227			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	4F0HT	35780831	Green Published, gold			2022-12-26	WOS:000848198300011
J	Shukla, S; Cho, WK; Elbasiony, E; Singh, RB; Mittal, SK; Chauhan, SK				Shukla, Sachin; Cho, Won Kyung; Elbasiony, Elsayed; Singh, Rohan B.; Mittal, Sharad K.; Chauhan, Sunil K.			Non-immune and immune functions of interleukin-36 gamma suppress epithelial repair at the ocular surface	FASEB JOURNAL			English	Article						epithelium; innate inflammation; interleukin 36; interleukin 36 gamma blockade; tissue injury; tissue regeneration	CELLS; ACTIVATION; PSORIASIS	Regulation of innate inflammation is critical for maintaining tissue homeostasis and barrier function, especially in those interfacing the external environments such as the skin and cornea. Expression of pro-inflammatory cytokines by injured tissues has been shown to exacerbate the inflammatory cascade, causing tissue damage. Interleukin 36, a subfamily of the IL-1 superfamily, consists of three pro-inflammatory agonists-IL36 alpha, IL36 beta, and IL36 gamma and an IL36 receptor antagonist (IL36Ra). The current investigation, for the first time, reports that IL36 gamma is the primary agonist expressed by the corneal epithelium, which is significantly upregulated following corneal injury. The function of IL36 gamma on non-immune cells, in addition to innate inflammatory cells, in regulating tissue homeostasis has not been well investigated. Using a loss-of-function approach via neutralizing antibody treatment, our data demonstrate that blocking endogenously expressed IL36 gamma in epithelial cells promotes rapid re-epithelialization in in vitro wound closure assay. Finally, by utilizing a naturally occurring antagonist IL36Ra in a well-established murine model of ocular injury, our study demonstrates that inhibition of IL36 gamma accelerates epithelial regeneration and suppresses tissue inflammation. Given rapid wound healing is critical for re-establishing normal tissue structure and function, our investigation on the function of IL36 gamma provides evidence for the development of novel IL36 gamma-targeting strategies to promote tissue repair.	[Shukla, Sachin; Cho, Won Kyung; Elbasiony, Elsayed; Singh, Rohan B.; Mittal, Sharad K.; Chauhan, Sunil K.] Harvard Med Sch, Massachusetts Eye & Ear, Schepens Eye Res Inst, Boston, MA 02115 USA; [Shukla, Sachin] LV Prasad Eye Inst, Hyderabad, India; [Singh, Rohan B.] Leiden Univ, Med Ctr, Dept Ophthalmol, Leiden, Netherlands	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute; L. V. Prasad Eye Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Mittal, SK (corresponding author), Harvard Med Sch, Massachusetts Eye & Ear, Schepens Eye Res Inst, Boston, MA 02115 USA.; Chauhan, SK (corresponding author), Schepens Eye Res Inst, 20 Staniford St, Boston, MA 02114 USA.	sharad_mittal@meei.harvard.edu; sunil_chauhan@meei.harvard.edu	SHUKLA, SACHIN/N-1274-2017; Chauhan, Sunil/HDN-5614-2022	SHUKLA, SACHIN/0000-0003-2113-6073; Singh, Rohan/0000-0002-2426-3900	Department of Defense [W81XWH-20-1-0822]; National Institutes of Health [R01EY024602, P30EY003790]	Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by Department of Defense (W81XWH-20-1-0822) and the National Institutes of Health (R01EY024602 and P30EY003790).	Amouzegar A, 2017, STEM CELLS, V35, P1532, DOI 10.1002/stem.2611; Basu S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009644; Boutet MA, 2016, CLIN EXP IMMUNOL, V184, P159, DOI 10.1111/cei.12761; Buhl AL, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01162; Cho WK, 2021, AM J PATHOL, V191, P1108, DOI 10.1016/j.ajpath.2021.02.016; Cho W, 2020, OCUL SURF, V18, P857, DOI 10.1016/j.jtos.2020.09.002; D'Erme AM, 2015, J INVEST DERMATOL, V135, P1025, DOI 10.1038/jid.2014.532; Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184; Ding LP, 2018, ONCOTARGET, V9, P2895, DOI 10.18632/oncotarget.22814; Eming SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009337; Foster AM, 2014, J IMMUNOL, V192, P6053, DOI 10.4049/jimmunol.1301481; Foulsham W, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44973-y; Funari VA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084425; Gao N, 2018, J IMMUNOL, V201, P688, DOI 10.4049/jimmunol.1800046; Gresnigt MS, 2013, SEMIN IMMUNOL, V25, P458, DOI 10.1016/j.smim.2013.11.003; Kovtun A, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/8173983; Laskin DL, 2011, ANNU REV PHARMACOL, V51, P267, DOI 10.1146/annurev.pharmtox.010909.105812; Lechler RI, 2005, NAT MED, V11, P605, DOI 10.1038/nm1251; Ljubimov AV, 2015, PROG RETIN EYE RES, V49, P17, DOI 10.1016/j.preteyeres.2015.07.002; Mai SZ, 2018, INT IMMUNOPHARMACOL, V58, P103, DOI 10.1016/j.intimp.2018.03.011; Mayadas TN, 2014, ANNU REV PATHOL-MECH, V9, P181, DOI 10.1146/annurev-pathol-020712-164023; Me R, 2021, J IMMUNOL, V207, P2868, DOI 10.4049/jimmunol.2001246; Mittal SK, 2019, STEM CELL TRANSL MED, V8, P1030, DOI 10.1002/sctm.19-0004; Mittal SK, 2018, INVEST OPHTH VIS SCI, V59, P1191, DOI 10.1167/iovs.17-23067; Mittal SK, 2016, STEM CELL REP, V7, P583, DOI 10.1016/j.stemcr.2016.09.001; Mittal SK, 2015, CURR OPIN IMMUNOL, V34, P22, DOI 10.1016/j.coi.2014.12.009; Oh JY, 2010, P NATL ACAD SCI USA, V107, P16875, DOI 10.1073/pnas.1012451107; Omoto M, 2017, MOL THER, V25, P1881, DOI 10.1016/j.ymthe.2017.04.020; Queen D, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00317; Ramadas RA, 2011, AM J RESP CELL MOL, V44, P134, DOI 10.1165/rcmb.2009-0315OC; Sahu SK, 2018, INVEST OPHTH VIS SCI, V59, P1732, DOI 10.1167/iovs.17-23398; Satoh TK, 2020, J CLIN INVEST, V130, P1417, DOI 10.1172/JCI128678; Sommerfeld SD, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aax4783; Vigne S, 2011, BLOOD, V118, P5813, DOI 10.1182/blood-2011-05-356873	34	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2022	36	8							e22414	10.1096/fj.202200174RR	http://dx.doi.org/10.1096/fj.202200174RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2Q4EU	35781326				2022-12-26	WOS:000820378600001
J	Steimle, BL; Bailey, DK; Smith, FM; Rosenblum, SL; Kosman, DJ; Hanson, P				Steimle, Brittany L.; Bailey, Danielle K.; Smith, Frances M.; Rosenblum, Shaina L.; Kosman, Daniel J.; Hanson, Phyllis			Calcium and the Ca-ATPase SPCA1 modulate plasma membrane abundance of ZIP8 and ZIP14 to regulate Mn(II) uptake in brain microvascular endothelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATHWAY CA2+-ATPASE SPCA1; P-TYPE ATPASE; ZINC-TRANSPORTER; MANGANESE ACCUMULATION; COPPER TRANSPORTER; MENKES PROTEIN; GOLGI; IRON; MUTATIONS; ATP7A	Manganese (II) accumulation in human brain microvascular endothelial cells is mediated by the metal-ion transporters ZRT IRT-like protein 8 (ZIP8) and ZRT IRT-like protein 14 (ZIP14). The plasma membrane occupancy of ZIP14, in particular, is increased in cells treated with Mn2+, lipopolysaccharide, or IL -6, but the mechanism of this regulation has not been eluci-dated. The calcium-transporting type 2C member 1 ATPase, SPCA1, is a Golgi-localized Ca2+-uptake transporter thought to support Golgi uptake of Mn2+ also. Here, we show using surface protein biotinylation, indirect immunofluorescence, and GFP-tagged proteins that cytoplasmic Ca2+ regulates ZIP8-and ZIP14-mediated manganese accumulation in human brain microvascular endothelial cells by increasing the plasma membrane localization of these transporters. We demonstrate that RNAi knockdown of SPCA1 expression results in an in-crease in cytoplasmic Ca2+ levels. In turn, we found increased cytoplasmic Ca2+ enhances membrane-localized ZIP8 and ZIP14 and a subsequent increase in 54Mn2+ uptake. Further-more, overexpression of WT SPCA1 or a gain-of-function mutant resulted in a decrease in cytoplasmic Ca2+ and Mn-54(2+) accumulation. While addition of Ca2+ positively regu-lated ZIP-mediated Mn-54(2+) uptake, we show chelation of Ca2+ diminished manganese transport. In conclusion, the modula-tion of ZIP8 and ZIP14 membrane cycling by cytoplasmic calcium is a novel finding and provides new insight into the regulation of the uptake of Mn2+ and other divalent metal ions-mediated ZIP metal transporters.	[Steimle, Brittany L.; Bailey, Danielle K.; Smith, Frances M.; Rosenblum, Shaina L.; Kosman, Daniel J.; Hanson, Phyllis] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Biochem, Buffalo 14260, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Bailey, DK (corresponding author), SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Biochem, Buffalo 14260, NY USA.	camkos@buffalo.edu		Smith, Frances M./0000-0001-5479-4692; Rosenblum, Shaina/0000-0002-6933-6392	National In- stitutes of Neurologic Diseases and Stroke of the Department of Health and Human Services, USA [RO3NS095063, RO1NS102337]	National In- stitutes of Neurologic Diseases and Stroke of the Department of Health and Human Services, USA	Acknowledgments Funding and additional information - This work was supported by grants RO3NS095063 and RO1NS102337 from the National In- stitutes of Neurologic Diseases and Stroke of the Department of Health and Human Services, USA to D. J. K.	Anguita E, 2017, BBA-MOL CELL RES, V1864, P915, DOI 10.1016/j.bbamcr.2016.10.022; Asthagiri D, 2004, J AM CHEM SOC, V126, P1285, DOI 10.1021/ja0382967; Aydemir TB, 2017, J NEUROSCI, V37, P5996, DOI 10.1523/JNEUROSCI.0285-17.2017; Becares ER, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10020213; Bin BH, 2011, J BIOL CHEM, V286, P40255, DOI 10.1074/jbc.M111.256784; Bowers K, 2018, TRAFFIC, V19, P813, DOI 10.1111/tra.12602; Campos-Bedolla P, 2014, ARCH MED RES, V45, P610, DOI 10.1016/j.arcmed.2014.11.018; Cotton F. A., 1988, ADV INORGANIC CHEM; Deshpande CN, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05446-4; Eigenmann DE, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-33; Fairclough RJ, 2003, J BIOL CHEM, V278, P24721, DOI 10.1074/jbc.M300509200; Fujishiro H, 2014, METALLOMICS, V6, P944, DOI 10.1039/c3mt00362k; Harper C, 2005, J CELL SCI, V118, P1673, DOI 10.1242/jcs.02297; Ikeda T, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2768063; Jain S, 2015, MOL BIOL CELL, V26, P218, DOI 10.1091/mbc.E14-07-1177; Jenkitkasemwong S, 2018, P NATL ACAD SCI USA, V115, pE1769, DOI 10.1073/pnas.1720739115; Ji CY, 2015, J NEUROCHEM, V133, P668, DOI 10.1111/jnc.13040; Katz AK, 1996, J AM CHEM SOC, V118, P5752, DOI 10.1021/ja953943i; Lane C, 2004, BIOMETALS, V17, P87, DOI 10.1023/A:1024413631537; Leitch S, 2011, BIOMETALS, V24, P159, DOI 10.1007/s10534-010-9384-3; Leyva-Illades D, 2014, J NEUROSCI, V34, P14079, DOI 10.1523/JNEUROSCI.2329-14.2014; Lin W, 2010, J BIOL CHEM, V285, P39013, DOI 10.1074/jbc.M110.180620; Liuzzi JP, 2005, P NATL ACAD SCI USA, V102, P6843, DOI 10.1073/pnas.0502257102; McCarthy RC, 2013, J BIOL CHEM, V288, P17932, DOI 10.1074/jbc.M113.455428; McCarthy RC, 2012, BIOMETALS, V25, P665, DOI 10.1007/s10534-012-9538-6; Mercadante CJ, 2019, J CLIN INVEST, V129, P5442, DOI 10.1172/JCI129710; Micaroni Massimo, 2010, Commun Integr Biol, V3, P504, DOI 10.4161/cib.3.6.13211; Micaroni M, 2010, TRAFFIC, V11, P1315, DOI 10.1111/j.1600-0854.2010.01096.x; Monty JF, 2005, J NUTR, V135, P2762, DOI 10.1093/jn/135.12.2762; Morgan SE, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10080534; Mukhopadhyay S, 2018, NEUROTOXICOLOGY, V64, P278, DOI 10.1016/j.neuro.2017.07.030; Mukhopadhyay S, 2011, P NATL ACAD SCI USA, V108, P858, DOI 10.1073/pnas.1013642108; Munaron L, 2002, INT J MOL MED, V10, P671; Nimmanon T, 2021, CELL MOL LIFE SCI, V78, P1781, DOI 10.1007/s00018-020-03616-6; Nishito Y, 2016, J BIOL CHEM, V291, P14773, DOI 10.1074/jbc.M116.728014; Okunade GW, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703029200; Petris MJ, 1999, HUM MOL GENET, V8, P2107, DOI 10.1093/hmg/8.11.2107; Pyle CJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169531; Quadri M, 2015, MOVEMENT DISORD, V30, P996, DOI 10.1002/mds.26202; Rose C, 1999, GASTROENTEROLOGY, V117, P640, DOI 10.1016/S0016-5085(99)70457-9; Scheiber IF, 2019, NUTRIENTS, V11, DOI 10.3390/nu11071473; Sepulveda MR, 2009, J NEUROSCI, V29, P12174, DOI 10.1523/JNEUROSCI.2014-09.2009; Steimle BL, 2019, J BIOL CHEM, V294, P19197, DOI 10.1074/jbc.RA119.009371; Stins MF, 2001, MICROB PATHOGENESIS, V30, P19, DOI 10.1006/mpat.2000.0406; Takeda A, 2003, BRAIN RES REV, V41, P79, DOI 10.1016/S0165-0173(02)00234-5; Takeda Atsushi, 2004, Clin Calcium, V14, P45; Telianidis J, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00044; Thomas D, 2000, CELL CALCIUM, V28, P213, DOI 10.1054/ceca.2000.0152; Tuschl K, 2013, LANCET, V381, P110; Van Baelen K, 2004, BBA-MOL CELL RES, V1742, P103, DOI 10.1016/j.bbamcr.2004.08.018; van Raaij SEG, 2019, BIOMETALS, V32, P211, DOI 10.1007/s10534-019-00183-7; Vanoevelen J, 2005, J BIOL CHEM, V280, P22800, DOI 10.1074/jbc.M501026200; Wang CY, 2012, J BIOL CHEM, V287, P34032, DOI 10.1074/jbc.M112.367284; Wootton LL, 2004, BBA-BIOMEMBRANES, V1664, P189, DOI 10.1016/j.bbamem.2004.05.009; Worzfeld T, 2016, J CEREBR BLOOD F MET, V36, P340, DOI 10.1177/0271678X15608644; Zhang L, 1995, J NEUROPHYSIOL, V74, P2225, DOI 10.1152/jn.1995.74.6.2225; Zhao NN, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121335; Zhao NN, 2014, P NATL ACAD SCI USA, V111, P9175, DOI 10.1073/pnas.1405355111; Zhu S, 2016, METALLOMICS, V8, P993, DOI 10.1039/c6mt00093b	59	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2022	298	8							102211	10.1016/j.jbc.2022.102211	http://dx.doi.org/10.1016/j.jbc.2022.102211			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	4X0OB	35787370	Green Published, gold			2022-12-26	WOS:000860550600003
J	Yang, Z; Lemacon, DS; Li, S; Cheruiyot, A; Kong, LZ; Tan, K; Cheng, C; Turkay, E; He, DL; You, ZS				Yang, Zheng; Lemacon, Delphine Sangotokun; Li, Shan; Cheruiyot, Abigael; Kong, Lingzhen; Tan, Ke; Cheng, Chen; Turkay, Ecenur; He, Dalin; You, Zhongsheng			Context-dependent pro- and anti-resection roles of ZKSCAN3 in the regulation of fork processing during replication stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMOLOGOUS RECOMBINATION; ZINC-FINGER; SCAN DOMAIN; DNA-DAMAGE; CANCER; BRCA2; DEGRADATION; STABILITY; REPAIR; RAD51	Uncontrolled resection of replication forks under stress can cause genomic instability and influence cancer formation. Extensive fork resection has also been implicated in the chemosensitivity of BReast CAncer gene BRCA-deficient cancers. However, how fork resection is controlled in different genetic contexts and how it affects chromosomal stability and cell survival remains incompletely understood. Here, we report a novel function of the transcription repressor ZKSCAN3 in fork protection and chromosomal stability maintenance under replication stress. We show disruption of ZKSCAN3 function causes excessive resection of replication forks by the exonu-clease Exo1 and homologous DNA recombination/repair pro-tein Mre11 following fork reversal. Interestingly, in BRCA1-deficient cells, we found ZKSCAN3 actually promotes fork resection upon replication stress. We demonstrate these anti -and pro-resection roles of ZKSCAN3, consisting of a SCAN box, Kruppel-associated box, and zinc finger domain, are mediated by its SCAN box domain and do not require the Kruppel-associated box or zinc finger domains, suggesting that the transcriptional function of ZKSCAN3 is not involved. Furthermore, despite the severe impact on fork structure and chromosomal stability, depletion of ZKSCAN3 did not affect the short-term survival of BRCA1-proficient or BRCA1-deficient cells after treatment with cancer drugs hydroxyurea, PARPi, or cisplatin. Our findings reveal a unique relationship between ZKSCAN3 and BRCA1 in fork protection and add to our understanding of the relationships between replication fork protection, chromosomal instability, and chemosensitivity.	[Yang, Zheng; He, Dalin] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Urol, Xian, Shaanxi, Peoples R China; [Yang, Zheng; Lemacon, Delphine Sangotokun; Li, Shan; Cheruiyot, Abigael; Kong, Lingzhen; Tan, Ke; Cheng, Chen; Turkay, Ecenur; You, Zhongsheng] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St. Louis, MO 63130 USA	Xi'an Jiaotong University; Washington University (WUSTL)	You, ZS (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, St. Louis, MO 63130 USA.	zyou@wustl.edu	Yang, Zheng/GQZ-2510-2022	Yang, Zheng/0000-0001-9691-8796	NIH [R01GM098535]; American Cancer Society Research Scholar Grant [RSG-13-212-01-DMC]; Siteman Investment Program grant from Washington University [5124]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Research Scholar Grant(American Cancer Society); Siteman Investment Program grant from Washington University	This work was supported by an NIH grant (R01GM098535), an American Cancer Society Research Scholar Grant (RSG-13-212-01-DMC), and a Siteman Investment Program grant from Washington University (5124) to Z. Y. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barthez M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66377-z; Berti M, 2016, NAT STRUCT MOL BIOL, V23, P103, DOI 10.1038/nsmb.3163; Bhat KP, 2018, CELL REP, V24, P538, DOI 10.1016/j.celrep.2018.06.061; Chaudhuri AR, 2016, NATURE, V535, P382, DOI 10.1038/nature18325; Chauhan S, 2013, MOL CELL, V50, P16, DOI 10.1016/j.molcel.2013.01.024; Chen H, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abb8941; Chen JY, 2020, CELL DEATH DIFFER, V27, P2552, DOI 10.1038/s41418-020-0521-4; Chi YY, 2018, BIOCHEM BIOPH RES CO, V503, P2583, DOI 10.1016/j.bbrc.2018.07.019; Cruz C, 2018, ANN ONCOL, V29, P1203, DOI 10.1093/annonc/mdy099; Daza-Martin M, 2019, NATURE, V571, P521, DOI 10.1038/s41586-019-1363-4; DelloRusso C, 2007, MOL CANCER RES, V5, P35, DOI 10.1158/1541-7786.MCR-06-0234; Ding X, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12425; Dungrawala H, 2017, MOL CELL, V67, P374, DOI 10.1016/j.molcel.2017.06.023; Faraoni I, 2018, CANCERS, V10, DOI 10.3390/cancers10120487; Feng WR, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00634-0; Fugger K, 2015, CELL REP, V10, P1749, DOI 10.1016/j.celrep.2015.02.028; Guillemette S, 2015, GENE DEV, V29, P489, DOI 10.1101/gad.256214.114; He YJ, 2018, NATURE, V563, P522, DOI 10.1038/s41586-018-0670-5; Higgs MR, 2015, MOL CELL, V59, P462, DOI 10.1016/j.molcel.2015.06.007; Hopkins JL, 2022, GENE DEV, V36, P278, DOI 10.1101/gad.349431.122; Hu HF, 2020, NUCLEIC ACIDS RES, V48, P6001, DOI 10.1093/nar/gkaa425; Huang MX, 2019, AM J CANCER RES, V9, P816; Kawahara T, 2016, ONCOTARGET, V7, P53599, DOI 10.18632/oncotarget.10679; Klug A, 2010, Q REV BIOPHYS, V43, P1, DOI 10.1017/S0033583510000089; Kolinjivadi AM, 2017, MOL CELL, V67, P867, DOI 10.1016/j.molcel.2017.07.001; Lee S, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19102859; Lemacon D, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01180-5; Li JQ, 2020, CANCER CELL INT, V20, DOI 10.1186/s12935-020-01307-7; Li S, 2019, MOL CELL, V74, P1123, DOI 10.1016/j.molcel.2019.04.003; Liang Y, 2012, NUCLEIC ACIDS RES, V40, P8721, DOI 10.1093/nar/gks611; Liu QH, 2000, GENE DEV, V14, P1448; Liu W, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc3598; Mijic S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01164-5; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Mukherjee C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11246-1; Noordermeer SM, 2019, TRENDS CELL BIOL, V29, P820, DOI 10.1016/j.tcb.2019.07.008; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Poole LA, 2017, CRIT REV BIOCHEM MOL, V52, P696, DOI 10.1080/10409238.2017.1380597; Powell SN, 2003, ONCOGENE, V22, P5784, DOI 10.1038/sj.onc.1206678; Prakash R, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016600; Quinet A, 2017, MOL CELL, V68, P830, DOI 10.1016/j.molcel.2017.11.022; Quinet A, 2017, METHOD ENZYMOL, V591, P55, DOI 10.1016/bs.mie.2017.03.019; Rondinelli B, 2017, NAT CELL BIOL, V19, P1371, DOI 10.1038/ncb3626; Rottenberg S, 2008, P NATL ACAD SCI USA, V105, P17079, DOI 10.1073/pnas.0806092105; Sander TL, 2000, J BIOL CHEM, V275, P12857, DOI 10.1074/jbc.275.17.12857; Schlacher K, 2012, CANCER CELL, V22, P106, DOI 10.1016/j.ccr.2012.05.015; Schlacher K, 2011, CELL, V145, P529, DOI 10.1016/j.cell.2011.03.041; Schlegel BP, 2006, CANCER RES, V66, P5181, DOI 10.1158/0008-5472.CAN-05-3209; Schumacher C, 2000, J BIOL CHEM, V275, P17173, DOI 10.1074/jbc.M000119200; Singh B, 2019, CURR GENET, V65, P677, DOI 10.1007/s00294-018-0923-8; Tadepally HD, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-176; Takano Y, 2020, ANTICANCER RES, V40, P81, DOI 10.21873/anticanres.13928; Thakar T, 2021, NUCLEIC ACIDS RES, V49, P7224, DOI 10.1093/nar/gkab344; Tubbs A, 2017, CELL, V168, DOI 10.1016/j.cell.2017.01.002; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; Vilas CK, 2018, TRENDS GENET, V34, P313, DOI 10.1016/j.tig.2017.12.011; Williams AJ, 1999, MOL CELL BIOL, V19, P8526; Yang L, 2011, ONCOGENE, V30, P1329, DOI 10.1038/onc.2010.515; Yang L, 2008, CANCER RES, V68, P4321, DOI 10.1158/0008-5472.CAN-08-0407; Yazinski SA, 2017, GENE DEV, V31, P318, DOI 10.1101/gad.290957.116; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897; Zhang XD, 2012, INT J BIOCHEM CELL B, V44, P1166, DOI 10.1016/j.biocel.2012.04.005	63	0	0	4	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2022	298	8							102215	10.1016/j.jbc.2022.102215	http://dx.doi.org/10.1016/j.jbc.2022.102215			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	4F0HT	35779634	gold, Green Published			2022-12-26	WOS:000848198300010
J	Moshynets, OV; Baranovskyi, TP; Cameron, S; Iungin, OS; Pokholenko, I; Jerdan, R; Kamyshnyi, A; Krikunov, AA; Potochilova, VV; Rudnieva, KL; Spiers, AJ				Moshynets, Olena V.; Baranovskyi, Taras P.; Cameron, Scott; Iungin, Olga S.; Pokholenko, Ianina; Jerdan, Robyn; Kamyshnyi, Aleksandr; Krikunov, Alexey A.; Potochilova, Viktoria V.; Rudnieva, Kateryna L.; Spiers, Andrew J.			Azithromycin possesses biofilm-inhibitory activity and potentiates non-bactericidal colistin methanesulfonate (CMS) and polymyxin B against Klebsiella pneumonia	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; PSEUDOMONAS-AERUGINOSA; IN-VITRO; PHARMACOKINETICS; MORTALITY	Novel antibiotic combinations may act synergistically to inhibit the growth of multidrug-resistant bacterial pathogens but predicting which combination will be successful is difficult, and standard antimicrobial susceptibility testing may not identify important physiological differences between planktonic free-swimming and biofilm-protected surface-attached sessile cells. Using a nominally macrolide-resistant model Klebsiella pneumoniae strain (ATCC 10031) we demonstrate the effectiveness of several macrolides in inhibiting biofilm growth in multi-well plates, and the ability of azithromycin (AZM) to improve the effectiveness of the antibacterial last-agent-of-choice for K. pneumoniae infections, colistin methanesulfonate (CMS), against biofilms. This synergistic action was also seen in biofilm tests of several K. pneumoniae hospital isolates and could also be identified in polymyxin B disc-diffusion assays on azithromycin plates. Our work highlights the complexity of antimicrobial-resistance in bacterial pathogens and the need to test antibiotics with biofilm models where potential synergies might provide new therapeutic opportunities not seen in liquid culture or colony-based assays.	[Moshynets, Olena V.; Iungin, Olga S.; Pokholenko, Ianina] Natl Acad Sci Ukraine, Inst Mol Biol & Genet, Kiev, Ukraine; [Baranovskyi, Taras P.] Shupyk Natl Healthcare Univ Ukraine, Kiev, Ukraine; [Baranovskyi, Taras P.; Potochilova, Viktoria V.; Rudnieva, Kateryna L.] Kyiv Reg Clin Hosp, Kiev, Ukraine; [Cameron, Scott; Jerdan, Robyn; Spiers, Andrew J.] Abertay Univ, Sch Appl Sci, Dundee, Scotland; [Iungin, Olga S.] Kyiv Natl Univ Technol & Design, Kiev, Ukraine; [Kamyshnyi, Aleksandr] I Horbachevsky Ternopil Natl Med Univ, Ternopol, Ukraine; [Krikunov, Alexey A.] Amosov Natl Inst Cardiovasc Surg, Kiev, Ukraine	National Academy of Sciences Ukraine; Institute of Molecular Biology & Genetics of NASU; University of Abertay Dundee; Ministry of Education & Science of Ukraine; Kyiv National University of Technologies & Design; I. Horbachevsky Ternopil State Medical University; National Academy of Medical Sciences of Ukraine; Amosov National Institute of Cardiovascular Surgery of the National Academy of Medical Sciences of Ukraine	Moshynets, OV (corresponding author), Natl Acad Sci Ukraine, Inst Mol Biol & Genet, Kiev, Ukraine.; Spiers, AJ (corresponding author), Abertay Univ, Sch Appl Sci, Dundee, Scotland.	moshynets@gmail.com; a.spiers@abertay.ac.uk	; Moshynets, Olena/O-8840-2015	Baranovskyi, Taras/0000-0001-9248-4097; Rudnieva, Kateryna/0000-0002-7834-233X; Iungin, Olga/0000-0001-8876-6075; Moshynets, Olena/0000-0002-2209-8681	National Research Foundation of Ukraine [2020.02/0246]	National Research Foundation of Ukraine	OMV received the research grant `Development of combined therapy for severe Klebsiella pneumoniae-associated nosocomial infections to overcome the antibiotic resistance' (2020.02/0246) from the National Research Foundation of Ukraine (https://nrfu.org.ua/en/).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albiger B, 2015, EUROSURVEILLANCE, V20, P17, DOI 10.2807/1560-7917.ES.2015.20.45.30062; Azeredo J, 2017, CRIT REV MICROBIOL, V43, P313, DOI 10.1080/1040841X.2016.1208146; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Benkova M, 2020, J APPL MICROBIOL, V129, P806, DOI 10.1111/jam.14704; Brisse S, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 6, THIRD EDITION, P159, DOI 10.1007/0-387-30746-x_8; Cai YY, 2015, EXPERT REV ANTI-INFE, V13, P1481, DOI 10.1586/14787210.2015.1093933; Ceri H, 1999, J CLIN MICROBIOL, V37, P1771, DOI 10.1128/JCM.37.6.1771-1776.1999; Daikos GL, 2010, J CHEMOTHERAPY, V22, P175, DOI 10.1179/joc.2010.22.3.175; Daikos GL, 2014, ANTIMICROB AGENTS CH, V58, P2322, DOI 10.1128/AAC.02166-13; European Committee on Antimicrobial Susceptibility Testing (EUCAST), 2021, BREAKPOINT TABLES IN; European Committee on Antimicrobial Susceptibility Testing. EUCAST, 2010, COL RAT CLIN BREAKP; Flemming HC, 2021, NPJ BIOFILMS MICROBI, V7, DOI 10.1038/s41522-020-00183-3; Galani I, 2014, INT J ANTIMICROB AG, V43, P370, DOI 10.1016/j.ijantimicag.2013.12.010; Gillis RJ, 2004, J CLIN MICROBIOL, V42, P5842, DOI 10.1128/JCM.42.12.5842-5845.2004; HiMedia Laboratories, 2019, TECHN DAT SHEET SD25; Imberti R, 2010, CHEST, V138, P1333, DOI 10.1378/chest.10-0463; Imperi F, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00178; Kali Arunava, 2016, J Basic Clin Pharm, V7, P93, DOI 10.4103/0976-0105.183265; Karvanen M, 2013, ANTIMICROB AGENTS CH, V57, P668, DOI 10.1128/AAC.00985-12; Lalitha Cheepurupalli, 2017, Front Cell Infect Microbiol, V7, P346, DOI 10.3389/fcimb.2017.00346; Lazoryshynetz VV., 2017, UKRAINIAN J CARDIOVA, V1, P110; Loban GA., 2021, ACTUALNI PROBLEMI SU, V1, P97; Mah TF, 2012, FUTURE MICROBIOL, V7, P1061, DOI [10.2217/FMB.12.76, 10.2217/fmb.12.76]; McLaughlin K, 2017, RES MICROBIOL, V168, P419, DOI 10.1016/j.resmic.2017.01.002; Michalopoulos AS, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-30; Michalopoulos AS, 2011, EXPERT OPIN DRUG MET, V7, P245, DOI 10.1517/17425255.2011.541439; Ministry of Health of Ukraine, 2007, 167 MIN HLTH UKR; Mohsen A, 2015, AM J EPIDEMIOL INFEC, V3, P1, DOI [10.12691/ajeid-3-1-1, DOI 10.12691/AJEID-3-1-1]; Moshynets O, 2020, METHODS APPL FLUORES, V8, DOI 10.1088/2050-6120/ab90e0; Moshynets OV., 2016, MICROBIAL BIOFILMS I, P3, DOI DOI 10.5772/62912; Musken M, 2017, NPJ BIOFILMS MICROBI, V3, DOI 10.1038/s41522-017-0030-5; Nirwati Hera, 2019, BMC Proc, V13, P20, DOI 10.1186/s12919-019-0176-7; Oliva A, 2015, INT J INFECT DIS, V33, P132, DOI 10.1016/j.ijid.2015.01.011; Olsen I, 2015, EUR J CLIN MICROBIOL, V34, P877, DOI 10.1007/s10096-015-2323-z; Orhan G, 2005, J CLIN MICROBIOL, V43, P140, DOI 10.1128/JCM.43.1.140-143.2005; Paul M, 2018, LANCET INFECT DIS, V18, P391, DOI 10.1016/S1473-3099(18)30099-9; Plachouras D, 2009, ANTIMICROB AGENTS CH, V53, P3430, DOI 10.1128/AAC.01361-08; Saiman L, 2003, JAMA-J AM MED ASSOC, V290, P1749, DOI 10.1001/jama.290.13.1749; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Seifi K, 2016, JUNDISHAPUR J MICROB, V9, DOI 10.5812/jjm.30682; Stoodley P., 1999, ROLE HYDRODYNAMICS A, P323; Swatton JE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147698; Tagliaferri E, 2015, CLIN MICROBIOL INFEC, V21, pE7, DOI 10.1016/j.cmi.2014.08.016; Tapalski DV., 2020, KMAX, V22; The European Committee on Antimicrobial Susceptibility Testing, 2017, EUCAST GUIDELINES DE; Tumbarello M, 2012, CLIN INFECT DIS, V55, P943, DOI 10.1093/cid/cis588; Tutar U., 2015, J CLIN EXPER INVEST, V6, P135, DOI DOI 10.5799/AHINJS.01.2015.02.0504; Yang D, 2008, J HOSP INFECT, V68, P369, DOI 10.1016/j.jhin.2008.02.001	48	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2022	17	7							e0270983	10.1371/journal.pone.0270983	http://dx.doi.org/10.1371/journal.pone.0270983			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6E4KA	35776759	gold, Green Published			2022-12-26	WOS:000883348200010
J	Borodin, AV; Emanuilova, ZV; Smolov, SY; Ogneva, O; Konovalova, N; Terentyeva, EJ; Serova, NI; Efimov, DN; Fisinin, VI; Greenberg, A; Alekseev, Y				Borodin, Alexander V.; Emanuilova, Zhanna V.; Smolov, Sergei Y.; Ogneva, Olga; Konovalova, Nina; Terentyeva, Elena J.; Serova, Natalia I.; Efimov, D. N.; Fisinin, V. I.; Greenberg, Anthony; Alekseev, Yakov			Eradication of avian leukosis virus subgroups J and K in broiler cross chickens by selection against infected birds using multilocus PCR	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; REVERSE TRANSCRIPTION; EVOLUTION ANALYSIS; SEQUENCE-ANALYSIS; TRANSMISSION; IDENTIFICATION; PROGRESS; DISEASE	The avian leukosis virus (ALV) is a serious threat to sustainable and economically viable commercial poultry management world-wide. Active infections can result in more than 20% flock loss, resulting in significant economic damage. ALV detection and elimination from flocks and breeding programs is complicated by high sequence variability and the presence of endogenous virus copies which show up as false positives in assays. Previously-developed approaches to virus detection are either too labor-intensive to implement on an industrial scale or suffer from high false negative or positive rates. We developed a novel multi-locus multiplex quantitative real-time PCR system to detect viruses belonging to the J and K genetic subgroups that are particularly prevalent in our region. We used this system to eradicate ALV from our broiler breeding program comprising thousands of individuals. Our approach can be generalized to other ALV subgroups and other highly genetically diverse pathogens.	[Borodin, Alexander V.; Emanuilova, Zhanna V.; Smolov, Sergei Y.; Ogneva, Olga] Minist Sci & Higher Educ Russian Federat, Breeding & Genet Ctr Smena, Bereznyaki, Russia; [Borodin, Alexander V.] Inst Med & Biol Res, Nizhnii Novgorod, Russia; [Konovalova, Nina; Terentyeva, Elena J.; Alekseev, Yakov] Syntol LLC, Moscow, Russia; [Serova, Natalia I.] Russian Acad Sci, All Russian Res Vet Inst Poultry Sci Branch Fed Sc, Technol Poultry Inst, St Petersburg, Russia; [Efimov, D. N.; Fisinin, V. I.] Russian Acad Sci, Fed Sci Ctr All Russian Res & Technol Poultry Ins, Sergiev Posad, Russia; [Greenberg, Anthony] Bayes Res, Ithaca, NY 14853 USA; [Alekseev, Yakov] Russian Acad Sci, Inst Analyt Instrumentat, St Petersburg, Russia	Russian Academy of Sciences; Russian Academy of Sciences; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences	Alekseev, Y (corresponding author), Syntol LLC, Moscow, Russia.; Greenberg, A (corresponding author), Bayes Res, Ithaca, NY 14853 USA.; Alekseev, Y (corresponding author), Russian Acad Sci, Inst Analyt Instrumentat, St Petersburg, Russia.	tonyg@bayesicresearch.org; jalex@syntol.ru		Serova, Natalia/0000-0003-2121-2048; Greenberg, Anthony/0000-0003-3296-5811	Ministry of Science and Higher Education of the Russian Federation; state assignment for Breeding and Genetic Center Smena [075-01297-20-00]	Ministry of Science and Higher Education of the Russian Federation; state assignment for Breeding and Genetic Center Smena	ZhVE, AMB, SVS: Ministry of Science and Higher Education of the Russian Federation, the state assignment for Breeding and Genetic Center Smena No. 075-01297-20-00. https://minobrnauki. gov.ru/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacon LD, 2004, AVIAN PATHOL, V33, P233, DOI 10.1080/0307943042000195731; Borodin AM., 2018, AGR BIOL IN RUSSIAN, V53, P842; Chang SW, 2013, AVIAN DIS, V57, P172, DOI 10.1637/10387-092612-Reg.1; Cui N, 2014, J GEN VIROL, V95, P2512, DOI 10.1099/vir.0.067264-0; Davidson I, 2002, AVIAN PATHOL, V31, P237, DOI 10.1080/03079450220136549; FADLY AM, 1981, AVIAN DIS, V25, P667, DOI 10.2307/1589997; FUJITA DJ, 1974, VIROLOGY, V60, P558, DOI 10.1016/0042-6822(74)90350-X; Gao YL, 2010, EMERG INFECT DIS, V16, P1637, DOI 10.3201/eid1610.100780; Gavora JS, 1995, AVIAN PATHOL, V24, P653, DOI 10.1080/03079459508419105; IGNJATOVIC J, 1990, AUST VET J, V67, P299, DOI 10.1111/j.1751-0813.1990.tb07801.x; Kim YB, 2002, J VIROL METHODS, V102, P1, DOI 10.1016/S0166-0934(01)00372-X; Lamien CE, 2011, J VIROL METHODS, V171, P134, DOI 10.1016/j.jviromet.2010.10.014; Li XJ, 2016, ARCH VIROL, V161, P2717, DOI 10.1007/s00705-016-2965-x; Liang XY, 2019, VIRUS GENES, V55, P726, DOI 10.1007/s11262-019-01695-7; Lv L, 2019, VET MICROBIOL, V231, P214, DOI 10.1016/j.vetmic.2019.03.021; Meng FF, 2016, J VET SCI, V17, P497, DOI 10.4142/jvs.2016.17.4.497; Nakamura S, 2011, AVIAN PATHOL, V40, P499, DOI 10.1080/03079457.2011.605783; Pandiri AR, 2012, AVIAN DIS, V56, P578, DOI 10.1637/9949-092611-ResNote.1; Payne LN, 1998, AVIAN PATHOL, V27, pS36, DOI 10.1080/03079459808419291; PAYNE LN, 1991, J GEN VIROL, V72, P801, DOI 10.1099/0022-1317-72-4-801; Payne LN, 1998, POULTRY SCI, V77, P1204, DOI 10.1093/ps/77.8.1204; Peng H, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0430-1; Plotnikov V., 2013, AGR BIOL IN RUSSIAN, V6, P36; Qin LT, 2013, J CLIN MICROBIOL, V51, P149, DOI 10.1128/JCM.02030-12; Shao HX, 2017, ARCH VIROL, V162, P2073, DOI 10.1007/s00705-017-3344-y; Smith LM, 1998, VIRUS RES, V54, P87, DOI 10.1016/S0168-1702(98)00022-7; SPENCER JL, 1984, AVIAN PATHOL, V13, P599, DOI 10.1080/03079458408418560; Su Q, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0111-4; Sung HW, 2002, AVIAN DIS, V46, P281, DOI 10.1637/0005-2086(2002)046[0281:HVTIFP]2.0.CO;2; Venugopal K, 1999, RES VET SCI, V67, P113, DOI 10.1053/rvsc.1998.0283; Wang PK, 2018, ARCH VIROL, V163, P377, DOI 10.1007/s00705-017-3601-0; WHITCOMB JM, 1992, ANNU REV CELL BIOL, V8, P275, DOI 10.1146/annurev.cb.08.110192.001423; Witter RL, 2001, AVIAN PATHOL, V30, P641, DOI 10.1080/03079450120092134; Yang S, 2002, J CLIN MICROBIOL, V40, P3449, DOI 10.1128/JCM.40.9.3449-3454.2002; Zavala G, 2002, AVIAN DIS, V46, P971, DOI 10.1637/0005-2086(2002)046[0971:PCRFDO]2.0.CO;2	35	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	6							e0269525	10.1371/journal.pone.0269525	http://dx.doi.org/10.1371/journal.pone.0269525			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3F0KH	35749432	Green Published, gold			2022-12-26	WOS:000830362700021
J	Fodil, S; Chevret, S; Rouzaud, C; Valade, S; Rabian, F; Mariotte, E; Raffoux, E; Itzykson, R; Boissel, N; Sebert, M; Ades, L; Zafrani, L; Azoulay, E; Lengline, E				Fodil, Sofiane; Chevret, Sylvie; Rouzaud, Camille; Valade, Sandrine; Rabian, Florence; Mariotte, Eric; Raffoux, Emmanuel; Itzykson, Raphael; Boissel, Nicolas; Sebert, Marie; Ades, Lionel; Zafrani, Lara; Azoulay, Elie; Lengline, Etienne			Post-remission outcomes in AML patients with high hyperleukocytosis and inaugural life-threatening complications	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; MANAGEMENT; LEUKOSTASIS; DIAGNOSIS; PROGNOSIS; ADMISSION; SURVIVAL; SUBTYPES	IntroductionPatients with hyperleukocytic (HL) acute myeloid leukemia (AML) are at higher risk of early death. Initial management of these patients is challenging, not fully codified and heterogenous. Retrospective studies showed that several symptomatic measures might decrease early death rate but long-term data are scarce. We aimed to analyze whether the therapeutic measures carried out urgently at diagnosis may influence the outcome among HL AML patients having achieved who survived inaugural complications. MethodsWe retrospectively reviewed all medical charts from patients admitted to Saint-Louis Hospital between January, 1(st) 1997 and December, 31st 2018 with newly diagnosed AML and white blood cell (WBC) count above 50x10(9)/L. Outcome measures were cumulative incidence of relapse (CIR), treatment-related mortality (TRM) defined as relapse-free death, and overall survival. Univariate and multivariate analyses were performed using Cox proportional hazards models. ResultsA total of 184 patients with HL AML in complete remission (CR) were included in this study. At 2 years after CR. 62.5% of patients were alive, at 5 years, cumulated incidence of relapse was 55.8%. We found that every therapeutic measure, including life-sustaining therapies carried out in the initial phase of the disease, did not increase the relapse risk. The use of hydroxyurea for more than 4 days was associated with a higher risk of relapse. At the end of the study, 94 patients (51.1%) were still alive including 23 patients out of 44 aged less than 60 yo that were able to return to work. ConclusionWe show that the use of emergency measures including life sustaining therapies does not come at the expense of a higher risk of relapse or mortality, except in the case of prolonged use of hydroxyurea. Patients with HL AML should be able to benefit from all available techniques, regardless of their initial severity.	[Fodil, Sofiane; Rouzaud, Camille; Raffoux, Emmanuel; Itzykson, Raphael; Lengline, Etienne] Univ Paris Diderot, Hop St Louis, Hematol Adulte, APHP, Paris, France; [Fodil, Sofiane] Sorbonne Univ, Paris, France; [Chevret, Sylvie] Hop St Louis, Serv Biostat & Informat Medicale, Paris, France; [Valade, Sandrine; Mariotte, Eric; Zafrani, Lara; Azoulay, Elie] Univ Paris Diderot, Hop St Louis, Med Intens Care Unit, APHP, Paris, France; [Rabian, Florence; Boissel, Nicolas] Univ Paris Diderot, Hop St Louis, Hematol Adolescents & Jeunes Adultes, APHP, Paris, France; [Sebert, Marie; Ades, Lionel] Univ Paris Diderot, Hop St Louis, Hematol Seniors, APHP, Paris, France; [Sebert, Marie; Ades, Lionel] Univ Paris, INSERM U944, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Lengline, E (corresponding author), Univ Paris Diderot, Hop St Louis, Hematol Adulte, APHP, Paris, France.	etienne.lengline@aphp.fr	LENGLINE, Etienne/GZG-5476-2022; Itzykson, Raphael/M-8517-2018	Itzykson, Raphael/0000-0003-2139-6262; Fodil, Sofiane/0000-0002-6713-1609				Ali AM, 2016, HEMATOL ONCOL, V34, P69, DOI 10.1002/hon.2292; Azoulay E, 2012, EUR RESPIR J, V39, P648, DOI 10.1183/09031936.00057711; Bertoli S, 2018, HAEMATOLOGICA, V103, P988, DOI 10.3324/haematol.2017.184267; Britten O, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8111341; Cairo MS, 2004, BRIT J HAEMATOL, V127, P3, DOI 10.1111/j.1365-2141.2004.05094.x; Cerrano M, 2020, LEUKEMIA LYMPHOMA, V61, P737, DOI 10.1080/10428194.2019.1683735; Dixit A, 2007, CLIN APPL THROMB-HEM, V13, P292, DOI 10.1177/1076029607302435; Dohner H, 2015, NEW ENGL J MED, V373, P1136, DOI 10.1056/NEJMra1406184; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Dusseaux MM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216991; Ferreyro BL, 2021, INTENS CARE MED, DOI 10.1007/s00134-021-06502-2; Giammarco S, 2017, EXPERT REV HEMATOL, V10, P147, DOI 10.1080/17474086.2017.1270754; Grimwade D, 2010, BLOOD, V116, P354, DOI 10.1182/blood-2009-11-254441; Kraguljac AP, 2016, CAN RESPIR J, V2016, DOI 10.1155/2016/3027656; Lengline E, 2012, LEUKEMIA LYMPHOMA, V53, P1352, DOI 10.3109/10428194.2011.649752; Levi M, 2009, BRIT J HAEMATOL, V145, P24, DOI [10.1111/j.1365-2141.2008.07445.x, 10.1111/j.1365-2141.2009.07600.x]; Malkan UY, 2017, TRANSFUS APHER SCI, V56, P880, DOI 10.1016/j.transci.2017.11.002; Mamez AC, 2016, LEUKEMIA LYMPHOMA, V57, P2281, DOI 10.3109/10428194.2016.1142083; Montesinos P, 2007, HAEMATOLOGICA, V93, P67, DOI 10.3324/haematol.11575; Moreau AS, 2014, LEUKEMIA LYMPHOMA, V55, P2556, DOI 10.3109/10428194.2014.887709; Ofran Y, 2016, BLOOD, V128, P488, DOI 10.1182/blood-2016-01-635060; Percival MEM, 2015, CANCER-AM CANCER SOC, V121, P2004, DOI 10.1002/cncr.29319; Rabbat A, 2005, BRIT J HAEMATOL, V129, P350, DOI 10.1111/j.1365-2141.2005.05459.x; Rollig C, 2015, BLOOD, V125, P3246, DOI 10.1182/blood-2014-10-551507; Saillard C, 2018, LEUKEMIA RES, V68, P29, DOI 10.1016/j.leukres.2018.02.015; Schellongowski P, 2011, HAEMATOL-HEMATOL J, V96, P231, DOI 10.3324/haematol.2010.031583; Shallis RM, 2021, BLOOD REV, V47, DOI 10.1016/j.blre.2020.100773; Shallis RM, 2020, EXPERT REV HEMATOL, V13, P489, DOI 10.1080/17474086.2020.1751609; Stahl M, 2020, LEUKEMIA, V34, P3149, DOI 10.1038/s41375-020-0783-3; Tallman MS, 2004, J CLIN ONCOL, V22, P1276, DOI 10.1200/JCO.2004.08.060; Thiede C, 2002, BLOOD, V99, P4326, DOI 10.1182/blood.V99.12.4326; Van de Louw A, 2016, LEUKEMIA LYMPHOMA, V57, P1319, DOI 10.3109/10428194.2015.1094695; van Gassel RJJ, 2020, CURR OPIN CLIN NUTR, V23, P96, DOI 10.1097/MCO.0000000000000628; Zafrani L, 2019, INTENS CARE MED, V45, P1608, DOI 10.1007/s00134-019-05768-x; Zhao J, 2021, LEUKEMIA LYMPHOMA, V62, P1195, DOI 10.1080/10428194.2020.1856835	35	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7							e0270744	10.1371/journal.pone.0270744	http://dx.doi.org/10.1371/journal.pone.0270744			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M2ZD	35797337	Green Published, gold			2022-12-26	WOS:000835328600007
J	Gir, E; Teles, SA; Menegueti, MG; Reis, RK; de Carvalho, MJ; Botelho, EP; Sousa, LRM; Coelho, HFC; Avila, FMP; Galvao, MTG; Nogueira, WP; Silva, ACDE				Gir, Elucir; Teles, Sheila Araujo; Menegueti, Mayra Goncalves; Reis, Renata Karina; de Carvalho, Milton Jorge; Botelho, Elia Pinheiro; Sousa, Laelson Rochelle Milanes; Coelho, Hemilio Fernandes Campos; avila, Fernanda Maria Pereira; Galvao, Marli Teresinha Gimeniz; Nogueira, Wynne Pereira; Silva, Ana Cristina de Oliveira e			Factors associated with the diagnosis of COVID-19 among Brazilian health professionals COVID-19 and health professionals	PLOS ONE			English	Article								IntroductionHealth professionals are on the front lines against the Coronavirus 2019 (COVID-19) pandemic and are at high risk for acquiring the infection. Failures in precautionary measures, inadequacy/scarcity of Personal Protective Equipment (PPE), and lack of social and family distancing may be associated with increased exposure and contamination by the new coronavirus. This study investigated the prevalence of COVID-19 among Brazilian health professionals and associated factors according to demographic and occupational characteristics. MethodsA cross-sectional, analytical study was conducted using an online survey with 12,086 health professionals from all regions of Brazil. Data were collected using an adaptation of the respondent-driven sampling method for the virtual environment. The outcome variable was the diagnosis of COVID-19. Bivariate and multiple logistic regression analyzes were used to identify an association between the diagnosis of COVID-19 and demographic and occupational variables. Variables were considered statistically significant based on pResultsMost participants were female, from the northeast region, and nursing professionals. A prevalence of 31.95% (95%CI: 31.0%, 32.9%) of COVID-19 was estimated. Following multiple regression analysis, the variables associated with the diagnosis of COVID-19 among health professionals were: male gender, married individuals, professionals who provide care to patients with COVID-19, who work in a field hospital, and those who work in institutions that did not offer enough quality PPE. ConclusionsThe study found a high prevalence of COVID-19 infection, with male professionals being those with greater chances. Inadequate supply or poor quality of PPE offered by health institutions compromises the health of professionals with an increase in positive diagnosis for COVID-19.	[Gir, Elucir; Menegueti, Mayra Goncalves; Reis, Renata Karina; Sousa, Laelson Rochelle Milanes] Univ Sao Paulo, Ribeirao Preto Sch Nursing, Ribeirao Preto, SP, Brazil; [Teles, Sheila Araujo] Univ Fed Goias, Coll Nursing, Goiania, GO, Brazil; [de Carvalho, Milton Jorge] Coll Med ABC, Dept Gynecol & Obstet, Santo Andre, SP, Brazil; [Botelho, Elia Pinheiro] Fed Univ, Belem, PA, Brazil; [Coelho, Hemilio Fernandes Campos] Univ Fed Paraiba, Dept Stat, Joao Pessoa, PB, Brazil; [avila, Fernanda Maria Pereira] Fluminense Fed Univ, Dept Nursing Rio Das Ostras, Rio das Ostras, RJ, Brazil; [Galvao, Marli Teresinha Gimeniz] Univ Fed Ceara, Dept Nursing, Fortaleza, CE, Brazil; [Nogueira, Wynne Pereira] Univ Fed Paraiba, Postgrad Program Nursing, Joao Pessoa, PB, Brazil; [Silva, Ana Cristina de Oliveira e] Univ Fed Paraiba, Dept Clin Nursing, Joao Pessoa, PB, Brazil	Universidade de Sao Paulo; Universidade Federal de Goias; Faculdade de Medicina do ABC; Universidade Federal da Paraiba; Universidade Federal do Ceara; Universidade Federal da Paraiba; Universidade Federal da Paraiba	Silva, ACDE (corresponding author), Univ Fed Paraiba, Dept Clin Nursing, Joao Pessoa, PB, Brazil.	anacris.os@gmail.com			National Council for Scientific and Technological Development (CNPq/Brazil) [401708/2020-9]	National Council for Scientific and Technological Development (CNPq/Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The research was funded by the National Council for Scientific and Technological Development (CNPq/Brazil) under process n degrees 401708/2020-9.	Anelli F, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1254; Ashinyo ME, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248282; Bitencourt SM, 2021, CIENC SAUDE COLETIVA, V26, P1013, DOI 10.1590/1413-81232021263.42082020; Buonafine CP, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05662-8; Teixeira CFD, 2020, CIENC SAUDE COLETIVA, V25, P3465, DOI 10.1590/1413-81232020259.19562020; Eysenbach G, 2004, J MED INTERNET RES, V6, P12, DOI 10.2196/jmir.6.3.e34; Gandra EC., 2020, BRAZ J DEV, V6, P53348, DOI [10.34117/bjdv6n7-833, DOI 10.34117/BJDV6N7-833]; Gomez-Ochoa SA, 2021, AM J EPIDEMIOL, V190, P161, DOI 10.1093/aje/kwaa191; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Heckathorn DD, 2002, AIDS BEHAV, V6, P55; Heckathorn DD, 2011, SOCIOL METHODOL, V41, P355, DOI 10.1111/j.1467-9531.2011.01244.x; Hosmer D., 2000, APPL LOGISTIC REGRES, V2; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Huete-Perez JA, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246084; Kaur U, 2022, J MED VIROL, V94, P407, DOI 10.1002/jmv.27320; Keeley AJ, 2020, EUROSURVEILLANCE, V25, P10, DOI 10.2807/1560-7917.ES.2020.25.14.2000433; Kluytmans-van Den Bergh MFQ, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.9673; Korth J, 2020, J CLIN VIROL, V128, DOI 10.1016/j.jcv.2020.104437; Lee K, 2009, GLOB INST, P1; Machida M, 2020, INT J INFECT DIS, V94, P139, DOI 10.1016/j.ijid.2020.04.014; Ministerio da Saude (BR), 2020, B EPIDEMIOLOGICO ESP, V52; Ministerio da Saude (BR), 2010, IND REC NUM PROF SAU; Ministerio da Saude (BR), 2020, B EPIDEMIOLOGICO ESP, V33; Rawlings JO., 1998, APPL REGRESSION ANAL; Self WH, 2020, MMWR-MORBID MORTAL W, V69, P1221, DOI 10.15585/mmwr.mm6935e2; Shah ASV, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m3582; Tabah A, 2020, J CRIT CARE, V59, P70, DOI 10.1016/j.jcrc.2020.06.005; Valliant R., 2013, PRACTICAL TOOLS DESI; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; Wang J, 2020, J HOSP INFECT, V105, P100, DOI 10.1016/j.jhin.2020.03.002; Wang JC, 2019, ANTIMICROB RESIST IN, V8, DOI 10.1186/s13756-019-0481-y; White RG, 2015, J CLIN EPIDEMIOL, V68, P1463, DOI 10.1016/j.jclinepi.2015.04.002	32	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	6							e0267121	10.1371/journal.pone.0267121	http://dx.doi.org/10.1371/journal.pone.0267121			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3F0KH	35749441	gold, Green Published			2022-12-26	WOS:000830362700085
J	Ji, LY; Cai, L; Ji, AAI				Ji, Liyan; Cai, Lin; Ji, Aiai			Respectfulness-processing revisited: An ERP study of Chinese sentence reading	PLOS ONE			English	Article							INTEGRATION; COMPREHENSION; KNOWLEDGE; INTERPLAY	In Mandarin Chinese, an important manifestation of respectfulness is the use of different forms of second-person pronouns. Jiang et al. (2013) examined the event-related potential (ERP) correlates of processing respectful and plain pronouns in Chinese. However, this study suffered from a few methodological limitations, which restricted both the reliability and functional interpretations of the study's findings. In the present study, we resolved these limitations and further investigated the neurocognitive mechanisms of processing the respectfulness of pronouns. In the present study, participants read 160 critical Chinese sentences with a second-person pronoun (ni or nin) that was either consistent or inconsistent with its prior sentence context in terms of respectfulness, as well as 240 filler sentences. Unlike the previous study that reported a 300-500 ms negative response (N400) for both types of inconsistent pronouns, a sustained positive response for Nin inconsistent and a sustained negativity response for Ni inconsistent in the late time window, the present study found an N400 response and late sustained negativity for Nin inconsistent, but not for Ni inconsistent. Furthermore, the cluster-based permutation showed a significant negative cluster for Nin inconsistent, extending from 432-622 ms. We related this negative response for Nin inconsistent with recent accounts of the N400 and late negativity. Finally, the absence of the ERP effect for the Ni condition was linked to the role of the pragmatic property of Ni.	[Ji, Liyan] Fujian Normal Univ, Sch Psychol, Fuzhou, Peoples R China; [Ji, Liyan] Peking Univ, Sch Psychol & Cognit Sci, Beijing, Peoples R China; [Cai, Lin] Keio Univ, Dept Elect & Elect Engn, Yokohama, Japan; [Ji, Aiai] Tiangong Univ, Mental Hlth Educ Ctr, Tianjin, Peoples R China	Fujian Normal University; Peking University; Keio University; Tiangong University	Ji, LY (corresponding author), Fujian Normal Univ, Sch Psychol, Fuzhou, Peoples R China.; Ji, LY (corresponding author), Peking Univ, Sch Psychol & Cognit Sci, Beijing, Peoples R China.	jiliyan0717@126.com			Natural Science Foundation of China [31371021, WHW20180]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of China (grant number: 31371021), the Wenghongwu Original Research Funding (WHW20180).	Agha A, 2007, STUD SOC CULT FOUND, V24, P1, DOI 10.2277/ 0521576857; Ashizuka A, 2015, NEUROSCI RES, V91, P48, DOI 10.1016/j.neures.2014.10.009; Baggio G, 2008, J MEM LANG, V59, P36, DOI 10.1016/j.jml.2008.02.005; Bambini V, 2019, DISCOURSE PROCESS, V56, P77, DOI 10.1080/0163853X.2017.1401876; Cai Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010729; Canal P, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01953; Egidi G, 2012, BRAIN LANG, V122, P199, DOI 10.1016/j.bandl.2011.12.008; Fukada A, 2004, J PRAGMATICS, V36, P1991, DOI 10.1016/j.pragma.2003.11.006; Hagoort P, 2004, SCIENCE, V304, P438, DOI 10.1126/science.1095455; Hahne A, 2002, COGNITIVE BRAIN RES, V13, P339, DOI 10.1016/S0926-6410(01)00127-6; Ji LY, 2022, COGN NEURODYNAMICS, V16, P101, DOI 10.1007/s11571-021-09700-2; Jiang XM, 2013, NEUROPSYCHOLOGIA, V51, P2210, DOI 10.1016/j.neuropsychologia.2013.07.021; Jiang XM, 2013, NEUROPSYCHOLOGIA, V51, P1857, DOI 10.1016/j.neuropsychologia.2013.06.009; Kaan E, 2016, BILING-LANG COGN, V19, P1, DOI 10.1017/S1366728914000844; KUTAS M, 1984, NATURE, V307, P161, DOI 10.1038/307161a0; Kwon N, 2016, FRONT PSYCHOL, V7, DOI [10.3389/fpsyg.2016.01302, 10.3389/fphyg.2016.01302]; Lewis AG, 2015, BRAIN LANG, V148, P51, DOI 10.1016/j.bandl.2015.01.003; Liang L., 2010, J CENTRAL S U FOREST, V4, P104; Mao Y, 2003, DISSERTATION; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Molinaro N, 2016, BRAIN LANG, V155, P36, DOI 10.1016/j.bandl.2016.03.002; Momo K, 2008, BRAIN LANG, V107, P81, DOI 10.1016/j.bandl.2007.12.003; Nieuwland MS, 2008, BRAIN LANG, V106, P119, DOI 10.1016/j.bandl.2008.05.001; Nieuwland MS, 2006, J COGNITIVE NEUROSCI, V18, P1098, DOI 10.1162/jocn.2006.18.7.1098; Nieuwland MS, 2014, J MEM LANG, V76, P1, DOI 10.1016/j.jml.2014.06.002; Politzer-Ahles S, 2013, BRAIN RES, V1490, P134, DOI 10.1016/j.brainres.2012.10.042; Regel S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096840; Regel S, 2011, J COGNITIVE NEUROSCI, V23, P277, DOI 10.1162/jocn.2010.21411; Rueschemeyer SA, 2015, PSYCHON B REV, V22, P128, DOI 10.3758/s13423-014-0654-x; Schacht A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091226; Schumacher PB., 2012, WHAT IS CONTEXT LING, P33, DOI 10.1075/la.196.05sch; Steinhauer K, 2012, BRAIN LANG, V120, P135, DOI 10.1016/j.bandl.2011.07.001; Tang XM, 2017, J NEUROLINGUIST, V42, P12, DOI 10.1016/j.jneuroling.2016.11.003; Tokimoto S, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.549839; Wang C, 2021, PSYCHOPHYSIOLOGY, V58, DOI 10.1111/psyp.13775; Wang H, 2015, DISSERTATION; Wang L, 2012, FRONT PSYCHOL, V3, DOI [10.3389/fpsyg.2012.00187, 10.3389/fpsyg.2012.00438]; Yu L, 2015, BRAIN RES, V1597, P139, DOI 10.1016/j.brainres.2014.12.013	38	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	6							e0258570	10.1371/journal.pone.0258570	http://dx.doi.org/10.1371/journal.pone.0258570			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3F0KH	35749463	Green Published, gold			2022-12-26	WOS:000830362700043
J	Mills, DJ; Petrovic, J; Mettler, J; Hamza, CA; Heath, NL				Mills, Devin J.; Petrovic, Julia; Mettler, Jessica; Hamza, Chloe A.; Heath, Nancy L.			The good, the bad, and the mixed: Experiences during COVID-19 among an online sample of adults	PLOS ONE			English	Article							MENTAL-HEALTH; IMPACT; GROWTH; NUMBER	Studies have outlined the negative consequences of the COVID-19 pandemic to psychological health. However, the potential within-individual diversity of experiences during COVID-19, and how such experiences relate to indices of psychological distress and COVID-19-specific stressors, remains to be explored. A large online sample of American MTurk Workers (N = 3,731; M-age = 39.54 years, SD = 13.12; 51.70% female) completed short assessments of psychological distress, COVID-19-specific stressors (e.g., wage loss, death), and seven items assessing negative and positive COVID-19 experiences. Latent profile analyses were used to identify underlying profiles of COVID-19 experiences. A four-profile solution was retained representing profiles that were: (1) predominantly positive (n = 839; 22.49%), (2) predominantly negative (n = 849; 22.76%), (3) moderately mixed (n = 1,748; 46.85%), and (4) high mixed (n = 295; 7.91%). The predominantly positive profile was associated with lower psychological distress, whereas both the predominantly negative and high mixed profiles were associated with higher psychological distress. Interestingly, specific COVID-19 stressful events were associated with the high mixed profile. The present study challenges the narrative that the impacts of COVID-19 have been unilaterally negative. Future directions for research are proposed.	[Mills, Devin J.] Texas Tech Univ, Dept Community Family & Addict Sci, Lubbock, TX 79409 USA; [Petrovic, Julia; Mettler, Jessica; Heath, Nancy L.] McGill Univ, Dept Educ & Counselling Psychol, Montreal, PQ, Canada; [Hamza, Chloe A.] Univ Toronto, Dept Appl Psychol & Human Dev, Toronto, ON, Canada	Texas Tech University System; Texas Tech University; McGill University; University of Toronto	Mills, DJ (corresponding author), Texas Tech Univ, Dept Community Family & Addict Sci, Lubbock, TX 79409 USA.	devin.mills@ttu.edu						Brown S, 2021, APPETITE, V156, DOI 10.1016/j.appet.2020.104977; Burki T, 2020, LANCET INFECT DIS, V20, P904, DOI 10.1016/S1473-3099(20)30568-5; Chandler J, 2016, ANNU REV CLIN PSYCHO, V12, P53, DOI 10.1146/annurev-clinpsy-021815-093623; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Diallo TMO, 2016, STRUCT EQU MODELING, V23, P507, DOI 10.1080/10705511.2016.1169188; Diener E, 2000, AM PSYCHOL, V55, P34, DOI 10.1037/0003-066X.55.1.34; Donker T, 2011, PSYCHIAT RES, V188, P58, DOI 10.1016/j.psychres.2011.01.016; Emery RL, 2021, SOC SCI MED, V276, DOI 10.1016/j.socscimed.2021.113826; Fancourt D., 2020, MEDRXIV; Ferguson SL, 2020, INT J BEHAV DEV, V44, P458, DOI 10.1177/0165025419881721; Fiorillo A, 2020, EUR PSYCHIAT, V63, DOI 10.1192/j.eurpsy.2020.35; Folkman S, 2008, ANXIETY STRESS COPIN, V21, P3, DOI 10.1080/10615800701740457; Hampshire A, 2020, MEDRXIV; Hamza CA, 2021, CAN PSYCHOL, V62, P20, DOI 10.1037/cap0000255; IBM Crop, 2019, IBM SPSS STAT WINDOW; Iob E, 2020, BRIT J PSYCHIAT, V217, P543, DOI 10.1192/bjp.2020.130; Keyes CLM, 2005, J CONSULT CLIN PSYCH, V73, P539, DOI 10.1037/0022-006X.73.3.539; Kimhi S, 2020, SOC SCI MED, V265, DOI 10.1016/j.socscimed.2020.113389; Kline RB, 2005, PRINCIPLES PRACTICE; Linley PA, 2005, AM PSYCHOL, V60, P262, DOI 10.1037/0003-066X.60.3.262b; Litman L, 2017, BEHAV RES METHODS, V49, P433, DOI 10.3758/s13428-016-0727-z; Lo YT, 2001, BIOMETRIKA, V88, P767, DOI 10.1093/biomet/88.3.767; Lowe B, 2005, J PSYCHOSOM RES, V58, P163, DOI 10.1016/j.jpsychores.2004.09.006; Luchetti M, 2020, AM PSYCHOL, V75, P897, DOI 10.1037/amp0000690; Luo M, 2020, PSYCHIAT RES, V291, DOI 10.1016/j.psychres.2020.113190; Makwana N, 2019, J FAM MED PRIM CARE, V8, P3090, DOI 10.4103/jfmpc.jfmpc_893_19; Mason W, 2012, BEHAV RES METHODS, V44, P1, DOI 10.3758/s13428-011-0124-6; Mathias K, 2020, INT J EQUITY HEALTH, V19, DOI 10.1186/s12939-020-01345-7; Muthen B., 2010, MPLUS USERS GUIDE; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; Olsen GD, 2004, J CONSUM PSYCHOL, V14, P374; Pan KY, 2021, LANCET PSYCHIAT, V8, P121, DOI 10.1016/S2215-0366(20)30491-0; Phillipou A, 2020, INT J EAT DISORDER, V53, P1158, DOI 10.1002/eat.23317; Pinkham AE, 2020, PSYCHIAT RES, V294, DOI 10.1016/j.psychres.2020.113493; Prati G, 2021, PSYCHOL MED, V51, P201, DOI 10.1017/S0033291721000015; Ran LY, 2020, SOC SCI MED, V262, DOI 10.1016/j.socscimed.2020.113261; Reger MA, 2020, JAMA PSYCHIAT, V77, P1093, DOI 10.1001/jamapsychiatry.2020.1060; Ryan RM, 1997, J PERS, V65, P529, DOI 10.1111/j.1467-6494.1997.tb00326.x; Sachser C, 2021, SOC SCI MED, V278, DOI 10.1016/j.socscimed.2021.113954; Salari N, 2020, GLOBALIZATION HEALTH, V16, DOI 10.1186/s12992-020-00589-w; Schmiedeberg C, 2021, SOC SCI MED, V276, DOI 10.1016/j.socscimed.2021.113859; Seligman MEP, 2000, AM PSYCHOL, V55, P5, DOI 10.1037/0003-066X.56.1.89; Stallard P, 2021, BJPSYCH OPEN, V7, DOI 10.1192/bjo.2021.1; Tein JY, 2013, STRUCT EQU MODELING, V20, P640, DOI 10.1080/10705511.2013.824781; Tull MT, 2020, PSYCHIAT RES, V289, DOI 10.1016/j.psychres.2020.113098; Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729; Watson D, 1999, J PERS SOC PSYCHOL, V76, P820, DOI 10.1037/0022-3514.76.5.820; Weissman RS, 2020, INT J EAT DISORDER, V53, P369, DOI 10.1002/eat.23279; Westerhof GJ, 2010, J ADULT DEV, V17, P110, DOI 10.1007/s10804-009-9082-y; Williams L, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0244873; Yamey G., 2020, TIME	51	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	6							e0269382	10.1371/journal.pone.0269382	http://dx.doi.org/10.1371/journal.pone.0269382			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3F0KH	35749457	gold, Green Published			2022-12-26	WOS:000830362700091
J	Lopez-Yus, M; Lorente-Cebrian, S; Del Moral-Bergos, R; Horndler, C; Garcia-Sobreviela, MP; Casamayor, C; Sanz-Paris, A; Bernal-Monterde, V; Arbones-Mainar, JM				Lopez-Yus, Marta; Lorente-Cebrian, Silvia; Del Moral-Bergos, Raquel; Horndler, Carlos; Pilar Garcia-Sobreviela, Maria; Casamayor, Carmen; Sanz-Paris, Alejandro; Bernal-Monterde, Vanesa; Arbones-Mainar, Jose M.			Identification of novel targets in adipose tissue involved in non-alcoholic fatty liver disease progression	FASEB JOURNAL			English	Article						adipose tissue; fatty liver; mesenchymal stem cell; obesity	CYTOKINE SIGNALING-3; STEM-CELLS; OBESITY; SUPPRESSOR; ADIPOGENESIS; LIPOGENESIS; METABOLISM; LIPIDS; DUSP1	Obesity is a major risk factor for the development of Nonalcoholic fatty liver disease (NAFLD). We hypothesize that a dysfunctional subcutaneous white adipose tissue (scWAT) may lead to an accumulation of ectopic fat in the liver. Our aim was to investigate the molecular mechanisms involved in the causative role of scWAT in NALFD progression. We performed a RNA-sequencing analysis in a discovery cohort (n = 45) to identify genes in scWAT correlated with fatty liver index, a qualitative marker of liver steatosis. We then validated those targets in a second cohort (n = 47) of obese patients who had liver biopsies available. Finally, we obtained scWAT mesenchymal stem cells (MSCs) from 13 obese patients at different stages of NAFLD and established in vitro models of human MSC (hMSC)-derived adipocytes. We observed impaired adipogenesis in hMSC-derived adipocytes as liver steatosis increased, suggesting that an impaired adipogenic capacity is a critical event in the development of NAFLD. Four genes showed a differential expression pattern in both scWAT and hMSC-derived adipocytes, where their expression paralleled steatosis degree: SOCS3, DUSP1, SIK1, and GADD45B. We propose these genes as key players in NAFLD progression. They could eventually constitute potential new targets for future therapies against liver steatosis.	[Lopez-Yus, Marta; Lorente-Cebrian, Silvia; Del Moral-Bergos, Raquel; Pilar Garcia-Sobreviela, Maria; Arbones-Mainar, Jose M.] Univ Hosp Miguel Servet, Inst Aragones Ciencias Salud IACS, Translat Res Unit, Adipocyte & Fat Biol Lab AdipoFat, Zaragoza, Spain; [Lopez-Yus, Marta; Lorente-Cebrian, Silvia; Del Moral-Bergos, Raquel; Horndler, Carlos; Pilar Garcia-Sobreviela, Maria; Casamayor, Carmen; Sanz-Paris, Alejandro; Bernal-Monterde, Vanesa; Arbones-Mainar, Jose M.] Inst Invest Sanitaria IIS Aragon, Zaragoza, Spain; [Lorente-Cebrian, Silvia] Univ Zaragoza, Dept Farmacol Fisiol & Med Legal & Forense, Zaragoza, Spain; [Lorente-Cebrian, Silvia] Univ Zaragoza, CITA, Inst Agroalimentario Aragon IA2, Zaragoza, Spain; [Horndler, Carlos] Miguel Servet Univ Hosp, Pathol Dept, Zaragoza, Spain; [Casamayor, Carmen] Miguel Servet Univ Hosp, Gen & Digest Surg Dept, Endocrine Bariatr & Breast Surg Unit, Zaragoza, Spain; [Sanz-Paris, Alejandro] Miguel Servet Univ Hosp, Nutr Dept, Zaragoza, Spain; [Bernal-Monterde, Vanesa] Miguel Servet Univ Hosp, Gastroenterol Dept, Zaragoza, Spain; [Arbones-Mainar, Jose M.] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBERObn, Madrid, Spain	Miguel Servet University Hospital; University of Zaragoza; University of Zaragoza; Miguel Servet University Hospital; Miguel Servet University Hospital; Miguel Servet University Hospital; Miguel Servet University Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III	Arbones-Mainar, JM (corresponding author), Hosp Univ Miguel Servet, Adipocyte & Fat Biol Lab AdipoFat, Inst Invest Sanitaria IIS, Unidad Invest Traslac,Inst Aragones Ciencias Salu, Isabel Catolica 1-3, Zaragoza 50009, Spain.	jmarbones.iacs@aragon.es	Lorente-Cebrián, Silvia/N-2578-2019; del moral, raquel/ABF-5069-2021; GARCIA-SOBREVIELA, MARIA PILAR/AHD-2939-2022	Lorente-Cebrián, Silvia/0000-0002-1033-6152; del moral, raquel/0000-0002-0914-5578; Lopez Yus, Marta/0000-0002-5822-9823; GARCIA-SOBREVIELA, MARIA PILAR/0000-0001-5485-8983; Bernal-Monterde, Vanesa/0000-0002-4016-2165; Arbones-Mainar, Jose M/0000-0002-8982-3737; Sanz Paris, Alejandro/0000-0002-7758-3588	Instituto de Salud Carlos III [PI17/02268]; FEDER founds: "Una manera de hacer Europa"; regional government of Aragon [B03_20R]; FEDER Aragon	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); FEDER founds: "Una manera de hacer Europa"; regional government of Aragon(Gobierno de Aragon); FEDER Aragon	This study was sponsored by a grant (PI17/02268) from the Instituto de Salud Carlos III and by FEDER founds: "Una manera de hacer Europa" and by the regional government of Aragon (B03_20R), co-financed with the FEDER Aragon 2014-2020: "Construyendo Europa desde Aragon".	Azzu V, 2020, GASTROENTEROLOGY, V158, P1899, DOI 10.1053/j.gastro.2019.12.054; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Choe SS, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00030; Fedchuk L, 2014, ALIMENT PHARM THER, V40, P1209, DOI 10.1111/apt.12963; Ferguson BS, 2016, J CELL PHYSIOL, V231, P1562, DOI 10.1002/jcp.25248; Fuhrmeister J, 2016, EMBO MOL MED, V8, P654, DOI 10.15252/emmm.201505801; Garin-Shkolnik T, 2014, DIABETES, V63, P900, DOI 10.2337/db13-0436; Guiu B, 2012, EUR RADIOL, V22, P855, DOI 10.1007/s00330-011-2326-9; Hammarstedt A, 2018, PHYSIOL REV, V98, P1911, DOI 10.1152/physrev.00034.2017; Ipsen DH, 2018, CELL MOL LIFE SCI, V75, P3313, DOI 10.1007/s00018-018-2860-6; Kahl S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094059; Kanuri G, 2013, INT J MOL SCI, V14, P11963, DOI 10.3390/ijms140611963; Khadir A, 2015, AM J PHYSIOL-ENDOC M, V308, pE71, DOI 10.1152/ajpendo.00577.2013; Kim H, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9010050; Kitazawa A, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0257352; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Large V, 2004, DIABETES METAB, V30, P294, DOI 10.1016/S1262-3636(07)70121-0; Lawan A, 2015, MOL CELL BIOL, V35, P26, DOI 10.1128/MCB.00503-14; Louwen F, 2018, OBES REV, V19, P888, DOI 10.1111/obr.12679; Mastrangelo A, 2016, BIOCHEM J, V473, P2187, DOI 10.1042/BCJ20160241; McQuaid SE, 2011, DIABETES, V60, P47, DOI 10.2337/db10-0867; Mossel DM., 2020, FRONT IMMUNOL, V11, P1; Nixon M, 2016, MOL METAB, V5, P34, DOI 10.1016/j.molmet.2015.10.004; Ogata H, 2006, ONCOGENE, V25, P2520, DOI 10.1038/sj.onc.1209281; Oliva-Olivera W, 2017, J CLIN ENDOCR METAB, V102, P478, DOI 10.1210/jc.2016-2256; Onate B, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-625; Perez LM, 2016, OBESITY, V24, P661, DOI 10.1002/oby.21405; Perez LM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123397; Perez-Diaz S, 2017, AM J PHYSIOL-CELL PH, V312, pC83, DOI 10.1152/ajpcell.00246.2016; Piepoli MF, 2016, EUR HEART J, V37, P2315, DOI 10.1093/eurheartj/ehw106; Qureshi K, 2007, WORLD J GASTROENTERO, V13, P3540, DOI 10.3748/wjg.v13.i26.3540; RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069; Sachithanandan N, 2010, HEPATOLOGY, V52, P1632, DOI 10.1002/hep.23861; Serena C, 2016, STEM CELLS, V34, P2559, DOI 10.1002/stem.2429; Shi H, 2006, DIABETES, V55, P699, DOI 10.2337/diabetes.55.03.06.db05-0841; Shi H, 2004, J BIOL CHEM, V279, P34733, DOI 10.1074/jbc.M403886200; Silva KR, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0029-x; Stefan N, 2008, ENDOCR REV, V29, P939, DOI 10.1210/er.2008-0009; Torres-Perez E, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0203-6; Virtue S, 2010, BBA-MOL CELL BIOL L, V1801, P338, DOI 10.1016/j.bbalip.2009.12.006; Yoon YS, 2009, J BIOL CHEM, V284, P10446, DOI 10.1074/jbc.M900096200; Younossi Z, 2018, NAT REV GASTRO HEPAT, V15, P11, DOI 10.1038/nrgastro.2017.109	43	1	1	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2022	36	8							e22429	10.1096/fj.202200118RR	http://dx.doi.org/10.1096/fj.202200118RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2R5UR	35792898	Green Submitted			2022-12-26	WOS:000821177600001
J	Maouche, N; Kishore, B; Bhatti, Z; Basu, S; Karim, F; Sundararaman, S; Collings, F; Tseu, B; Leary, H; Ryman, N; Reddy, U; Vallance, GD; Kothari, J; Ramasamy, K				Maouche, Nadjoua; Kishore, Bhuvan; Bhatti, Zara; Basu, Supratik; Karim, Farheen; Sundararaman, Sharadha; Collings, Freya; Tseu, Bing; Leary, Heather; Ryman, Noel; Reddy, Udaya; Vallance, Grant D.; Kothari, Jaimal; Ramasamy, Karthik			Panobinostat in combination with bortezomib and dexamethasone in multiply relapsed and refractory myeloma; UK routine care cohort	PLOS ONE			English	Article							PLUS BORTEZOMIB; OUTCOMES; PROGRESSION; SURVIVAL; SAFETY; LBH589; RISK	The combination of panobinostat, bortezomib and dexamethasone (PanBorDex) is available as a treatment option for relapsed refractory multiple myeloma (RRMM) based on the PANORAMA-1 trial which investigated this triplet in early relapse. In routine clinical care, PanBorDex is used primarily in later relapses and is commonly administered in attenuated dosing schedules to mitigate the treatment-related toxicity. We set out to evaluate efficacy and safety outcomes with PanBorDex later in the disease course and evaluate the role of attenuated dosing schedules. This was a retrospective evaluation of patients treated in routine clinical practice between 2016-2019 across seven heamatology centres in the UK; patients who received at least one dose of PanBorDex were eligible for inclusion. The dosing schedule of panobinostat (10mg, 15mg or 20mg, twice or three times a week) and bortezomib (0.7mg/m(2), 1mg/m(2) or 1.3mg/m(2) once or twice weekly) was as per treating physician choice. Patients received treatment until disease progression or unacceptable toxicity. The primary outcome is response rates according to IMWG criteria. Key secondary endpoints include progression-free survival (PFS) and overall survival (OS). Other secondary endpoints include rates of adverse events according to CTCAE criteria. In total, 61 patients were eligible for inclusion and received PanBorDex primarily as >= 5th line of treatment. One third of patients received PanBorDex at full dose, for the remaining two thirds, treatment was given in reduced dose intensities. The overall response rate was 44.2%, including 14.7% very good partial response (VGPR) rates; 68.8% of patients derived clinical benefit with stable disease or better. The median PFS was 3.4 months; non-refractory patients and those who achieved VGPR benefited from prolonged PFS of 11.4 months and 17.7 months, respectively. The median OS was 9.5 months. The triplet was associated with 45% and 18% incidence of grade 3-4 thrombocytopenia and diarrhea, respectively.	[Maouche, Nadjoua; Vallance, Grant D.; Kothari, Jaimal; Ramasamy, Karthik] Oxford Univ Hosp NHS Fdn Trust, Dept Haematol, Oxford, England; [Kishore, Bhuvan; Bhatti, Zara] Univ Hosp Birmingham NHS Fdn Trust, Dept Haematol, Birmingham, W Midlands, England; [Basu, Supratik; Karim, Farheen; Sundararaman, Sharadha] Royal Wolverhampton NHS Trust, Dept Haematol, Wolverhampton, England; [Collings, Freya] Great Western Hosp NHS Fdn Trust, Dept Haematol, Swindon, Wilts, England; [Tseu, Bing] Buckinghamshire Healthcare NHS Trust, Dept Haematol, Amersham, Bucks, England; [Leary, Heather] Milton Keynes Univ Hosp NHS Fdn Trust, Dept Haematol, Milton Keynes, Bucks, England; [Ryman, Noel; Reddy, Udaya] Hampshire Hosp NHS Fdn Trust, Dept Haematol, Basingstoke, Hants, England	Oxford University Hospitals NHS Foundation Trust; University of Birmingham	Maouche, N (corresponding author), Oxford Univ Hosp NHS Fdn Trust, Dept Haematol, Oxford, England.	nadjoua.maouche@ouh.nhs.uk		Basu, Supratik/0000-0003-2206-4796; Maouche, Nadjoua/0000-0001-6870-1127; Ramasamy, Karthik/0000-0003-3385-3707				Atadja P, 2009, CANCER LETT, V280, P233, DOI 10.1016/j.canlet.2009.02.019; Bird S, 2020, BRIT J HAEMATOL, V191, P927, DOI 10.1111/bjh.17076; Cavenagh JD, 2018, CL LYMPH MYELOM LEUK, V18, P501, DOI 10.1016/j.clml.2018.05.007; Chim CS, 2018, LEUKEMIA, V32, P252, DOI 10.1038/leu.2017.329; Dimopoulos MA, 2021, ANN ONCOL, V32, P309, DOI 10.1016/j.annonc.2020.11.014; Durer C, 2020, BLOOD REV, V39, DOI 10.1016/j.blre.2019.100616; Gandhi UH, 2019, LEUKEMIA, V33, P2266, DOI 10.1038/s41375-019-0435-7; Hansen VL, 2018, CL LYMPH MYELOM LEUK, V18, P400, DOI 10.1016/j.clml.2018.03.002; Health NI of Institute NCI, COMMON TERMINOLOGY C; Hideshima T, 2011, MOL CANCER THER, V10, P2034, DOI 10.1158/1535-7163.MCT-11-0433; Hulin C, 2019, HEALTH SCI REP-US, V2, DOI 10.1002/hsr2.104; Jordan K, 2014, SUPPORT CARE CANCER, V22, P417, DOI 10.1007/s00520-013-1991-4; Keats JJ, 2012, BLOOD, V120, P1067, DOI 10.1182/blood-2012-01-405985; Kumar SK, 2012, LEUKEMIA, V26, P149, DOI 10.1038/leu.2011.196; Lamanuzzi A, 2021, AM J PATHOL, V191, P748, DOI 10.1016/j.ajpath.2020.12.016; Laubach JP, 2021, LANCET ONCOL, V22, P142, DOI 10.1016/S1470-2045(20)30680-X; Moreau P, 2019, BLOOD CANCER J, V9, DOI 10.1038/s41408-019-0200-1; Moreau P, 2011, LANCET ONCOL, V12, P431, DOI 10.1016/S1470-2045(11)70081-X; Ocio EM, 2010, HAEMATOL-HEMATOL J, V95, P794, DOI 10.3324/haematol.2009.015495; Palumbo A, 2015, BLOOD, V125, P2068, DOI 10.1182/blood-2014-12-615187; Rajkumar SV, 2011, BLOOD, V117, P4691, DOI 10.1182/blood-2010-10-299487; Ramasamy K, 2021, BLOOD REV, V49, DOI 10.1016/j.blre.2021.100808; Richardson PG, 2018, BLOOD CANCER J, V8, DOI 10.1038/s41408-018-0141-0; Richardson PG, 2016, BLOOD, V127, P713, DOI 10.1182/blood-2015-09-665018; Richardson PG, 2013, BLOOD, V122, P2331, DOI 10.1182/blood-2013-01-481325; San-Miguel JF, 2017, BRIT J HAEMATOL, V179, P66, DOI 10.1111/bjh.14821; Sonneveld P, 2016, HAEMATOLOGICA, V101, P995, DOI 10.3324/haematol.2016.148882; Sonneveld P, 2016, BLOOD, V127, P2955, DOI 10.1182/blood-2016-01-631200; Yong K, 2016, BRIT J HAEMATOL, V175, P252, DOI 10.1111/bjh.14213	29	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2022	17	7							e0270854	10.1371/journal.pone.0270854	http://dx.doi.org/10.1371/journal.pone.0270854			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4D5OE	35797277	Green Published, gold			2022-12-26	WOS:000847189000001
J	Ham, Y; Bae, S; Lee, H; Ha, Y; Choi, H; Park, JHF; Park, HYF; Hong, IF				Ham, Yeajin; Bae, Suyeong; Lee, Heerim; Ha, Yaena; Choi, Heesu; Park, Ji-Hyuk F.; Park, Hae Yean F.; Hong, Ickpyo F.			Item-level psychometrics of the Ascertain Dementia Eight-Item Informant Questionnaire	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; QUALITY-OF-LIFE; VALIDITY; AD8; ASSOCIATIONS; RELIABILITY; CRITERIA; DECLINE; MEMORY; TOOLS	The aim of this study is to evaluate the item-level psychometrics of the Ascertain Dementia Eight-Item Informant Questionnaire (AD-8) by examining its dimensionality, rating scale integrity, item fit statistics, item difficulty hierarchy, item-person match, and precision. We used confirmatory factor analysis and the Rasch rating scale model for analyzing the data extracted from the proxy versions of the 2019 and 2020 National Health and Aging Trends Study, USA. A total of 403 participants were included in the analysis. The confirmatory factor analysis with a 1-factor model using the robust weighted least squares (WLSMV) estimator indicated a unidimensional measurement structure (chi(2) = 41.015, df = 20, p = 0.004; root mean square error of approximation = 0.051; comparative fit index = 0.995; Tucker-Lewis Index = 0.993;). The findings indicated that the AD-8 has no misfitting items and no differential item functioning across sex and gender. The items were evenly distributed in the item difficulty rating (range: -2.30 to 0.98 logits). While there were floor effects, the AD-8 revealed good reliability (Rasch person reliability = 0.67, Cronbach's alpha = 0.89). The Rasch analysis reveals that the AD-8 has excellent psychometric properties that can be used as a screening assessment tool in clinical settings allowing clinicians to measure dementia both quickly and efficiently. To summarize, the AD-8 could be a useful primary screening tool to be used with additional diagnostic testing, if the patient is accompanied by a reliable informant.	[Ham, Yeajin; Bae, Suyeong; Lee, Heerim; Ha, Yaena; Choi, Heesu] Yonsei Univ, Grad Sch, Dept Occupat Therapy, Wonju, Gangwon, South Korea; [Park, Ji-Hyuk F.; Park, Hae Yean F.; Hong, Ickpyo F.] Yonsei Univ, Coll Software & Digital Healthcare Convergence, Dept Occupat Therapy, Wonju, Gangwon, South Korea	Yonsei University; Yonsei University	Hong, IF (corresponding author), Yonsei Univ, Coll Software & Digital Healthcare Convergence, Dept Occupat Therapy, Wonju, Gangwon, South Korea.	ihong@yonsei.ac.kr	ham, yeajin/HGD-1625-2022; Ham, Yeajin/HGD-1943-2022	Hong, Ickpyo/0000-0001-5404-7646; Ham, Yeajin/0000-0001-8745-7318	Ministry of Education of Republic of Korea; National Research Foundation of Korea [NRF-2021S1A3A2A02096338]; Institute of Convergence Science (ICONS) at Yonsei University	Ministry of Education of Republic of Korea(Ministry of Education (MOE), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea); Institute of Convergence Science (ICONS) at Yonsei University	This work was supported by the Ministry of Education of the Republic of Korea and the National Research Foundation of Korea (NRF-2021S1A3A2A02096338) and the Institute of Convergence Science (ICONS) at Yonsei University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd Razak MA, 2019, PUBLIC HEALTH, V169, P84, DOI 10.1016/j.puhe.2019.01.001; [Anonymous], 2019, DIV POP HLTH; [Anonymous], 2020, AGING HLTH 2020; Baghaei P., 2007, RASCH MEAS T, V21, P1105; Bevan S, 2013, SOC SCI RES, V42, P1750, DOI 10.1016/j.ssresearch.2013.08.003; Bond T.G., 2013, APPL RASCH MODEL FUN, DOI [10.4324/9781410614575, DOI 10.4324/9781410614575]; Brown T.A., 2015, CONFIRMATORY FACTOR, V2nd ed., DOI DOI 10.5860/CHOICE.44-2769; Chan QL, 2016, J ALZHEIMERS DIS, V49, P121, DOI 10.3233/JAD-150390; Christensen H, 2001, PSYCHOL AGING, V16, P588, DOI 10.1037//0882-7974.16.4.588; Denny A, 2021, GERIATR NURS, V42, P262, DOI 10.1016/j.gerinurse.2020.08.009; Dong YH, 2013, J ALZHEIMERS DIS, V35, P159, DOI 10.3233/JAD-122026; Donizzetti AR, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16081329; Fieo R, 2018, J GERONTOL A-BIOL, V73, P1695, DOI 10.1093/gerona/glx235; Fisher Jr W, 2007, RASCH MEAS, P6; Galvin JE, 2007, ARCH NEUROL-CHICAGO, V64, P718, DOI 10.1001/archneur.64.5.718; Galvin JE, 2006, NEUROLOGY, V67, P1942, DOI 10.1212/01.wnl.0000247042.15547.eb; Gulledge Caleb M, 2019, JB JS Open Access, V4, DOI 10.2106/JBJS.OA.19.00015; Hemmy LS, 2020, ANN INTERN MED, V172, P678, DOI 10.7326/M19-3889; Hendry K, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011121.pub2; Hobart JC, 2007, LANCET NEUROL, V6, P1094, DOI 10.1016/S1474-4422(07)70290-9; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hughes TF, 2010, AM J ALZHEIMERS DIS, V25, P432, DOI 10.1177/1533317510368399; Kasper J.D., 2021, NATL HLTH AGING TREN; Kasper JD, 2020, NATL HLTH AGING TREN; Koopmans AB, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00303; Linacre J., 1994, RASCH MEASUREMENT T, V7, P328; Linacre J. M., 1993, USERS GUIDE BIGSTEPS; Linacre John M, 2002, J Appl Meas, V3, P85; LINDENBERGER U, 1994, PSYCHOL AGING, V9, P339, DOI 10.1037/0882-7974.9.3.339; Ling Ling, 2020, Nihon Koshu Eisei Zasshi, V67, P800, DOI 10.11236/jph.67.11_800; Livingston G, 2017, LANCET, V390, P2673, DOI 10.1016/S0140-6736(17)31363-6; Low A, 2020, INT PSYCHOGERIATR, V32, P141, DOI 10.1017/S1041610219000504; Morris GM, 2020, ALZ DIS ASSOC DIS, V34, P112, DOI 10.1097/WAD.0000000000000362; Nakata E, 2009, NEUROEPIDEMIOLOGY, V33, P103, DOI 10.1159/000222092; Rand S, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-017-0682-0; Rasmussen J, 2019, DEGENER NEUROL NEURO, V9, P123, DOI 10.2147/DNND.S228939; Reeve BB, 2007, MED CARE, V45, pS22, DOI 10.1097/01.mlr.0000250483.85507.04; Resnick B, 2022, J AM MED DIR ASSOC, V23, P1236, DOI 10.1016/j.jamda.2021.11.016; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Shaik MA, 2016, INT PSYCHOGERIATR, V28, P443, DOI 10.1017/S1041610215001702; Sun M, 2018, INT J GERIATR PSYCH, V33, pE280, DOI 10.1002/gps.4788; Tchkonia T, 2018, JAMA-J AM MED ASSOC, V320, P1319, DOI 10.1001/jama.2018.12440; Tennant A., 2007, RASCH MEAS T, V20, P1082; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Thacker EL, 2013, NEUROLOGY, V81, P119, DOI 10.1212/WNL.0b013e31829a33d1; Tiel Chan, 2019, Dement. neuropsychol., V13, P293, DOI 10.1590/1980-57642018dn13-030005; Usarel C, 2019, INT PSYCHOGERIATR, V31, P223, DOI 10.1017/S1041610218000674; Verlinden VJA, 2016, ALZHEIMERS DEMENT, V12, P144, DOI 10.1016/j.jalz.2015.08.001; Wyse Adam E, 2013, J Appl Meas, V14, P118; Zieky M, 1993, PRACTICAL QUESTIONS	50	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7								10.1371/journal.pone.0270204	http://dx.doi.org/10.1371/journal.pone.0270204			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M5FN	35789335	gold, Green Published			2022-12-26	WOS:000835487000001
J	Whittall, J; Orkin, A; Handford, C; Klaiman, M; Leece, P; Charles, MJ; Wright, A; Turner, SM; Morrison, L; Strike, C; Campbell, D				Whittall, Jonathan; Orkin, Aaron; Handford, Curtis; Klaiman, Michelle; Leece, Pamela; Charles, Mercy J.; Wright, Amy; Turner, Suzanne M.; Morrison, Laurie; Strike, Carol; Campbell, Douglas			Resuscitation simulation among people who are likely to witness opioid overdose: Experiences from the SOONER Trial	PLOS ONE			English	Article							NALOXONE; CARE	The opioid crisis is a growing public health emergency and increasing resources are being directed towards overdose education. Simulation has emerged as a novel strategy for training overdose response, yet little is known about training non-clinicians in bystander resuscitation. Understanding the perspectives of individuals who are likely to experience or witness opioid overdose is critical to ensure that emergency response is effective. The Surviving Opioid Overdose with Naloxone Education and Resuscitation (SOONER) study evaluates the effectiveness of a novel naloxone education and distribution tool among people who are non-clinicians and likely to witness opioid overdose. Participants' resuscitation skills are evaluated using a realistic overdose simulation as the primary outcome of the trial. The purpose of our study is to describe the experience of participants with the simulation process in the SOONER study. We employed a semi-structured debriefing interview and a follow up qualitative interview to understand the experience of participants with simulation. A qualitative content analysis was performed using data from 21 participants who participated in the SOONER study. Our qualitative analysis identified 5 themes and 17 subthemes which described the experience of participants within the simulation process. These themes included realism, valuing practical experience, improving self-efficacy, gaining new perspective and bidirectional learning. Our analysis found that simulation was a positive and empowering experience for participants in the SOONER trial, most of whom are marginalized in society. Our study supports the notion that expanding simulation-based education to non-clinicians may offer an acceptable and effective way of supplementing current opioid overdose education strategies. Increasing the accessibility of simulation-based education may represent a paradigm shift whereby simulation is transformed from a primarily academic practice into a patient-based community resource.	[Whittall, Jonathan; Orkin, Aaron; Handford, Curtis] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada; [Orkin, Aaron] Inner City Hlth Associates, Toronto, ON, Canada; [Orkin, Aaron] St Josephs Hlth Ctr, Dept Emergency Med, Unity Hlth Toronto, Toronto, ON, Canada; [Klaiman, Michelle] St Michaels Hosp, Dept Emergency Med, Unity Hlth, Toronto, ON, Canada; [Leece, Pamela; Wright, Amy] Publ Hlth Ontario, Toronto, ON, Canada; [Charles, Mercy J.; Campbell, Douglas] St Michaels Hosp, Li Ka Shing Knowledge Inst, Appl Hlth Res Ctr AHRC, Unity Hlth, Toronto, ON, Canada; [Wright, Amy] St Michaels Hosp, Canada SOONER Project Community Advisory Comm, Unity Hlth, Toronto, ON, Canada; [Turner, Suzanne M.] McMaster Univ, Dept Family Med, Hamilton, ON, Canada; [Morrison, Laurie] St Michaels Hosp, Li Ka Shing Knowledge Inst, Rescu, Toronto, ON, Canada; [Strike, Carol] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Campbell, Douglas] Univ Toronto, Dept Paediat, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Saint Joseph's Health Centre, Toronto; Western University (University of Western Ontario); University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; McMaster University; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto	Campbell, D (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Appl Hlth Res Ctr AHRC, Unity Hlth, Toronto, ON, Canada.; Campbell, D (corresponding author), Univ Toronto, Dept Paediat, Toronto, ON, Canada.	Douglas.Campbell@unityhealth.to	Orkin, Aaron/K-2500-2014	Orkin, Aaron/0000-0002-1111-8720				Abelsson A, 2018, AUSTRALAS J PARAMEDI, V15, P594; Adamson K, 2015, NURS EDUC PERSPECT, V36, P281, DOI 10.5480/15-1655; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Canadian Institute for Health Information (CA), 2018, OP REL HARMS CAN; Edwards F., PREVENTATIVE MED REP, V20; Eppich W, 2015, SIMUL HEALTHC, V10, P106, DOI 10.1097/SIH.0000000000000072; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Fernandez-Mendez F, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/9837508; Franko TS, 2019, J AM PHARM ASSOC, V59, P375, DOI 10.1016/j.japh.2018.12.022; Friedrich MJ, 2002, JAMA-J AM MED ASSOC, V288, P2808, DOI 10.1001/jama.288.22.2808; Gaba D. M., 2001, Simulation & Gaming, V32, P175, DOI 10.1177/104687810103200206; Goldberg SA, 2018, PREHOSP EMERG CARE, V22, P788, DOI 10.1080/10903127.2018.1461284; Goldshtein D, 2020, BMJ SIMUL TECHNOL EN, V6, P3, DOI 10.1136/bmjstel-2018-000387; Kneebone Roger L, 2016, Adv Simul (Lond), V1, P27, DOI 10.1186/s41077-016-0028-8; Kobayashi L, 2017, SIMUL HEALTHC, V12, P22, DOI 10.1097/SIH.0000000000000182; Kreek MJ, 2011, ANN NY ACAD SCI, V1231, P65, DOI 10.1111/j.1749-6632.2011.06152.x; Massoth C, 2019, BMC MED EDUC, V19, DOI 10.1186/s12909-019-1464-7; Nimbalkar Archana, 2015, BMC Res Notes, V8, P636, DOI 10.1186/s13104-015-1623-9; Orkin A, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029436; Orkin AM, 2021, RESUSC PLUS, V6, DOI 10.1016/j.resplu.2021.100131; Ornato JP, 2020, AM J EMERG MED, V38, P1787, DOI 10.1016/j.ajem.2020.05.103; Petrosoniak Andrew, 2018, Adv Simul (Lond), V3, P8, DOI 10.1186/s41077-018-0067-4; Petrosoniak A, 2017, EMERG MED AUSTRALAS, V29, P83, DOI 10.1111/1742-6723.12705; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Sahu Sandeep, 2010, J Emerg Trauma Shock, V3, P378, DOI 10.4103/0974-2700.70758; Schneider KE, 2021, INT J DRUG POLICY, V92, DOI 10.1016/j.drugpo.2020.102859; Smink DS, 2017, JAMA SURG, V152, P825, DOI 10.1001/jamasurg.2017.1086; Wakeman SE, 2017, J GEN INTERN MED, V32, P17, DOI 10.1007/s11606-016-3799-7; Wen LS, 2020, LANCET, V396, P1316, DOI 10.1016/S0140-6736(20)32113-9; Wenger E., 1998, SYSTEMS THINKER, V9, P2	30	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7								10.1371/journal.pone.0270829	http://dx.doi.org/10.1371/journal.pone.0270829			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M5FN	35789220	gold, Green Published			2022-12-26	WOS:000835487000013
J	Dalui, S; Dasgupta, A; Adhikari, S; Das, C; Roy, S				Dalui, Sambit; Dasgupta, Anirban; Adhikari, Swagata; Das, Chandrima; Roy, Siddhartha			Human testis-specific Y-encoded protein-like protein 5 is a histone H3/H4-specific chaperone that facilitates histone deposition in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOSOME ASSEMBLY PROTEIN-1; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; DNA METHYLATION; CORE PARTICLE; CHROMATIN; BINDING; VPS75; H3-H4; NAP1	DNA and core histones are hierarchically packaged into a complex organization called chromatin. The nucleosome assembly protein (NAP) family of histone chaperones is involved in the deposition of histone complexes H2A/H2B and H3/H4 onto DNA and prevents nonspecific aggregation of histones. Testis-specific Y-encoded protein (TSPY)-like protein 5 (TSPYL5) is a member of the TSPY-like protein family, which has been previously reported to interact with ubiquitin-specific protease USP7 and regulate cell proliferation and is thus implicated in various cancers, but its interaction with chromatin has not been investigated. In this study, we characterized the chromatin association of TSPYL5 and found that it preferentially binds histone H3/H4 via its C-terminal NAP-like domain both in vitro and ex vivo. We identified the critical residues involved in the TSPYL5-H3/H4 interaction and further quantified the binding affinity of TSPYL5 toward H3/H4 using biolayer interferometry. We then determined the binding stoichiometry of the TSPYL5-H3/H4 complex in vitro using a chemical cross-linking assay and size-exclusion chromatography coupled with multiangle laser light scattering. Our results indicate that a TSPYL5 dimer binds to either two histone H3/H4 dimers or a single tetramer. We further demonstrated that TSPYL5 has a specific affinity toward longer DNA fragments and that the same histone-binding residues are also critically involved in its DNA binding. Finally, employing histone deposition and supercoiling assays, we confirmed that TSPYL5 is a histone chaperone responsible for histone H3/H4 deposition and nucleosome assembly. We conclude that TSPYL5 is likely a new member of the NAP histone chaperone family.	[Dalui, Sambit; Dasgupta, Anirban; Roy, Siddhartha] CSIR, Indian Inst Chem Biol, Struct Biol & Bioinformat Div, Kolkata, India; [Adhikari, Swagata; Das, Chandrima] Saha Inst Nucl Phys, Biophys & Struct Genom Div, Kolkata, India; [Adhikari, Swagata; Das, Chandrima] Homi Bhaba Natl Inst, Mumbai, Maharashtra, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Saha Institute of Nuclear Physics; Homi Bhabha National Institute	Roy, S (corresponding author), CSIR, Indian Inst Chem Biol, Struct Biol & Bioinformat Div, Kolkata, India.	roysiddhartha@iicb.res.in		DALUI, SAMBIT/0000-0002-1534-3415	Department of Science and Technology-Science and Engineering Research Board [EMR/2016/006233]; Council of Scientific and Industrial Research grant [MLP-139]; Swarna Jayanti Fellowship (Department of Science and Technology [SJF/LSA-02/2017-18]; Council of Scientific and Industrial Research-Senior Research Fellowship; University Grants Commission-Senior Research Fellowship	Department of Science and Technology-Science and Engineering Research Board; Council of Scientific and Industrial Research grant; Swarna Jayanti Fellowship (Department of Science and Technology; Council of Scientific and Industrial Research-Senior Research Fellowship(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission-Senior Research Fellowship	This work was supported by research grants received from Department of Science and Technology-Science and Engineering Research Board (grant no.: EMR/2016/006233) and Council of Scientific and Industrial Research grant (grant no.: MLP-139) to S. R. and Swarna Jayanti Fellowship (Department of Science and Technology (grant no.: SJF/LSA-02/2017-18); to C. D.). S. D. and A. D. are supported by Council of Scientific and Industrial Research-Senior Research Fellowship and University Grants Commission-Senior Research Fellowship, respectively.	Abdiche Y, 2008, ANAL BIOCHEM, V377, P209, DOI 10.1016/j.ab.2008.03.035; Aguilar-Gurrieri C, 2016, EMBO J, V35, P1465, DOI 10.15252/embj.201694105; Allis CD, 2016, NAT REV GENET, V17, P487, DOI 10.1038/nrg.2016.59; Andrews AJ, 2008, J BIOL CHEM, V283, P32412, DOI 10.1074/jbc.M805918200; Andrews AJ, 2010, MOL CELL, V37, P834, DOI 10.1016/j.molcel.2010.01.037; Baek M, 2021, SCIENCE, V373, P871, DOI 10.1126/science.abj8754; Bellelli R, 2018, MOL CELL, V72, P112, DOI 10.1016/j.molcel.2018.08.043; Berndsen CE, 2008, NAT STRUCT MOL BIOL, V15, P948, DOI 10.1038/nsmb.1459; Bowman A, 2014, NUCLEIC ACIDS RES, V42, P6038, DOI 10.1093/nar/gku232; Bowman A, 2011, MOL CELL, V41, P398, DOI 10.1016/j.molcel.2011.01.025; Cervoni N, 2002, J BIOL CHEM, V277, P25026, DOI 10.1074/jbc.M202256200; Chen SD, 2015, GENE DEV, V29, P1326, DOI 10.1101/gad.261115.115; Daganzo SM, 2003, CURR BIOL, V13, P2148, DOI 10.1016/S0960-9822(03)00869-8; Das C, 2010, TRENDS BIOCHEM SCI, V35, P476, DOI 10.1016/j.tibs.2010.04.001; Dutta S, 2001, MOL CELL, V8, P841, DOI 10.1016/S1097-2765(01)00354-9; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; English CM, 2005, BIOCHEMISTRY-US, V44, P13673, DOI 10.1021/bi051333h; Episkopou H, 2019, MOL CELL, V75, P469, DOI 10.1016/j.molcel.2019.05.027; Epping MT, 2011, NAT CELL BIOL, V13, P102, DOI 10.1038/ncb2142; Fan ZS, 2003, CELL, V112, P659, DOI 10.1016/S0092-8674(03)00150-8; FUJIINAKATA T, 1992, J BIOL CHEM, V267, P20980; GERMOND JE, 1975, P NATL ACAD SCI USA, V72, P1843, DOI 10.1073/pnas.72.5.1843; Gurard-Levin ZA, 2014, ANNU REV BIOCHEM, V83, P487, DOI 10.1146/annurev-biochem-060713-035536; Hammond CM, 2017, NAT REV MOL CELL BIO, V18, P141, DOI 10.1038/nrm.2016.159; Hammond CM, 2016, NUCLEIC ACIDS RES, V44, P6157, DOI 10.1093/nar/gkw209; Huang C, 2020, ONCOL REP, V44, P449, DOI 10.3892/or.2020.7639; Huang HD, 2015, NAT STRUCT MOL BIOL, V22, P618, DOI 10.1038/nsmb.3055; Jamai A, 2009, MOL CELL, V35, P377, DOI 10.1016/j.molcel.2009.07.001; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Jung Y, 2008, LAB INVEST, V88, P153, DOI 10.1038/labinvest.3700706; Kim EJ, 2010, BIOCHEM BIOPH RES CO, V392, P448, DOI 10.1016/j.bbrc.2010.01.045; Kim TY, 2006, CANCER RES, V66, P7490, DOI 10.1158/0008-5472.CAN-05-4552; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lai WKM, 2017, NAT REV MOL CELL BIO, V18, P548, DOI 10.1038/nrm.2017.47; Liu YW, 2010, J BIOL CHEM, V285, P4251, DOI 10.1074/jbc.M109.055996; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MATSUMOTO K, 1993, J BIOL CHEM, V268, P10582; Mattiroli F, 2017, ELIFE, V6, DOI 10.7554/eLife.22799; Mattiroli F, 2015, EMBO REP, V16, P1454, DOI 10.15252/embr.201540840; McBryant SJ, 2003, J BIOL CHEM, V278, P44574, DOI 10.1074/jbc.M305636200; Mosammaparast N, 2002, EMBO J, V21, P6527, DOI 10.1093/emboj/cdf647; Mosammaparast N, 2001, J CELL BIOL, V153, P251, DOI 10.1083/jcb.153.2.251; Mousson F, 2005, P NATL ACAD SCI USA, V102, P5975, DOI 10.1073/pnas.0500149102; Muto S, 2007, P NATL ACAD SCI USA, V104, P4285, DOI 10.1073/pnas.0603762104; Nicetto D, 2019, SCIENCE, V363, P294, DOI 10.1126/science.aau0583; Orphanides G, 1999, NATURE, V400, P284, DOI 10.1038/22350; Osakabe A, 2013, J CELL SCI, V126, P1323, DOI 10.1242/jcs.112623; Pardal AJ, 2019, ESSAYS BIOCHEM, V63, P29, DOI 10.1042/EBC20180055; Park YJ, 2006, P NATL ACAD SCI USA, V103, P1248, DOI 10.1073/pnas.0508002103; Park YJ, 2008, J MOL BIOL, V375, P1076, DOI 10.1016/j.jmb.2007.11.031; Park YJ, 2006, BIOCHEM CELL BIOL, V84, P549, DOI 10.1139/O06-088; Pchelintsev NA, 2013, CELL REP, V3, P1012, DOI 10.1016/j.celrep.2013.03.026; Qiao HM, 2018, CELL REP, V22, P2279, DOI 10.1016/j.celrep.2018.02.019; Ray-Gallet D, 2011, MOL CELL, V44, P928, DOI 10.1016/j.molcel.2011.12.006; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Sauer PV, 2017, ELIFE, V6, DOI 10.7554/eLife.23474; Selth L, 2007, J BIOL CHEM, V282, P12358, DOI 10.1074/jbc.C700012200; Shao LP, 2017, DNA CELL BIOL, V36, P1108, DOI 10.1089/dna.2017.3904; Shen Y, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0589-7; SMITH S, 1991, EMBO J, V10, P971, DOI 10.1002/j.1460-2075.1991.tb08031.x; Tang Y, 2008, P NATL ACAD SCI USA, V105, P12206, DOI 10.1073/pnas.0802393105; Tang Y, 2011, STRUCTURE, V19, P221, DOI 10.1016/j.str.2010.12.012; Toth KF, 2005, J BIOL CHEM, V280, P15690, DOI 10.1074/jbc.M413329200; Varadi M, 2022, NUCLEIC ACIDS RES, V50, pD439, DOI 10.1093/nar/gkab1061; Yadav T, 2018, SCIENCE, V361, P1332, DOI 10.1126/science.aat8950; Yamaguchi L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00136-5; Zhang ZM, 2015, CELL REP, V12, P1400, DOI 10.1016/j.celrep.2015.07.046	71	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2022	298	8							102200	10.1016/j.jbc.2022.102200	http://dx.doi.org/10.1016/j.jbc.2022.102200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3S2VB	35772497	gold, Green Published			2022-12-26	WOS:000839458000008
J	Ying, C; Jin, CM; Zeng, SY; Chao, M; Hu, X				Ying, Chang; Jin, Chengmeng; Zeng, Siying; Chao, Ming; Hu, Xun			Alkalization of cellular pH leads to cancer cell death by disrupting autophagy and mitochondrial function	ONCOGENE			English	Article							PERMEABILITY TRANSITION PORE; ACTIVATED PROTEIN-KINASE; HEPATOCELLULAR-CARCINOMA; TRANSARTERIAL CHEMOEMBOLIZATION; INHIBITION; AMPK; MODULATION; MACHINERY; APOPTOSIS; EFFICACY	We previously found that lactic acidosis in the tumor environment was permissive to cancer cell surviving under glucose deprivation and demonstrated that neutralizing lactic acidosis restored cancer cell susceptibility to glucose deprivation. We then reported that alternate infusion of bicarbonate and anticancer agent into tumors via tumor feeding artery markedly enhanced the efficacy of transarterial chemoembolization (TACE) in the local control of hepatocellular carcinoma (HCC). Here we sought to further investigate the mechanism by which bicarbonate enhances the anticancer activity of TACE. We propose that interfering cellular pH by bicarbonate could induce a cascade of molecular events leading to cancer cell death. Alkalizing cellular pH by bicarbonate decreased pH gradient (Delta pH), membrane potential (Delta psi(m)), and proton motive force (Delta p) across the inner membrane of mitochondria; disruption of oxidative phosphorylation (OXPHOS) due to collapsed Delta p led to a significant increase in adenosine monophosphate (AMP), which activated the classical AMPK-mediated autophagy. Meanwhile, the autophagic flux was ultimately blocked by increased cellular pH, reduced OXPHOS, and inhibition of lysosomal proton pump in alkalized lysosome. Bicarbonate also induced persistent mitochondrial permeability (MPT) and damaged mitochondria. Collectively, this study reveals that interfering cellular pH may provide a valuable approach to treat cancer.	[Ying, Chang; Jin, Chengmeng; Zeng, Siying; Hu, Xun] Zhejiang Univ, Affiliated Hosp 2, Canc Inst,Key Lab Canc Intervent & Prevent, Sch Med,China Natl Minist Educ,Zhejiang Prov Key, Hangzhou, Peoples R China; [Chao, Ming] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Intervent Radiol,Dept Radiol, Hangzhou, Peoples R China	Zhejiang University; Zhejiang University	Hu, X (corresponding author), Zhejiang Univ, Affiliated Hosp 2, Canc Inst,Key Lab Canc Intervent & Prevent, Sch Med,China Natl Minist Educ,Zhejiang Prov Key, Hangzhou, Peoples R China.; Chao, M (corresponding author), Zhejiang Univ, Affiliated Hosp 2, Sch Med, Intervent Radiol,Dept Radiol, Hangzhou, Peoples R China.	chaoming@zju.edu.cn; huxun@zju.edu.cn	Zeng, Siying/HDO-3064-2022		China Natural Sciences Foundation [82073038, 81772947]; Zhejiang Provincial Department of Sciences and Technologies [2018C03009]; Fundamental Research Funds for the Central Universities [2017XZZX001-01, 2019FZJD009]; National Ministry of Education, China	China Natural Sciences Foundation(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Department of Sciences and Technologies; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Ministry of Education, China(Ministry of Education, China)	This work has been supported in part by China Natural Sciences Foundation projects (82073038, 81772947 to XH), a key project (2018C03009) funded by Zhejiang Provincial Department of Sciences and Technologies (to XH & MC), and the Fundamental Research Funds for the Central Universities (2017XZZX001-01, 2019FZJD009, to XH), National Ministry of Education, China. We thank Dr. Guo-Hua Fong (University of Connecticut School of Medicine, USA) for critical readings of our manuscript and constructive comments, Dr. Wei Liu (Zhejiang University) for the kind gift of plasmids GFP-LC3, Cherry-GFP-LC3, and Dr. Shanrong Cai for the statistical assistance (Zhejiang University).	Ahmad F, 2019, J LIPID RES, V60, P98, DOI 10.1194/jlr.M088245; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Bartel K, 2019, J BIOL CHEM, V294, P17239, DOI 10.1074/jbc.RA119.010243; BERNARDI P, 1992, J BIOL CHEM, V267, P2934; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Bruix J, 2002, HEPATOLOGY, V35, P519, DOI 10.1053/jhep.2002.32089; Caricato R, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00319; Chao M, 2016, ELIFE, V5, DOI [10.7754/eLife.15691, 10.7554/eLife.15691]; Chen JC, 2019, J BIOL CHEM, V294, P11994, DOI 10.1074/jbc.RA118.007161; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; de Vasconcelos NM, 2019, CELL DEATH DIFFER, V26, P146, DOI 10.1038/s41418-018-0106-7; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, 2019, J Hepatol, V70, P817, DOI 10.1016/j.jhep.2019.01.020; Gong YN, 2017, CELL, V169, P286, DOI 10.1016/j.cell.2017.03.020; Goodall ML, 2016, DEV CELL, V37, P337, DOI 10.1016/j.devcel.2016.04.018; Gowans GJ, 2013, CELL METAB, V18, P556, DOI 10.1016/j.cmet.2013.08.019; Hawley SA, 2016, DIABETES, V65, P2784, DOI 10.2337/db16-0058; Hu X, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2016.47; Ibrahim-Hashim A, 2012, J UROLOGY, V188, P624, DOI 10.1016/j.juro.2012.03.113; Jansen MC, 2005, EJSO-EUR J SURG ONC, V31, P331, DOI 10.1016/j.ejso.2004.10.011; Jin CM, 2020, J BIOL CHEM, V295, P6425, DOI 10.1074/jbc.RA119.012312; Ju JS, 2010, AUTOPHAGY, V6, P929, DOI 10.4161/auto.6.7.12785; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kloditz K, 2019, CELL DEATH DISCOV, V5, DOI 10.1038/s41420-019-0146-x; Lencioni R, 2016, HEPATOLOGY, V64, P106, DOI 10.1002/hep.28453; Liu B, 2014, AUTOPHAGY, V10, P416, DOI 10.4161/auto.27286; Liu J, 2020, CELL CHEM BIOL, V27, P420, DOI 10.1016/j.chembiol.2020.02.005; Liu YE, 2020, MEDCOMM, V1, P129, DOI 10.1002/mco2.16; Llovet JM, 2002, LANCET, V359, P1734, DOI 10.1016/S0140-6736(02)08649-X; Malhi H, 2006, HEPATOLOGY, V43, pS31, DOI 10.1002/hep.21062; Martin NK, 2012, BRIT J CANCER, V106, P1280, DOI 10.1038/bjc.2012.58; Martin NK, 2011, MATH BIOSCI, V230, P1, DOI 10.1016/j.mbs.2010.12.002; Mauvezin C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8007; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Oakhill JS, 2011, SCIENCE, V332, P1433, DOI 10.1126/science.1200094; Pasquier A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11170-4; Perera R, 2015, NATURE, V524, P361, DOI 10.1038/nature14587; Perry SW, 2011, BIOTECHNIQUES, V50, P98, DOI 10.2144/000113610; Piscaglia F, 2018, LIVER CANCER, V7, P104, DOI 10.1159/000485471; Piscaglia F, 2010, DIGEST LIVER DIS, V42, pS258, DOI 10.1016/S1590-8658(10)60514-2; Poburko D, 2011, J BIOL CHEM, V286, P11672, DOI 10.1074/jbc.M110.159962; Raoul JL, 2011, CANCER TREAT REV, V37, P212, DOI 10.1016/j.ctrv.2010.07.006; Rasola A, 2010, P NATL ACAD SCI USA, V107, P726, DOI 10.1073/pnas.0912742107; Russo M, 2018, BIOCHEM PHARMACOL, V153, P51, DOI 10.1016/j.bcp.2018.02.007; Shlomovitz I, 2019, CELL COMMUN SIGNAL, V17, DOI 10.1186/s12964-019-0437-0; Tsujimoto Y, 2007, APOPTOSIS, V12, P835, DOI 10.1007/s10495-006-0525-7; Vaseva AV, 2012, CELL, V149, P1536, DOI 10.1016/j.cell.2012.05.014; Wu H, 2012, J PATHOL, V227, P189, DOI 10.1002/path.3978; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; Xie JS, 2014, SCI REP-UK, V4, DOI 10.1038/srep04927; Yang KX, 2016, NANOMEDICINE-UK, V11, DOI 10.2217/nnm-2016-0289; Yoshii SR, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091865; Yue W, 2013, AUTOPHAGY, V9, P714, DOI 10.4161/auto.23997; Zargarian S, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002711; Zois CE, 2009, AUTOPHAGY, V5, P442, DOI 10.4161/auto.5.4.7667	58	0	0	7	7	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 29	2022	41	31					3886	3897		10.1038/s41388-022-02396-6	http://dx.doi.org/10.1038/s41388-022-02396-6		JUL 2022	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	3I9OZ	35780182				2022-12-26	WOS:000819907600001
J	Bai, X; Gan, XN; Yang, RQ; Zhang, CL; Luo, XQ; Luo, CQ; Chen, SL				Bai, Xue; Gan, Xiuni; Yang, Ruiqi; Zhang, Chuanlai; Luo, Xiaoqin; Luo, Chengqin; Chen, Senlin			Construction of a competency evaluation index system for front-line nurses during the outbreak of major infectious diseases: A Delphi study	PLOS ONE			English	Article								Introductio As the frequency of infectious diseases rises, it's more important than ever to pay attention to the competency level of front-line nurses as the primary force in front-line rescue, which has an impact on the quality of anti-epidemic response. This paper aims to construct the competency evaluation index system for front-line nurses during the outbreak of major infectious diseases. Materials and methods This study combined literature review, critical incident technique interviews, and semi-structured in-depth interviews, as well as two rounds of Delphi expert correspondence, to construct a competence evaluation index system for front-line nurses during the outbreak of major infectious diseases. The study used purposive sampling to select 26 experts from 11 provinces and cities across China to conduct two rounds of Delphi expert consultation, and the indicators were selected based on the mean importance score > 3.5 and the coefficient of variation < 0.25, and the weights of the indicators were calculated by the Analytic Hierarchy Process. The effective recovery rates of the two rounds of correspondence questionnaires were 93.1% and 96%. Results The effective recovery rates of the two rounds of correspondence questionnaires were 93.1% and 96%, the authority coefficients of experts were 0.96 and 0.98, the Kendall's coordination coefficients of the first, second, and third level indexes were 0.281, 0.132, and 0.285 (P < 0.001), 0.259, 0.158, and 0.415 (P < 0.001). The final index system includes 4 primary indicators (Knowledge System of Infectious Diseases, Nursing Skills for Infectious Diseases, Related Professional Abilities for Infectious Diseases, and Comprehensive Quality), 10 secondary indicators, and 64 tertiary indicators. Conclusion The competency evaluation index system of front-line nurses during the outbreak of major infectious diseases is scientific, reasonable, and practical, which can provide a scientific basis for nursing managers to accurately understand, describe, analyze, and evaluate the competence level of nursing staff and scientifically implement the allocation of human resources in the future, as well as serve as a content framework for subsequent training programs.	[Bai, Xue; Gan, Xiuni] Chongqing Med Univ, Hosp 2, Dept Nursing, Chongqing, Peoples R China; [Yang, Ruiqi; Zhang, Chuanlai] Chongqing Med Univ, Hosp 2, Dept Intens Care Unit, Chongqing, Peoples R China; [Luo, Xiaoqin] Chongqing Med Univ, Hosp 2, Dept Resp Med, Chongqing, Peoples R China; [Luo, Chengqin] Chongqing Med Univ, Hosp 2, Dept Emergency Med, Chongqing, Peoples R China; [Chen, Senlin] Chongqing Med Univ, Hosp 1, Dept Endocrinol & Breast Surg, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Gan, XN (corresponding author), Chongqing Med Univ, Hosp 2, Dept Nursing, Chongqing, Peoples R China.	ganxn@163.com			Chongqing Science and Health Joint Medical Research Project [2020FYYX011]; Chinese Nursing Association's 2020 Annual Project on Scientific Research [ZHKY202004]	Chongqing Science and Health Joint Medical Research Project; Chinese Nursing Association's 2020 Annual Project on Scientific Research	This work was supported by Chongqing Science and Health Joint Medical Research Project (2020FYYX011) and The Chinese Nursing Association's 2020 Annual Project on Scientific Research (ZHKY202004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablah Elizabeth, 2013, Am J Disaster Med, V8, P49, DOI 10.5055/ajdm.2013.0110; Belton I, 2019, TECHNOL FORECAST SOC, V147, P72, DOI 10.1016/j.techfore.2019.07.002; Bian H., 2021, CHINESE J PRACTICAL, V37, P2122, DOI [10.3760/cma.j.cn211501-20201025-04297, DOI 10.3760/CMA.J.CN211501-20201025-04297]; Black M, 2018, WORK, V60, P539, DOI 10.3233/WOR-182761; Campos-Luna I, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45810-y; Chang AM, 2010, J ADV NURS, V66, P2320, DOI 10.1111/j.1365-2648.2010.05367.x; Diamond IR, 2014, J CLIN EPIDEMIOL, V67, P401, DOI 10.1016/j.jclinepi.2013.12.002; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; Fang XE, 2020, ANN PALLIAT MED, V9, P3304, DOI 10.21037/apm-20-1454; Fernandez CSP, 2006, J PUBLIC HEALTH MAN, V12, P590; Garcia AG, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093173; [韩琳 Han Lin], 2020, [中华护理杂志, Chinese Journal of Nursing], V55, P355; [阚庭 Kan Ting], 2018, [中华护理杂志, Chinese Journal of Nursing], V53, P461; [李红 Li Hong], 2021, [护理学杂志, Journal of Nursing Science], V36, P58; [林音 Lin Yin], 2021, [中华护理杂志, Chinese Journal of Nursing], V56, P1158; Liu Y, 2021, J PROF NURS, V37, P501, DOI 10.1016/j.profnurs.2021.01.011; [马瑞珩 Ma Ruiheng], 2021, [中华护理教育, Chinese Journal of Nursing Education], V18, P485; [满国静 Man Guojing], 2013, [护理学杂志, Journal of Nursing Science], V28, P42; Murphy GT, 2013, HEALTH POLICY PLANN, V28, P739, DOI 10.1093/heapol/czs115; [乔文玲 Qiao Wenling], 2014, [中国护理管理, Chinese Nursing Management], V14, P696; Sher L, 2020, QJM-INT J MED, V113, P707, DOI 10.1093/qjmed/hcaa202; Spencer LM., 1993, COMPETENCE WORK MODE, P222; Wang M, 2015, THESIS JILIN U; Wu C, 2021, BMC INFECT DIS, V21, DOI 10.1186/s12879-021-06402-2; Xu S, 2018, THESIS JINZHOU MED U; Zhang J, 2013, THESIS 2 MILITARY ME; Zhang XN, 2020, NURS CRIT CARE, V25, P45, DOI 10.1111/nicc.12467; Zheng Y., 2020, CHINESE J NURSING, V55, P98; [钟淑馨 Zhong Shuxin], 2020, [中国护理管理, Chinese Nursing Management], V20, P226	29	0	0	8	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2022	17	7							e0270902	10.1371/journal.pone.0270902	http://dx.doi.org/10.1371/journal.pone.0270902			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6E4KA	35776753	Green Published, gold			2022-12-26	WOS:000883348200006
J	Klich, S; Kosendiak, A; Krymski, I; Kawczynski, A; Madeleine, P; Fernandez-de-las-Penas, C				Klich, Sebastian; Kosendiak, Aureliusz; Krymski, Igor; Kawczynski, Adam; Madeleine, Pascal; Fernandez-de-las-Penas, Cesar			Ultrasound imaging of patellar tendon thickness in elite sprint track cyclists and elite soccer players: An intra-rater and inter-rater reliability study	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; PAIN SENSITIVITY; MUSCLE; ULTRASONOGRAPHY; AGREEMENT; ACHILLES; HYPERTROPHY; SONOGRAPHY; MORPHOLOGY; ACCURACY	The goal of our study was to investigate the relative and absolute intra-rater and inter-rater reliability of ultrasound assessment of patellar tendon (PT) thickness assessed over four locations, in track cyclists and soccer players. Fifteen male elite track cyclists and 15 male elite soccer players participated. Tendon thickness was measured over 4 locations placed at 5-10-15-20 mm inferior to the apex of the patella by two experienced examiners. Each examiner took two US images for the test measurements with a 10-min rest period. After a 30-min period, the subjects underwent a retest measurements that were also repeated 1-week after. A two-way analysis of variance revealed a significant group x location interaction on PT thickness for Examiner 1 (p = .001, eta(2) = .81) and Examiner 2 (p = 0.001, eta(2) = 0.78). Intra-rater reliability ranged from good to excellent (ICC2,k >= 0.75), whereas inter-rater reliability was good (ICC2,k >= 0.75) in both groups. Ultrasonographic assessment of PT was found to be a reliable method to assess tendon thickness. The middle location of the PT (corresponding to 15 and 20 mm) can be considered the most reliable spot to measure PT thickness. The PT thickness was larger among track cyclists than soccer players, with larger differences over the distal location (15 mm). Ultrasonographic assessment of PT was found to be a reliable method to assess tendon thickness. The middle location of the PT corresponding to 15 mm and 20 mm can be considered the most reliable area to measure PT thickness.	[Klich, Sebastian; Kawczynski, Adam] Wroclaw Univ Hlth & Sport Sci, Dept Paralymp Sport, Wroclaw, Poland; [Kosendiak, Aureliusz] Wroclaw Med Univ, Study Phys Educ & Sport, Wroclaw, Poland; [Krymski, Igor] Polish Cycling Federat, Pruszkow, Poland; [Madeleine, Pascal] Aalborg Univ, Dept Hlth Sci & Technol, Sport Sci Performance & Technol, Aalborg, Denmark; [Fernandez-de-las-Penas, Cesar] Univ Rey Juan Carlos, Dept Phys Therapy Occupat Therapy Rehabil & Phys M, Madrid, Spain; [Fernandez-de-las-Penas, Cesar] Univ Rey Juan Carlos, Catedra Inst Docencia Clin & Invest Fisioterapia T, Madrid, Spain	Wroclaw Medical University; Aalborg University; Universidad Rey Juan Carlos; Universidad Rey Juan Carlos	Klich, S (corresponding author), Wroclaw Univ Hlth & Sport Sci, Dept Paralymp Sport, Wroclaw, Poland.	sebastian.klich@awf.wroc.pl	Kawczynski, Adam/AAK-3031-2021; Klich, Sebastian/AAM-7805-2021	Kawczynski, Adam/0000-0001-7840-3799; Klich, Sebastian/0000-0002-8182-2975				Althunyan AK, 2017, J FAM COMMUNITY MED, V24, P23, DOI 10.4103/2230-8229.197178; Arifin W.N., 2022, SAMPLE SIZE CALCULAT; Basso O, 2002, CLIN ORTHOP RELAT R, P246; Beggs I., 2016, MUSCULOSKELETAL ULTR; Binderup AT, 2010, EUR J PAIN, V14, P705, DOI 10.1016/j.ejpain.2009.11.001; Black J, 2004, J ULTRAS MED, V23, P671, DOI 10.7863/jum.2004.23.5.671; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Castro J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219057; Couppe C, 2009, J APPL PHYSIOL, V107, P880, DOI 10.1152/japplphysiol.00291.2009; Ekizos A, 2013, J ELECTROMYOGR KINES, V23, P1278, DOI 10.1016/j.jelekin.2013.08.004; del Bano-Aledo ME, 2017, MLTJ-MUSCLE LIGAMENT, V7, P192, DOI 10.11138/mltj/2017.7.1.192; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fredberg U, 2008, ULTRASCHALL MED, V29, P60, DOI 10.1055/s-2007-963027; Fredberg U, 2002, AM J SPORT MED, V30, P488, DOI 10.1177/03635465020300040701; Gellhorn AC, 2013, ULTRASOUND MED BIOL, V39, P791, DOI 10.1016/j.ultrasmedbio.2012.12.001; Holm PM, 2019, J BODYW MOV THER, V23, P344, DOI 10.1016/j.jbmt.2019.02.004; Kartus J, 2000, KNEE SURG SPORT TR A, V8, P275, DOI 10.1007/s001670000132; Klich S., 2020, CENTRAL EUR J SPORT, V29, P5, DOI 10.18276/cej.2020.1-01; Klich S, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.607208; Klich S, 2018, PHYS THER SPORT, V32, P42, DOI 10.1016/j.ptsp.2018.04.022; Kongsgaard M, 2007, ACTA PHYSIOL, V191, P111, DOI 10.1111/j.1748-1716.2007.01714.x; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Koppenhaver SL, 2009, J ORTHOP SPORT PHYS, V39, P604, DOI 10.2519/jospt.2009.3088; Kositsky A, 2020, ULTRASOUND MED BIOL, V46, P55, DOI 10.1016/j.ultrasmedbio.2019.09.013; Kottner J, 2011, INT J NURS STUD, V48, P661, DOI 10.1016/j.ijnurstu.2011.01.016; Kulig K, 2013, SCAND J MED SCI SPOR, V23, pe81, DOI 10.1111/sms.12021; Kulig K, 2014, MED PROBL PERFORM AR, V29, P221, DOI 10.21091/mppa.2014.4044; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Madeleine P, 2014, J ORTHOP SPORT PHYS, V44, P587, DOI 10.2519/jospt.2014.5117; O'Brien TD, 2010, J BIOMECH, V43, P1190, DOI 10.1016/j.jbiomech.2009.11.028; O'Connor PJ, 2004, EUR RADIOL, V14, P1968, DOI 10.1007/s00330-004-2448-4; Peers KHE, 2005, SPORTS MED, V35, P71, DOI 10.2165/00007256-200535010-00006; Penailillo L, 2015, MED SCI SPORT EXER, V47, P708, DOI 10.1249/MSS.0000000000000473; Roberts CS, 1999, ARTHROSCOPY, V15, P388, DOI 10.1016/S0749-8063(99)70056-3; Ronnestad BR, 2012, J STRENGTH COND RES, V26, P158, DOI 10.1519/JSC.0b013e318218dd94; Seynnes OR, 2009, J APPL PHYSIOL, V107, P523, DOI 10.1152/japplphysiol.00213.2009; Skou ST, 2013, CLIN IMAG, V37, P934, DOI 10.1016/j.clinimag.2013.01.007; Swamy GN, 2012, ACTA ORTHOP BELG, V78, P764; Toprak U, 2012, DIAGN INTERV RADIOL, V18, P200, DOI 10.4261/1305-3825.DIR.4339-11.2; Visnes H, 2015, SCAND J MED SCI SPOR, V25, P205, DOI 10.1111/sms.12191; Wallwork TL, 2007, J ORTHOP SPORT PHYS, V37, P608, DOI 10.2519/jospt.2007.2418; Warden SJ, 2007, AM J SPORT MED, V35, P427, DOI 10.1177/0363546506294858; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Zhang ZJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108337	44	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7								10.1371/journal.pone.0270871	http://dx.doi.org/10.1371/journal.pone.0270871			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M5FN	35789336	Green Published, gold			2022-12-26	WOS:000835487000019
J	Lebedev, TD; Khabusheva, ER; Mareeva, SR; Ivanenko, KA; Morozov, AV; Spirin, PV; Rubtsov, PM; Snezhkina, AV; Kudryavtseva, AV; Sorokin, MI; Buzdin, AA; Prassolov, VS				Lebedev, Timofey D.; Khabusheva, Elmira R.; Mareeva, Sofia R.; Ivanenko, Karina A.; Morozov, Alexey V.; Spirin, Pavel V.; Rubtsov, Petr M.; Snezhkina, Anastasiya V.; Kudryavtseva, Anna V.; Sorokin, Maxim I.; Buzdin, Anton A.; Prassolov, Vladimir S.			Identification of cell type-specific correlations between ERK activity and cell viability upon treatment with ERK1/2 inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEK INHIBITION; PHASE-I; CANCER; BRAF; MUTATIONS; PATHWAY; RAF; SENSITIVITY; ACTIVATION; DISCOVERY	Increased MAPK signaling is a hallmark of various cancers and is a central regulator of cell survival. Direct ERK1/2 inhibition is considered a promising approach to avoid ERK1/2 reactivation caused by upstream kinases BRAF, MEK1/2, and KRAS, as well as by receptor tyrosine kinase inhibitors, but the dynamics and selectivity of ERK1/2 inhibitors are much less studied compared with BRAF or MEK inhibitors. Using ERK1/2 and downstream kinase ELK1 reporter cell lines of lung cancer (H1299; NRAS(Q61K)), colon cancer (HCT-116; KRAS(G13D)), neuroblastoma (SH-SY5Y), and leukemia (U937), we examined the relationship between ERK inhibition and drug-induced toxicity for five ERK inhibitors: SCH772984, ravoxertinib, LY3214996, ulixertinib, and VX-11e, as well as one MEK inhibitor, PD0325901. Comparing cell viability and ERK inhibition revealed different ERK dependencies for these cell lines. We identify several drugs, such as SCH772984 and VX-11e, which induce excessive toxicity not directly related to ERK1/2 inhibition in specific cell lines. We also show that PD0325901, LY3214996, and ulixertinib are prone to ERK1/2 reactivation over time. We distinguished two types of ERK1/2 reactivation: the first could be reversed by adding a fresh dose of inhibitors, while the second persists even after additional treatments. We also showed that cells that became resistant to the MEK1/2 inhibitor PD0325901 due to ERK1/2 reactivation remained sensitive to ERK1/2 inhibitor ulixertinib. Our data indicate that correlation of ERK inhibition with drug-induced toxicity in multiple cell lines may help to find more selective and effective ERK1/2 inhibitors.	[Lebedev, Timofey D.; Khabusheva, Elmira R.; Mareeva, Sofia R.; Ivanenko, Karina A.; Morozov, Alexey V.; Spirin, Pavel V.; Rubtsov, Petr M.; Snezhkina, Anastasiya V.; Kudryavtseva, Anna V.; Prassolov, Vladimir S.] Russian Acad Sci, Engelhardt Inst Mol Biol, Dept Canc Cell Biol, Moscow, Russia; [Lebedev, Timofey D.; Khabusheva, Elmira R.; Spirin, Pavel V.; Kudryavtseva, Anna V.; Prassolov, Vladimir S.] Russian Acad Sci, Engelhardt Inst Mol Biol, Ctr Precis Genome Editing & Genet Technol Biomed, Moscow, Russia; [Mareeva, Sofia R.; Buzdin, Anton A.] Natl Res Univ, Moscow Inst Phys & Technol, Dolgoprudnyi, Moscow, Russia; [Sorokin, Maxim I.; Buzdin, Anton A.] Sechenov First Moscow State Med Univ, Inst Personalized Oncol, Moscow, Russia; [Sorokin, Maxim I.; Buzdin, Anton A.] Shemyakin Ovchinnikov Inst Bioorgan Chem, Grp Genom Regulat Cell Signaling Syst, Moscow, Russia; [Sorokin, Maxim I.; Buzdin, Anton A.] OmicsWay Corp, Dept Bioinformat & Mol Networks, Walnut, CA USA	Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Moscow Institute of Physics & Technology; Sechenov First Moscow State Medical University; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Lebedev, TD (corresponding author), Russian Acad Sci, Engelhardt Inst Mol Biol, Dept Canc Cell Biol, Moscow, Russia.; Lebedev, TD (corresponding author), Russian Acad Sci, Engelhardt Inst Mol Biol, Ctr Precis Genome Editing & Genet Technol Biomed, Moscow, Russia.	lebedevtd@gmail.com	Morozov, Alexey/G-2480-2014	Morozov, Alexey/0000-0003-4310-8073; Ivanenko, Karina/0000-0001-8496-3338	Ministry of Science and Higher Education of the Russian Federation [075-15-2019-1660]; center	Ministry of Science and Higher Education of the Russian Federation; center	Acknowledgments-We thank Boris Fehse and Kristoffer Riecken (University Medical Center Hamburg-Eppendorf, Hamburg, Germany) for providing LeGO packaging vectors and Carol Stocking and Thomas Dobner (Heinrich-Pette Institute for Experimental Virology, Hamburg, Germany) for providing cell lines. Creation and analysis of reporter cell lines and analysis of mutational and transcriptomic features were supported by grant 075-15-2019-1660 from the Ministry of Science and Higher Education of the Russian Federation. Part of this work (library preparations and whole-transcriptome sequencing) was performed using the equipment of EIMB RAS ?Genome? center (http:// www.eimb.ru/rus/ckp/ccu_genome_c.php) .	Abdel-Wahab O, 2014, CANCER DISCOV, V4, P538, DOI 10.1158/2159-8290.CD-13-1038; Aikin TJ, 2020, ELIFE, V9, DOI 10.7554/eLife.60541; Alves S, 2015, ONCOTARGET, V6, P30787, DOI 10.18632/oncotarget.5021; Aronov AM, 2009, J MED CHEM, V52, P6362, DOI 10.1021/jm900630q; Barbosa R, 2021, MOL CANCER RES, V19, P361, DOI 10.1158/1541-7786.MCR-20-0687; Bhagwat SV, 2020, MOL CANCER THER, V19, P325, DOI 10.1158/1535-7163.MCT-19-0183; Blum Y, 2019, MOL SYST BIOL, V15, DOI 10.15252/msb.20198947; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boston SR, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-7; Callahan MK, 2012, NEW ENGL J MED, V367, P2316, DOI 10.1056/NEJMoa1208958; Chaikuad A, 2014, NAT CHEM BIOL, V10, P853, DOI [10.1038/NCHEMBIO.1629, 10.1038/nchembio.1629]; Crowe MS, 2021, MOL CANCER RES, V19, P1063, DOI 10.1158/1541-7786.MCR-20-1022; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Diehl JN, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.101335; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dry JR, 2010, CANCER RES, V70, P2264, DOI 10.1158/0008-5472.CAN-09-1577; Duncan JS, 2012, CELL, V149, P307, DOI 10.1016/j.cell.2012.02.053; Eleveld TF, 2018, CANCER RES, V78, P6297, DOI 10.1158/0008-5472.CAN-18-1045; Gagliardi M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65250-3; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Germann UA, 2017, MOL CANCER THER, V16, P2351, DOI 10.1158/1535-7163.MCT-17-0456; Gerosa L, 2020, CELL SYST, V11, P478, DOI 10.1016/j.cels.2020.10.002; Goedhart J, 2021, MOL BIOL CELL, V32, P470, DOI 10.1091/mbc.E20-09-0583; Goedhart J, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000581; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Haura EB, 2010, CLIN CANCER RES, V16, P2450, DOI 10.1158/1078-0432.CCR-09-1920; Hobbs GA, 2016, J CELL SCI, V129, P1287, DOI 10.1242/jcs.182873; Jang IS, 2014, BIOCOMPUT-PAC SYM, P63; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Kuchenov D, 2016, CELL CHEM BIOL, V23, P1550, DOI 10.1016/j.chembiol.2016.11.008; Larkin J, 2014, NEW ENGL J MED, V371, P1867, DOI 10.1056/NEJMoa1408868; Lebedev T, 2021, ONCOGENE, V40, P6258, DOI 10.1038/s41388-021-02018-7; Lebraud H, 2018, CHEM SCI, V9, P8608, DOI 10.1039/c8sc02754d; Li BT, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.2508; Lito P, 2014, CANCER CELL, V25, P697, DOI 10.1016/j.ccr.2014.03.011; Liu FF, 2018, ACTA PHARM SIN B, V8, P552, DOI 10.1016/j.apsb.2018.01.008; Long GV, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6694; Lord SJ, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.202001064; Morris EJ, 2013, CANCER DISCOV, V3, P742, DOI 10.1158/2159-8290.CD-13-0070; Nickols NG, 2019, PROSTATE CANCER P D, V22, P531, DOI 10.1038/s41391-019-0134-5; Nissim L, 2017, CELL, V171, P1138, DOI 10.1016/j.cell.2017.09.049; Ohashi K, 2013, CLIN CANCER RES, V19, P2584, DOI 10.1158/1078-0432.CCR-12-3173; Ojesina AI, 2014, NATURE, V506, P371, DOI 10.1038/nature12881; Planchard D, 2016, LANCET ONCOL, V17, P984, DOI 10.1016/S1470-2045(16)30146-2; Prior IA, 2020, CANCER RES, V80, P2969, DOI 10.1158/0008-5472.CAN-19-3682; Regot S, 2014, CELL, V157, P1724, DOI 10.1016/j.cell.2014.04.039; Rudolph J, 2015, BIOCHEMISTRY-US, V54, P22, DOI 10.1021/bi501101v; Samatar AA, 2014, NAT REV DRUG DISCOV, V13, P928, DOI 10.1038/nrd4281; Sanchez-Vega F, 2018, CELL, V173, P321, DOI 10.1016/j.cell.2018.03.035; Shin M, 2018, CHEM SCI, V9, P2419, DOI 10.1039/c8sc00043c; Spirin P, 2017, ONCOTARGET, V8, P56991, DOI 10.18632/oncotarget.18503; Sullivan RJ, 2018, CANCER DISCOV, V8, P184, DOI 10.1158/2159-8290.CD-17-1119; Tanaka N, 2021, CANCER DISCOV, V11, P1913, DOI 10.1158/2159-8290.CD-21-0365; Vagapova E, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9121846; Vagapova ER, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-90701-w; Varga A, 2020, CLIN CANCER RES, V26, P1229, DOI 10.1158/1078-0432.CCR-19-2574; Wagle MC, 2018, NPJ PRECIS ONCOL, V2, DOI 10.1038/s41698-018-0051-4; Yaeger R, 2019, CANCER DISCOV, V9, P329, DOI 10.1158/2159-8290.CD-18-1321; Yang WJ, 2013, NUCLEIC ACIDS RES, V41, pD955, DOI 10.1093/nar/gks1111	59	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2022	298	8							102226	10.1016/j.jbc.2022.102226	http://dx.doi.org/10.1016/j.jbc.2022.102226			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	4F0HN	35787369	gold, Green Published			2022-12-26	WOS:000848197700004
J	Leech, JT; Brennan, A; Don, NA; Mason, JM; Kad, NM				Leech, James T.; Brennan, Andrew; Don, Nicola A.; Mason, Jody M.; Kad, Neil M.			In vitro single molecule and bulk phase studies reveal the AP-1 transcription factor cFos binds to DNA without its partner cJun br	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-FOS; JUN; PROLIFERATION; DIMERIZATION; ACTIVATION; PROTEINS; STRESS	The AP-1 transcription factor family crucially regulates progression of the cell cycle, as well as playing roles in proliferation, differentiation, and the stress response. The two best described AP-1 family members, cFos and cJun, are known to dimerize to form a functional AP-1 heterodimer that binds to a consensus response element sequence. Although cJun can also homodimerize and bind to DNA, the canonical view is that cFos cannot bind DNA without heterodimerizing with cJun. Here, we show that cFos can actually bind to DNA in the absence of cJun in vitro. Using dual color single molecule imaging of cFos alone, we directly visualize binding to and movement on DNA. Of all these DNA-bound proteins, detailed analysis suggested 30 to 46% were homodimers. Furthermore, we constructed fluores-cent protein fusions of cFos and cJun for Forster resonance energy transfer experiments. These constructs indicated complete dimerization of cJun, but although cFos could dimerize, its extent was reduced. Finally, to provide orthogonal confirmation of cFos binding to DNA, we performed bulk-phase circular dichroism experiments that showed clear structural changes in DNA; these were found to be specific to the AP-1 consensus sequence. Taken together, our results clearly show cFos can interact with DNA both as monomers and dimers independently of its archetypal partner, cJun.	[Leech, James T.; Don, Nicola A.; Kad, Neil M.] Univ Kent, Sch Biosci, Canterbury, England; [Brennan, Andrew; Mason, Jody M.] Univ Bath, Dept Biol & Biochem, Bath, England	University of Kent; University of Bath	Kad, NM (corresponding author), Univ Kent, Sch Biosci, Canterbury, England.; Mason, JM (corresponding author), Univ Bath, Dept Biol & Biochem, Bath, England.	n.kad@kent.ac.uk; j.mason@bath.ac.uk	; Mason, Jody/A-9329-2011	Brennan, Andrew/0000-0001-8239-4311; Kad, Neil/0000-0002-3491-8595; Mason, Jody/0000-0002-4118-1958	Biotechnology and Biological Sciences Research Council [BB/R017921/1, BB/P00847X/1, BB/R017956/1, BB/T018275/1]; Cancer Research UK [A26941]; MRC [MR/T028254/1]	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Biotechnology and Biological Sciences Research Council BB/R017921/1, BB/P00847X/1 to N. M. K. and BB/R017956/1 and BB/T018275/1 to J. M. M. J. M. M. is grateful to Cancer Research UK (A26941) and to the MRC (MR/T028254/1) .	Ashida Reiko, 2005, Inflammopharmacology, V13, P113, DOI 10.1163/156856005774423935; Bahrami Shahram, 2016, Advances in Biological Regulation, V62, P37, DOI 10.1016/j.jbior.2016.05.001; Baxter D, 2017, ACS CHEM BIOL, V12, P2051, DOI 10.1021/acschembio.7b00303; Brennan A, 2022, JACS AU, V2, P996, DOI 10.1021/jacsau.2c00105; Bustamante C, 2003, NATURE, V421, P423, DOI 10.1038/nature01405; Eckert RL, 2013, J SKIN CANCER, V2013, DOI 10.1155/2013/537028; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Fasman G.D., 1996, CIRCULAR DICHROISM C; Fricke F, 2015, SCI REP-UK, V5, DOI 10.1038/srep14072; GLOVER JNM, 1995, NATURE, V373, P257, DOI 10.1038/373257a0; Grondin B, 2007, MOL CELL BIOL, V27, P2919, DOI 10.1128/MCB.00936-06; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; HALAZONETIS TD, 1988, CELL, V55, P917, DOI 10.1016/0092-8674(88)90147-X; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; Karin M, 2001, IUBMB LIFE, V52, P17; Kohler JJ, 2001, BIOCHEMISTRY-US, V40, P130, DOI 10.1021/bi001881p; Kuno M, 2000, J CHEM PHYS, V112, P3117, DOI 10.1063/1.480896; Leaner VD, 2007, CURR CANCER THER REV, V3, P1, DOI 10.2174/157339407780126665; Liu G, 2014, SCI REP-UK, V4, DOI 10.1038/srep05543; Lv XW, 2018, VIROL J, V15, DOI 10.1186/s12985-018-1087-3; Mason JM, 2006, P NATL ACAD SCI USA, V103, P8989, DOI 10.1073/pnas.0509880103; McCullock TW, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0219886; NAKABEPPU Y, 1988, CELL, V55, P907, DOI 10.1016/0092-8674(88)90146-8; Newton MD, 2019, NAT STRUCT MOL BIOL, V26, P185, DOI 10.1038/s41594-019-0188-z; Olive M, 1997, J BIOL CHEM, V272, P18586, DOI 10.1074/jbc.272.30.18586; OSHEA EK, 1989, SCIENCE, V245, P646, DOI 10.1126/science.2503872; PATEL LR, 1994, P NATL ACAD SCI USA, V91, P7360, DOI 10.1073/pnas.91.15.7360; Rao T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059415; RAUSCHER FJ, 1988, GENE DEV, V2, P1687, DOI 10.1101/gad.2.12b.1687; RIGGS AD, 1970, J MOL BIOL, V53, P401, DOI 10.1016/0022-2836(70)90074-4; Seldeen KL, 2011, FEBS J, V278, P2090, DOI 10.1111/j.1742-4658.2011.08124.x; Seldeen KL, 2009, BIOCHEMISTRY-US, V48, P12213, DOI 10.1021/bi901392k; Seldeen KL, 2009, BIOCHEMISTRY-US, V48, P1975, DOI 10.1021/bi802068s; Shen Q, 2008, ONCOGENE, V27, P366, DOI 10.1038/sj.onc.1210643; Simons M, 2015, SCI REP-UK, V5, DOI 10.1038/srep18486; SMEAL T, 1989, GENE DEV, V3, P2091, DOI 10.1101/gad.3.12b.2091; Springall L, 2016, METHODS MOL BIOL, V1431, P141, DOI 10.1007/978-1-4939-3631-1_11; Szaloki N, 2015, MOL CELL BIOL, V35, P3785, DOI 10.1128/MCB.00346-15; Vamosi G, 2008, BIOPHYS J, V94, P2859, DOI 10.1529/biophysj.107.120766; Vleugel MM, 2006, HUM PATHOL, V37, P668, DOI 10.1016/j.humpath.2006.01.022; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; WEBSTER KA, 1994, CIRC RES, V74, P679, DOI 10.1161/01.RES.74.4.679; Zhou HM, 2005, DNA RES, V12, P139, DOI 10.1093/dnares/12.2.139	43	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2022	298	8							102229	10.1016/j.jbc.2022.102229	http://dx.doi.org/10.1016/j.jbc.2022.102229			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	4F0HN	35787376	Green Accepted, Green Published, gold			2022-12-26	WOS:000848197700003
J	Cheng, Y; Sun, FM; Thornton, K; Jing, XF; Dong, J; Yun, G; Pisano, M; Zhan, FH; Kim, SH; Katzenellenbogen, JA; Katzenellenbogen, BS; Hari, P; Janz, S				Cheng, Yan; Sun, Fumou; Thornton, Krista; Jing, Xuefang; Dong, Jing; Yun, Grant; Pisano, Michael; Zhan, Fenghuang; Kim, Sung Hoon; Katzenellenbogen, John A.; Katzenellenbogen, Benita S.; Hari, Parameswaran; Janz, Siegfried			FOXM1 regulates glycolysis and energy production in multiple myeloma	ONCOGENE			English	Article							TRANSCRIPTION FACTOR FOXM1; CONNECTIVITY MAP; PROGRESSION; PROMOTES; TARGET; PLASTICITY; HSP90; CELLS	The transcription factor, forkhead box M1 (FOXM1), has been implicated in the natural history and outcome of newly diagnosed high-risk myeloma (HRMM) and relapsed/refractory myeloma (RRMM), but the mechanism with which FOXM1 promotes the growth of neoplastic plasma cells is poorly understood. Here we show that FOXM1 is a positive regulator of myeloma metabolism that greatly impacts the bioenergetic pathways of glycolysis and oxidative phosphorylation (OxPhos). Using FOXM1-deficient myeloma cells as principal experimental model system, we find that FOXM1 increases glucose uptake, lactate output, and oxygen consumption in myeloma. We demonstrate that the novel 1,1-diarylethylene small-compound FOXM1 inhibitor, NB73, suppresses myeloma in cell culture and human-in-mouse xenografts using a mechanism that includes enhanced proteasomal FOXM1 degradation. Consistent with the FOXM1-stabilizing chaperone function of heat shock protein 90 (HSP90), the HSP90 inhibitor, geldanamycin, collaborates with NB73 in slowing down myeloma. These findings define FOXM1 as a key driver of myeloma metabolism and underscore the feasibility of targeting FOXM1 for new approaches to myeloma therapy and prevention.	[Cheng, Yan; Dong, Jing; Yun, Grant; Pisano, Michael; Hari, Parameswaran; Janz, Siegfried] Med Coll Wisconsin, Dept Med, Div Hematol & Oncol, Milwaukee, WI 53226 USA; [Thornton, Krista] Univ Iowa, Dept Pathol, Master Sci Grad Program, Iowa City, IA 52242 USA; [Jing, Xuefang] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA; [Pisano, Michael] Univ Iowa, Interdisciplinary Grad Program Immunol, Iowa City, IA USA; [Zhan, Fenghuang] Univ Arkansas Med Sci, Myeloma Ctr, Div Hematol & Oncol, Dept Med, Little Rock, AR 72205 USA; [Zhan, Fenghuang] Univ Arkansas Med Sci, Winthrop P Rockefeller Canc Inst, Little Rock, AR 72205 USA; [Kim, Sung Hoon; Katzenellenbogen, John A.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Katzenellenbogen, Benita S.] Univ Illinois, Mol & Integrat Physiol & Canc Ctr, Urbana, IL 61801 USA; [Hari, Parameswaran; Janz, Siegfried] Med Coll Wisconsin, Ctr Canc, Milwaukee, WI 53226 USA	Medical College of Wisconsin; University of Iowa; University of Iowa; University of Iowa; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Medical College of Wisconsin	Janz, S (corresponding author), Med Coll Wisconsin, Dept Med, Div Hematol & Oncol, Milwaukee, WI 53226 USA.; Janz, S (corresponding author), Med Coll Wisconsin, Ctr Canc, Milwaukee, WI 53226 USA.	sjanz@mcw.edu		Zhan, Fenghuang/0000-0001-5417-2973; Jing, Xuefang/0000-0002-8670-4505; Dong, Jing/0000-0001-9856-5963; Sun, Fumou/0000-0003-2034-3492	Breast Cancer Research Foundation [083, 084]; NCI [R01CA151354, R01CA236814]; DoD [CA180190]; Riney Family Multiple Myeloma Research Program award; MCW Milwaukee William G. Schuett, Jr., Multiple Myeloma Research Endowment; Myeloma Crowd Research Initiative award	Breast Cancer Research Foundation; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DoD(United States Department of Defense); Riney Family Multiple Myeloma Research Program award; MCW Milwaukee William G. Schuett, Jr., Multiple Myeloma Research Endowment; Myeloma Crowd Research Initiative award	We wish to acknowledge expert technical assistance from MCW Cancer Center core facility staff, especially Monika Zielonka, Redox and Bioenergetics Shared Resource (CCRBSR); Galina Petrova, Flow Cytometry Shared Resource; and Donna McAllister, Biomedical Imaging Shared Resource. This work was supported by Breast Cancer Research Foundation grants 083 (to BSK) and 084 (to JAK); by NCI R01CA236814, DoD CA180190, Myeloma Crowd Research Initiative and Riney Family Multiple Myeloma Research Program awards (to FZ); and by NCI R01CA151354 (to SJ). Additional support was provided by the MCW Milwaukee William G. Schuett, Jr., Multiple Myeloma Research Endowment.	Abdollahi P, 2021, FASEB J, V35, DOI 10.1096/fj.202001920RR; Bajpai R, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15051-z; Barger CJ, 2019, CANCERS, V11, DOI 10.3390/cancers11020251; Bergamaschi A, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0436-4; Bhat UG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005592; Black M, 2020, MOL BIOL CELL, V31, P1411, DOI 10.1091/mbc.E19-07-0413; Bloedjes TA, 2021, CANCERS, V13, DOI 10.3390/cancers13030396; Boreel DF, 2021, CLIN CANCER RES, V27, P2970, DOI 10.1158/1078-0432.CCR-20-3913; Borhani S, 2020, EXPERT OPIN THER TAR, V24, P205, DOI 10.1080/14728222.2020.1727888; Buchner M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7471; Caillot M, 2020, ONCOGENESIS, V9, DOI 10.1038/s41389-020-00253-3; Cui JJ, 2014, CLIN CANCER RES, V20, P2595, DOI 10.1158/1078-0432.CCR-13-2407; Dalva-Aydemir S, 2015, CLIN CANCER RES, V21, P1161, DOI 10.1158/1078-0432.CCR-14-1088; Deribe YL, 2018, NAT MED, V24, P1047, DOI 10.1038/s41591-018-0019-5; Dey P, 2020, CANCERS, V12, DOI 10.3390/cancers12092677; Duncan K, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.61; El Arfani C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041200; Fujiwara S, 2015, EXP HEMATOL ONCOL, V4, DOI 10.1186/s40164-015-0008-z; Gormally MV, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6165; Grenert JP, 1997, J BIOL CHEM, V272, P23843, DOI 10.1074/jbc.272.38.23843; Gu C, 2016, LEUKEMIA, V30, P873, DOI 10.1038/leu.2015.334; Gu CY, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-5015-0; Gu CY, 2018, BLOOD CANCER J, V8, DOI 10.1038/s41408-018-0060-0; Gu ZM, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0392-4; Hajek R, 2013, BRIT J HAEMATOL, V163, P551, DOI 10.1111/bjh.12563; Halasi M, 2016, J BIOL CHEM, V291, P142, DOI 10.1074/jbc.M115.678227; Hassanzadeh A, 2019, ANTI-CANCER AGENT ME, V19, P1523, DOI 10.2174/1871520619666190729150442; He YH, 2015, LEUKEMIA RES, V39, P1428, DOI 10.1016/j.leukres.2015.09.019; Hegde NS, 2011, NAT CHEM, V3, P725, DOI [10.1038/NCHEM.1114, 10.1038/nchem.1114]; Hoang PH, 2020, BLOOD CANCER J, V10, DOI 10.1038/s41408-020-0315-4; Hou Y, 2015, NAT IMMUNOL, V16, P810, DOI 10.1038/ni.3204; Jang JS, 2019, BLOOD CANCER J, V9, DOI 10.1038/s41408-018-0160-x; Kalathil D, 2021, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.626836; Koo CY, 2012, BBA-GENE REGUL MECH, V1819, P28, DOI 10.1016/j.bbagrm.2011.09.004; Lagana A, 2018, LEUKEMIA, V32, P120, DOI 10.1038/leu.2017.197; Lam WY, 2016, IMMUNITY, V45, P60, DOI 10.1016/j.immuni.2016.06.011; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lis P, 2016, MOLECULES, V21, DOI 10.3390/molecules21121730; Maiso P, 2015, CANCER RES, V75, P2071, DOI 10.1158/0008-5472.CAN-14-3400; Marlein CR, 2019, CANCER RES, V79, P2285, DOI 10.1158/0008-5472.CAN-18-0773; Misund K, 2020, LEUKEMIA, V34, P322, DOI 10.1038/s41375-019-0543-4; Mitsiades CS, 2006, BLOOD, V107, P1092, DOI 10.1182/blood-2005-03-1158; Nakano A, 2012, J BIOENERG BIOMEMBR, V44, P31, DOI 10.1007/s10863-012-9412-9; Pracht K, 2021, EUR J IMMUNOL, V51, P1089, DOI 10.1002/eji.202048993; Qin XD, 2017, SCI REP-UK, V7, DOI 10.1038/srep45305; Radhakrishnan SK, 2006, CANCER RES, V66, P9731, DOI 10.1158/0008-5472.CAN-06-1576; Ray A, 2020, ONCOGENE, V39, P2786, DOI 10.1038/s41388-020-1172-0; Ryu D, 2020, CLIN CANCER RES, V26, P935, DOI 10.1158/1078-0432.CCR-19-0694; Sanchez J, 2020, CURR CANCER DRUG TAR, V20, P253, DOI 10.2174/1568009619666191202101330; Sanchez WY, 2013, BRIT J CANCER, V108, P1624, DOI 10.1038/bjc.2013.120; Shukla S, 2019, MOL CANCER THER, V18, P1217, DOI 10.1158/1535-7163.MCT-18-0709; Subramanian A, 2017, CELL, V171, P1437, DOI 10.1016/j.cell.2017.10.049; Trasanidis N, 2022, BLOOD, V139, P1939, DOI 10.1182/blood.2021014391; Waldschmidt JM, 2021, CLIN CANCER RES, V27, P6432, DOI 10.1158/1078-0432.CCR-21-2040; Wang HS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18028-z; Wang Y, 2016, ONCOTARGET, V7, P47985, DOI 10.18632/oncotarget.10103; Xiang Y, 2020, LIFE SCI, V256, DOI 10.1016/j.lfs.2020.117971; Xu SL, 2019, CANCER RES, V79, P2748, DOI 10.1158/0008-5472.CAN-18-2799; Zhan X, 2017, ONCOTARGET, V8, P111213, DOI 10.18632/oncotarget.22740; Zhang HY, 2018, MOL ONCOL, V12, P1579, DOI 10.1002/1878-0261.12363; Zhang W, 2021, MOL ONCOL, V15, P1466, DOI 10.1002/1878-0261.12879; Ziegler Y, 2019, NPJ BREAST CANCER, V5, DOI 10.1038/s41523-019-0141-7	62	2	2	7	7	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 5	2022	41	32					3899	3911		10.1038/s41388-022-02398-4	http://dx.doi.org/10.1038/s41388-022-02398-4		JUL 2022	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	3O2GY	35794249	Green Published, hybrid			2022-12-26	WOS:000823188300001
J	Toulabi, SB; Jablonski, B; Holm, DG; Carolan, MS; Heuberger, AL				Toulabi, Sahar B.; Jablonski, Becca; Holm, David G.; Carolan, Michael S.; Heuberger, Adam L.			Grower decision-making factors in adoption of specialty cultivars: A case study of potatoes in the San Luis Valley	PLOS ONE			English	Article							IMPROVED NATURAL GRASSLAND; CATTLE FARMERS INTENTION; WILLINGNESS-TO-PAY; PLANNED BEHAVIOR; PREFERENCE HETEROGENEITY; ENVIRONMENTAL BEHAVIOR; AGRICULTURAL PRACTICES; RATIONAL-EXPECTATIONS; DAIRY FARMERS; MANAGEMENT	Potatoes are the most consumed vegetable worldwide and play an important role in the U.S. economy. Growers make critical decisions each year in choosing which cultivar to grow, based on factors such as yield, resilience to the growing environment, and utility in the food industry. Current research supports the finding that less-common specialty cultivars (SCs) have benefits for human health. However, growers have been slow to adopt SCs into mainstream operations. Here, we identify major factors in the decision-making process that determine whether a population of growers in the San Luis Valley, Colorado, a major potatogrowing region, adopt SC potatoes. We used a combination of ethnographic techniques and quantitative methods to examine drivers of adoption. The data demonstrate grower perceptions within potato farming and the complexity of interacting factors in decision-making. An integration of the Theory of Planned Behavior, Rational Expectation Hypothesis, and Diffusion of Innovation models identifies economic and social factors that influence grower decision-making. Growers that were more aware of specialty cultivar innovation and associated consumer demand were more open to SCs adoption. Other influencing factors include a grower's experience selling a SC in the previous year and access to diverse markets. Based on these data, we developed a new model to explain grower decision-making processes in adopting SCs. The model demonstrates that one current barrier to adoption is access to buyers, including warehouses, retailers, and households. Taken together, this research demonstrates how rational expectations stem from economic outcomes, knowledge, and experience in the potato industry. These results are important in helping to consider opportunities for growers to access new, higher value markets, while also improving consumer access to nutritious cultivars.	[Toulabi, Sahar B.; Holm, David G.; Heuberger, Adam L.] Colorado State Univ, Dept Hort & Landscape Architecture, Ft Collins, CO 80523 USA; [Jablonski, Becca] Colorado State Univ, Dept Agr & Resource Econ, Ft Collins, CO 80523 USA; [Carolan, Michael S.] Colorado State Univ, Dept Sociol, Ft Collins, CO 80523 USA; [Heuberger, Adam L.] Colorado State Univ, Dept Soil & Crop Sci, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University; Colorado State University; Colorado State University	Jablonski, B (corresponding author), Colorado State Univ, Dept Agr & Resource Econ, Ft Collins, CO 80523 USA.	Becca.Jablonski@colostate.edu			Colorado State University's Office of the Vice President for Research Catalyst for Innovative Partnerships Program; Foundation for Food and Agriculture Research; Colorado Potato Administrative Committee Area II; Colorado Agricultural Experiment Station	Colorado State University's Office of the Vice President for Research Catalyst for Innovative Partnerships Program; Foundation for Food and Agriculture Research; Colorado Potato Administrative Committee Area II; Colorado Agricultural Experiment Station	The research reported in this publication was supported by Colorado State University's Office of the Vice President for Research Catalyst for Innovative Partnerships Program, the Foundation for Food and Agriculture Research, the Colorado Potato Administrative Committee Area II, and the Colorado Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adedeji T. O., 2013, Journal of Development and Agricultural Economics, V5, P365; Adnan N, 2018, LAND USE POLICY, V79, P575, DOI 10.1016/j.landusepol.2018.08.033; Adrian AM, 2005, COMPUT ELECTRON AGR, V48, P256, DOI 10.1016/j.compag.2005.04.004; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Ajzen I., 1985, ACTION CONTROL, P11, DOI DOI 10.1007/978-3-642-69746-3_2; Bandura Albert, 1977, SOCIAL LEARNING THEO; Barbieri J.C., 2016, RAI REV ADMINISTRACA, V13, P116, DOI DOI 10.1016/J.RAI.2016.04.004; Bartova V., 2015, AMINO ACID COMPOSITI, V40; Bartova V, 2009, J AGR FOOD CHEM, V57, P9028, DOI 10.1021/jf900897b; Baumgart-Getz A, 2012, J ENVIRON MANAGE, V96, P17, DOI 10.1016/j.jenvman.2011.10.006; Bechtold KB, 2014, FOOD POLICY, V47, P97, DOI 10.1016/j.foodpol.2014.05.007; Blackstock KL, 2010, SCI TOTAL ENVIRON, V408, P5631, DOI 10.1016/j.scitotenv.2009.04.029; Borges JAR, 2016, LAND USE POLICY, V55, P193, DOI 10.1016/j.landusepol.2016.04.004; Borges JAR, 2016, J ENVIRON PSYCHOL, V45, P89, DOI 10.1016/j.jenvp.2015.12.001; Borges JAR, 2014, LIVEST SCI, V169, P163, DOI 10.1016/j.livsci.2014.09.014; Bradshaw J.E., 2019, QUALITY BREEDING FIE, P41, DOI DOI 10.1007/978-3-030-04609-5_3; Bruijnis M, 2013, LIVEST SCI, V155, P103, DOI 10.1016/j.livsci.2013.04.005; Burton RJF, 2004, J RURAL STUD, V20, P359, DOI 10.1016/j.jrurstud.2003.12.001; Burton RJF, 2014, J ENVIRON MANAGE, V135, P19, DOI 10.1016/j.jenvman.2013.12.005; Chaparro JM, 2018, FRONT NUTR, V5, DOI 10.3389/fnut.2018.00036; Choudhary AK, 2018, IND CROP PROD, V124, P495, DOI 10.1016/j.indcrop.2018.07.069; Cooper RG, 2008, J PROD INNOVAT MANAG, V25, P213, DOI 10.1111/j.1540-5885.2008.00296.x; Danso-Abbeam G, 2018, COGENT ECON FINANC, V5, DOI 10.1080/23322039.2017.1416896; Daxini A, 2019, LAND USE POLICY, V85, P428, DOI 10.1016/j.landusepol.2019.04.002; de Lauwere C, 2012, LIVEST SCI, V143, P151, DOI 10.1016/j.livsci.2011.09.007; de-Magistris T, 2016, NUTRIENTS, V8, DOI 10.3390/nu8120830; Deressa TT, 2009, GLOBAL ENVIRON CHANG, V19, P248, DOI 10.1016/j.gloenvcha.2009.01.002; Ebert AW, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9060736; Edwards-Jones G, 2006, ANIM SCI, V82, P783, DOI 10.1017/ASC2006112; Evans George W., 2001, LEARNING EXPECTATION; Martinez-Garcia CG, 2013, LIVEST SCI, V152, P228, DOI 10.1016/j.livsci.2012.10.007; Ghadim AKA, 2005, AGR ECON-BLACKWELL, V33, P1, DOI 10.1111/j.1574-0862.2005.00433.x; Ghimire R, 2016, J S ASIAN DEV, V11, P113, DOI 10.1177/0973174116629254; Godin B, 2014, J INNOV ECON MANAG, P11, DOI 10.3917/jie.015.0011; Herforth N., 2015, GLOBALFOOD DISCUSSIO, P5; Hill R., 2016, 28 CSR COL STAT U; Hofmann J, 2018, ERNAHRUNGS UMSCHAU, V65, pM140, DOI 10.4455/eu.2018.011; Hopkins S.A., 2003, EUR J INNOV MANAG, V6, P80, DOI DOI 10.1108/14601060310475237; Hosmer DW, 2013, WILEY SER PROBAB ST, P1, DOI 10.1002/9781118548387; Ingram J, 2008, AGR HUM VALUES, V25, P405, DOI 10.1007/s10460-008-9134-0; Inman A, 2018, LAND USE POLICY, V70, P16, DOI 10.1016/j.landusepol.2017.09.042; Jongeneel RA, 2008, LAND USE POLICY, V25, P81, DOI 10.1016/j.landusepol.2007.03.001; Kabii T, 2006, ENVIRON CONSERV, V33, P11, DOI 10.1017/S0376892906002761; Kubow S, 2014, MOL NUTR FOOD RES, V58, P2235, DOI 10.1002/mnfr.201400013; Kuehne G, 2017, AGR SYST, V156, P115, DOI 10.1016/j.agsy.2017.06.007; Lacy K, 2016, J AGR RESOUR ECON, V41, P116; Lapple D, 2013, ECOL ECON, V88, P11, DOI 10.1016/j.ecolecon.2012.12.025; Lambert DM, 2007, LAND USE POLICY, V24, P72, DOI 10.1016/j.landusepol.2005.12.002; Lastra-Bravo XB, 2015, ENVIRON SCI POLICY, V54, P1, DOI 10.1016/j.envsci.2015.06.002; Mac A, 2002, J CLEAN PROD, V10, P259, DOI 10.1016/S0959-6526(01)00025-7; Makinen S, 2016, J FUNCT FOODS, V25, P160, DOI 10.1016/j.jff.2016.05.016; Marangunic N, 2015, UNIVERSAL ACCESS INF, V14, P81, DOI 10.1007/s10209-014-0348-1; Marra M, 2003, AGR SYST, V75, P215, DOI 10.1016/S0308-521X(02)00066-5; Matuschke I, 2009, AGR ECON-BLACKWELL, V40, P493, DOI 10.1111/j.1574-0862.2009.00393.x; Mmbando Frank E., 2016, Journal of Human Ecology, V53, P49; Mutari B, 2021, J ETHNOBIOL ETHNOMED, V17, DOI 10.1186/s13002-021-00442-3; MUTH JF, 1961, ECONOMETRICA, V29, P315, DOI 10.2307/1909635; Ngokkuen C., 2012, Quarterly Journal of International Agriculture, V51, P157; Ojo S.O, 2014, INT J AGR SCI NATURA, V1, P40; Paustian M, 2017, PRECIS AGRIC, V18, P701, DOI 10.1007/s11119-016-9482-5; Peksa A, 2013, FOOD CHEM, V141, P2960, DOI 10.1016/j.foodchem.2013.05.125; Pham T.T., 2017, GLOBALFOOD DISCUSSIO; Pihlanto A, 2008, FOOD CHEM, V109, P104, DOI 10.1016/j.foodchem.2007.12.023; PRESS SJ, 1978, J AM STAT ASSOC, V73, P699, DOI 10.2307/2286261; Price JC, 2014, J RURAL STUD, V34, P65, DOI 10.1016/j.jrurstud.2013.10.001; QUALTRICSXM, 2019, QUALTR XM; Read DL, 2013, J ENVIRON PSYCHOL, V36, P70, DOI 10.1016/j.jenvp.2013.07.001; Reichardt M, 2009, PRECIS AGRIC, V10, P525, DOI 10.1007/s11119-009-9112-6; Rimal RN, 2005, COMMUN RES, V32, P389, DOI 10.1177/0093650205275385; Roberts R. K., 2004, Journal of Agricultural and Applied Economics, V36, P143; Rogers E, 2003, DIFFUSION INNOVATION, DOI DOI 10.2307/2573300; Rogers E.M., 1995, DIFFUSION INNOVATION, V4th ed.; Rose DC, 2018, FOOD ENERGY SECUR, V7, DOI 10.1002/fes3.155; Salehi F, 2021, FOOD SCI NUTR, V9, P4666, DOI 10.1002/fsn3.2430; SARGENT TJ, 1976, J MONETARY ECON, V2, P169, DOI 10.1016/0304-3932(76)90032-5; Schaak H, 2018, AGR SYST, V165, P230, DOI 10.1016/j.agsy.2018.06.015; Senger I, 2017, J RURAL STUD, V49, P32, DOI 10.1016/j.jrurstud.2016.10.006; Siebert R, 2006, SOCIOL RURALIS, V46, P318, DOI 10.1111/j.1467-9523.2006.00420.x; Subramanian NK, 2017, GENET RESOUR CROP EV, V64, P1927, DOI 10.1007/s10722-016-0483-z; Suvi WT, 2021, J CROP IMPROV, V35, P51, DOI 10.1080/15427528.2020.1795771; Swarup S, 2021, CROP SCI, V61, P839, DOI 10.1002/csc2.20377; Szakaly Z, 2019, APPETITE, V138, P94, DOI 10.1016/j.appet.2019.03.020; Teratanavat R, 2006, J FOOD SCI, V71, pS533, DOI 10.1111/j.1750-3841.2006.00120.x; Tsang C, 2018, PLANT FOOD HUM NUTR, V73, P203, DOI 10.1007/s11130-018-0673-2; Tuorila H, 2020, CURR OPIN FOOD SCI, V33, P1, DOI 10.1016/j.cofs.2019.09.004; USDA and ERS, 2021, VEG PULS OUTL; USDA and ERS, 2021, US COUNTR LEV POV; USDA and NASS, 2021, POT 2020 SUMM; USDA/NASS, 2022, CROP VAL 2021 SUMM; USDA NASS and C.D.O. Agriculture, 2021, COL AGR STAT; Vanslembrouck I, 2002, J AGR ECON, V53, P489, DOI 10.1111/j.1477-9552.2002.tb00034.x; Vasquez AK, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222442; Veisi H, 2012, ASIAN J TECHNOL INNO, V20, P67, DOI 10.1080/19761597.2012.681435; Wang GL, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235927; Wang YD, 2019, J ENVIRON MANAGE, V237, P15, DOI 10.1016/j.jenvman.2019.02.070; Wauters E, 2010, LAND USE POLICY, V27, P86, DOI 10.1016/j.landusepol.2009.02.009; Yigezu Y.A., 2015, MODELING FARMERS ADO; Zeweld W, 2017, J ENVIRON MANAGE, V187, P71, DOI 10.1016/j.jenvman.2016.11.014	98	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2022	17	6							e0270636	10.1371/journal.pone.0270636	http://dx.doi.org/10.1371/journal.pone.0270636			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5I4AJ	35771836	gold, Green Published			2022-12-26	WOS:000868301200001
J	Zhu, MY; Bao, DF; Yu, YX; Shen, DN; Yi, MZ				Zhu, Mengyao; Bao, Defu; Yu, Yuxiang; Shen, Danni; Yi, Minzhe			Differences in thinking flexibility between novices and experts based on eye tracking	PLOS ONE			English	Article							DESIGN	The influence of thinking flexibility on design is often underestimated by researchers in the field of design education. In this study, morphological analysis was used as a tool to develop design proposals and eye tracking technology was applied to track the attention. The feature of thinking activities in problem-solving between two groups (novice and expert) was analyzed by Heat map and Gaze plot in qualitative, and measured by indicators such as fixation and saccade in quantitative. Findings suggested that, i) Experts showed more fixation duration and fixation numbers in thinking activities, and the attention containing more AOIs was positively related to the rationality of the scheme. ii) Saccades with greater amplitude were more beneficial to the novelty of scheme. iii) Experts considered the information of each block in a balanced way, while novices tended to ignore unimportant blocks. These results will have a far-reaching impact on the development of designers' thinking and help novices to exercise creative thinking and produce high-quality designs.	[Zhu, Mengyao; Bao, Defu; Yu, Yuxiang; Shen, Danni; Yi, Minzhe] Zhejiang Sci Tech Univ, Art & Design Inst, Hangzhou, Zhejiang, Peoples R China	Zhejiang Sci-Tech University	Bao, DF; Yu, YX (corresponding author), Zhejiang Sci Tech Univ, Art & Design Inst, Hangzhou, Zhejiang, Peoples R China.	490344007@qq.com; yuyuxiang0612@zstu.edu.cn		Bao, Defu/0000-0002-4321-9673	National Social Science Foundation [18CG198]; Philosophy and Social Science Planning Project of Zhejiang Province [21NDQN234YB]	National Social Science Foundation; Philosophy and Social Science Planning Project of Zhejiang Province	Art project of National Social Science Foundation (18CG198) Philosophy and Social Science Planning Project of Zhejiang Province (21NDQN234YB).	Atman CJ, 2007, J ENG EDUC, V96, P359, DOI 10.1002/j.2168-9830.2007.tb00945.x; Badke-Schaub P., 2010, P 8 DESIGN THINKING, P39; Balakrishnan B, 2022, INT J TECHNOL DES ED, V32, P1799, DOI 10.1007/s10798-021-09652-y; Casakin H., 1999, DESIGN STUDIES, V20, P153, DOI 10.1016/S0142-694X(98)00032-5; Clement J, 2013, J RETAIL CONSUM SERV, V20, P234, DOI 10.1016/j.jretconser.2013.01.003; Cross N, 2004, DESIGN STUD, V25, P427, DOI 10.1016/j.destud.2004.06.002; Cross N, 2007, BOARD INT RES DES, P1, DOI 10.1007/978-3-7643-8485-2; Cross N, 2001, DESIGN KNOWING LEARN, P79; Debue N, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01099; Feldman DH, 1994, U COGNITIVE DEV; Gero JS, 2013, INT J DES CREAT INNO, V1, P196, DOI 10.1080/21650349.2013.801760; Gibbert M, 2012, COGNITIVE SCI, V36, P992, DOI 10.1111/j.1551-6709.2012.01247.x; Goldberg J. H., 2002, Proceedings ETRA 2002. Eye Tracking Research and Applications Symposium, P51, DOI 10.1145/507072.507082; Goldschmidt G, 2013, CREATIVITY RATIONALE, P41; Goldschmidt G, 2016, CREATIVITY RES J, V28, P115, DOI 10.1080/10400419.2016.1162497; Haupt G, 2015, INT J TECHNOL DES ED, V25, P483, DOI 10.1007/s10798-014-9295-7; Hsieh LC, 2017, T CAN SOC MECH ENG, V41, P657, DOI 10.1139/tcsme-2017-501; Hyona J, 2002, J EDUC PSYCHOL, V94, P44, DOI 10.1037//0022-0663.94.1.44; Jacob RJK, 2003, MIND'S EYE: COGNITIVE AND APPLIED ASPECTS OF EYE MOVEMENT RESEARCH, P573, DOI 10.1016/B978-044451020-4/50031-1; Jonassen David, 2003, J RES TECHNOL EDUC, V35, P362, DOI DOI 10.1080/15391523.2003.10782391; Keskin M, 2020, ISPRS INT J GEO-INF, V9, DOI 10.3390/ijgi9070429; Keskin M, 2019, ISPRS INT GEO-INF, V8, DOI 10.3390/ijgi8120546; KUMAR VK, 1991, J CREATIVE BEHAV, V25, P320, DOI 10.1002/j.2162-6057.1991.tb01144.x; Leahy K, 2019, INT J TECHNOL DES ED, V29, P759, DOI 10.1007/s10798-018-9473-0; Liang CY, 2019, INT J DES CREAT INNO, V7, P213, DOI 10.1080/21650349.2018.1562995; Di Stasi LL, 2011, APPL ERGON, V42, P807, DOI 10.1016/j.apergo.2011.01.003; Martinec T, 2019, RES ENG DES, V30, P103, DOI 10.1007/s00163-018-00305-1; Mintzes JJ, 2005, TEACHING SCI UNDERST; Mobley M.I., 1992, CREATIVITY RES J, V5, P125, DOI DOI 10.1080/10400419209534428; Nodine CF, 1987, EYE MOVEMENTS PHYSL, P573, DOI DOI 10.1016/B978-0-444-70113-8.50081-3; Park H, 2016, COMPUT HUM BEHAV, V63, P796, DOI 10.1016/j.chb.2016.06.016; Perkins DN, 1985, DEV MINDS RESOURCE B, P172; Robson SG, 2020, APPL COGNITIVE PSYCH, V34, P984, DOI 10.1002/acp.3676; Roth K, 2020, CREAT INNOV MANAG, V29, P667, DOI 10.1111/caim.12408; Sarkar P, 2011, DESIGN STUD, V32, P348, DOI 10.1016/j.destud.2011.01.002; Scott GA, 2005, CREATIVITY RES J, V17, P79, DOI 10.1207/s15326934crj1701_7; Shah J. J., 2003, Design Studies, V24, P111, DOI 10.1016/S0142-694X(02)00034-0; Shen DN, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0254933; Smith KM, 2015, DESIGN STUD, V36, P77, DOI 10.1016/j.destud.2014.09.001; Tikhomirova T, 2020, BEHAV SCI-BASEL, V10, DOI 10.3390/bs10100158; Torrance E., 1964, ROLE EVALUATION CREA; Tran KN, 2022, INT J TECHNOL DES ED, V32, P585, DOI 10.1007/s10798-020-09598-7; Ware C., 1987, SIGCHI Bulletin, P183, DOI 10.1145/1165387.275627; Wong JJ, 2016, INT J ART DES EDUC, V35, P140, DOI 10.1111/jade.12044; Wu YH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234473; Yu R, 2017, INT C RES DESIGN, P457; Zhu YQ, 2018, J MANAGE, V44, P2094, DOI 10.1177/0149206316638161	47	0	0	10	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2022	17	6							e0269363	10.1371/journal.pone.0269363	http://dx.doi.org/10.1371/journal.pone.0269363			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5F3XB	35771796	Green Published, gold			2022-12-26	WOS:000866250700001
J	Huang, C; Lv, XM; Chen, PC; Liu, JY; He, CB; Chen, L; Wang, HB; Moness, ML; Dong, JX; Rueda, BR; Davis, JS; Wang, C				Huang, Cong; Lv, Xiangmin; Chen, Peichao; Liu, Jiyuan; He, Chunbo; Chen, Li; Wang, Hongbo; Moness, Madelyn L.; Dong, Jixin; Rueda, Bo R.; Davis, John S.; Wang, Cheng			Human papillomavirus targets the YAP1-LATS2 feedback loop to drive cervical cancer development	ONCOGENE			English	Article							ONCOGENE-INDUCED SENESCENCE; HIPPO SIGNALING PATHWAY; CELLULAR SENESCENCE; NATURAL-HISTORY; HPV INFECTION; EXPRESSION; WORLDWIDE; ESTROGEN; YAP/TAZ; P53	Human papillomavirus (HPV) infection is very common in sexually active women, but cervical cancer only develops in a small fraction of HPV-infected women, suggesting that unknown intrinsic factors associated with the unique genetic/genomic background of the high-risk population play a critical role in cervical carcinogenesis. Although our previous studies have identified the hyperactivated YAP1 oncogene as a critical contributor to cervical cancer, the molecular mechanism by which YAP1 drives cervical cancer is unknown. In the present study, we found that although the hyperactivated YAP1 caused a malignant transformation of immortalized cervical epithelial cells, it induced cellular senescence in cultures of primary human cervical epithelial cells (HCvECs). However, the hyperactivated YAP1 induced malignant transformation of HCvECs in the presence of high-risk HPV E6/E7 proteins, suggesting that the hyperactivated YAP1 synergizes with HPV to initiate cervical cancer development. Our mechanistic studies demonstrate that YAP1, via up-regulating LATS2, formed a YAP1-LATS2 negative feedback loop in cervical epithelial cells to maintain homeostasis of cervical tissue. Intriguingly, we found that high-risk HPV targets LATS2 to disrupt the feedback loop leading to the malignant transformation of cervical epithelial cells. Finally, we report that mitomycin C, an FDA-approved drug that could upregulate LATS2 and drive cellular senescence in vitro and in vivo, induced a regression of cervical cancer in a pre-clinial animal model. Thus, high-risk HPV targeting the YAP1-LATS2 feedback loop represents a new mechanism of cervical cancer development.	[Huang, Cong; Lv, Xiangmin; Chen, Peichao; Liu, Jiyuan; He, Chunbo; Chen, Li; Wang, Hongbo; Moness, Madelyn L.; Rueda, Bo R.; Wang, Cheng] Harvard Med Sch, Massachusetts Gen Hosp, Vincent Dept Obstet & Gynecol, Vincent Ctr Reprod Biol, Boston, MA 02114 USA; [Chen, Peichao] Wenzhou Univ, Coll Life & Environm Sci, Wenzhou 325035, Zhejiang, Peoples R China; [He, Chunbo; Dong, Jixin; Davis, John S.] Univ Nebraska Med Ctr, Fred & Pamela Canc Ctr, Omaha, NE 68198 USA; [Chen, Li] Chinese Acad Sci, Key Lab Anim Ecol & Conservat Biol, Beijing 100101, Peoples R China; [Davis, John S.] Univ Nebraska Med Ctr, Dept Obstet & Gynecol, Olson Ctr Womens Hlth, Omaha, NE 68198 USA; [Davis, John S.] Vet Adm Nebraska Western Iowa Healthcare Syst, Omaha, NE 68105 USA; [Huang, Cong] Peking Univ Shenzhen Hosp, Shenzhen Peking Univ Hong Kong Univ Sci & Technol, Dept Dermatol, Shenzhen 518036, Peoples R China	Harvard University; Harvard Medical School; Massachusetts General Hospital; Wenzhou University; University of Nebraska System; University of Nebraska Medical Center; Chinese Academy of Sciences; University of Nebraska System; University of Nebraska Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Nebraska-Western Iowa Health Care System; Hong Kong University of Science & Technology; Peking University	Wang, C (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Vincent Dept Obstet & Gynecol, Vincent Ctr Reprod Biol, Boston, MA 02114 USA.	cwang34@mgh.harvard.edu		Rueda, Bo/0000-0001-9489-8699	National Cancer Institute/National Institute of Health [1R01CA197976, 1R01CA201500]; Vincent Memorial Hospital Foundation/Vincent Center for Reproductive Biology, Colleen's Dream Foundation; Ruggles Family Foundation; Veterans Administration Senior Research Career Scientist Award; Nile Albright Research Foundation	National Cancer Institute/National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Vincent Memorial Hospital Foundation/Vincent Center for Reproductive Biology, Colleen's Dream Foundation; Ruggles Family Foundation; Veterans Administration Senior Research Career Scientist Award; Nile Albright Research Foundation	This work was supported by the National Cancer Institute/National Institute of Health (1R01CA197976, 1R01CA201500), the Vincent Memorial Hospital Foundation/Vincent Center for Reproductive Biology, Colleen's Dream Foundation (no number), and the Ruggles Family Foundation. JSD is the recipient of a Veterans Administration Senior Research Career Scientist Award. BR was supported by the Nile Albright Research Foundation.	Arbyn M, 2020, LANCET GLOB HEALTH, V8, pE191, DOI 10.1016/S2214-109X(19)30482-6; Billman GE, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00200; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Boyer SN, 1996, CANCER RES, V56, P4620; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Braig M, 2006, CANCER RES, V66, P2881, DOI 10.1158/0008-5472.CAN-05-4006; Brake T, 2005, P NATL ACAD SCI USA, V102, P2490, DOI 10.1073/pnas.0409883102; Brandman O, 2008, SCIENCE, V322, P390, DOI 10.1126/science.1160617; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Burk RD, 2017, NATURE, V543, P378, DOI 10.1038/nature21386; Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)02151-1; Castellsague X, 2006, JNCI-J NATL CANCER I, V98, P303, DOI 10.1093/jnci/djj067; Castellsague X, 2008, GYNECOL ONCOL, V110, pS4, DOI 10.1016/j.ygyno.2008.07.045; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Childs BG, 2015, NAT MED, V21, P1424, DOI 10.1038/nm.4000; Chung SH, 2010, TRENDS ENDOCRIN MET, V21, P504, DOI 10.1016/j.tem.2010.03.005; Chung SH, 2008, CANCER RES, V68, P9928, DOI 10.1158/0008-5472.CAN-08-2051; Courtois-Cox S, 2008, ONCOGENE, V27, P2801, DOI 10.1038/sj.onc.1210950; Dai XM, 2015, CELL RES, V25, P1175, DOI 10.1038/cr.2015.101; Dey A, 2020, NAT REV DRUG DISCOV, V19, P480, DOI 10.1038/s41573-020-0070-z; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; Ferrell JE, 2013, CURR OPIN CELL BIOL, V25, P676, DOI 10.1016/j.ceb.2013.07.007; Fu D, 2014, ENDOCR-RELAT CANCER, V21, P297, DOI 10.1530/ERC-13-0339; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; HARVEY M, 1995, CANCER RES, V55, P1146; He CB, 2019, CELL REP, V26, P2636, DOI 10.1016/j.celrep.2019.02.004; He CB, 2019, EMBO REP, V20, DOI 10.15252/embr.201744948; He CB, 2015, EMBO MOL MED, V7, P1426, DOI 10.15252/emmm.201404976; Howlader N, 2012, SEER CANC STAT REV 1; Hua G, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.207; Korotkevich G., 2016, BIORXIV; Koutsky Laura, 1997, American Journal of Medicine, V102, P3; Kulasingam SL, 2002, JAMA-J AM MED ASSOC, V288, P1749, DOI 10.1001/jama.288.14.1749; Lee S, 2019, NAT CELL BIOL, V21, P94, DOI 10.1038/s41556-018-0249-2; Li XM, 2013, INT J MOL SCI, V14, P2431, DOI 10.3390/ijms14022431; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Liu XL, 2018, ACTA PHARMACOL SIN, V39, P1553, DOI 10.1038/aps.2017.198; Lv XM, 2017, MOL CANCER THER, V16, P1080, DOI 10.1158/1535-7163.MCT-16-0626; Mo JS, 2014, EMBO REP, V15, P642, DOI 10.15252/embr.201438638; Modell H, 2015, ADV PHYSIOL EDUC, V39, P259, DOI 10.1152/advan.00107.2015; Molano M, 2003, AM J EPIDEMIOL, V158, P486, DOI 10.1093/aje/kwg171; Moroishi T, 2015, GENE DEV, V29, P1271, DOI 10.1101/gad.262816.115; Moya IM, 2019, NAT REV MOL CELL BIO, V20, P211, DOI 10.1038/s41580-018-0086-y; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Perez-Plasencia C., 2008, INT ARCH MED, V1; Pyeon D, 2007, CANCER RES, V67, P4605, DOI 10.1158/0008-5472.CAN-06-3619; Riley RR, 2003, CANCER RES, V63, P4862; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosty C, 2005, ONCOGENE, V24, P7094, DOI 10.1038/sj.onc.1208854; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Schiffman Mark H, 2003, J Natl Cancer Inst, V95, pE2; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Shah R, 2020, J WOMENS HEALTH, V29, P799, DOI 10.1089/jwh.2019.7858; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Stelzle D, 2021, LANCET GLOB HEALTH, V9, pE161, DOI 10.1016/S2214-109X(20)30459-9; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Turrigiano G, 2007, CURR OPIN NEUROBIOL, V17, P318, DOI 10.1016/j.conb.2007.04.004; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wang C, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.397; Wang C, 2019, MOL CELL ONCOL, V6, DOI 10.1080/23723556.2019.1612677; Wang C, 2010, ENDOCRINOLOGY, V151, P2319, DOI 10.1210/en.2009-1489; Woodman CBJ, 2007, NAT REV CANCER, V7, P11, DOI 10.1038/nrc2050; Wyld L, 2020, CANCERS, V12, DOI 10.3390/cancers12082134; Xing BY, 2021, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.606335; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zanconato F, 2016, CANCER CELL, V29, P783, DOI 10.1016/j.ccell.2016.05.005; Zhang Y, 2021, GENOME RES, V31, DOI 10.1101/gr.275193.120	71	1	1	2	2	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 22	2022	41	30					3761	3777		10.1038/s41388-022-02390-y	http://dx.doi.org/10.1038/s41388-022-02390-y		JUN 2022	17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	3D1SP	35761037				2022-12-26	WOS:000817034400001
J	Bibi, A; Khan, I; Zaman, K; Sriyanto, S; Sasmoko, A; Khan, A				Bibi, Aisha; Khan, Imran; Zaman, Khalid; Sriyanto, Sriyanto; Sasmoko, Aqeel; Khan, Aqeel			Does money buy health? evaluation of stock market performance and economic growth in the wake of the COVID-19 pandemic	PLOS ONE			English	Article							IMPACT; EXPECTANCY	The novel coronavirus pandemic of 2019 (COVID-19) has significantly harmed numerous social and economic activities worldwide, drawing researchers and governments' attention to the problem and tackling it via persistent healthcare measures. The study's primary purpose is to examine the effects of total coronavirus cases, total fatalities, total recovered cases, unemployment, and trade openness on stock prices and economic growth in the world's top 39 affected nations. An analysis of the coronavirus outbreaks found that wealthier countries had a well-established healthcare infrastructure, but they were disproportionately affected by the virus. Conversely, the less wealthy nations had inadequate healthcare infrastructures, but they were not as affected as the wealthier countries. Is it possible to buy health with money? That was the question at the heart of the study's money-and-health curve. The robust least square regression results indicate that an increase in coronavirus cases influences economic growth and stock market performance due to massive healthcare funding distributed globally, sustaining economic and financial activities for a shorter period. However, a continuous increase in coronavirus fatalities depresses the stock market, resulting in financial depression worldwide. Additionally, a rise in overall coronavirus recovered cases has a negative effect on the country's economic development and stock market performance because of greater uncertainty in economic and financial activities. Case fatality ratios influence economic growth, whereas case recovery ratios decrease economic and financial performance due to greater healthcare concerns across countries. Finally, trade openness is critical in sustaining the country's economic development and stock market performance in the wake of the COVID-19 epidemic.	[Bibi, Aisha; Khan, Imran; Zaman, Khalid] Univ Haripur, Dept Econ, Haripur, Khyber Pakhtunk, Pakistan; [Sriyanto, Sriyanto] Univ Muhammadiyah Purwokerto, Social Studies Dept, Purwokerto, Jawa Tengah, Indonesia; [Sasmoko, Aqeel] Bina Nusantara Univ, Fac Humanities, Primary Teacher Educ Dept, Jakarta, Indonesia; [Khan, Aqeel] Univ Teknol Malaysia UTM, Fac Social Sci & Humanities, Skudai Johor, Malaysia	Universitas Muhammadiyah Purwokerto; Universitas Bina Nusantara; Universiti Teknologi Malaysia	Zaman, K (corresponding author), Univ Haripur, Dept Econ, Haripur, Khyber Pakhtunk, Pakistan.	khalid_zaman786@yahoo.com		Sriyanto, Sriyanto/0000-0002-0819-4132; Zaman, Khalid/0000-0002-2585-2790				Ahmed MZ, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102092; Alam MN, 2020, J ASIAN FINANC ECON, V7, P131, DOI 10.13106/jafeb.2020.vol7.no7.131; Alava JJ, 2022, ENVIRON SCI POLICY, V130, P1, DOI 10.1016/j.envsci.2022.01.006; Altig D, 2020, J PUBLIC ECON, V191, DOI 10.1016/j.jpubeco.2020.104274; Anser MK, 2021, ENVIRON SCI POLLUT R, V28, P63215, DOI 10.1007/s11356-021-15275-6; Anser MK, 2021, ENVIRON SCI POLLUT R, V28, P49820, DOI 10.1007/s11356-021-13873-y; Belitski M, 2022, SMALL BUS ECON, V58, P593, DOI 10.1007/s11187-021-00544-y; Bloom DE, 2021, HEALTH AFFAIR, V40, P410, DOI 10.1377/hlthaff.2020.02012; Buheji M., 2020, AM J EC, V10, P97, DOI DOI 10.5923/J.ECONOMICS.20201002.05; Bui D, 2022, WORLD DEV, V153, DOI 10.1016/j.worlddev.2022.105828; Canuto O., 2020, IMPACT CORONAVIRUS G; Chakraborty I, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138882; Chan J, 2021, INT J CONTEMP HOSP M, V33, P1668, DOI 10.1108/IJCHM-09-2020-1013; Chaudhary Vishal, 2021, Nanotechnology for Environmental Engineering, V6, DOI 10.1007/s41204-021-00102-7; Chohan UW, 2020, EC016UC CASS NAT AFF; Coccia M, 2021, ENVIRON RES, V199, DOI 10.1016/j.envres.2021.111339; Crawford J, 2022, SUSTAINABILITY-BASEL, V14, DOI 10.3390/su14031879; Ehtesham M, 2020, CUREUS, V12, DOI 10.7759/cureus.8853; Fan Y, 2022, ANN REGIONAL SCI, DOI 10.1007/s00168-021-01103-9; Fernandes G, 2022, B WORLD HEALTH ORGAN, V100, P174, DOI 10.2471/BLT.21.287177; Fernandes N., 2020, WP1240E IESE BUS SCH, DOI [10.2139/ssrn.3557504, DOI 10.2139/SSRN.3557504]; Gharehgozli Orkideh, 2020, Econ Disaster Clim Chang, V4, P561, DOI 10.1007/s41885-020-00069-w; Guo H, 2020, FRONT BUS RES CHINA, V14, DOI 10.1186/s11782-020-00087-1; He LS, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249579; He PL, 2020, EMERG MARK FINANC TR, V56, P2198, DOI 10.1080/1540496X.2020.1785865; He Q, 2020, ECON POLIT STUD-EPS, V8, P275, DOI 10.1080/20954816.2020.1757570; Hohler J, 2021, AGRIBUSINESS, V37, P171, DOI 10.1002/agr.21678; HUBER PJ, 1973, ANN STAT, V1, P799, DOI 10.1214/aos/1176342503; Imai N., 2020, 2 IMP COLL; Inegbedion H, 2021, HELIYON, V7, DOI 10.1016/j.heliyon.2021.e06943; Jena PR, 2021, ECON ANAL POLICY, V69, P324, DOI 10.1016/j.eap.2020.12.013; Katper N.K., 2020, ADV IN SCI, V5, P645, DOI 10.25046/aj050477; Kaye AD, 2021, BEST PRAC RES-CL ANA, V35, P293, DOI 10.1016/j.bpa.2020.11.009; Khan A, 2021, CONTEMP ECON, V15, P64, DOI 10.5709/ce.1897-9254.436; Khan K, 2020, J ASIAN FINANC ECON, V7, P463, DOI 10.13106/jafeb.2020.vol7.no7.463; Khilar RP., 2022, ACAD ENTREPRENEURSHI, V28, P1; Konig M., 2020, COVID EC, V57, P132; Kotishwar A., 2020, ACAD ACCOUNTING FINA, V24, P1; Kumar MP, 2021, MATER TODAY-PROC, V37, P2553, DOI 10.1016/j.matpr.2020.08.493; Kumari P, 2022, S ASIAN J BUS STUD, DOI 10.1108/SAJBS-05-2021-0185; Lal P, 2021, AEROSOL AIR QUAL RES, V21, DOI 10.4209/aaqr.2020.02.0229; Li Jiawei, 2020, JMIR Public Health Surveill, V6, pe18700, DOI 10.2196/18700; Liu L., 2020, ENERGY RES LETT, V1, P13154, DOI [10.46557/001c.13154, DOI 10.46557/001C.13154]; Liu YP, 2020, ASIAN BUS MANAG, V19, P277, DOI 10.1057/s41291-020-00119-x; Liu ZF, 2021, RES INT BUS FINANC, V57, DOI 10.1016/j.ribaf.2021.101419; Machmuddah Z., 2020, J OPEN INNOV TECHNOL, V6, P99, DOI [10.3390/joitmc6040099, DOI 10.3390/JOITMC6040099]; Malik MO, 2021, PROD PLAN CONTROL, V32, P1020, DOI 10.1080/09537287.2020.1784481; Mavlutova I, 2022, SUSTAINABILITY-BASEL, V14, DOI 10.3390/su14010339; Minondo A, 2021, APPL ECON ANAL, V29, P58, DOI 10.1108/AEA-11-2020-0156; Murshed S.M., 2022, CONSEQUENCES COVID 1, DOI [10.1007/978-3-030-82339-9_5, DOI 10.1007/978-3-030-82339-9_5]; Padhan R, 2021, ECON ANAL POLICY, V70, P220, DOI 10.1016/j.eap.2021.02.012; Pak A, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00241; Pineiro-Chousa J, 2022, TECHNOL FORECAST SOC, V175, DOI 10.1016/j.techfore.2021.121365; Qin XL, 2022, OPER MANAGE RES, V15, P195, DOI 10.1007/s12063-020-00177-6; Rahman ML, 2021, FINANC RES LETT, V38, DOI 10.1016/j.frl.2020.101832; Rasheed R, 2021, ENVIRON SCI POLLUT R, V28, P19926, DOI 10.1007/s11356-020-12070-7; Renko M, 2012, SMALL BUS ECON, V39, P667, DOI 10.1007/s11187-011-9354-3; Rousseeuw P.J., 1984, LECTURE NOTES STATIS, V26, P256, DOI DOI 10.1007/978-1-4615-7821-5_15; Salem N., 2021, AUSTR J HUMAN RIGHTS, V27, P232; Sarkodie SA, 2021, ENVIRON DEV SUSTAIN, V23, P5005, DOI 10.1007/s10668-020-00801-2; Shafi M., 2020, RES GLOBAL, V2, DOI DOI 10.1016/J.RESGLO.2020.100018; Shamsi S, 2022, ENVIRON SCI POLLUT R, V29, P17530, DOI 10.1007/s11356-021-17004-5; Shigemura J, 2020, PSYCHIAT CLIN NEUROS, V74, P281, DOI 10.1111/pcn.12988; Singh BB, 2021, ONE HEALTH-AMSTERDAM, V13, DOI 10.1016/j.onehlt.2021.100283; Slusarczyk B, 2022, ENERGIES, V15, DOI 10.3390/en15010332; Song H, 2020, FRONT BUS RES CHINA, V14, DOI 10.1186/s11782-020-00095-1; Song J, 2020, LEARN INDIVID DIFFER, V78, DOI 10.1016/j.lindif.2020.101839; Sriyanto S, 2022, FORESIGHT, V24, P429, DOI 10.1108/FS-07-2021-0136; Su CW, 2022, ECON RES-EKON ISTRAZ, V35, P1752, DOI 10.1080/1331677X.2021.1912627; Susilawati S., 2020, BIRCI J HUMANIT SOC, V3, P1147, DOI [10.33258/birci.v3i2.954, DOI 10.33258/BIRCI.V3I2.954]; Uddin M, 2021, J BUS RES, V128, P31, DOI 10.1016/j.jbusres.2021.01.061; Vandenberg O, 2021, NAT REV MICROBIOL, V19, P171, DOI 10.1038/s41579-020-00461-z; Victor V, 2021, ECONOMIES, V9, DOI 10.3390/economies9020073; Waheed R, 2020, J PUBLIC AFF, V20, DOI 10.1002/pa.2290; Wang CL, 2021, FRONT PSYCHIATRY, V12, DOI 10.3389/fpsyt.2021.643783; Wang Q, 2021, J CLEAN PROD, V295, DOI 10.1016/j.jclepro.2021.126265; Wang QJ, 2021, INT J GREEN ENERGY, V18, P443, DOI 10.1080/15435075.2020.1865367; Wei PP, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.682693; World Bank, 2021, WORLD DEV IND 2021; Worldometer, 2021, COR UPD; Yang YS, 2020, J AUTOIMMUN, V109, DOI 10.1016/j.jaut.2020.102434; YOHAI VJ, 1987, ANN STAT, V15, P642, DOI 10.1214/aos/1176350366; Yu Z, 2022, OPER MANAGE RES, V15, P233, DOI 10.1007/s12063-021-00179-y; Zhang Y., 2021, ENERGY RES LETT, V2, P27019	84	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7								10.1371/journal.pone.0269879	http://dx.doi.org/10.1371/journal.pone.0269879			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M3CI	35793280	Green Published, gold			2022-12-26	WOS:000835338100031
J	Lastrucci, V; Collini, F; Forni, S; D'Arienzo, S; Di Fabrizio, V; Buscemi, P; Lorini, C; Gemmi, F; Bonaccorsi, G				Lastrucci, Vieri; Collini, Francesca; Forni, Silvia; D'Arienzo, Sara; Di Fabrizio, Valeria; Buscemi, Primo; Lorini, Chiara; Gemmi, Fabrizio; Bonaccorsi, Guglielmo			The indirect impact of COVID-19 pandemic on the utilization of the emergency medical services during the first pandemic wave: A system-wide study of Tuscany Region, Italy	PLOS ONE			English	Article							HOSPITAL ADMISSIONS; POPULATION; ADJUSTMENT; VISITS; RISK; CARE	BackgroundUtilization of Emergency Medical Services (EMS) declined during COVID-19 pandemic, but most of the studies analyzed components of the EMS system individually. The study aimed to evaluate the indirect impact of COVID-19 pandemic on the utilization of all the components of the EMS system of Tuscany Region (Italy) during the first pandemic wave. MethodsAdministrative data from the health care system of Tuscany were used. Changes in utilization for out-of-hospital emergency calls and emergency vehicle dispatched, emergency department (ED) visits, and patients being admitted from the ED to an inpatient hospital bed (hospitalizations from ED) during the first pandemic wave were analyzed in relation with corresponding periods of the previous two years. Percentage changes and 95%CI were calculated with Poisson models. Standardized Ratios were calculated to evaluate changes in in-hospital mortality and hospitalizations requiring ICU. ResultsSignificant declines were observed in the utilization of all the EMS considered starting from the week in which the first case of COVID-19 was diagnosed in Italy till the end of the first pandemic wave. During the epidemic peak, the maximum decreases were observed: -33% for the emergency calls, -45% for the dispatch of emergency vehicles, -71% for ED admissions. Furthermore, a decline of 37% for hospitalizations from ED was recorded. Significant decreases in ED admissions for life threatening medical conditions were observed: acute cerebrovascular disease (-36%, 95% CI: -43, -29), acute myocardial infarction (-42%, 95% CI: -52, -31) and renal failure (-42%, 95% CI: -52, -31). No significant differences were found between the observed and the expected in-hospital mortality and hospitalizations requiring ICU during the epidemic peak. ConclusionAll the components of the EMS showed large declines in their utilization during COVID-19 pandemic; furthermore, major reductions were observed for admissions for time-dependent and life-threatening conditions. Efforts should be made to ensure access to safe and high-quality emergency care during pandemic.	[Lastrucci, Vieri] Meyer Childrens Univ Hosp, Epidemiol Unit, Florence, Italy; [Lastrucci, Vieri; Lorini, Chiara; Bonaccorsi, Guglielmo] Univ Florence, Dept Hlth Sci, Florence, Italy; [Collini, Francesca; Forni, Silvia; D'Arienzo, Sara; Di Fabrizio, Valeria; Gemmi, Fabrizio] Reg Hlth Agcy Tuscany, Qual & Equ Unit, Florence, Italy; [Buscemi, Primo] Univ Florence, Med Specializat Sch Hyg & Prevent Med, Florence, Italy	University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; University of Florence; University of Florence	Lastrucci, V (corresponding author), Meyer Childrens Univ Hosp, Epidemiol Unit, Florence, Italy.; Lastrucci, V (corresponding author), Univ Florence, Dept Hlth Sci, Florence, Italy.	vieri.lastrucci@meyer.it	Gemmi, Fabrizio/ABB-4101-2020	bonaccorsi, guglielmo/0000-0002-5171-4308; Lastrucci, Vieri/0000-0003-0762-6666; Gemmi, Fabrizio/0000-0002-1266-8433				Acampa Maurizio, 2021, Cardiovascular & Hematological Disorders - Drug Targets, V21, P179, DOI 10.2174/1871529X21666210927094058; Adiamah A, 2021, EUR J TRAUMA EMERG S, V47, P637, DOI [10.1007/s00068-020-01593-w, 10.1093/bjs/znab134.074]; Agency for Healthcare Research and Quality, CLIN CLASS SOFTW FAC; Birkmeyer JD, 2020, HEALTH AFFAIR, V39, P2010, DOI 10.1377/hlthaff.2020.00980; Boccia S, 2020, JAMA INTERN MED, V180, P927, DOI 10.1001/jamainternmed.2020.1447; Bonaccorsi G, 2021, INT J INFECT DIS, V112, P130, DOI 10.1016/j.ijid.2021.09.027; Calicchio M, 2021, FRONT PEDIATR, V9, DOI 10.3389/fped.2021.674111; Campo G, 2021, LANCET REG HEALTH-EU, V3, DOI 10.1016/j.lanepe.2021.100055; Chiba H, 2021, J TRAUMA ACUTE CARE, V90, P708, DOI 10.1097/TA.0000000000003061; Cowen ME, 1998, MED CARE, V36, P1108, DOI 10.1097/00005650-199807000-00016; D'Ascenzi F, 2021, FRONT CARDIOVASC MED, V8, DOI 10.3389/fcvm.2021.625569; De Filippo O, 2020, NEW ENGL J MED, V383, P88, DOI 10.1056/NEJMc2009166; Dell'Era Gabriele, 2022, J Cardiovasc Med (Hagerstown), V23, P22, DOI 10.2459/JCM.0000000000001189; Douiri A, 2021, STROKE, V52, P2125, DOI 10.1161/STROKEAHA.120.032253; Druss BG, 2002, HEALTH AFFAIR, V21, P105, DOI 10.1377/hlthaff.21.4.105; Gabet A, 2021, EUR J NEUROL, V28, P3279, DOI 10.1111/ene.14831; Gambazza S, 2021, HEALTHCARE-BASEL, V9, DOI 10.3390/healthcare9070791; Giannouchos TV, 2021, AM J EMERG MED, V40, P20, DOI 10.1016/j.ajem.2020.12.009; Istituto Superiore di Sanita,, 2020, IMP EP COVID 19 MORT; Kraaijvanger N, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1935-z; Kruizinga MD, 2021, EUR J PEDIATR, V180, P2271, DOI 10.1007/s00431-021-04015-0; Kurotschka PK, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.623904; Kwan Nick, 2022, Am J Emerg Med, V51, P424, DOI 10.1016/j.ajem.2021.03.065; Lastrucci V, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph182413386; Lastrucci V, 2021, INT J INFECT DIS, V109, P182, DOI 10.1016/j.ijid.2021.06.058; Lastrucci V, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8040778; Lastrucci V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204458; Lastrucci V, 2018, PRIM HEALTH CARE RES, V19, P131, DOI 10.1017/S146342361700055X; Lerner EB, 2020, ACAD EMERG MED, V27, P693, DOI 10.1111/acem.14051; Lu TH, 2005, HEALTH POLICY, V71, P151, DOI 10.1016/j.healthpol.2004.08.005; Nourazari S, 2021, AM J EMERG MED, V42, P203, DOI 10.1016/j.ajem.2020.11.029; Porat T, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.573397; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; Rabbone I, 2021, CHILDREN-BASEL, V8, DOI 10.3390/children8110962; Raucci U, 2021, ITAL J PEDIATR, V47, DOI 10.1186/s13052-021-00976-y; Rusconi F, 2021, ACTA PAEDIATR, V110, P2796, DOI 10.1111/apa.16019; Santi L, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248995; Satty T, 2021, AM J EMERG MED, V42, P1, DOI 10.1016/j.ajem.2020.12.078; Spadea T, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-00982-4; Trier F, 2022, ACTA ANAESTH SCAND, V66, P265, DOI 10.1111/aas.13997; Vedovetto A, 2014, HEALTH SERV RES, V49, P1290, DOI 10.1111/1475-6773.12161; World Health Organization, LISTINGS WHOS RESPON	42	3	3	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7							e0264806	10.1371/journal.pone.0264806	http://dx.doi.org/10.1371/journal.pone.0264806			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3N5GC	35776703	Green Published, gold			2022-12-26	WOS:000836174600001
J	Wenta, T; Schmidt, A; Zhang, Q; Devarajan, R; Singh, P; Yang, XY; Ahtikoski, A; Vaarala, M; Wei, GH; Manninen, A				Wenta, Tomasz; Schmidt, Anette; Zhang, Qin; Devarajan, Raman; Singh, Prateek; Yang, Xiayun; Ahtikoski, Anne; Vaarala, Markku; Wei, Gong-Hong; Manninen, Aki			Disassembly of alpha 6 beta 4-mediated hemidesmosomal adhesions promotes tumorigenesis in PTEN-negative prostate cancer by targeting plectin to focal adhesions	ONCOGENE			English	Article							EXPRESSION; INTEGRIN; INHIBITION; LANDSCAPE; CARCINOMA; EVOLUTION; HALLMARKS; INVASION; TUMORS; CELLS	Loss of alpha 6 beta 4-dependent hemidesmosomal adhesions has been observed during prostate cancer progression. However, the significance and underlying mechanisms by which aberrant hemidesmosome assembly may modulate tumorigenesis remain elusive. Using an extensive CRISPR/Cas9-mediated genetic engineering approaches in different prostate cancer cell lines combined with in vivo tumorigenesis studies in mice, bone marrow-on-chip assays and bioinformatics, as well as histological analysis of prostate cancer patient cohorts, we demonstrated that simultaneous loss of PTEN and hemidesmosomal adhesions induced several tumorigenic properties including proliferation, migration, resistance to anoikis, apoptosis, and drug treatment in vitro, and increased metastatic capacity in vivo. These effects were plectin-depended and plectin was associated with actin-rich adhesions upon hemidesmosome disruption in PTEN-negative prostate cancer cells leading to activation of EGFR/PI3K/Akt- and FAK/Src-pathways. These results suggest that analysis of PTEN and hemidesmosomal proteins may have diagnostic value helping to stratify prostate cancer patients with high risk for development of aggressive disease and highlight actin-associated plectin as a potential therapeutic target specifically in PTEN/hemidesmosome dual-negative prostate cancer.	[Wenta, Tomasz; Schmidt, Anette; Zhang, Qin; Devarajan, Raman; Yang, Xiayun; Wei, Gong-Hong; Manninen, Aki] Univ Oulu, Fac Biochem & Mol Med, Dis Networks Res Unit, Oulu, Finland; [Singh, Prateek] Finnadvance, Oulu, Finland; [Ahtikoski, Anne; Vaarala, Markku] Oulu Univ Hosp, Dept Urol, Oulu, Finland; [Ahtikoski, Anne; Vaarala, Markku] Oulu Univ Hosp, Dept Pathol, Oulu, Finland; [Ahtikoski, Anne; Vaarala, Markku] Oulu Univ Hosp, Dept Radiol, Oulu, Finland; [Ahtikoski, Anne; Vaarala, Markku] Oulu Univ Hosp, Med Res Ctr, Oulu, Finland; [Ahtikoski, Anne; Vaarala, Markku] Univ Oulu, Oulu, Finland; [Wei, Gong-Hong] Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China; [Wei, Gong-Hong] Fudan Univ, Dept Biochem & Mol Biol, Sch Basic Med Sci, Shanghai, Peoples R China; [Wei, Gong-Hong] Fudan Univ, Key Lab Metab & Mol Med, Minist Educ, Sch Basic Med Sci, Shanghai, Peoples R China	University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu; Fudan University; Fudan University; Fudan University	Manninen, A (corresponding author), Univ Oulu, Fac Biochem & Mol Med, Dis Networks Res Unit, Oulu, Finland.	aki.manninen@oulu.fi	Devarajan, Raman/GOH-0098-2022; Manninen, Aki/AAC-8067-2019; Ahtikoski, Anne/GQH-8901-2022; Vaarala, Markku/B-4116-2013	Manninen, Aki/0000-0002-6263-8101; Ahtikoski, Anne/0000-0003-4100-5900; Wenta, Tomasz/0000-0002-1927-9959; Vaarala, Markku/0000-0003-4735-815X	University of Oulu including Oulu University Hospital	University of Oulu including Oulu University Hospital	Open Access funding provided by University of Oulu including Oulu University Hospital.	Alix-Panabieres C, 2021, CANCER DISCOV, V11, P858, DOI 10.1158/2159-8290.CD-20-1311; Allen MV, 1998, HUM PATHOL, V29, P311, DOI 10.1016/S0046-8177(98)90109-5; Andrews S., 2010, FASTQC QUALITY CONTR; Armenia J, 2018, NAT GENET, V50, P645, DOI 10.1038/s41588-018-0078-z; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Bausch D, 2011, CLIN CANCER RES, V17, P302, DOI 10.1158/1078-0432.CCR-10-0999; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Buckup M, 2021, ONCOGENE, V40, P663, DOI 10.1038/s41388-020-01557-9; Burch TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065005; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chaudhari PR, 2017, EXP CELL RES, V360, P125, DOI 10.1016/j.yexcr.2017.08.034; Cooperberg MR, 2009, JNCI-J NATL CANCER I, V101, P878, DOI 10.1093/jnci/djp122; COX DR, 1972, J R STAT SOC B, V34, P187; Dasari A, 2020, NAT REV CLIN ONCOL, V17, P757, DOI 10.1038/s41571-020-0392-0; Davis TL, 2001, PROSTATE, V46, P240; Demetriou MC, 2004, J CELL BIOCHEM, V91, P26, DOI 10.1002/jcb.10675; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fraser M, 2017, NATURE, V541, P359, DOI 10.1038/nature20788; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Geerts D, 1999, J CELL BIOL, V147, P417, DOI 10.1083/jcb.147.2.417; Gerhauser C, 2018, CANCER CELL, V34, P996, DOI 10.1016/j.ccell.2018.10.016; Glinsky GV, 2004, J CLIN INVEST, V113, P913, DOI 10.1172/JCI200420032; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Gu JG, 1998, J CELL BIOL, V143, P1375, DOI 10.1083/jcb.143.5.1375; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hoadley KA, 2018, CELL, V173, P291, DOI 10.1016/j.cell.2018.03.022; Jamaspishvili T, 2018, NAT REV UROL, V15, P222, DOI 10.1038/nrurol.2018.9; Kang HM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180251; Kassambara A, 2021, PACKAGE SURVMINERDRA; Katada K, 2012, J PROTEOMICS, V75, P1803, DOI 10.1016/j.jprot.2011.12.018; KNOX JD, 1994, AM J PATHOL, V145, P167; Kumar A, 2016, NAT MED, V22, P369, DOI 10.1038/nm.4053; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Latonen L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03573-6; Litjens SHM, 2006, TRENDS CELL BIOL, V16, P376, DOI 10.1016/j.tcb.2006.05.004; Liu PB, 2006, CANCER RES, V66, P4011, DOI 10.1158/0008-5472.CAN-05-3055; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Martini V, 2019, CANCERS, V11, DOI 10.3390/cancers11111659; Myllymaki S-M, 2019, MATTERS, DOI [10.19185/matters.201902000007, DOI 10.19185/MATTERS.201902000007]; Myllymaki SM, 2019, MOL CELL PROTEOMICS, V18, P277, DOI 10.1074/mcp.RA118.001095; Nakagawa T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002318; Dalton GN, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1535-z; Okubo K, 2017, EJSO-EUR J SURG ONC, V43, P1050, DOI 10.1016/j.ejso.2017.01.241; Persad S, 2000, P NATL ACAD SCI USA, V97, P3207, DOI 10.1073/pnas.060579697; R Studio Team, 2019, R STUDIO INTEGRATED; RCore Team, 2020, R LANG ENV STAT COMP; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Sandhofer N, 2015, LEUKEMIA, V29, P828, DOI 10.1038/leu.2014.305; Sartor AO, 2008, UROLOGY, V72, P12, DOI 10.1016/j.urology.2008.10.004; Schlomm T, 2016, EUR UROL, V69, P1157, DOI 10.1016/j.eururo.2016.02.024; SEIFERT GJ, 1992, EUR J CELL BIOL, V59, P138; Setlur SR, 2008, JNCI-J NATL CANCER I, V100, P815, DOI 10.1093/jnci/djn150; Sinha A, 2019, CANCER CELL, V35, P414, DOI 10.1016/j.ccell.2019.02.005; Song BG, 2021, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.616440; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Swift S, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1017cs31; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Therneau T., **DATA OBJECT**; TM Therneau., 2000, MODELING SURVIVAL DA, DOI DOI 10.1007/978; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Turnham DJ, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9112342; van den Dries K, 2013, MOL BIOL CELL, V24, P2112, DOI 10.1091/mbc.E12-12-0856; van den Dries K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2402; Vlietstra RJ, 1998, CANCER RES, V58, P2720; Walko G, 2015, CELL TISSUE RES, V360, P529, DOI 10.1007/s00441-015-2216-6; Wang W, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.201904137; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Whitington T, 2016, NAT GENET, V48, P387, DOI 10.1038/ng.3523; Witkowski CM, 2000, CARCINOGENESIS, V21, P325, DOI 10.1093/carcin/21.2.325; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158; Zhang K, 2017, ONCOGENE, V36, P5681, DOI 10.1038/onc.2017.177	72	0	0	5	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 22	2022	41	30					3804	3820		10.1038/s41388-022-02389-5	http://dx.doi.org/10.1038/s41388-022-02389-5		JUL 2022	17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	3D1SP	35773413	Green Published, hybrid			2022-12-26	WOS:000819316400001
J	Desalegn, M; Garoma, G; Tamrat, H; Desta, A; Prakash, A				Desalegn, Mitiku; Garoma, Gelana; Tamrat, Habtamu; Desta, Adane; Prakash, Ajay			The prevalence of AstraZeneca COVID-19 vaccine side effects among Nigist Eleni Mohammed memorial comprehensive specialized hospital health workers. Cross sectional survey	PLOS ONE			English	Article							RESIDENTS	IntroductionThe best way to eradicate corona virus disease (COVID-19) viral infection is mass vaccination. Many studies demonstrate vaccination is associated with some local and systemic side effects. This study aimed to provide evidence on AstraZeneca COVID-19 vaccine side effects. MethodologyInstitutional based cross-sectional survey was conducted among 254 health workers at Nigist Eleni Mohammed memorial comprehensive specialized hospital (from July 01/ 2021 to July 30/2021). Data were collected consecutively through self-administered online survey created on Google Forms of platform which had been randomly delivered via (Facebook or telegram pages). Demographic data of participants, side effect after first and second dose of vaccine were covered. ResultThe prevalence of at least one side effect after first dose was 91.3% and after second dose was 67%. Injection site pain (63.8% vs. 50.4%), headache (48.8% vs. 33.5%), fever (38.8% vs. 20.9%), muscle pain (38.8% vs. 21.7%), fatigue (26% vs. 28.7%, tenderness at the site (27.6% vs. 21.7%), and joint pain (27.6% vs. 20.9%) were the most commonly reported side effects after first and second dose vaccine respectively. Most of participants reported that their symptoms emerged after 6hr of vaccination and only less than 5% of participant's symptoms lasted more than 72hr of post vaccination. The younger age (<= 29 year) were more susceptible to at least one side effect (chi 2 = 4.2; p = 0.04) after first dose. ConclusionThe prevalence of side effect after first and second dose vaccine was higher. Most of the symptoms were short lived and mild. This result might help to solve an emerging public health challenge (vaccine hesitancy) nurtured by misinformation related to vaccines safety.	[Desalegn, Mitiku] Wachemo Univ, Coll Med & Hlth Sci, Dept Anesthesia, Hossana, Ethiopia; [Garoma, Gelana] Addis Ababa Univ, Coll Hlth Sci, Dept Oral & Maxillofacial Surg, Addis Ababa, Ethiopia; [Tamrat, Habtamu] Wachemo Univ, Coll Med & Hlth Sci, Dept Orthoped, Hosanna, Ethiopia; [Desta, Adane] Wachemo Univ, Coll Med & Hlth Sci, Dept Surg, Hosanna, Ethiopia; [Prakash, Ajay] Wachemo Univ, Coll Med & Hlth Sci, Dept Dent, Hosanna, Ethiopia	Addis Ababa University	Garoma, G (corresponding author), Addis Ababa Univ, Coll Hlth Sci, Dept Oral & Maxillofacial Surg, Addis Ababa, Ethiopia.	gelana.garoma2021@gmail.com	Desalegn, Mitiku/GQH-0610-2022	Garoma, Gelana/0000-0003-4616-7837				Andrzejczak-Grzadko S, 2021, EUR REV MED PHARMACO, V25, P4418, DOI 10.26355/eurrev_202106_26153; [Anonymous], 2020, SCI BRIEF SARS COV 2; Coleman CM, 2014, J VIROL, V88, P5209, DOI 10.1128/JVI.03488-13; Dror AA, 2020, EUR J EPIDEMIOL, V35, P775, DOI 10.1007/s10654-020-00671-y; El-Sahly HM, 2000, CLIN INFECT DIS, V31, P96, DOI 10.1086/313937; El-Shitany NA, 2021, INT J GEN MED, V14, P1389, DOI 10.2147/IJGM.S310497; England PH, 2020, COVID 19 VACCINATION, P1; Guo YR, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-00240-0; Haidere MF, 2021, BIOMOL THER, V29, P1, DOI 10.4062/biomolther.2020.178; Jayadevan R., 2021, MEDRXIV, DOI [10.1101/2021.02.08.21251366, DOI 10.1101/2021.02.08.21251366]; Kaur A, 2021, CURR PHARM DESIGN, V27, P3551, DOI 10.2174/1381612827999210111185608; Klugar M, 2021, BIOLOGY-BASEL, V10, DOI 10.3390/biology10080752; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Nguyen TL, 2018, IEEE INT CONF BIG DA, P5411, DOI 10.1109/BigData.2018.8622377; Norwegian Medicines Agencies, 2021, REP SUSP ADV REACT C, P1; Riad A, 2021, J CLIN MED, V10, DOI 10.3390/jcm10071428; Saeed BQ, 2021, INT J INFECT DIS, V111, P219, DOI 10.1016/j.ijid.2021.08.013; Szmyd B, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9030218	18	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	6							e0265140	10.1371/journal.pone.0265140	http://dx.doi.org/10.1371/journal.pone.0265140			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3F0KH	35749520	Green Published, gold			2022-12-26	WOS:000830362700044
J	Marshall, S; McNeil, N; Seal, EL; Nicholson, M				Marshall, Samantha; McNeil, Nicola; Seal, Emma Louise; Nicholson, Matthew			Elite sport hubs during COVID-19: The job demands and resources that exist for athletes	PLOS ONE			English	Article							ROLE OVERLOAD; BURNOUT; STRESS; HEALTH; IMPACT; MATCH; MODEL	In response to the COVID-19 pandemic, elite sport leagues implemented hubs, or 'bubbles', which restricted athletes' movements and social interactions in order to minimise the risk of athlete infection and allow competitions to continue. This was a new way of working and living for elite athletes and there was a dearth of literature on this topic. The main objective of the study was to investigate the impacts of the hub model on athletes over time, and what job demands and resources existed for athletes through the application of Demerouti et al. (2001) Job Demands-Resources Model. Multiple sequential semi-structured interviews were conducted with Women's National Basketball League (WNBL) athletes during the 2020 season, which was held entirely in a hub in North Queensland, Australia. The key job demands in an elite sport hub identified were the volume of work, simultaneous overload and underload, and nature of work in the hub. The key resources that emerged include recovery services, control and player agency, and constructive social relations. Despite the presence of job resources, which work to counteract, or buffer job demands in order to reduce work stress and improve motivation, they were found to be insufficient for athletes and inequitably distributed between clubs. The intensity of the hub model also amplified demands present in all WNBL seasons. This research is therefore useful for planning of future elite sport leagues to improve the type and amount of resources available to athletes, thereby improving athlete wellbeing and performance both within and outside a hub model.	[Marshall, Samantha] La Trobe Univ, Ctr Sport & Social Impact, Melbourne, Vic, Australia; [McNeil, Nicola] La Trobe Univ, Dept Management & Mkt, Melbourne, Vic, Australia; [Seal, Emma Louise] RMIT Univ, Social & Global Studies Ctr, Melbourne, Vic, Australia; [Nicholson, Matthew] Monash Univ Malaysia, Malaysia Off PVC & President, Subang Jaya, Selangor, Malaysia	La Trobe University; La Trobe University; Royal Melbourne Institute of Technology (RMIT); Monash University; Monash University Sunway	Marshall, S (corresponding author), La Trobe Univ, Ctr Sport & Social Impact, Melbourne, Vic, Australia.	Samantha.Marshall@latrobe.edu.au	; Seal, Emma/L-7745-2016	Marshall, Samantha/0000-0001-7866-3427; Seal, Emma/0000-0001-8476-9201	Basketball Australia	Basketball Australia	This study was supported by a PhD Industry Scholarship with Basketball Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker A.B., 2003, EUR J WORK ORGAN PSY, V12, P393, DOI DOI 10.1080/13594320344000165; Bakker A.B., 2014, WELLBEING COMPLETE R, P1, DOI [DOI 10.1002/9781118539415.WBWELL019, 10.1002/9781118539415.wbwell019]; Bakker AB, 2017, J OCCUP HEALTH PSYCH, V22, P273, DOI 10.1037/ocp0000056; Bakker AB, 2005, J OCCUP HEALTH PSYCH, V10, P170, DOI 10.1037/1076-8998.10.2.170; Balk YA, 2020, APPL PSYCHOL-INT REV, V69, P120, DOI 10.1111/apps.12188; Balk YA, 2018, J SPORT SCI MED, V17, P237; Balk YA, 2017, PSYCHOL SPORT EXERC, V33, P7, DOI 10.1016/j.psychsport.2017.07.006; Bowes A, 2022, MANAG SPORT LEIS, V27, P513, DOI 10.1080/23750472.2020.1825988; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Clarkson BG, 2022, MANAG SPORT LEIS, V27, P44, DOI 10.1080/23750472.2020.1766377; Clarkson BG., 2021, I ANAL GENDER INEQUA; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; DeFreese JD, 2021, J CLIN SPORT PSYCHOL, V15, P89, DOI 10.1123/jcsp.2019-0084; Demerouti E, 2001, J APPL PSYCHOL, V86, P499, DOI 10.1037//0021-9010.86.3.499; Evans AB, 2020, EUR J SPORT SOC, V17, P85, DOI 10.1080/16138171.2020.1765100; Fiorilli G, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248345; FISHER CD, 1993, HUM RELAT, V46, P395, DOI 10.1177/001872679304600305; Fletcher D, 2012, SCAND J MED SCI SPOR, V22, P545, DOI 10.1111/j.1600-0838.2010.01242.x; Fraina M, 2020, J STUDY SPORTS ATHL, V14, P140, DOI 10.1080/19357397.2020.1768033; FREY JH, 1991, ANNU REV SOCIOL, V17, P503, DOI 10.1146/annurev.so.17.080191.002443; Halson SL, 2004, SPORTS MED, V34, P967, DOI 10.2165/00007256-200434140-00003; Lee RT, 1996, J APPL PSYCHOL, V81, P123, DOI 10.1037/0021-9010.81.2.123; Logue M., 2020, NEWSCOMAU INTERNET; Ludvigsen JAL, 2022, MANAG SPORT LEIS, V27, P129, DOI 10.1080/23750472.2020.1782252; Madigan DJ., 2021, SPORT HEAL, V38, P4; McCloskey B, 2020, LANCET, V395, P1096, DOI 10.1016/S0140-6736(20)30681-4; Mehrsafar AH, 2020, BRAIN BEHAV IMMUN, V87, P147, DOI 10.1016/j.bbi.2020.05.011; Nauright J, 2020, SPORT SOC, V23, P1703, DOI 10.1080/17430437.2020.1834196; Pacewicz CE, 2020, PSYCHOL SPORT EXERC, V50, DOI 10.1016/j.psychsport.2020.101709; Pape M, 2020, GENDER SOC, V34, P81, DOI 10.1177/0891243219867914; Parasuraman S, 2000, J Occup Health Psychol, V5, P74, DOI 10.1037/1076-8998.5.1.74; Pons J, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.611872; Raedeke TD, 2004, J SPORT EXERCISE PSY, V26, P525, DOI 10.1123/jsep.26.4.525; Rowe D, 2020, J SOCIOL, V56, P704, DOI 10.1177/1440783320941284; SALES SM, 1970, ORGAN BEHAV HUM PERF, V5, P592, DOI 10.1016/0030-5073(70)90042-5; Samuel RD, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.567966; Shultz KS, 2010, STRESS HEALTH, V26, P99, DOI 10.1002/smi.1268; van Woerkom M, 2016, J APPL PSYCHOL, V101, P141, DOI 10.1037/apl0000033; Washif JA, 2022, SPORTS MED, V52, P933, DOI 10.1007/s40279-021-01573-z; WNBL, 2020, WNBLHUB SEAS WILL GE; WNBL, 2020, WNBL NEWS; WNBL, 2017, HIST WNBL	42	2	2	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7								10.1371/journal.pone.0269817	http://dx.doi.org/10.1371/journal.pone.0269817			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M5FN	35788207	gold, Green Published			2022-12-26	WOS:000835487000011
J	Petrovan, SO; Al-Fulaij, N; Christie, A; Andrews, H				Petrovan, Silviu O.; Al-Fulaij, Nida; Christie, Alec; Andrews, Henry			Why link diverse citizen science surveys? Widespread arboreal habits of a terrestrial amphibian revealed by mammalian tree surveys in Britain	PLOS ONE			English	Article							LOCOMOTOR MODE; EVOLUTION; ANURANS; MICROHABITATS; MORPHOLOGY; PATTERNS; ECOLOGY	Terrestrial anurans, with their typically short limbs, heavy-set bodies and absent claws or toe pads are incongruous tree climbers, but even occasional arboreal locomotion could offer substantial advantages for evading predators or accessing new shelter or food resources. Despite recent interest, arboreal behaviour remains rarely and unsystematically described for terrestrial amphibians in Europe, likely due to fundamental differences in survey methods and therefore a lack of field data. However, other taxa surveys specifically target trees and tree cavities. We undertook collaborations and large-scale data searches with two major citizen science projects surveying for arboreal mammals in Britain to investigate potential tree climbing by amphibians at a national scale. Remarkably, we found widespread arboreal usage by amphibians in England and Wales, with occupancy of hazel dormouse (Muscardinus avellenarius) nest boxes, tree cavities investigated as potential bat roosts and even a bird nest, by common toads (Bufo bufo), but few additional records of frogs or newts. Of the 277-400 sites surveyed annually for dormice since 2009 at least 18 sites had amphibians recorded in nest boxes while of the 1388 trees surveyed for bats a total 1.4% (19 trees) had toads present. Common toads were found using cavities in seven tree species and especially goat willow (Salix caprea). Toads are potentially attracted to tree cavities and arboreal nests because they provide safe and damp microenvironments which can support an abundance of invertebrate prey but the importance of such tree microhabitats for toad conservation remains unknown and our results should be interpreted cautiously. We encourage expanding and linking of unrelated biodiversity monitoring surveys and citizen science initiatives as valuable tools for investigating ecological traits and interactions.	[Petrovan, Silviu O.; Christie, Alec] Univ Cambridge, Dept Zool, Conservat Sci Grp, Cambridge, England; [Petrovan, Silviu O.] Froglife Trust, Peterborough, England; [Al-Fulaij, Nida] Peoples Trust Endangered Species, London, England; [Christie, Alec] Univ Cambridge Downing Coll, Cambridge, England; [Andrews, Henry] Bat Tree Habitat Key, Barnstaple, England	University of Cambridge; University of Cambridge	Petrovan, SO (corresponding author), Univ Cambridge, Dept Zool, Conservat Sci Grp, Cambridge, England.; Petrovan, SO (corresponding author), Froglife Trust, Peterborough, England.	sop21@cam.ac.uk	Petrovan, Silviu/ADM-9976-2022; Christie, Alec/E-1697-2018	Petrovan, Silviu/0000-0002-3984-2403; Christie, Alec/0000-0002-8465-8410				Agasyan A., 2009, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2009.RLTS.T54596A11159939.en, DOI 10.2305/IUCN.UK.2009.RLTS.T54596A11159939.EN]; [Anonymous], NBN ATLAS 2021 LUCIL; Arias-Robledo G., 2019, THESIS U BRISTOL; Astley HC, 2016, J EXP BIOL, V219, P3163, DOI 10.1242/jeb.142315; Basile M, 2020, J ENVIRON MANAGE, V264, DOI 10.1016/j.jenvman.2020.110401; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beebee TJC., 1985, FROGS TOADS; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bright Paul, 1996, P1; Bringsoe H., 2016, MERTENSIELLA, V24, P146; Bringsoe Henrik, 2013, Mertensiella, V19, P131; BTHK, BTHK ANN ACC TREE SP; Centers for Disease Control and Prevention (CDC), 2021, NATL HLTH NUTR EXAMI; Citadini JM, 2018, J EVOLUTION BIOL, V31, P371, DOI 10.1111/jeb.13228; Cockle KL, 2011, FRONT ECOL ENVIRON, V9, P377, DOI 10.1890/110013; de Noronha Janaina da Costa, 2013, Herpetological Bulletin, P21; Forest Research, 2021, PROV WOODL STAT 2021; Forsman ED, 2007, HERPETOL CONSERV BIO, V2, P113; Goodwin CED, 2017, MAMMAL REV, V47, P183, DOI 10.1111/mam.12091; Gosa Alberto, 2003, Herpetological Review, V34, P355; Groom Q, 2021, ECOGRAPHY, V44, P1781, DOI 10.1111/ecog.05790; Hartel T, 2008, APPL HERPETOL, V5, P1, DOI 10.1163/157075408783489248; Hothorn T., 2008, MULTCOMP SIMULTANEOU; Hudson CM, 2016, BIOL J LINN SOC, V119, P992, DOI 10.1111/bij.12827; Johann F, 2016, FOREST ECOL MANAG, V380, P70, DOI 10.1016/j.foreco.2016.08.037; Jorgensen ME, 2013, J EVOLUTION BIOL, V26, P929, DOI 10.1111/jeb.12128; Karantanis NE, 2017, MAMM BIOL, V83, P51, DOI 10.1016/j.mambio.2016.12.004; Langowski JKA, 2018, FRONT ZOOL, V15, DOI 10.1186/s12983-018-0273-x; Maia-Carneiro T., 2020, BRAZILIAN J BIOL SCI, V7, P149, DOI [10.21472/bjbs(2020)071602, DOI 10.21472/BJBS(2020)071602]; McEntire KD, 2016, COPEIA, V104, P124, DOI 10.1643/OT-14-214; Mcinroy Clare, 2015, Herpetological Bulletin, P15; MuMIn Barton K., 2021, **DATA OBJECT**; Oliveira BF, 2019, ECOGRAPHY, V42, P249, DOI 10.1111/ecog.03636; Petrovan SO, 2020, BIODIVERS CONSERV, V29, P1767, DOI 10.1007/s10531-020-01956-0; Petrovan SO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161943; Petrovic TG, 2017, CR BIOL, V340, P250, DOI 10.1016/j.crvi.2017.02.004; R Core Team, 2020, R LANG ENV STAT COMP; Roy HE, UNDERSTANDING CITIZE; RSPB, 2021, BIRDS WILDL BIRDS; Salazar RD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148269; Smith JM, 2006, J COMP PHYSIOL A, V192, P1193, DOI 10.1007/s00359-006-0151-4; Smith M., 1969, THE NEW NATURALIST, V20; Speybroeck J., 2016, FIELD GUIDE AMPHIBIA; Stroup W.W., 2012, GEN LINEAR MIXED MOD; Toledo LF, 2007, J ZOOL, V271, P170, DOI 10.1111/j.1469-7998.2006.00195.x; Vassallo AI, 2021, EVOL BIOL, V48, P293, DOI 10.1007/s11692-021-09539-9; Wheeler PM, 2019, BIOL CONSERV, V232, P274, DOI 10.1016/j.biocon.2019.01.021; White I., 2019, HAZEL DORMOUSE REINT; Winter S, 2008, FOREST ECOL MANAG, V255, P1251, DOI 10.1016/j.foreco.2007.10.029	49	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7								10.1371/journal.pone.0265156	http://dx.doi.org/10.1371/journal.pone.0265156			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M3CI	35793361	Green Published, gold, Green Submitted			2022-12-26	WOS:000835338100024
J	Suarez-Varon, G; Mendoza-Cruz, E; Acosta, A; Cruz, MVS; Cortez, D; Hernandez-Gallegos, O				Suarez-Varon, Gabriel; Mendoza-Cruz, Eva; Acosta, Armando; Cruz, Maricela Villagran-Santa; Cortez, Diego; Hernandez-Gallegos, Oswaldo			Genetic determination and JARID2 over-expression in a thermal incubation experiment in Casque-Headed Lizard	PLOS ONE			English	Article							DEPENDENT SEX DETERMINATION; TEMPERATURE; COOCCURRENCE; DOSAGE	Non-avian reptiles, unlike mammals and birds, have undergone numerous sex determination changes. Casque-Headed Lizards have replaced the ancestral XY system shared across pleurodonts with a new pair of XY chromosomes. However, the evolutionary forces that triggered this transition have remained unclear. An interesting hypothesis suggests that species with intermediate states, with sex chromosomes but also thermal-induced sex reversal at specific incubation temperatures, could be more susceptible to sex determination turnovers. We contrasted genotypic data (presence/absence of the Y chromosome) against the histology of gonads of embryos from stages 35-37 incubated at various temperatures, including typical male-producing (26 degrees C) and female-producing (32 degrees C) temperatures. Our work apparently reports for the first time the histology of gonads, including morphological changes, from stages 35-37 of development in the family Corytophanidae. We also observed that all embryos developed hemipenes, suggesting sex-linked developmental heterochrony. We observed perfect concordance between genotype and phenotype at all temperatures. However, analysis of transcriptomic data from embryos incubated at 26 degrees C and 32 degrees C identified transcript variants of the chromatin modifiers JARID2 and KDM6B that have been linked to temperature-dependent sex determination in other reptiles. Our work tested the validity of a mixed sex determination system in the family Corytophanidae. We found that XY chromosomes are dominant; however, our work supports the hypothesis of a conserved transcriptional response to incubation temperatures across non-avian reptiles that could be a reminiscence of an ancestral sex determination system.	[Suarez-Varon, Gabriel; Hernandez-Gallegos, Oswaldo] Univ Autonoma Estado Mexico, Fac Ciencias, Inst Literario Ctr 100, Lab Herpetol, Toluca, Estado De Mexic, Mexico; [Mendoza-Cruz, Eva; Cruz, Maricela Villagran-Santa] Univ Nacl Autonoma Mexico, Fac Ciencias, Dept Biol Comparada, Lab Biol Tisular & Reproductora, Mexico City, Mexico; [Acosta, Armando; Cortez, Diego] UNAM, Ctr Ciencias Genomicas, Cuernavaca, Mexico	Universidad Autonoma del Estado de Morelos; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Cortez, D (corresponding author), UNAM, Ctr Ciencias Genomicas, Cuernavaca, Mexico.	dcortez@ccg.unam.mx		Cortez, Diego/0000-0003-0654-6349	PAPIIT-UNAM [RA-200516, RA-200518]; PAPIIT-UNAM; CONACyT Basic Science [254240]; UAEMex [4668/2019SF]	PAPIIT-UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); PAPIIT-UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); CONACyT Basic Science; UAEMex	This study was supported by grants from PAPIIT-UNAM (No. RA-200516 and No. RA-200518; https://dgapa.unam.mx/index.php/impulso-a-la-investigacion/papiit) and CONACyT Basic Science grant (No. 254240; https://conacyt.mx/) awarded to D.C., and UAEMex 4668/2019SF (https://www.uaemex.mx/) to OH	Acosta A, 2019, GENOME BIOL EVOL, V11, P2666, DOI 10.1093/gbe/evz196; Altmanova M, 2018, ZOOLOGY, V126, P98, DOI 10.1016/j.zool.2017.11.007; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bachtrog D, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001899; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Cornejo-Paramo P, 2020, BMC EVOL BIOL, V20, DOI 10.1186/s12862-020-01671-y; Cornejo-Paramo P, 2020, GENOME BIOL EVOL, V12, P924, DOI 10.1093/gbe/evaa104; Czerwinski M, 2016, DEV BIOL, V420, P166, DOI 10.1016/j.ydbio.2016.09.018; Deveson IW, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700731; Dissanayake DSB, 2021, HEREDITY, V126, P805, DOI 10.1038/s41437-021-00406-z; DUFAURE JP, 1961, ARCH ANAT MICROSC MO, V50, P309; Gamble T, 2015, MOL BIOL EVOL, V32, P1296, DOI 10.1093/molbev/msv023; Ge CT, 2018, SCIENCE, V360, P645, DOI 10.1126/science.aap8328; Georges A, 2010, SEX DEV, V4, P7, DOI 10.1159/000279441; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haltenhof T, 2020, MOL CELL, V78, P57, DOI 10.1016/j.molcel.2020.01.028; Hill PL, 2018, GENOME BIOL EVOL, V10, P1079, DOI 10.1093/gbe/evy042; Holleley CE, 2015, NATURE, V523, P79, DOI 10.1038/nature14574; Marin R, 2017, GENOME RES, V27, P1974, DOI 10.1101/gr.223727.117; Martinez-Torres M, 2015, EVOL DEV, V17, P270, DOI 10.1111/ede.12134; Neaves L, 2006, J EXP ZOOL PART A, V305A, P74, DOI 10.1002/jez.a.249; Nielsen SV, 2019, BIOL LETTERS, V15, DOI 10.1098/rsbl.2019.0498; Pennell MW, 2018, MOL ECOL, V27, P3950, DOI 10.1111/mec.14540; Pincheira-Donoso D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059741; Quinn AE, 2007, SCIENCE, V316, P411, DOI 10.1126/science.1135925; Quinn AE, 2009, MOL GENET GENOMICS, V281, P665, DOI 10.1007/s00438-009-0437-7; Radder RS, 2008, BIOL LETTERS, V4, P176, DOI 10.1098/rsbl.2007.0583; Robert KA, 2001, NATURE, V412, P698, DOI 10.1038/35089135; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rovatsos M, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2013.1093; Sabath N, 2016, ECOL EVOL, V6, P5207, DOI 10.1002/ece3.2277; Sarre SD, 2004, BIOESSAYS, V26, P639, DOI 10.1002/bies.20050; Shine R, 2002, ECOL LETT, V5, P486, DOI 10.1046/j.1461-0248.2002.00351.x; Suarez-Varon G, 2021, REV MEX BIODIVERS, V92, DOI 10.22201/ib.20078706e.2021.92.3795; Whiteley SL, 2021, SEX DEV, V15, P148, DOI 10.1159/000515687; Whiteley SL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33170-y	36	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7							e0263804	10.1371/journal.pone.0263804	http://dx.doi.org/10.1371/journal.pone.0263804			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M2ZD	35797377	Green Published, gold			2022-12-26	WOS:000835328600018
J	Taylor, G; Frommherz, Y; Katikaridis, P; Layer, D; Sinning, I; Carroni, M; Weber-Ban, E; Mogk, A				Taylor, Gabrielle; Frommherz, Yannick; Katikaridis, Panagiotis; Layer, Dominik; Sinning, Irmgard; Carroni, Marta; Weber-Ban, Eilika; Mogk, Axel			Antibacterial peptide CyclomarinA creates toxicity by deregulating the Mycobacterium tuberculosis ClpC1-ClpP1P2 protease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADAPTER PROTEIN; COMPLEX; CLPS	The ring-forming AAA+ hexamer ClpC1 associates with the peptidase ClpP1P2 to form a central ATP-driven protease in Mycobacterium tuberculosis (Mtb). ClpC1 is essential for Mtb viability and has been identified as the target of antibacterial peptides like CyclomarinA (CymA) that exhibit strong toxicity toward Mtb. The mechanistic actions of these drugs are poorly understood. Here, we dissected how ClpC1 activity is controlled and how this control is deregulated by CymA. We show that ClpC1 exists in diverse activity states correlating with its assembly. The basal activity of ClpC1 is low, as it predominantly exists in an inactive nonhexameric resting state. We show that CymA stimulates ClpC1 activity by promoting formation of supercomplexes composed of multiple ClpC1 hexameric rings, enhancing ClpC1-ClpP1P2 degradation ac-tivity toward various substrates. Both the ClpC1 resting state and the CymA-induced alternative assembly state rely on in-teractions between the ClpC1 coiled-coil middle domains (MDs). Accordingly, we found that mutation of the conserved aromatic F444 residue located at the MD tip blocks MD in-teractions and prevents assembly into higher order complexes, thereby leading to constitutive ClpC1 hexamer formation. We demonstrate that this assembly state exhibits the highest ATPase and proteolytic activities, yet its heterologous expres-sion in Escherichia coli is toxic, indicating that the formation of such a state must be tightly controlled. Taken together, these findings define the basis of control of ClpC1 activity and show how ClpC1 overactivation by an antibacterial drug generates toxicity.	[Taylor, Gabrielle; Weber-Ban, Eilika] Swiss Fed Inst Technol, Inst Mol Biol & Biophys, Zurich, Switzerland; [Frommherz, Yannick; Katikaridis, Panagiotis; Mogk, Axel] Univ Heidelberg ZMBH, DKFZ ZMBH Alliance, Ctr Mol Biol, Heidelberg, Germany; [Frommherz, Yannick; Katikaridis, Panagiotis; Mogk, Axel] Deutsch Krebsforschungszentrum DKFZ, Div Chaperones & Proteases, Heidelberg, Germany; [Layer, Dominik; Sinning, Irmgard] Heidelberg Univ, Biochem Ctr BZH, Heidelberg, Germany; [Carroni, Marta] Stockholm Univ, Swedish Cryo EM Facil, Sci Life Lab, Solna, Sweden	Swiss Federal Institutes of Technology Domain; ETH Zurich; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Stockholm University	Weber-Ban, E (corresponding author), Swiss Fed Inst Technol, Inst Mol Biol & Biophys, Zurich, Switzerland.; Mogk, A (corresponding author), Univ Heidelberg ZMBH, DKFZ ZMBH Alliance, Ctr Mol Biol, Heidelberg, Germany.; Mogk, A (corresponding author), Deutsch Krebsforschungszentrum DKFZ, Div Chaperones & Proteases, Heidelberg, Germany.	eilika@mol.biol.ethz.ch; a.mogk@zmbh.uni-heidelberg.de		Carroni, Marta/0000-0002-7697-6427; Layer, Dominik/0000-0002-1577-7651; Taylor, Gabrielle/0000-0001-7960-8745	Deutsche Forschungsgemeinschaft [MO970/4-3]; ETH Zurich research grant [ETH-40 16-1]; Heidelberg Biosciences International Graduate School	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ETH Zurich research grant(ETH Zurich); Heidelberg Biosciences International Graduate School	This work was supported by a grant of the Deutsche Forschungsgemeinschaft (grant no.: MO970/4-3) to A.M. and by an ETH Zurich research grant (grant no.: ETH-40 16-1) to E.W.-B. P.K. was supported by the Heidelberg Biosciences International Graduate School.	Abrishami V, 2013, BIOINFORMATICS, V29, P2460, DOI 10.1093/bioinformatics/btt429; Akopian T, 2012, EMBO J, V31, P1529, DOI 10.1038/emboj.2012.5; Bhandari V, 2018, ACS CHEM BIOL, V13, P1413, DOI 10.1021/acschembio.8b00124; Brotz-Oesterhelt H, 2021, FRONT MOL BIOSCI, V8, DOI 10.3389/fmolb.2021.690902; Brotz-Oesterhelt H, 2005, NAT MED, V11, P1082, DOI 10.1038/nm1306; Carroni Marta, 2017, Elife, V6, DOI 10.7554/eLife.30120; Choules MP, 2019, ANTIMICROB AGENTS CH, V63, DOI [10.1128/aac.02204-18, 10.1128/AAC.02204-18]; de la Rosa-Trevin JM, 2016, J STRUCT BIOL, V195, P93, DOI 10.1016/j.jsb.2016.04.010; Deville C, 2019, CELL REP, V27, P3433, DOI 10.1016/j.celrep.2019.05.075; Erbse A, 2006, NATURE, V439, P753, DOI 10.1038/nature04412; Famulla K, 2016, MOL MICROBIOL, V101, P194, DOI 10.1111/mmi.13362; Gao W, 2015, ANTIMICROB AGENTS CH, V59, P880, DOI 10.1128/AAC.04054-14; Gates SN, 2020, PROTEIN SCI, V29, P407, DOI 10.1002/pro.3743; Gavrish E, 2014, CHEM BIOL, V21, P509, DOI 10.1016/j.chembiol.2014.01.014; Kirstein J, 2006, EMBO J, V25, P1481, DOI 10.1038/sj.emboj.7601042; Kirstein J, 2009, EMBO MOL MED, V1, P37, DOI 10.1002/emmm.200900002; Kotamarthi HC, 2020, CELL REP, V30, P2644, DOI 10.1016/j.celrep.2020.01.110; Lee H, 2016, J IND MICROBIOL BIOT, V43, P205, DOI 10.1007/s10295-015-1709-3; Leodolter J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125345; Mahmoud SA, 2018, ANNU REV BIOCHEM, V87, P677, DOI 10.1146/annurev-biochem-062917-012848; Marsee JD, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113651; Maurer M, 2019, CELL CHEM BIOL, V26, P1169, DOI 10.1016/j.chembiol.2019.05.008; Morreale F.E., 2021, 447781 BIORXIV; Olivares AO, 2016, NAT REV MICROBIOL, V14, P33, DOI 10.1038/nrmicro.2015.4; Sauer RT, 2011, ANNU REV BIOCHEM, V80, P587, DOI 10.1146/annurev-biochem-060408-172623; Schlothauer T, 2003, P NATL ACAD SCI USA, V100, P2306, DOI 10.1073/pnas.0535717100; Schmitt EK, 2011, ANGEW CHEM INT EDIT, V50, P5889, DOI 10.1002/anie.201101740; Schmitz KR, 2014, MOL MICROBIOL, V93, P617, DOI 10.1111/mmi.12694; Trentini DB, 2016, NATURE, V539, P48, DOI 10.1038/nature20122; Vasudevan D, 2013, J BIOL CHEM, V288, P30883, DOI 10.1074/jbc.M113.493767; Wang F, 2011, NATURE, V471, P331, DOI 10.1038/nature09780; Wolf NM, 2020, ACTA CRYSTALLOGR D, V76, P458, DOI 10.1107/S2059798320004027; Wolf NM, 2019, ACS INFECT DIS, V5, P829, DOI 10.1021/acsinfecdis.8b00276; Zeth K, 2002, NAT STRUCT BIOL, V9, P906, DOI 10.1038/nsb869; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Ziemski M, 2021, FEBS J, V288, P111, DOI 10.1111/febs.15335; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	38	3	3	4	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2022	298	8							102202	10.1016/j.jbc.2022.102202	http://dx.doi.org/10.1016/j.jbc.2022.102202			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3H4VJ	35768046	Green Published, gold			2022-12-26	WOS:000832034800001
J	Bhattacharyay, S; Milosevic, I; Wilson, L; Menon, DK; Stevens, RD; Steyerberg, EW; Nelson, DW; Ercole, A; CTR TBI Investigators Participants				Bhattacharyay, Shubhayu; Milosevic, Ioan K.; Wilson, Lindsay D.; Menon, David W.; Stevens, Robert W.; Steyerberg, Ewout; Nelson, David; Ercole, Ari; CTR TBI Investigators Participants, Soojin			The leap to ordinal: Detailed functional prognosis after traumatic brain injury with a flexible modelling approach	PLOS ONE			English	Article							NEUROTRAUMA EFFECTIVENESS RESEARCH; EXTERNAL VALIDATION; OUTCOME PREDICTION; REGRESSION-MODELS; HEAD-INJURY; CENTER-TBI; IMPACT; CARE; MULTICENTER; CALIBRATION	When a patient is admitted to the intensive care unit (ICU) after a traumatic brain injury (TBI), an early prognosis is essential for baseline risk adjustment and shared decision making. TBI outcomes are commonly categorised by the Glasgow Outcome Scale-Extended (GOSE) into eight, ordered levels of functional recovery at 6 months after injury. Existing ICU prognostic models predict binary outcomes at a certain threshold of GOSE (e.g., prediction of survival [GOSE > 1]). We aimed to develop ordinal prediction models that concurrently predict probabilities of each GOSE score. From a prospective cohort (n = 1,550, 65 centres) in the ICU stratum of the Collaborative European NeuroTrauma Effectiveness Research in TBI (CENTER-TBI) patient dataset, we extracted all clinical information within 24 hours of ICU admission (1,151 predictors) and 6-month GOSE scores. We analysed the effect of two design elements on ordinal model performance: (1) the baseline predictor set, ranging from a concise set of ten validated predictors to a token-embedded representation of all possible predictors, and (2) the modelling strategy, from ordinal logistic regression to multinomial deep learning. With repeated k-fold cross-validation, we found that expanding the baseline predictor set significantly improved ordinal prediction performance while increasing analytical complexity did not. Half of these gains could be achieved with the addition of eight high-impact predictors to the concise set. At best, ordinal models achieved 0.76 (95% CI: 0.74-0.77) ordinal discrimination ability (ordinal c-index) and 57% (95% CI: 54%- 60%) explanation of ordinal variation in 6-month GOSE (Somers' D-xy). Model performance and the effect of expanding the predictor set decreased at higher GOSE thresholds, indicating the difficulty of predicting better functional outcomes shortly after ICU admission. Our results motivate the search for informative predictors that improve confidence in prognosis of higher GOSE and the development of ordinal dynamic prediction models.	[Bhattacharyay, Shubhayu; Milosevic, Ioan K.; Menon, David W.; Ercole, Ari] Univ Cambridge, Div Anaesthesia, Cambridge, England; [Bhattacharyay, Shubhayu] Univ Cambridge, Dept Clin Neurosci, Cambridge, England; [Bhattacharyay, Shubhayu; Stevens, Robert W.] Johns Hopkins Univ, Lab Computat Intens Care Med, Baltimore, MD 21287 USA; [Wilson, Lindsay D.] Univ Stirling, Div Psychol, Stirling, Scotland; [Stevens, Robert W.] Johns Hopkins Univ, Dept Anesthesiol & Crit Care Med, Baltimore, MD USA; [Steyerberg, Ewout] Leiden Univ, Dept Biomed Data Sci, Med Ctr, Leiden, Netherlands; [Nelson, David] Karolinska Inst, Dept Physiol & Pharmacol, Sect Perioperat Med & Intens Care, Stockholm, Sweden; [Ercole, Ari] Cambridge Ctr Artificial Intelligence Med, Cambridge, England	University of Cambridge; University of Cambridge; Johns Hopkins University; University of Stirling; Johns Hopkins University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Karolinska Institutet	Bhattacharyay, S (corresponding author), Univ Cambridge, Div Anaesthesia, Cambridge, England.; Bhattacharyay, S (corresponding author), Univ Cambridge, Dept Clin Neurosci, Cambridge, England.; Bhattacharyay, S (corresponding author), Johns Hopkins Univ, Lab Computat Intens Care Med, Baltimore, MD 21287 USA.	sb2406@cam.ac.uk	Ercole, Ari/B-6288-2009	Ercole, Ari/0000-0001-8350-8093; Bhattacharyay, Shubhayu/0000-0001-7428-5588; Volovici, Victor/0000-0002-5798-5360; Zeiler, Frederick/0000-0003-1737-0510; Wilson, Lindsay/0000-0003-4113-2328; Golubovic, Jagos/0000-0001-5524-246X; Menon, David/0000-0002-3228-9692; Williams, Guy/0000-0001-5223-6654	National Institute for Health Research (NIHR) Brain Injury MedTech Co-operative based at Cambridge University Hospitals NHS Foundation Trust and University of Cambridge; European Union 7th Framework programme (EC ) [602150]; Hannelore Kohl Stiftung (Germany); OneMind (USA); Integra LifeSciences Corporation (USA); International Initiative for TBI Research (InTBIR) investigators; United Kingdom Engineering and Physical Sciences Research Council (EPSRC) [T022159]; Gates Cambridge fellowship	National Institute for Health Research (NIHR) Brain Injury MedTech Co-operative based at Cambridge University Hospitals NHS Foundation Trust and University of Cambridge; European Union 7th Framework programme (EC ); Hannelore Kohl Stiftung (Germany); OneMind (USA); Integra LifeSciences Corporation (USA); International Initiative for TBI Research (InTBIR) investigators; United Kingdom Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Gates Cambridge fellowship	The research was supported by the National Institute for Health Research (NIHR) Brain Injury MedTech Co-operative based at Cambridge University Hospitals NHS Foundation Trust and University of Cambridge. The views expressed are those of the author(s) and not necessarily those of the NHS, NIHR or the Department of Health and Social Care. CENTER-TBI was supported by the European Union 7th Framework programme (EC grant 602150). Additional funding was obtained from the Hannelore Kohl Stiftung (Germany), from OneMind (USA), and from Integra LifeSciences Corporation (USA). CENTER-TBI also acknowledges interactions and support from the International Initiative for TBI Research (InTBIR) investigators. CSD3 is supported by the United Kingdom Engineering and Physical Sciences Research Council (EPSRC Tier-2 capital grant EP/ T022159/1). SB is currently funded by a Gates Cambridge fellowship. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin PC, 2019, STAT MED, V38, P4051, DOI 10.1002/sim.8281; Austin PC, 2014, STAT MED, V33, P517, DOI 10.1002/sim.5941; Bengio Y, 2003, J MACH LEARN RES, V3, P1137, DOI 10.1162/153244303322533223; Bhattacharyay S, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-02974-w; CENTER-TBI Investigators and Participants, CENTER TBI INV PART; Chen K., 2013, ADV NEURAL INF PROCE, V26, P3111, DOI DOI 10.5555/2999792.2999959; COX DR, 1958, BIOMETRIKA, V45, P562, DOI 10.1093/biomet/45.3-4.562; Deasy J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-79142-z; Dijkland SA, 2019, J NEUROTRAUM, DOI 10.1089/neu.2019.6401; Doiron D, 2017, INT J EPIDEMIOL, V46, P1372, DOI 10.1093/ije/dyx180; Ercole A, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0253425; Falcon W.A., 2019, PYTORCH LIGHTNING; Farzaneh N, 2021, NPJ DIGIT MED, V4, DOI 10.1038/s41746-021-00445-0; Futoma J, 2020, LANCET DIGIT HEALTH, V2, pE489, DOI 10.1016/S2589-7500(20)30186-2; Gravesteijn BY, 2020, J CLIN EPIDEMIOL, V122, P95, DOI 10.1016/j.jclinepi.2020.03.005; Griffin AD, 2019, BRAIN, V142, P3550, DOI 10.1093/brain/awz290; Han JL, 2014, J NEUROTRAUM, V31, P1146, DOI 10.1089/neu.2013.3003; Harrell FE, 1998, STAT MED, V17, P909, DOI 10.1002/(SICI)1097-0258(19980430)17:8<909::AID-SIM753>3.0.CO;2-O; Harrell FE, 2015, SPRINGER SER STAT, P311, DOI 10.1007/978-3-319-19425-7_13; HILDEN J, 1991, MED DECIS MAKING, V11, P95, DOI 10.1177/0272989X9101100204; Horton L, 2018, J NEUROTRAUM, V35, P2005, DOI 10.1089/neu.2018.5648; Izzy S, 2013, NEUROCRIT CARE, V19, P347, DOI 10.1007/s12028-013-9925-z; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kean J, 2014, ARCH PHYS MED REHAB, V95, P1225, DOI 10.1016/j.apmr.2014.03.023; KIM JO, 1971, AM J SOCIOL, V76, P891, DOI 10.1086/225004; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kunzmann K, 2021, J NEUROTRAUM, V38, P455, DOI 10.1089/neu.2019.6858; Licht C, 2010, THESIS U BAMBERG; Lingsma H, 2013, J TRAUMA ACUTE CARE, V74, P639, DOI 10.1097/TA.0b013e31827d602e; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Lundberg SM, 2017, ADV NEUR IN, V30; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; McMillan T, 2016, NAT REV NEUROL, V12, P477, DOI 10.1038/nrneurol.2016.89; Meiring C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206862; MILLER ME, 1993, MED DECIS MAKING, V13, P49, DOI 10.1177/0272989X9301300107; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Panczykowski DM, 2012, J NEUROTRAUM, V29, P47, DOI 10.1089/neu.2010.1482; Paszke A, 2019, ADV NEUR IN, V32; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; R Core Team, 2020, R LANG ENV STAT COMP; Raj R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53889-6; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Seabold S., 2010, P 9 PYTHON SCI C, P92, DOI [DOI 10.25080/MAJORA-92BF1922-011, 10.25080/MAJORA-92BF1922-011]; SOMERS RH, 1962, AM SOCIOL REV, V27, P799, DOI 10.2307/2090408; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; TEASDALE G, 1974, LANCET, V2, P81; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Thelin EP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00351; Thorsen-Meyer HC, 2020, LANCET DIGIT HEALTH, V2, pE179, DOI 10.1016/S2589-7500(20)30018-2; Tsamardinos I, 2018, MACH LEARN, V107, P1895, DOI 10.1007/s10994-018-5714-4; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; van Buuren S, 2011, J STAT SOFTW, V45, P1; Van Calster B, 2016, J CLIN EPIDEMIOL, V74, P167, DOI 10.1016/j.jclinepi.2015.12.005; Van Calster B, 2012, BIOMETRICAL J, V54, P674, DOI 10.1002/bimj.201200026; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; van Veen E, 2021, INTENS CARE MED, V47, P1115, DOI 10.1007/s00134-021-06484-1; Virtanen P, 2020, NAT METHODS, V17, P261, DOI 10.1038/s41592-019-0686-2; Wallace EJ, 2018, NEUROSCI BIOBEHAV R, V92, P93, DOI 10.1016/j.neubiorev.2018.05.023; Wang KKW, 2013, PROC SPIE, V8723, DOI 10.1117/12.2020030; Wettervik TS, 2019, J NEUROTRAUM, V36, P1818, DOI 10.1089/neu.2018.6157; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2002, J NEUROTRAUM, V19, P999, DOI 10.1089/089771502760341910; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zeiler FA, 2019, J NEUROTRAUM, V36, P1505, DOI 10.1089/neu.2018.6182; Zeiler FA, 2018, J NEUROTRAUM, V35, P1107, DOI 10.1089/neu.2017.5472; Zeiler FA, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00331; Zuckerman DA, 2022, J NEUROTRAUM, V39, P1010, DOI 10.1089/neu.2021.0356	71	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2022	17	7							e0270973	10.1371/journal.pone.0270973	http://dx.doi.org/10.1371/journal.pone.0270973			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6G0CU	35788768	Green Published, Green Submitted, gold			2022-12-26	WOS:000884428700002
J	Dutta, S; Polavaram, NS; Islam, R; Bhattacharya, S; Bodas, S; Mayr, T; Roy, S; Albala, SAY; Toma, MI; Darehshouri, A; Borkowetz, A; Conrad, S; Fuessel, S; Wirth, M; Baretton, GB; Hofbauer, LC; Ghosh, P; Pienta, KJ; Klinkebiel, DL; Batra, SK; Muders, MH; Datta, K				Dutta, Samikshan; Polavaram, Navatha Shree; Islam, Ridwan; Bhattacharya, Sreyashi; Bodas, Sanika; Mayr, Thomas; Roy, Sohini; Albala, Sophie Alvarez Y.; Toma, Marieta, I; Darehshouri, Anza; Borkowetz, Angelika; Conrad, Stefanie; Fuessel, Susanne; Wirth, Manfred; Baretton, Gustavo B.; Hofbauer, Lorenz C.; Ghosh, Paramita; Pienta, Kenneth J.; Klinkebiel, David L.; Batra, Surinder K.; Muders, Michael H.; Datta, Kaustubh			Neuropilin-2 regulates androgen-receptor transcriptional activity in advanced prostate cancer	ONCOGENE			English	Article							NUCLEAR-PORE COMPLEXES; PROTEINS; NUP98	Aberrant transcriptional activity of androgen receptor (AR) is one of the dominant mechanisms for developing of castration-resistant prostate cancer (CRPC). Analyzing AR-transcriptional complex related to CRPC is therefore important towards understanding the mechanism of therapy resistance. While studying its mechanism, we observed that a transmembrane protein called neuropilin-2 (NRP2) plays a contributory role in forming a novel AR-transcriptional complex containing nuclear pore proteins. Using immunogold electron microscopy, high-resolution confocal microscopy, chromatin immunoprecipitation, proteomics, and other biochemical techniques, we delineated the molecular mechanism of how a specific splice variant of NRP2 becomes sumoylated upon ligand stimulation and translocates to the inner nuclear membrane. This splice variant of NRP2 then stabilizes the complex between AR and nuclear pore proteins to promote CRPC specific gene expression. Both full-length and splice variants of AR have been identified in this specific transcriptional complex. In vitro cell line-based assays indicated that depletion of NRP2 not only destabilizes the AR-nuclear pore protein interaction but also inhibits the transcriptional activities of AR. Using an in vivo bone metastasis model, we showed that the inhibition of NRP2 led to the sensitization of CRPC cells toward established anti-AR therapies such as enzalutamide. Overall, our finding emphasize the importance of combinatorial inhibition of NRP2 and AR as an effective therapeutic strategy against treatment refractory prostate cancer.	[Dutta, Samikshan; Polavaram, Navatha Shree; Islam, Ridwan; Bhattacharya, Sreyashi; Bodas, Sanika; Roy, Sohini; Klinkebiel, David L.; Batra, Surinder K.; Datta, Kaustubh] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Mayr, Thomas; Muders, Michael H.] Univ Bonn, Med Fac, Rudolf Becker Lab Prostate Canc Res, Bonn, Germany; [Mayr, Thomas; Toma, Marieta, I; Muders, Michael H.] Univ Bonn, Med Fac, Inst Pathol, Bonn, Germany; [Mayr, Thomas; Toma, Marieta, I; Baretton, Gustavo B.; Muders, Michael H.] Tech Univ Dresden, Inst Pathol, Dresden, Germany; [Albala, Sophie Alvarez Y.] Univ Nebraska, Dept Agron & Hort, Lincoln, NE USA; [Darehshouri, Anza] UT Southwestern Med Ctr, Dept Cell Biol, Dallas, TX USA; [Borkowetz, Angelika; Fuessel, Susanne; Wirth, Manfred] Tech Univ Dresden, Dept Urol, Dresden, Germany; [Conrad, Stefanie; Hofbauer, Lorenz C.] Tech Univ Dresden, Dept Med 3, Div Endocrinol & Metab Bone Dis, Dresden, Germany; [Conrad, Stefanie; Hofbauer, Lorenz C.] Tech Univ Dresden, Ctr Hlth Aging, Dresden, Germany; [Baretton, Gustavo B.; Hofbauer, Lorenz C.] German Res Ctr DKFZ, German Canc Consortium DKTK, Partner Site Dresden, Heidelberg, Germany; [Baretton, Gustavo B.] Univ Hosp, Univ Canc Ctr UCC, Tumor & Normal Tissue Bank, Dresden, Germany; [Baretton, Gustavo B.] Tech Univ Dresden, Fac Med, Dresden, Germany; [Ghosh, Paramita] Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA; [Pienta, Kenneth J.] Johns Hopkins Univ, Sch Med, Brady Urol Inst, Baltimore, MD USA	University of Nebraska System; University of Nebraska Medical Center; University of Bonn; University of Bonn; Technische Universitat Dresden; University of Nebraska System; University of Nebraska Lincoln; University of Texas System; University of Texas Southwestern Medical Center Dallas; Technische Universitat Dresden; Technische Universitat Dresden; Technische Universitat Dresden; Helmholtz Association; German Cancer Research Center (DKFZ); Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; University of California System; University of California Davis; Johns Hopkins University	Dutta, S; Datta, K (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.	samikshan.dutta@unmc.edu; kaustubh.datta@unmc.edu		Dutta, samikshan/0000-0002-4160-1422	Lageschulte Fund [1R21CA241234-01, NE-LB506]; DoD [W81XWH2110628]; DFG [273676790, 416001651]; Rudolf-Becker-Foundation; DFG;  [R01CA182435];  [R01CA239343]	Lageschulte Fund; DoD(United States Department of Defense); DFG(German Research Foundation (DFG)); Rudolf-Becker-Foundation; DFG(German Research Foundation (DFG)); ; 	This work was supported by grants for SD (1R21CA241234-01, NE-LB506, Lageschulte Fund), KD (R01CA182435, R01CA239343, DoD W81XWH2110628), MHM and LHH (DFG project number 273676790), and MHM (DFG project number 416001651). MM is funded by the Rudolf-Becker-Foundation for his professorship. The construction of the prostate cancer tissue microarray was funded by the DFG Forschergruppe-1586 SKELMET to LCH and SF.	Ark AV, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00180; Asangani IA, 2014, NATURE, V510, P278, DOI 10.1038/nature13229; Borkowetz A, 2020, INT J CANCER, V146, P2619, DOI 10.1002/ijc.32679; Coleman DJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40518-5; Coutinho I, 2016, ENDOCR-RELAT CANCER, V23, pT179, DOI 10.1530/ERC-16-0422; D'Angelo MA, 2018, NUCLEUS-PHILA, V9, P142, DOI 10.1080/19491034.2017.1395542; Dieppois G, 2010, J CELL SCI, V123, P1989, DOI 10.1242/jcs.053694; Drozdz MM, 2017, NUCLEUS-PHILA, V8, P34, DOI 10.1080/19491034.2016.1252893; Dutta S, 2016, SCI REP-UK, V6, DOI 10.1038/srep23588; Franks TM, 2013, TRENDS CELL BIOL, V23, P112, DOI 10.1016/j.tcb.2012.10.013; Fricker M, 1997, J CELL BIOL, V136, P531, DOI 10.1083/jcb.136.3.531; Garcia-Oliver E, 2012, BBA-GENE REGUL MECH, V1819, P555, DOI 10.1016/j.bbagrm.2011.11.011; Gemmill RM, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aag0528; Giacinti S, 2018, ANTICANCER RES, V38, P6029, DOI 10.21873/anticanres.12953; Gomez-Cavazos JS, 2015, J CELL BIOL, V208, P671, DOI 10.1083/jcb.201410047; He YD, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21860-7; Holzer K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10133-z; Ibarra A, 2016, GENE DEV, V30, P2253, DOI 10.1101/gad.287417.116; Ibarra A, 2015, GENE DEV, V29, P337, DOI 10.1101/gad.256495.114; Imamura Y, 2016, INT J UROL, V23, P654, DOI 10.1111/iju.13137; Kersemans V, 2013, J MAGN RESON IMAGING, V37, P1499, DOI 10.1002/jmri.23829; Kitazawa T, 2017, NEURON, V96, P259, DOI 10.1016/j.neuron.2017.09.059; Kuhn TM, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8111414; Kuhn TM, 2019, J CELL BIOL, V218, P2945, DOI 10.1083/jcb.201807139; Labade AS, 2016, EPIGENET CHROMATIN, V9, DOI 10.1186/s13072-016-0106-0; Liang Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003308; Massie CE, 2011, EMBO J, V30, P2719, DOI 10.1038/emboj.2011.158; Palancade B, 2007, MOL BIOL CELL, V18, P2912, DOI 10.1091/mbc.E07-02-0123; Parker MW, 2015, STRUCTURE, V23, P677, DOI 10.1016/j.str.2015.01.018; Polavaram NS, 2021, BONE RES, V9, DOI 10.1038/s41413-021-00136-2; Powers E, 2020, J HEMATOL ONCOL, V13, DOI 10.1186/s13045-020-00978-z; Ptak C, 2014, CURR OPIN CELL BIOL, V28, P46, DOI 10.1016/j.ceb.2014.02.001; Raices M, 2017, DEV CELL, V41, P540, DOI 10.1016/j.devcel.2017.05.007; Raices M, 2017, CURR OPIN CELL BIOL, V46, P26, DOI 10.1016/j.ceb.2016.12.006; Rodriguez-Bravo V, 2018, CELL, V174, P1200, DOI 10.1016/j.cell.2018.07.015; Rodriguez-Navarro S, 2004, CELL, V116, P75, DOI 10.1016/S0092-8674(03)01025-0; Rossignol M, 2000, GENOMICS, V70, P211, DOI 10.1006/geno.2000.6381; Roumiguie M, 2021, FUTURE ONCOL, V17, P1811, DOI 10.2217/fon-2020-1104; Ruben GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021923; Savoy RM, 2015, ENDOCR-RELAT CANCER, V22, P369, DOI 10.1530/ERC-15-0021; Schmidt KT, 2021, NAT REV UROL, V18, P209, DOI 10.1038/s41585-021-00438-4; Schweizer MT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198389; Shafran JS, 2019, MOL CANCER RES, V17, P1627, DOI 10.1158/1541-7786.MCR-18-1279; Sharma NL, 2013, CANCER CELL, V23, P35, DOI 10.1016/j.ccr.2012.11.010; Stanton MJ, 2013, CANCER RES, V73, P160, DOI 10.1158/0008-5472.CAN-11-3635; Su YL, 2018, GENE DEV, V32, P1398, DOI 10.1101/gad.314377.118; Sulpice E, 2008, BLOOD, V111, P2036, DOI 10.1182/blood-2007-04-084269; Sump B, 2017, GENE DEV, V31, P2201, DOI 10.1101/gad.310359.117; Tan KN, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21186622; Tucci M, 2018, ONCOTARGETS THER, V11, P7353, DOI 10.2147/OTT.S153764; Tucci M, 2018, MINERVA UROL NEFROL, V70, P144, DOI 10.23736/S0393-2249.17.03066-1; Wang LM, 2020, J CLIN INVEST, V130, P1782, DOI 10.1172/JCI126327	52	3	3	4	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 22	2022	41	30					3747	3760		10.1038/s41388-022-02382-y	http://dx.doi.org/10.1038/s41388-022-02382-y		JUN 2022	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	3D1SP	35754042				2022-12-26	WOS:000815742800001
J	Darphorn, TN; Sintanneland, BKV; Grootemaat, AH; van der Wel, N; Brul, SJ; ter Kuile, BJ				Darphorn, Tania N.; Koenders-van Sintanneland, Belinda; Grootemaat, Anita H.; van der Wel, Nicole; Brul, Stanley J.; ter Kuile, Benno J.			Transfer dynamics of multi-resistance plasmids in Escherichia coli isolated from meat	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; BIOFILM FORMATION; GENES; FOOD; CONJUGATION; SPREAD	Resistance plasmids are crucial for the transfer of antimicrobial resistance and thus form a matter of concern for veterinary and human healthcare. To study plasmid transfer, foodborne Escherichia coli isolates harboring one to five known plasmids were co-incubated with a general recipient strain. Plasmid transfer rates under standardized conditions varied by a factor of almost 10(6), depending on the recipient/donor strain combination. After 1 hour transconjugants never accounted for more than 3% of the total number of cells. Transconjugants were formed from 14 donors within 1 hour of co-incubation, but in the case of 3 donors 24 hours were needed. Transfer rates were also measured during longer co-incubation, between different species and during repeated back and forth transfer. Longer co-incubation resulted in the transfer of more types of resistance. Maximum growth rates of donor strains varied by a factor of 3. Donor strains often had higher growth rates than the corresponding transconjugants, which grew at the same rate as or slightly faster than the recipient. Hence, possessing one or more plasmids does not seem to burden the harboring strain metabolically. Transfer was species specific and repeated transfer of one plasmid did not result in different transfer rates over time. Transmission Electron microcopy was used to analyze the morphology of the connection between co-incubated strains. Connection by more pili between the cells resulted in better aggregate formation and corresponded with higher transfer rates.	[Darphorn, Tania N.; Koenders-van Sintanneland, Belinda; Brul, Stanley J.; ter Kuile, Benno J.] Univ Amsterdam, Swammerdam Inst Life Sci, Lab Mol Biol & Microbial Food Safety, Amsterdam, Netherlands; [Grootemaat, Anita H.; van der Wel, Nicole] Acad Med Ctr, Electron Microscopy Ctr Amsterdam, Dept Cell Biol & Histol, Amsterdam, Netherlands; [ter Kuile, Benno J.] Netherlands Food & Consumer Prod Safety Author, Off Risk Assessment, Utrecht, Netherlands	University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	ter Kuile, BJ (corresponding author), Univ Amsterdam, Swammerdam Inst Life Sci, Lab Mol Biol & Microbial Food Safety, Amsterdam, Netherlands.; ter Kuile, BJ (corresponding author), Netherlands Food & Consumer Prod Safety Author, Off Risk Assessment, Utrecht, Netherlands.	b.h.terkuile@uva.nl		Ter Kuile, Benno/0000-0002-8523-8135				Alderliesten JB, 2020, BMC MICROBIOL, V20, DOI 10.1186/s12866-020-01825-4; Arutyunov D, 2013, PLASMID, V70, P18, DOI 10.1016/j.plasmid.2013.03.010; Benz F, 2021, ISME J, V15, P862, DOI 10.1038/s41396-020-00819-4; Bortolaia V, 2020, J ANTIMICROB CHEMOTH, V75, P3491, DOI 10.1093/jac/dkaa345; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; Centers for Disease Control Prevention, 2021, ANTIMICROBIAL RESIST; Darphorn TS, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-81683-w; Dierikx C, 2013, J ANTIMICROB CHEMOTH, V68, P60, DOI 10.1093/jac/dks349; Dimitriu T, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.1110; Dionisio F, 2002, GENETICS, V162, P1525; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Evans C. G. T., 1970, METHODS MICROBIOLOGY, V2, DOI [10.1016/S0580-9517(08)70227-7, DOI 10.1016/S0580-9517(08)70227-7]; Fischer J, 2017, VET MICROBIOL, V200, P107, DOI 10.1016/j.vetmic.2016.05.021; Gama JA, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.02033; Garcia-Fernandez A, 2009, J ANTIMICROB CHEMOTH, V63, P274, DOI 10.1093/jac/dkn470; Garnett JA, 2012, P NATL ACAD SCI USA, V109, P3950, DOI 10.1073/pnas.1106733109; Grohmann E, 2003, MICROBIOL MOL BIOL R, V67, P277, DOI 10.1128/MMBR.67.2.277-301.2003; Haft RJF, 2009, ISME J, V3, P761, DOI 10.1038/ismej.2009.22; Kaesbohrer A, 2019, VET MICROBIOL, V233, P52, DOI 10.1016/j.vetmic.2019.03.025; Koraimann G, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00054; Llosa M, 2002, MOL MICROBIOL, V45, P1, DOI 10.1046/j.1365-2958.2002.03014.x; LUNDQUIST PD, 1986, GENETICS, V113, P483; Madsen JS, 2012, FEMS IMMUNOL MED MIC, V65, P183, DOI 10.1111/j.1574-695X.2012.00960.x; May T, 2008, J BACTERIOL, V190, P7479, DOI 10.1128/JB.00823-08; Molin S, 2003, CURR OPIN BIOTECH, V14, P255, DOI 10.1016/S0958-1669(03)00036-3; Mughini-Gras L, 2019, LANCET PLANET HEALTH, V3, pE357, DOI 10.1016/S2542-5196(19)30130-5; National Institute for Public Health and the Environment, 2020, NETHM MAR 2020; Pietsch M, 2021, ANTIBIOTICS-BASEL, V10, DOI 10.3390/antibiotics10010090; Prensky H, 2021, MOL SYST BIOL, V17, DOI 10.15252/msb.20209913; Reisner A, 2006, J BACTERIOL, V188, P3582, DOI 10.1128/JB.188.10.3582-3588.2006; Sakuda A, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00490-18; Schroder G, 2005, PLASMID, V54, P1, DOI 10.1016/j.plasmid.2005.02.001; Schuurmans JM, 2009, J MICROBIOL METH, V79, P44, DOI 10.1016/j.mimet.2009.07.017; Stine OC, 2007, INT J ANTIMICROB AG, V29, P348, DOI 10.1016/j.ijantimicag.2006.11.015; Tacconelli E, 2018, LANCET INFECT DIS, V18, P318, DOI [10.1016/s1473-3099(17)30753-3, 10.1016/S1473-3099(17)30753-3]; Threlfall EJ, 2000, INT J FOOD MICROBIOL, V62, P1, DOI 10.1016/S0168-1605(00)00351-2; Trunk T, 2018, AIMS MICROBIOL, V4, P140, DOI 10.3934/microbiol.2018.1.140; Verraes C, 2013, INT J ENV RES PUB HE, V10, P2643, DOI 10.3390/ijerph10072643; Virolle C, 2020, GENES-BASEL, V11, DOI 10.3390/genes11111239; Zatyka M, 1998, FEMS MICROBIOL REV, V21, P291, DOI 10.1016/S0168-6445(97)00061-2	40	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7							e0270205	10.1371/journal.pone.0270205	http://dx.doi.org/10.1371/journal.pone.0270205			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M2ZD	35797379	Green Published, gold			2022-12-26	WOS:000835328600008
J	Diehm, YF; Kotsougiani-Fischer, D; Porst, E; Haug, V; Siegwart, LC; Overhoff, D; Kneser, U; Fischer, S				Diehm, Yannick F.; Kotsougiani-Fischer, Dimitra; Porst, Elena; Haug, Valentin; Siegwart, Laura C.; Overhoff, Daniel; Kneser, Ulrich; Fischer, Sebastian			Oral doxycycline prevents skin-associated adverse effects induced by injectable collagenase in a rodent model of capsular contracture around silicone implants	PLOS ONE			English	Article							CLOSTRIDIUM-HISTOLYTICUM INJECTION; NONSURGICAL TREATMENT; DUPUYTRENS DISEASE; PEYRONIES-DISEASE; CLINICAL-EFFICACY; IN-VIVO; SAFETY; TOLERABILITY; FASCIECTOMY; MINOCYCLINE	BackgroundThe collagenase of the bacterium Clostridium histolyticum (CCH) is already an established treatment for fibroproliferative diseases like M. Dupuytren and M. Peyronie Although results are comparable to surgical intervention, skin laceration is a severe and relevant side effect. Doxycycline (DOX) recently rose interest as an inhibitor of matrix-metalloproteinases alongside its capabilities of skin accumulation. It therefore might be a potential skin protective agent in the use of CCH. MethodsFor simulation of a fibroproliferative disease adjacent to the skin, we utilized a rodent model of capsular fibrosis involving silicone implants and subsequent fibrotic capsule formation. For in-vitro studies, fibrotic capsules were excised and incubated with 0.9 mg/ml CCH and four different doses of DOX. For in-vivo experiments, animals received 0.0, 0.3 or 0.9 mg/ml CCH injections into the fibrotic capsules with or without prior oral DOX administration. Outcome analysis included histology, immunohistochemistry, gene expression analysis, chemical collagen and DOX concentration measurements as well as mu CT imaging. ResultsIn-vitro, DOX showed a dose-dependent inhibition of CCH activity associated with increasing capsule thickness and collagen density and content. In-vivo, oral DOX administration did neither interfere with capsule formation nor in effectiveness of CCH dissolving fibrotic capsule tissue. However, skin thickness and especially collagen density was significantly higher compared to control groups. This led to a reduced rate of clinical skin lacerations after DOX administration. ConclusionDOX inhibits CCH and accumulates in the skin. Thereby, DOX can effectively reduce skin laceration after CCH treatment.	[Diehm, Yannick F.; Kotsougiani-Fischer, Dimitra; Porst, Elena; Haug, Valentin; Siegwart, Laura C.; Kneser, Ulrich; Fischer, Sebastian] Heidelberg Univ, Burn Trauma Ctr, BG Trauma Ctr Ludwigshafen, Dept Hand Plast & Reconstruct Surg, Ludwigshafen, Germany; [Overhoff, Daniel] Heidelberg Univ, Univ Med Ctr Mannheim, Med Fac Mannheim, Dept Radiol & Nucl Med, Mannheim, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Fischer, S (corresponding author), Heidelberg Univ, Burn Trauma Ctr, BG Trauma Ctr Ludwigshafen, Dept Hand Plast & Reconstruct Surg, Ludwigshafen, Germany.	sfischer@hotmail.de		Kneser, Ulrich/0000-0002-3402-2860; , Sebastian/0000-0003-3445-1902				Axisa B, 2000, J CHROMATOGR B, V744, P359, DOI 10.1016/S0378-4347(00)00261-9; Badalamente MA, 2002, J HAND SURG-AM, V27A, P788, DOI 10.1053/jhsu.2002.35299; Badalamente MA., 1996, DRUG DELIV, V3, P35; CUNHA BA, 1982, THER DRUG MONIT, V4, P115, DOI 10.1097/00007691-198206000-00001; DEBELLIS R, 1954, NATURE, V174, P1191, DOI 10.1038/1741191a0; Diehm YF, 2021, AESTHET PLAST SURG, V45, P1273, DOI 10.1007/s00266-020-01970-1; Diehm YF, 2019, AESTHET PLAST SURG, V43, P836, DOI 10.1007/s00266-018-1267-y; EPSTEIN EH, 1978, J BIOL CHEM, V253, P1336; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fischer S, 2017, AESTHET PLAST SURG, V41, P211, DOI 10.1007/s00266-016-0724-8; Fischer S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156428; Fischer S, 2015, PLAST RECONSTR SURG, V136, P981, DOI 10.1097/PRS.0000000000001698; Fischer S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132131; Freshwater M Felix, 2012, Hand (N Y), V7, P348, DOI 10.1007/s11552-012-9424-2; Gelbard M, 2013, J UROLOGY, V190, P199, DOI 10.1016/j.juro.2013.01.087; Gelbard M, 2012, J UROLOGY, V187, P2268, DOI 10.1016/j.juro.2012.01.032; GELBARD MK, 1982, UROL RES, V10, P135; Gilpin D, 2010, J HAND SURG-AM, V35A, P2027, DOI 10.1016/j.jhsa.2010.08.007; Godin B, 2007, ADV DRUG DELIVER REV, V59, P1152, DOI 10.1016/j.addr.2007.07.004; GOLUB LM, 1983, J PERIODONTAL RES, V18, P516, DOI 10.1111/j.1600-0765.1983.tb00388.x; Hammoudeh ZS, 2014, PLAST RECONSTR SURG, V134, p497E, DOI 10.1097/PRS.0000000000000433; Hay DC, 2014, J HAND SURG-EUR VOL, V39, P463, DOI 10.1177/1753193413488305; Holzer LA, 2009, NEW ENGL J MED, V361, P2579; Hurst LC, 2009, NEW ENGL J MED, V361, P968, DOI 10.1056/NEJMoa0810866; Jung CM, 1999, J BACTERIOL, V181, P2816, DOI 10.1128/JB.181.9.2816-2822.1999; Kimmitt BA, 2018, AM J VET RES, V79, P555, DOI 10.2460/ajvr.79.5.555; Levine LA, 2015, J SEX MED, V12, P248, DOI 10.1111/jsm.12731; Liu X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116071; MACLENNAN JD, 1953, J CLIN INVEST, V32, P1317, DOI 10.1172/JCI102860; Peak TC, 2015, BIOL-TARGETS THER, V9, P107, DOI 10.2147/BTT.S65619; Peimer CA, 2015, J HAND SURG-EUR VOL, V40, P141, DOI 10.1177/1753193414528843; Peimer CA, 2015, J HAND SURG-AM, V40, P1597, DOI 10.1016/j.jhsa.2015.04.036; Reichenberger MA, 2014, AESTHET PLAST SURG, V38, P244, DOI 10.1007/s00266-013-0235-9; Sangkum P, 2015, UROLOGY, V86, DOI 10.1016/j.urology.2015.06.013; Schonauer E., 2017, INHIBITION ACTIVITY, P69; Scientific T, SAFETY DATASHEET DOX; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Smith GN, 1998, J RHEUMATOL, V25, P532; SUSSMAN BJ, 1971, CLIN ORTHOP RELAT R, P181; SUSSMAN BJ, 1981, JAMA-J AM MED ASSOC, V245, P730, DOI 10.1001/jama.245.7.730; Syed F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031430; van Ravenzwaay B, 2004, HUM EXP TOXICOL, V23, P421, DOI 10.1191/0960327104ht471oa; Warwick D, 2016, J PLAST SURG HAND SU, V50, P251, DOI 10.3109/2000656X.2016.1159568; Watt AJ, 2010, J HAND SURG-AM, V35A, P534, DOI 10.1016/j.jhsa.2010.01.003; Zah V, 2020, CLINICOECONOMIC OUTC, V12, P635, DOI 10.2147/CEOR.S269957	45	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7								10.1371/journal.pone.0270112	http://dx.doi.org/10.1371/journal.pone.0270112			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M3CI	35793344	Green Published, gold			2022-12-26	WOS:000835338100036
J	Mori, H; Ueno, S; Ujino-Ihara, T; Fujiwara, T; Yamashita, K; Kanetani, S; Endo, R; Matsumoto, A; Uchiyama, K; Yoshida, T; Sakai, Y; Moriguchi, Y; Kusano, R; Tsumura, Y				Mori, Hideki; Ueno, Saneyoshi; Ujino-Ihara, Tokuko; Fujiwara, Takeshi; Yamashita, Kana; Kanetani, Seiichi; Endo, Ryota; Matsumoto, Asako; Uchiyama, Kentaro; Yoshida, Takahiro; Sakai, Yoshimi; Moriguchi, Yoshinari; Kusano, Ryouichi; Tsumura, Yoshihiko			Genotype-by-environment interaction and genetic dissection of heartwood color in Cryptomeria japonica based on multiple common gardens and quantitative trait loci mapping	PLOS ONE			English	Article							WOOD COLOR; GROWTH; IDENTIFICATION; INFERENCE; SELECTION; DENSITY; L.	The heartwood color of a major plantation tree Cryptomeria japonica shows high variability among clones and cultivars, and brighter heartwood has higher value in the usage of non-laminated wood such as in traditional construction, which makes heartwood color an important trait in breeding of this species. However, the genetic basis of the interactions between genetics and the environment on heartwood color has been understudied while these are necessary for effective breeding programs in multiple environmental condition. The objectives of the present study were to evaluate the effects of genetics and environments on heartwood color and how they interact in contrasting environments, and to identify genomic regions controlling heartwood color in C. japonica across multiple environments. Heartwood color in terms of L*a*b* color space and spectral reflectance was measured in common gardens established in three contrasting sites. Quantitative trait loci (QTL) that affect heartwood color were identified using previously constructed highly saturated linkage maps. Results found that heartwood color was largely genetically controlled, and genotype-by-environment interaction explained one-third of the total genetic variance of heartwood color. The effect of the environment was small compared to the effect of genetics, whereas environmental effects largely varied among heartwood color traits. QTL analysis identified a large number of QTLs with small to moderate effects (phenotypic variation explained of 6.6% on average). Some of these QTLs were stably expressed in multiple environments or had pleiotropic effects on heartwood color and moisture content. These results indicated that genetic variation in phenotypic plasticity plays an important role in regulating heartwood color and that the identified QTLs would maximize the breeding efficiency of heartwood color in C. japonica in heterogeneous environments.	[Mori, Hideki; Ueno, Saneyoshi; Ujino-Ihara, Tokuko; Yamashita, Kana; Matsumoto, Asako; Uchiyama, Kentaro; Yoshida, Takahiro; Tsumura, Yoshihiko] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki, Japan; [Fujiwara, Takeshi] Forest Biores Ctr, Forestry & Forest Prod Res Inst, Hitachi, Ibaraki, Japan; [Kanetani, Seiichi; Sakai, Yoshimi] Kyushu Res Ctr, Forestry & Forest Prod Res Inst, Chuo, Kumamoto, Japan; [Endo, Ryota] Chiba Prefectural Agr & Forestry Res Ctr, Forestry Res Inst, Chiba, Japan; [Moriguchi, Yoshinari] Niigata Univ, Grad Sch Sci & Technol, Nishi-ku, Niigata, Japan; [Kusano, Ryouichi] Kumamoto Prefecture Forestry Res Ctr, Kumamoto, Japan; [Endo, Ryota] Chiba Univ, Fac Educ, Chiba, Japan; [Tsumura, Yoshihiko] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan	Forestry & Forest Products Research Institute - Japan; Forestry & Forest Products Research Institute - Japan; Forestry & Forest Products Research Institute - Japan; Niigata University; Chiba University; University of Tsukuba	Matsumoto, A (corresponding author), Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki, Japan.	asakon@ffpri.affrc.go.jp	MORI, Hideki/AAB-4705-2020	MORI, Hideki/0000-0001-7496-5217; Yamashita, Kana/0000-0003-1843-2525	Forestry and Forest Products Research Institute [20142]	Forestry and Forest Products Research Institute(Forestry & Forest Products Research Institute - Japan)	This research project was submitted as an intra-institutional project and AM received a research grant from the Forestry and Forest Products Research Institute (grant #20142).Although co-researchers HM, SU, TU, TF, KY, SK, AM, KU, TY and YS are employed and paid salaries by the Forestry and Forest Products Research Institute, the institute has no additional role in the research design, data collection, analysis, publication decision and manuscript preparation for this research project.	Amusant N, 2008, ANN FOREST SCI, V65, DOI 10.1051/forest:2008061; Bivand RS, 2018, TEST-SPAIN, V27, P716, DOI 10.1007/s11749-018-0599-x; Bradbury G, 2011, HOLZFORSCHUNG, V65, P349, DOI 10.1515/HF.2011.042; Brown GR, 2003, GENETICS, V164, P1537; Collard BCY, 2005, EUPHYTICA, V142, P169, DOI 10.1007/s10681-005-1681-5; Csordos D, 2014, BIORESOURCES, V9, P7099; de Villemereuil P, 2016, HEREDITY, V116, P249, DOI 10.1038/hdy.2015.93; Freeman JS, 2013, NEW PHYTOL, V198, P1121, DOI 10.1111/nph.12237; Goodrich B., 2020, RSTANARM BAYESIAN AP, V2, P1; Goto S, 2021, GENES-BASEL, V12, DOI 10.3390/genes12081110; Grattapaglia D, 2011, TREE GENET GENOMES, V7, P241, DOI 10.1007/s11295-010-0328-4; Hallingback HR, 2016, GCB BIOENERGY, V8, P670, DOI 10.1111/gcbb.12280; Hirata S, 2020, J WOOD SCI, V66, DOI 10.1186/s10086-020-01883-2; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Iwata H, 2016, BREEDING SCI, V66, P100, DOI 10.1270/jsbbs.66.100; Iwata H, 2011, TREE GENET GENOMES, V7, P747, DOI 10.1007/s11295-011-0371-9; Jannink JL, 2010, BRIEF FUNCT GENOMICS, V9, P166, DOI 10.1093/bfgp/elq001; Kawazumi K., 1991, Bulletin of the Kyushu University Forests, P29; Miyamoto N, 2016, SILVAE GENET, V65, P80, DOI 10.1515/sg-2016-0020; Montes CS, 2008, NEW FOREST, V35, P57, DOI 10.1007/s11056-007-9060-9; Montwe D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04039-5; Mori H, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228278; Mori H, 2019, TREE GENET GENOMES, V15, DOI 10.1007/s11295-019-1346-5; Moriguchi Y, 2016, TREE GENET GENOMES, V12, DOI 10.1007/s11295-016-1011-1; Morikawa T., 1996, B KYUSHU U FOR, V74, P41, DOI 10.15017/10922; Mosedale JR, 1996, FORESTRY, V69, P111, DOI 10.1093/forestry/69.2.111; Moya R, 2013, SILVAE GENET, V62, P142, DOI 10.1515/sg-2013-0019; Moya R, 2010, ANN FOREST SCI, V67, DOI 10.1051/forest/2009088; Nakada R, 1998, MOKUZAI GAKKAISHI, V44, P395; Neale D.B., 2019, CONIFERS GENOMES VAR, DOI [10.1007/978-3-319-46807-5, DOI 10.1007/978-3-319-46807-5_1, DOI 10.1007/978-3-319-46807-5]; Neale DB, 2011, NAT REV GENET, V12, P111, DOI 10.1038/nrg2931; Nishizawa E., 2003, Journal of the Japanese Forestry Society, V85, P234; Oda Kazuyuki, 1994, Science Bulletin of the Faculty of Agriculture Kyushu University, V48, P171; Ohba K., 1993, CLONAL FORESTRY 2 CO, P66; Piironen J, 2020, ELECTRON J STAT, V14, P2155, DOI 10.1214/20-EJS1711; Piironen J, 2017, ELECTRON J STAT, V11, P5018, DOI 10.1214/17-EJS1337SI; R Core Team, 2020, R LANG ENV STAT COMP; RINK G, 1987, WOOD FIBER SCI, V19, P93; Sugimoto H, 2018, J WOOD SCI, V64, P738, DOI 10.1007/s10086-018-1751-7; Sugimoto H, 2018, MOKUZAI GAKKAISHI, V64, P66; Thavamanikumar S, 2014, TREE GENET GENOMES, V10, P1661, DOI [10.1007/s11295-01, 10.1007/s11295-014-0787-0]; Tsumura Y., 2011, WILD CROP RELATIVES, P49, DOI DOI 10.1007/978-3-642-21250-5_3; Tsushima S., 2006, J JAPAN WOOD RES SOC; Ueno S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-136; Vehtari A., 2016, LOO EFFICIENT LEAVE; Rodriguez-Alvarez MX, 2018, SPAT STAT-NETH, V23, P52, DOI 10.1016/j.spasta.2017.10.003; Zobel B.J., 1995, GENETICS WOOD PRODUC	47	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7								10.1371/journal.pone.0270522	http://dx.doi.org/10.1371/journal.pone.0270522			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M3CI	35793335	Green Published, gold			2022-12-26	WOS:000835338100002
J	Skrzat-Klapaczynska, A; Paciorek, M; Horban, A; Kowalska, JD				Skrzat-Klapaczynska, Agata; Paciorek, Marcin; Horban, Andrzej; Kowalska, Justyna D.			Factors associated with the risk of upper respiratory tract bacterial infections among HIV-positive patients	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; COMBINATION ANTIRETROVIRAL THERAPY; PNEUMONIA; AIDS; ADULTS; IMMUNODEFICIENCY; MICROBIOLOGY; COLONIZATION; MORTALITY; DISEASES	Background The risk and characteristics of upper respiratory tract (URT) bacterial infections (URT-BI) among HIV (+) patients is understudied. We analyzed factors associated with its occurrence and the spectrum of culturable pathogens among patients routinely followed at the HIV Out-Patient Clinic in Warsaw. Methods All HIV (+) patients with available URT swab culture were included into analyses. Patients were followed from the day of registration in the clinic until first positive URT swab culture or last clinical visit from January 1, 2007 to July 31, 2016. Cox proportional hazard models were used to identify factors associated with positive URT swabs culture (those with p < 0.1 in univariate included into multivariable). Results In total 474 patients were included into the analyses, 166 with culturable URT swab. In general, 416 (87.8%) patients were male, 342 (72.1%) were infected through MSM contact, 253 (53.4%) were on antiretroviral therapy. Median follow-up time was 3.4 (1.3-5.7) years, age 35.2 (30.6-42.6) years and CD4+ count 528 (400-685) cells/mu l. The most common cultured bacteria were S. aureus (40.4%) and S. pyogenes (13.9%) (Table 1). Patients with culturable URT-BI were more likely to be MSM (68.5% vs 78.9%; p < 0.016), have detectable viral load (20.9% vs 12.0%; p < 0.0001) and CD4+ cell count < 500 cells/mu l (55.2% vs 39.0%; p = 0.003) (Table 2). In multivariate survival analyses detectable viral load (HR3.13; 95%Cl: 2.34-4.19) and MSM (1.63;1.09-2.42) were increasing, but older age (0.63;0.58-0.69, per 5 years older) and higher CD4+ count (0.90;0.85-0.95, per 100 cells/mu l) decreasing the risk of culturable URT-BI (Table 2). Conclusions Culturable URT-BI are common among HIV-positive patients with high CD4+ count. Similarly to general population most common cultured bacteria were S. aureus and S. pyogenes. Risk factors identified in multivariate survival analysis indicate that younger MSM patients with detectable HIV viral load are at highest risk. In clinical practice this group of patients requires special attention.	[Skrzat-Klapaczynska, Agata; Paciorek, Marcin; Horban, Andrzej; Kowalska, Justyna D.] Med Univ Warsaw, Hosp Infect Dis, Dept Adults Infect Dis, Warsaw, Poland; [Kowalska, Justyna D.] HIV Out Patient Clin, Hosp Infect Dis, Warsaw, Poland	Medical University of Warsaw	Skrzat-Klapaczynska, A (corresponding author), Med Univ Warsaw, Hosp Infect Dis, Dept Adults Infect Dis, Warsaw, Poland.	agata.skrzat@op.pl		Skrzat-Klapaczynska, Agata/0000-0002-6367-5633				Baker JV, 2008, AIDS, V22, P841, DOI 10.1097/QAD.0b013e3282f7cb76; Bangsberg David R, 2007, Curr HIV/AIDS Rep, V4, P65, DOI 10.1007/s11904-007-0010-0; Bosch AATM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003057; Bourbeau PP, 2003, J CLIN MICROBIOL, V41, P3467, DOI 10.1128/JCM.41.8.3467-3472.2003; Brook Itzhak, 2011, Proc Am Thorac Soc, V8, P90, DOI 10.1513/pats.201006-038RN; Cole J, 2013, CURR HIV-AIDS REP, V10, P244, DOI 10.1007/s11904-013-0161-0; Crothers K, 2011, AM J RESP CRIT CARE, V183, P388, DOI 10.1164/rccm.201006-0836OC; Crum-Cianflone NF, 2007, INT J STD AIDS, V18, P521, DOI 10.1258/095646207781439702; Deeks SG, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.35; Diaz PT, 2000, ANN INTERN MED, V132, P369, DOI 10.7326/0003-4819-132-5-200003070-00006; Fournier B, 2005, CLIN MICROBIOL REV, V18, P521, DOI 10.1128/CMR.18.3.521-540.2005; Francois B, 2021, LANCET INFECT DIS, V21, P1313, DOI 10.1016/S1473-3099(20)30995-6; Gordon RJ, 2008, CLIN INFECT DIS, V46, pS350, DOI 10.1086/533591; Grief SN, 2013, PRIMARY CARE, V40, P757, DOI 10.1016/j.pop.2013.06.004; Hidron Alicia I, 2010, Infect Drug Resist, V3, P73; Imaz A, 2010, AIDS REV, V12, P153; Kirk GD, 2007, CLIN INFECT DIS, V45, P103, DOI 10.1086/518606; Kohli R, 2006, CLIN INFECT DIS, V43, P90, DOI 10.1086/504871; Kowalska JD, 2012, AIDS, V26, P315, DOI 10.1097/QAD.0b013e32834e8805; Le Moing V, 2006, HIV MED, V7, P261, DOI 10.1111/j.1468-1293.2006.00370.x; Lindbaek M, 2005, BRIT J GEN PRACT, V55, P615; Lundgren JD, 2008, AIDS, V22, pF17, DOI 10.1097/QAD.0b013e32830fe35e; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Martinez E, 2007, HIV MED, V8, P251, DOI 10.1111/j.1468-1293.2007.00468.x; Mehta NJ, 2000, CHEST, V118, P1133, DOI 10.1378/chest.118.4.1133; Miller M, 2007, CLIN INFECT DIS, V45, P343, DOI 10.1086/519429; Mocroft A, 2009, CLIN INFECT DIS, V48, P1138, DOI 10.1086/597468; Neuhaus J, 2010, J INFECT DIS, V201, P1788, DOI 10.1086/652749; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Payne SC, 2007, CLIN INFECT DIS, V45, pE121, DOI 10.1086/522763; Reekie J, 2011, AIDS, V25, P2259, DOI 10.1097/QAD.0b013e32834cdb4b; Reekie J, 2010, CANCER-AM CANCER SOC, V116, P5306, DOI 10.1002/cncr.25311; Shet A, 2009, J INFECT DIS, V200, P88, DOI 10.1086/599315; Sogaard OS, 2013, J INFECTION, V66, P439, DOI 10.1016/j.jinf.2012.12.012; Thorlund K, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2683-3; Torres A, 2013, THORAX, V68, P1057, DOI 10.1136/thoraxjnl-2013-204282; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Young BC, 2017, ELIFE, V6, DOI 10.7554/eLife.30637	38	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7							e0270770	10.1371/journal.pone.0270770	http://dx.doi.org/10.1371/journal.pone.0270770			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M2ZD	35797374	Green Submitted, gold, Green Published			2022-12-26	WOS:000835328600020
J	Miao, RR; Zhan, S; Cui, SX; Qu, XJ				Miao, Rong-Rong; Zhan, Sheng; Cui, Shu-Xiang; Qu, Xian-Jun			Intestinal aberrant sphingolipid metabolism shaped-gut microbiome and bile acids metabolome in the development of hepatic steatosis	FASEB JOURNAL			English	Article						BAs metabolome; conjugated bile acids; gut microbiota; intestinal SphK1; S1P; intestinal SphK2	SPHINGOSINE-1-PHOSPHATE RECEPTOR 2; BETA; ACTIVATION; DISEASE; ROLES	Conjugated bile acids (CBAs) play major roles in hepatic gene regulation via nuclear S1P-inhibited histone deacetylase (HDACs). Gut microbiota modifies bile acid pool to generate CBAs and then CBAs returned to liver to regulate hepatic genes, fatty liver, and non-alcoholic fatty liver disease (NAFLD). However, it is not yet known how the gut microbiota was modified under the environment of inflammatory bowel disease (IBD). Here, we revealed that aberrant intestinal sphingosine kinases (SphKs), a major risk factor of IBD, modified gut microbiota by increasing the proportions of Firmicutes and Verrucomicrobia, which were associated with the increase in CBAs. When exposed to a high-fat diet (HFD), sphingosine kinases 2 knockout (SphK2KO) mice developed more severity of intestinal inflammation and hepatic steatosis than their wild-type (WT) littermates. Due to knockdown of nuclear SphK2, Sphk2KO mice exhibited an increase in sphingosine kinases 1 (SphK1) and sphingosine-1-phosphate (S1P) in intestinal epithelial cells. Therefore, the microbiota was modified in the environment of the SphK1/S1P-induced IBD. 16S rDNA amplicon sequencing of cecal contents indicated an increase of Firmicutes and Verrucomicrobia. Ultra-performance liquid chromatography coupled to tandem mass spectrometry (UPLC-MS/MS) measured an increase in CBAs, including taurocholic acid (TCA), taurodeoxycholic acid (TDCA), and glycocholic acid (GCA), in cecal contents and liver tissues of Sphk2KO mice. These CBAs accumulated in the liver promoted hepatic steatosis through downregulating the acetylation of H3K9, H3K14, H3K18 and H3K27 due to the CBAs-S1PR2-nuclear SphK2-S1P signaling pathway was blocked in HFD-SphK2KO mice. In summary, intestinal aberrant sphingolipid metabolism developed hepatic steatosis through the increase in CBAs associated with an increase in Firmicutes and Verrucomicrobia.	[Miao, Rong-Rong; Zhan, Sheng; Qu, Xian-Jun] Capital Med Univ, Sch Basic Med Sci, Dept Pharmacol, Beijing, Peoples R China; [Cui, Shu-Xiang] Capital Med Univ, Sch Publ Hlth, Toxicol & Sanit Chem, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Qu, XJ (corresponding author), Capital Med Univ, Sch Basic Med Sci, Dept Pharmacol, Beijing, Peoples R China.	qxj@ccmu.edu.cn			Beijing Municipal Natural Science Foundation [7212149]; National Natural Science Foundation of China [82173841/81872884/81973350]	Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Beijing Municipal Natural Science Foundation (7212149) and National Natural Science Foundation of China (82173841/81872884/81973350).	Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Begley M, 2005, FEMS MICROBIOL REV, V29, P625, DOI 10.1016/j.femsre.2004.09.003; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Boursier J, 2016, HEPATOLOGY, V63, P764, DOI 10.1002/hep.28356; Cani PD, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01765; Crespo I, 2017, NUTRIENTS, V9, DOI 10.3390/nu9030288; Di Pardo A, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00100; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Fuss IJ, 2002, J IMMUNOL, V168, P900, DOI 10.4049/jimmunol.168.2.900; Gaidos JKJ, 2017, DIGEST DIS SCI, V62, P1362, DOI 10.1007/s10620-017-4552-8; Gerard P, 2016, CELL MOL LIFE SCI, V73, P147, DOI 10.1007/s00018-015-2061-5; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Huang FJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12896-x; Hylemon Phillip B, 2017, Liver Res, V1, P10, DOI 10.1016/j.livres.2017.03.002; Inagaki T, 2006, P NATL ACAD SCI USA, V103, P3920, DOI 10.1073/pnas.0509592103; Jia W, 2018, NAT REV GASTRO HEPAT, V15, P111, DOI 10.1038/nrgastro.2017.119; Jiao N, 2018, GUT, V67, P1881, DOI 10.1136/gutjnl-2017-314307; Kapil S, 2016, J GASTROEN HEPATOL, V31, P213, DOI 10.1111/jgh.13058; Karuppuchamy T, 2017, MUCOSAL IMMUNOL, V10, P162, DOI 10.1038/mi.2016.35; Kwong E, 2015, ACTA PHARM SIN B, V5, P151, DOI 10.1016/j.apsb.2014.12.009; Liang J, 2013, CANCER CELL, V23, P107, DOI 10.1016/j.ccr.2012.11.013; Liu RP, 2014, HEPATOLOGY, V60, P908, DOI 10.1002/hep.27085; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Lundberg DS, 2013, NAT METHODS, V10, P999, DOI 10.1038/nmeth.2634; Marra F, 2018, J HEPATOL, V68, P280, DOI 10.1016/j.jhep.2017.11.014; MIDTVEDT T, 1974, AM J CLIN NUTR, V27, P1341, DOI 10.1093/ajcn/27.11.1341; Miele L, 2009, HEPATOLOGY, V49, P1877, DOI 10.1002/hep.22848; Milosevic I, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020395; Mizugishi K, 2005, MOL CELL BIOL, V25, P11113, DOI 10.1128/MCB.25.24.11113-11121.2005; Nagahashi M, 2016, J LIPID RES, V57, P1636, DOI 10.1194/jlr.R069286; Nagahashi M, 2015, HEPATOLOGY, V61, P1216, DOI 10.1002/hep.27592; Ni Y, 2016, ANAL CHEM, V88, P8802, DOI 10.1021/acs.analchem.6b02222; Nielsen OH, 2017, TRENDS MOL MED, V23, P362, DOI 10.1016/j.molmed.2017.02.002; Rao A, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf4823; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Safari Z, 2019, CELL MOL LIFE SCI, V76, P1541, DOI 10.1007/s00018-019-03011-w; Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003; Snider AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113998; Studer E, 2012, HEPATOLOGY, V55, P267, DOI 10.1002/hep.24681; Suh JH, 2018, INFLAMM BOWEL DIS, V24, P1321, DOI 10.1093/ibd/izy007; Verhoog S, 2019, NUTRIENTS, V11, DOI 10.3390/nu11071565; Volynets V, 2012, DIGEST DIS SCI, V57, P1932, DOI 10.1007/s10620-012-2112-9; Wahlstrom A, 2016, CELL METAB, V24, P41, DOI 10.1016/j.cmet.2016.05.005; Wang JH, 2013, P NATL ACAD SCI USA, V110, P17017, DOI 10.1073/pnas.1315558110; Wang YQ, 2017, HEPATOLOGY, V65, P2005, DOI 10.1002/hep.29076; Xie GX, 2016, INT J CANCER, V139, P1764, DOI 10.1002/ijc.30219	46	1	1	6	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2022	36	8							e22398	10.1096/fj.202200148RR	http://dx.doi.org/10.1096/fj.202200148RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2R5TB	35792869				2022-12-26	WOS:000821173400001
J	Tlili, M; Acevedo, H; Descoteaux, A; Germain, M; Heinonen, KM				Tlili, Mouna; Acevedo, Hamlet; Descoteaux, Albert; Germain, Marc; Heinonen, Krista M.			Cell-intrinsic Wnt4 ligand regulates mitochondrial oxidative phosphorylation in macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOSOMAL ACID LIPASE; ALTERNATIVE ACTIVATION; METABOLISM; GLYCOLYSIS; PATHWAY; CANCER; GENE; IMMUNOMETABOLISM; PROLIFERATION; LEISHMANIA	Macrophages respond to their environment by adopting a predominantly inflammatory or anti-inflammatory profile, depending on the context. The polarization of the subsequent response is regulated by a combination of intrinsic and extrinsic signals and is associated with alterations in macro-phage metabolism. Although macrophages are important producers of Wnt ligands, the role of Wnt signaling in regulating metabolic changes associated with macrophage polarization remains unclear. Wnt4 upregulation has been shown to be associated with tissue repair and suppression of age-associated inflammation, which led us to generate Wnt4-deficient bone marrow-derived macrophages to investigate its role in metabolism. We show that loss of Wnt4 led to modified mitochondrial structure, enhanced oxidative phosphorylation, and depleted intracellular lipid reserves, as the cells depended on fatty acid oxidation to fuel their mitochondria. Further we found that enhanced lipolysis was dependent on protein kinase C-mediated activation of lysosomal acid lipase in Wnt4-deficient bone marrow-derived macrophages. Although not irreversible, these metabolic changes promoted parasite survival during infection with Leishmania donovani. In conclusion, our results indicate that enhanced macrophage fatty acid oxidation impairs the control of intracellular pathogens, such as Leishmania. We further suggest that Wnt4 may represent a potential target in atherosclerosis, which is characterized by lipid storage in macrophages leading to them becoming foam cells.	[Tlili, Mouna; Acevedo, Hamlet; Descoteaux, Albert; Heinonen, Krista M.] Inst Natl Rech Sci, Ctr Armand Frappier Sante Biotechnol, Laval, PQ, Canada; [Germain, Marc] Univ Quebec Trois Rivieres, Grp Rech Signalisat Cellulaire, Trois Rivieres, PQ, Canada; [Germain, Marc] Univ Quebec Trois Rivieres, Dept Biol Med, Trois Rivieres, PQ, Canada; [Germain, Marc; Heinonen, Krista M.] CERMO FC, Montreal, PQ, Canada; [Germain, Marc] Univ Quebec, Reseau Intersectoriel Rech Sante, Quebec City, PQ, Canada	University of Quebec; Institut national de la recherche scientifique (INRS); University of Quebec; University of Quebec Trois Rivieres; University of Quebec; University of Quebec Trois Rivieres; University of Quebec	Heinonen, KM (corresponding author), Inst Natl Rech Sci, Ctr Armand Frappier Sante Biotechnol, Laval, PQ, Canada.; Heinonen, KM (corresponding author), CERMO FC, Montreal, PQ, Canada.	krista.heinonen@inrs.ca	Heinonen, Krista M/G-9769-2016	Heinonen, Krista M/0000-0002-2410-4432; Descoteaux, Albert/0000-0002-0633-5309; Acevedo Ospina, Hamlet Adolfo/0000-0003-4296-6738	Natural Sciences and Engineering Research Council of Canada (NSERC) [419226 - 2012, 2018 - 05258]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC Discovery grants #419226 - 2012 and #2018 - 05258 to K. M. H.) . K. M. H. is a FRQS Junior Research Scholar. A.D. holds the Canada Research Chair on the Biology of intracellular parasitism.	Abidin BM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006422; Altomare DA, 2012, CURR MED CHEM, V19, P3748; Artyomov MN, 2016, SEMIN IMMUNOL, V28, P417, DOI 10.1016/j.smim.2016.10.004; Au DT, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/7902841; Bordonaro M, 2009, VITAM HORM, V80, P563, DOI 10.1016/S0083-6729(08)00619-5; Borrell-Pages M, 2011, EUR HEART J, V32, P2841, DOI 10.1093/eurheartj/ehr062; Bryan NS, 2007, FREE RADICAL BIO MED, V43, P645, DOI 10.1016/j.freeradbiomed.2007.04.026; Cader MZ, 2016, NAT IMMUNOL, V17, P1046, DOI 10.1038/ni.3532; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Cassim S, 2020, CANCERS, V12, DOI 10.3390/cancers12051119; Cavallo-Medved Dora, 2011, AFCS Nat Mol Pages, V2011; Chafey P, 2009, PROTEOMICS, V9, P3889, DOI 10.1002/pmic.200800609; Chakraborty A, 2017, J IMMUNOL, V199, P992, DOI 10.4049/jimmunol.1601927; Chandak PG, 2010, J BIOL CHEM, V285, P20192, DOI 10.1074/jbc.M110.107854; Chen N, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00792; Chen XS, 2016, ACTA PHARMACOL SIN, V37, P1013, DOI 10.1038/aps.2016.47; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Clemente N, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/7675437; Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032; CROSS M, 1988, P NATL ACAD SCI USA, V85, P6232, DOI 10.1073/pnas.85.17.6232; Dairaku T, 2014, MOL GENET METAB, V111, P193, DOI 10.1016/j.ymgme.2013.11.003; Danhier P, 2017, BBA-BIOENERGETICS, V1858, P556, DOI 10.1016/j.bbabio.2017.02.001; Du JR, 2018, EXP THER MED, V16, P1975, DOI 10.3892/etm.2018.6397; Duque GA, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00491; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Frey JL, 2018, ENDOCRINOLOGY, V159, P272, DOI 10.1210/en.2017-00850; Frey JL, 2015, MOL CELL BIOL, V35, P1979, DOI 10.1128/MCB.01343-14; Gordon S, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0392-4; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; Grisham MB, 1996, METHOD ENZYMOL, V268, P237; Grumolato L, 2010, GENE DEV, V24, P2517, DOI 10.1101/gad.1957710; Hammami A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006616; Heap RE, 2021, LIFE SCI ALLIANCE, V4, DOI 10.26508/lsa.202000957; Heinonen KM, 2006, P NATL ACAD SCI USA, V103, P2776, DOI 10.1073/pnas.0508563103; Heinonen KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019279; Hetu-Arbour R, 2021, STEM CELLS, V39, P1207, DOI 10.1002/stem.3385; Hirayama D, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010092; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Huang SCC, 2014, NAT IMMUNOL, V15, P846, DOI 10.1038/ni.2956; Hung LY, 2019, J IMMUNOL, V203, P511, DOI 10.4049/jimmunol.1900363; Hung LY, 2019, MUCOSAL IMMUNOL, V12, P64, DOI 10.1038/s41385-018-0096-2; Ishitani T, 2003, MOL CELL BIOL, V23, P131, DOI 10.1128/MCB.23.1.131-139.2003; Italiani P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00514; Jha AK, 2015, IMMUNITY, V42, P419, DOI 10.1016/j.immuni.2015.02.005; Kang S, 2005, MOL CELL BIOL, V25, P1272, DOI 10.1128/MCB.25.4.1272-1282.2005; Kelly B, 2015, CELL RES, V25, P771, DOI 10.1038/cr.2015.68; Lammers B, 2011, ARTERIOSCL THROM VAS, V31, P67, DOI 10.1161/ATVBAHA.110.215814; Ley K, 2017, J IMMUNOL, V199, P2191, DOI 10.4049/jimmunol.1701135; Liu D, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00083; Liu LL, 2016, P NATL ACAD SCI USA, V113, P1564, DOI 10.1073/pnas.1518000113; Malsin ES, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01813; Mendez-Lucas A, 2017, CANCER RES, V77, P4355, DOI 10.1158/0008-5472.CAN-17-0498; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Muxel SM, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02682; Namgaladze D, 2016, BBA-MOL CELL BIOL L, V1861, P1796, DOI 10.1016/j.bbalip.2016.09.002; Naskar D, 2014, J IMMUNOL, V192, P4386, DOI 10.4049/jimmunol.1302817; Neumann J, 2010, FASEB J, V24, P4599, DOI 10.1096/fj.10-160994; Nomura M, 2016, NAT IMMUNOL, V17, P216, DOI 10.1038/ni.3366; Oelschlaegel D, 2020, CANCERS, V12, DOI 10.3390/cancers12092579; Ouchi N, 2010, SCIENCE, V329, P454, DOI 10.1126/science.1188280; Ouimet M, 2011, CELL METAB, V13, P655, DOI 10.1016/j.cmet.2011.03.023; Papa S, 2019, ONCOGENE, V38, P2223, DOI 10.1038/s41388-018-0582-8; Park BS, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.97; Pate KT, 2014, EMBO J, V33, P1454, DOI 10.15252/embj.201488598; Pearn L, 2007, BLOOD, V109, P4461, DOI 10.1182/blood-2006-09-047217; Podinovskaia M, 2015, FUTURE MICROBIOL, V10, P111, DOI 10.2217/fmb.14.103; Remmerie A, 2018, CELL IMMUNOL, V330, P27, DOI 10.1016/j.cellimm.2018.01.020; Ries S, 1998, J LIPID RES, V39, P2125; Schaale K, 2011, EUR J CELL BIOL, V90, P553, DOI 10.1016/j.ejcb.2010.11.004; Shan J, 2009, GENESIS, V47, P782, DOI 10.1002/dvg.20566; Singh RK, 2016, J CELL SCI, V129, P1072, DOI 10.1242/jcs.181743; Spath GF, 2001, EXP PARASITOL, V99, P97, DOI 10.1006/expr.2001.4656; Tomiotto-Pellissier F, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02529; Traves PG, 2012, J IMMUNOL, V188, P1402, DOI 10.4049/jimmunol.1101781; Trevisan T, 2018, CELL REP, V23, P1742, DOI 10.1016/j.celrep.2018.04.017; Valledor AF, 1999, J IMMUNOL, V163, P2452; Van den Bossche J, 2017, TRENDS IMMUNOL, V38, P395, DOI 10.1016/j.it.2017.03.001; Van den Bossche J, 2015, JOVE-J VIS EXP, DOI 10.3791/53424; Van Ginderachter JA, 2006, IMMUNOBIOLOGY, V211, P487, DOI 10.1016/j.imbio.2006.06.002; Wang CQ, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-6; Wang F, 2018, ARTERIOSCL THROM VAS, V38, P1468, DOI 10.1161/ATVBAHA.118.311059; Wolf AM, 2008, J NEUROSCI, V28, P3456, DOI 10.1523/JNEUROSCI.0029-08.2008; Yan JW, 2020, TRENDS CELL BIOL, V30, P979, DOI 10.1016/j.tcb.2020.09.006; Yang WW, 2012, NAT CELL BIOL, V14, P1295, DOI 10.1038/ncb2629; Yu B, 2014, NAT MED, V20, P1009, DOI 10.1038/nm.3586; Yu JSL, 2016, DEVELOPMENT, V143, P3050, DOI 10.1242/dev.137075; Zhang Z, 2019, CELL BIOSCI, V9, DOI 10.1186/s13578-019-0317-8; Zhuang XQ, 2017, NAT CELL BIOL, V19, P1274, DOI 10.1038/ncb3613	90	0	0	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2022	298	8							102193	10.1016/j.jbc.2022.102193	http://dx.doi.org/10.1016/j.jbc.2022.102193			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	4X0OB	35764169	gold, Green Published			2022-12-26	WOS:000860550600012
J	Xie, J; Robinson, SD; Gilding, EK; Jami, S; Deuis, JR; Rehm, FBH; Yap, K; Ragnarsson, L; Chan, LY; Hamilton, BR; Harvey, PJ; Craik, DJ; Vetter, I; Durek, T				Xie, Jing; Robinson, Samuel D.; Gilding, Edward K.; Jami, Sina; Deuis, Jennifer R.; Rehm, Fabian B. H.; Yap, Kuok; Ragnarsson, Lotten; Chan, Lai Yue; Hamilton, Brett R.; Harvey, Peta J.; Craik, David J.; Vetter, Irina; Durek, Thomas			Neurotoxic and cytotoxic peptides underlie the painful stings of the tree nettle Urtica ferox	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEW-ZEALAND NETTLE; ANTIMICROBIAL PEPTIDES; SODIUM-CHANNELS; TOXINS; MECHANISMS; PROTEINS; THIONINS	The stinging hairs of plants from the family Urticaceae inject compounds that inflict pain to deter herbivores. The sting of the New Zealand tree nettle (Urtica ferox) is among the most painful of these and can cause systemic symptoms that can even be life-threatening; however, the molecular species effecting this response have not been elucidated. Here we reveal that two classes of peptide toxin are responsible for the symptoms of U. ferox stings: Delta-Uf1a is a cytotoxic thionin that causes pain via disruption of cell membranes, while beta/delta-Uf2a defines a new class of neurotoxin that causes pain and systemic symptoms via modulation of voltage-gated sodium (NaV) channels. We demonstrate using whole-cell patch-clamp electrophysiology experiments that beta/delta-Uf2a is a potent modulator of human NaV1.5 (EC50: 55 nM), NaV1.6 (EC50: 0.86 nM), and Na(V)1.7 (EC50: 208 nM), where it shifts the activation threshold to more negative potentials and slows fast inactivation. We further found that both toxin classes are widespread among members of the Urticeae tribe within Urticaceae, suggesting that they are likely to be pain-causing agents underlying the stings of other Urtica species. Comparative analysis of nettles of Urtica, and the recently described pain-causing peptides from nettles of another genus, Dendrocnide, indicates that members of tribe Urticeae have developed a diverse arsenal of pain-causing peptides.	[Xie, Jing; Robinson, Samuel D.; Gilding, Edward K.; Jami, Sina; Deuis, Jennifer R.; Rehm, Fabian B. H.; Yap, Kuok; Ragnarsson, Lotten; Chan, Lai Yue; Harvey, Peta J.; Craik, David J.; Vetter, Irina; Durek, Thomas] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Hamilton, Brett R.] Univ Queensland, Ctr Microscopy & Microanal, Brisbane, Qld, Australia; [Craik, David J.; Durek, Thomas] Univ Queensland, Australian Res Council, Ctr Excellence Innovat Peptide & Prot Sci, Brisbane, Qld, Australia; [Vetter, Irina] Univ Queensland, Sch Pharm, Brisbane, Qld, Australia	University of Queensland; University of Queensland; University of Queensland; University of Queensland	Vetter, I; Durek, T (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia.; Durek, T (corresponding author), Univ Queensland, Australian Res Council, Ctr Excellence Innovat Peptide & Prot Sci, Brisbane, Qld, Australia.; Vetter, I (corresponding author), Univ Queensland, Sch Pharm, Brisbane, Qld, Australia.	i.vetter@imb.uq.edu.au; t.durek@uq.edu.au	Craik, David/B-1695-2010	Craik, David/0000-0003-0007-6796; Xie, Jing/0000-0002-0397-8341; Jami, Sina/0000-0001-7134-7448; Hamilton, Brett/0000-0002-2921-7620; Gilding, Edward Kalani/0000-0003-1720-1282	Australian Research Council (ARC) [DP200102377]; ARC Laureate fellowship [FL150100146]; Centre of Excellence [CE200100012]; NHMRC [APP1162503, APP1139961]	Australian Research Council (ARC)(Australian Research Council); ARC Laureate fellowship(Australian Research Council); Centre of Excellence; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by Australian Research Council (ARC) discovery project DP200102377 (I. V. and T. D.), an ARC Laureate fellowship FL150100146 (D. J. C.) and Centre of Excellence (CE200100012) and NHMRC fellowships APP1162503 (I. V.) and APP1139961 (J. R. D.).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bennett DL, 2019, PHYSIOL REV, V99, P1079, DOI 10.1152/physrev.00052.2017; Blackman J. G., 1966, P U OTAGO MED SCH, V44, P25; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen H, 2001, J GEN PHYSIOL, V117, P505, DOI 10.1085/jgp.117.6.505; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CLARK FP, 1993, NEW ZEAL MED J, V106, P234; Connor H. E., 1977, POISONOUS PLANTS NZ, P182; Deuis JR, 2017, NEUROPHARMACOLOGY, V127, P87, DOI 10.1016/j.neuropharm.2017.04.014; DIZWANI AGM, 1981, P U OTAGO MED SCH, V59, P70; Durek T, 2013, ACS CHEM BIOL, V8, P1215, DOI 10.1021/cb400012k; EMMELIN N, 1947, J PHYSIOL-LONDON, V106, P440, DOI 10.1113/jphysiol.1947.sp004225; Ensikat HJ, 2021, TOXINS, V13, DOI 10.3390/toxins13020141; FLORACK DEA, 1994, PLANT MOL BIOL, V26, P25, DOI 10.1007/BF00039517; Gilding EK, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abb8828; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guntert P, 2015, J BIOMOL NMR, V62, P453, DOI 10.1007/s10858-015-9924-9; Haberlandt G, 1886, SITZ BER AKAD WIEN, V93, P123; Hammond-Tooke GD, 2007, MUSCLE NERVE, V35, P804, DOI 10.1002/mus.20730; Huang Y, 2015, PEPTIDES, V68, P175, DOI 10.1016/j.peptides.2015.03.012; Johansson S, 2003, CELL MOL LIFE SCI, V60, P165, DOI 10.1007/s000180300011; JUNG ML, 1990, CANCER LETT, V51, P103, DOI 10.1016/0304-3835(90)90044-X; Kanzaki M, 2010, NEUROTOXICOLOGY, V31, P709, DOI 10.1016/j.neuro.2010.07.004; King GF, 2008, TOXICON, V52, P264, DOI 10.1016/j.toxicon.2008.05.020; Kittow NC, 2013, NEW ZEAL VET J, V61, P60, DOI 10.1080/00480169.2012.704625; Leebens-Mack JH, 2019, NATURE, V574, P679, DOI 10.1038/s41586-019-1693-2; Parry GJ, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k5006; Parthasarathy A, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100438; PILGRIM RLC, 1959, PROC R SOC SER B-BIO, V151, P48, DOI 10.1098/rspb.1959.0049; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Silverstein KAT, 2007, PLANT J, V51, P262, DOI 10.1111/j.1365-313X.2007.03136.x; Stec B, 2006, CELL MOL LIFE SCI, V63, P1370, DOI 10.1007/s00018-005-5574-5; Tam JP, 2015, PHARMACEUTICALS-BASE, V8, P711, DOI 10.3390/ph8040711; THURSTON E L, 1969, Botanical Review, V35, P393, DOI 10.1007/BF02858878; War AR, 2012, PLANT SIGNAL BEHAV, V7, P1306, DOI 10.4161/psb.21663; Willox S., 1969, THESIS U OTAGO; Wood JR, 2020, NEW ZEAL J ECOL, V44, DOI 10.20417/nzjecol.44.3	38	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2022	298	8							102218	10.1016/j.jbc.2022.102218	http://dx.doi.org/10.1016/j.jbc.2022.102218			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3Z6GX	35780839	gold, Green Published			2022-12-26	WOS:000844516800001
J	Nabilou, P; Danielsen, K; Kimer, N; Hove, J; Bendtsen, F; Moller, S				Nabilou, Puria; Danielsen, Karen; Kimer, Nina; Hove, Jens; Bendtsen, Flemming; Moller, Soren			Blunted cardiovascular effects of beta-blockers in patients with cirrhosis: relation to severity?	JOURNAL OF HEPATOLOGY			English	Meeting Abstract	International Liver Congress	JUN 22-26, 2022	London, ENGLAND						[Nabilou, Puria; Danielsen, Karen; Bendtsen, Flemming] Hvidovre Univ Hosp, Div Med, Gastro Unit, Hvidovre, Denmark; [Kimer, Nina] Univ Copenhagen, Bridge Translat Excellence Program, Novo Nordisk Ctr Basic Metab Res, Copenhagen, Denmark; [Hove, Jens] Hvidovre Univ Hosp, Dept Cardiol, Hvidovre, Denmark; [Hove, Jens; Bendtsen, Flemming; Moller, Soren] Hvidovre Univ Hosp, Dept Clin Med, Hvidovre, Denmark; [Moller, Soren] Hvidovre Univ Hosp, Dept Clin Physiol & Nucl Med, Ctr Funct & Diagnost Imaging & Res, Hvidovre, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen		purianabilou@hotmail.com	Kimer, Nina/F-7625-2017	Kimer, Nina/0000-0002-4807-1575; Hove, Jens/0000-0002-5600-5623; Nabilou, Puria/0000-0002-4764-4423					0	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0168-8278	1600-0641		J HEPATOL	J. Hepatol.	JUL	2022	77			1		FRI489	S610	S610						1	Gastroenterology & Hepatology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Gastroenterology & Hepatology	2Z0KW	35763518	gold, Green Published			2022-12-26	WOS:000826275103175
J	Meng, XY; Wang, L; He, M; Yang, ZY; Jiao, Y; Hu, YB; Wang, KR				Meng, Xiangyu; Wang, Ling; He, Miao; Yang, Zhaoying; Jiao, Yan; Hu, Yubo; Wang, Keren			Cysteine conjugate beta-lyase 2 (CCBL2) expression as a prognostic marker of survival in breast cancer patients	PLOS ONE			English	Article							KYNURENINE AMINOTRANSFERASE III; ANDROGEN RECEPTOR EXPRESSION; INDUCED FORMIC ACIDURIA; NEOADJUVANT CHEMOTHERAPY; GLUTAMINE; METABOLISM; BIOMARKERS; TRICHLOROETHYLENE; ESTROGEN; THERAPY	Objective Cysteine conjugate beta-lyase 2 (CCBL2), also known as kynurenine aminotransferase 3 (KAT3) or glutamine transaminase L (GTL), plays an essential role in transamination and cytochrome P450. Its correlation with some other cancers has been explored, but breast cancer (BC) not yet. Methods The mRNA and protein expression of CCBL2 in BC cell lines and patient samples were detected by RT-qPCR and immunohistochemistry (IHC). BC patients' clinical information and RNA-Seq expression were acquired via The Cancer Genome Atlas (TCGA) database. Patients were categorized into high/low CCBL2 expression groups based on the optimal cutoff value (8.973) determined by receiver operating characteristic (ROC) curve. We investigated CCBL2 and clinicopathological characteristics' relationship using Chi-square tests, estimated diagnostic capacity using ROC curves and drew survival curves using KaplanMeier estimate. We compared survival differences using Cox regression and externally validated using Gene Expression Omnibus (GEO) database. We evaluated enriched signaling pathways using gene set enrichment analysis (GSEA), explored CCBL2 and relevant genes' relationship using tumor immunoassay resource (TIMER) databases and used the human protein atlas (HPA) for pan-cancer analysis and IHC. Results CCBL2 was overexpressed in normal human cell lines and tissues. CCBL2 expression was lower in BC tissues (n = 1104) than in normal tissues (n = 114), validated by GEO database. Several clinicopathologic features were related to CCBL2, especially estrogen receptor (ER), progesterone receptor (PR) and clinical stages. The low expression group exhibited poor survival. CCBL2's area under curve (AUC) analysis showed finite diagnostic capacity. Multivariate cox-regression analysis indicated CCBL2 independently predicted BC survival. GSEA showed enriched pathways: early estrogen response, MYC and so on. CCBL2 positively correlated with estrogen, progesterone and androgen receptors. CCBL2 was downregulated in most cancers and was associated with their survival, including renal and ovarian cancers. Conclusions Low CCBL2 expression is a promising poor BC survival independent prognostic marker.	[Meng, Xiangyu; Yang, Zhaoying; Wang, Keren] Jilin Univ, China Japan Union Hosp, Dept Breast Surg, Changchun, Jilin, Peoples R China; [Wang, Ling] Second Hosp Jilin Univ, Dept Obstet & Gynecol, Changchun, Jilin, Peoples R China; [He, Miao] Second Hosp Jilin Univ, Dept Anesthesia, Changchun, Jilin, Peoples R China; [Jiao, Yan] First Hosp Jilin Univ, Dept Hepatobiliary & Pancreat Surg, Changchun, Jilin, Peoples R China; [Hu, Yubo] Jilin Univ, China Japan Union Hosp, Dept Anesthesia, Changchun, Jilin, Peoples R China	Jilin University; Jilin University; Jilin University; Jilin University; Jilin University	Wang, KR (corresponding author), Jilin Univ, China Japan Union Hosp, Dept Breast Surg, Changchun, Jilin, Peoples R China.; Hu, YB (corresponding author), Jilin Univ, China Japan Union Hosp, Dept Anesthesia, Changchun, Jilin, Peoples R China.	huyubo717@jlu.edu.cn; wangkr@jlu.edu.cn						Anand A, 2017, BREAST CARE, V12, P160, DOI 10.1159/000458433; Anastasiadi Z, 2017, UPDATES SURG, V69, P313, DOI 10.1007/s13304-017-0424-1; Bernfeld E, 2019, TRENDS ENDOCRIN MET, V30, P357, DOI 10.1016/j.tem.2019.03.003; BIRCH PJ, 1988, EUR J PHARMACOL, V154, P85, DOI 10.1016/0014-2999(88)90367-6; Braden AM, 2014, CURR PHARM DESIGN, V20, P4879; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chen L, 2015, INT J MOL SCI, V16, P22830, DOI 10.3390/ijms160922830; Clarke C, 2013, CARCINOGENESIS, V34, P2300, DOI 10.1093/carcin/bgt208; Cooper AJL., 2015, GLUTAMINE CLIN NUTR, P37; Cooper AJL, 2011, AMINO ACIDS, V41, P7, DOI 10.1007/s00726-010-0552-0; Cristofori P, 2015, CELL BIOL TOXICOL, V31, P1, DOI 10.1007/s10565-015-9293-x; Deng H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088034; DeSantis C, 2014, CA-CANCER J CLIN, V64, P52, DOI 10.3322/caac.21203; Fahrmann JF, 2020, JNCI-J NATL CANCER I, V112, P607, DOI 10.1093/jnci/djz182; Gao Y, 2021, J PHARMACEUT BIOMED, V193, DOI 10.1016/j.jpba.2020.113755; Han Q, 2019, CURR MED CHEM, V26, P4944, DOI 10.2174/0929867326666190325095223; Han Q, 2010, CELL MOL LIFE SCI, V67, P353, DOI 10.1007/s00018-009-0166-4; Han Q, 2009, MOL CELL BIOL, V29, P784, DOI 10.1128/MCB.01272-08; Harbeck N, 2017, LANCET, V389, P1134, DOI [10.1016/s0140-6736(16)31891-8, 10.1016/S0140-6736(16)31891-8]; Hare SH, 2017, AM J CANCER RES, V7, P383; Huiart L, 2013, BREAST CANCER RES TR, V138, P325, DOI 10.1007/s10549-013-2422-4; Kyle RA, 2007, J CLIN ONCOL, V25, P2464, DOI 10.1200/JCO.2007.12.1269; Le A, 2012, CELL METAB, V15, P110, DOI 10.1016/j.cmet.2011.12.009; Li G, 2017, ADV EXP MED BIOL, V1026, P27, DOI 10.1007/978-981-10-6020-5_2; Lin FDL, 2012, J CLIN PATHOL, V65, P64, DOI 10.1136/jclinpath-2011-200318; Lock EA, 2017, TOXICOLOGY, V378, P76, DOI 10.1016/j.tox.2017.01.004; Loibl S, 2011, BREAST CANCER RES TR, V130, P477, DOI 10.1007/s10549-011-1715-8; Loke SY, 2018, EUR J CANCER, V92, P54, DOI 10.1016/j.ejca.2017.12.025; Maruani DM, 2012, ONCOGENE, V31, P5073, DOI 10.1038/onc.2011.657; Masuda H, 2013, CLIN CANCER RES, V19, P5533, DOI 10.1158/1078-0432.CCR-13-0799; Oshi M, 2020, CANCERS, V12, DOI 10.3390/cancers12123557; Passera E, 2011, FEBS J, V278, P1882, DOI 10.1111/j.1742-4658.2011.08106.x; Pedersen IS, 2018, MOL MED, V24, DOI 10.1186/s10020-018-0058-x; Pinto JT, 2014, J BIOL CHEM, V289, P30950, DOI 10.1074/jbc.M114.591461; Polet F, 2013, J INTERN MED, V273, P156, DOI 10.1111/joim.12016; Sridharan S, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21041199; Stone TW, 2007, EUR J NEUROSCI, V25, P2656, DOI 10.1111/j.1460-9568.2007.05540.x; Thike AA, 2014, MODERN PATHOL, V27, P352, DOI 10.1038/modpathol.2013.145; Udupa S, 2019, PROTEOMICS, V19, DOI 10.1002/pmic.201800451; Ullah MF, 2019, ADV EXP MED BIOL, V1152, P51, DOI 10.1007/978-3-030-20301-6_4; Voils SA, 2018, THROMB RES, V165, P6, DOI 10.1016/j.thromres.2018.03.003; Walsh EM, 2020, SEMIN ONCOL, V47, P187, DOI 10.1053/j.seminoncol.2020.05.010; Weaver O, 2018, AM J ROENTGENOL, V210, P271, DOI 10.2214/AJR.17.18708; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Yamnik RL, 2009, J BIOL CHEM, V284, P6361, DOI 10.1074/jbc.M807532200; Yang Cihan, 2016, Biochem Biophys Rep, V8, P234, DOI 10.1016/j.bbrep.2016.09.008; Yaqoob N, 2014, TOXICOLOGY, V323, P70, DOI 10.1016/j.tox.2014.06.004; Yu P, 2006, GENE, V365, P111, DOI 10.1016/J.gene.2005.09.034; Zhao HQ, 2021, BREAST CANCER-TOKYO, V28, P187, DOI 10.1007/s12282-020-01146-4	49	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2022	17	6							e0269998	10.1371/journal.pone.0269998	http://dx.doi.org/10.1371/journal.pone.0269998			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5G0IK	35771747	gold, Green Published			2022-12-26	WOS:000866691600001
J	Sarker, R; Islam, MS; Moonajilin, MS; Rahman, M; Gesesew, HA; Ward, PR				Sarker, Rumpa; Islam, Md Saiful; Moonajilin, Mst Sabrina; Rahman, Mahmudur; Gesesew, Hailay Abrha; Ward, Paul R.			Knowledge of breast cancer and breast self-examination practices and its barriers among university female students in Bangladesh: Findings from a cross-sectional study	PLOS ONE			English	Article							YOUNG-WOMEN; POPULATION; AWARENESS; MAMMOGRAPHY; ATTITUDE	Early diagnosis of breast cancer is the best approach towards its control that may result in alleviating related mortality and morbidity. This study aimed to evaluate knowledge about breast cancer and both practices and perceived barriers to breast self-examination among female university students in Bangladesh. A cross-sectional study was carried out with 400 female students of Jahangirnagar University, Bangladesh. Participants were sampled from female dormitories at the university from January to April 2020. Proportionate stratified random sampling was conducted to calculate the study sample from each dormitory. A validated semi-structured self-reported questionnaire was employed to collect data from participants during the survey periods. The questionnaire consisted of demographic variables, items about knowledge about breast cancer, breast self-examination practices and its barriers. We applied descriptive and inferential statistics and data were analyzed using the Statistical Package for the Social Sciences (SPSS). Participants were aged between 18-26 years and comprised university students of first year (20%), second year (24%), third year (22%), fourth year (21%) and Master's (14%). 18% of them reported positive family history (mother, aunt, sister/cousin, grandmother) of breast cancer. The overall mean score of total knowledge items was 15 (SD = 3) out of 43, with an overall correct rate of 34%. The mean score of total knowledge items was significantly higher (p<0.001) among Master's students and students with family members who have had breast cancer. Only one in five students (21%) ever practiced breast self-examination. The mean score of practice of breast self-examination was significantly higher (p<0.001) among participants who reported having family member of breast cancer. Total knowledge score about breast cancer and practice of breast self-examination were significantly correlated with each other (r = 0.54; p<0.001). About 33% participants reported 'lack of knowledge' as the main barrier to practicing breast self-examination followed by 'I do not have the symptoms' (22%), and 'shyness/uncomfortable feelings' (17%). The study revealed low levels of knowledge about breast cancer and low breast self-examination practices. Our findings highlight the need to develop, implement and promote socially, culturally and demographically appropriate educational interventions programs aimed at breast cancer and breast self-examination awareness and practice in Bangladesh.	[Sarker, Rumpa; Islam, Md Saiful; Moonajilin, Mst Sabrina; Rahman, Mahmudur] Jahangirnagar Univ, Dept Publ Hlth & Informat, Dhaka, Bangladesh; [Islam, Md Saiful] Ctr Adv Res Excellence Publ Hlth, Dhaka, Bangladesh; [Gesesew, Hailay Abrha] Mekelle Univ, Sch Hlth Sci, Dept Epidemiol, Mekelle, Ethiopia; [Gesesew, Hailay Abrha; Ward, Paul R.] Torrens Univ Australia, Ctr Res Hlth Policy, Adelaide, SA, Australia	Jahangirnagar University; Mekelle University; Torrens University Australia	Islam, MS (corresponding author), Jahangirnagar Univ, Dept Publ Hlth & Informat, Dhaka, Bangladesh.; Islam, MS (corresponding author), Ctr Adv Res Excellence Publ Hlth, Dhaka, Bangladesh.	islam.msaiful@outlook.com	Islam, Md. Saiful/AAS-1169-2020	Islam, Md. Saiful/0000-0003-3979-2423; Ward, Paul/0000-0002-5559-9714	National Science and Technology Fellowship, Bangladesh	National Science and Technology Fellowship, Bangladesh	This study was partially supported by the National Science and Technology Fellowship, Bangladesh 2020-21. The reward of this fellowship was 634.54 US$. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadian M, 2012, LIFE SCI J, V9, P585; Ahmed BA, 2010, ASIAN PAC J CANCER P, V11, P101; Ahmed MS., 2020, ASIAN PAC J CAN CARE, V5, P19; Akhtari-Zavare M, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1491-8; Al-Dubai SAR, 2012, ASIAN PAC J CANCER P, V13, P1627, DOI 10.7314/APJCP.2012.13.4.1627; Al-Dubai SAR, 2011, ASIAN PAC J CANCER P, V12, P2531; Alam AA, 2006, ANN SAUDI MED, V26, P272, DOI 10.5144/0256-4947.2006.272; Alam NE, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0257271; Alwan N. A. S., 2012, Eastern Mediterranean Health Journal, V18, P337; Anderson Benjamin O, 2003, Breast J, V9 Suppl 2, pS51, DOI 10.1046/j.1524-4741.9.s2.4.x; Aruna S., 2010, PRISMS NURS PRACT, V5, P34; Boulos Dina Nabih Kamel, 2013, Glob J Health Sci, V6, P154, DOI 10.5539/gjhs.v6n1p154; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; DeSantis C, 2014, CA-CANCER J CLIN, V64, P52, DOI 10.3322/caac.21203; Gilani SI, 2010, J PAK MED ASSOC, V60, P205; Hellquist BN, 2011, CANCER-AM CANCER SOC, V117, P714, DOI 10.1002/cncr.25650; Hortobagyi Gabriel N, 2005, Clin Breast Cancer, V6, P391, DOI 10.3816/CBC.2005.n.043; Hossain MS, 2014, CANCER EPIDEMIOL, V38, P465, DOI 10.1016/j.canep.2014.08.004; HUGULEY CM, 1988, CANCER, V62, P1389, DOI 10.1002/1097-0142(19881001)62:7<1389::AID-CNCR2820620725>3.0.CO;2-0; Hussain SA, 2013, JPN J CLIN ONCOL, V43, P1159, DOI 10.1093/jjco/hyt140; Iheanacho P, 2013, ENUGU CAMPUS, V3, P29571; Internarional Research On Cancer, 2020, CANC FACT SHEET; Islam RM, 2016, MATURITAS, V84, P68, DOI 10.1016/j.maturitas.2015.11.002; Karayurt O, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-359; Moore SG, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-9; Nemenqani D. M., 2014, Open Journal of Preventive Medicine, V4, P69; Rafique S, 2018, BIOMED J SCI TECH RE, V4, P4; Sama CB, 2017, PAN AFR MED J, V28, DOI 10.11604/pamj.2017.28.91.10986; Shalini, 2011, INDIAN J PALLIAT CAR, V17, P150, DOI 10.4103/0973-1075.84538; WARDLE J, 1995, EUR J CANCER PREV, V4, P61, DOI 10.1097/00008469-199502000-00005; World Health organization, WHO SUPP EARL DET CO; Yan YY, 2009, GLOBAL J HLTH SCI, V1, P97, DOI DOI 10.5539/GJHS.V1N2P97]; Yip CH, 2007, EXPERT REV ANTICANC, V7, P1095, DOI 10.1586/14737140.7.8.1095; Youlden DR, 2012, CANCER EPIDEMIOL, V36, P237, DOI 10.1016/j.canep.2012.02.007	34	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2022	17	6							e0270417	10.1371/journal.pone.0270417	http://dx.doi.org/10.1371/journal.pone.0270417			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3Y7ND	35763525	Green Published, gold			2022-12-26	WOS:000843907900001
J	Wang, SS; Lu, MQ; Liu, XY; Ji, JT; Pan, C				Wang, Shengsheng; Lu Mengqing; Liu, Xingyi; Ji, Jiangtao; Pan Chen			Calibration and analysis of discrete element simulation parameters of Chinese cabbage seeds	PLOS ONE			English	Article							MODEL PARAMETERS	Objective To improve the accuracy of parameters used in discrete element simulation test of Chinese cabbage seeds harvesting process. Methods Firstly, the key physical parameters of Chinese cabbage seeds were measured. According to the results, the discrete element simulation model was established and the value range of simulation test parameters was determined. Then, the actual repose angle of Chinese cabbage seeds was obtained by physical accumulation test using bottomless conical cylinder lifting method. Plackett-Burman test, steepest climb test, Box-Behnken test and parameter optimization test were carried out in sequence with the actual angle of repose as the response value. Finally, the obtained parameters are verified. Results 1. The Plackett-Burman test showed that the seed-seed rolling friction coefficient, the seed-steel rolling friction coefficient, the seed-seed static friction coefficient, and the seed-steel static friction coefficient had significant effects on the repose angle of Chinese cabbage seeds (P<0.05). 2. The optimization test showed that the seed-seed rolling friction coefficient was 0.08, the seed-steel rolling friction coefficient was 0.109, the seed-seed static friction coefficient was 0.496, and the seed-steel static friction coefficient was 0.415. 3. The validation test showed that the repose angle of Chinese cabbage seeds under such parameter was 23.62 degrees, and the error with the repose angle of the physical test was 0.73%. Conclusion The study show that the discrete element simulation parameters of Chinese cabbage seeds model and calibration are reliable, which can provide reference for the discrete element simulation of Chinese cabbage seeds.	[Wang, Shengsheng; Lu Mengqing; Liu, Xingyi; Ji, Jiangtao; Pan Chen] Henan Univ Sci & Technol, Coll Agr Equipment Engn, Luoyang, Peoples R China; [Wang, Shengsheng; Ji, Jiangtao] Collaborat Innovat Ctr Machinery Equipment Adv Mf, Luoyang, Peoples R China	Henan University of Science & Technology	Ji, JT (corresponding author), Henan Univ Sci & Technol, Coll Agr Equipment Engn, Luoyang, Peoples R China.; Ji, JT (corresponding author), Collaborat Innovat Ctr Machinery Equipment Adv Mf, Luoyang, Peoples R China.	jjt0907@163.com			National Natural Science Foundation of China [:52005163]; Experimental Technology Development Fund of Henan University of Science and Technology [SY2122006]; Graduate Innovation Fund of Henan University of Science and Technology [CXJJ-2021KJ04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Experimental Technology Development Fund of Henan University of Science and Technology; Graduate Innovation Fund of Henan University of Science and Technology	This study was supported by the National Natural Science Foundation of China (Grant No. :52005163), the Experimental Technology Development Fund of Henan University of Science and Technology (Grant No. :SY2122006), and the Graduate Innovation Fund of Henan University of Science and Technology (Grant No. :CXJJ-2021KJ04).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Gao JY, 2019, CHINA SEED IND, P38; Ghodki BM, 2019, COMPUT PART MECH, V6, P3, DOI 10.1007/s40571-018-0194-7; Hao Jianjun, 2021, Transactions of the Chinese Society of Agricultural Engineering, V37, P36, DOI 10.11975/j.issn.1002-6819.2021.12.005; [郝建军 Hao Jianjun], 2019, [农业工程学报, Transactions of the Chinese Society of Agricultural Engineering], V35, P34; He Y., 2017, CHIN AGR SCI B, V33, P133; Horabik J, 2017, BIOSYST ENG, V161, P106, DOI 10.1016/j.biosystemseng.2017.06.009; Hou JunMing, 2019, Journal of Shenyang Agricultural University, V50, P565; [侯占峰 Hou Zhanfeng], 2020, [农业工程学报, Transactions of the Chinese Society of Agricultural Engineering], V36, P46; Hu GM, 2010, ANAL SIMULATION PART; Huang XiaoMao, 2014, Transactions of the Chinese Society of Agricultural Engineering, V30, P22; Khodabakhshian R., 2012, Agricultural Engineering International: CIGR Journal, V14, P203; Liu CaiLing, 2016, Transactions of the Chinese Society of Agricultural Engineering, V32, P294; Liu FanYi, 2016, Transactions of the Chinese Society of Agricultural Engineering, V32, P247; [鹿芳媛 Lu Fangyuan], 2018, [农业机械学报, Transactions of the Chinese Society for Agricultural Machinery], V49, P93; [马文鹏 Ma Wenpeng], 2020, [农业机械学报, Transactions of the Chinese Society for Agricultural Machinery], V51, P136; Ma Zheng, 2013, Nongye Jixie Xuebao = Transactions of the Chinese Society for Agricultural Machinery, V44, P22; Mousaviraad M, 2017, T ASABE, V60, P1403, DOI 10.13031/trans.12200; National Bureau of Statistics, 2020 CHIN STAT YB; Qiu R, 2016, AGR MACHINERY USE MA, P10; [石林榕 Shi Linrong], 2019, [农业工程学报, Transactions of the Chinese Society of Agricultural Engineering], V35, P25; Shi LinRong, 2018, Transactions of the Chinese Society of Agricultural Engineering, V34, P35; Wang MeiMei, 2018, Journal of South China Agricultural University, V39, P111; [王云霞 Wang Yunxia], 2016, [农业工程学报, Transactions of the Chinese Society of Agricultural Engineering], V32, P36; [吴孟宸 Wu Mengchen], 2020, [农业工程学报, Transactions of the Chinese Society of Agricultural Engineering], V36, P30; Xu B, 2021, INMATEH-AGRIC ENG, V64, P175, DOI 10.35633/inmateh-64-17; [于庆旭 Yu Qingxu], 2020, [农业机械学报, Transactions of the Chinese Society for Agricultural Machinery], V51, P123; [曾智伟 Zeng Zhiwei], 2021, [农业机械学报, Transactions of the Chinese Society for Agricultural Machinery], V52, P1; Zhang YQ, 2016, J SHANXI AGR U NATUR, V36, P224; Zhu K, 2021, IN PRESS; [朱明 Zhu Ming], 2015, [农业工程学报, Transactions of the Chinese Society of Agricultural Engineering], V31, P1	30	0	0	11	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2022	17	6							e0270415	10.1371/journal.pone.0270415	http://dx.doi.org/10.1371/journal.pone.0270415			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5F3NS	35749575	Green Published, gold			2022-12-26	WOS:000866226400001
J	Zhou, F; Wang, ZZ; Xiong, K; Zhang, ML; Wang, Y; Wang, MD				Zhou, Feng; Wang, Zhenzhi; Xiong, Kang; Zhang, Meiling; Wang, Yuan; Wang, Maode			Alantolactone reduced neuron injury via activating PI3K/Akt signaling pathway after subarachnoid hemorrhage in rats	PLOS ONE			English	Article							EARLY BRAIN-INJURY; APOPTOSIS; MICROGLIA; INFLAMMATION; MANAGEMENT	Subarachnoid hemorrhage (SAH) is a common disease with high morbidity and mortality, which can cause pathological, physiological, and biological reactions. SAH causes a series of responses such as neuronal and cerebral cortex damage, which in turn leads to inflammation and apoptosis. Traditional Chinese medicine has a strong anti-inflammatory effect, such as Alantolactone (ATL). However, studies on ATL therapy for SAH have not been reported. We observed the neurological scores, brain water content, Evans blue (EB) extravasation, neuroinflammation, and apoptosis via performing an enzyme-linked immunosorbent assay (ELISA), western blotting, immunofluorescence staining, and other methods after SAH. In this study, we found that ATL treatment attenuated the neurologic deficits, inhibited neuronal apoptosis and inflammatory reaction, promoted polarization of microglia toward the M2 phenotype, and activated the PI3K/Akt signaling pathway. ATL can reduce the neurons and cerebral cortex damage of SAH rats through activating PI3K/Akt signaling pathway.	[Zhou, Feng; Wang, Maode] Xi An Jiao Tong Univ, Dept Neurosurg, Affiliated Hosp 1, Xian, Shaanxi, Peoples R China; [Zhou, Feng] Shaanxi Univ Chinese Med, Dept Neurosurg, Affiliated Hosp, Xianyang, Shaanxi, Peoples R China; [Wang, Zhenzhi; Xiong, Kang; Zhang, Meiling] Shaanxi Univ Chinese Med, Dept Chinese & Western Med, Xianyang, Shaanxi, Peoples R China; [Wang, Yuan] Shaanxi Univ Chinese Med, Combinat Acupuncture & Med Innovat Res Ctr, Xianyang, Shaanxi, Peoples R China	Xi'an Jiaotong University; Shaanxi University of Chinese Medicine; Shaanxi University of Chinese Medicine; Shaanxi University of Chinese Medicine	Wang, MD (corresponding author), Xi An Jiao Tong Univ, Dept Neurosurg, Affiliated Hosp 1, Xian, Shaanxi, Peoples R China.	maodewang@163.com			National Key Innovation Project of Traditional Chinese Medicine [(2019) 128]; Xianyang City Young and Middle-aged Science and Technology Leading Talent Cultivation Project (Major Technology Innovation Project) [2019k0152]	National Key Innovation Project of Traditional Chinese Medicine; Xianyang City Young and Middle-aged Science and Technology Leading Talent Cultivation Project (Major Technology Innovation Project)	This study was supported by a grant from the National Key Innovation Project of Traditional Chinese Medicine (teaching Letter of Traditional Chinese Medicine (2019) 128), and the Xianyang City Young and Middle-aged Science and Technology Leading Talent Cultivation Project (Major Technology Innovation Project) (2019k0152). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argudin MA, 2017, J ANTIMICROB CHEMOTH, V72, P56, DOI 10.1093/jac/dkw380; Bian LH, 2012, CNS NEUROSCI THER, V18, P895, DOI 10.1111/cns.12001; Bolouki A, 2019, PAK J MED HLTH SCI, V13, P198; Caner B, 2012, J NEUROCHEM, V123, P12, DOI 10.1111/j.1471-4159.2012.07939.x; Chan DYC, 2019, WORLD NEUROSURG, V125, pE665, DOI 10.1016/j.wneu.2019.01.145; Chen JY, 2015, J PINEAL RES, V59, P469, DOI 10.1111/jpi.12278; Chen JF, 2022, NEURAL REGEN RES, V17, P1404, DOI 10.4103/1673-5374.330589; Chen YJ, 2015, STROKE, V46, pE91, DOI 10.1161/STROKEAHA.115.008779; Crowley RW, 2011, STROKE, V42, P919, DOI 10.1161/STROKEAHA.110.597005; Gulec I, 2021, BRAIN RES, V1765, DOI 10.1016/j.brainres.2021.147508; Heinz R, 2021, J NEUROINFLAMM, V18, DOI 10.1186/s12974-021-02085-3; Im SS, 2007, J MED FOOD, V10, P503, DOI 10.1089/jmf.2006.209; Kim M, 2017, INT IMMUNOPHARMACOL, V49, P187, DOI 10.1016/j.intimp.2017.05.037; Korja M, 2016, NEUROLOGY, V87, P1118, DOI 10.1212/WNL.0000000000003091; Kramer AH, 2010, NEUROCRIT CARE, V12, P285, DOI 10.1007/s12028-009-9306-9; Kumar TP, 2019, MOL NEUROBIOL, V56, P1992, DOI 10.1007/s12035-018-1213-7; Lee JY, 2009, NEUROSURGERY, V65, P331, DOI 10.1227/01.NEU.0000345649.78556.26; Lee KC, 2018, MOLECULES, V23, DOI 10.3390/molecules23082016; Li SS, 2012, CANCER BIOTHER RADIO, V27, P88, DOI 10.1089/cbr.2011.1031; Li TL, 2013, INT J CARDIOL, V166, P158, DOI 10.1016/j.ijcard.2011.10.107; Liang YX, 2006, CHINESE J MEDICAL HI, V36, P3; Lim HS, 2015, PHYTOTHER RES, V29, P1088, DOI 10.1002/ptr.5354; Liu L, 2018, MOL NEUROBIOL, V55, P8346, DOI 10.1007/s12035-018-1006-z; Mo J, 2019, REDOX BIOL, V20, P75, DOI 10.1016/j.redox.2018.09.022; Nakazawa Takuya, 2015, No Shinkei Geka, V43, P465, DOI 10.11477/mf.1436203047; Negishi Y, 2015, PHARMACEUTICS, V7, P344, DOI 10.3390/pharmaceutics7030344; Nelson SE, 2018, NEUROCRIT CARE, V29, P241, DOI 10.1007/s12028-018-0534-8; Nishikawa H, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8020030; Okada T, 2019, MOL NEUROBIOL, V56, P8203, DOI 10.1007/s12035-019-01668-9; Orihuela R, 2016, BRIT J PHARMACOL, V173, P649, DOI 10.1111/bph.13139; Peng YC, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01830-4; Ransohoff RM, 2016, NAT NEUROSCI, V19, P987, DOI 10.1038/nn.4338; Schneider U, 2015, ACTA NEUROPATHOL, V130, P215, DOI 10.1007/s00401-015-1440-1; Sehba FA, 2012, PROG NEUROBIOL, V97, P14, DOI 10.1016/j.pneurobio.2012.02.003; Serrone JC, 2015, EXPERT REV NEUROTHER, V15, P367, DOI 10.1586/14737175.2015.1018892; Shao AW, 2014, INT J MED SCI, V11, P1073, DOI 10.7150/ijms.9282; Shi HX, 2016, NAT IMMUNOL, V17, P250, DOI 10.1038/ni.3333; Shi Y, 2011, J BIOMOL SCREEN, V16, P525, DOI 10.1177/1087057111398486; Sugawara T, 2008, J NEUROSCI METH, V167, P327, DOI 10.1016/j.jneumeth.2007.08.004; Tan LW, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070739; Tso MK, 2014, TRANSL STROKE RES, V5, P174, DOI 10.1007/s12975-014-0323-4; Venti M, 2012, FRONT NEUROL NEUROSC, V30, P149, DOI 10.1159/000333625; Wang F, 2020, NEUROCHEM RES, V45, P1758, DOI 10.1007/s11064-020-03037-8; Wang X, 2018, AM J TRANSL RES, V10, P368; Wang X, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0563-8; West KA, 2002, DRUG RESIST UPDATE, V5, P234, DOI 10.1016/S1368-7646(02)00120-6; Wu XY, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.766178; Xia DY, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.770744; Xie ZY, 2018, NEUROPHARMACOLOGY, V128, P142, DOI 10.1016/j.neuropharm.2017.09.040; Xu PF, 2021, TRANSL STROKE RES, V12, P643, DOI 10.1007/s12975-020-00840-x; Yan N, 2016, MOL NEUROBIOL, V53, P4449, DOI 10.1007/s12035-015-9380-2; Yang MT, 2018, EUR J PHARMACOL, V828, P60, DOI 10.1016/j.ejphar.2018.03.021; Yuejiang L, 2018, CHINESE COMMUNITY DO; Zhang Y, 2013, MOL MED REP, V8, P967, DOI 10.3892/mmr.2013.1640; Zhu QQ, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1211-8	55	0	0	5	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2022	17	6							e0270410	10.1371/journal.pone.0270410	http://dx.doi.org/10.1371/journal.pone.0270410			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5E8OO	35749405	gold, Green Published			2022-12-26	WOS:000865881800001
J	Li, YY; Guo, Q; Zhang, KY; Wang, H; Jia, CS; Guo, DL; Guo, LL; Hou, XG				Li, Yuying; Guo, Qi; Zhang, Kaiyue; Wang, Hao; Jia, Changsong; Guo, Dalong; Guo, Lili; Hou, Xiaogai			Dormancy-release, germination and seedling growth of Paeonia ostii 'Fengdan' seeds under measures of physical and chemical treatment and sowing	PLOS ONE			English	Article							DIFFERENT CULTIVATION AREAS; IMPROVES SALT TOLERANCE; TRITICUM-AESTIVUM L.; ORYZA-SATIVA L.; 5-AMINOLEVULINIC ACID; MONOTERPENE GLYCOSIDES; RESPONSE PATHWAYS; GIBBERELLIC-ACID; LOW-TEMPERATURE; WATER-UPTAKE	Paeonia ostii 'Fengdan', a woody oleaginous plant native from China, is considered an oil crop with economic potential. However, a low germination rate was still a restriction for Paeonia ostii 'Fengdan' production. The present research evaluated the germination, rooting and physiological characteristics of seedlings of Paeonia ostii 'Fengdan' in response to different physical treatments and the application of exogenous chemicals. Results indicated that seeds stored in sand at room temperature, and soaked in water for 3 days prior to planting, had a beneficial effect on hypocotyl dormancy-breaking. The rate of rooting and root growth of Paeonia ostii 'Fengdan' were significantly improved with 5 cm sowing depth in 15-20celcius soils. Compared with other sowing depths, the rooting percentage was significantly increased by 1.19% (2.5 cm), 0.98% (7.5 cm) and 1.47% (10 cm), respectively. Epicotyl dormancy was relieved when taproot length reached 50 mm. Soaking seeds in 0.76 mmol/L 5-aminolevulinic acid for 48 hours had the greatest beneficial effect on seed germination and seedling growth, the germination percentage was significantly increased by 4.25% (24 h) and 5.08% (72 h) compared with other treatments. While seed soaked in 10 mmol/L sodium nitroprusside for 48 hours also exhibited enhanced seedling growth, and the germination percentage was significantly increased by 4.36% (24 h) and 7.40% (72 h). Those results benefited seed germination and seedling growth of Paeonia ostii 'Fengdan' which could suggest the promotion of its industrial values and productive potentials. The mechanism of seed breaking dormancy and germination of Paeonia ostii 'Fengdan' needs further study.	[Li, Yuying; Guo, Qi; Zhang, Kaiyue; Wang, Hao; Guo, Lili; Hou, Xiaogai] Henan Univ Sci & Technol, Coll Agron, Coll Tree Peony, Luoyang, Henan, Peoples R China; [Jia, Changsong] Beijing Changsong Technol Co Ltd, Beijing, Peoples R China; [Guo, Dalong] Henan Univ Sci & Technol, Coll Forestry, Luoyang, Henan, Peoples R China	Henan University of Science & Technology; Henan University of Science & Technology	Guo, LL; Hou, XG (corresponding author), Henan Univ Sci & Technol, Coll Agron, Coll Tree Peony, Luoyang, Henan, Peoples R China.	guolili@haust.edu.cn; hkdhxg@haust.edu.cn	Guo, Da-Long/M-3197-2019	Guo, Da-Long/0000-0001-5379-5255	National Natural Science Foundation of China [U1804233]; Innovation Scientists and Technicians Troop Construction Projects of Henan Province [202101510003]; Science and Technology Major Project of Luoyang [2101099A]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Scientists and Technicians Troop Construction Projects of Henan Province; Science and Technology Major Project of Luoyang	Xiaogai Hou: the National Natural Science Foundation of China (U1804233), Innovation Scientists and Technicians Troop Construction Projects of Henan Province (202101510003), Science and Technology Major Project of Luoyang (2101099A). The funders had role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akram NA, 2013, J PLANT GROWTH REGUL, V32, P663, DOI 10.1007/s00344-013-9325-9; Ali Q, 2017, PLANT PHYSIOL BIOCH, V119, P50, DOI 10.1016/j.plaphy.2017.08.010; Ali Q, 2018, ARCH AGRON SOIL SCI, V64, P84, DOI 10.1080/03650340.2017.1335393; Ali T, 2010, AFR J BIOTECHNOL, V9, P6588; Amato M, 2002, CROP SCI, V42, P773, DOI 10.2135/cropsci2002.0773; BARTON LELA V., 1933, CONTR BOYCE THOMPSON INST, V5, P451; BARTON LELA V., 1957, CONTR BOYCE THOMPSON INST, V19, P201; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Benech-Arnold RL, 1999, SEED SCI RES, V9, P39, DOI 10.1017/S0960258599000045; Chen FL, 2016, IND CROP PROD, V94, P266, DOI 10.1016/j.indcrop.2016.08.048; Cheng FangYun, 2008, Acta Horticulturae Sinica, V35, P553; Delledonne M, 1998, NATURE, V394, P585, DOI 10.1038/29087; Doussan C, 2006, PLANT SOIL, V283, P99, DOI 10.1007/s11104-004-7904-z; El-Shraiy A.M., 2009, AUSTR J BASIC APPL S, V3, P3514; Fang SZ, 2006, SCI HORTIC-AMSTERDAM, V110, P305, DOI 10.1016/j.scienta.2006.06.031; Finch-Savage WE, 2006, NEW PHYTOL, V171, P501, DOI 10.1111/j.1469-8137.2006.01787.x; Fu JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107152; Ge J., 2018, Cercetari Agronomice in Moldova, V51, P25, DOI 10.2478/cerce-2018-0023; Geneve RL, 2003, HORTSCIENCE, V38, P336, DOI 10.21273/HORTSCI.38.3.336; Ghanbari F., 2013, International Journal of Biosciences (IJB), V3, P95; Guo Q, 2017, SCI HORTIC-AMSTERDAM, V219, P294, DOI 10.1016/j.scienta.2017.03.017; Gupta P, 2017, PLANT SOIL, V411, P483, DOI 10.1007/s11104-016-3043-6; Habib N, 2010, PAK J BOT, V42, P4071; Hajihashemi S, 2022, J PLANT GROWTH REGUL, DOI 10.1007/s00344-022-10596-3; Han RH, 2018, GRASSL SCI, V64, P100, DOI 10.1111/grs.12189; Hao HP, 2014, ANN BOT-LONDON, V113, P443, DOI 10.1093/aob/mct273; Ochoa MJ, 2015, J PROF ASSOC CACTUS, V17, P50; Koornneef M, 2002, CURR OPIN PLANT BIOL, V5, P33, DOI 10.1016/S1369-5266(01)00219-9; Kosar F, 2015, S AFR J BOT, V96, P71, DOI 10.1016/j.sajb.2014.10.015; Krekler WH., 1962, PEONIES AM HORTICULT; Lan YR, 2019, SEED SCI TECHNOL, V47, P13, DOI 10.15258/sst.2019.47.1.02; Li HS, 2000, EXPT PRINCIPLE TECHN; Li SF, 2007, THESIS; Li SS, 2015, FOOD CHEM, V173, P133, DOI 10.1016/j.foodchem.2014.10.017; Li Wanru, 2019, ACTA BOTANICA BOREALI-OCCIDENTALIA SINICA, V39, P1819, DOI 10.7606/j.issn.1000-4025.2019.10.1819; [梁金凤 LIANG Jinfeng], 2010, [生态环境学报, Ecology and Environmental Sciences], V19, P945; Liu C., 2014, THESIS; Liu CuiXia, 2011, China Vegetables, P72; Liu P, 2019, IND CROP PROD, V133, P63, DOI 10.1016/j.indcrop.2019.01.054; Liu P, 2018, IND CROP PROD, V118, P259, DOI 10.1016/j.indcrop.2018.03.033; Liu P, 2018, IND CROP PROD, V111, P371, DOI 10.1016/j.indcrop.2017.10.043; Liu Tao, 2010, ACTA BOTANICA BOREALI-OCCIDENTALIA SINICA, V30, P2047; Luksiene Z, 2007, INT J FOOD MICROBIOL, V116, P153, DOI 10.1016/j.ijfoodmicro.2006.12.040; Malamy JE, 2005, PLANT CELL ENVIRON, V28, P67, DOI 10.1111/j.1365-3040.2005.01306.x; Mares DJ., 2005, 32 ANN C PLANT GROWT, V33, P78; Meng JS., 2017, SEED, V36, P50, DOI [10.16590/j.cnki.1001-4705.2017.06.050, DOI 10.16590/J.CNKI.1001-4705.2017.06.050]; Nasr Seyed Mohammad Hosseini, 2013, Forest Science and Practice, V15, P130, DOI 10.1007/s11632-013-0209-7; Parvaiz Ahmad, 2012, African Journal of Biotechnology, V11, P2694, DOI 10.5897/AJB11.3203; Porceddu M, 2016, J PLANT ECOL, V9, P464, DOI 10.1093/jpe/rtv074; Porra RJ, 1997, PHOTOCHEM PHOTOBIOL, V65, P492, DOI 10.1111/j.1751-1097.1997.tb08596.x; Ren HongYan, 2016, Journal of Zhejiang A&F University, V33, P537; REN Z-S, 1992, Acta Botanica Yunnanica, V14, P80; Sharma I, 2011, ACTA PHYSIOL PLANT, V33, P1723, DOI 10.1007/s11738-010-0709-1; Sheteiwy M, 2017, ENVIRON EXP BOT, V137, P58, DOI 10.1016/j.envexpbot.2017.02.007; Shou Z., 2016, J SICHUAN FOR SCI, V37, DOI [10.16779/j.cnki.1003-5508.2016.01.015, DOI 10.16779/J.CNKI.1003-5508.2016.01.015]; Tanaka-Oda A, 2009, J FOREST RES-JPN, V14, P251, DOI 10.1007/s10310-009-0129-5; Wang H, 2002, S AFR J BOT, V68, P386, DOI 10.1016/S0254-6299(15)30402-6; Wang XJ, 2019, HORTIC RES-ENGLAND, V6, DOI 10.1038/s41438-019-0194-7; Wen SS, 2016, SCI HORTIC-AMSTERDAM, V201, P10, DOI 10.1016/j.scienta.2016.01.022; Wu Y, 2019, PLANT GROWTH REGUL, V87, P357, DOI 10.1007/s10725-018-0463-8; Xiao RX., 2018, PLANT PHYSL J, V54, P1417, DOI [10.13592/j.cnki.ppj.2018.0300, DOI 10.13592/J.CNKI.PPJ.2018.0300]; Xiong JL, 2018, PLANT PHYSIOL BIOCH, V124, P88, DOI 10.1016/j.plaphy.2018.01.001; Yamauchi Y, 2004, PLANT CELL, V16, P367, DOI 10.1105/tpc.018143; Yang ZJ., 2015, NORTHEN HORTICULTURE, P201, DOI [10.11937/bfyy.201521052, DOI 10.11937/BFYY.201521052]; Ye JB, 2017, SCI HORTIC-AMSTERDAM, V217, P266, DOI 10.1016/j.scienta.2017.02.009; Yu X., 2014, SEED SCI BIOTECHNOL, V1, P11; Zare Salman, 2011, Journal of Forestry Research (Harbin), V22, P35, DOI 10.1007/s11676-011-0121-8; Zhang JJ, 2007, SCI HORTIC-AMSTERDAM, V114, P104, DOI 10.1016/j.scienta.2007.05.009; Zhang KL, 2019, PLANTA, V249, P291, DOI 10.1007/s00425-018-3017-4; Zhang Y, 2018, IND CROP PROD, V125, P248, DOI 10.1016/j.indcrop.2018.08.067	70	0	0	7	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7								10.1371/journal.pone.0270767	http://dx.doi.org/10.1371/journal.pone.0270767			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M5FN	35789330	Green Published, gold			2022-12-26	WOS:000835487000006
J	Rahman, T; Gasbarro, D; Alam, K				Rahman, Taslima; Gasbarro, Dominic; Alam, Khurshid			Financial risk protection in health care in Bangladesh in the era of Universal Health Coverage	PLOS ONE			English	Article							OUT-OF-POCKET; DEVELOPMENT ASSISTANCE; PREPAID PRIVATE; PAYMENTS; COUNTRIES; IMPOVERISHMENT; EXPENDITURE; GOVERNMENT; TRENDS; ASIA	BackgroundEnsuring financial risk protection in health care and achieving universal health coverage (UHC) by 2030 is one of the crucial Sustainable Development Goals (SDGs) targets for many low- and middle-income countries (LMICs), including Bangladesh. We examined the critical trajectory of financial risk protection against out-of-pocket (OOP) health expenditure in Bangladesh. MethodsUsing Bangladesh Household Income and Expenditure Survey data from 2005, 2010, and 2016, we examined the levels and distributions of catastrophic health expenditure (CHE) and impoverishment incidences. We used the normative food, housing, and utilities method, refining it by categorizing households with zero OOP expenses by reasons. ResultsOOP expenditure doubled between 2005 and 2016 (USD 115.6 in 2005, USD 162.1 in 2010, USD 242.9 in 2016), accompanied by rising CHE (11.5% in 2005, 11.9% in 2010, 16.6% in 2016) and impoverishment incidence (1.5% in 2005, 1.6% in 2010, 2.3% in 2016). While further impoverishment of the poor households due to OOP expenditure (3.6% in 2005, 4.1% in 2010, 3.9% in 2016) was a more severe problem than impoverishment of the non-poor, around 5.5% of non-poor households were always at risk of impoverishment. The poorest households were the least financially protected throughout the study period (lowest vs. highest quintile CHE: 29.5% vs. 7.6%, 33.2% vs. 7.2%, and 37.6% vs. 13.0% in 2005, 2010, and 2016, respectively). The disparity in CHE among households with and without chronic illness was also remarkable in 2016 (25.0% vs. 9.1%). ConclusionFinancial risk protection in Bangladesh exhibits a deteriorated trajectory from 2005 to 2016, posing a significant challenge to achieving UHC and, thus, the SDGs by 2030. The poorest and chronically ill households disproportionately lacked financial protection. Reversing the worsening trends of CHE and impoverishment and addressing the inequities in their distributions calls for implementing UHC and thus providing financial protection against illness.	[Rahman, Taslima; Gasbarro, Dominic; Alam, Khurshid] Murdoch Univ, Murdoch Business Sch, Perth, WA, Australia; [Rahman, Taslima] Univ Dhaka, Inst Hlth Econ, Dhaka, Bangladesh	Murdoch University; University of Dhaka	Rahman, T (corresponding author), Murdoch Univ, Murdoch Business Sch, Perth, WA, Australia.; Rahman, T (corresponding author), Univ Dhaka, Inst Hlth Econ, Dhaka, Bangladesh.	Taslima.Rahman@murdoch.edu.au		Rahman, Taslima/0000-0002-8051-353X; Alam, Khurshid/0000-0002-7402-7519				Ahmed S, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3337-x; Alam K, 2018, J GLOB HEALTH, V8, DOI 10.7189/jogh.08.020408; Alam K, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-179; [Anonymous], 2022, CONS PRIC IND; [Anonymous], 2021, GLOBAL HLTH EXPENDIT; [Anonymous], 2022, OFF EXCH RAT LCU US; [Anonymous], 2022, GDP GROWTH ANN BANGL; [Anonymous], 2020, GLOBAL HLTH ESTIMATE; [Anonymous], 2015, TRACK UN HLTH COV 1; [Anonymous], 2017, RESOLUTION ADOPTED G; [Anonymous], 2015, GOING UNIVERSAL 24 D; Antunes AF, 2018, HEALTH POLICY PLANN, V33, P906, DOI 10.1093/heapol/czy073; Australian Bureau of Statistics, 2017, 65030 HOUS EXP SURV; Bangladesh Bureau of Statistics, 2019, FIN REP HOUS INC EXP; Bangladesh Bureau of Statistics (BBS), 2019, REP HOUS INC EXP SUR; Bangladesh Health Watch, 2017, NONC DIS BANGL CURR; Cashin C., 2017, EARMARKING HLTH THEO; Cylus J, 2018, B WORLD HEALTH ORGAN, V96, P599, DOI 10.2471/BLT.18.209031; Datta BK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208504; Datta BK, 2018, SSM-POPUL HLTH, V6, P252, DOI 10.1016/j.ssmph.2018.10.001; Dieleman J, 2017, LANCET, V389, P1981, DOI 10.1016/S0140-6736(17)30874-7; Dieleman JL, 2017, LANCET, V389, P2005, DOI 10.1016/S0140-6736(17)30873-5; Directorate General of Health Services Health Services Division, 2018, MULT ACT PLAN PREV C; Elfarra Reem Mohyeldin, 2021, WHO South East Asia J Public Health, V10, P37, DOI 10.4103/WHO-SEAJPH.WHO-SEAJPH_50_21; Gabani J, 2019, INT J EQUITY HEALTH, V18, DOI 10.1186/s12939-019-1095-y; Ghimire M, 2018, INT J EQUITY HEALTH, V17, DOI 10.1186/s12939-018-0736-x; Goyanka R., 2019, INDIAN J HUM DEV, V13, P121, DOI [DOI 10.1177/0973703019872360, 10.1177/0973703019872360]; Hamid SA, 2014, APPL HEALTH ECON HEA, V12, P421, DOI 10.1007/s40258-014-0100-2; Hsu J, 2018, INT J EQUITY HEALTH, V17, DOI 10.1186/s12939-018-0749-5; Islam MA, 2018, HEALTH SYST REFORM, V4, P65, DOI 10.1080/23288604.2018.1442650; Jan S, 2018, LANCET, V391, P2047, DOI 10.1016/S0140-6736(18)30323-4; Joe W, 2015, HEALTH POLICY PLANN, V30, P728, DOI 10.1093/heapol/czu050; Kaiser K, 2016, SIN TAX REFORM PHILI, DOI [10.1596/978-1-4648-0806-7, DOI 10.1596/978-1-4648-0806-7]; Karan A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105162; Khan JAM, 2017, HEALTH POLICY PLANN, V32, P1102, DOI 10.1093/heapol/czx048; Kruk ME, 2009, HEALTH AFFAIR, V28, P1056, DOI 10.1377/hlthaff.28.4.1056; Kwesiga B, 2020, BMC HEALTH SERV RES, V20, DOI 10.1186/s12913-020-05500-2; Lu CL, 2009, B WORLD HEALTH ORGAN, V87, P238, DOI 10.2471/BLT.08.054379; Ministry of Health and Family Welfare, 2012, EXP SOC PROT HLTH U; Ministry of Health and Family Welfare, 2017, BANGL NAT HLTH ACC 1; Mirelman AJ, 2019, INT J HEALTH PLAN M, V34, pE203, DOI 10.1002/hpm.2637; Mirelman AJ, 2016, HEALTH POLICY PLANN, V31, P785, DOI 10.1093/heapol/czv134; Mohanty SK, 2021, INT J EQUITY HEALTH, V20, DOI 10.1186/s12939-021-01421-6; Molla A, 2020, J POVERTY, V24, P627, DOI 10.1080/10875549.2020.1742269; Moreno-Serra R, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001087; Murphy A, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2019-002040; Murray CJL., 1999, WHO FRAMEWORK HLTH S, P1; O'Donnell O., 2008, Analyzing health equity using household survey data: a guide to techniques and their implementation; Pandey A, 2018, B WORLD HEALTH ORGAN, V96, P18, DOI 10.2471/BLT.17.191759; Rahman MS, 2018, LANCET GLOB HEALTH, V6, pE84, DOI 10.1016/s2214-109x(17)30413-8; Rawal LB, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029562; Ruger JP, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001294; Saksena P, 2010, DRIVERS CATASTROPHIC; Saksena P, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001701; Salari P, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2019-001809; Thomson S., 2016, Eurohealth, V22, P23; Thomson S., 2016, PUBLIC HLTH PANORAMA, V2, P357; United Nations, SDG IND MET REP; Van Doorslaer E, 2007, HEALTH ECON, V16, P1159, DOI 10.1002/hec.1209; van Doorslaer E, 2006, LANCET, V368, P1357, DOI 10.1016/S0140-6736(06)69560-3; Wagstaff A, 2003, HEALTH ECON, V12, P921, DOI 10.1002/hec.776; Wagstaff A, 2020, WORLD BANK RES OBSER, V35, P123, DOI 10.1093/wbro/lkz009; Wagstaff A, 2020, LANCET GLOB HEALTH, V8, pE39, DOI 10.1016/S2214-109X(19)30463-2; Wagstaff A, 2018, LANCET GLOB HEALTH, V6, pE169, DOI [10.1016/S2214-109X(17)30486-2, 10.1016/S2214-109X(17)30429-1, 10.1016/s2214-109x(17)30486-2]; Wang H, 2018, B WORLD HEALTH ORGAN, V96, P610, DOI 10.2471/BLT.18.209858; WHO, UNIVERSAL HLTH COVER; World Bank, 2019, CONT CAR NCDS BANGL; World Health Organization, 2022, GLOB HLTH OBS; World Health Organization Regional Office for Europe, 2019, CAN PEOPL AFF PAY HL; World Health Organization World Bank, 2017, TRACK UN HLTH COV 20; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5; Xu K., 2005, DISTRIBUTION HLTH PA; Xu K, 2007, HEALTH AFFAIR, V26, P972, DOI 10.1377/hlthaff.26.4.972; Yerramilli P, 2018, HEALTH POLICY, V122, P493, DOI 10.1016/j.healthpol.2018.02.006; Zhang C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209126; Zhao Y, 2020, TROP MED INT HEALTH, V25, P236, DOI 10.1111/tmi.13344	76	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	6							e0269113	10.1371/journal.pone.0269113	http://dx.doi.org/10.1371/journal.pone.0269113			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3F0KH	35749437	Green Published, gold			2022-12-26	WOS:000830362700025
J	Yin, JH; Song, HY; Zeng, KX				Yin, Jing-hua; Song, Hai-ying; Zeng, Ke-xin			Does a smart business environment promote corporate investment? a case study of Hangzhou	PLOS ONE			English	Article							BIG DATA; CITY; CITIES; GOVERNMENT; PLATFORM; COSTS	As a result of business environment reforms in China's Hangzou, the cost of business has reduced, the confidence of Hangzhou enterprises has survived the COVID-19 outbreak, and foreign investment continues to increase. Nevertheless, Hangzhou's business environment has shortcomings, such as insufficient technology, talent, and intelligent infrastructure. Two unresolved questions persist: (i) Has the smart business environment stimulated corporate investment by reducing system costs and boosting corporate confidence? (ii) How do the commercial climate's shortcomings impact the relationship between the intelligent business environment and business costs/confidence? We examined the impact of a local smart business environment on the corporate investment scale in Hangzhou using factor analysis, cluster analysis, linear regression, and path analyses of data from 297 firm managers. Smart governance improved public administration, financing, and rule of law. The business environment promoted investment by increasing business confidence and decreasing institutional costs. Weak intelligent property protection and legal fairness hindered the positive influence of smart governance on business confidence and system costs. This is the first study combining business environment, smart city, and smart governance concepts to analyze the influence of local smart business environments on business confidence, institutional costs, and investment. Our conclusion on the limitation effect of intelligent business environment on enterprise investment attempts to inspire further research on the intersection of business environments and smart cities. The law of intelligent business environment attracting investment obtained in the context of China, the largest developing country with diversified economic development, is of great significance for other developing countries. Countries can attract investment and promote economic development through intelligent governance. Developing countries should construct smart service platforms, coordinate supervision of public credit, reduce financing constraint, construct a government under the rule of law, improve the quality of land management, and protect intellectual property rights.	[Yin, Jing-hua; Song, Hai-ying] Zhejiang Int Studies Univ, Sch Int Business, Hangzhou, Zhejiang, Peoples R China; [Zeng, Ke-xin] Hangzhou Dianzi Univ, Coll Econ, Hangzhou, Zhejiang, Peoples R China	Zhejiang International Studies University; Hangzhou Dianzi University	Song, HY (corresponding author), Zhejiang Int Studies Univ, Sch Int Business, Hangzhou, Zhejiang, Peoples R China.	5374514@qq.com		Song, Haiying/0000-0002-3526-5418; Yin, Jinghua/0000-0001-9619-5479	Scientific Research Fund of Zhejiang Provincial Education Department [Y202148108]; Zhejiang Provincial Soft Science Project [2020C35035]; National Social Science Foundation of China [17CJL036]	Scientific Research Fund of Zhejiang Provincial Education Department; Zhejiang Provincial Soft Science Project; National Social Science Foundation of China	This research was funded by a Project Supported by Scientific Research Fund of Zhejiang Provincial Education Department, grant number Y202148108, Recipient J-H Y, Zhejiang Provincial Soft Science Project, grant number 2020C35035, Recipient J-H Y, and National Social Science Foundation of China, grant number 17CJL036, Recipient K-X Z.	Academy of Greater Bay Area Studies, 2019, EV REP BUS ENV CHIN; [Anonymous], 2021, DAILY C; [Anonymous], 2021, HANGZHOU DAILY; [Anonymous], 2021, TECHWEB NEWS; [Anonymous], 2021, CHINAS URBAN BUSINES; Barsky RB, 2012, AM ECON REV, V102, P1343, DOI 10.1257/aer.102.4.1343; Ben Yahia N, 2021, INT J INFORM MANAGE, V56, DOI 10.1016/j.ijinfomgt.2019.11.005; Bennett S., 1976, PRINCIPAL FACTOR ANA; Bergan JR, 2021, PATH ANAL, DOI [10.1002/9780470373699.speced1548, DOI 10.1002/9780470373699.SPECED1548]; Bian YJ, 2018, CHINA QUART, V235, P597, DOI 10.1017/S0305741018000541; Blanck M, 2019, CITIES, V88, P48, DOI 10.1016/j.cities.2018.12.032; Brown A, 2017, GOV INFORM Q, V34, P167, DOI 10.1016/j.giq.2017.03.003; Caprotti F, 2022, GEOJOURNAL, V87, P1559, DOI 10.1007/s10708-020-10320-2; Fuchong Liao., 2020, CONT E CONMANAG, V7, P74; Goodman N, 2020, CAN GEOGR-GEOGR CAN, V64, P416, DOI 10.1111/cag.12607; Hangzhou Economic and Information Technology Commission, 2012, SMART HANGZ HOU CONS; Hangzhou Government, 2020, HANGZHOU DAILY; He S., 2018, CREDIT HANGZHOU YOUR; Heaton JB, 2002, FINANC MANAGE, V31, P33, DOI 10.2307/3666221; Hecking C., 2020, SPIEGEL; Horak S, 2022, INT J EMERG MARK, V17, P1273, DOI 10.1108/IJOEM-07-2020-0745; Hu Q, 2021, J URBAN AFF, V43, P504, DOI 10.1080/07352166.2019.1694413; Huang J., 2019, ACAD RES, V9, P98; Huang X., 2017, CHIEF FINANCIAL OFFI, V3, P56; Humayun M., 2020, EMPLOYING RECENT TEC, P87; Jackowicz K, 2021, INT J EMERG MARK, V16, P2092, DOI 10.1108/IJOEM-11-2019-0928; JENSEN MC, 1976, J FINANC ECON, V3, P305, DOI 10.1016/0304-405X(76)90026-X; Jiang N., 2020, THE PEOPLES DAILY; Klarin A, 2019, INT J EMERG MARK, V14, P410, DOI 10.1108/IJOEM-05-2016-0138; Koty AC., 2019, CHINA BRIEFING; Leleux C, 2018, MEDIA COMMUN-LISBON, V6, P163, DOI 10.17645/mac.v6i4.1639; Linders D, 2012, GOV INFORM Q, V29, P446, DOI 10.1016/j.giq.2012.06.003; Liu Y., 2018, CHINA DAILY; Lu H., 2019, CHINA L SCI, V9, P37; Lu J., 2020, HANGZHOU DAILY; Meijer A, 2016, INT REV ADM SCI, V82, P392, DOI 10.1177/0020852314564308; Nam T., 2011, P 12 ANN INT DIG GOV, P282, DOI [DOI 10.1145/2037556.2037602, 10.1145/2037556.2037602]; North CM, 2004, SOUTH ECON J, V71, P103, DOI 10.2307/4135313; NORTH DC, 1987, ECON INQ, V25, P419, DOI 10.1111/j.1465-7295.1987.tb00750.x; Okwechime E, 2018, INF SYST E-BUS MANAG, V16, P601, DOI 10.1007/s10257-017-0344-0; Park SH, 2001, STRATEGIC MANAGE J, V22, P455, DOI 10.1002/smj.167; Porro O, 2020, ENERGIES, V13, DOI 10.3390/en13102415; Qianshen D., 2020, CHINA L SCI, V2, P1; Tran QT, 2020, INT J EMERG MARK, V15, P1185, DOI 10.1108/IJOEM-07-2019-0573; Rana NP, 2019, INFORM SYST FRONT, V21, P503, DOI 10.1007/s10796-018-9873-4; Bolivar MPR, 2018, ACAD-REV LATINOAM AD, V31, P277, DOI 10.1108/ARLA-04-2017-0133; Sancino A, 2020, PUBLIC MANAG REV, V22, P701, DOI 10.1080/14719037.2020.1718189; Shen G. B., 2019, FINANCE TRADE EC, V12, P143, DOI 10.19795/j.cnki.cn11-1166/f.20191204.003; Singh A., 1998, FUNDAMENTALS LOGIC; State Council, 2019, REG OPT BUS ENV; STIGLITZ JE, 1981, AM ECON REV, V71, P393; Tan SY, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12030899; Tang J., 2021, ZHEJIANG DAILY; Tang Y., 2020, RES FINANC ISSUES, V2, P81; Vidiasova L, 2020, SUSTAIN CITIES SOC, V59, DOI 10.1016/j.scs.2020.102158; Wai N., 2019, SHANGHAI EC REV, V10, P1061; Wang YP., 2019, SOC SCI YUNNAN, V228, P46; World Bank, 2018, DOING BUS REP; Wu YZ, 2018, J CLEAN PROD, V173, P60, DOI 10.1016/j.jclepro.2017.01.047; Xie H., 2018, J FINAN ECON POLICY, V10, P84; Xu DQ., 2018, CHIN J LAW, V40, P20; Yakovlev A, 2021, INT J EMERG MARK, V16, P347, DOI 10.1108/IJOEM-08-2019-0667; Yan P., 2016, J HUBEI U EC HUMANIT, V13, P42; Yang J., 2018, J SHANXI FIN EC U, V40, P1; Yang Z., 2014, J GUANGDONG I PUBLIC, V26, P76; Ye BF., 2019, CHINA LAW REV, V25, P169; Yu CP, 2020, IEEE ACCESS, V8, P116024, DOI 10.1109/ACCESS.2020.3004367; Yu J, 2019, TECHNOL FORECAST SOC, V142, P168, DOI 10.1016/j.techfore.2018.11.017; Zhang J., 2018, J HUMANIT, V2, P35; Zhang Q., 2012, ACAD EXCH, V4, P78; Zheng G., 2014, SEC MARK HERALD, V3, P72; Zhu Y., 2019, BUSINESS ENV REPORT; Zouain DM., INFORM SYSTEMS TECHN, P234	73	0	0	21	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7								10.1371/journal.pone.0269089	http://dx.doi.org/10.1371/journal.pone.0269089			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M3CI	35793371	Green Published, gold			2022-12-26	WOS:000835338100019
J	Bandekar, SJ; Chen, CL; Ravala, SK; Cash, JN; Avramova, LV; Zhalnina, MV; Gutkind, JS; Li, S; Tesmer, JJG				Bandekar, Sumit J.; Chen, Chun-Liang; Ravala, Sandeep K.; Cash, Jennifer N.; V. Avramova, Larisa; V. Zhalnina, Mariya; Gutkind, J. Silvio; Li, Sheng; Tesmer, John J. G.			Structural/functional studies of Trio provide insights into its configuration and show that conserved linker elements enhance its activity for Rac1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; RHO-GTPASES; SH3 DOMAIN; GEF DOMAIN; ACTIVATION; REVEALS; BINDING; DBL; PATHWAY; SYSTEM	Trio is a large and highly conserved metazoan signaling scaffold that contains two Dbl family guanine nucleotide exchange factor (GEF) modules, TrioN and TrioC, selective for Rac and RhoA GTPases, respectively. The GEF activities of TrioN and TrioC are implicated in several cancers, especially uveal melanoma. However, little is known about how these modules operate in the context of larger fragments of Trio. Here we show via negative stain electron microscopy that the N-terminal region of Trio is extended and could thus serve as a rigid spacer between the N-terminal putative lipid-binding domain and TrioN, whereas the C-terminal half of Trio seems globular. We found that regions C-terminal to TrioN enhance its Rac1 GEF activity and thus could play a regulatory role. We went on to characterize a minimal, well-behaved Trio fragment with enhanced activity, Trio(1284-1959), in complex with Rac1 using cryo-electron microscopy and hydrogen-deuterium exchange mass spectrometry and found that the region conferring enhanced activity is disordered. Deletion of two different strongly conserved motifs in this region eliminated this enhancement, suggesting that they form transient intra-molecular interactions that promote GEF activity. Because Dbl family RhoGEF modules have been challenging to directly target with small molecules, characterization of accessory Trio domains such as these may provide alternate routes for the development of therapeutics that inhibit Trio activity in human cancer.	[Bandekar, Sumit J.] Univ Michigan, Dept Med Chem, Ann Arbor, MI USA; [Bandekar, Sumit J.] Univ Michigan, Life Sci Inst, Ann Arbor, MI USA; [Chen, Chun-Liang; Ravala, Sandeep K.; V. Avramova, Larisa; V. Zhalnina, Mariya; Tesmer, John J. G.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Chen, Chun-Liang; Ravala, Sandeep K.; V. Avramova, Larisa; V. Zhalnina, Mariya; Tesmer, John J. G.] Purdue Univ, Dept Med Chem, W Lafayette, IN 47907 USA; [Chen, Chun-Liang; Ravala, Sandeep K.; V. Avramova, Larisa; V. Zhalnina, Mariya; Tesmer, John J. G.] Purdue Univ, Dept Mol Pharmacol, W Lafayette, IN 47907 USA; [Cash, Jennifer N.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA USA; [Gutkind, J. Silvio] Univ Calif San Diego, Dept Pharmacol, San Diego, CA USA; [Gutkind, J. Silvio] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA USA; [Li, Sheng] Univ Calif San Diego, Dept Med, La Jolla, CA USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of California System; University of California Davis; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Tesmer, JJG (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.; Tesmer, JJG (corresponding author), Purdue Univ, Dept Med Chem, W Lafayette, IN 47907 USA.; Tesmer, JJG (corresponding author), Purdue Univ, Dept Mol Pharmacol, W Lafayette, IN 47907 USA.	jtesmer@purdue.edu	Gutkind, J Silvio/J-1201-2016	Gutkind, J Silvio/0000-0002-5150-4482; Bandekar, Sumit/0000-0003-2728-7366; Ravala, Sandeep Kaur/0000-0001-5925-9998; Chen, Chun-Liang/0000-0003-4625-4340	National Institutes of Health [CA221289, HL071818, CA254402, F31CA224804]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding and additional information-This work was supported by the National Institutes of Health grants CA221289, HL071818, and CA254402 (to J. J. G. T.) and F31CA224804 (to S. J. B.) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aittaleb M, 2010, MOL PHARMACOL, V77, P111, DOI 10.1124/mol.109.061234; Aravind L, 1999, CURR BIOL, V9, pR195, DOI 10.1016/S0960-9822(99)80127-4; Bandekar SJ, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aav2449; Bankaitis VA, 2010, TRENDS BIOCHEM SCI, V35, P150, DOI 10.1016/j.tibs.2009.10.008; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Bouquier N, 2009, CHEM BIOL, V16, P391, DOI 10.1016/j.chembiol.2009.02.006; Brecht M, 2004, J BIOTECHNOL, V112, P151, DOI 10.1016/j.jbiotec.2004.04.030; Brown WC, 2011, PROTEIN EXPRES PURIF, V77, P34, DOI 10.1016/j.pep.2011.01.007; Carragher B, 2000, J STRUCT BIOL, V132, P33, DOI 10.1006/jsbi.2000.4314; Carvajal RD, 2018, J CLIN ONCOL, V36, P1232, DOI 10.1200/JCO.2017.74.1090; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chhatriwala MK, 2007, J MOL BIOL, V368, P1307, DOI 10.1016/j.jmb.2007.02.060; Cook DR, 2014, ONCOGENE, V33, P4021, DOI 10.1038/onc.2013.362; Djinovic-Carugo K, 2002, FEBS LETT, V513, P119, DOI 10.1016/S0014-5793(01)03304-X; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Estrach S, 2002, CURR BIOL, V12, P307, DOI 10.1016/S0960-9822(02)00658-9; Feng XD, 2014, CANCER CELL, V25, P831, DOI 10.1016/j.ccr.2014.04.016; Grant T, 2018, ELIFE, V7, DOI 10.7554/eLife.35383; Gray JL, 2020, ANGEW CHEM INT EDIT, V59, P6342, DOI 10.1002/anie.201900585; Kaneko T, 2008, FRONT BIOSCI-LANDMRK, V13, P4938, DOI 10.2741/3053; Kim K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04810-6; Kristelly R, 2004, J BIOL CHEM, V279, P47352, DOI 10.1074/jbc.M406056200; Lutz S, 2007, SCIENCE, V318, P1923, DOI 10.1126/science.1147554; Mallone F, 2020, CANCERS, V12, DOI 10.3390/cancers12102761; Medley QG, 2000, J BIOL CHEM, V275, P36116, DOI 10.1074/jbc.M003775200; Miller KE, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00447; Mitin N, 2007, NAT STRUCT MOL BIOL, V14, P814, DOI 10.1038/nsmb1290; Nishida K, 1999, FEBS LETT, V459, P186, DOI 10.1016/S0014-5793(99)01244-2; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Ortega E, 2016, J BIOL CHEM, V291, P18643, DOI 10.1074/jbc.M116.732909; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Rojas RJ, 2007, J BIOL CHEM, V282, P29201, DOI 10.1074/jbc.M703458200; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Schiller MR, 2006, J BIOL CHEM, V281, P18774, DOI 10.1074/jbc.M512482200; Schmidt S, 2002, FEBS LETT, V523, P35, DOI 10.1016/S0014-5793(02)02928-9; Schmidt Susanne, 2014, Small GTPases, V5, pe29769, DOI 10.4161/sgtp.29769; Sievers F, 2021, METHODS MOL BIOL, V2231, P3, DOI 10.1007/978-1-0716-1036-7_1; Skowronek KR, 2004, J BIOL CHEM, V279, P37895, DOI 10.1074/jbc.M312677200; Slabinski L, 2007, BIOINFORMATICS, V23, P3403, DOI 10.1093/bioinformatics/btm477; Son K, 2015, CYTOSKELETON, V72, P47, DOI 10.1002/cm.21210; Soykan T, 2014, EMBO J, V33, P2113, DOI 10.15252/embj.201488143; Taylor VG, 2016, J BIOL CHEM, V291, P5138, DOI 10.1074/jbc.M115.712075; Vaque JP, 2013, MOL CELL, V49, P94, DOI 10.1016/j.molcel.2012.10.018; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Walters BT, 2012, J AM SOC MASS SPECTR, V23, P2132, DOI 10.1007/s13361-012-0476-x; Williams SL, 2007, GENE DEV, V21, P2731, DOI 10.1101/gad.1592007; Yoshizuka N, 2004, J BIOL CHEM, V279, P43998, DOI 10.1074/jbc.M406082200; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	51	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	298	8							102209	10.1016/j.jbc.2022.102209	http://dx.doi.org/10.1016/j.jbc.2022.102209			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5R8XW	35779635	Green Published, gold			2022-12-26	WOS:000874789500001
J	Chagas, JAC; Soares, MAKM; Franco, LVR; Barros, MH				Clarck Chagas, Jhulia Almeida; Kfouri Martins Soares, Maria Antonia; Ribeiro Franco, Leticia Veloso; Barros, Mario H.			Overexpression of MRX9 impairs processing of RNAs encoding mitochondrial oxidative phosphorylation factors COB and COX1 in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEAD-BOX PROTEIN; MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; MEMBRANE SYSTEM; GENE-EXPRESSION; ATP SYNTHASE; NUCLEAR GENE; TRANSLATION; OXIDASE; MUTANTS	Mitochondrial translation is a highly regulated process, and newly synthesized mitochondrial products must first associate with several nuclear-encoded auxiliary factors to form oxidative phosphorylation complexes. The output of mitochondrial products should therefore be in stoichiometric equilibrium with the nuclear-encoded products to prevent unnecessary energy expense or the accumulation of pro-oxidant assembly modules. In the mitochondrial DNA of Saccharomyces cerevisiae, COX1 encodes subunit 1 of the cytochrome c oxidase and COB the central core of the cytochrome bc1 electron transfer complex; however, factors regulating the expression of these mitochondrial products are not completely described. Here, we identified Mrx9p as a new factor that controls COX1 and COB expression. We isolated MRX9 in a screen for mitochondrial factors that cause poor accumulation of newly synthesized Cox1p and compromised transition to the respiratory metabolism. Northern analyses indicated lower levels of COX1 and COB mature mRNAs accompanied by an accumulation of unprocessed transcripts in the presence of excess Mrx9p. In a strain devoid of mitochondrial introns, MRX9 overexpression did not affect COX1 and COB translation or respiratory adaptation, implying Mrx9p regulates processing of COX1 and COB RNAs. In addition, we found Mrx9p was localized in the mitochondrial inner membrane, facing the matrix, as a portion of it cosedimented with mitoribosome subunits and its removal or overexpression altered Mss51p sedimentation. Finally, we showed accumulation of newly synthesized Cox1p in the absence of Mrx9p was diminished in cox14 null mutants. Taken together, these data indicate a regulatory role of Mrx9p in COX1 RNA processing.	[Clarck Chagas, Jhulia Almeida; Kfouri Martins Soares, Maria Antonia; Ribeiro Franco, Leticia Veloso; Barros, Mario H.] Univ Sao Paulo, Inst Ciencias Biomed, Dept Microbiol, Sao Paulo, Brazil	Universidade de Sao Paulo	Barros, MH (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Dept Microbiol, Sao Paulo, Brazil.	mariohb@usp.br	Barros, Mario H/B-8118-2012	Barros, Mario/0000-0003-2977-9815	Fundacao de Amparo a Pesquisa de Sao Paulo [FAPESP 2013/07937-8, FAPESP 2020/05812-7]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [CNPq 302337/2018-0]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil (CAPES) [001]; FAPESP [FAPESP-2020/05173-8, 2019/23984-2, 2019/02799-2]	Fundacao de Amparo a Pesquisa de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by grants and fellowships from Fundacao de Amparo a Pesquisa de Sao Paulo (FAPESP 2013/07937-8; FAPESP 2020/05812-7), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq 302337/2018-0) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil (CAPES) -Finance Code 001. Jhulia Chagas, Maria Kfouri and Leticia Franco were fellowship recipients from FAPESP (FAPESP-2020/05173-8, 2019/23984-2, 2019/02799-2).	Anderson J. M., 2022, MOL BIOL CELL, V33; Barrientos A, 2004, EMBO J, V23, P3472, DOI 10.1038/sj.emboj.7600358; Barrientos A, 2002, EMBO J, V21, P43, DOI 10.1093/emboj/21.1.43; Barros MH, 2020, MITOCHONDRION, V50, P94, DOI 10.1016/j.mito.2019.10.008; Barros MH, 2017, MOL BIOL CELL, V28, P1426, DOI 10.1091/mbc.E16-11-0775; Barros MH, 2006, J BIOL CHEM, V281, P3743, DOI 10.1074/jbc.M510778200; Barros MH, 2002, FEBS LETT, V516, P119, DOI 10.1016/S0014-5793(02)02514-0; BONITZ SG, 1980, J BIOL CHEM, V255, P1922; Cogliati S, 2021, BIOCHEM SOC T, V49, P2655, DOI 10.1042/BST20210460; Costanzo M, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1420; CRIVELLONE MD, 1988, J BIOL CHEM, V263, P14323; De Silva D, 2017, NUCLEIC ACIDS RES, V45, P6628, DOI 10.1093/nar/gkx426; De Silva D, 2013, CELL METAB, V18, P712, DOI 10.1016/j.cmet.2013.10.007; DECOSTER E, 1990, MOL GEN GENET, V224, P111, DOI 10.1007/BF00259457; DEDEKEN RH, 1966, J GEN MICROBIOL, V44, P149, DOI 10.1099/00221287-44-2-149; DELASALLE H, 1982, CELL, V28, P721, DOI 10.1016/0092-8674(82)90051-4; Derbikova KS, 2018, BIOCHEMISTRY-MOSCOW+, V83, P87, DOI 10.1134/S0006297918020013; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Desai N, 2017, SCIENCE, V355, P528, DOI 10.1126/science.aal2415; DIECKMANN CL, 1985, J BIOL CHEM, V260, P1513; DIECKMANN CL, 1994, INT REV CYTOL, V152, P145, DOI 10.1016/S0074-7696(08)62556-5; Dujon B, 2020, YEAST, V37, P191, DOI 10.1002/yea.3445; Fontanesi F, 2006, AM J PHYSIOL-CELL PH, V291, pC1129, DOI 10.1152/ajpcell.00233.2006; Fontanesi F, 2013, IUBMB LIFE, V65, P397, DOI 10.1002/iub.1156; Fontanesi F, 2011, J BIOL CHEM, V286, P555, DOI 10.1074/jbc.M110.188805; Fontanesi F, 2010, MOL CELL BIOL, V30, P245, DOI 10.1128/MCB.00983-09; Fox TD, 2012, GENETICS, V192, P1203, DOI 10.1534/genetics.112.141267; Franco LVR, 2018, J BIOL CHEM, V293, P16899, DOI 10.1074/jbc.RA118.004138; GAMPEL A, 1987, MOL CELL BIOL, V7, P2545, DOI 10.1128/MCB.7.7.2545; Geldon S, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.720656; Glerum DM, 1997, FEBS LETT, V412, P410, DOI 10.1016/S0014-5793(97)00799-0; Glerum DM, 1996, J BIOL CHEM, V271, P20531, DOI 10.1074/jbc.271.34.20531; GLERUM DM, 1995, J BIOL CHEM, V270, P15585, DOI 10.1074/jbc.270.26.15585; Goke A, 2020, MOL BIOL CELL, V31, P527, DOI 10.1091/mbc.E19-08-0470; Gomes F, 2017, J BIOL CHEM, V292, P17011, DOI 10.1074/jbc.M117.788588; Gruschke S, 2010, J BIOL CHEM, V285, P19022, DOI 10.1074/jbc.M110.113837; Guedes-Monteiro RF, 2019, BBA-MOL CELL RES, V1866, P806, DOI 10.1016/j.bbamcr.2019.02.002; Guedes-Monteiro RF, 2018, CELL BIOL INT, V42, P630, DOI 10.1002/cbin.10913; Herrmann J. M., 1994, CELL BIOL LAB HDB, VI, P538; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; Hillman GA, 2019, J BIOL CHEM, V294, P9813, DOI 10.1074/jbc.RA119.008476; Huang HR, 2005, P NATL ACAD SCI USA, V102, P163, DOI 10.1073/pnas.0407896101; Jin C, 1997, CURR GENET, V31, P228, DOI 10.1007/s002940050199; Kabala AM, 2022, GENETICS, V220, DOI 10.1093/genetics/iyac007; Kaur J, 2011, EMBO REP, V12, P950, DOI 10.1038/embor.2011.133; Kehrein K, 2015, CELL REP, V10, P843, DOI 10.1016/j.celrep.2015.01.012; Khalimonchuk O, 2007, J BIOL CHEM, V282, P17442, DOI 10.1074/jbc.M702379200; Krause K, 2004, MOL BIOL CELL, V15, P2674, DOI 10.1091/mbc.E04-02-0126; LAZOWSKA J, 1980, CELL, V22, P333, DOI 10.1016/0092-8674(80)90344-X; MANON S, 1989, BIOCHIM BIOPHYS ACTA, V985, P127, DOI 10.1016/0005-2736(89)90356-8; MANTHEY GM, 1995, EMBO J, V14, P4031, DOI 10.1002/j.1460-2075.1995.tb00074.x; Marbois B, 2005, J BIOL CHEM, V280, P20231, DOI 10.1074/jbc.M501315200; Mashkevich G, 1997, J BIOL CHEM, V272, P14356, DOI 10.1074/jbc.272.22.14356; Mays JN, 2019, NUCLEIC ACIDS RES, V47, P5746, DOI 10.1093/nar/gkz266; MCMULLIN TW, 1993, J BIOL CHEM, V268, P11737; McStay GP, 2013, J BIOL CHEM, V288, P26546, DOI 10.1074/jbc.M113.498592; McStay GP, 2013, FEBS LETT, V587, P943, DOI 10.1016/j.febslet.2013.02.022; McStay GP, 2013, MOL BIOL CELL, V24, P440, DOI 10.1091/mbc.E12-10-0749; Moda BS, 2016, CURR GENET, V62, P607, DOI 10.1007/s00294-016-0566-6; Moller-Hergt BV, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7100172; Moller-Hergt BV, 2018, MOL BIOL CELL, V29, P2386, DOI 10.1091/mbc.E18-04-0227; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; MUROFF I, 1990, EMBO J, V9, P2765, DOI 10.1002/j.1460-2075.1990.tb07464.x; MYERS AM, 1985, EMBO J, V4, P2087, DOI 10.1002/j.1460-2075.1985.tb03896.x; Ndi M, 2018, J MOL BIOL, V430, P3892, DOI 10.1016/j.jmb.2018.04.036; NOBREGA FG, 1980, J BIOL CHEM, V255, P9828; Ott M, 2016, ANNU REV BIOCHEM, V85, P77, DOI 10.1146/annurev-biochem-060815-014334; Mayorga JP, 2016, J BIOL CHEM, V291, P9343, DOI 10.1074/jbc.M116.721985; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; PAYNE MJ, 1993, CURR GENET, V24, P126, DOI 10.1007/BF00324676; Pearce SF, 2017, TRENDS BIOCHEM SCI, V42, P625, DOI 10.1016/j.tibs.2017.02.003; Perez-Martinez X, 2003, EMBO J, V22, P5951, DOI 10.1093/emboj/cdg566; Pierrel F, 2007, EMBO J, V26, P4335, DOI 10.1038/sj.emboj.7601861; Poon WW, 1999, J BIOL CHEM, V274, P21665, DOI 10.1074/jbc.274.31.21665; Rak M, 2016, MOL BIOL CELL, V27, P919, DOI 10.1091/mbc.E15-09-0642; Rak M, 2009, P NATL ACAD SCI USA, V106, P18509, DOI 10.1073/pnas.0910351106; REPETTO B, 1990, MOL CELL BIOL, V10, P4221, DOI 10.1128/MCB.10.8.4221; Franco LVR, 2020, BIOL CHEM, V401, P835, DOI 10.1515/hsz-2020-0112; Franco LVR, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233177; RODEL G, 1986, CURR GENET, V11, P41, DOI 10.1007/BF00389424; Roloff GA, 2015, MOL BIOL CELL, V26, P2885, DOI 10.1091/mbc.E15-04-0222; Rudan M, 2018, ELIFE, V7, DOI 10.7554/eLife.35330; Salvatori R, 2020, MOL CELL, V77, P887, DOI 10.1016/j.molcel.2019.11.019; Santos B, 2022, YEAST, V39, P208, DOI 10.1002/yea.3678; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; SERAPHIN B, 1989, NATURE, V337, P84, DOI 10.1038/337084a0; Seshadri SR, 2020, NUCLEIC ACIDS RES, V48, P6759, DOI 10.1093/nar/gkaa424; Singh AP, 2020, MOL CELL, V79, P1051, DOI 10.1016/j.molcel.2020.07.024; Steele DF, 1996, P NATL ACAD SCI USA, V93, P5253, DOI 10.1073/pnas.93.11.5253; Su CH, 2014, J BIOL CHEM, V289, P31605, DOI 10.1074/jbc.M114.602706; Suhm T, 2018, CELL METAB, V27, P1309, DOI 10.1016/j.cmet.2018.04.011; TZAGOLOFF A, 1975, J BIOL CHEM, V250, P8228; Tzschoppe K, 2000, BIOL CHEM, V381, P1175, DOI 10.1515/BC.2000.145; VALENCIK ML, 1989, EMBO J, V8, P3899, DOI 10.1002/j.1460-2075.1989.tb08569.x; Veniamin S, 2011, FREE RADICAL BIO MED, V51, P1589, DOI 10.1016/j.freeradbiomed.2011.06.024; Verma Y, 2021, MOL BIOL CELL, V32, DOI 10.1091/mbc.E20-07-0457; Zambrano A, 2007, MOL BIOL CELL, V18, P523, DOI 10.1091/mbc.E06-09-0803; Zampol MA, 2010, BIOCHEM BIOPH RES CO, V402, P82, DOI 10.1016/j.bbrc.2010.09.118; Zeng XM, 2007, GENETICS, V175, P55, DOI 10.1534/genetics.106.065821; Zhang DY, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.101135	100	0	0	8	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2022	298	8							102214	10.1016/j.jbc.2022.102214	http://dx.doi.org/10.1016/j.jbc.2022.102214			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3S2WH	35779633	gold, Green Published			2022-12-26	WOS:000839461200012
J	Dou, QH; Turanov, AA; Mariotti, M; Hwang, JY; Wang, HF; Lee, SG; Paulo, JA; Yim, SH; Gygi, SP; Chung, JJ; Gladyshev, VN				Dou, Qianhui; Turanov, Anton A.; Mariotti, Marco; Hwang, Jae Yeon; Wang, Huafeng; Lee, Sang -Goo; Paulo, Joao A.; Yim, Sun Hee; Gygi, Stephen P.; Chung, Jean-Ju; Gladyshev, Vadim N.			Selenoprotein TXNRD3 supports male fertility via the redox regulation of spermatogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIOREDOXIN-GLUTATHIONE-REDUCTASE; RNA-BINDING PROTEINS; MITOCHONDRIAL; ABUNDANCE; DEFICIENCY; SELENIUM; FOCUS; GENE; DNA	Thioredoxin/glutathione reductase (TXNRD3) is a selenoprotein composed of thioredoxin reductase and glutaredoxin domains. This NADPH-dependent thiol oxidoreductase evolved through gene duplication within the Txnrd family, is expressed in the testes, and can reduce both thioredoxin and glutathione in vitro; however, the function of this enzyme remains unknown. To characterize the function of TXNRD3 in vivo, we generated a strain of mice bearing deletion of Txnrd3 gene. We show that these Txnrd3 knockout mice are viable and without discernable gross phenotypes, and also that TXNRD3 deficiency leads to fertility impairment in male mice. We found that Txnrd3 knockout animals exhibited a lower fertilization rate in vitro, a sperm movement phenotype, and an altered thiol redox status in sperm cells. Proteomic analyses further revealed a broad range of substrates reduced by TXNRD3 during sperm maturation, presumably as a part of sperm quality control. Taken together, these results show that TXNRD3 plays a critical role in male reproduction via the thiol redox control of spermatogenesis.	[Dou, Qianhui; Turanov, Anton A.; Mariotti, Marco; Lee, Sang -Goo; Yim, Sun Hee; Gladyshev, Vadim N.] Brigham & Womens Hosp, Harvard Med Sch, Dept Med, Div Genet, Boston, MA 02115 USA; [Mariotti, Marco] Univ Barcelona, Dept Genet Microbiol & Stat, Barcelona, Catalonia, Spain; [Hwang, Jae Yeon; Wang, Huafeng; Chung, Jean-Ju] Yale Sch Med, Dept Cellular & Mol Physiol, New Haven, CT USA; [Paulo, Joao A.; Gygi, Stephen P.] Harvard Med Sch, Dept Cell Biol, Boston, MA USA; [Chung, Jean-Ju] Yale Sch Med, Dept Obstet & Gynecol, New Haven, CT USA; [Gladyshev, Vadim N.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Barcelona; Yale University; Harvard University; Harvard Medical School; Yale University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Gladyshev, VN (corresponding author), Brigham & Womens Hosp, Harvard Med Sch, Dept Med, Div Genet, Boston, MA 02115 USA.; Gladyshev, VN (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.	vgladyshev@rics.bwh.harvard.edu		Chung, Jean-Ju/0000-0001-8018-1355; Wang, Huafeng/0000-0002-7326-4379; Hwang, Jae Yeon/0000-0002-6493-4182; Dou, Qianhui/0000-0002-2418-4858	NIH [R01GM065204, DK117149, R01HD096745]; Yale School of Medicine	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale School of Medicine	This work was supported by NIH R01GM065204 and DK117149 to V. N. G., and the start-up funds from Yale School of Medicine and NIH R01HD096745 to J. -J. C. The content is solely the responsibility of the authors and does not necessarily represent the of fi cial views of the National Institutes of Health.	Agarwal A, 2016, ASIAN J ANDROL, V18, P282, DOI 10.4103/1008-682X.170445; Agarwal A, 2014, WORLD J MENS HEALTH, V32, P1, DOI 10.5534/wjmh.2014.32.1.1; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Arner ESJ, 2009, BBA-GEN SUBJECTS, V1790, P495, DOI 10.1016/j.bbagen.2009.01.014; Asghari A, 2017, SYST BIOL REPROD MED, V63, P100, DOI 10.1080/19396368.2016.1263367; Baba Shahid P., 2018, Current Opinion in Toxicology, V7, P133, DOI 10.1016/j.cotox.2018.03.005; Balhorn R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-227; Bao JQ, 2016, REPRODUCTION, V151, pR55, DOI 10.1530/REP-15-0562; Bonilla M, 2008, J BIOL CHEM, V283, P17898, DOI 10.1074/jbc.M710609200; Conrad M, 2004, MOL CELL BIOL, V24, P9414, DOI 10.1128/MCB.24.21.9414-9423.2004; Dorey A, 2021, FRONT CELL INFECT MI, V11, DOI 10.3389/fcimb.2021.667272; Fujii J., 2014, SPERMATOGENESIS, V4, pe979108, DOI [10.4161/21565562.2014.979108, DOI 10.4161/21565562.2014.979108]; Fujii J, 2015, FREE RADICAL BIO MED, V83, P373, DOI 10.1016/j.freeradbiomed.2015.01.025; Gerashchenko MV, 2010, J BIOL CHEM, V285, P4595, DOI 10.1074/jbc.M109.070532; Gibb Z, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.116.140509; Han X, 2018, NUCLEIC ACIDS RES, V46, P1038, DOI 10.1093/nar/gkx1272; Hasegawa A, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.134023; Hill BG, 2009, FREE RADICAL BIO MED, V47, P675, DOI 10.1016/j.freeradbiomed.2009.06.012; Homma T, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-74667-9; Hutchison JM, 2017, BIOPHYS J, V113, P1925, DOI 10.1016/j.bpj.2017.08.050; Hwang JY, 2019, CELL, V177, P1480, DOI 10.1016/j.cell.2019.03.047; Jakupoglu C, 2005, MOL CELL BIOL, V25, P1980, DOI 10.1128/MCB.25.5.1980-1988.2005; Jiang Y, 2014, SCIENCE, V344, P1168, DOI 10.1126/science.1252806; Kwon WS, 2015, SCI REP-UK, V5, DOI 10.1038/srep15654; Lizio M, 2019, NUCLEIC ACIDS RES, V47, pD752, DOI 10.1093/nar/gky1099; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; Meikar O, 2014, RNA, V20, P483, DOI 10.1261/rna.043729.113; Merkin J, 2012, SCIENCE, V338, P1593, DOI 10.1126/science.1228186; Mi YJ, 2015, MOL REPROD DEV, V82, P907, DOI 10.1002/mrd.22536; Miller D, 2010, REPRODUCTION, V139, P287, DOI 10.1530/REP-09-0281; Pan YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062039; Paoletti AC, 2006, P NATL ACAD SCI USA, V103, P18928, DOI 10.1073/pnas.0606379103; Park YJ, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10010098; Paronetto MP, 2010, INT J ANDROL, V33, P2, DOI 10.1111/j.1365-2605.2009.00959.x; Rahman MS, 2017, MOL REPROD DEV, V84, P749, DOI 10.1002/mrd.22810; Ramalho-Santos J, 2009, HUM REPROD UPDATE, V15, P553, DOI 10.1093/humupd/dmp016; Ryu DY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17488-7; Saadi HAS, 2013, J PROTEOMICS, V82, P64, DOI 10.1016/j.jprot.2013.02.027; Sabeti P, 2016, INT J REPROD BIOMED, V14, P231; Shibanuma M, 2011, FREE RADICAL RES, V45, P672, DOI 10.3109/10715762.2011.564169; Su D, 2005, J BIOL CHEM, V280, P26491, DOI 10.1074/jbc.M503638200; Sun QA, 2005, BIOCHEMISTRY-US, V44, P14528, DOI 10.1021/bi051321w; Sutherland JM, 2015, ASIAN J ANDROL, V17, P529, DOI 10.4103/1008-682X.151397; Tasaki E, 2017, J CLIN BIOCHEM NUTR, V60, P156, DOI 10.3164/jcbn.16-96; Turanov AA, 2010, METHOD ENZYMOL, V474, P245, DOI 10.1016/S0076-6879(10)74014-3; Wang H., 2021, J BIOL CHEM, V298; Weng ZQ, 2014, ARCH TOXICOL, V88, P1007, DOI 10.1007/s00204-014-1192-z; Wu CG, 2011, ANTIOXID REDOX SIGN, V15, P2565, DOI 10.1089/ars.2010.3831; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Yu Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4230; Zhang DG, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10040535; Zhou JC, 2017, J NUTR, V147, P1947, DOI 10.3945/jn.117.252544; Zybailov BL, 2007, MOL BIOSYST, V3, P354, DOI 10.1039/b701483j	53	2	2	6	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2022	298	8							102183	10.1016/j.jbc.2022.102183	http://dx.doi.org/10.1016/j.jbc.2022.102183			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	4X0OB	35753352	gold, Green Published			2022-12-26	WOS:000860550600011
J	Freeman, SL; Skafar, V; Kwon, H; Fielding, AJ; Moody, PCE; Martinez, A; Issoglio, FM; Inchausti, L; Smircich, P; Zeida, A; Piacenza, L; Radi, R; Raven, EL				Freeman, Samuel L.; Skafar, Vera; Kwon, Hanna; Fielding, Alistair J.; Moody, Peter C. E.; Martinez, Alejandra; Issoglio, Federico M.; Inchausti, Lucas; Smircich, Pablo; Zeida, Ari; Piacenza, Lucia; Radi, Rafael; Raven, Emma L.			Crystal structure of Trypanosoma cruzi heme peroxidase and characterization of its substrate specificity and compound I intermediate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C PEROXIDASE; LEISHMANIA-MAJOR PEROXIDASE; ENGINEERED CATION SITE; HIGH-FIELD EPR; ASCORBATE-PEROXIDASE; ELECTRON-TRANSFER; THIYL RADICALS; CHAGAS-DISEASE; BINDING-SITE; FERRYL HEME	The protozoan parasite Trypanosoma cruzi is the causative agent of American trypanosomiasis, otherwise known as Chagas disease. To survive in the host, the T. cruzi parasite needs antioxidant defense systems. One of these is a hybrid heme peroxidase, the T. cruzi ascorbate peroxidase-cytochrome c peroxidase enzyme (TcAPx-CcP). TcAPx-CcP has high sequence identity to members of the class I peroxidase family, notably ascorbate peroxidase (APX) and cytochrome c peroxidase (CcP), as well as a mitochondrial peroxidase from Leishmania major (LmP). The aim of this work was to solve the structure and examine the reactivity of the TcAPx-CcP enzyme. Low temperature electron para-magnetic resonance spectra support the formation of an exchange-coupled [Fe(IV)=O Trp(233)(center dot+)] compound I radical species, analogous to that used in CcP and LmP. We demonstrate that TcAPx-CcP is similar in overall structure to APX and CcP, but there are differences in the substrate -binding regions. Furthermore, the electron transfer pathway from cytochrome c to the heme in CcP and LmP is preserved in the TcAPx-CcP structure. Integration of steady state ki-netic experiments, molecular dynamic simulations, and bio-informatic analyses indicates that TcAPx-CcP preferentially oxidizes cytochrome c but is still competent for oxidization of ascorbate. The results reveal that TcAPx-CcP is a credible cytochrome c peroxidase, which can also bind and use ascorbate in host cells, where concentrations are in the millimolar range. Thus, kinetically and functionally TcAPx-CcP can be considered a hybrid peroxidase.	[Freeman, Samuel L.; Raven, Emma L.] Univ Bristol, Sch Chem, Bristol, England; [Skafar, Vera; Martinez, Alejandra; Zeida, Ari; Piacenza, Lucia; Radi, Rafael] Univ Republica, Fac Med, Dept Bioquim, Montevideo, Uruguay; [Skafar, Vera; Martinez, Alejandra; Zeida, Ari; Piacenza, Lucia; Radi, Rafael] Univ Republica, Fac Med, Ctr Invest Biomed CEINBIO, Montevideo, Uruguay; [Kwon, Hanna; Moody, Peter C. E.] Univ Leicester, Dept Mol & Cell Biol, Leicester, England; [Kwon, Hanna; Moody, Peter C. E.] Univ Leicester, Leicester Inst Struct & Chem Biol, Leicester, England; [Fielding, Alistair J.] Liverpool John Moore Univ, Ctr Nat Prod Discovery, Sch Pharm & Biomol Sci, Liverpool, England; [Issoglio, Federico M.] Univ Buenos Aires, Inst Quim Biol, CONICET, Fac Ciencias Exactas & Nat,IQUIBICEN, Buenos Aires, Argentina; [Issoglio, Federico M.] Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, Oeiras, Portugal; [Inchausti, Lucas; Smircich, Pablo] Inst Invest Biol Clemente Estable, Lab Bioinformat, Dept Genom, Montevideo, Uruguay; [Inchausti, Lucas; Smircich, Pablo] Univ Republica, Fac Ciencias, Lab Interacc Mol, Montevideo, Uruguay	University of Bristol; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; University of Leicester; University of Leicester; Liverpool John Moores University; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Universidade Nova de Lisboa; Instituto de Investigaciones Biologicas Clemente Estable Uruguay; Universidad de la Republica, Uruguay	Raven, EL (corresponding author), Univ Bristol, Sch Chem, Bristol, England.; Radi, R (corresponding author), Univ Republica, Fac Med, Dept Bioquim, Montevideo, Uruguay.; Radi, R (corresponding author), Univ Republica, Fac Med, Ctr Invest Biomed CEINBIO, Montevideo, Uruguay.	emma.raven@bristol.ac.uk; rradi@fmed.edu.uy		Issoglio, Federico/0000-0001-9225-7855; Fielding, Alistair/0000-0002-4437-9791; Martinez D'Alto, Alejandra/0000-0002-1850-7446	Royal Society [IC170118, RSWF\R3\183003]; Diamond Light Source for beamtime; Programa de Desarrollo de Ciencias Basicas (PEDECIBA, Uruguay); Universidad de la Republica	Royal Society(Royal Society of London); Diamond Light Source for beamtime; Programa de Desarrollo de Ciencias Basicas (PEDECIBA, Uruguay); Universidad de la Republica	We thank the Royal Society for funding (grant IC170118 to R. R. and E. L. R., and RSWF\R3\183003 to P. C. E. M.), the National Engineering and Physical Sciences Research Council EPR service and facility for instrument and EI_2020 and CSIC Grupos_2018 to R. R.), and Diamond Light Source for beamtime (proposal MX23269). Additional funding was provided by Programa de Desarrollo de Ciencias Basicas (PEDECIBA, Uruguay). V. S. was partially funded by a graduate student fellowship from Universidad de la Republica.	Adak S, 2005, BIOCHEM J, V390, P465, DOI 10.1042/BJ20050311; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Bern C, 2011, CLIN MICROBIOL REV, V24, P655, DOI 10.1128/CMR.00005-11; Bleifuss G, 2001, BIOCHEMISTRY-US, V40, P15362, DOI 10.1021/bi010707d; Bonagura CA, 1996, BIOCHEMISTRY-US, V35, P6107, DOI 10.1021/bi960122x; Bonagura CA, 1999, BIOCHEMISTRY-US, V38, P5538, DOI 10.1021/bi982996k; Bonagura CA, 1999, J BIOL CHEM, V274, P37827, DOI 10.1074/jbc.274.53.37827; Bonney KM, 2014, PARASITE, V21, DOI 10.1051/parasite/2014012; Capece L, 2011, BIOCHEMISTRY-US, V50, P10910, DOI 10.1021/bi201439m; Casadei CM, 2014, SCIENCE, V345, P193, DOI 10.1126/science.1254398; Case D. A., 2018, AMBER 2018; CLARK D, 1994, MOL BIOCHEM PARASIT, V66, P143, DOI 10.1016/0166-6851(94)90045-0; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Estrada D, 2018, BIOCHEM J, V475, P1235, DOI [10.1042/BCJ20170698, 10.1042/bcj20170698]; Everse J., 1991, PEROXIDASES CHEM BIO; Fielding AJ, 2008, BIOCHEMISTRY-US, V47, P9781, DOI 10.1021/bi801032k; Fielding AJ, 2011, J AM CHEM SOC, V133, P9052, DOI 10.1021/ja202207t; GERFEN GJ, 1993, J AM CHEM SOC, V115, P6420, DOI 10.1021/ja00067a071; HOUSEMAN ALP, 1993, BIOCHEMISTRY-US, V32, P4430, DOI 10.1021/bi00067a036; Hugo M, 2017, P NATL ACAD SCI USA, V114, pE1326, DOI 10.1073/pnas.1618611114; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ivancich A, 2001, J AM CHEM SOC, V123, P5050, DOI 10.1021/ja0036514; Jasion VS, 2012, P NATL ACAD SCI USA, V109, P18390, DOI 10.1073/pnas.1213295109; Jasion VS, 2012, BIOCHEMISTRY-US, V51, P2453, DOI 10.1021/bi300169x; Jasion VS, 2011, J BIOL CHEM, V286, P24608, DOI 10.1074/jbc.M111.230524; Jeschke G, 2005, BBA-BIOENERGETICS, V1707, P91, DOI 10.1016/j.bbabio.2004.02.012; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jurrus E, 2018, PROTEIN SCI, V27, P112, DOI 10.1002/pro.3280; Kolberg M, 2002, ARCH BIOCHEM BIOPHYS, V403, P141, DOI 10.1016/S0003-9861(02)00264-3; Kolberg M, 2002, ARCH BIOCHEM BIOPHYS, V397, P57, DOI 10.1006/abbi.2001.2658; Kwon H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13445; Lad L, 2002, EUR J BIOCHEM, V269, P3182, DOI 10.1046/j.1432-1033.2002.02998.x; Lad L, 2002, BIOCHEMISTRY-US, V41, P13774, DOI 10.1021/bi0261591; Leesch VW, 2000, BIOCHEMISTRY-US, V39, P10132, DOI 10.1021/bi000760m; Levine M, 1996, P NATL ACAD SCI USA, V93, P3704, DOI 10.1073/pnas.93.8.3704; LUQUETTI AO, 1986, T ROY SOC TROP MED H, V80, P462, DOI 10.1016/0035-9203(86)90347-0; Macdonald IK, 2006, BIOCHEMISTRY-US, V45, P7808, DOI 10.1021/bi0606849; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Martinez A, 2019, P NATL ACAD SCI USA, V116, P8879, DOI 10.1073/pnas.1821487116; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moody PCE, 2018, ACCOUNTS CHEM RES, V51, P427, DOI 10.1021/acs.accounts.7b00463; Murphy EJ, 2012, FEBS J, V279, P1632, DOI 10.1111/j.1742-4658.2011.08425.x; Murphy EJ, 2008, BIOCHEMISTRY-US, V47, P13933, DOI 10.1021/bi801480r; NELSON DP, 1972, ANAL BIOCHEM, V49, P474, DOI 10.1016/0003-2697(72)90451-4; Alvarez MN, 2011, J BIOL CHEM, V286, P6627, DOI 10.1074/jbc.M110.167247; PATTERSON WR, 1995, BIOCHEMISTRY-US, V34, P4342, DOI 10.1021/bi00013a024; Pearl NM, 2008, BIOCHEMISTRY-US, V47, P2766, DOI 10.1021/bi702271r; PELLETIER H, 1992, SCIENCE, V258, P1748, DOI 10.1126/science.1334573; Piacenza L, 2019, J EXP MED, V216, P501, DOI 10.1084/jem.20181886; Piacenza L, 2013, ANTIOXID REDOX SIGN, V19, P723, DOI 10.1089/ars.2012.4618; Pond AE, 1998, INORG CHIM ACTA, V276, P250; Rastelli G, 2010, J COMPUT CHEM, V31, P797, DOI 10.1002/jcc.21372; Raven E L, 2000, Subcell Biochem, V35, P317; Raven EL, 2003, NAT PROD REP, V20, P367, DOI 10.1039/b210426c; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Sharp K. H., 2003, DALTON T, V2003, P4208; Sharp KH, 2003, NAT STRUCT BIOL, V10, P303, DOI 10.1038/nsb913; SIVARAJA M, 1989, SCIENCE, V245, P738, DOI 10.1126/science.2549632; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Wilkinson SR, 2005, P NATL ACAD SCI USA, V102, P11645, DOI 10.1073/pnas.0504251102; Wilkinson SR, 2002, P NATL ACAD SCI USA, V99, P13453, DOI 10.1073/pnas.202422899	64	0	0	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2022	298	8							102204	10.1016/j.jbc.2022.102204	http://dx.doi.org/10.1016/j.jbc.2022.102204			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	4F0HN	35772495	gold, Green Accepted, Green Published			2022-12-26	WOS:000848197700005
J	Xu, H; Guan, JN; Jin, ZC; Yin, C; Wu, SN; Sun, W; Zhang, HW; Yan, B				Xu, Hao; Guan, Jiani; Jin, Zhichun; Yin, Cheng; Wu, Shengnan; Sun, Wen; Zhang, Hanwen; Yan, Bin			Mechanical force modulates macrophage proliferation via Piezo1-AKT-Cyclin D1 axis	FASEB JOURNAL			English	Article						cell proliferation; cyclin D1; ion channel; macrophage; mechanobiology; orthodontics	CYCLIN D1; CELL; DIFFERENTIATION; MECHANOBIOLOGY; POLARIZATION; RECRUITMENT; GROWTH; SHAPE	Orthodontic tooth movement (OTM) is induced by biomechanical stimuli and facilitated by periodontal tissue remodeling, where multiple immune cells participate in this progression. It has been demonstrated that macrophage is essential for mechanical force-induced tissue remodeling. In this study, we first found that mechanical force significantly induced macrophage proliferation in human periodontal samples and murine OTM models. Yet, how macrophages perceive mechanical stimuli and thereby modulate their biological behaviors remain elusive. To illustrate the mechanisms of mechanical force-induced macrophage proliferation, we subsequently identified Piezo1, a novel mechanosensory ion channel, to modulate macrophage response subjected to mechanical stimuli. Mechanical force upregulates Piezo1 expression in periodontal tissues and cultured bone-marrow-derived macrophages (BMDMs). Remarkably, suppressing Piezo1 with GsMTx4 retarded OTM through reduced macrophage proliferation. Moreover, knockdown of Piezo1 effectively inhibited mechanical force-induced BMDMs proliferation. RNA sequencing was further performed to dissect the underlying mechanisms of Piezo1-mediated mechanotransduction utilizing mechanical stretch system. We revealed that Piezo1-activated AKT/GSK3 beta signaling was closely associated with macrophage proliferation upon mechanical stimuli. Importantly, Cyclin D1 (Ccnd1) was authenticated as a critical downstream factor of Piezo1 that facilitated proliferation by enhancing Rb phosphorylation. We generated genetically modified mice in which Ccnd1 could be deleted in macrophages in an inducible manner. Conditional ablation of Ccnd1 inhibited periodontal macrophage proliferation and therefore delayed OTM. Overall, our findings highlight that proliferation driven by mechanical force is a key process by which macrophages infiltrate in periodontal tissue during OTM, where Piezo1-AKT-Ccnd1 axis plays a pivotal role.	[Xu, Hao; Guan, Jiani; Jin, Zhichun; Yin, Cheng; Wu, Shengnan; Yan, Bin] Nanjing Med Univ, Stomatol Hosp, Dept Orthodont, Nanjing 210029, Peoples R China; [Xu, Hao; Guan, Jiani; Jin, Zhichun; Yin, Cheng; Wu, Shengnan; Sun, Wen; Yan, Bin] Nanjing Med Univ, Jiangsu Key Lab Oral Dis, Nanjing, Peoples R China; [Xu, Hao; Guan, Jiani; Jin, Zhichun; Yin, Cheng; Wu, Shengnan; Yan, Bin] Jiangsu Prov Engn Res Ctr Stomatol Translat Med, Nanjing, Peoples R China; [Zhang, Hanwen] Nanjing Med Univ, Sch Basic Med Sci, Nanjing 211166, Jiangsu, Peoples R China; [Zhang, Hanwen] Nanjing Med Univ, Collaborat Innovat Ctr Cardiovasc Dis Translat, Key Lab Targeted Intervent Cardiovasc Dis, Nanjing, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Yan, B (corresponding author), Nanjing Med Univ, Stomatol Hosp, Dept Orthodont, Nanjing 210029, Peoples R China.; Zhang, HW (corresponding author), Nanjing Med Univ, Sch Basic Med Sci, Nanjing 211166, Jiangsu, Peoples R China.	hanwenzhang@njmu.edu.cn; byan@njmu.edu.cn			Key Medical Research Projects of Jiangsu Health Commission [ZDA2020003]; National Natural Science Foundation of China (NSFC) [82071143, 81571005]; Priority Academic Program Development of Jiangsu Higher Education Institutions [PAPD-2018-87]	Key Medical Research Projects of Jiangsu Health Commission; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions	Key Medical Research Projects of Jiangsu Health Commission, Grant/Award Number: ZDA2020003; National Natural Science Foundation of China (NSFC), Grant/Award Number: 82071143 and 81571005; Priority Academic Program Development of Jiangsu Higher Education Institutions, Grant/Award Number: PAPD-2018-87	Akei H, 2006, AM J PHYSIOL-LUNG C, V291, pL572, DOI 10.1152/ajplung.00060.2006; Atcha H, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.689397; Atcha H, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23482-5; Collin O, 2008, CURR BIOL, V18, P1288, DOI 10.1016/j.cub.2008.07.046; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Davies LC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2877; Taddei SRD, 2012, J BIOMECH, V45, P2729, DOI 10.1016/j.jbiomech.2012.09.006; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; Gentek R, 2014, IMMUNOL REV, V262, P56, DOI 10.1111/imr.12224; Gois EG, 2012, ANGLE ORTHOD, V82, P495, DOI 10.2319/033011-230.1; Hasegawa K, 2021, J PATHOL, V253, P80, DOI 10.1002/path.5553; He D, 2015, J DENT RES, V94, P1286, DOI 10.1177/0022034515589714; He JH, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-03481-6; Ishiuchi S, 2007, J NEUROSCI, V27, P7987, DOI 10.1523/JNEUROSCI.2180-07.2007; Iskratsch T, 2014, NAT REV MOL CELL BIO, V15, P825, DOI 10.1038/nrm3903; Jiang N, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.666631; Ladoux B, 2017, NAT REV MOL CELL BIO, V18, P743, DOI 10.1038/nrm.2017.98; Lee YJ, 2014, NATURE, V510, P547, DOI 10.1038/nature13267; Li XH, 2019, ELIFE, V8, DOI 10.7554/eLife.49631; Lin WM, 2021, BONE RES, V9, DOI 10.1038/s41413-021-00141-5; Miroshnikova YA, 2018, NAT CELL BIOL, V20, P69, DOI 10.1038/s41556-017-0005-z; Orsini EM, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.767319; Poole K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4520; Sager HB, 2016, CIRC RES, V119, P853, DOI 10.1161/CIRCRESAHA.116.309001; Sasaki F, 2020, BIOCHEM BIOPH RES CO, V521, P806, DOI 10.1016/j.bbrc.2019.10.174; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Sieweke MH, 2013, SCIENCE, V342, P946, DOI 10.1126/science.1242974; Sima C, 2019, J LEUKOCYTE BIOL, V105, P473, DOI 10.1002/JLB.1RU0818-310R; Solis AG, 2019, NATURE, V573, P69, DOI 10.1038/s41586-019-1485-8; Sun WJ, 2019, ELIFE, V8, DOI 10.7554/eLife.47454; Szczot M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat9892; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Uda Y, 2017, CURR OSTEOPOROS REP, V15, P318, DOI 10.1007/s11914-017-0373-0; Wang LJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14146-6; Wang Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34907-5; Zhang MM, 2019, CELL REP, V26, P1419, DOI 10.1016/j.celrep.2019.01.056; Zhang XX, 2020, CURR OPIN BIOTECH, V66, P236, DOI 10.1016/j.copbio.2020.09.004; Zhao SJ, 2020, THERANOSTICS, V10, P17, DOI 10.7150/thno.36930; Zhu XB, 2016, GENET TEST MOL BIOMA, V20, P529, DOI 10.1089/gtmb.2016.0020	40	2	2	9	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2022	36	8							e22423	10.1096/fj.202200314R	http://dx.doi.org/10.1096/fj.202200314R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2P0OZ	35775626	hybrid			2022-12-26	WOS:000819452300001
J	Almomani, I; Ahmed, M; El-Shafai, W				Almomani, Iman; Ahmed, Mohanned; El-Shafai, Walid			Android malware analysis in a nutshell	PLOS ONE			English	Article								This paper offers a comprehensive analysis model for android malware. The model presents the essential factors affecting the analysis results of android malware that are vision-based. Current android malware analysis and solutions might consider one or some of these factors while building their malware predictive systems. However, this paper comprehensively highlights these factors and their impacts through a deep empirical study. The study comprises 22 CNN (Convolutional Neural Network) algorithms, 21 of them are well-known, and one proposed algorithm. Additionally, several types of files are considered before converting them to images, and two benchmark android malware datasets are utilized. Finally, comprehensive evaluation metrics are measured to assess the produced predictive models from the security and complexity perspectives. Consequently, guiding researchers and developers to plan and build efficient malware analysis systems that meet their requirements and resources. The results reveal that some factors might significantly impact the performance of the malware analysis solution. For example, from a security perspective, the accuracy, F1-score, precision, and recall are improved by 131.29%, 236.44%, 192%, and 131.29%, respectively, when changing one factor and fixing all other factors under study. Similar results are observed in the case of complexity assessment, including testing time, CPU usage, storage size, and pre-processing speed, proving the importance of the proposed android malware analysis model.	[Almomani, Iman; Ahmed, Mohanned; El-Shafai, Walid] Prince Sultan Univ, Comp Sci Dept, Secur Engn Lab, Riyadh, Saudi Arabia; [Almomani, Iman] Univ Jordan, King Abdullah II Sch Informat Technol, Comp Sci Dept, Amman, Jordan; [El-Shafai, Walid] Menoufia Univ, Fac Elect Engn, Elect & Elect Commun Engn Dept, Menoufia, Egypt	Prince Sultan University; University of Jordan; Egyptian Knowledge Bank (EKB); Menofia University	Almomani, I (corresponding author), Prince Sultan Univ, Comp Sci Dept, Secur Engn Lab, Riyadh, Saudi Arabia.; Almomani, I (corresponding author), Univ Jordan, King Abdullah II Sch Informat Technol, Comp Sci Dept, Amman, Jordan.	imomani@psu.edu.sa	Ahmed, Mr. Mohanned/GXF-2854-2022	Ahmed, Mr. Mohanned/0000-0002-8506-2045; Almomani, Iman/0000-0003-4639-516X				Abadi M, 2016, PROCEEDINGS OF OSDI'16: 12TH USENIX SYMPOSIUM ON OPERATING SYSTEMS DESIGN AND IMPLEMENTATION, P265; Acharya V., 2021, INT C COMPUTING COMM, P1; Ahmed AA, 2020, J AMB INTEL HUM COMP, DOI 10.1007/s12652-020-01848-9; Al Khayer Aala, 2020, 2020 First International Conference of Smart Systems and Emerging Technologies (SMARTTECH), P197, DOI 10.1109/SMART-TECH49988.2020.00053; Almomani I., 2019, 2019 INT C COMP INF, P1; Almomani I, 2022, IEEE ACCESS, V10, P2700, DOI 10.1109/ACCESS.2022.3140341; Almomani I, 2021, IEEE ACCESS, V9, P57674, DOI 10.1109/ACCESS.2021.3071450; Almomani IM, 2020, IEEE ACCESS, V8, P216671, DOI 10.1109/ACCESS.2020.3041432; Arp D, 2014, 21ST ANNUAL NETWORK AND DISTRIBUTED SYSTEM SECURITY SYMPOSIUM (NDSS 2014), DOI 10.14722/ndss.2014.23247; Arslan RS, 2021, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.533; Bello I, 2021, J AMB INTEL HUM COMP, V12, P8699, DOI 10.1007/s12652-020-02630-7; Brownlee J., 2018, DEEP LEARNING PYTHON; D'Angelo G, 2022, CLUSTER COMPUT, V25, P2487, DOI 10.1007/s10586-021-03490-2; Ding YX, 2020, J AMB INTEL HUM COMP, DOI 10.1007/s12652-020-02196-4; El-Shafai W, 2021, APPL SCI-BASEL, V11, DOI 10.3390/app11146446; Feng PB, 2018, IEEE ACCESS, V6, P30996, DOI 10.1109/ACCESS.2018.2844349; Ganesan S., 2021, 2021 INT C SYSTEM CO, P1; Gaurav A, 2022, ENTERP INF SYST-UK, DOI 10.1080/17517575.2021.2023764; Geron A., 2019, HANDS ON MACHINE LEA, V2nd; Hodnett M., 2018, GUIDE CANINE FELINE; Joseph F.J.J., 2021, ADV DEEP LEARNING EN, P85; Kim JY, 2022, COMPUT SECUR, V112, DOI 10.1016/j.cose.2021.102501; Kumar S, 2022, J INF SECUR APPL, V64, DOI 10.1016/j.jisa.2021.103063; Li X., 2022, SECUR COMMUN NETW, V2022; Li YJ, 2017, PROCEEDINGS OF THE 2017 EURO-ASIA CONFERENCE ON ENVIRONMENT AND CSR: TOURISM, SOCIETY AND EDUCATION SESSION, PT I, P192, DOI 10.1007/978-3-319-66332-6_9; Naseer M., 2021, J PHYS C SERIES, V1807; Qaddoura R, 2021, SENSORS-BASEL, V21, DOI 10.3390/s21092987; Selvaganapathy S., 2021, J CYBER SECUR MOBIL, P177, DOI DOI 10.13052/JCSM2245-1439.1017; Sihag V, 2021, SECUR COMMUN NETW, V2021, DOI 10.1155/2021/9099476; Singh J, 2021, J SYST ARCHITECT, V112, DOI 10.1016/j.sysarc.2020.101861; Singh J, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20247013; Sriram S, 2020, IEEE CONF COMPUT, P740, DOI 10.1109/INFOCOMWKSHPS50562.2020.9162661; Sugunan K., 2018, ADV BIG DATA CLOUD C, P147, DOI DOI 10.1007/978-981-10-7200-0_13; Suresh P., 2022, MACHINE LEARNING BIO, P177; Taheri R, 2020, FUTURE GENER COMP SY, V105, P230, DOI 10.1016/j.future.2019.11.034; Unver HM, 2020, SN APPL SCI, V2, DOI 10.1007/s42452-020-3132-2; VASILEV, 2019, PYTHON DEEP LEARNING; Venkatraman S, 2019, J INF SECUR APPL, V47, P377, DOI 10.1016/j.jisa.2019.06.006; Vu LN, 2021, IEEE ACCESS, V9, P39680, DOI 10.1109/ACCESS.2021.3063748; Yadav P, COMPUT INTELL-US; Yadav P, 2020, COMPUT SECUR, V115, DOI 10.1016/j.cose.2022.102622; Yuan BG, 2020, COMPUT SECUR, V92, DOI 10.1016/j.cose.2020.101740; Zhang H, 2020, INT C SEC PRIV NEW C, P186; Zhao Y.-l., 2018, INT J NETW SECUR, V20, P1061	47	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7								10.1371/journal.pone.0270647	http://dx.doi.org/10.1371/journal.pone.0270647			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M5FN	35788205	gold, Green Published			2022-12-26	WOS:000835487000010
J	Marbaniang, I; Joshi, S; Sangle, S; Khaire, S; Thakur, R; Chavan, A; Gupte, N; Kulkarni, V; Deshpande, P; Nimkar, S; Mave, V				Marbaniang, Ivan; Joshi, Samir; Sangle, Shashikala; Khaire, Samir; Thakur, Rahul; Chavan, Amol; Gupte, Nikhil; Kulkarni, Vandana; Deshpande, Prasad; Nimkar, Smita; Mave, Vidya			Smokeless tobacco use and oral potentially malignant disorders among people living with HIV (PLHIV) in Pune, India: Implications for oral cancer screening in PLHIV	PLOS ONE			English	Article								IntroductionIn India, smokeless tobacco (SLT) is a predominant form of tobacco used among people living with HIV (PLHIV). Despite SLT being a risk factor for oral potentially malignant disorders (OPMDs), no prior studies have quantified the association of OPMDs with SLT use among PLHIV. This limits the planning of preventive and control strategies for oral cancer among PLHIV, who are at higher risk for the disease. MethodsWe enrolled 601 PLHIV and 633 HIV-uninfected individuals in an oral cancer screening study at BJ Government Medical College, Pune, India. Oral cavity images were collected using an m-Health application and reviewed by three clinicians. Participants with two clinician positive diagnoses were deemed to have suspected OPMDs. Prevalence ratios (PRs) were used to quantify the association between suspected OPMDs and SLT use among PLHIV. PRs for current SLT users, across HIV status and use duration were also estimated. Corrected PRs were obtained by modifying the maximum likelihood estimation. Models were adjusted for age, smoking, alcohol use and CD4 counts. ResultsOf those enrolled, 61% were men, median age was 36 years (IQR: 28-44), and 33% currently use SLT. Proportion of current SLT users was similar across PLHIV and HIV-uninfected groups but use duration for current SLT use was higher among PLHIV(p<0.05). Among PLHIV, current SLT users had a 5-times (95% CI:3.1-7.0) higher prevalence of suspected OPMDs, compared to non-users. Relative to HIV uninfected individuals with the same SLT use duration, significant associations with suspected OPMDs were seen for PLHIV with<10 use years (PR: 3.5, 95% CI: 1.5-8.1) but not for PLHIV with >= 10 use years (PR: 1.3, 95% CI: 0.9-1.8). ConclusionPLHIV that are current SLT users are at high risk of OPMDs and potentially oral cancer. The development of strategies for screening, early detection, and management of OPMDs must be considered for this group.	[Marbaniang, Ivan; Chavan, Amol; Gupte, Nikhil; Kulkarni, Vandana; Deshpande, Prasad; Nimkar, Smita; Mave, Vidya] Johns Hopkins Univ, Byramjee Jeejeebhoy Govt Med Coll, Clin Res Site, Pune, India; [Marbaniang, Ivan] McGill Univ, Dept Epidemiol, Montreal, PQ, Canada; [Joshi, Samir; Thakur, Rahul] Byramjee Jeejeebhoy Govt Med Coll, Dept Otorhinolaryngol & Head & Neck Surg, Pune, India; [Sangle, Shashikala] Byramjee Jeejeebhoy Govt Med Coll, Dept Med, Pune, India; [Khaire, Samir] Byramjee Jeejeebhoy Govt Med Coll, Dept Dent, Pune, India; [Gupte, Nikhil; Mave, Vidya] Johns Hopkins Univ, Ctr Clin Global Hlth Educ, Baltimore, MD USA	B.J. Govt. Medical College & Sassoon General Hospitals, Pune; Johns Hopkins University; McGill University; B.J. Govt. Medical College & Sassoon General Hospitals, Pune; B.J. Govt. Medical College & Sassoon General Hospitals, Pune; B.J. Govt. Medical College & Sassoon General Hospitals, Pune; Johns Hopkins University	Marbaniang, I (corresponding author), Johns Hopkins Univ, Byramjee Jeejeebhoy Govt Med Coll, Clin Res Site, Pune, India.; Marbaniang, I (corresponding author), McGill Univ, Dept Epidemiol, Montreal, PQ, Canada.	ivanmarb@gmail.com			amfAR, The Foundation for AIDS Research; U.S. National Institutes of Health's National Institute of Allergy and Infectious Diseases; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Cancer Institute; National Institute of Mental Health; National Institute on Drug Abuse; National Heart, Lung, and Blood Institute; National Institute on Alcohol Abuse and Alcoholism; National Institute of Diabetes and Digestive and Kidney Diseases; Fogarty International Center, International Epidemiology Databases to Evaluate AIDS (IeDEA) [U01AI069907]; NIH [UM1AI069465]	amfAR, The Foundation for AIDS Research; U.S. National Institutes of Health's National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Fogarty International Center, International Epidemiology Databases to Evaluate AIDS (IeDEA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by amfAR, The Foundation for AIDS Research, with support from the U.S. National Institutes of Health's National Institute of Allergy and Infectious Diseases, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, the National Cancer Institute, the National Institute of Mental Health, the National Institute on Drug Abuse, the National Heart, Lung, and Blood Institute, the National Institute on Alcohol Abuse and Alcoholism, the National Institute of Diabetes and Digestive and Kidney Diseases, and the Fogarty International Center, as part of the International Epidemiology Databases to Evaluate AIDS (IeDEA; U01AI069907) and the NIH-funded Johns Hopkins Baltimore-Washington-India Clinical Trials Unit for NIAID Networks (UM1AI069465). The content and views expressed are those of the authors and does not necessarily represent the official views of any of the governments or institutions mentioned above. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabdullah JH, 2018, TELEMED E-HEALTH, V24, P639, DOI 10.1089/tmj.2017.0132; [Anonymous], 2019, WHO REPORT GLOBAL TO; Beachler DC, 2014, ORAL ONCOL, V50, P1169, DOI 10.1016/j.oraloncology.2014.09.011; Birur N Praveen, 2018, J Contemp Dent Pract, V19, P1122; Birur PN, 2015, J AM DENT ASSOC, V146, P886, DOI 10.1016/j.adaj.2015.05.020; Cheung L, 2021, J CLIN ONCOL, V39, P663, DOI 10.1200/JCO.20.02855; GLOBOCAN WHO International Agency for Research on Cancer, LIP OR CAV CANC INC; Godbole SV, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004850; Government of India MoHFW, SMOKELESS TOBACCO PU; Government of India MoHFW, OP FRAM MAN COMM CAN; Government of India MoHFW WHO TISS., GLOBAL ADULT TOBACCO; Haron N, 2017, TELEMED E-HEALTH, V23, P192, DOI 10.1089/tmj.2016.0128; Keogh RH, 2020, STAT MED, V39, P2197, DOI 10.1002/sim.8532; Khan Z, 2018, NICOTINE TOB RES, V20, P12, DOI 10.1093/ntr/ntw310; Kumar Sandeep, 2015, Adv Prev Med, V2015, P208519, DOI 10.1155/2015/208519; Lash T., 2009, APPL QUANTITATIVE BI, P94; Liao LJ, 2015, OR SURG OR MED OR PA, V119, P101, DOI 10.1016/j.oooo.2014.09.020; Lyles RH, 2011, EPIDEMIOLOGY, V22, P589, DOI 10.1097/EDE.0b013e3182117c85; Mallath MK, 2014, LANCET ONCOL, V15, pE205, DOI 10.1016/S1470-2045(14)70115-9; Mdege ND, 2017, LANCET GLOB HEALTH, V5, pE578, DOI [10.1016/S2214-109X(17)30170-5, 10.1016/s2214-109x(17)30170-5]; Mello FW, 2018, J ORAL PATHOL MED, V47, P633, DOI 10.1111/jop.12726; Misra Vatsala, 2009, Indian J Community Med, V34, P321, DOI 10.4103/0970-0218.58391; Mohan P, 2020, JCO GLOB ONCOL, V6, P688, DOI 10.1200/JGO.19.00350; Nadeau Christine, 2018, Dent Clin North Am, V62, P1, DOI 10.1016/j.cden.2017.08.001; Rajaraman P, 2015, LANCET ONCOL, V16, pE352, DOI 10.1016/S1470-2045(15)00078-9; Ramesh RM, 2022, TROP DOCT, V52, P53, DOI 10.1177/00494755211049973; Sankaranarayanan R, 2013, ORAL ONCOL, V49, P314, DOI 10.1016/j.oraloncology.2012.11.004; Shaw PA, 2020, STAT MED, V39, P2232, DOI 10.1002/sim.8531; Shiels MS, 2017, CLIN INFECT DIS, V64, P468, DOI 10.1093/cid/ciw764; Sivakumar T T, 2018, J Oral Maxillofac Pathol, V22, P413, DOI 10.4103/jomfp.JOMFP_202_17; Vinayagamoorthy K, 2019, AUST J RURAL HEALTH, V27, P170, DOI 10.1111/ajr.12496; Warnakulasuriya S, 2020, ORAL ONCOL, V102, DOI 10.1016/j.oraloncology.2019.104550	32	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7								10.1371/journal.pone.0270876	http://dx.doi.org/10.1371/journal.pone.0270876			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M5FN	35788753	gold, Green Published			2022-12-26	WOS:000835487000024
J	Raschke, R; Rangan, P; Agarwal, SC; Uppalapu, S; Sher, N; Curry, S; Heise, CW				Raschke, Robert; Rangan, Pooja; Agarwal, Sumit C.; Uppalapu, Suresh; Sher, Nehan; Curry, Steven; Heise, C. William			COVID-19 Time of Intubation Mortality Evaluation (C-TIME): A system for predicting mortality of patients with COVID-19 pneumonia at the time they require mechanical ventilation	PLOS ONE			English	Article							HOSPITAL MORTALITY; ACUTE PHYSIOLOGY; SOFA SCORE; APACHE IV; MODEL; RISK	Background An accurate system to predict mortality in patients requiring intubation for COVID-19 could help to inform consent, frame family expectations and assist end-of-life decisions. Research objective To develop and validate a mortality prediction system called C-TIME (COVID-19 Time of Intubation Mortality Evaluation) using variables available before intubation, determine its discriminant accuracy, and compare it to acute physiology and chronic health evaluation (APACHE IVa) and sequential organ failure assessment (SOFA). Methods A retrospective cohort was set in 18 medical-surgical ICUs, enrolling consecutive adults, positive by SARS-CoV 2 RNA by reverse transcriptase polymerase chain reaction or positive rapid antigen test, and undergoing endotracheal intubation. All were followed until hospital discharge or death. The combined outcome was hospital mortality or terminal extubation with hospice discharge. Twenty-five clinical and laboratory variables available 48 hours prior to intubation were entered into multiple logistic regression (MLR) and the resulting model was used to predict mortality of validation cohort patients. Area under the receiver operating curve (AUROC) was calculated for C-TIME, APACHE IVa and SOFA. Results The median age of the 2,440 study patients was 66 years; 61.6 percent were men, and 50.5 percent were Hispanic, Native American or African American. Age, gender, COPD, minimum mean arterial pressure, Glasgow Coma scale score, and PaO2/FiO(2) ratio, maximum creatinine and bilirubin, receiving factor Xa inhibitors, days receiving non-invasive respiratory support and days receiving corticosteroids prior to intubation were significantly associated with the outcome variable. The validation cohort comprised 1,179 patients. C-TIME had the highest AUROC of 0.75 (95%CI 0.72-0.79), vs 0.67 (0.64-0.71) and 0.59 (0.55-0.62) for APACHE and SOFA, respectively (Chi(2) P < 0.0001). Conclusions C-TIME is the only mortality prediction score specifically developed and validated for COVID-19 patients who require mechanical ventilation. It has acceptable discriminant accuracy and goodness-of-fit to assist decision-making just prior to intubation. The C-TIME mortality prediction calculator can be freely accessed on-line at .	[Raschke, Robert; Curry, Steven; Heise, C. William] Univ Arizona, Div Clin Data Analyt & Decis Support, Coll Med Phoenix, Phoenix, AZ 85004 USA; [Raschke, Robert; Rangan, Pooja; Agarwal, Sumit C.; Uppalapu, Suresh; Sher, Nehan] Univ Arizona, Coll Med Phoenix, Phoenix, AZ 85004 USA; [Rangan, Pooja; Agarwal, Sumit C.; Uppalapu, Suresh] Banner Univ, Dept Internal Med, Med Ctr Phoenix, Phoenix, AZ USA; [Curry, Steven; Heise, C. William] Banner Univ, Dept Med Toxicol, Med Ctr Phoenix, Phoenix, AZ USA	University of Arizona; University of Arizona	Raschke, R (corresponding author), Univ Arizona, Div Clin Data Analyt & Decis Support, Coll Med Phoenix, Phoenix, AZ 85004 USA.; Raschke, R (corresponding author), Univ Arizona, Coll Med Phoenix, Phoenix, AZ 85004 USA.	Raschkebob@gmail.com		Heise, Craig/0000-0002-4795-1060; Raschke, Robert/0000-0003-3495-7065	Flinn Foundation [2196]	Flinn Foundation	Guarantor statement: Dr Raschke had full access to all of the data in the study and takes personal responsibility for the integrity of the data and the accuracy of the data analysis.	A.Montgomery, 2020, medRxiv, DOI 10.1101/2020.06.22.20137273; Abdulaal A, 2020, J MED INTERNET RES, V22, DOI 10.2196/20259; Altschul DJ, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73962-9; Antommaria AHM, 2020, ANN INTERN MED, V173, P188, DOI 10.7326/M20-1738; Arizona Department of Health Services, COVID 19 DAT DASHB; Berenguer J, 2021, THORAX, V76, P920, DOI 10.1136/thoraxjnl-2020-216001; Berry DA, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0255228; Chen B, 2021, COMPUT STRUCT BIOTEC, V19, P1694, DOI 10.1016/j.csbj.2021.03.012; Chen RC, 2020, CHEST, V158, P97, DOI 10.1016/j.chest.2020.04.010; Chowdhury MEH, 2021, COGN COMPUT, DOI 10.1007/s12559-020-09812-7; El-Solh AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0244629; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; Ghidini M, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13030508; Halasz G, 2021, J MED INTERNET RES, V23, DOI 10.2196/29058; Kadri SS, 2021, ANN INTERN MED, V174, P1240, DOI 10.7326/M21-1213; Keegan MT, 2012, CHEST, V142, P851, DOI 10.1378/chest.11-2164; Knight SR, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3339; Lim ZJ, 2021, AM J RESP CRIT CARE, V203, P54, DOI 10.1164/rccm.202006-2405OC; Liu SJ, 2020, AM J EMERG MED, V38, P2074, DOI 10.1016/j.ajem.2020.07.019; Manocha KK, 2021, J AM HEART ASSOC, V10, DOI 10.1161/JAHA.120.018477; Moreno-Perez O, 2021, JAMA INTERN MED, V181, P1000, DOI 10.1001/jamainternmed.2021.0491; Nattino G, 2017, STATA J, V17, P1003, DOI 10.1177/1536867X1701700414; P. D. Sottile, 2021, medRxiv, DOI 10.1101/2021.01.14.21249793; Papoutsi E, 2021, CRIT CARE, V25, DOI 10.1186/s13054-021-03540-6; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Raschke RA, 2021, JAMA-J AM MED ASSOC, V325, P1469, DOI 10.1001/jama.2021.1545; Ronda VE, 2021, MED CLIN-BARCELONA, V157, P99, DOI [10.1016/j.medcli.2021.01.002, 10.1016/j.medcle.2021.01.011]; Shang YF, 2020, ECLINICALMEDICINE, V24, DOI 10.1016/j.eclinm.2020.100426; Shi YY, 2021, INT J CLIN PRACT, V75, DOI 10.1111/ijcp.13926; Torres-Macho J, 2020, J CLIN MED, V9, DOI 10.3390/jcm9103066; Truog RD, 2020, NEW ENGL J MED, V382, P1973, DOI 10.1056/NEJMp2005689; Usher-Smith JA, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3139; Vandenbrande J, 2021, CRIT CARE RES PRACT, V2021, DOI 10.1155/2021/5443083; Vasilevskis EE, 2009, CHEST, V136, P89, DOI 10.1378/chest.08-2591; Vincent JL, 2010, CRIT CARE, V14, DOI 10.1186/cc8204; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wang K, 2020, CLIN INFECT DIS, V71, P2079, DOI 10.1093/cid/ciaa538; Weng ZH, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02505-7; Wynants L, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1328; Yan L, 2020, NAT MACH INTELL, V2, P283, DOI 10.1038/s42256-020-0180-7; Yang Z, 2021, MEDICINE, V100, DOI 10.1097/MD.0000000000026900; Yu CZ, 2020, AM J PREV MED, V59, P168, DOI 10.1016/j.amepre.2020.05.002; Yuan Y, 2022, ENGINEERING-PRC, V8, P116, DOI [10.1016/j.eng.2020.10.0132095-8099, 10.1016/j.eng.2020.10.013]; Zimmerman JE, 2006, CRIT CARE MED, V34, P1297, DOI 10.1097/01.CCM.0000215112.84523.F0	45	1	1	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7								10.1371/journal.pone.0270193	http://dx.doi.org/10.1371/journal.pone.0270193			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M3CI	35793312	gold, Green Published, Green Submitted			2022-12-26	WOS:000835338100033
J	Abdulaziz, EN; Bell, TA; Rashid, B; Heacock, ML; Begic, T; Skinner, OS; Yaseen, MA; Chao, LH; Mootha, VK; Pierik, AJ; Cracan, V				Abdulaziz, Evana N.; Bell, Tristan A.; Rashid, Bazlur; Heacock, Mina L.; Begic, Tarik; Skinner, Owen S.; Yaseen, Mohammad A.; Chao, Luke H.; Mootha, Vamsi K.; Pierik, Antonio J.; Cracan, Valentin			A natural fusion of flavodiiron, rubredoxin, and rubredoxin oxidoreductase domains is a self-sufficient water-forming oxidase of Trichomonas vaginalis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; NADH-OXIDASE; ELECTRON-TRANSFER; DESULFOVIBRIO-VULGARIS; CRYSTAL-STRUCTURE; MOORELLA-THERMOACETICA; REDUCED NICOTINAMIDE; OXYGEN REDUCTASE; CRYO-EM; PROTEIN	Microaerophilic pathogens such as Giardia lamblia, Entamoeba histolytica, and Trichomonas vaginalis have robust oxygen consumption systems to detoxify oxygen and maintain intracellular redox balance. This oxygen consumption results from H2O-forming NADH oxidase (NOX) activity of two distinct flavin-containing systems: H2O-forming NOXes and multicomponent flavodiiron proteins (FDPs). Neither system is membrane bound, and both recycle NADH into oxidized NAD+ while simultaneously removing O2 from the local environment. However, little is known about the specific contributions of these systems in T. vaginalis. In this study, we use bioinformatics and biochemical analyses to show that T. vaginalis lacks a NOX-like enzyme and instead harbors three paralogous genes (FDPF1-3), each encoding a natural fusion product between the N-terminal FDP, central rubredoxin (Rb), and Cterminal NADH:Rb oxidoreductase domains. Unlike a "standalone" FDP that lacks Rb and oxidoreductase domains, this natural fusion protein with fully populated flavin redox centers directly accepts reducing equivalents of NADH to catalyze the four-electron reduction of oxygen to water within a single polypeptide with an extremely high turnover. Furthermore, using single-particle cryo-EM, we present structural insights into the spatial organization of the FDP core within this multidomain fusion protein. Together, these results contribute exposure to oxic conditions.	[Abdulaziz, Evana N.; Heacock, Mina L.; Cracan, Valentin] Scintillon Inst, Redox Biol & Metab Lab, San Diego, CA 92121 USA; [Bell, Tristan A.; Skinner, Owen S.; Chao, Luke H.; Mootha, Vamsi K.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA USA; [Rashid, Bazlur; Begic, Tarik; Pierik, Antonio J.] Univ Kaiserslautern, Fac Chem, Kaiserslautern, Germany; [Skinner, Owen S.; Mootha, Vamsi K.] Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA USA; [Yaseen, Mohammad A.] Northeastern Univ, Dept Bioengn, Boston, MA USA; [Cracan, Valentin] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Abdulaziz, Evana N.] Amgen Inc, Thousand Oaks, CA 91320 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Kaiserslautern; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Northeastern University; Scripps Research Institute; Amgen	Cracan, V (corresponding author), Scintillon Inst, Redox Biol & Metab Lab, San Diego, CA 92121 USA.; Cracan, V (corresponding author), Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA.	vcracan@scripps.edu		Skinner, Owen/0000-0002-5023-0029; Begic, Tarik/0000-0001-9897-5700; Chao, Luke/0000-0002-4849-4148				Afonine PV, 2018, ACTA CRYSTALLOGR D, V74, P531, DOI 10.1107/S2059798318006551; AHMED SA, 1989, J BIOL CHEM, V264, P19864; Aliverti A, 1999, METH MOL B, V131, P9; [Anonymous], 2015, PYMOL MOL GRAPHICS S; BAERNSTEIN HD, 1963, J PARASITOL, V49, P12, DOI 10.2307/3275663; Bepler T, 2019, NAT METHODS, V16, P1153, DOI 10.1038/s41592-019-0575-8; Brown DM, 1998, INT J PARASITOL, V28, P149, DOI 10.1016/S0020-7519(97)00172-0; Brown DM, 1996, EUR J BIOCHEM, V241, P155, DOI 10.1111/j.1432-1033.1996.0155t.x; Castillo-Villanueva A, 2016, PROTEIN J, V35, P24, DOI 10.1007/s10930-015-9643-9; Di Matteo A, 2008, J BIOL CHEM, V283, P4061, DOI 10.1074/jbc.M705605200; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Folgosa F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28453-3; Folgosa F, 2018, FEMS MICROBIOL LETT, V365, DOI 10.1093/femsle/fnx267; Frazao C, 2000, NAT STRUCT BIOL, V7, P1041; Gao H, 2019, INT J BIOL MACROMOL, V123, P629, DOI 10.1016/j.ijbiomac.2018.11.096; Gomes CM, 2000, BIOCHEMISTRY-US, V39, P16230, DOI 10.1021/bi001844y; Goncalves VL, 2014, J BIOL CHEM, V289, P28260, DOI 10.1074/jbc.M114.579086; Grunden AA, 2005, APPL ENVIRON MICROB, V71, P1522, DOI 10.1128/AEM.71.3.1522-1530.2005; Hagelueken G, 2007, P NATL ACAD SCI USA, V104, P12276, DOI 10.1073/pnas.0702919104; Hampl V, 2009, P NATL ACAD SCI USA, V106, P3859, DOI 10.1073/pnas.0807880106; Hayashi T, 2010, BIOCHEMISTRY-US, V49, P7040, DOI 10.1021/bi100788y; Herzik MA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08991-8; HIGUCHI M, 1992, ORAL MICROBIOL IMMUN, V7, P309, DOI 10.1111/j.1399-302X.1992.tb00594.x; Hillmann F, 2009, FEBS LETT, V583, P241, DOI 10.1016/j.febslet.2008.12.004; Hodges AL, 2018, NURS CLIN N AM, V53, P189, DOI 10.1016/j.cnur.2018.01.013; Jenney FE, 2001, METHOD ENZYMOL, V334, P45; Kawasaki S, 2009, APPL ENVIRON MICROB, V75, P1021, DOI 10.1128/AEM.01425-08; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/NMETH.2727, 10.1038/nmeth.2727]; Lamien-Meda A, 2020, PARASITOL RES, V119, P683, DOI 10.1007/s00436-019-06572-8; Lee HJ, 1998, BIOCHEMISTRY-US, V37, P15513, DOI 10.1021/bi981853v; LEE WY, 1995, ARCH BIOCHEM BIOPHYS, V318, P80, DOI 10.1006/abbi.1995.1207; LEGALL J, 1988, BIOCHEMISTRY-US, V27, P1636, DOI 10.1021/bi00405a037; Leitsch D, 2018, TRENDS PARASITOL, V34, P576, DOI 10.1016/j.pt.2018.04.007; LINSTEAD DJ, 1988, MOL BIOCHEM PARASIT, V27, P125, DOI 10.1016/0166-6851(88)90032-1; Lountos GT, 2006, BIOCHEMISTRY-US, V45, P9648, DOI 10.1021/bi060692p; LOVENBERG W, 1965, P NATL ACAD SCI USA, V54, P193, DOI 10.1073/pnas.54.1.193; Mark H, 2015, AM J NURS, V115, P34, DOI 10.1097/01.NAJ.0000471245.76692.28; MASSEY V, 1966, BIOCHEMISTRY-US, V5, P3181, DOI 10.1021/bi00874a016; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Muller M, 2012, MICROBIOL MOL BIOL R, V76, P444, DOI 10.1128/MMBR.05024-11; Nishikawa K, 2010, PROTEINS, V78, P1066, DOI 10.1002/prot.22650; Ogboo BC, 2022, REDOX BIOL, V52, DOI 10.1016/j.redox.2022.102298; Ojha S, 2007, PLOS COMPUT BIOL, V3, P1268, DOI 10.1371/journal.pcbi.0030121; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PIERIK AJ, 1993, EUR J BIOCHEM, V212, P237, DOI 10.1111/j.1432-1033.1993.tb17655.x; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Romao CV, 2016, J BIOL INORG CHEM, V21, P39, DOI 10.1007/s00775-015-1329-4; ROSS RP, 1992, J MOL BIOL, V227, P658, DOI 10.1016/0022-2836(92)90215-6; SAEKI K, 1989, J BACTERIOL, V171, P4736, DOI 10.1128/jb.171.9.4736-4741.1989; Saraiva LM, 2004, ADV MICROB PHYSIOL, V49, P77, DOI 10.1016/S0065-2911(04)49002-X; Silaghi-Dumitrescu R, 2005, BIOCHEMISTRY-US, V44, P6492, DOI 10.1021/bi0473049; Silaghi-Dumitrescu R, 2003, BIOCHEMISTRY-US, V42, P2806, DOI 10.1021/bi027253k; Silaghi-Dumitrescu R, 2005, BIOCHEMISTRY-US, V44, P3572, DOI 10.1021/bi0477337; Smutna T, 2009, EUKARYOT CELL, V8, P47, DOI 10.1128/EC.00276-08; Stein A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063090; Swartz PD, 1996, BIOPHYS J, V71, P2958, DOI 10.1016/S0006-3495(96)79533-4; TANABE M, 1979, EXP PARASITOL, V48, P135, DOI 10.1016/0014-4894(79)90063-8; Titov DV, 2016, SCIENCE, V352, P231, DOI 10.1126/science.aad4017; Valentino H, 2021, ACS OMEGA, V6, P18537, DOI 10.1021/acsomega.1c03047; Vicente JB, 2005, J BIOL CHEM, V280, P34599, DOI 10.1074/jbc.M506349200; Vicente JB, 2008, METHOD ENZYMOL, V437, P21, DOI 10.1016/S0076-6879(07)37002-X; Vicente JB, 2008, METHOD ENZYMOL, V437, P3, DOI 10.1016/S0076-6879(07)37001-8; Vicente JB, 2012, EUKARYOT CELL, V11, P1112, DOI 10.1128/EC.00149-12; Vicente JB, 2009, ARCH BIOCHEM BIOPHYS, V488, P9, DOI 10.1016/j.abb.2009.06.011; Wallen JR, 2015, BIOCHEMISTRY-US, V54, P6815, DOI 10.1021/acs.biochem.5b00676; Warrenfeltz S, 2018, METHODS MOL BIOL, V1757, P69, DOI 10.1007/978-1-4939-7737-6_5; Yoon KS, 1999, J BIOL CHEM, V274, P29772, DOI 10.1074/jbc.274.42.29772; ZANETTI G, 1968, J BIOL CHEM, V243, P4013; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	73	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2022	298	8							102210	10.1016/j.jbc.2022.102210	http://dx.doi.org/10.1016/j.jbc.2022.102210			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	4F0HN	35780837	Green Submitted, Green Published, gold			2022-12-26	WOS:000848197700006
J	Abdullaev, A; Abdurakhimov, A; Mirakbarova, Z; Ibragimova, S; Tsoy, V; Nuriddinov, S; Dalimova, D; Turdikulova, S; AbdurakhmonovID, I				Abdullaev, Alisher; Abdurakhimov, Abrorjon; Mirakbarova, Zebinisa; Ibragimova, Shakhnoza; Tsoy, Vladimir; Nuriddinov, Sharofiddin; Dalimova, Dilbar; Turdikulova, Shahlo; AbdurakhmonovID, Ibrokhim			Genome sequence diversity of SARS-CoV-2 obtained from clinical samples in Uzbekistan	PLOS ONE			English	Article							PROTEIN STABILITY; CORONAVIRUS; PREDICTION; TOOL	Tracking temporal and spatial genomic changes and evolution of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are among the most urgent research topics worldwide, which help to elucidate the coronavirus disease 2019 (COVID-19) pathogenesis and the effect of deleterious variants. Our current study concentrates genetic diversity of SARS-CoV-2 variants in Uzbekistan and their associations with COVID-19 severity. Thirty-nine whole genome sequences (WGS) of SARS-CoV-2 isolated from PCR-positive patients from Tashkent, Uzbekistan for the period of July-August 2021, were generated and further subjected to further genomic analysis. Genome-wide annotations of clinical isolates from our study have revealed a total of 223 nucleotide-level variations including SNPs and 34 deletions at different positions throughout the entire genome of SARS-CoV-2. These changes included two novel mutations at the Nonstructural protein (Nsp) 13: A85P and Nsp12: Y479N, which were unreported previously. There were two groups of co-occurred substitution patterns: the missense mutations in the Spike (S): D614G, Open Reading Frame (ORF) 1 b: P314L, Nsp3: F924, 5'UTR:C241T; Nsp3:P2046L and Nsp3:P2287S, and the synonymous mutations in the Nsp4:D2907 (C8986T), Nsp6:T3646A and Nsp14: A1918V regions, respectively. The "Nextstrain" clustered the largest number of SARS-CoV- 2 strains into the Delta Glade (n = 32; 82%), followed by two Alpha-originated (n = 4; 10,3%) and 20A (n = 3; 7,7%) clades. Geographically the Delta Glade sample sequences were grouped into several clusters with the SARS-CoV genotypes from Russia, Denmark, USA, Egypt and Bangladesh. Phylogenetically, the Delta isolates in our study belong to the two main subclades 21A (56%) and 21J (44%). We found that females were more affected by 21A, whereas males by 21J variant (chi(2) = 4.57; p <= 0.05, n = 32). The amino acid substitution ORF7a:P45L in the Delta isolates found to be significantly associated with disease severity. In conclusion, this study evidenced that Identified novel substitutions Nsp13: A85P and Nsp12: Y479N, have a destabilizing effect, while missense substitution ORF7a: P45L significantly associated with disease severity.	[Abdullaev, Alisher; Abdurakhimov, Abrorjon; Mirakbarova, Zebinisa; Ibragimova, Shakhnoza; Tsoy, Vladimir; Nuriddinov, Sharofiddin; Dalimova, Dilbar; Turdikulova, Shahlo; AbdurakhmonovID, Ibrokhim] Ctr Adv Technol, Tashkent, Uzbekistan; [AbdurakhmonovID, Ibrokhim] Acad Sci Uzbek, Ctr Genom & Bioinformat, Tashkent, Uzbekistan	Academy of Sciences of Uzbekistan; Center of Genomics & Bioinformatics	Abdullaev, A (corresponding author), Ctr Adv Technol, Tashkent, Uzbekistan.	abdullaev_alisher@yahoo.com	Abdurakhmonov, Ibrokhim/F-5588-2015	Abdurakhmonov, Ibrokhim/0000-0001-9563-0686	Ministry of Innovative Development, Republic of Uzbekistan [A-(Sym)PB-2021-125]	Ministry of Innovative Development, Republic of Uzbekistan	This study has been supported by the research grant from the Ministry of Innovative Development, Republic of Uzbekistan (Research Grant number:A-(Sym)PB-2021-125). There was no additional external or internal funding received for this study.	Ayubov MS, 2022, PLOS ONE, V17, DOI 10.1371/journal.pone.0266417; Caldararu O, 2021, BMC BIOINFORMATICS, V22, DOI 10.1186/s12859-021-04030-w; Cherian S, 2021, MICROORGANISMS, V9, DOI 10.3390/microorganisms9071542; Cleemput S, 2020, BIOINFORMATICS, V36, P3552, DOI 10.1093/bioinformatics/btaa145; COVID-19 Map-Johns Hopkins Coronavirus Resource Center, US; Dao TL, 2021, J CLIN MED, V10, DOI 10.3390/jcm10122635; Das JK, 2021, GENE REP, V25, DOI 10.1016/j.genrep.2021.101044; Hadfield J, 2018, BIOINFORMATICS, V34, P4121, DOI 10.1093/bioinformatics/bty407; Hanel K, 2006, J BIOMED SCI, V13, P281, DOI 10.1007/s11373-005-9043-9; Hamed SM, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-87713-x; Harvey WT, 2021, NAT REV MICROBIOL, V19, P409, DOI 10.1038/s41579-021-00573-0; Kannan SR, 2021, J AUTOIMMUN, V124, DOI 10.1016/j.jaut.2021.102715; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Klink GV, 2022, VIRUS EVOL, V8, DOI 10.1093/ve/veac017; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Lau BT, 2021, GENOME MED, V13, DOI 10.1186/s13073-021-00882-2; Lauring AS, 2021, JAMA-J AM MED ASSOC, V325, P529, DOI 10.1001/jama.2020.27124; Lobiuc A, 2021, BIOLOGY-BASEL, V10, DOI 10.3390/biology10121276; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Makarenkov V, 2021, BMC ECOL EVOL, V21, DOI 10.1186/s12862-020-01732-2; Mercatelli D, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.01800; Mousavizadeh L, 2021, J MICROBIOL IMMUNOL, V54, P159, DOI 10.1016/j.jmii.2020.03.022; Nelson CA, 2005, STRUCTURE, V13, P75, DOI 10.1016/j.str.2004.10.010; Parthiban V, 2006, NUCLEIC ACIDS RES, V34, pW239, DOI 10.1093/nar/gkl190; Rahnavard A, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-02548-w; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanavia T, 2020, COMPUT STRUCT BIOTEC, V18, P1968, DOI 10.1016/j.csbj.2020.07.011; Shu YL, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.13.30494; Singer J., 2020, COV GLUE WEB APPL TR, DOI [10.20944/preprints202006.0225.v1, DOI 10.20944/PREPRINTS202006.0225.V1]; Snijder EJ, 2016, ADV VIRUS RES, V96, P59, DOI 10.1016/bs.aivir.2016.08.008; Spitzer M, 2014, NAT METHODS, V11, P121, DOI 10.1038/nmeth.2811; Su CM, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-92941-2; Tan YJ, 2020, MBIO, V11, DOI 10.1128/mBio.00760-20; Tokuriki N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000002; Vazquez C, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0253089; Wada Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep36197; Wang M, 2020, SMALL, V16, DOI 10.1002/smll.202002169; Wang WJ, 2021, CELL MOL IMMUNOL, V18, P945, DOI 10.1038/s41423-020-00619-y; Wang Y, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-69342-y; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Yi KJ, 2021, EXP MOL MED, V53, P1229, DOI 10.1038/s12276-021-00658-z; Yin CC, 2020, GENOMICS, V112, P3588, DOI 10.1016/j.ygeno.2020.04.016; Yuen CK, 2020, EMERG MICROBES INFEC, V9, P1418, DOI 10.1080/22221751.2020.1780953; Zhang SX, 2021, RISK MANAG HEALTHC P, V14, P3775, DOI 10.2147/RMHP.S326051; Zhou ZL, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102187	45	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2022	17	6							e0270314	10.1371/journal.pone.0270314	http://dx.doi.org/10.1371/journal.pone.0270314			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6S7VC	35759503	gold, Green Published			2022-12-26	WOS:000893189600001
J	Chand, V; Liao, XB; Guzman, G; Benevolenskaya, E; Raychaudhuri, P				Chand, Vaibhav; Liao, Xiubei; Guzman, Grace; Benevolenskaya, Elizaveta; Raychaudhuri, Pradip			Hepatocellular carcinoma evades RB1-induced senescence by activating the FOXM1-FOXO1 axis	ONCOGENE			English	Article							RETINOBLASTOMA TUMOR-SUPPRESSOR; TRANSCRIPTIONAL PROGRAM; FOXM1; PHOSPHORYLATION; PROTEIN; GENES; RB; PROGRESSION; BINDING; PRB	Hepatocellular carcinoma (HCC) is one of the deadliest cancers. The retinoblastoma protein (RB1), a regulator of cell proliferation, is functionally inactivated in HCC by CYCLIN D/E-mediated phosphorylation. However, the mechanism of RB1-inactivation is unclear because only small percentages of HCCs exhibit amplification of CYCLIN D/E or mutations in the CDK-inhibitory genes. We show that FOXM1, which is overexpressed and critical for HCC, plays essential roles in inactivating RB1 and suppressing RB1-induced senescence of the HCC cells. Mechanistically, FOXM1 binds RB1 and DNMT3B to repress the expression of FOXO1, leading to a decrease in the levels of the CDK-inhibitors, creating an environment for phosphorylation and inactivation of RB1. Consistent with that, inhibition of FOXM1 causes increased expression of FOXO1 with consequent activation of RB1, leading to senescence of the HCC cells, in vitro and in vivo. Also, repression-deficient mutants of FOXM1 induce senescence that is blocked by depletion of RB1 or FOXO1. We provide evidence that human HCCs rely upon this FOXM1-FOXO1 axis for phosphorylation and inactivation of RB1. The observations demonstrate the existence of a new autoregulatory loop of RB1-inactivation in HCC involving a FOXM1-FOXO1 axis that is required for phosphorylation of RB1 and for aggressive progression of HCC.	[Chand, Vaibhav; Liao, Xiubei; Benevolenskaya, Elizaveta; Raychaudhuri, Pradip] Univ Illinois, Coll Med, Dept Biochem & Mol Genet MC 669, 900S Ashland Ave, Chicago, IL 60607 USA; [Guzman, Grace] Univ Illinois, Coll Med, Dept Pathol, Chicago, IL 60612 USA; [Raychaudhuri, Pradip] Jesse Brown VA Med Ctr, 820S Damen Ave, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Raychaudhuri, P (corresponding author), Univ Illinois, Coll Med, Dept Biochem & Mol Genet MC 669, 900S Ashland Ave, Chicago, IL 60607 USA.; Raychaudhuri, P (corresponding author), Jesse Brown VA Med Ctr, 820S Damen Ave, Chicago, IL 60612 USA.	pradip@uic.edu		Benevolenskaya, Elizaveta/0000-0003-3573-1754; raychaudhuri, pradip/0000-0003-2968-4701	Department of Veterans Affair (Biomedical Laboratory Research Development Service) [I01 BX000131]; NIH [5 RO1 CA243247, RO1 CA211095]	Department of Veterans Affair (Biomedical Laboratory Research Development Service); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a grant (I01 BX000131) from the Department of Veterans Affair (Biomedical Laboratory Research Development Service), and a grant from the NIH (5 RO1 CA243247) to PR. The contents do not represent the views of the U.S. Department of Veterans Affairs or the United States Government. EB acknowledges support from NIH grant (RO1 CA211095).	Ahn SM, 2014, HEPATOLOGY, V60, P1972, DOI 10.1002/hep.27198; Akinyemiju T, 2017, JAMA ONCOL, V3, P1683, DOI 10.1001/jamaoncol.2017.3055; Baker GL, 2005, CELL CYCLE, V4, P330; Barsotti AM, 2009, ONCOGENE, V28, P4295, DOI 10.1038/onc.2009.282; Benevolenskaya EV, 2005, MOL CELL, V18, P623, DOI 10.1016/j.molcel.2005.05.012; Berman SD, 2008, MOL CANCER RES, V6, P1440, DOI 10.1158/1541-7786.MCR-08-0176; Calo E, 2010, NATURE, V466, P1110, DOI 10.1038/nature09264; Carr JR, 2012, CELL REP, V1, P715, DOI 10.1016/j.celrep.2012.05.005; Chand V, 2019, MOL CANCER RES, V17, P1063, DOI 10.1158/1541-7786.MCR-18-0968; Chen YJ, 2009, J BIOL CHEM, V284, P30695, DOI 10.1074/jbc.M109.007997; Chicas A, 2010, CANCER CELL, V17, P376, DOI 10.1016/j.ccr.2010.01.023; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Diep CH, 2013, CELL CYCLE, V12, P1433, DOI 10.4161/cc.24550; Dimri GP, 1996, BIOL SIGNAL, V5, P154; Dimri GP, 1996, MOL BIOL CELL, V7, P3102; Fu Z, 2008, NAT CELL BIOL, V10, P1076, DOI 10.1038/ncb1767; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Jiao W, 2006, J BIOL CHEM, V281, P38098, DOI 10.1074/jbc.M605271200; Kalinichenko VV, 2004, GENE DEV, V18, P830, DOI 10.1101/gad.1200704; Knudsen ES, 2019, TRENDS CANCER, V5, P308, DOI 10.1016/j.trecan.2019.03.005; Kopanja D, 2015, J HEPATOL, V63, P429, DOI 10.1016/j.jhep.2015.03.023; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Liu JK, 2021, ONCOL LETT, V21, DOI 10.3892/ol.2021.12660; Major ML, 2004, MOL CELL BIOL, V24, P2649, DOI 10.1128/MCB.24.7.2649-2661.2004; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Marceau AH, 2019, ELIFE, V8, DOI 10.7554/eLife.46131; Midorikawa Y, 2020, CANCER RES, V80, P3810, DOI 10.1158/0008-5472.CAN-20-0225; Mukhopadhyay NK, 2017, SCI REP-UK, V7, DOI 10.1038/srep46017; Narasimha AM, 2014, ELIFE, V3, DOI 10.7554/eLife.02872; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; Nowak K, 2007, BBA-GENE STRUCT EXPR, V1769, P244, DOI 10.1016/j.bbaexp.2007.04.001; Park HJ, 2008, ONCOGENE, V27, P1696, DOI 10.1038/sj.onc.1210814; Park HJ, 2011, EMBO MOL MED, V3, P21, DOI 10.1002/emmm.201000107; Park JW, 2019, J HEPATOL, V70, P684, DOI 10.1016/j.jhep.2018.11.029; Pozo OJ, 2007, ANAL BIOANAL CHEM, V389, P1765, DOI 10.1007/s00216-007-1407-8; Reed CA, 2009, ONCOGENE, V28, P4434, DOI 10.1038/onc.2009.303; Rubin SM, 2020, MOL CELL, V80, P183, DOI 10.1016/j.molcel.2020.08.020; Ruscetti M, 2020, CELL, V181, P424, DOI 10.1016/j.cell.2020.03.008; Shang YK, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000010892; Siegel R., 2015, CA-CANCER J CLIN, V65, P29, DOI [10.3322/caac.21254, DOI 10.3322/CAAC.21254, DOI 10.3322/caac.21208]; Song BN, 2018, EXP MOL MED, V50, DOI 10.1038/emm.2017.159; Topacio BR, 2019, MOL CELL, V74, P758, DOI 10.1016/j.molcel.2019.03.020; Viatour P, 2011, J EXP MED, V208, P1963, DOI 10.1084/jem.20110198; Wang IC, 2005, MOL CELL BIOL, V25, P10875, DOI 10.1128/MCB.25.24.10875-10894.2005; Zappia MP, 2019, CELL REP, V26, P702, DOI 10.1016/j.celrep.2018.12.080; Zucman-Rossi J, 2015, GASTROENTEROLOGY, V149, P1226, DOI 10.1053/j.gastro.2015.05.061	46	2	2	1	1	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 22	2022	41	30					3778	3790		10.1038/s41388-022-02394-8	http://dx.doi.org/10.1038/s41388-022-02394-8		JUN 2022	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	3D1SP	35761036				2022-12-26	WOS:000817034400002
J	Kumar, V; Mishra, A; Yadav, AK; Rathaur, S; Singh, A				Kumar, Vipin; Mishra, Ayushi; Yadav, Awadehesh Kumar; Rathaur, Sushma; Singh, Anchal			Lymphatic filarial serum proteome profiling for identification and characterization of diagnostic biomarkers	PLOS ONE			English	Article							CLASSIFICATION; EXPRESSION	Lymphatic Filariasis (LF) affects more than 863 million people in tropical and subtropical areas of the world, causing high morbidity and long illnesses leading to social exclusion and loss of wages. A combination of drugs Ivermectin, Diethylcarbamazine citrate and Albendazole is recommended by WHO to accelerate the Global Programme to Eliminate Lymphatic Filariasis (GPELF). To assess the outcome of GPELF, to re-evaluate and to formulate further strategies there is an imperative need for high quality diagnostic markers. This study was undertaken to identify Lymphatic Filarial biomarkers which can detect LF infections in asymptomatic cases and would also serve as indicators for differentiating among different clinical stages of the disease. A combination of Fourier-transform infrared spectroscopy (FT-IR), MMP zymography, SDS-PAGE, classical 2DE along with MALDI-TOF/MS was done to identify LF biomarkers from serum samples of different stages of LF patients. FT-IR spectroscopy coupled with univariate and multivariate analysis of LF serum samples, revealed significant differences in peak intensity at 3300, 2950, 1645, 1540 and 1448 cm(-1) (p<0.05). The proteomics analysis results showed that various proteins were differentially expressed (p<0.05), including C-reactive protein, alpha-1-antitrypsin, heterogeneous nuclear ribonucleoprotein D like, apolipoproteins A-I and A-IV in different LF clinical stages. Functional pathway analysis suggested the involvement of differentially expressed proteins in vital physiological pathways like acute phase response, hemostasis, complement and coagulation cascades. Furthermore, the differentiation between different stages of LF cases and biomarkers identified in this study clearly demonstrates the potential of the human serum profiling approach for LF detection. To our knowledge, this is the first report of comparative human serum profiling in different categories of LF patients.	[Kumar, Vipin; Mishra, Ayushi; Rathaur, Sushma; Singh, Anchal] Banaras Hindu Univ, Inst Sci, Dept Biochem, Varanasi, Uttar Pradesh, India; [Yadav, Awadehesh Kumar] Minist Hlth & Family Welf, Natl Ctr Dis Control, Varanasi, Uttar Pradesh, India	Banaras Hindu University (BHU); National Centre for Disease Control (NCDC)	Singh, A (corresponding author), Banaras Hindu Univ, Inst Sci, Dept Biochem, Varanasi, Uttar Pradesh, India.	anchalsinghbhu@yahoo.com		Singh, Anchal/0000-0003-3254-7257				Anuradha R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002749; Anuradha R, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001681; Baghel MS, 2017, HIPPOCAMPUS, V27, P845, DOI 10.1002/hipo.22735; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; de Souza DK, 2017, PAN AFR MED J, V27, DOI 10.11604/pamj.2017.27.65.11004; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Di Carlo A, 2012, ONCOL REP, V28, P1051, DOI 10.3892/or.2012.1864; dos Santos AR, 2021, PLOS NEGLECT TROP D, V15, DOI 10.1371/journal.pntd.0009714; Frankowski H, 2012, METHODS MOL BIOL, V814, P221, DOI 10.1007/978-1-61779-452-0_15; Hsieh JF, 2007, BIOMICROFLUIDICS, V1, DOI 10.1063/1.2399892; Jain S, 2011, J PHARM BIOALLIED SC, V3, P118, DOI 10.4103/0975-7406.76489; Jaiswal P, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00251; Kumar M, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0637-3; Kumar V, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-01384-4; LAL RB, 1991, J CLIN IMMUNOL, V11, P46, DOI 10.1007/BF00918794; Manfredi M, 2019, EXPERT REV PROTEOMIC, V16, P733, DOI 10.1080/14789450.2019.1654862; Menikou S, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01156; Mi HY, 2021, NUCLEIC ACIDS RES, V49, pD394, DOI 10.1093/nar/gkaa1106; Mwanga EP, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2982-9; Odunuga OO., 2013, BIOCH COMP, V1, P3, DOI [http%3A//dx.doi.org/10.7243/2052-9341-1-3, DOI 10.7243/2052-9341-1-3]; Pang ZQ, 2021, NUCLEIC ACIDS RES, V49, pW388, DOI 10.1093/nar/gkab382; Reczynska D, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10090502; Roy S., 2019, CLIN SPECTROSC, V1, DOI [10.1016/j.clispe.2020.100001, DOI 10.1016/J.CLISPE.2020.100001]; Santana MFM, 2020, LIPIDS HEALTH DIS, V19, DOI 10.1186/s12944-020-01381-w; Santos MCD, 2018, ANAL METHODS-UK, V10, P1280, DOI 10.1039/c7ay02784b; Shah C, 2006, BLOOD, V108, P1751, DOI 10.1182/blood-2005-11-011932; Singh AK, 2015, INFECT IMMUN, V83, P1853, DOI 10.1128/IAI.02833-14; Singh A, 2010, T ROY SOC TROP MED H, V104, P524, DOI 10.1016/j.trstmh.2010.02.007; Sproston NR, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00754; Srivastava R, 2012, J PROTEOMICS, V76, P56, DOI 10.1016/j.jprot.2012.04.007; Su KY, 2020, CANCERS, V12, DOI 10.3390/cancers12010115; Taylor MJ, 2010, LANCET, V376, P1175, DOI 10.1016/S0140-6736(10)60586-7; Tsypin M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226012; Wanji S, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004184; Weil GJ, 2011, ACTA TROP, V120, pS19, DOI 10.1016/j.actatropica.2010.04.010; Won KY, 2021, PLOS NEGLECT TROP D, V15, DOI 10.1371/journal.pntd.0009968; World Health Organisation, 2017, WHOHTMNTDPCT201707; World Health Organization, 2020, Weekly Epidemiological Record, V95, P509; World Health Organization (WHO), 2020, END NEGL ATT SUST DE; Yang X, 2021, SPECTROCHIM ACTA A, V263, DOI 10.1016/j.saa.2021.120181	40	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7								10.1371/journal.pone.0270635	http://dx.doi.org/10.1371/journal.pone.0270635			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M3CI	35793325	Green Published, gold			2022-12-26	WOS:000835338100041
J	Ruiz-Mar, MG; Heckel, G; Solana-Arellano, E; Schramm, Y; Garcia-Aguilar, MC; Arteaga, MC				Ruiz-Mar, Maria Guadalupe; Heckel, Gisela; Solana-Arellano, Elena; Schramm, Yolanda; Garcia-Aguilar, Maria C.; Arteaga, Maria Clara			Human activities disturb haul out and nursing behavior of Pacific harbor seals at Punta Banda Estuary, Mexico	PLOS ONE			English	Article							PHOCA-VITULINA-RICHARDII; LACTATION PERFORMANCE; SEASONAL-CHANGES; MILK-COMPOSITION; GREY SEALS; STRESS; GROWTH; SIZE; CONSEQUENCES; MANAGEMENT	Humans frequently interact with Pacific harbor seals (Phoca vitulina richardii) at Punta Banda Estuary, Baja California, Mexico, due to the high incidence of recreational activities people undertake there. The immediate effect of these interactions is that seals flush to the water, reducing their time on land and, probably, increasing their energy expenditure. On-land observations were used to study the impact of different sources of disturbance on seal behavior and evaluate their effect on the amount of time dedicated to nursing over three pupping seasons, (2015-2017), with 0.58-0.81 disturbance events/hour recorded over the entire sampling period. Terrestrial vehicles were the source with the highest disturbance rate (number of disturbance events/h), followed closely by pedestrians. However, the proportion of seals affected was highest when pedestrians were the disturbance source. Recovery events (seals hauling out after flushing) occurred after 34% of disturbance events, after less than half of which the same number of hauled-out seals as there were prior to the disturbance were observed. Recovery time varied among the years studied, of which 2017 saw the longest recovery time. In addition, pedestrians were the disturbance source with the longest recovery time. Given that resting on land is essential for pup survival, which depends on both the establishment of the mother-pup bond from birth and its maintenance throughout nursing, flushing behavior may have significant implications for the entire colony during the nursing season. We recorded a decrease in nursing duration, which did not return to the same level even after recovery and the resumption of nursing. Terrestrial vehicles were found to be the disturbance source that shortened nursing events most significantly.	[Ruiz-Mar, Maria Guadalupe; Heckel, Gisela; Arteaga, Maria Clara] Ctr Invest Cient & Educ Super Ensenada, Conservat Biol Dept, Ensenada, Baja California, Mexico; [Solana-Arellano, Elena] Ctr Invest Cient & Educ Super Ensenada, Marine Ecol Dept, Ensenada, Baja California, Mexico; [Schramm, Yolanda] Univ Autonoma Baja Calif, Fac Marine Sci, Ensenada, Baja California, Mexico; [Garcia-Aguilar, Maria C.] Ctr Invest Cient & Educ Super Ensenada, Biol Oceanog Dept, Ensenada, Baja California, Mexico	CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; Universidad Autonoma de Baja California; CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada	Heckel, G (corresponding author), Ctr Invest Cient & Educ Super Ensenada, Conservat Biol Dept, Ensenada, Baja California, Mexico.	gheckel@cicese.mx	Heckel, Gisela/K-9170-2016	Heckel, Gisela/0000-0002-6003-7898	National Council for Science and Technology (CONACYT) [340034]; Secretaria de Medio Ambiente y Recursos Naturales (SEMARNAT or Environment and Natural Resources Ministry)	National Council for Science and Technology (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Secretaria de Medio Ambiente y Recursos Naturales (SEMARNAT or Environment and Natural Resources Ministry)	The present study was carried out under permit No. SGPA/DGVS/1140/16, awarded by the Secretaria de Medio Ambiente y Recursos Naturales (SEMARNAT or Environment and Natural Resources Ministry). E. Lopez, G. Sandoval, N. Robles, F. Smith, R. Preciado, E. Padilla, and D. Lubinsky assisted in the field work. MGR-M received scholarship No. 340034 from the National Council for Science and Technology (CONACYT). The manuscript was copyedited by Benjamin Stewart.	Acevedo-Whitehouse K, 2009, PHILOS T R SOC B, V364, P3429, DOI 10.1098/rstb.2009.0128; ALLEN SG, 1984, FISH B-NOAA, V82, P493; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Arias-del-Razo A, 2016, MAR MAMMAL SCI, V32, P1416, DOI 10.1111/mms.12339; Becker BH, 2011, AQUAT CONSERV, V21, P247, DOI 10.1002/aqc.1181; Bolstad WM., 2007, INTRO BAYESIAN STAT; BONESS DJ, 1994, BEHAV ECOL SOCIOBIOL, V34, P95; Boness DJ, 1996, BIOSCIENCE, V46, P645, DOI 10.2307/1312894; BONESS DJ, 1992, CAN J ZOOL, V70, P1640, DOI 10.1139/z92-228; Boveng PL, 2003, MAR MAMMAL SCI, V19, P111, DOI 10.1111/j.1748-7692.2003.tb01096.x; Bowen W.D., 1991, P66; Bowen WD, 2001, FUNCT ECOL, V15, P325, DOI 10.1046/j.1365-2435.2001.00530.x; BRYDEN M M, 1968, Australian Journal of Zoology, V16, P739, DOI 10.1071/ZO9680739; CONANP [Comision Nacional de Areas Naturales Protegidas], 2001, PLAN MAN SIT RAMS ES; Congreso de la Union, 1931, DIARIO OFICIAL FEDER; Cottrell PE, 2002, MAR MAMMAL SCI, V18, P721, DOI 10.1111/j.1748-7692.2002.tb01069.x; Crocker DE, 2001, ECOLOGY, V82, P3541, DOI 10.2307/2680171; Curtin S, 2009, CURR ISSUES TOUR, V12, P59, DOI 10.1080/13683500802295663; Dube Y, 2003, CAN J ZOOL, V81, P188, DOI 10.1139/Z02-231; Fedak MA, 1996, PHYSIOL ZOOL, V69, P887, DOI 10.1086/physzool.69.4.30164234; Fernandez Martin E., 2016, CIENC, V43, P195; Fox KS, 2008, THESIS S JOSE STATE; Frid A, 2002, CONSERV ECOL, V6; Friedman EM, 2002, TOXICOL SCI, V67, P4, DOI 10.1093/toxsci/67.1.4; Gabrielsen Geir Wing, 1995, P95; Garrison T, 2005, OCEANOGRAPHY INVITAT; Grigg EK, 2012, J MAMMAL, V93, P282, DOI 10.1644/11-MAMM-A-128.1; Harding KC, 2005, FUNCT ECOL, V19, P129, DOI 10.1111/j.0269-8463.2005.00945.x; HARKONEN T, 1987, J ZOOL, V213, P535; Henry Edwige, 2001, Aquatic Mammals, V27, P140; Hoover AA, 1983, THESIS U ALASKA FAIR; Hoover-Miller A, 2013, J WILDLIFE MANAGE, V77, P689, DOI 10.1002/jwmg.510; Jansen JK, 2010, J WILDLIFE MANAGE, V74, P1186, DOI 10.2193/2008-192; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; Jemison LA, 2001, MAR MAMMAL SCI, V17, P585, DOI 10.1111/j.1748-7692.2001.tb01006.x; Johnson A, 2007, CAN J ZOOL, V85, P290, DOI 10.1139/Z06-213; Karpovich SA, 2015, J EXP MAR BIOL ECOL, V473, P110, DOI 10.1016/j.jembe.2015.07.016; Kastelein R. A., 1994, Aquatic Mammals, V20, P11; Knight J, 2009, SOC ANIM, V17, P167, DOI 10.1163/156853009X418091; KOVACS KM, 1990, APPL ANIM BEHAV SCI, V26, P15, DOI 10.1016/0168-1591(90)90083-P; Kruskal J, 1978, MULTIDIMENSIONAL SCA; Lang SLC, 2005, CAN J ZOOL, V83, P1525, DOI [10.1139/z05-149, 10.1139/Z05-149]; LAWSON JW, 1987, J MAMMAL, V68, P445, DOI 10.2307/1381496; LAWSON JW, 1985, J MAMMAL, V66, P395, DOI 10.2307/1381259; Le Boeuf BJ, 2013, AQUAT MAMM, V39, P132, DOI 10.1578/AM.39.2.2013.132; LEBOEUF BJ, 1972, BEHAVIOUR, V42, P121; Leonard BE, 2006, NEUROIMMUNOMODULAT, V13, P268, DOI 10.1159/000104854; Lewis TM, 2000, FINAL REPORT GLACIER; London JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038180; Loya Salinas D.H., 1992, Ciencias Marinas, V18, P57; Lubinsky-Jinich D, 2017, AQUAT MAMM, V43, P73, DOI 10.1578/AM.43.1.2017.73; Mellish JAE, 1999, PHYSIOL BIOCHEM ZOOL, V72, P677, DOI 10.1086/316708; NEWBY TC, 1973, J MAMMAL, V54, P540, DOI 10.2307/1379151; Oftedal O.T., 1987, Current Mammalogy, V1, P175; Osinga N, 2012, MAMM BIOL, V77, P281, DOI 10.1016/j.mambio.2012.02.005; Padilla AM, 1990, THESIS U NACL AUTONO; Paterson W, 2012, J THERM BIOL, V37, P454, DOI 10.1016/j.jtherbio.2012.03.004; Petel TV, 2008, APPL ANIM BEHAV SCI, V112, P205, DOI 10.1016/j.applanim.2007.07.005; Reeves RR, 2002, GUIDE MARINE MAMMALS; REIJNDERS PJH, 1981, BIOL CONSERV, V19, P213, DOI 10.1016/0006-3207(81)90036-7; RIEDMAN M, 1979, PHYSIOL ZOOL, V52, P240, DOI 10.1086/physzool.52.2.30152567; RIEDMAN M, 1990, PINNIPEDS SEALS SEA; Romero ML, 2007, INT J COMP PSYCHOL, V20, P89; Rosen DAS, 1998, CAN J ZOOL, V76, P1520, DOI 10.1139/cjz-76-8-1520; Rosen DAS, 1990, THESIS MEMORIAL U NE; Scheffer Victor B., 1944, AMER MIDLAND NAT, V32, P373, DOI 10.2307/2421307; Selvaggi E, 2001, EUROPEAN CETACEAN SO; SEMARNAT, 2010, NOM059SEMARNAT2010; STEWART REA, 1984, HOLARCTIC ECOL, V7, P182; Su Y.-S., 2012, R2JAGS PACKAGE RUNNI; Suryan RM, 1999, FISH B-NOAA, V97, P332; Suryan RM, 1995, THESIS S JOSE STATE; Tablado Z, 2017, BIOL REV, V92, P216, DOI 10.1111/brv.12224; TERHUNE JM, 1985, J MAMMAL, V66, P392, DOI 10.2307/1381258; Terhune JM, 1996, ANIM BEHAV, V51, P757, DOI 10.1006/anbe.1996.0080; Thompson PM, 1998, CAN J ZOOL, V76, P1044, DOI 10.1139/cjz-76-6-1044; THOMPSON PM, 1989, J ZOOL, V217, P281, DOI 10.1111/j.1469-7998.1989.tb02488.x; Trumble SJ, 1995, THESIS CALIFORNIA ST; Wetzels R, 2012, PSYCHON B REV, V19, P1057, DOI 10.3758/s13423-012-0295-x; Wingfield JC, 2013, FUNCT ECOL, V27, P37, DOI 10.1111/1365-2435.12039	80	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7								10.1371/journal.pone.0270129	http://dx.doi.org/10.1371/journal.pone.0270129			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M3CI	35793316	Green Published, gold			2022-12-26	WOS:000835338100004
J	Long, KR; Li, XK; Su, D; Zeng, S; Li, HK; Zhang, Y; Zhang, BW; Yang, WY; Li, PH; Li, XM; Wang, X; Tang, QZ; Lu, L; Jin, L; Ma, JD; Li, MZ				Long, Keren; Li, Xiaokai; Su, Duo; Zeng, Sha; Li, Hengkuan; Zhang, Yu; Zhang, Biwei; Yang, Wenying; Li, Penghao; Li, Xuemin; Wang, Xun; Tang, Qianzi; Lu, Lu; Jin, Long; Ma, Jideng; Li, Mingzhou			Exploring high-resolution chromatin interaction changes and functional enhancers of myogenic marker genes during myogenic differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; TRANSCRIPTIONAL ENHANCERS; MYOD; EXPRESSION; PROMOTER; ACTIVATION; MECHANISMS; LANDSCAPE; ELEMENTS; DATABASE	Skeletal muscle differentiation (myogenesis) is a complex and highly coordinated biological process regulated by a series of myogenic marker genes. Chromatin interactions between gene's promoters and their enhancers have an important role in transcriptional control. However, the high-resolution chromatin interactions of myogenic genes and their functional enhancers during myogenesis remain largely unclear. Here, we used circularized chromosome conformation capture coupled with next generation sequencing (4C-seq) to investigate eight myogenic marker genes in C2C12 myoblasts (C2C12-MBs) and C2C12 myotubes (C2C12-MTs). We revealed dynamic chromatin interactions of these marker genes during differentiation and identified 163 and 314 significant interaction sites (SISs) in C2C12-MBs and C2C12-MTs, respectively. The interacting genes of SISs in C2C12-MTs were mainly involved in muscle development, and histone modifications of the SISs changed during differentiation. Through functional genomic screening, we also identified 25 and 41 putative active enhancers in C2C12-MBs and C2C12-MTs, respectively. Using luciferase reporter assays for putative enhancers of Myog and Myh3, we identified eight activating enhancers. Furthermore, dCas9-KRAB epigenome editing and RNA-Seq revealed a role for Myog enhancers in the regulation of Myog expression and myogenic differentiation in the native genomic context. Taken together, this study lays the groundwork for understanding 3D chromatin interaction changes of myogenic genes during myogenesis and provides insights that contribute to our understanding of the role of enhancers in regulating myogenesis.	[Long, Keren; Li, Xiaokai; Su, Duo; Zeng, Sha; Li, Hengkuan; Zhang, Yu; Zhang, Biwei; Yang, Wenying; Li, Xuemin; Wang, Xun; Tang, Qianzi; Lu, Lu; Jin, Long; Ma, Jideng; Li, Mingzhou] Sichuan Agr Univ, Inst Anim Genet & Breeding, Coll Anim Sci & Technol, Chengdu, Peoples R China; [Li, Penghao] Chengdu Xinan Gynecol Hosp Co Ltd, Jinxin Res Inst Reprod Med & Genet, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University	Li, MZ (corresponding author), Sichuan Agr Univ, Inst Anim Genet & Breeding, Coll Anim Sci & Technol, Chengdu, Peoples R China.	mingzhou.li@sicau.edu.cn		zhang, yu/0000-0001-6761-518X	National Key R & D Program of China [2020YFA0509500, 2021YFA0805903, 2021YFD1300800]; National Natural Science Foundation of China [U19A2036, 32102512]; Sichuan Science and Technology Program [2021ZDZX0008, 2021YFYZ0009, 2022JDJQ0054]	National Key R & D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sichuan Science and Technology Program	Acknowledgments-This work was supported by the National Key R & D Program of China (2020YFA0509500, 2021YFA0805903 and 2021YFD1300800) , the National Natural Science Foundation of China (U19A2036 and 32102512) , the Sichuan Science and Technology Program (2021ZDZX0008, 2021YFYZ0009 and 2022JDJQ0054) .	Adhikari A, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245618; Amano T, 2009, DEV CELL, V16, P47, DOI 10.1016/j.devcel.2008.11.011; Anwar S, 2015, DEV GROWTH DIFFER, V57, P570, DOI 10.1111/dgd.12239; Asp P, 2011, P NATL ACAD SCI USA, V108, pE149, DOI 10.1073/pnas.1102223108; Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Bergstrom DA, 2002, MOL CELL, V9, P587, DOI 10.1016/S1097-2765(02)00481-1; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Blais A, 2005, GENE DEV, V19, P553, DOI 10.1101/gad.1281105; Bonello GB, 2011, J IMMUNOL, V186, P7025, DOI 10.4049/jimmunol.0900643; Brandt MM, 2018, J AM SOC NEPHROL, V29, P462, DOI 10.1681/ASN.2016080875; Buckingham M, 2006, CURR OPIN GENET DEV, V16, P525, DOI 10.1016/j.gde.2006.08.008; Buecker C, 2012, TRENDS GENET, V28, P276, DOI 10.1016/j.tig.2012.02.008; Burattini S, 2004, EUR J HISTOCHEM, V48, P223; Cai MY, 2016, SCI REP-UK, V6, DOI 10.1038/srep22462; Cai MY, 2015, SCI REP-UK, V5, DOI 10.1038/srep14558; Cao Y, 2006, EMBO J, V25, P502, DOI 10.1038/sj.emboj.7600958; Chen L, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006484; Chen TP, 2014, NAT REV GENET, V15, P93, DOI 10.1038/nrg3607; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dixon JR, 2015, NATURE, V518, P331, DOI 10.1038/nature14222; Doynova MD, 2017, SKELET MUSCLE, V7, DOI 10.1186/s13395-017-0122-1; Du C, 2012, MOL CELLS, V34, P133, DOI 10.1007/s10059-012-2286-1; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; EDMONDSON DG, 1992, MOL CELL BIOL, V12, P3665, DOI 10.1128/MCB.12.9.3665; de Lima JE, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms222312727; Fornes O, 2020, NUCLEIC ACIDS RES, V48, pD87, DOI 10.1093/nar/gkz1001; Fraser J, 2015, MICROBIOL MOL BIOL R, V79, P347, DOI 10.1128/MMBR.00006-15; Ganassi M, 2020, ELIFE, V9, DOI 10.7554/eLife.60445; Ganassi M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06583-6; Gao F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-345; Geeven G, 2018, NUCLEIC ACIDS RES, V46, DOI 10.1093/nar/gky443; Grubert F, 2020, NATURE, V583, P737, DOI 10.1038/s41586-020-2151-x; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; He MN, 2018, INT J BIOL SCI, V14, P1571, DOI 10.7150/ijbs.25328; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hernandez-Hernandez O, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.578712; Hodgkins A, 2015, BIOINFORMATICS, V31, P3078, DOI 10.1093/bioinformatics/btv308; Hu H, 2019, NUCLEIC ACIDS RES, V47, pD33, DOI 10.1093/nar/gky822; Ishibashi J, 2005, J CELL BIOL, V171, P471, DOI 10.1083/jcb.200502101; Jin Wei, 2016, Biochem Biophys Rep, V6, P209, DOI 10.1016/j.bbrep.2016.04.009; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Krijger PHL, 2020, METHODS, V170, P17, DOI 10.1016/j.ymeth.2019.07.014; Lee H, 2019, TRENDS GENET, V35, P892, DOI 10.1016/j.tig.2019.09.006; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Li Y, 2020, NATURE, V578, P472, DOI 10.1038/s41586-019-1910-z; Liu HL, 2015, BIOINFORMATICS, V31, P3676, DOI 10.1093/bioinformatics/btv423; Liu N, 2014, P NATL ACAD SCI USA, V111, P4109, DOI 10.1073/pnas.1401732111; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loo LH, 2009, J CELL BIOL, V187, P375, DOI 10.1083/jcb.200904140; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maqbool MA, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.108048; Meissner JD, 2007, J CELL PHYSIOL, V211, P138, DOI 10.1002/jcp.20916; Mello MLS, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.645518; Millay DP, 2014, GENE DEV, V28, P1641, DOI 10.1101/gad.247205.114; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; Nardone J, 2004, NAT IMMUNOL, V5, P768, DOI 10.1038/ni0804-768; Odaka YS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33235-y; Ooi WF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12983; Palazzo AF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004351; Pan J, 2020, CANCER RES, V80, P2722, DOI 10.1158/0008-5472.CAN-20-0390; Peng YL, 2018, ANIM MODEL EXP MED, V1, P169, DOI 10.1002/ame2.12032; Pott S, 2015, NAT GENET, V47, P8, DOI 10.1038/ng.3167; Ridgeway AG, 2000, J BIOL CHEM, V275, P41, DOI 10.1074/jbc.275.1.41; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x; Schiaffino S, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0046-6; Schoenfelder S, 2015, GENOME RES, V25, P582, DOI 10.1101/gr.185272.114; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Shrager JB, 2000, J MUSCLE RES CELL M, V21, P345, DOI 10.1023/A:1005635030494; Shrestha S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203843; Shyamsunder P, 2019, BLOOD, V133, P2507, DOI 10.1182/blood.2018886077; Siersbaek R, 2017, MOL CELL, V66, P420, DOI 10.1016/j.molcel.2017.04.010; Sincennes MC, 2016, STEM CELL TRANSL MED, V5, P282, DOI 10.5966/sctm.2015-0266; Snetkova V, 2021, NAT GENET, V53, P521, DOI 10.1038/s41588-021-00812-3; Splinter E, 2012, METHODS, V58, P221, DOI 10.1016/j.ymeth.2012.04.009; Stephens M, 2017, BIOSTATISTICS, V18, P275, DOI 10.1093/biostatistics/kxw041; THAYER MJ, 1989, CELL, V58, P241, DOI 10.1016/0092-8674(89)90838-6; Thongjuea S, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt373; Tsai PF, 2018, MOL CELL, V71, P129, DOI 10.1016/j.molcel.2018.06.008; van de Werken HJG, 2012, NAT METHODS, V9, P969, DOI [10.1038/NMETH.2173, 10.1038/nmeth.2173]; van de Werken HJG, 2012, METHOD ENZYMOL, V513, P89, DOI 10.1016/B978-0-12-391938-0.00004-5; Velica P, 2011, MUSCLE NERVE, V44, P366, DOI 10.1002/mus.22056; Vihervaara A, 2018, NAT REV GENET, V19, P385, DOI 10.1038/s41576-018-0001-6; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Walter C, 2019, BIOINFORMATICS, V35, P4938, DOI 10.1093/bioinformatics/btz426; Wittkopp PJ, 2012, NAT REV GENET, V13, P59, DOI 10.1038/nrg3095; Wood WM, 2013, DEV BIOL, V384, P114, DOI 10.1016/j.ydbio.2013.09.012; Yoshida N, 1998, J CELL SCI, V111, P769; Yuan RQ, 2021, DNA RES, V28, DOI 10.1093/dnares/dsab003; Zhang HF, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc4062; Zhang JB, 2021, FUNCT INTEGR GENOMIC, V21, P59, DOI 10.1007/s10142-020-00761-w; Zhang N, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19999-w; Zhao T, 2020, STEM CELL REP, V14, P493, DOI 10.1016/j.stemcr.2020.02.002; [周丽娜 Zhou Lina], 2013, [上海交通大学学报. 医学版, Journal of Shanghai Jiaotong University .Medical Science], V33, P1423; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6	95	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2022	298	8							102149	10.1016/j.jbc.2022.102149	http://dx.doi.org/10.1016/j.jbc.2022.102149			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	4X0OB	35787372	Green Published, gold			2022-12-26	WOS:000860550600006
J	Denis, J; Rabhi, K; Le Loc'h, F; Lasram, FB; Boutin, K; Kazour, M; Diop, M; Gruselle, MC; Amara, R				Denis, Jeremy; Rabhi, Khalef; Le Loc'h, Francois; Lasram, Frida Ben Rais; Boutin, Kevin; Kazour, Maria; Diop, Mamadou; Gruselle, Marie-Christine; Amara, Rachid			Role of estuarine habitats for the feeding ecology of the European eel (Anguilla anguilla L.)	PLOS ONE			English	Article							STABLE-ISOTOPES; PHENOTYPIC PLASTICITY; STOMACH CONTENTS; FOOD-WEB; MIGRATORY BEHAVIOR; TROPHIC POSITION; FRESH-WATER; FISH; GROWTH; COMMUNITY	This study aims to characterize and compare the feeding ecology of the European eels (Anguilla anguilla L.) during the continental phase (i.e. yellow and silver) along a salinity gradient (i.e. lower, middle and upper) in six northern France estuaries (i.e. brackish water). The diet and stable isotopic (i.e. delta N-15 and delta C-13 values) compositions of eels collected with a fyke net in six estuaries (Slack, Wimereux, Liane, Canche, Authie and Somme estuaries) located along the French coast of the eastern English Channel per season over a year were described by combining gut content and stable isotope analyses. Eel guts were dominated by typical BW prey, Malacostraca and Actinopterygii (54% and 40%, respectively), with the gammare Gammarus zaddachi and the green crab Carcinus maenas (38% and 14%, respectively), and smaller yellow eels of A. anguilla and juvenile European flounder, Platichthys flesus (19% and 14%, respectively) being the most frequently found in their guts. The delta C-13 values of a majority of eels confirmed the sea- and brackish water-specific carbon resources. Dietary and isotopic niche revealed no clear change between total length, silvering stages and seasons, but a significant difference between salinity gradients and estuaries. Eels delta C-13 values showed significant enrichment from upper to lower along the estuaries while the delta N-15 values showed an inverse effect, with the lowest values in the lower part and highest in the upper part. Higher variability in delta C-13 values in larger estuaries suggested that eels feed on a wide range of food sources than in smaller estuaries. While eels in the smaller estuaries fed mainly on Actinopterygii prey, eels in the larger ones had a lower trophic level (i.e. delta N-15 values) and fed mainly on Malacostraca prey. This spatial difference in dietary and isotopic niche is discussed in relation to biological structure of eel and environmental variables.	[Denis, Jeremy; Rabhi, Khalef; Lasram, Frida Ben Rais; Boutin, Kevin; Kazour, Maria; Diop, Mamadou; Amara, Rachid] Univ Littoral Cote dOpale, Univ Lille, CNRS, IRD,UMR 8187, Wimereux, France; [Le Loc'h, Francois] Univ Brest, IRD, CNRS, Ifremer,LEMAR, Plouzane, France; [Gruselle, Marie-Christine] OFB, Parc Nat Marin Estuaires Picards & Mer Opale, St Etienne Au Mont, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Institut de Recherche pour le Developpement (IRD); Universite de Lille - ISITE; Universite de Lille; Universite du Littoral-Cote-d'Opale; Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale; Office Francais de la Biodiversite OFB	Denis, J (corresponding author), Univ Littoral Cote dOpale, Univ Lille, CNRS, IRD,UMR 8187, Wimereux, France.	jeremy.denis@univ-littoral.fr	Le Loc'h, François/A-5038-2008	Le Loc'h, François/0000-0002-3372-6997; Boutin, Kevin/0000-0001-6007-2039; AMARA, Rachid/0000-0002-7183-1333; Denis, Jeremy/0000-0003-4448-2040	Parc Naturel Marins des Estuaires Picards et de la Mer d'Opale [2018-28]; Region Hauts de France [PFEA621220CR0310022]; European Maritime Fisheries Fund [PFEA621220CR0310022]	Parc Naturel Marins des Estuaires Picards et de la Mer d'Opale; Region Hauts de France(Region Hauts-de-France); European Maritime Fisheries Fund	This research was funded by "Parc Naturel Marins des Estuaires Picards et de la Mer d'Opale" (DECISION N degrees 2018-28 09/03/2018) and "European Maritime Fisheries Fund" (PFEA621220CR0310022) and "Re ' gion Hauts de France" (PFEA621220CR0310022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allardi J, 2001, ATLAS POISSONS EAU D; Als TD, 2011, MOL ECOL, V20, P1333, DOI 10.1111/j.1365-294X.2011.05011.x; Amara R, 2003, ENVIRON BIOL FISH, V67, P191, DOI 10.1023/A:1025646622066; Anderson MJ, 2001, CAN J FISH AQUAT SCI, V58, P626, DOI 10.1139/cjfas-58-3-626; Arai T, 2006, ESTUAR COAST SHELF S, V67, P569, DOI 10.1016/j.ecss.2006.01.001; Arai T, 2012, J FISH BIOL, V81, P442, DOI 10.1111/j.1095-8649.2012.03353.x; Arai T., 2016, BIOL ECOLOGY ANGUILL; Arai T, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e05176; Arai T, 2013, AQUAT ECOL, V47, P57, DOI 10.1007/s10452-012-9424-x; Baudoin J.M., 2014, ASSESSING PASSAGE OB; Belpaire CGJ, 2009, ECOL FRESHW FISH, V18, P197, DOI 10.1111/j.1600-0633.2008.00337.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERG J, 1979, MAR BIOL, V50, P263, DOI 10.1007/BF00394208; Birmingham M., 2005, BENTHIC MACROINVERTE; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Bouaziz R, 2021, REG STUD MAR SCI, V44, DOI 10.1016/j.rsma.2021.101694; Bouchereau JL, 2009, ACTA ADRIAT, V50, P159; BOWMAN RE, 1986, ENVIRON BIOL FISH, V16, P171, DOI 10.1007/BF00005169; Cabana G, 1996, P NATL ACAD SCI USA, V93, P10844, DOI 10.1073/pnas.93.20.10844; Cairns DK, 2009, J FISH BIOL, V74, P2094, DOI 10.1111/j.1095-8649.2009.02290.x; Capoccioni F, 2021, MAR FRESHWATER RES, V72, P1208, DOI 10.1071/MF20144; Chouvelon T, 2011, MAR ECOL PROG SER, V433, P107, DOI 10.3354/meps09159; Chow S, 2010, MAR ECOL PROG SER, V402, P233, DOI 10.3354/meps08448; Clarke K. R., 2001, CHANGES MARINE COMMU; Correia MJ, 2018, ICES J MAR SCI, V75, P1975, DOI 10.1093/icesjms/fsy073; Cortes E, 1997, CAN J FISH AQUAT SCI, V54, P726, DOI 10.1139/cjfas-54-3-726; COSTA JL, 1992, J FISH BIOL, V41, P841, DOI 10.1111/j.1095-8649.1992.tb02712.x; Cucherousset J, 2011, OECOLOGIA, V167, P75, DOI 10.1007/s00442-011-1974-4; Dannewitz J, 2005, P ROY SOC B-BIOL SCI, V272, P1129, DOI 10.1098/rspb.2005.3064; Daverat F, 2006, MAR ECOL PROG SER, V307, P247, DOI 10.3354/meps307247; Daverat F, 2006, MAR ECOL PROG SER, V308, P231, DOI 10.3354/meps308231; Daverat F, 2012, ECOL FRESHW FISH, V21, P325, DOI 10.1111/j.1600-0633.2011.00541.x; Day JW., 2012, ESTUARINE ECOLOGY, V2nd ed, P1, DOI [10.1002/9781118412787.ch1, DOI 10.1002/9781118412787.CH1]; De Meyer J, 2016, J EXP BIOL, V219, P354, DOI 10.1242/jeb.131714; Deelder C. L., 1984, FAO FISH SYNOP, V80, P1; DEGANI G, 1983, BAMIDGEH, V35, P53; DENIE HW, 1982, HYDROBIOLOGIA, V95, P307, DOI 10.1007/BF00044491; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; Dorner H, 2009, J FISH BIOL, V74, P2115, DOI 10.1111/j.1095-8649.2009.02289.x; Dorner H, 2003, J FISH BIOL, V62, P491, DOI 10.1046/j.1095-8649.2003.00035.x; Durif C, 2005, J FISH BIOL, V66, P1025, DOI 10.1111/j.0022-1112.2005.00662.x; Durif Caroline, 2009, P103; Edeline E, 2007, MAR ECOL PROG SER, V341, P229, DOI 10.3354/meps341229; Elliott Michael, 2002, pi; EZZAT AE, 1977, MAR BIOL, V41, P287, DOI 10.1007/BF00394917; Fricke H., 1995, TRACKING ARTIFICIALL, P5; Fry B, 2002, ESTUARIES, V25, P264, DOI 10.1007/BF02691313; FRY B, 1988, LIMNOL OCEANOGR, V33, P1182, DOI 10.4319/lo.1988.33.5.1182; Geeraerts C, 2010, ECOTOXICOLOGY, V19, P239, DOI 10.1007/s10646-009-0424-0; GROSS MR, 1988, SCIENCE, V239, P1291, DOI 10.1126/science.239.4845.1291; Haegeman B, 2011, J THEOR BIOL, V269, P150, DOI 10.1016/j.jtbi.2010.10.006; Harrod C, 2005, OECOLOGIA, V144, P673, DOI 10.1007/s00442-005-0161-x; Harrod C, 2006, ARCH HYDROBIOL, V167, P281, DOI 10.1127/0003-9136/2006/0167-0281; HELFMAN GS, 1991, ECOLOGY, V72, P310, DOI 10.2307/1938924; Herve M., 2020, **DATA OBJECT**; HYNES HBN, 1950, J ANIM ECOL, V19, P36, DOI 10.2307/1570; HYSLOP EJ, 1980, J FISH BIOL, V17, P411, DOI 10.1111/j.1095-8649.1980.tb02775.x; Imbert H, 2008, HORM BEHAV, V53, P69, DOI 10.1016/j.yhbeh.2007.06.011; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Jacoby DMP, 2015, GLOB ECOL CONSERV, V4, P321, DOI 10.1016/j.gecco.2015.07.009; Jessop BM, 2002, MAR ECOL PROG SER, V233, P217, DOI 10.3354/meps233217; KNIGHTS B, 1987, J FISH BIOL, V31, P265, DOI 10.1111/j.1095-8649.1987.tb05230.x; Kotake A, 2005, MAR ECOL PROG SER, V293, P213, DOI 10.3354/meps293213; Lake JL, 2001, CAN J FISH AQUAT SCI, V58, P870, DOI 10.1139/cjfas-58-5-870; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; Layman Craig A., 2005, P395; Lincoln RJ, 1979, BRIT MARINE AMPHIPOD; Lomolino MV, 2000, J BIOGEOGR, V27, P17, DOI 10.1046/j.1365-2699.2000.00377.x; Lysy M., 2014, NICHEROVER NICHE REG; Marohn L, 2013, J SEA RES, V77, P100, DOI 10.1016/j.seares.2012.10.006; Martin J., 2011, INVERTEBRES MARINS G; MATHUR D, 1977, AM MIDL NAT, V97, P89, DOI 10.2307/2424687; McLusky D.S., 2004, ESTUARINE ECOSYSTEM; Meirland A, 2013, ACTION 9 ISOTOPES AC, p125p; Melia P, 2006, J FISH BIOL, V68, P876, DOI 10.1111/j.0022-1112.2006.00975.x; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; MONACO ME, 1992, J BIOGEOGR, V19, P251, DOI 10.2307/2845450; MOORE JW, 1976, J FISH BIOL, V9, P375, DOI 10.1111/j.1095-8649.1976.tb04686.x; Morais P., 2016, INTRO FISH MIGRATION; Moriarty C, 2003, EEL BIOLOGY, P89; Moriarty C., 1972, Irish Fish Invest (Ser A), VNo. 10, P1; Nicolas D, 2010, ESTUAR COAST SHELF S, V88, P329, DOI 10.1016/j.ecss.2010.04.010; Oksanen J., 2013, PACKAGE VEGAN R PACK, V254, P20; PANKHURST NW, 1984, CAN J ZOOL, V62, P1143, DOI 10.1139/z84-165; PARKER PL, 1964, GEOCHIM COSMOCHIM AC, V28, P1155, DOI 10.1016/0016-7037(64)90067-5; Parzanini C, 2021, J FISH BIOL, V99, P1110, DOI 10.1111/jfb.14815; Pasquaud S, 2008, ESTUAR COAST SHELF S, V78, P267, DOI 10.1016/j.ecss.2007.12.014; Patey G, 2018, CAN J FISH AQUAT SCI, V75, P1270, DOI 10.1139/cjfas-2017-0025; Pinkas L., 1971, Fish Bull California, VNo. 152, P5; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Pratt DR, 2014, ECOSYSTEMS, V17, P182, DOI 10.1007/s10021-013-9716-6; Quero J-C, 1979, PLEURONECTIFORMES, P41; Righton D, 2021, FISH FISH, V22, P762, DOI 10.1111/faf.12549; RYAN PA, 1986, ENVIRON BIOL FISH, V15, P47, DOI 10.1007/BF00005388; SCHOENER TW, 1970, ECOLOGY, V51, P408, DOI 10.2307/1935376; Selleslagh J, 2009, ESTUAR COAST SHELF S, V81, P149, DOI 10.1016/j.ecss.2008.10.008; Selleslagh J, 2008, ESTUAR COAST SHELF S, V77, P721, DOI 10.1016/j.ecss.2007.11.004; Selleslagh J, 2012, J MAR BIOL ASSOC UK, V92, P85, DOI 10.1017/S0025315411000336; Simpson SD, 2015, GLOBAL CHANGE BIOL, V21, P586, DOI 10.1111/gcb.12685; Sousa R, 2008, AQUAT CONSERV, V18, P1063, DOI 10.1002/aqc.871; Svedang H, 1997, J FISH BIOL, V50, P475, DOI 10.1111/j.1095-8649.1997.tb01943.x; Swanson HK, 2015, ECOLOGY, V96, P318, DOI 10.1890/14-0235.1; Tesch FW., 2003, EEL BLACKWELL SCI, DOI [10.1111/j.0022-1112.2004.00509a.x, DOI 10.1111/J.0022-1112.2004.00509A.X]; Tzeng WN, 2000, MAR BIOL, V137, P93, DOI 10.1007/s002270000330; Van den Thillart G, 2007, J MAR SCI TECH-TAIW, V15, P1; Vasconi M, 2019, FOOD CONTROL, V102, P112, DOI 10.1016/j.foodcont.2019.03.004; Verhelst P, 2018, PEERJ, V6, DOI 10.7717/peerj.5773; Whitaker D., 2014, PACKAGE CLUSTSIG R P; Yokouchi K, 2009, J FISH BIOL, V74, P857, DOI 10.1111/j.1095-8649.2008.02167.x; ZARET TM, 1971, ECOLOGY, V52, P336, DOI 10.2307/1934593	110	1	1	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7								10.1371/journal.pone.0270348	http://dx.doi.org/10.1371/journal.pone.0270348			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M3CI	35793283	Green Published, Green Submitted, gold			2022-12-26	WOS:000835338100026
J	Freeman, CM; Barthman-Thompson, L; Klinger, R; Woo, I; Thorne, KM				Freeman, Chase M.; Barthman-Thompson, Laureen; Klinger, Robert; Woo, Isa; Thorne, Karen M.			Assessing small-mammal trapping design using spatially explicit capture recapture (SECR) modeling on long-term monitoring data	PLOS ONE			English	Article							SPECIES RICHNESS; DENSITY-ESTIMATION; ABUNDANCE; DIVERSITY; HABITAT; CONSERVATION; PRODUCTIVITY; POPULATIONS; PATTERNS; DURATION	Few studies have evaluated the optimal sampling design for tracking small mammal population trends, especially for rare or difficult to detect species. Spatially explicit capture-recapture (SECR) models present an advancement over non-spatial models by accounting for individual movement when estimating density. The salt marsh harvest mouse (SMHM; Reithrodontomys raviventris) is a federal and California state listed endangered species endemic to the San Francisco Bay-Delta estuary, California, USA; where a population in a subembayment has been continually monitored over an 18-year period using mark-recapture methods. We analyzed capture data within a SECR modeling framework that allowed us to account for differences in detection and movement between sexes. We compared the full dataset to subsampling scenarios to evaluate how the grid size (area) of the trap design, trap density (spacing), and number of consecutive trapping occasions (duration) influenced density estimates. To validate the subsampling methods, we ran Monte Carlo simulations based on the true parameter estimates for each specific year. We found that reducing the area of the trapping design by more than 36% resulted in the inability of the SECR model to replicate density estimates within the SE of the original density estimates. However, when trapping occasions were reduced from 4 to 3-nights the density estimates were indistinguishable from the full dataset. Furthermore, reducing trap density by 50% also resulted in density estimates comparable to the full dataset and was a substantially better model than reducing the trap area by 50%. Overall, our results indicated that moderate reductions in the number of trapping occasions or trap density could yield similar density estimates when using a SECR approach. This approach allows the optimization of field trapping efforts and designs by reducing field efforts while maintaining the same population estimate compared to the full dataset. Using a SECR approach may help other wildlife programs identify sampling efficiencies without sacrificing data integrity for long term monitoring of population densities.	[Freeman, Chase M.; Thorne, Karen M.] US Geol Survey, Western Ecol Res Ctr, Davis, CA 95616 USA; [Barthman-Thompson, Laureen] Calif Dept Fish & Wildlife, Stockton, CA USA; [Klinger, Robert] US Geol Survey, Western Ecol Res Ctr, Sacramento, CA USA; [Woo, Isa] US Geol Survey, Western Ecol Res Ctr, Moffett Field, CA USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Thorne, KM (corresponding author), US Geol Survey, Western Ecol Res Ctr, Davis, CA 95616 USA.	kthorne@usgs.gov	Woo, Isa/P-4885-2018	Woo, Isa/0000-0002-8447-9236; Freeman, Chase/0000-0003-4211-6709	California Department of Fish Wildlife [F13AP00955]; U.S. Fish and Wildlife Service: Endangered Species Act (Section-6); USGS Western Ecological Research Center; USGS Ecosystem Mission Area	California Department of Fish Wildlife; U.S. Fish and Wildlife Service: Endangered Species Act (Section-6); USGS Western Ecological Research Center; USGS Ecosystem Mission Area	Grant authors: LT, IW. The grant # was: F13AP00955 from the California Department of Fish & Wildlife. U.S. Fish and Wildlife Service: Endangered Species Act (Section-6) Grant-in-Aid Program. USGS Western Ecological Research Center and USGS Ecosystem Mission Area.	ABRAMSKY Z, 1984, NATURE, V309, P150, DOI 10.1038/309150a0; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Allen CR, 2015, ADAPTIVE MANAGEMENT; Anderson DR, 2001, WILDLIFE SOC B, V29, P1294; Andrade A, 2014, J ARID ENVIRON, V106, P18, DOI 10.1016/j.jaridenv.2014.02.004; Beard GR, 1999, ENVIRON MONIT ASSESS, V54, P239, DOI 10.1023/A:1005917929050; Bias MA, 1999, SOUTHWEST NAT, V44, P348; Blanc L, 2013, J WILDLIFE MANAGE, V77, P372, DOI 10.1002/jwmg.453; Bonecker ST, 2009, MAMM BIOL, V74, P469, DOI 10.1016/j.mambio.2009.05.010; Borchers DL, 2008, BIOMETRICS, V64, P377, DOI 10.1111/j.1541-0420.2007.00927.x; Bragina EV, 2015, CONSERV BIOL, V29, P844, DOI 10.1111/cobi.12450; Buckland ST, 2000, BIOMETRICS, V56, P1, DOI 10.1111/j.0006-341X.2000.00001.x; Caro TM, 2001, BIOL CONSERV, V98, P251, DOI 10.1016/S0006-3207(00)00105-1; Carrillo E, 2000, CONSERV BIOL, V14, P1580, DOI 10.1046/j.1523-1739.2000.99103.x; Caughlan L., 2001, ECOL INDIC, V1, DOI [10.1016/S1470-160X(01)00015-2, DOI 10.1016/S1470-160X(01)00015-2]; Chase MK, 2000, CONSERV BIOL, V14, P474, DOI 10.1046/j.1523-1739.2000.98312.x; COLLINS SL, 1991, ECOLOGY, V72, P654, DOI 10.2307/2937205; Conard JM, 2008, ACTA THERIOL, V53, P143, DOI 10.1007/BF03194247; Cully JF, 2010, ECOGRAPHY, V33, P667, DOI 10.1111/j.1600-0587.2009.05746.x; Efford M, 2004, OIKOS, V106, P598, DOI 10.1111/j.0030-1299.2004.13043.x; Efford MG, 2016, SECR SPATIALLY EXPLI; Efford MG, 2013, OIKOS, V122, P918, DOI 10.1111/j.1600-0706.2012.20440.x; Efford MG, 2009, ENVIRON ECOL STAT SE, V3, P255, DOI 10.1007/978-0-387-78151-8_11; Fleishman E, 2016, MAR MAMMAL SCI, V32, P1004, DOI 10.1111/mms.12310; Gardner B, 2009, ECOLOGY, V90, P1106, DOI 10.1890/07-2112.1; Goals Project, 1999, BAYL EC HAB GOALS; Gurnell J., 2006, P1; Hurst ZM, 2014, MAMM BIOL, V79, P17, DOI 10.1016/j.mambio.2013.08.008; Jareno D, 2014, ECOL INDIC, V36, P111, DOI 10.1016/j.ecolind.2013.07.019; Kelt DA, 2014, BIOL REV, V89, P705, DOI 10.1111/brv.12080; Krebs CJ, 2011, J MAMMAL, V92, P974, DOI 10.1644/10-MAMM-A-313.1; Kristensen TV, 2018, ECOSPHERE, V9, DOI 10.1002/ecs2.2217; Lambert TD, 2005, J MAMMAL, V86, P982, DOI 10.1644/1545-1542(2005)86[982:VISMSR]2.0.CO;2; Link WA, 2002, J WILDLIFE MANAGE, V66, P277, DOI 10.2307/3803160; MacKenzie DI, 2003, ECOLOGY, V84, P2200, DOI 10.1890/02-3090; MALY MS, 1985, ACTA THERIOL, V30, P165, DOI 10.4098/AT.arch.85-10; Marcot BG, 2020, ECOL EVOL, V10, P662, DOI 10.1002/ece3.5860; Marques TA, 2011, ECOLOGY, V92, P526, DOI 10.1890/10-1440.1; McCain CM, 2018, J BIOGEOGR, V45, P2533, DOI 10.1111/jbi.13432; Nicolas V, 2010, AFR J ECOL, V48, P1092, DOI 10.1111/j.1365-2028.2010.01221.x; Osbourne JD, 2005, WILDLIFE SOC B, V33, P814, DOI 10.2193/0091-7648(2005)33[814:EOHOSD]2.0.CO;2; OTIS DL, 1978, WILDLIFE MONOGR, P1; Parmenter RR, 2003, ECOL MONOGR, V73, P1, DOI 10.1890/0012-9615(2003)073[0001:SMDEAF]2.0.CO;2; Pearson DE, 2003, WILDLIFE SOC B, V31, P454; R Core Team, 2020, R LANG ENV STAT COMP; Rivard DH, 2000, CONSERV BIOL, V14, P1099, DOI 10.1046/j.1523-1739.2000.98247.x; ROBINSON GR, 1992, SCIENCE, V257, P524, DOI 10.1126/science.257.5069.524; Romairone J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198766; Royle J. A., 2008, HIERARCHICAL MODELIN; Royle JA, 2008, ECOLOGY, V89, P2281, DOI 10.1890/07-0601.1; SCHMOLDT DL, 1994, ENVIRON MANAGE, V18, P707, DOI 10.1007/BF02394635; SEALANDER JOHN A., 1958, JOUR MAMMAL, V39, P215, DOI 10.2307/1376194; SEBER GAF, 1986, BIOMETRICS, V42, P267, DOI 10.2307/2531049; Smith KR, 2019, J WILDLIFE MANAGE, V83, P1687, DOI 10.1002/jwmg.21752; Smith Katherine R., 2018, San Francisco Estuary & Watershed Science, V16, P1; Sollmann R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034575; Stanko M, 2002, OECOLOGIA, V131, P289, DOI 10.1007/s00442-002-0889-5; STEPHENSON PJ, 1994, BIOL CONSERV, V69, P213, DOI 10.1016/0006-3207(94)90062-0; Sun CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088025; Sustaita D, 2011, J WILDLIFE MANAGE, V75, P1498, DOI 10.1002/jwmg.187; Taylor AK, 2011, ANN ZOOL FENN, V48, P45, DOI 10.5735/086.048.0105; Taylor BL, 2007, MAR MAMMAL SCI, V23, P157, DOI 10.1111/j.1748-7692.2006.00092.x; Thom RM, 2000, ECOL ENG, V15, P365, DOI 10.1016/S0925-8574(00)00086-0; U.S. Fish and Wildlife Service, 2013, REC PLAN TID MARSH E, P623; U.S. Fish and Wildlife Service, 1970, FED REGISTER, V35, P16047; U.S. Fish and Wildlife Service, 1981, 1181F130 US FISH WIL; U.S. Fish and Wildlife Service, 1984, SALT MARSH HARV MOUS; US Fish and Wildlife Service, 2013, DEV SURV PROT HDB VE; WIENER JG, 1972, J MAMMAL, V53, P868, DOI 10.2307/1379222; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4	71	0	0	5	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7								10.1371/journal.pone.0270082	http://dx.doi.org/10.1371/journal.pone.0270082			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M5FN	35788575	Green Published, gold			2022-12-26	WOS:000835487000035
J	Lee, HW; Gu, MJ; Yoo, G; Choi, IW; Lee, SH; Kim, Y; Ha, SK				Lee, Hee-Weon; Gu, Min Ji; Yoo, Guijae; Choi, In-Wook; Lee, Sang-Hoon; Kim, Yoonsook; Ha, Sang Keun			Glycolaldehyde induces synergistic effects on vascular inflammation in TNF-alpha-stimulated vascular smooth muscle cells	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; KAPPA-B ACTIVATION; ENDOTHELIAL DYSFUNCTION; ADHESION MOLECULE-1; RECEPTOR; ATHEROSCLEROSIS; METHYLGLYOXAL; RAGE; CALCIFICATION; COMPLICATIONS	Atherosclerosis is a chronic inflammatory disease that contributes to disease progression is associated with the expression of adhesion molecules in vascular smooth muscle cells (VSMCs). Glycolaldehyde (GA) has been shown to impair cellular function in various disorders, including diabetes, and renal diseases. This study investigated the effect of GA on the expression of adhesion molecules in the mouse VSMC line, MOVAS-1. Co-incubation of VSMCs with GA (25-50 mu M) dose-dependently increased the protein and mRNA level of Vcam-1 and ICAM-1. Additionally, GA upregulated intracellular ROS production and phosphorylation of MAPK and NK-kappa B. GA also elevated TNF-alpha-induced PI3K-AKT activation. Furthermore, GA enhanced TNF-alpha-activated I kappa B alpha kinase activation, subsequent I kappa B alpha degradation, and nuclear translocation of NF-kappa B. These findings suggest that GA stumulated VSMC adhesive capacity and the induction of VCAM-1 and ICAM-1 in VSMCs through inhibition of MAPK and NF-kappa B signaling pathways, providing insights into the effect of GA to induce inflammation within atherosclerotic lesions.	[Lee, Hee-Weon; Gu, Min Ji; Yoo, Guijae; Choi, In-Wook; Lee, Sang-Hoon; Kim, Yoonsook; Ha, Sang Keun] Korea Food Res Inst, Wonju, South Korea; [Lee, Sang-Hoon; Ha, Sang Keun] Univ Sci & Technol, Div Food Biotechnol, Daejeon, South Korea	Korea Food Research Institute (KFRI); University of Science & Technology (UST)	Ha, SK (corresponding author), Korea Food Res Inst, Wonju, South Korea.; Ha, SK (corresponding author), Univ Sci & Technol, Div Food Biotechnol, Daejeon, South Korea.	skha@kfri.re.kr			Main Research Program [E 0210200]; Korea Food Research Institute (KFRI) - Ministry of Science and National Research Foundation of Korea (NRF) - Korea government(MSIT) [E 0210200, NRF-2020R1A2C2012608]; Korea government(MSIT) [NRF-2020R1A2C2012608]	Main Research Program; Korea Food Research Institute (KFRI) - Ministry of Science and National Research Foundation of Korea (NRF) - Korea government(MSIT); Korea government(MSIT)(Ministry of Science & ICT (MSIT), Republic of Korea)	This research was supported by the Main Research Program (E 0210200) of the Korea Food Research Institute (KFRI) funded by the Ministry of Science and National Research Foundation of Korea (NRF) grant funded by the Korea government(MSIT) (NRF-2020R1A2C2012608). The fundes have role in conceptualization, formal analysis, investigation, project administration, and writing of the manuscript.	Adamopoulos C, 2016, CELL MOL LIFE SCI, V73, P1685, DOI 10.1007/s00018-015-2091-z; Basta G, 2004, CARDIOVASC RES, V63, P582, DOI 10.1016/j.cardiores.2004.05.001; Bierhaus A, 2005, ANN NY ACAD SCI, V1043, P676, DOI 10.1196/annals.1333.077; Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7; Brown BE, 2005, DIABETOLOGIA, V48, P361, DOI 10.1007/s00125-004-1648-4; Cantero AV, 2007, FASEB J, V21, P3096, DOI 10.1096/fj.06-7536com; Chappey O, 1997, EUR J CLIN INVEST, V27, P97, DOI 10.1046/j.1365-2362.1997.710624.x; Cybulsky MI, 2001, J CLIN INVEST, V107, P1255, DOI 10.1172/JCI11871; Galkina E, 2007, ARTERIOSCL THROM VAS, V27, P2292, DOI 10.1161/ATVBAHA.107.149179; Gomes R, 2005, BIOCHEM J, V385, P339, DOI 10.1042/BJ20040833; Hanssen NMJ, 2014, BIOCHEM SOC T, V42, P443, DOI 10.1042/BST20140001; Hansson GK, 2001, ARTERIOSCL THROM VAS, V21, P1876, DOI 10.1161/hq1201.100220; Ishibashi Y, 2010, BIOCHEM BIOPH RES CO, V391, P1405, DOI 10.1016/j.bbrc.2009.12.075; Libby P, 2002, SCI AM, V286, P47; Lim S, 2014, BMB REP, V47, P1, DOI 10.5483/BMBRep.2014.47.1.285; Linton MF, 2003, INT J OBESITY, V27, pS35, DOI 10.1038/sj.ijo.0802498; Morita M, 2013, J DIABETES COMPLICAT, V27, P11, DOI 10.1016/j.jdiacomp.2012.07.006; Mullenix PS, 2005, ANN VASC SURG, V19, P130, DOI 10.1007/s10016-004-0153-z; Neumann A, 1999, FEBS LETT, V453, P283, DOI 10.1016/S0014-5793(99)00731-0; Oldfield MD, 2001, J CLIN INVEST, V108, P1853; Preiss DJ, 2007, INT J CLIN PRACT, V61, P697, DOI 10.1111/j.1742-1241.2007.01330.x; Ramasamy R, 2005, GLYCOBIOLOGY, V15, p16R, DOI 10.1093/glycob/cwi053; ROSS R, 1973, SCIENCE, V180, P1332, DOI 10.1126/science.180.4093.1332; Ross R, 1990, Adv Nephrol Necker Hosp, V19, P79; San Martin A, 2007, FREE RADICAL BIO MED, V42, P1671, DOI 10.1016/j.freeradbiomed.2007.02.002; Sano H, 1999, MECH AGEING DEV, V107, P333, DOI 10.1016/S0047-6374(99)00011-1; Sato K, 2013, BIOL PHARM BULL, V36, P1111, DOI 10.1248/bpb.b13-00046; SCHMIDT AM, 1995, J CLIN INVEST, V96, P1395, DOI 10.1172/JCI118175; Schmidt AM, 2000, BBA-MOL CELL RES, V1498, P99, DOI 10.1016/S0167-4889(00)00087-2; Soldatos G, 2006, CURR HYPERTENS REP, V8, P472, DOI 10.1007/s11906-006-0025-8; Sousa MM, 2000, LAB INVEST, V80, P1101, DOI 10.1038/labinvest.3780116; Tanikawa T, 2009, J VASC RES, V46, P572, DOI 10.1159/000226225; Ukeda H, 1997, BIOSCI BIOTECH BIOCH, V61, P2039, DOI 10.1271/bbb.61.2039; Vanhoutte PM, 1997, EUR HEART J, V18, pE19, DOI 10.1016/S0195-668X(97)90005-1; Vlassara H, 1996, ANN MED, V28, P419, DOI 10.3109/07853899608999102; Wang ZQ, 2012, ATHEROSCLEROSIS, V221, P387, DOI 10.1016/j.atherosclerosis.2012.01.019; Wei Q, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-13; Xie JL, 2013, CELL SIGNAL, V25, P2185, DOI 10.1016/j.cellsig.2013.06.013; Yamagishi S, 2015, MOL MED, V21, pS32, DOI 10.2119/molmed.2015.00067; Yamagishi S, 2012, BBA-GEN SUBJECTS, V1820, P663, DOI 10.1016/j.bbagen.2011.03.014; Zhang FL, 2006, J CARDIOVASC PHARM, V48, P47, DOI 10.1097/01.fjc.0000242058.72471.0c; Zhang XY, 2013, MOL CELL BIOCHEM, V374, P191, DOI 10.1007/s11010-012-1519-0; Zhou YJ, 2009, LIFE SCI, V85, P670, DOI 10.1016/j.lfs.2009.09.006	43	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7								10.1371/journal.pone.0270249	http://dx.doi.org/10.1371/journal.pone.0270249			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M5FN	35788200	Green Published, gold			2022-12-26	WOS:000835487000007
J	Lopez, C; Zanga, D; Juarez-Escario, A; Munoz, P; Eizaguirre, M				Lopez, Carmen; Zanga, Daniela; Juarez-Escario, Alejandro; Munoz, Pilar; Eizaguirre, Matilde			Parental effects of Bt toxin and vitamin A on Helicoverpa armigera	PLOS ONE			English	Article							LEPIDOPTERA; RESISTANCE; INSECTS	The increase in the area cultivated with vitamin-enriched transgenic crops producing Bt toxin raises the question of whether the addition of vitamins will in any way mitigates the effect of the toxin on the phytophagous insects that feed on those crops. On the other hand, the parental effect that feeding on these enriched transgenic crops may have on the offspring of the phytophagous that survive on them is not well known. In this work, the effect of vitamin A (beta-carotene) addition to diets with or without Bt toxin on Helicoverpa armigera larvae and their offspring was determined. The addition of vitamin A did not have any beneficial effect either for the larvae fed on enriched diets nor for their offspring. However, parental effects due to dietary feeding with the toxin were detected since adults from larvae fed on the Bt diet had higher mating success than those fed on the toxin-free diet, although there were no differences on the fertility of mated females regardless of whether their previous larvae fed on the Bt or non-Bt diet. A certain adaptive effect to the toxin was also noted since the mortality of larvae whose previous generation fed on diet with Bt was lower than that of the larvae that came from larvae fed on a non-Bt diet. It would be interesting to determine if H. armigera adults prefer to mate and lay eggs in the same type of crops in which they have developed or if feeding on different crops, such as corn or alfalfa, causes different paternal effects on the offspring. These aspects can be of great importance in the development of resistance of this species to the Bt toxin.	[Lopez, Carmen; Zanga, Daniela; Juarez-Escario, Alejandro; Munoz, Pilar; Eizaguirre, Matilde] Univ Lleida, Agrotecnio Ctr, Dept Plant Prod & Forestry Sci, Lleida, Spain	Universitat de Lleida	Eizaguirre, M (corresponding author), Univ Lleida, Agrotecnio Ctr, Dept Plant Prod & Forestry Sci, Lleida, Spain.	matilde.eizaguirre@udl.cat		Eizaguirre, Matilde/0000-0001-9371-3314	Ministerio de Ciencia, Innovacion y Universidades [AGL2017-84127-R]	Ministerio de Ciencia, Innovacion y Universidades(Spanish Government)	The authors thank Teresa Estela her administrative support and Joan Safont for his invaluable help in the general rearing of insects. Thanks to Professor Ramon Albajes for his unconditional support.	Albajes R., 2022, PHYTOMA, V335, P36; [Anonymous], 1989, JMPPRO 15 2 0 STAT P; [Anonymous], 2018, GOLD RIC MEETS FOOD; Cahenzli F, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2856; Cayrol RA, ENTOMOLOGIE APPLIQUE, V2; Chinedu O, 2018, FOOD POLICY, V79, P132, DOI 10.1016/j.foodpol.2018.06.006; Chow JK, 2005, CHEMOECOLOGY, V15, P129, DOI 10.1007/s00049-005-0304-x; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Downes S, 2016, CURR OPIN INSECT SCI, V15, P78, DOI 10.1016/j.cois.2016.04.002; EIZAGUIRRE M, 1992, ENTOMOL GEN, V17, P277; Eizaguirre M., 2010, IOBC/WPRS Bulletin, V52, P49; Fischer B, 2019, INSECT CONSERV DIVER, V12, P173, DOI 10.1111/icad.12344; FITT GP, 1989, ANNU REV ENTOMOL, V34, P17, DOI 10.1146/annurev.en.34.010189.000313; Garcia RQ, 2015, J EVOLUTION BIOL, V28, P347, DOI 10.1111/jeb.12571; Guo JG, 2021, J PEST SCI, V94, P959, DOI 10.1007/s10340-020-01307-6; Guo JG, 2019, CROP PROT, V124, DOI 10.1016/j.cropro.2019.104873; ICRISAT International Crops Research Institute for the Semi-Tropics, 2018, ANN REPORT; ISAAA (International Service for the Acquisition of Agri-biotech Applications), BRIEF 54 2018 GLOB S; Joussen N, 2012, P NATL ACAD SCI USA, V109, P15206, DOI 10.1073/pnas.1202047109; Lopez C, 2021, INSECTS, V12, DOI 10.3390/insects12080718; Lorch A., 2007, MUCH BT TOXIN GE MON; Moreau J, 2006, FUNCT ECOL, V20, P592, DOI 10.1111/j.1365-2435.2006.01145.x; Paula DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095422; Perez-Hedo M, 2013, ENTOMOL EXP APPL, V148, P56, DOI 10.1111/eea.12074; ROSSITER MC, 1991, OECOLOGIA, V87, P288, DOI 10.1007/BF00325268; Giron-Calva PS, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246696; Torres-Vila LM, 2002, CROP PROT, V21, P1003, DOI 10.1016/S0261-2194(02)00081-9; Unnevehr L., 2007, AgBioForum, V10, P124; ZALUCKI MP, 1986, AUST J ZOOL, V34, P779, DOI 10.1071/ZO9860779; Zanga D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199317; Zhang HN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022874	31	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7								10.1371/journal.pone.0269585	http://dx.doi.org/10.1371/journal.pone.0269585			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M3CI	35793308	gold, Green Published			2022-12-26	WOS:000835338100044
J	Reboul, A; Mascaro, O; Claidiere, N; Fagot, J				Reboul, Anne; Mascaro, Olivier; Claidiere, Nicolas; Fagot, Joel			Are monkeys sensitive to informativeness: An experimental study with baboons (Papio papio)	PLOS ONE			English	Article							COMPUTERIZED TEST SYSTEMS; REINFORCEMENT SIGNALS; MACACA-MULATTA; HUMANS; UNCERTAINTY; RESPONSES	Informativeness (defined as reduction of uncertainty) is central in human communication. In the present study, we investigate baboons' sensitivity to informativeness by manipulating the informativity of a cue relative to a response display and by allowing participants to anticipate their answers or to wait for a revealed answer (with variable delays). Our hypotheses were that anticipations would increase with informativity, while response times to revealed trials would decrease with informativity. These predictions were verified in Experiment 1. In Experiments 2 and 3, we manipulated rewards (rewarding anticipation responses at 70% only) to see whether reward tracking alone could account for the results in Experiment 1. We observed that the link between anticipations and informativeness disappeared, but not the link between informativeness and decreased RTs for revealed trials. Additionally, in all three experiments, the number of correct answers in revealed trials with fast reaction times (< 250ms) increased with informativeness. We conclude that baboons are sensitive to informativeness as an ecologically sound means to tracking reward.	[Reboul, Anne; Claidiere, Nicolas; Fagot, Joel] Aix Marseille Univ, CNRS, LPC, Marseille, France; [Reboul, Anne; Claidiere, Nicolas; Fagot, Joel] CNRS UAR846, Stn Primatol Celphedia, Rousset, France; [Reboul, Anne; Claidiere, Nicolas; Fagot, Joel] Univ Aix Marseille, Inst Language Commun & Brain, CNRS, Aix En Provence, France; [Mascaro, Olivier] Univ Paris, Integrat Neurosci & Cognit Ctr, CNRS, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Reboul, A (corresponding author), Aix Marseille Univ, CNRS, LPC, Marseille, France.; Reboul, A (corresponding author), CNRS UAR846, Stn Primatol Celphedia, Rousset, France.; Reboul, A (corresponding author), Univ Aix Marseille, Inst Language Commun & Brain, CNRS, Aix En Provence, France.	areboul50@gmail.com	Claidiere, Nicolas/HGE-8036-2022	Claidiere, Nicolas/0000-0002-4472-6597				Aguirre M., 2021, THESIS U LYONS; Arnold K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065660; Bannard C, 2017, PSYCHOL SCI, V28, P954, DOI 10.1177/0956797617699848; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beran MJ, 2006, J EXP PSYCHOL-ANIM B, V32, P111, DOI 10.1037/0097-7403.32.2.111; Brown EK, 2017, BEHAV PROCESS, V135, P132, DOI 10.1016/j.beproc.2016.12.004; Couchman JJ, 2010, J COMP PSYCHOL, V124, P356, DOI 10.1037/a0020129; Cummins C., 2019, OXFORD HDB EXPT SEMA, DOI DOI 10.1093/OXFORDHB/9780198791768.013.11; Fagot J, 2019, J HUM EVOL, V126, P39, DOI 10.1016/j.jhevol.2018.10.006; Fagot J, 2014, AM J PRIMATOL, V76, P56, DOI 10.1002/ajp.22193; Fagot J, 2010, BEHAV RES METHODS, V42, P507, DOI 10.3758/BRM.42.2.507; Falaus A, 2013, PALG STUD PRAGM LANG, P1; Frank MC., 2016, PSYARXIV, DOI [10.31234/osf.io/f9y6b, DOI 10.31234/OSF.IO/F9Y6B]; Frank MC, 2014, COGNITIVE PSYCHOL, V75, P80, DOI 10.1016/j.cogpsych.2014.08.002; Grice Herbert Paul, 1975, SPEECH ACTS, P41, DOI DOI 10.1163/9789004368811_003; Hick WE, 1952, Q J EXP PSYCHOL, V4, P11, DOI 10.1080/17470215208416600; HYMAN R, 1953, J EXP PSYCHOL, V45, P188, DOI 10.1037/h0056940; Kornell N, 2007, PSYCHOL SCI, V18, P64, DOI 10.1111/j.1467-9280.2007.01850.x; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Ouattara K, 2009, P NATL ACAD SCI USA, V106, P22026, DOI 10.1073/pnas.0908118106; Ouattara K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007808; Proust J., 2019, ANIM BEHAV COG, V6, P309, DOI [DOI 10.26451/ABC.06.04.10.2019, 10.26451/abc.06.04.10.2019]; R Core Team, 2020, R LANG ENV STAT COMP; Schlenker P, 2014, LINGUIST PHILOS, V37, P439, DOI 10.1007/s10988-014-9155-7; Shields WE, 2005, J GEN PSYCHOL, V132, P165; Shields WE, 1997, J EXP PSYCHOL GEN, V126, P147, DOI 10.1037/0096-3445.126.2.147; Smith JD, 2006, J EXP PSYCHOL GEN, V135, P282, DOI 10.1037/0096-3445.135.2.282; Smith JD, 2018, J COMP PSYCHOL, V132, P152, DOI 10.1037/com0000100; Smith JD, 2010, ANIM COGN, V13, P93, DOI 10.1007/s10071-009-0249-5; Smith JD, 1997, COGNITION, V62, P75, DOI 10.1016/S0010-0277(96)00726-3; Sperber D., 1995, RELEVANCE COMMUNICAT, V2nd ed.	31	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7								10.1371/journal.pone.0270502	http://dx.doi.org/10.1371/journal.pone.0270502			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M5FN	35789339	Green Published, gold			2022-12-26	WOS:000835487000008
J	Brandebura, AN; Kolson, DR; Amick, EM; Ramadan, J; Kersting, MC; Nichol, RH; Holcomb, PS; Mathers, PH; Stoilov, P; Spirou, GA				Brandebura, Ashley N.; Kolson, Douglas R.; Amick, Emily M.; Ramadan, Jad; Kersting, Matthew C.; Nichol, Robert H.; Holcomb, Paul S.; Mathers, Peter H.; Stoilov, Peter; Spirou, George A.			Transcriptional profiling reveals roles of intercellular Fgf9 signaling in astrocyte maturation and synaptic refinement during brainstem development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUPERIOR OLIVARY COMPLEX; GENE-EXPRESSION; MEDIAL NUCLEUS; EXTRACELLULAR-MATRIX; PERINEURONAL NET; CRITICAL PERIOD; TRAPEZOID BODY; CALYX; LOCALIZATION; OLIGODENDROCYTES	Neural tissue maturation is a coordinated process under tight transcriptional control. We previously analyzed the kinetics of gene expression in the medial nucleus of the trapezoid body (MNTB) in the brainstem during the critical postnatal phase of its development. While this work revealed timed execution of transcriptional programs, it was blind to the specific cells where gene expression changes occurred. Here, we utilized single-cell RNA-Seq to determine transcriptional profiles of each major MNTB cell type. We discerned directional signaling patterns between neuronal, glial, and vascular-associated cells for VEGF, TGF beta, and Delta-Notch pathways during a robust period of vascular remodeling in the MNTB. Furthermore, we describe functional outcomes of the disruption of neuron-astrocyte fibroblast growth factor 9 (Fgf9) signaling. We used a conditional KO (cKO) approach to genetically delete Fgf9 from principal neurons in the MNTB, which led to an early onset of glial fibrillary acidic protein (Gfap) expression in astrocytes. In turn, Fgf9 cKO mice show increased levels of astrocyte-enriched brevican (Bcan), a component of the perineuronal net matrix that ensheaths principal neurons in the MNTB and the large calyx of Held terminal, while levels of the neuron-enriched hyaluronan and proteoglycan link protein 1 (Hapinl) were unchanged. Finally, volumetric analysis of vesicular glutamate transporters 1 and 2 (Vglut1/2), which serves as a proxy for terminal size, revealed an increase in calyx of Held volume in the Fgf9 cKO. Overall, we demonstrate a coordinated neuron-astrocyte Fgf9 signaling network that functions to regulate astrocyte maturation, perineuronal net structure, and synaptic refinement.	[Brandebura, Ashley N.] West Virginia Univ, Grad Program Biochem & Mol Biol, Morgantown, WV 26506 USA; [Brandebura, Ashley N.; Mathers, Peter H.; Stoilov, Peter] West Virginia Univ, Dept Biochem, Morgantown, WV 26506 USA; [Brandebura, Ashley N.; Kolson, Douglas R.; Ramadan, Jad; Holcomb, Paul S.; Mathers, Peter H.] West Virginia Univ, Rockefeller Neurosci Inst, Morgantown, WV 26506 USA; [Kolson, Douglas R.; Ramadan, Jad; Holcomb, Paul S.; Mathers, Peter H.] West Virginia Univ, Dept Otolaryngol HNS, Morgantown, WV 26506 USA; [Kolson, Douglas R.; Mathers, Peter H.] West Virginia Univ, Dept Ophthalmol, Morgantown, WV 26506 USA; [Amick, Emily M.; Kersting, Matthew C.; Nichol, Robert H.; Spirou, George A.] Univ S Florida, Dept Med Engn, Tampa, FL 33620 USA; [Brandebura, Ashley N.] Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA	West Virginia University; West Virginia University; West Virginia University; West Virginia University; West Virginia University; State University System of Florida; University of South Florida; Salk Institute	Mathers, PH; Stoilov, P (corresponding author), West Virginia Univ, Dept Biochem, Morgantown, WV 26506 USA.; Mathers, PH (corresponding author), West Virginia Univ, Rockefeller Neurosci Inst, Morgantown, WV 26506 USA.; Mathers, PH (corresponding author), West Virginia Univ, Dept Otolaryngol HNS, Morgantown, WV 26506 USA.; Mathers, PH (corresponding author), West Virginia Univ, Dept Ophthalmol, Morgantown, WV 26506 USA.; Spirou, GA (corresponding author), Univ S Florida, Dept Med Engn, Tampa, FL 33620 USA.	pmathers@hsc.wvu.edu; pstoilov@hsc.wvu.edu; gspirou@usf.edu		Brandebura, Ashley/0000-0001-9862-0977	NIH [R01 DC007695, R01 EY025536, F31 DC017080]; NIDCD [CoBRE P30 GM103503]; John W. and Jeanette S. Straton Fund (Endowed Chair award); WVCTSI Grant [U54 GM104942]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); John W. and Jeanette S. Straton Fund (Endowed Chair award); WVCTSI Grant	This work was supported by NIH grants R01 DC007695 (G. A. S.), R01 EY025536 (P. S.), and F31 DC017080 (A. N. B.) from NIDCD, CoBRE P30 GM103503 and the John W. and Jeanette S. Straton Fund (Endowed Chair award to G. A. S., West Virginia University). The West Virginia University Genomics Core Facility is supported by the WVCTSI Grant (U54 GM104942). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Altieri SC, 2015, DEV BIOL, V408, P99, DOI 10.1016/j.ydbio.2015.10.008; Barritt AW, 2006, J NEUROSCI, V26, P10856, DOI 10.1523/JNEUROSCI.2980-06.2006; Bekku Y, 2003, MOL CELL NEUROSCI, V24, P148, DOI 10.1016/S1044-7431(03)00133-7; Bekku Y, 2012, J COMP NEUROL, V520, P1721, DOI 10.1002/cne.23009; Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Blobe GC, 2001, J BIOL CHEM, V276, P24627, DOI 10.1074/jbc.M100188200; Blosa M, 2013, NEUROSCIENCE, V228, P215, DOI 10.1016/j.neuroscience.2012.10.003; Blosa M, 2015, J PHYSIOL-LONDON, V593, P4341, DOI 10.1113/JP270849; Brandebura AN, 2018, DEV NEUROBIOL, V78, P1097, DOI 10.1002/dneu.22633; BRAUN PE, 1988, J NEUROSCI, V8, P3057; Burns JC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9557; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Clarke LE, 2013, NAT REV NEUROSCI, V14, P311, DOI 10.1038/nrn3484; Dinh ML, 2014, NEUROSCIENCE, V278, P237, DOI 10.1016/j.neuroscience.2014.08.016; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Ehmann H, 2013, J BIOL CHEM, V288, P25865, DOI 10.1074/jbc.M113.490508; Ford MC, 2009, J COMP NEUROL, V514, P92, DOI 10.1002/cne.21998; FRIAUF E, 1993, J COMP NEUROL, V334, P59, DOI 10.1002/cne.903340105; Futai K, 2001, J NEUROSCI, V21, P3342, DOI 10.1523/JNEUROSCI.21-10-03342.2001; Haines Ricci J, 2011, Int J Biochem Mol Biol, V2, P8; Harris JA, 2005, J COMP NEUROL, V493, P460, DOI 10.1002/cne.20776; HECHT D, 1995, GROWTH FACTORS, V12, P223, DOI 10.3109/08977199509036882; Held H., 1893, ARCH ANAT PHYSIOL, V17, P201; HELFERT RH, 1989, BRAIN RES, V501, P269, DOI 10.1016/0006-8993(89)90644-6; Hoffpauir BK, 2006, J NEUROSCI, V26, P5511, DOI 10.1523/JNEUROSCI.5525-05.2006; Hoffpauir BK, 2010, J PHYSIOL-LONDON, V588, P4365, DOI 10.1113/jphysiol.2010.198564; Holcomb PS, 2013, J NEUROSCI, V33, P12954, DOI 10.1523/JNEUROSCI.1087-13.2013; Joshi I, 2002, J PHYSIOL-LONDON, V540, P861; KANDLER K, 1993, J COMP NEUROL, V328, P161, DOI 10.1002/cne.903280202; Kandler K, 2009, NAT NEUROSCI, V12, P711, DOI 10.1038/nn.2332; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kim G, 2003, NAT NEUROSCI, V6, P282, DOI 10.1038/nn1015; Kimmel RA, 2000, GENE DEV, V14, P1377; Korber C, 2014, EUR J NEUROSCI, V40, P2867, DOI 10.1111/ejn.12661; Kolson DR, 2016, DEV NEUROBIOL, V76, P166, DOI 10.1002/dneu.22306; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lin YS, 2006, GENESIS, V44, P150, DOI 10.1002/gene.20194; Lum M, 2009, J NEUROSCI RES, V87, P2201, DOI 10.1002/jnr.22047; Lun Aaron T L, 2016, F1000Res, V5, P2122; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mancuso Michael R., 2008, Lymphatic Research and Biology, V6, P173, DOI 10.1089/lrb.2008.1014; Marrs GS, 2013, DEV NEUROBIOL, V73, P384, DOI 10.1002/dneu.22069; McCarthy DJ, 2017, BIOINFORMATICS, V33, P1179, DOI 10.1093/bioinformatics/btw777; Mokry J, 1999, Gen Physiol Biophys, V18 Suppl 1, P25; MOREST D. KENT, 1968, BRAIN RES, V9, P288, DOI 10.1016/0006-8993(68)90235-7; Muller AM, 2002, EXP MOL PATHOL, V72, P221, DOI 10.1006/exmp.2002.2424; Nakamura PA, 2011, HEARING RES, V276, P70, DOI 10.1016/j.heares.2010.11.004; Namihira M, 2009, DEV CELL, V16, P245, DOI 10.1016/j.devcel.2008.12.014; Ornitz DM, 2015, WIRES DEV BIOL, V4, P215, DOI 10.1002/wdev.176; Pierfelice T, 2011, NEURON, V69, P840, DOI 10.1016/j.neuron.2011.02.031; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Reemst K, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00566; Reyes-Haro D, 2010, J GEN PHYSIOL, V135, P583, DOI 10.1085/jgp.200910354; Ribot J, 2021, SCIENCE, V373, P77, DOI 10.1126/science.abf5273; Rinholm JE, 2011, J NEUROSCI, V31, P538, DOI 10.1523/JNEUROSCI.3516-10.2011; Robertson HR, 2009, J NEUROSCI, V29, P7929, DOI 10.1523/JNEUROSCI.6093-08.2009; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosenstein JM, 1998, P NATL ACAD SCI USA, V95, P7086, DOI 10.1073/pnas.95.12.7086; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Rusu SI, 2011, DEV NEUROBIOL, V71, P284, DOI 10.1002/dneu.20856; Saliu A, 2014, J COMP NEUROL, V522, P971, DOI 10.1002/cne.23473; Schmidt S, 2020, NEUROSCIENCE, V442, P69, DOI 10.1016/j.neuroscience.2020.06.040; SHIOTA C, 1989, DEV BRAIN RES, V45, P83, DOI 10.1016/0165-3806(89)90010-2; Shrestha BR, 2018, CELL, V174, P1229, DOI 10.1016/j.cell.2018.07.007; Sinclair JL, 2017, J NEUROSCI, V37, P8239, DOI 10.1523/JNEUROSCI.3728-16.2017; Sivaramakrishnan S., 2018, OXFORD HDB AUDITORY, P245; Snaidero N, 2014, J CELL SCI, V127, P2999, DOI 10.1242/jcs.151043; Steinert JR, 2008, NEURON, V60, P642, DOI 10.1016/j.neuron.2008.08.025; Sun SH, 2018, CELL, V174, P1247, DOI 10.1016/j.cell.2018.07.008; Taschenberger H, 2000, J NEUROSCI, V20, P9162; Wang DF, 2012, CELL TISSUE RES, V349, P147, DOI 10.1007/s00441-012-1375-y; Weiss A, 2013, WIRES DEV BIOL, V2, P47, DOI 10.1002/wdev.86; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; ZOOK JM, 1982, J COMP NEUROL, V207, P1, DOI 10.1002/cne.902070102	75	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2022	298	8							102176	10.1016/j.jbc.2022.102176	http://dx.doi.org/10.1016/j.jbc.2022.102176			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3S2VB	35753346	gold, Green Published			2022-12-26	WOS:000839458000005
J	Machcinska, S; Walendzik, K; Kopcewicz, M; Wisniewska, J; Rokka, A; Paakkonen, M; Slowinska, M; Gawronska-Kozak, B				Machcinska, Sylwia; Walendzik, Katarzyna; Kopcewicz, Marta; Wisniewska, Joanna; Rokka, Anne; Paakkonen, Mirva; Slowinska, Mariola; Gawronska-Kozak, Barbara			Hypoxia reveals a new function of Foxn1 in the keratinocyte antioxidant defense system	FASEB JOURNAL			English	Article						Ccn; Foxn1; hypoxia; keratinocytes; thioredoxin system	THIOREDOXIN-GLUTATHIONE REDUCTASE; EUKARYOTIC PROMOTER DATABASE; GROWTH-FACTOR PRODUCTION; TRANSCRIPTIONAL CONTROL; EMERGING ROLE; WOUND REPAIR; CCN FAMILY; SKIN; EXPRESSION; OXYGEN	Skin exposed to environmental threats, including injuries and oxidative stress, develops an efficient but not fully recognized system of repair and antioxidant protection. Here, using mass spectrometry analysis (LC-MS/MS), followed by in vitro and in vivo experiments, we provided evidence that Foxn1 in keratinocytes regulates elements of the electron transport chain and participates in the thioredoxin system (Txn2, Txnrd3, and Srxn1) induction, particularly in a hypoxic environment. We first showed that Foxn1 in keratinocytes upregulates glutathione thioredoxin reductase 3 (Txnrd3) protein expression, and high levels of Txnrd3 mRNA were detected in injured skin of Foxn1(+/+) mice. We also showed that Foxn1 strongly downregulated the Ccn2 protein expression, participating in epidermal reconstruction after injury. An in vitro assay revealed that Foxn1 controls keratinocyte migration, stimulating it under normoxia and suppressing it under hypoxia. Keratinocytes overexpressing Foxn1 and exposed to hypoxia displayed a reduced ability to promote angiogenesis by downregulating Vegfa expression. In conclusion, this study showed a new mechanism in which Foxn1, along with hypoxia, participates in the activation of antioxidant defense and controls the functional properties of keratinocytes.	[Machcinska, Sylwia; Walendzik, Katarzyna; Kopcewicz, Marta; Wisniewska, Joanna; Slowinska, Mariola; Gawronska-Kozak, Barbara] Polish Acad Sci, Inst Anim Reprod & Food Res, Tuwima 10, PL-10748 Olsztyn, Poland; [Rokka, Anne; Paakkonen, Mirva] Univ Turku, Turku Biosci Ctr, Turku, Finland; [Rokka, Anne; Paakkonen, Mirva] Abo Akad Univ, Turku, Finland	Polish Academy of Sciences; Institute of Animal Reproduction & Food Research of the Polish Academy of Sciences; University of Turku; Abo Akademi University	Gawronska-Kozak, B (corresponding author), Polish Acad Sci, Inst Anim Reprod & Food Res, Tuwima 10, PL-10748 Olsztyn, Poland.	b.kozak@pan.olsztyn.pl	KOPCEWICZ, Marta/H-7199-2017	KOPCEWICZ, Marta/0000-0002-9776-4941; MACHCINSKA-ZIELINSKA, Sylwia/0000-0003-3892-4519; Rokka, Anne/0000-0003-1482-9154	National Science Centre Poland [2017/27/B/NZ5/02610]	National Science Centre Poland(National Science Centre, Poland)	National Science Centre Poland, Grant/Award Number: 2017/27/B/NZ5/02610	Alfaro MP, 2013, LAB INVEST, V93, P81, DOI 10.1038/labinvest.2012.162; Bellavia G, 2014, J DERMATOL SCI, V73, P3, DOI 10.1016/j.jdermsci.2013.08.007; Bredenkamp N, 2014, DEVELOPMENT, V141, P1627, DOI 10.1242/dev.103614; Sanchez MC, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7080098; Cao XK, 2020, BIOL CHEM, V401, P1215, DOI 10.1515/hsz-2020-0181; Cowburn AS, 2014, J INVEST DERMATOL, V134, P801, DOI 10.1038/jid.2013.395; Damdimopoulos AE, 2002, J BIOL CHEM, V277, P33249, DOI 10.1074/jbc.M203036200; Dreos R, 2015, NUCLEIC ACIDS RES, V43, pD92, DOI 10.1093/nar/gku1111; Dreos R, 2017, NUCLEIC ACIDS RES, V45, pD51, DOI 10.1093/nar/gkw1069; Du HY, 2018, BIOCHEM BIOPH RES CO, V505, P966, DOI 10.1016/j.bbrc.2018.09.001; Dunn LL, 2010, ARTERIOSCL THROM VAS, V30, P2089, DOI 10.1161/ATVBAHA.110.209643; Gawronska-Kozak B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150635; Gawronska-Kozak B, 2011, MATRIX BIOL, V30, P290, DOI 10.1016/j.matbio.2011.04.004; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; He J, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-03923-1; Holbourn KP, 2008, TRENDS BIOCHEM SCI, V33, P461, DOI 10.1016/j.tibs.2008.07.006; Huang QH, 2015, CIRCULATION, V131, P1082, DOI 10.1161/CIRCULATIONAHA.114.012725; Kallio PJ, 1998, EMBO J, V17, P6573, DOI 10.1093/emboj/17.22.6573; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2019, NUCLEIC ACIDS RES, V47, pD590, DOI 10.1093/nar/gky962; Karlenius Therese Christina, 2010, Cancers (Basel), V2, P209, DOI 10.3390/cancers2020209; Kimmel HM, 2016, WOUNDS, V28, P264; Kiwanuka E, 2013, J SURG RES, V185, pE109, DOI 10.1016/j.jss.2013.05.065; Koopman Werner J H, 2010, Antioxid Redox Signal, V12, P1431, DOI 10.1089/ars.2009.2743; Kopcewicz MM, 2017, WOUND REPAIR REGEN, V25, P248, DOI 10.1111/wrr.12524; Kur-Piotrowska A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23794-5; Kur-Piotrowska A, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3401-z; Landen NX, 2016, CELL MOL LIFE SCI, V73, P3861, DOI 10.1007/s00018-016-2268-0; Lau LF, 2011, CELL MOL LIFE SCI, V68, P3149, DOI 10.1007/s00018-011-0778-3; Lee D, 1999, DEV BIOL, V208, P362, DOI 10.1006/dbio.1999.9221; Lee S, 2013, ANTIOXID REDOX SIGN, V18, P1165, DOI 10.1089/ars.2011.4322; Li J, 2007, DIFFERENTIATION, V75, P694, DOI 10.1111/j.1432-0436.2007.00176.x; Li J, 2015, INT J MOL MED, V36, P1451, DOI 10.3892/ijmm.2015.2390; Lokmic Z, 2012, INT REV CEL MOL BIO, V296, P139, DOI 10.1016/B978-0-12-394307-1.00003-5; Machcinska S, 2021, FASEB J, V35, DOI 10.1096/fj.202001907R; Mascharak S, 2021, SCIENCE, V372, P362, DOI 10.1126/science.aba2374; Mecklenburg L, 2005, EXP DERMATOL, V14, P797, DOI 10.1111/j.1600-0625.2005.00362.x; Mecklenburg L, 2004, J INVEST DERMATOL, V123, P1001, DOI 10.1111/j.0022-202X.2004.23442.x; Mi HY, 2021, NUCLEIC ACIDS RES, V49, pD394, DOI 10.1093/nar/gkaa1106; Mori R, 2014, AM J PATHOL, V184, P2465, DOI 10.1016/j.ajpath.2014.05.012; Muri J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04274-w; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; O'Toole EA, 1997, J CLIN INVEST, V100, P2881, DOI 10.1172/JCI119837; Pastar I, 2014, ADV WOUND CARE, V3, P445, DOI 10.1089/wound.2013.0473; Piipponen M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21228790; Potter CS, 2011, J INVEST DERMATOL, V131, P828, DOI 10.1038/jid.2010.391; Prowse DM, 1999, DEV BIOL, V212, P54, DOI 10.1006/dbio.1999.9328; Quan TH, 2009, J CELL COMMUN SIGNAL, V3, P19, DOI 10.1007/s12079-009-0044-8; Raudvere U, 2019, NUCLEIC ACIDS RES, V47, pW191, DOI 10.1093/nar/gkz369; Rinnerthaler M, 2015, BIOMOLECULES, V5, P545, DOI 10.3390/biom5020545; Rittie L, 2011, J CELL COMMUN SIGNAL, V5, P69, DOI 10.1007/s12079-010-0114-y; Ross C, 2011, EXP DERMATOL, V20, P58, DOI 10.1111/j.1600-0625.2010.01190.x; Roussel X, 2008, J BIOL CHEM, V283, P22371, DOI 10.1074/jbc.M800493200; Rundlof AK, 2004, FREE RADICAL BIO MED, V36, P641, DOI 10.1016/j.freeradbiomed.2003.12.004; Sano H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050212; Schafer M, 2007, ANNU REV CELL DEV BI, V23, P69, DOI 10.1146/annurev.cellbio.23.090506.123609; Schlake T, 1997, P NATL ACAD SCI USA, V94, P3842, DOI 10.1073/pnas.94.8.3842; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Singh B, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0765-9; Sisco M, 2008, WOUND REPAIR REGEN, V16, P661, DOI 10.1111/j.1524-475X.2008.00416.x; Su D, 2005, J BIOL CHEM, V280, P26491, DOI 10.1074/jbc.M503638200; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Tang D, 2017, SCI REP-UK, V7, DOI 10.1038/srep43926; Telorack M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005800; Tottoli EM, 2020, PHARMACEUTICS, V12, DOI 10.3390/pharmaceutics12080735; Walendzik K, 2020, J INVEST DERMATOL, V140, P1166, DOI 10.1016/j.jid.2019.11.010; Weiner L, 2007, CELL, V130, P932, DOI 10.1016/j.cell.2007.07.024; Welsh SJ, 2002, CANCER RES, V62, P5089; Weninger W, 1996, LAB INVEST, V75, P647; Williams DL, 2013, ANTIOXID REDOX SIGN, V19, P735, DOI 10.1089/ars.2012.4670; Wisniewska J, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22115469; Xia YP, 2001, J INVEST DERMATOL, V116, P50, DOI 10.1046/j.1523-1747.2001.00209.x; Xiao HJ, 2013, INT J MED SCI, V10, P1412, DOI 10.7150/ijms.5630; Yoshihara E, 2014, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00514; Zhang HY, 2011, P NATL ACAD SCI USA, V108, P2270, DOI 10.1073/pnas.1019603108; Zhou J, 2007, J BIOL CHEM, V282, P7482, DOI 10.1074/jbc.M608289200	78	2	2	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2022	36	8							e22436	10.1096/fj.202200249RR	http://dx.doi.org/10.1096/fj.202200249RR			25	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2R5PZ	35792861	hybrid			2022-12-26	WOS:000821165400001
J	Penkert, RR; Vargas, E; Prehoda, KE				Penkert, Rhiannon R.; Vargas, Elizabeth; Prehoda, Kenneth E.			Energetic determinants of animal cell polarity regulator Par-3 interaction with the Par complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; BINDING; APKC; LINKS; CDC42; HOMOLOG; DOMAINS; RAC	The animal cell polarity regulator Par-3 recruits the Par complex (consisting of Par-6 and atypical PKC, aPKC) to specific sites on the cell membrane. Although numerous physical interactions have been reported between Par-3 and the Par complex, it is unclear how each of these interactions contributes to the overall binding. Using a purified, intact Par complex and a quantitative binding assay, here, we found that the energy required for this interaction is provided by the second and third PDZ protein interaction domains of Par-3. We show that both Par-3 PDZ domains bind to the PDZ-binding motif of aPKC in the Par complex, with additional binding energy contributed from the adjacent catalytic domain of aPKC. In addition to highlighting the role of Par-3 PDZ domain interactions with the aPKC kinase domain and PDZ-binding motif in stabilizing Par-3-Par complex assembly, our results indicate that each Par-3 molecule can potentially recruit two Par complexes to the membrane during cell polarization. These results provide new insights into the energetic determinants and structural stoichiometry of the Par-3-Par complex assembly.	[Penkert, Rhiannon R.; Vargas, Elizabeth; Prehoda, Kenneth E.] Univ Oregon, Inst Mol Biol, Dept Chem & Biochem, Eugene 97403, OR USA	University of Oregon	Prehoda, KE (corresponding author), Univ Oregon, Inst Mol Biol, Dept Chem & Biochem, Eugene 97403, OR USA.	prehoda@uoregon.edu		Vargas, Elizabeth/0000-0001-9970-3512	NIH [GM127092]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding and additional information - This work was supported by NIH grant GM127092 (K. E. P.) . The content is solely the re- sponsibility of the authors and does not necessarily represent the of fi cial views of the National Institutes of Health.	Bailey MJ, 2015, DEV CELL, V35, P199, DOI 10.1016/j.devcel.2015.09.016; Garrard SM, 2003, EMBO J, V22, P1125, DOI 10.1093/emboj/cdg110; Graybill C, 2012, J BIOL CHEM, V287, P21003, DOI 10.1074/jbc.M112.360495; Ho J, 2019, NAT METHODS, V16, P565, DOI 10.1038/s41592-019-0470-3; Holly RW, 2020, CURR BIOL, V30, P893, DOI 10.1016/j.cub.2019.12.055; Holly RW, 2019, DEV CELL, V49, P678, DOI 10.1016/j.devcel.2019.05.002; Izumi Y, 1998, J CELL BIOL, V143, P95, DOI 10.1083/jcb.143.1.95; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Lang CF, 2017, DEVELOPMENT, V144, P3405, DOI 10.1242/dev.139063; Li BS, 2010, DEV BIOL, V344, P745, DOI 10.1016/j.ydbio.2010.05.506; Li J, 2010, DEV BIOL, V340, P88, DOI 10.1016/j.ydbio.2010.01.023; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Martin E, 2021, FEBS J, V288, P7073, DOI 10.1111/febs.15710; Noda Y, 2001, GENES CELLS, V6, P107, DOI 10.1046/j.1365-2443.2001.00404.x; Pollard TD, 2010, MOL BIOL CELL, V21, P4061, DOI 10.1091/mbc.E10-08-0683; Qiu RG, 2000, CURR BIOL, V10, P697, DOI 10.1016/S0960-9822(00)00535-2; Remenyi A, 2006, CURR OPIN STRUC BIOL, V16, P676, DOI 10.1016/j.sbi.2006.10.008; Renschler FA, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aam9899; Riga A, 2020, CURR OPIN CELL BIOL, V62, P1, DOI 10.1016/j.ceb.2019.07.017; Soriano EV, 2016, DEV CELL, V38, P384, DOI 10.1016/j.devcel.2016.07.018; Thompson BJ, 2022, FEBS J, V289, P596, DOI 10.1111/febs.15754; Whitney DS, 2016, BIOCHEMISTRY-US, V55, P1455, DOI 10.1021/acs.biochem.5b01342; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361; Wu XD, 2020, DEV CELL, V55, P18, DOI 10.1016/j.devcel.2020.06.012	24	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2022	298	8							102223	10.1016/j.jbc.2022.102223	http://dx.doi.org/10.1016/j.jbc.2022.102223			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	4F0HT	35787373	gold, Green Published			2022-12-26	WOS:000848198300006
J	Yang, JP; Banas, VS; Patel, KD; Rivera, GSM; Mydy, LS; Gulick, AM; Wencewicz, TA				Yang, Jinping; Banas, Victoria S.; Patel, Ketan D.; Rivera, Gerry S. M.; Mydy, Lisa S.; Gulick, Andrew M.; Wencewicz, Timothy A.			An acyl-adenylate mimic reveals the structural basis for substrate recognition by the iterative siderophore synthetase DesD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYZES CYCLODIMERIZATION; MYCOBACTERIUM-TUBERCULOSIS; ONE ENZYME; BIOSYNTHESIS; INHIBITION; ANTIBIOTICS; CLUSTER; LIGASE; IDENTIFICATION; SPECIFICITY	Siderophores are conditionally essential metabolites used by microbes for environmental iron sequestration. Most Streptomyces strains produce hydroxamate-based desferriox-amine (DFO) siderophores composed of repeating units of N-1- hydroxy-cadaverine (or N-1-hydroxy-putrescine) and succinate. The DFO biosynthetic operon, desABCD, is highly conserved in Streptomyces; however, expression of desABCD alone does not account for the vast structural diversity within this natural product class. Here, we report the in vitro reconstitution and biochemical characterization of four DesD orthologs from Streptomyces strains that produce unique DFO siderophores. Under in vitro conditions, all four DesD orthologs displayed similar saturation steady-state kinetics (V-max = 0.9-2.5 mu M.min(-1)) and produced the macrocyclic trimer DFOE as the favored product, suggesting a conserved role for DesD in the biosynthesis of DFO siderophores. We further synthesized a structural mimic of N-1-hydroxy-N-1- succinyl-cadaverine (HSC)-acyl-adenylate, the HSC-acyl sulfamoyl adenosine analog (HSC-AMS), and obtained crystal structures of DesD in the ATP-bound, AMP/PPi-bound, and HSC-AMS/Pi-bound forms. We found HSC-AMS inhibited DesD orthologs (IC50 values = 48-53 mu M) leading to accumulation of linear trimeric DFOG and di-HSC at the expense of macrocyclic DFOE. Addition of exogenous PPi enhanced DesD inhibition by HSC-AMS, presumably via stabilization of the DesD-HSC-AMS complex, similar to the proposed mode of adenylate stabilization where PPi remains buried in the active site. In conclusion, our data suggest that acyl-AMS derivatives may have utility as chemical probes and bisubstrate inhibitors to reveal valuable mechanistic and structural insight for this unique family of adenylating enzymes.	[Yang, Jinping; Banas, Victoria S.; Rivera, Gerry S. M.; Wencewicz, Timothy A.] Washington Univ St Louis, Dept Chem, St. Louis, MO 63130 USA; [Patel, Ketan D.; Mydy, Lisa S.; Gulick, Andrew M.] Sunny Buffalo, Dept Struct Biol, Jacobs Sch Med & Biomed Sci, Buffalo, NY 14203 USA	Washington University (WUSTL); State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Wencewicz, TA (corresponding author), Washington Univ St Louis, Dept Chem, St. Louis, MO 63130 USA.; Gulick, AM (corresponding author), Sunny Buffalo, Dept Struct Biol, Jacobs Sch Med & Biomed Sci, Buffalo, NY 14203 USA.	amgulick@buffalo.edu; wencewicz@wustl.edu		Mydy, Lisa/0000-0002-6976-4426; Yang, Jinping/0000-0002-9791-4751; Banas, Victoria/0000-0001-7385-5550	NSF [1654611]; National Cancer Institute [ACB-12002]; NIH [S10 OD012289, DE-AC02-76SF00515]; National Institute of General Medical Sciences [AGM-12006, P30GM138396]; Argonne National Laboratory [DE-AC02-06CH11357]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [P30GM133894]; DOE Office of Biological and Environmental Research; National Institutes of Health, National Institute of General Medical Sciences;  [R35GM136235]	NSF(National Science Foundation (NSF)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Argonne National Laboratory(United States Department of Energy (DOE)); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); 	Research was supported by NSF CAREER Award 1654611 to T.A.W., and NIH Award R35GM136235 to A.M.G. GM/CA@APS has been funded by the National Cancer Institute (ACB-12002) and the National Institute of General Medical Sciences (AGM-12006, P30GM138396) . This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Of fi ce of Science User Facility oper- ated for the DOE Of fi ce of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357. The Eiger 16M detector at GM/CA-XSD was funded by NIH grant S10 OD012289. Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract No. DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by the National Institutes of Health, National Institute of General Medical Sciences (P30GM133894) .	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Al Shaer D, 2020, EUR J MED CHEM, V208, DOI 10.1016/j.ejmech.2020.112791; Bailey DC, 2018, J BIOL CHEM, V293, P7841, DOI 10.1074/jbc.RA118.002798; Bailey DC, 2016, BIOCHEMISTRY-US, V55, P3559, DOI 10.1021/acs.biochem.6b00409; Barona-Gomez F, 2004, J AM CHEM SOC, V126, P16282, DOI 10.1021/ja045774k; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Bickel H, 1965, Antimicrob Agents Chemother (Bethesda), V5, P951; BICKEL H, 1966, TETRAHEDRON, VS, P171; Blin K, 2021, NUCLEIC ACIDS RES, V49, pW29, DOI 10.1093/nar/gkab335; Carroll CS, 2018, CRIT REV BIOCHEM MOL, V53, P356, DOI 10.1080/10409238.2018.1476449; Challis GL, 2005, CHEMBIOCHEM, V6, P601, DOI 10.1002/cbic.200400283; Ciulli A, 2008, CHEMBIOCHEM, V9, P2606, DOI 10.1002/cbic.200800437; Codd R, 2018, ACS CHEM BIOL, V13, P11, DOI 10.1021/acschembio.7b00851; Cruz-Morales P, 2017, FEMS MICROBIOL ECOL, V93, DOI 10.1093/femsec/fix086; Dell M, 2022, NAT PROD REP, V39, P453, DOI 10.1039/d1np00019e; Duckworth BP, 2011, CHEM BIOL, V18, P1432, DOI 10.1016/j.chembiol.2011.08.013; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fan F, 2007, BIOCHEMISTRY-US, V46, P11421, DOI 10.1021/bi7011492; Ferreras JA, 2005, NAT CHEM BIOL, V1, P29, DOI 10.1038/nchembio706; Finking R, 2003, CHEMBIOCHEM, V4, P903, DOI 10.1002/cbic.200300666; Gadakh B, 2015, EUR J MED CHEM, V93, P227, DOI 10.1016/j.ejmech.2015.02.010; Gaeumann E., 1974, Patent No. 3852424; Ghosh M, 1996, BIOORGAN MED CHEM, V4, P43, DOI 10.1016/0968-0896(95)00161-1; Gulick AM, 2009, ACS CHEM BIOL, V4, P811, DOI 10.1021/cb900156h; GUNTER K, 1993, J BACTERIOL, V175, P3295; Hider RC, 2010, NAT PROD REP, V27, P637, DOI 10.1039/b906679a; Hoffmann KM, 2020, BIOCHEMISTRY-US, V59, P3427, DOI 10.1021/acs.biochem.9b00899; Kadi N, 2008, CHEM COMMUN, P5119, DOI 10.1039/b813029a; Kadi N, 2008, J AM CHEM SOC, V130, P10458, DOI 10.1021/ja8027263; Kadi N, 2007, NAT CHEM BIOL, V3, P652, DOI 10.1038/nchembio.2007.23; Kadi N, 2009, METHOD ENZYMOL, V458, P431, DOI 10.1016/S0076-6879(09)04817-4; Kamtekar S, 2003, P NATL ACAD SCI USA, V100, P1673, DOI 10.1073/pnas.0437911100; Koizumi M, 1999, J AM CHEM SOC, V121, P5799, DOI 10.1021/ja990851a; KOPP LE, 1972, J BIOL CHEM, V247, P3558; Kuhn ML, 2016, ACS INFECT DIS, V2, P579, DOI 10.1021/acsinfecdis.6b00082; Lemoine F, 2019, NUCLEIC ACIDS RES, V47, pW260, DOI 10.1093/nar/gkz303; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Linne U, 2004, METHOD ENZYMOL, V388, P293; Lux MC, 2019, J ANTIBIOT, V72, P325, DOI 10.1038/s41429-019-0171-2; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Mydy LS, 2020, BIOCHEMISTRY-US, V59, P2143, DOI 10.1021/acs.biochem.0c00250; Nolan KP, 2022, ACS CHEM BIOL, V17, P426, DOI 10.1021/acschembio.1c00879; Nusca TD, 2012, J BIOL CHEM, V287, P16058, DOI 10.1074/jbc.M112.359349; Oke Muse, 2010, Journal of Structural and Functional Genomics, V11, P167, DOI 10.1007/s10969-010-9090-y; Oves-Costales D, 2009, CHEM COMMUN, P6530, DOI 10.1039/b913092f; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qiao CH, 2007, J MED CHEM, V50, P6080, DOI 10.1021/jm070905o; Qiao CH, 2007, J AM CHEM SOC, V129, P6350, DOI 10.1021/ja069201e; Rath VL, 1998, STRUCT FOLD DES, V6, P439, DOI 10.1016/S0969-2126(98)00046-X; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Ronan JL, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0068; Rutschlin S, 2018, CHEM-EUR J, V24, P16044, DOI 10.1002/chem.201803494; Rutschlin S, 2018, ACS CHEM BIOL, V13, P1153, DOI 10.1021/acschembio.8b00084; Rutschlin S, 2017, CELL CHEM BIOL, V24, P598, DOI 10.1016/j.chembiol.2017.03.017; Salomone-Stagni M, 2018, J STRUCT BIOL, V202, P236, DOI 10.1016/j.jsb.2018.02.002; Schmelz S, 2011, J MOL BIOL, V412, P495, DOI 10.1016/j.jmb.2011.07.059; Schmelz S, 2009, CURR OPIN STRUC BIOL, V19, P666, DOI 10.1016/j.sbi.2009.09.004; Schmelz S, 2009, NAT CHEM BIOL, V5, P174, DOI 10.1038/nchembio.145; Schmidt BM, 2018, GIGASCIENCE, V7, DOI 10.1093/gigascience/giy079; Senges CHR, 2018, P NATL ACAD SCI USA, V115, P2490, DOI 10.1073/pnas.1715713115; Shapovalov MV, 2011, STRUCTURE, V19, P844, DOI 10.1016/j.str.2011.03.019; Sikora AL, 2010, BIOCHEMISTRY-US, V49, P3648, DOI 10.1021/bi100350c; Somu RV, 2006, J MED CHEM, V49, P31, DOI 10.1021/jm051060o; Tang JY, 2020, ACS CHEM BIOL, V15, P2731, DOI 10.1021/acschembio.0c00523; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; UEDA H, 1991, BIOCHIM BIOPHYS ACTA, V1080, P126, DOI 10.1016/0167-4838(91)90138-P; VERTESY L, 1995, HELV CHIM ACTA, V78, P46, DOI 10.1002/hlca.19950780105; Vertesy L., 1995, Patent No. 5475094; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Wencewicz TA, 2013, BIOCONJUGATE CHEM, V24, P473, DOI 10.1021/bc300610f; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	71	2	2	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2022	298	8							102166	10.1016/j.jbc.2022.102166	http://dx.doi.org/10.1016/j.jbc.2022.102166			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	4F0HN	35750210	Green Published, gold			2022-12-26	WOS:000848197700009
J	Shen, J; Huang, QW; Jia, WY; Feng, SJ; Liu, L; Li, XL; Tao, DD; Xie, DX				Shen, Jie; Huang, Qingwen; Jia, Weiyi; Feng, Shengjie; Liu, Liang; Li, Xiaolan; Tao, Deding; Xie, Daxing			YAP1 induces invadopodia formation by transcriptionally activating TIAM1 through enhancer in breast cancer	ONCOGENE			English	Article							NUCLEOTIDE EXCHANGE FACTOR; HIPPO SIGNALING PATHWAY; METASTASIS; CORTACTIN; BINDING; ASSOCIATION; PODOSOMES; MOLECULE; INVASION; COMPLEX	Yes-associated protein 1 (YAP1), a central component of the Hippo pathway, plays an important role in tumor metastasis; however, the underlying mechanism remains to be elucidated. Invadopodia are actin-rich protrusions containing multiple proteases and have been widely reported to promote cell invasiveness by degrading the extracellular matrix. In the present study, we report that YAP1 induces invadopodia formation and promotes tumor metastasis in breast cancer cells. We also identify TIAM1, a guanine nucleotide exchange factor, as a target of the YAP1-TEAD4 complex. Our results demonstrate that YAP1 could promote TEAD4 binding to the enhancer region of TIAM1, which activates TIAM1 expression, subsequently increasing RAC1 activity and inducing invadopodia formation. These findings reveal the functional role of Hippo signaling in the regulation of invadopodia and provide potential molecular targets for preventing tumor metastasis in breast cancer.	[Shen, Jie; Huang, Qingwen; Jia, Weiyi; Feng, Shengjie; Liu, Liang; Li, Xiaolan; Tao, Deding; Xie, Daxing] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Mol Med Ctr, Wuhan, Peoples R China; [Shen, Jie; Huang, Qingwen; Jia, Weiyi; Feng, Shengjie; Liu, Liang; Xie, Daxing] Huazhong Univ Sci & Technol, Tongji Hosp, Dept GI Surg, Tongji Med Coll, Wuhan, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Xie, DX (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Mol Med Ctr, Wuhan, Peoples R China.; Xie, DX (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Dept GI Surg, Tongji Med Coll, Wuhan, Peoples R China.	dxxie@tjh.tjmu.edu.cn		Shen, Jie/0000-0002-8442-7268	National Natural Science Foundation of China [81572861, 81773053]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (Grant numbers: 81572861, 81773053).	Aguirre-Gamboa R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074250; Alonso DF, 2011, CURR PHARM BIOTECHNO, V12, P1974; Baik M, 2019, METHODSX, V6, P718, DOI 10.1016/j.mex.2019.03.024; Benjamin DC, 2020, CANCER RES, V80, P3867, DOI 10.1158/0008-5472.CAN-20-0212; Bernards A, 2004, TRENDS CELL BIOL, V14, P377, DOI 10.1016/j.tcb.2004.05.003; Boissier P, 2014, CELL SIGNAL, V26, P483, DOI 10.1016/j.cellsig.2013.11.034; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Caldon CE, 2012, MOL CANCER THER, V11, P1488, DOI 10.1158/1535-7163.MCT-11-0963; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Clark ES, 2007, CANCER RES, V67, P4227, DOI 10.1158/0008-5472.CAN-06-3928; Diamantopoulou Z, 2017, CANCER CELL, V31, P621, DOI 10.1016/j.ccell.2017.03.007; Diaz B, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000368; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Eckert MA, 2011, CANCER CELL, V19, P372, DOI 10.1016/j.ccr.2011.01.036; Espanel X, 2001, J BIOL CHEM, V276, P14514, DOI 10.1074/jbc.M008568200; Feldker N, 2020, EMBO J, V39, DOI 10.15252/embj.2019103209; Feng SJ, 2022, CANCER LETT, V532, DOI 10.1016/j.canlet.2022.215588; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Galouzis CC, 2022, CURR OPIN CELL BIOL, V75, DOI 10.1016/j.ceb.2022.01.010; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Harper K, 2010, CANCER RES, V70, P4634, DOI 10.1158/0008-5472.CAN-09-3813; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Hatzis C, 2011, JAMA-J AM MED ASSOC, V305, P1873, DOI 10.1001/jama.2011.593; Head JA, 2003, MOL BIOL CELL, V14, P3216, DOI 10.1091/mbc.e02-11-0753; Jacquemin P, 1996, J BIOL CHEM, V271, P21775, DOI 10.1074/jbc.271.36.21775; Khan A, 2018, NUCLEIC ACIDS RES, V46, pD260, DOI 10.1093/nar/gkx1126; Kudlik G, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21218117; Lin KC, 2017, TRENDS BIOCHEM SCI, V42, P862, DOI 10.1016/j.tibs.2017.09.003; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Lohmer LL, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005786; Lohmer LL, 2014, CELL ADHES MIGR, V8, P246, DOI 10.4161/cam.28406; Maugeri-Sacca M, 2015, EXPERT REV MOL MED, V17, DOI 10.1017/erm.2015.12; Mo JS, 2014, EMBO REP, V15, P642, DOI 10.15252/embr.201438638; Moroishi T, 2015, NAT REV CANCER, V15, P73, DOI 10.1038/nrc3876; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Paz H, 2014, ONCOGENE, V33, P4193, DOI 10.1038/onc.2013.393; Pereira B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11479; Pocaterra A, 2020, J CELL SCI, V133, DOI 10.1242/jcs.230425; Qadir MI, 2015, CHEM BIOL DRUG DES, V86, P432, DOI 10.1111/cbdd.12556; Qiao YT, 2017, CELL REP, V19, P1495, DOI 10.1016/j.celrep.2017.04.075; Revach OY, 2016, EXP CELL RES, V343, P82, DOI 10.1016/j.yexcr.2016.02.003; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rosenberg BJ, 2017, MOL BIOL CELL, V28, P1347, DOI 10.1091/mbc.E16-12-0885; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Sabatier R, 2011, BREAST CANCER RES TR, V126, P407, DOI 10.1007/s10549-010-0897-9; Seano G, 2015, CELL CYCLE, V14, P1370, DOI 10.1080/15384101.2015.1026523; Shao DD, 2014, CELL, V158, P171, DOI 10.1016/j.cell.2014.06.004; Shen J, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0850-z; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun X, 2020, NUCLEIC ACIDS RES, V48, P7182, DOI 10.1093/nar/gkaa482; Surviladze Z., 2010, PROBE REPORTS NIH MO; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tong M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02240-6; Vinci M, 2015, JOVE-J VIS EXP, DOI 10.3791/52686; Wang ZY, 2014, P NATL ACAD SCI USA, V111, pE89, DOI 10.1073/pnas.1319190110; Wang ZQ, 2016, METHODS MOL BIOL, V1406, P203, DOI 10.1007/978-1-4939-3444-7_18; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Yang H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109980; Yu HX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051239; Zagryazhskaya-Masson A, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.201910132; Zanconato F, 2018, NAT MED, V24, P1599, DOI 10.1038/s41591-018-0158-8; Zanconato F, 2015, NAT CELL BIOL, V17, P1218, DOI 10.1038/ncb3216; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhu C, 2019, MOL CELL, V75, P791, DOI 10.1016/j.molcel.2019.06.010	67	1	1	2	2	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 29	2022	41	31					3830	3845		10.1038/s41388-022-02344-4	http://dx.doi.org/10.1038/s41388-022-02344-4		JUN 2022	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	3I9OZ	35773411	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000819316500002
J	Chen, MM; Yang, ZY; Gan, HJ; Wang, Y; Li, CD; Gao, YX				Chen, Meimei; Yang, Zhaoyang; Gan, Huijian; Wang, Yang; Li, Chandong; Gao, Yuxing			Investigation into potential mechanisms of metabolic syndrome by integrative analysis of metabolomics and proteomics	PLOS ONE			English	Article								Metabolic syndrome (MetS) is a complex syndrome cluster of metabolic disorders, which greatly increases the risks of diabetic and cardiovascular diseases. Although it has become a significantly worldwide public health burden, its pathogenesis largely remains unknown. In this study, we first performed an integrated analysis of proteomic and metabonomic data of liver tissues of rats between MetS and control groups to reveal possible mechanisms of MetS. A total of 16 significantly perturbed pathways were identified, of which three pathways were shared by patients with MetS and diabetes identified by analysis of serum samples, including alanine, aspartate and glutamate metabolism, valine, leucine and isoleucine biosynthesis, and glycine, serine and threonine metabolism. Additionally, it was found that 18 differential metabolites were closely related with 36 differential proteins, which were considered as significantly discriminant metabolites and proteins between two groups and were mainly involved in metabolic processes of gamma-aminobutyric acid and acetyl-CoA, biosynthetic processes of cholesterol and amino acids. The results of PPI network analysis and topological parameter calculation of four methods revealed that 16 proteins can serve as hub proteins of MetS. Followed by searching the PubMed database and molecular docking of Cyp7a1 and Got1, we concluded that atorvastatin and resveratrol may be potential drugs for MetS.	[Chen, Meimei; Yang, Zhaoyang; Gan, Huijian; Wang, Yang; Li, Chandong] Fujian Univ Tradit Chinese Med, Coll Tradit Chinese Med, Fuzhou, Fujian, Peoples R China; [Chen, Meimei; Yang, Zhaoyang; Gan, Huijian; Wang, Yang; Li, Chandong] Fujian Univ Tradit Chinese Med, Fujian Key Lab TCM Hlth Status Identificat, Fuzhou, Fujian, Peoples R China; [Chen, Meimei; Yang, Zhaoyang; Gan, Huijian; Wang, Yang; Li, Chandong] Fujian Univ Tradit Chinese Med, Engn Res Ctr, Fuzhou, Fujian, Peoples R China; [Gao, Yuxing] Xiamen Univ, Coll Chem & Chem Engn, Xiamen, Fujian, Peoples R China	Fujian University of Traditional Chinese Medicine; Fujian University of Traditional Chinese Medicine; Fujian University of Traditional Chinese Medicine; Xiamen University	Chen, MM; Li, CD (corresponding author), Fujian Univ Tradit Chinese Med, Coll Tradit Chinese Med, Fuzhou, Fujian, Peoples R China.; Chen, MM; Li, CD (corresponding author), Fujian Univ Tradit Chinese Med, Fujian Key Lab TCM Hlth Status Identificat, Fuzhou, Fujian, Peoples R China.; Chen, MM; Li, CD (corresponding author), Fujian Univ Tradit Chinese Med, Engn Res Ctr, Fuzhou, Fujian, Peoples R China.	chenmeimei1984@163.com; fjzylcd@126.com			Fujian Provincial Natural Science fund subject of China [2022J01361, 2019J01347]; Natural Science fund subject of Fujian University of traditional Chinese Medicine [X2021018]; National Natural Science Foundation programs of China [U1705286, 81973751, 81873237, 82004257]	Fujian Provincial Natural Science fund subject of China; Natural Science fund subject of Fujian University of traditional Chinese Medicine; National Natural Science Foundation programs of China(National Natural Science Foundation of China (NSFC))	Chen M. received Fujian Provincial Natural Science fund subject of China (2022J01361, 2019J01347) and Natural Science fund subject of Fujian University of traditional Chinese Medicine (X2021018-emphasis); Li C., Yang Z., Gan H. and Wang Y. received National Natural Science Foundation programs of China (U1705286, 81973751, 81873237 and 82004257), respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-Rabo MM, 2020, J BIOCHEM MOL TOXIC, V34, DOI 10.1002/jbt.22465; Adams SH, 2011, ADV NUTR, V2, P445, DOI 10.3945/an.111.000737; Aktay G, 2019, J BIOCHEM MOL TOXIC, V33, DOI 10.1002/jbt.22295; Arca M, 2007, DRUGS, V67, P43, DOI 10.2165/00003495-200767001-00005; Chan AML, 2021, NUTRIENTS, V13, DOI 10.3390/nu13082497; Chen H, 2016, P NATL ACAD SCI USA, V113, P5754, DOI 10.1073/pnas.1601355113; Chen MM, 2019, MOLECULES, V24, DOI 10.3390/molecules24162959; Chen Q, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-56; Chen YT, 2018, INT J MOL MED, V41, P3327, DOI 10.3892/ijmm.2018.3535; Chen Z., 2017, J LIAONING U TRADIT, V19, P75; Dunn WB, 2011, NAT PROTOC, V6, P1060, DOI 10.1038/nprot.2011.335; Gonzalez-Franquesa A, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-016-0763-1; He R, 2020, J PROTEOMICS, V228, DOI 10.1016/j.jprot.2020.103924; He YQ, 2020, NUTR METAB, V17, DOI 10.1186/s12986-020-00456-w; Hou CY, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030535; Huang D., 2017, CHINA MED HERALD, V14, P114; Jiang PJ, 2018, J PROTEOMICS, V182, P45, DOI 10.1016/j.jprot.2018.05.001; Lent-Schochet D, 2019, WORLD J DIABETES, V10, P23, DOI 10.4239/wjd.v10.i1.23; Li S., 2016, CHINESE PUBLIC HLTH, V5, P678; Li YY, 2020, CTS-CLIN TRANSL SCI, V13, P1271, DOI 10.1111/cts.12817; Lonardo A, 2015, DIGEST LIVER DIS, V47, P181, DOI 10.1016/j.dld.2014.09.020; Lv YT, 2019, MOLECULES, V24, DOI 10.3390/molecules24071423; Meireles LMC, 2010, NUCLEIC ACIDS RES, V38, pW407, DOI 10.1093/nar/gkq502; Palmnas MSA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21585-6; Pang ZQ, 2021, NUCLEIC ACIDS RES, V49, pW388, DOI 10.1093/nar/gkab382; Pinkosky SL, 2017, TRENDS MOL MED, V23, P1047, DOI 10.1016/j.molmed.2017.09.001; Ramakrishanan N, 2018, J DIABETES COMPLICAT, V32, P791, DOI 10.1016/j.jdiacomp.2018.05.014; Rees SD, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-83; Sadi G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124968; Saklayen MG, 2018, CURR HYPERTENS REP, V20, DOI 10.1007/s11906-018-0812-z; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sookoian S, 2012, WORLD J GASTROENTERO, V18, P3775, DOI 10.3748/wjg.v18.i29.3775; Sun Y, 2020, J CLIN ENDOCR METAB, V105, DOI 10.1210/clinem/dgz240; 't Hart LM, 2018, J CLIN ENDOCR METAB, V103, P4569, DOI 10.1210/jc.2018-01165; WHO, 1999, DEF DIAGN CLASS DIAB; Yamada Y, 2017, INT J CARDIOL, V240, P332, DOI 10.1016/j.ijcard.2017.04.103; Yuan Y, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.600561	37	1	1	6	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7								10.1371/journal.pone.0270593	http://dx.doi.org/10.1371/journal.pone.0270593			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M5FN	35789338	Green Published, gold			2022-12-26	WOS:000835487000016
J	Desta, M; Mekonen, Z; Alemu, AA; Demelash, M; Getaneh, T; Bazezew, Y; Kassa, GM; Wakgari, N				Desta, Melaku; Mekonen, Zenebe; Alemu, Addisu Alehegn; Demelash, Minychil; Getaneh, Temesgen; Bazezew, Yibelu; Kassa, Getachew Mullu; Wakgari, Negash			Determinants of obstructed labour and its adverse outcomes among women who gave birth in Hawassa University referral Hospital: A case-control study	PLOS ONE			English	Article							MATERNAL MORTALITY; OBSTETRIC CARE; HEALTH; PREVENTION; MACROSOMIA; STILLBIRTH; PARTOGRAPH; COUNTRIES; NUTRITION; OBESITY	BackgroundGlobally, obstructed labour accounted for 22% of maternal morbidities and up to 70% of perinatal deaths. It is one of the most common preventable causes of maternal and perinatal mortality in low-income countries. However, there are limited studies on the determinants of obstructed labor in Ethiopia. Therefore, this study was conducted to assess determinants and outcomes of obstructed labor among women who gave birth in Hawassa University Hospital, Ethiopia. MethodsA hospital-based case-control study design was conducted in Hawassa University Hospital among 468 women. All women who were diagnosed with obstructed labour and two consecutive controls giving birth on the same day were enrolled in this study. A pretested data extraction tool was used for data collection from the patient charts. Multivariable logistic regression was employed to identify determinants of obstructed labor. ResultsA total of 156 cases and 312 controls were included with an overall response rate of 96.3%. Women who were primipara [AOR 0.19; 95% CI 0.07, 0.52] and multigravida [AOR 0.17; 95% CI 0.07, 0.41] had lower odds of obstructed labour. While contracted pelvis [AOR 3.98; 95% CI 1.68, 9.42], no partograph utilization [AOR 5.19; 95% CI 1.98, 13.6], duration of labour above 24 hours [AOR 7.61; 95% CI 2.98, 19.8] and estimated distance of 10 to 50 kilometers from the hospital [AOR 3.89; 95% CI 1.14, 13.3] had higher odds. Higher percentage of maternal (65.2%) and perinatal (60%) complications occurred among cases (p-value < 0.05). Obstructed labour accounted for 8.3% of maternal deaths and 39.7% of stillbirth. Uterine rupture, post-partum haemorrhage and sepsis were the common adverse outcomes among cases. ConclusionParity, contracted pelvis, non-partograph utilization, longer duration of labour and longer distance from health facilities were determinants of obstructed labour. Maternal and perinatal morbidity and mortality due to obstructed labour are higher. Therefore, improvement of partograph utilization to identify complications early, birth preparedness, complication readiness and provision of timely interventions are recommended to prevent such complications.	[Desta, Melaku; Alemu, Addisu Alehegn; Getaneh, Temesgen; Bazezew, Yibelu; Kassa, Getachew Mullu] Debre Markos Univ, Coll Hlth Sci, Dept Midwifery, Debre Markos, Ethiopia; [Mekonen, Zenebe] Hawassa Univ, Sch Med, Dept Obstet & Gynecol, Hawassa, Ethiopia; [Demelash, Minychil] Wachamo Univ, Coll Hlth Sci, Dept Midwifery, Wachamo, Ethiopia; [Wakgari, Negash] Ambo Univ, Coll Med & Hlth Sci, Dept Midwifery, Ambo, Ethiopia	Hawassa University; Ambo University	Desta, M (corresponding author), Debre Markos Univ, Coll Hlth Sci, Dept Midwifery, Debre Markos, Ethiopia.	Melakd2018@gmail.com		desta, melaku/0000-0002-4955-2346; Alemu, Addisu Alehegn/0000-0001-6415-6635				Abraham W, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-256; Addisu D, 2021, MIDWIFERY, V95, DOI 10.1016/j.midw.2021.102930; Adeoye IA, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-93; Agbozo F, 2016, MIDWIFERY, V40, P200, DOI 10.1016/j.midw.2016.06.016; Ahmed Y., 2017, EC GYNAECOLOGY, V4, P126; Aimukhametova G, 2012, NAGOYA J MED SCI, V74, P83; Ali A, 2010, TRAINING COURSE SEXU; Ali AA, 2010, J OBSTET GYNAECOL, V30, P376, DOI 10.3109/01443611003672096; Aliyu S., 2016, INTERNAL MED, V6, P1000222; Alkire BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034595; Aminu M, 2014, BJOG-INT J OBSTET GY, V121, P141, DOI 10.1111/1471-0528.12995; [Anonymous], 2015, INT FED OBST GYN MAN, V4; Astatikie G, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1302-z; Ayenew AA, 2021, REPROD HEALTH, V18, DOI 10.1186/s12978-021-01103-0; Bailey PE, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1479-1; Bako B, 2018, SAHEL MED J, V21, P117; Bayou G, 2012, ETHIOP J HEALTH SCI, V22, P153; Berhan Y, 2014, ETHIOP J HEALTH SCI, V24, P15, DOI 10.4314/ejhs.v24i0.3S; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Black RE, 2016, LANCET, V388, P2811, DOI 10.1016/S0140-6736(16)00738-8; Cunha Antonio Jose Ledo Alves da, 2017, Rev Peru Med Exp Salud Publica, V34, P36, DOI 10.17843/rpmesp.2017.341.2765; Dangal G., 2006, INT J GYNECOL OBSTET, V7, P1; Dile M, 2020, WOMENS HEALTH, V16, DOI 10.1177/1745506520949727; Endris N, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/6587853; Fantu S, 2010, ETHIOP J HEALTH SCI, V20, P145; Gans-Lartey F, 2013, MIDWIFERY, V29, P461, DOI 10.1016/j.midw.2012.03.002; Gebresilasea GU., 2017, N ETHIOPIA INT J NUR, V9, P77, DOI [10.5897/IJNM2017.0261, DOI 10.5897/IJNM2017.0261]; Gedefaw M., 2014, OPEN J EPIDEMIOLOGY, V4, P199, DOI [10.4236/ojepi.2014.44026, DOI 10.4236/OJEPI.2014.44026]; Gudina AT., 2016, J GYNECOL OBSTET, V4, P12; Gupta R., 2012, INT J BIOL MED RES, V3, P2185; Hailu M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021432; Hanson C, 2015, LANCET GLOB HEALTH, V3, pE387, DOI 10.1016/S2214-109X(15)00048-0; Harrison MS, 2016, AM J PERINAT, V33, P873, DOI 10.1055/s-0036-1571322; Harrison MS, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-S2-S9; Henok A., 2015, J WOMENS HLTH CARE, V4, P2167; Hofmeyr GJ, 2009, INT J GYNECOL OBSTET, V107, pS21, DOI 10.1016/j.ijgo.2009.07.017; Islam JA, 2012, J SHAHEED SUHRAWARDY, V4, P43; Kabakyenga JK, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-73; Kalisa R., 2016, AM J PUBLIC HLTH RES, V4, P191; Kalliala I, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j4511; Kaso M, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-55; Kassebaum NJ, 2016, LANCET, V388, P1775, DOI 10.1016/S0140-6736(16)31470-2; Konje JC, 2000, AM J CLIN NUTR, V72, p291S, DOI 10.1093/ajcn/72.1.291S; Koyanagi A, 2013, LANCET, V381, P476, DOI 10.1016/S0140-6736(12)61605-5; Kozuki N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S3; Lavender T, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005461.pub5; Liyew EF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179013; Mathai M, 2009, CLIN OBSTET GYNECOL, V52, P256, DOI 10.1097/GRF.0b013e3181a4f163; Mekango DE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183886; Mitteroecker P, 2017, P NATL ACAD SCI USA, V114, P11669, DOI 10.1073/pnas.1712203114; Mohammed AA, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-102; Mohapatra S., AGE, V20, P20; Nakimuli A, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0362-3; Nilsson M, 2016, NATURE, V534, P320, DOI 10.1038/534320a; Nwogu-Ikojo EE, 2008, J OBSTET GYNAECOL, V28, P596, DOI 10.1080/01443610802281682; Onubi OJ, 2016, J PUBLIC HEALTH-UK, V38, pE218, DOI 10.1093/pubmed/fdv138; Petersen EE, 2019, MMWR-MORBID MORTAL W, V68, P423, DOI 10.15585/mmwr.mm6818e1; Said AS, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1044-3; Shewasinad S., 2017, ETHIOPIA GLOBAL J RE, V2; Soren M., 2018, INDIAN J APPL RES, V8; Souza JP, 2010, B WORLD HEALTH ORGAN, V88, P113, DOI 10.2471/BLT.08.057828; Wells JCK, 2017, ANAT REC, V300, P716, DOI 10.1002/ar.23540; WHO (World Health Organization), 2015, STRAT END PREV MAT M; Wolde T, 2014, PREVALENCE UNDERNUTR, P65; Wube TT., 2018, CLIN MED RES, V7, P135	66	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	6							e0268938	10.1371/journal.pone.0268938	http://dx.doi.org/10.1371/journal.pone.0268938			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3F0KH	35749473	Green Published, gold			2022-12-26	WOS:000830362700034
J	Lacey, A; Whyte, E; O'Keeffe, S; O'Connor, S; Moran, K				Lacey, Aisling; Whyte, Enda; O'Keeffe, Sinead; O'Connor, Siobhan; Moran, Kieran			A qualitative examination of the factors affecting the adoption of injury focused wearable technologies in recreational runners	PLOS ONE			English	Article							EXTREMITY RUNNING INJURIES; GROUND REACTION FORCES; RISK-FACTORS; PROTECTIVE FACTORS; KINETIC ASYMMETRY; USER ACCEPTANCE; FEMALE RUNNERS; SPORT; KINEMATICS; FRAMEWORK	PurposeUnderstanding the perceived efficacy and ease of use of technologies will influence initial adoption and sustained utilization. The objectives of this study were to determine the metrics deemed important by runners for monitoring running-related injury (RRI) risk, and identify the facilitators and barriers to their use of injury focused wearable technologies. MethodsA qualitative focus group study was undertaken. Nine semi-structured focus groups with male (n = 13) and female (n = 14) recreational runners took place. Focus groups were audio and video recorded, and transcribed verbatim. Transcripts were thematically analysed. A critical friend approach was taken to data coding, and multiple methods of trustworthiness were executed. ResultsExcessive loading and inadequate recovery were deemed the most important risk factors to monitor for RRI risk. Other important factors included training activities, injury status and history, and running technique. The location and method of attachment of a wearable device, the design of a smartphone application, and receiving useful injury-related information will affect recreational runners' adoption of injury focused technologies. ConclusionsOvertraining, training-related and individual-related risk factors are essential metrics that need to be monitored for RRI risk. RRI apps should include the metrics deemed important by runners, once there is supporting evidence-based research. The difficulty and/or ease of use of a device, and receiving useful feedback will influence the adoption of injury focused running technologies. There is a clear willingness from recreational runners to adopt injury focused wearable technologies whilst running.	[Lacey, Aisling; Whyte, Enda; O'Keeffe, Sinead; O'Connor, Siobhan; Moran, Kieran] Dublin City Univ, Sch Hlth & Human Performance, Dublin, Ireland; [Lacey, Aisling; Moran, Kieran] Insight SFI Res Ctr Data Analyt, Dublin, Ireland; [Whyte, Enda; O'Keeffe, Sinead; O'Connor, Siobhan] Dublin City Univ, Ctr Injury Prevent & Performance, Sch Hlth & Human Performance, Dublin, Ireland	Dublin City University; Dublin City University	Lacey, A (corresponding author), Dublin City Univ, Sch Hlth & Human Performance, Dublin, Ireland.; Lacey, A (corresponding author), Insight SFI Res Ctr Data Analyt, Dublin, Ireland.	aisling.lacey5@mail.dcu.ie	; O Connor, Siobhan/Q-8568-2018	Lacey, Aisling/0000-0003-1242-8736; O Connor, Siobhan/0000-0002-2001-0746	Science Foundation Ireland (SFI) [SFI/12/RC/2289_P2]; European Regional Development Fund; Science Foundation Ireland	Science Foundation Ireland (SFI)(Science Foundation Ireland); European Regional Development Fund(European Commission); Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	The authors would like to thank the focus groups participants for their participation.	Aldiabat KM, 2018, QUAL REP, V23, P245; Alnasser A, 2019, JMIR MHEALTH UHEALTH, V7, DOI 10.2196/10923; Baltich J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125196; Bardus M, 2021, SENSORS-BASEL, V21, DOI 10.3390/s21134472; Bergmann JHM, 2011, ANN BIOMED ENG, V39, P2299, DOI 10.1007/s10439-011-0339-9; Bertelsen ML, 2017, SCAND J MED SCI SPOR, V27, P1170, DOI 10.1111/sms.12883; Boeije H, 2002, QUAL QUANT, V36, P391, DOI 10.1023/A:1020909529486; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Bredeweg SW, 2013, GAIT POSTURE, V38, P847, DOI 10.1016/j.gaitpost.2013.04.014; Brindle RA, 2020, SPORTS MED, V50, P331, DOI 10.1007/s40279-019-01207-5; Brown, 2020, OXFORD HDB IDENTITIE, P295; Bunn Jennifer A, 2018, Int J Exerc Sci, V11, P503; Burke A, 2021, ORTHOP J SPORTS MED, V9, DOI 10.1177/23259671211020283; Busetto L, 2018, INT J INTEGR CARE, V18, DOI 10.5334/ijic.3587; Canhoto AI, 2017, J MARKET MANAG-UK, V33, P32, DOI 10.1080/0267257X.2016.1234505; Carroll J.M., ICONFERENCE 2015 P; Celik Y, 2021, MED ENG PHYS, V87, P9, DOI 10.1016/j.medengphy.2020.11.005; Ceyssens L, 2019, SPORTS MED, V49, P1095, DOI 10.1007/s40279-019-01110-z; Charmaz K., 2017, CONSTRUCTING GROUNDE; Clermont CA, 2020, INT J HUM-COMPUT INT, V36, P31, DOI 10.1080/10447318.2019.1597575; Cowan D, 2016, QUAL RES SPORT EXERC, V8, P505, DOI 10.1080/2159676X.2016.1206608; Daoud AI, 2012, MED SCI SPORT EXER, V44, P1325, DOI 10.1249/MSS.0b013e3182465115; DAVIS FD, 1989, MIS QUART, V13, P319, DOI 10.2307/249008; Davis IS, 2016, BRIT J SPORT MED, V50, P887, DOI 10.1136/bjsports-2015-094579; DeJong AF, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246300; Dempster J., 2021, PHYS ACTIVITY HLTH, V5, P133, DOI 10.5334/paah.109; Desai P, 2021, J ORTHOP SPORT PHYS, V51, P144, DOI 10.2519/jospt.2021.9673; Dixon SJ, 2000, MED SCI SPORT EXER, V32, P1919, DOI 10.1097/00005768-200011000-00016; Feng Y., 2019, ASLIB J INFORM MANAG, V71; Finch C, 2006, J SCI MED SPORT, V9, P3, DOI 10.1016/j.jsams.2006.02.009; Fokkema T, 2020, BMJ OPEN SPORT EXERC, V6, DOI 10.1136/bmjsem-2020-000780; Furlong LAM, 2018, MED SCI SPORT EXER, V50, P1241, DOI 10.1249/MSS.0000000000001560; Gijon-Nogueron G, 2015, J AM PODIAT MED ASSN, V105, P532, DOI 10.7547/14-069.1; Giraldo-Pedroza A, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20226637; Goss Donald L, 2012, US Army Med Dep J, P25; Goswami SP., 2019, INT J MIND BRAIN COG, V10; Hermsen S, 2017, JMIR MHEALTH UHEALTH, V5, DOI 10.2196/mhealth.7311; Holt NL, 2016, ROUT INT HANDB, P24; Hreljac Alan, 2005, Phys Med Rehabil Clin N Am, V16, P651; Hulme A, 2017, SPORTS MED, V47, P869, DOI 10.1007/s40279-016-0636-4; Jalloul N, 2018, BIOMED J, V41, P249, DOI 10.1016/j.bj.2018.06.003; Janssen M, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072276; Jensen MM, 2014, P 26 AUSTR COMP HUM, P527, DOI [10.1145/2686612.2686696, DOI 10.1145/2686612.2686696]; Kakouris N, 2021, J SPORT HEALTH SCI, V10, P513, DOI 10.1016/j.jshs.2021.04.001; Kalantari M., 2017, INT J TECHNOLOGY MAR, V12, P274, DOI [10.1504/IJTMKT.2017.089665, DOI 10.1504/IJTMKT.2017.089665, DOI 10.1504/IJTMKT.2017.10008634]; Karahanoglu A, 2021, SENSORS-BASEL, V21, DOI 10.3390/s21113687; Kennedy TJT, 2006, MED EDUC, V40, P101, DOI 10.1111/j.1365-2929.2005.02378.x; Kiernan D, 2018, J BIOMECH, V73, P201, DOI 10.1016/j.jbiomech.2018.04.001; Kinney DA, 2019, AM J HEALTH EDUC, V50, P298, DOI 10.1080/19325037.2019.1642265; Kononova A, 2019, JMIR MHEALTH UHEALTH, V7, DOI 10.2196/mhealth.9832; Kuru A, 2016, INT J HUM-COMPUT INT, V32, P847, DOI 10.1080/10447318.2016.1202461; Lazar A, 2015, PROCEEDINGS OF THE 2015 ACM INTERNATIONAL JOINT CONFERENCE ON PERVASIVE AND UBIQUITOUS COMPUTING (UBICOMP 2015), P635, DOI 10.1145/2750858.2804288; Luczak T, 2020, INT J SPORTS SCI COA, V15, P26, DOI 10.1177/1747954119885244; Malasinghe LP, 2019, J AMB INTEL HUM COMP, V10, P57, DOI 10.1007/s12652-017-0598-x; Malisoux L, 2015, SCAND J MED SCI SPOR, V25, P110, DOI 10.1111/sms.12154; Malisoux L, 2020, AM J SPORT MED, V48, P473, DOI 10.1177/0363546519892578; McGannon KR, 2021, INT J SPORT EXERC PS, V19, P359, DOI 10.1080/1612197X.2019.1655779; Menheere D, 2020, P 11 NORD C HUM COMP, P1; Messier SP, 2018, AM J SPORT MED, V46, P2211, DOI 10.1177/0363546518773755; Moore IS, 2019, CURR SPORT MED REP, V18, P437, DOI 10.1249/JSR.0000000000000667; Mulvad B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204742; Nigg BM, 2012, J BIOMECH, V45, P1692, DOI 10.1016/j.jbiomech.2012.03.027; O'Brien BC, 2014, ACAD MED, V89, P1245, DOI 10.1097/ACM.0000000000000388; Papi E, 2015, MED ENG PHYS, V37, P698, DOI 10.1016/j.medengphy.2015.03.017; Patel S, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-21; Pobiruchin M, 2017, JMIR MHEALTH UHEALTH, V5, DOI 10.2196/mhealth.6395; Robadey J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205191; Rogers E.M., 2003, DIFFUSION INNOVATION, V5th; Runkeeper, PREV INJ IMPR YOUR R; Runner's World, WHAT IS BEST SURF RU; Runner's World, INJ COULD YOUR FOOT; Saragiotto BT, 2014, J ORTHOP SPORT PHYS, V44, P733, DOI 10.2519/jospt.2014.5710; Saragiotto BT, 2014, SPORTS MED, V44, P1153, DOI 10.1007/s40279-014-0194-6; Satterthwaite P, 1999, BRIT J SPORT MED, V33, P22, DOI 10.1136/bjsm.33.1.22; Saw AE, 2015, J SPORT SCI MED, V14, P732; Schubert AG, 2014, SPORTS HEALTH, V6, P210, DOI 10.1177/1941738113508544; Smith B, 2018, INT REV SPORT EXER P, V11, P101, DOI [10.1080/1750984X.2017.1317357, 10.1080/1750984x.2017.1317357]; Sparkes A. C., 2014, QUALITATIVE RES METH; Stragier J, 2018, BEHAV INFORM TECHNOL, V37, P815, DOI 10.1080/0144929X.2018.1484516; STRUTZEL E, 1968, NURS RES, V17, P364; Taunton JE, 2003, BRIT J SPORT MED, V37, P239, DOI 10.1136/bjsm.37.3.239; Tessutti V, 2012, J SPORT SCI, V30, P1545, DOI 10.1080/02640414.2012.713975; Tracy SJ, 2010, QUAL INQ, V16, P837, DOI 10.1177/1077800410383121; van der Worp H, 2016, BRIT J SPORT MED, V50, P450, DOI 10.1136/bjsports-2015-094924; van der Worp MP, 2016, J ORTHOP SPORT PHYS, V46, P462, DOI 10.2519/jospt.2016.6402; van der Worp MP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114937; van Gent RN, 2007, BRIT J SPORT MED, V41, P469, DOI 10.1136/bjsm.2006.033548; van Poppel D, 2021, J SPORT HEALTH SCI, V10, P14, DOI 10.1016/j.jshs.2020.06.006; Vannatta CN, 2020, CLIN BIOMECH, V75, DOI 10.1016/j.clinbiomech.2020.104991; Venkatesh V, 2003, MIS QUART, V27, P425, DOI 10.2307/30036540; Verhagen E, 2018, TRANSL SPORTS MED, V1, P54; Verhagen E, 2021, BMJ OPEN SPORT EXERC, V7, DOI 10.1136/bmjsem-2021-001117; Vos S, 2016, PROCEDIA ENGINEER, V147, P799, DOI 10.1016/j.proeng.2016.06.311; Wang L, 2012, RES SPORTS MED, V20, P75, DOI 10.1080/15438627.2012.660816; Wiesner M, 2018, JMIR MHEALTH UHEALTH, V6, DOI 10.2196/mhealth.9623; Yamato TP, 2015, J ORTHOP SPORT PHYS, V45, P375, DOI 10.2519/jospt.2015.5741; Zadpoor AA, 2011, CLIN BIOMECH, V26, P23, DOI 10.1016/j.clinbiomech.2010.08.005; Zifchock RA, 2006, J BIOMECH, V39, P2792, DOI 10.1016/j.jbiomech.2005.10.003; Zifchock RA, 2008, HUM MOVEMENT SCI, V27, P888, DOI 10.1016/j.humov.2008.03.007	99	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7								10.1371/journal.pone.0265475	http://dx.doi.org/10.1371/journal.pone.0265475			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M3CI	35793284	Green Submitted, Green Published, gold			2022-12-26	WOS:000835338100025
J	Sun, JD; Fan, XX; Li, HT				Sun, Jiandong; Fan, Xuexiu; Li, Haitian			How do high-performance work systems affect work fatigue: The mediating effect of job responsibility and role overload	PLOS ONE			English	Article							INTENSIFICATION; RESOURCES; BURNOUT; STRESS; LEVEL; CONSERVATION; ENGAGEMENT; MOTIVATION; CHALLENGE; CONFLICT	Work fatigue refers to physical, mental, and emotional exhaustion, resulting in the inability to work. Hitherto research indicate a close relationship between high-performance work systems and work fatigue, and there may be a double-edged sword effect of high-performance work systems on work fatigue. However, a comprehensive theoretical framework has not been developed to understand the relationship between them. Based on the challenge-hindrance stress model, this study employs role overload and job responsibility as mediating variables in a conceptual framework to understand the impact of high-performance work systems on work fatigue. Using the partial least square structural equation model and a sample of 360 employees in China, the mediating effects of role overload and job responsibility were confirmed. Further, the internal mechanisms of how high-performance work systems affect work fatigue are discussed, its adverse effects are confirmed, and its practical implications are proposed.	[Sun, Jiandong] Guilin Univ Aerosp Technol, Sch Management, Guilin City, Guangxi Zhuang, Peoples R China; [Fan, Xuexiu] Guilin Univ Aerosp Technol, Sch Foreign Language & Int Business, Guilin City, Guangxi Zhuang, Peoples R China; [Li, Haitian] Southwest Med Univ, Sch Pharm, Luzhou, Peoples R China	Guilin University of Aerospace Technology; Guilin University of Aerospace Technology; Southwest Medical University	Fan, XX (corresponding author), Guilin Univ Aerosp Technol, Sch Foreign Language & Int Business, Guilin City, Guangxi Zhuang, Peoples R China.	Helen-F@nuaa.edu.cn			Guangxi Philosophy and Social Science Planning 'Research on the Influencing Factors and Typical Models of Subversive Innovation of New Start-ups in Guangxi under Data-Driven' [21FGL045]	Guangxi Philosophy and Social Science Planning 'Research on the Influencing Factors and Typical Models of Subversive Innovation of New Start-ups in Guangxi under Data-Driven'	This study is supported by Guangxi Philosophy and Social Science Planning Research Topic Research on the Influencing Factors and Typical Models of Subversive Innovation of New Start-ups in Guangxi under Data-Driven', NO.21FGL045. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas J., 2021, RES GLOB, V3, P100037, DOI [DOI 10.1016/J.RESGLO.2021.100037, 10.1016/J.RESGLO.2021.100037]; Abbas J., 2021, CURR RES BEHAV SCI, V2, DOI [10.1016/j.crbeha.2021.100033, DOI 10.1016/J.CRBEHA.2021.100033]; Abbas J, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11113006; AMABILE TM, 1990, SAGE FOC ED, V115, P61; [Anonymous], 1983, STRESS RES; Aryee S, 2012, J APPL PSYCHOL, V97, P287, DOI 10.1037/a0025739; Bakker A. B., 2018, HDB WELL BEING; Boxall P, 2014, WORK EMPLOY SOC, V28, P963, DOI 10.1177/0950017013512714; Boxall P, 2009, HUM RESOUR MANAG J, V19, P3, DOI 10.1111/j.1748-8583.2008.00082.x; BRETZ RD, 1994, PERS PSYCHOL, V47, P275, DOI 10.1111/j.1744-6570.1994.tb01725.x; Brown SP, 2005, J APPL PSYCHOL, V90, P972, DOI 10.1037/0021-9010.90.5.972; Cavanaugh MA, 2000, J APPL PSYCHOL, V85, P65, DOI 10.1037/0021-9010.85.1.65; Crawford ER, 2010, J APPL PSYCHOL, V95, P834, DOI 10.1037/a0019364; Cropanzano R., 2001, ADV ORG JUSTICE, P119; Elovainio M, 2001, J APPL PSYCHOL, V86, P418, DOI 10.1037//0021-9010.86.3.418; Frone MR, 2018, STRESS HEALTH, V34, P674, DOI 10.1002/smi.2828; Frone MR, 2015, J OCCUP HEALTH PSYCH, V20, P273, DOI 10.1037/a0038700; [高中华 Gao Zhonghua], 2014, [心理学报, Acta Psychologica Sinica], V46, P552; Guest DE, 2017, HUM RESOUR MANAG J, V27, P22, DOI 10.1111/1748-8583.12139; HACKMAN JR, 1976, ORGAN BEHAV HUM PERF, V16, P250, DOI 10.1016/0030-5073(76)90016-7; Han J, 2020, HUM RESOUR MANAGE R, V30, DOI 10.1016/j.hrmr.2019.100699; Hobfoll SE, 2018, ANNU REV ORGAN PSYCH, V5, P103, DOI 10.1146/annurev-orgpsych-032117-104640; Jensen JM, 2013, J MANAGE, V39, P1699, DOI 10.1177/0149206311419663; Kane-Frieder RE, 2014, HUM RELAT, V67, P357, DOI 10.1177/0018726713495068; Kelliher C, 2010, HUM RELAT, V63, P83, DOI 10.1177/0018726709349199; Kroon B, 2009, PERS REV, V38, P509, DOI 10.1108/00483480910978027; Lazarus R.S., 1984, EMOTION ADAPTATION; Lederer W, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206050; Leong CS, 1996, HUM RELAT, V49, P1345, DOI 10.1177/001872679604901004; LePine JA, 2004, J APPL PSYCHOL, V89, P883, DOI 10.1037/0021-9010.89.5.883; Macky K, 2008, ASIA PAC J HUM RESOU, V46, P38, DOI 10.1177/1038411107086542; MCCAULEY CD, 1994, J APPL PSYCHOL, V79, P544, DOI 10.1037/0021-9010.79.4.544; Messersmith JG, 2011, J APPL PSYCHOL, V96, P1105, DOI 10.1037/a0024710; Oppenauer V, 2018, INT J HUM RESOUR MAN, V29, P311, DOI 10.1080/09585192.2016.1146321; Ortqvist D., 2006, INT J STRESS MANAGE, V13, P399, DOI [10.1037/1072-5245.13.4.399, DOI 10.1037/1072-5245.13.4.399, DOI 10.1037/1072-5245.-13.4.399]; Park HI, 2014, APPL PSYCHOL-INT REV, V63, P607, DOI 10.1111/apps.12008; Park S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236931; PETERSON MF, 1995, ACAD MANAGE J, V38, P429, DOI 10.2307/256687; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; Ramsay H, 2000, BRIT J IND RELAT, V38, P501, DOI 10.1111/1467-8543.00178; Sun LY, 2007, ACAD MANAGE J, V50, P558, DOI 10.5465/AMJ.2007.25525821; Topcic M, 2016, INT J HUM RESOUR MAN, V27, P45, DOI 10.1080/09585192.2015.1043136; Van De Voorde K, 2015, HUM RESOUR MANAG J, V25, P62, DOI 10.1111/1748-8583.12062; Wang H.L., 2016, MANAGE WORLD, V110, P125, DOI [10.19744/j.cnki.11-1235/f.2016.08.010, DOI 10.19744/J.CNKI.11-1235/F.2016.08.010]; Webster JR, 2011, J VOCAT BEHAV, V79, P505, DOI 10.1016/j.jvb.2011.02.001; Winwood PC, 2005, J OCCUP ENVIRON MED, V47, P594, DOI 10.1097/01.jom.0000161740.71049.c4; Zhang, 2009, PSYCHOL DEV ED, V1, P114, DOI [10.16187/j.cnki.issn1001-4918.2009.01.017, DOI 10.16187/J.CNKI.ISSN1001-4918.2009.01.017]; Zhang MQ, 2013, INT J HUM RESOUR MAN, V24, P3196, DOI [10.1080/09585192.2013.775026, 10.1080/09585192.2013.763849]; Zhang XM, 2017, ORGAN BEHAV HUM DEC, V143, P54, DOI 10.1016/j.obhdp.2017.02.003	49	0	0	12	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7								10.1371/journal.pone.0269452	http://dx.doi.org/10.1371/journal.pone.0269452			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M3CI	35793365	gold, Green Published			2022-12-26	WOS:000835338100005
J	Swami, V; Hochstoger, S; Kargl, E; Stieger, S				Swami, Viren; Hochstoger, Samantha; Kargl, Erik; Stieger, Stefan			Hangry in the field: An experience sampling study on the impact of hunger on anger, irritability, and affect	PLOS ONE			English	Article							SELF-CONTROL; INDIVIDUAL-DIFFERENCES; CORE AFFECT; APPETITE; AGGRESSION; VALIDITY; QUESTIONNAIRE; SENSATIONS; DEPLETION; BEHAVIOR	The colloquial term "hangry" refers to the notion that people become angry when hungry, but very little research has directly determined the extent to which the relationship between hunger and negative emotions is robust. Here, we examined associations between everyday experiences of hunger and negative emotions using an experience sampling method. Sixty-four participants from Central Europe completed a 21-day experience sampling phase in which they reported their hunger, anger, irritability, pleasure, and arousal at five time-points each day (total = 9,142 responses). Results indicated that greater levels of self-reported hunger were associated with greater feelings of anger and irritability, and with lower pleasure. These findings remained significant after accounting for participant sex, age, body mass index, dietary behaviours, and trait anger. In contrast, associations with arousal were not significant. These results provide evidence that everyday levels of hunger are associated with negative emotionality and supports the notion of being "hangry".	[Swami, Viren] Anglia Ruskin Univ, Sch Psychol & Sport Sci, Cambridge, England; [Swami, Viren] Perdana Univ, Ctr Psychol Med, Kuala Lumpur, Malaysia; [Hochstoger, Samantha; Kargl, Erik; Stieger, Stefan] Karl Landsteiner Univ Hlth Sci, Dept Psychol & Psychodynam, Krems An Der Donau, Austria	Anglia Ruskin University; Perdana University	Stieger, S (corresponding author), Karl Landsteiner Univ Hlth Sci, Dept Psychol & Psychodynam, Krems An Der Donau, Austria.	stefan.stieger@kl.ac.at	Stieger, Stefan/G-2572-2012	Stieger, Stefan/0000-0002-7784-6624				Anderberg RH, 2016, NEUROPSYCHOPHARMACOL, V41, P1199, DOI 10.1038/npp.2015.297; Barrett L. F., 2007, SOCIAL PSYCHOL UNCON, P173; Barrett LF, 1999, CURR DIR PSYCHOL SCI, V8, P10, DOI 10.1111/1467-8721.00003; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Baumeister RF, 1998, J PERS SOC PSYCHOL, V74, P1252, DOI 10.1037/0022-3514.74.5.1252; Being Taylor-Brown E., 2018, GUT FEELING DIGESTIV, P109, DOI [10.1007/978-3-030-01857-3_6, DOI 10.1007/978-3-030-01857-3_6]; Bolger N., 2013, INTENSIVE LONGITUDIN; Brennan R.L., 2001, GEN THEORY, DOI [10.1007/978-1-4757-3456-0, DOI 10.1007/978-1-4757-3456-0]; Bushman BJ, 2014, P NATL ACAD SCI USA, V111, P6254, DOI 10.1073/pnas.1400619111; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; Carter EC, 2015, J EXP PSYCHOL GEN, V144, P796, DOI 10.1037/xge0000083; Cummings DE, 2006, PHYSIOL BEHAV, V89, P71, DOI 10.1016/j.physbeh.2006.05.022; Curran PJ, 2011, ANNU REV PSYCHOL, V62, P583, DOI 10.1146/annurev.psych.093008.100356; Dang JH, 2021, SOC PSYCHOL PERS SCI, V12, P14, DOI 10.1177/1948550619887702; Dang JH, 2019, SOC PSYCHOL-GERMANY, V50, P277, DOI 10.1027/1864-9335/a000399; DEGRAAF C, 1993, APPETITE, V21, P156, DOI 10.1016/0195-6663(93)90008-8; DeWall CN, 2011, AGGRESSIVE BEHAV, V37, P73, DOI 10.1002/ab.20366; DeWall CN, 2010, PERS INDIV DIFFER, V49, P823, DOI 10.1016/j.paid.2010.06.030; Eck KM, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16183238; Edmunds D, 2021, ANIM BEHAV, V177, P183, DOI 10.1016/j.anbehav.2021.05.001; Enders CK, 2007, PSYCHOL METHODS, V12, P121, DOI 10.1037/1082-989X.12.2.121; Flint A, 2000, INT J OBESITY, V24, P38, DOI 10.1038/sj.ijo.0801083; Fokidis HB, 2013, ENDOCRINOLOGY, V154, P4328, DOI 10.1210/en.2013-1171; Friese M, 2019, PERS SOC PSYCHOL REV, V23, P107, DOI 10.1177/1088868318762183; Gailliot M., 2013, PSYCHOLOGY, V4, P59, DOI [https://doi.org/10.4236/PSYCH.2013.41008, DOI 10.4236/PSYCH.2013.41008, 10.4236/psych.2013.41008, DOI 10.4236/psych.2013.41008]; Gotz FM, 2020, COLLABRA-PSYCHOL, V6, DOI 10.1525/collabra.262; Grunert SC., 1989, DIAGNOSTICA, V2, P167; Hausser JA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12579-7; Hamaker E.L., 2012, HDB RES METHODS STUD, P43, DOI DOI 10.5860/CHOICE.50-1159; Harthoorn LF, 2008, EUR J APPL PHYSIOL, V102, P601, DOI 10.1007/s00421-007-0622-5; Herzberg P. Y., 2003, J DIFFERENTIAL DIAGN, V24, P311; Hoemann K, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-69180-y; Kievit RA, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00513; Kim C, 2018, TWITTER; Kuppens P, 2007, EMOTION, V7, P262, DOI 10.1037/1528-3542.7.2.262; Kurzban R, 2010, EVOL PSYCHOL-US, V8, P244, DOI 10.1177/147470491000800208; Ludecke D., 2021, SJSTATS STAT FUNCTIO, DOI [10.5281/zenodo.1284472, DOI 10.5281/ZENODO.1284472]; Ma QY, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.651760; MacCormack JK, 2019, SOC PERSONAL PSYCHOL, V13, DOI 10.1111/spc3.12496; MacCormack JK, 2019, EMOTION, V19, P301, DOI 10.1037/emo0000422; Macht M, 2004, ECOL FOOD NUTR, V43, P327, DOI 10.1080/03670240490454723; Mehl M.R., 2012, HDB RES METHODS STUD; Miles E, 2016, J EXP PSYCHOL GEN, V145, DOI 10.1037/xge0000185; MONELLO LF, 1967, AM J CLIN NUTR, V20, P253, DOI 10.1093/ajcn/20.3.253; Nakagawa S, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2017.0213; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; NARENS L, 1981, THEOR DECIS, V13, P1, DOI 10.1007/BF02342603; Nezlek J.B., 2012, HDB RES METHODS STUD, P357, DOI DOI 10.1080/10705511.2011.557329; Nugraha B, 2017, APPETITE, V111, P38, DOI 10.1016/j.appet.2016.12.030; R Core Team, 2020, R LANG ENV STAT COMP; Renner B, 2012, APPETITE, V59, P117, DOI 10.1016/j.appet.2012.04.004; RUSSELL JA, 1989, J PERS SOC PSYCHOL, V57, P493, DOI 10.1037/0022-3514.57.3.493; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Russell JA, 2003, PSYCHOL REV, V110, P145, DOI 10.1037/0033-295X.110.1.145; Russell JA, 2017, EMOT REV, V9, P111, DOI 10.1177/1754073916639658; Shabat-Simon M, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00750; Shrout PE, 2012, HDB RES METHODS STUD, P302; Slack KS, 2005, SOC SERV REV, V79, P511, DOI 10.1086/430894; Solianik R, 2018, BEHAV BRAIN RES, V338, P166, DOI 10.1016/j.bbr.2017.10.028; Stelick A, 2018, CURR OPIN FOOD SCI, V21, P26, DOI 10.1016/j.cofs.2018.05.005; Stevenson RJ, 2015, APPETITE, V95, P44, DOI 10.1016/j.appet.2015.06.008; Stieger S, 2022, INT J ENVIRON HEAL R, V32, P870, DOI 10.1080/09603123.2020.1803805; Stieger S, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00901; Stratton RJ, 1998, EUR J CLIN NUTR, V52, P737, DOI 10.1038/sj.ejcn.1600636; Swami V, 2020, BODY IMAGE, V32, P167, DOI 10.1016/j.bodyim.2020.01.003; Swami V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057623; Todd J, 2020, BODY IMAGE, V34, P101, DOI 10.1016/j.bodyim.2020.05.011; Twisk JWR, 2006, APPL MULTILEVEL ANAL; Venables WN., 2002, MODERN APPL STAT S 4; Winkielman P, 2005, PERS SOC PSYCHOL B, V31, P121, DOI 10.1177/0146167204271309; Yeomans MR, 2017, APPETITE, V110, P1, DOI 10.1016/j.appet.2016.12.008	71	1	1	6	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7								10.1371/journal.pone.0269629	http://dx.doi.org/10.1371/journal.pone.0269629			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M3CI	35793289	Green Published, Green Accepted, gold			2022-12-26	WOS:000835338100046
J	Novotna, M; Svadlenka, L; Jovcic, S; Simic, V				Novotna, Michaela; Svadlenka, Libor; Jovcic, Stefan; Simic, Vladimir			Micro-hub location selection for sustainable last-mile delivery	PLOS ONE			English	Article							DECISION-MAKING; PARCEL DELIVERY; TIME WINDOWS; AHP METHOD; PICKUP; LOGISTICS; MOBILITY	Sustainable Last-Mile Delivery (LMD) is one of the key phases in city logistics. Micro-hubs in cities are new emerging solutions for an easier and viable last-mile delivery process. The important question in smart and modern cities is the determination of the best micro-hub location for the LMD. This paper solves the micro-hub location selection for sustainable LMD using the multi-criteria decision-making (MCDM) techniques. The main reason for solving the micro-hub location selection is to make the last-mile delivery process in Pardubice as easier and effortless as possible. The Best-Worst Method (BWM), Criteria Importance Through Intercriteria Correlation (CRITIC) method, and Weighted Aggregated Sum Product Assessment (WASPAS) method are coupled to solve the micro-hub location selection for sustainable LMD. First, five criteria and alternatives are identified and discussed with the experts. Second, the hybrid criteria importance is determined by combining the BWM and CRITIC methods. Third, the obtained hybrid weights are integrated within the WASPAS method to rank the micro-hub locations. The findings of the Hybrid BWM-CRITIC-WASPAS model show the Alternative 2 ("Hurka") as the best possible location for Pardubice in the context of the LMD. In addition, a comparative analysis with some of the existing MCDM approaches is conducted for the same problem and its results show a high level of matching with the applied hybrid BWM-CRITIC-WASPAS method, which means that Alternative 2 ("Hurka") is strongly recommended as a micro-hub location for sustainable LMD in Pardubice.	[Novotna, Michaela; Svadlenka, Libor; Jovcic, Stefan] Univ Pardubice, Dept Transport Management Mkt & Logist, Fac Transport Engn, Pardubice, Czech Republic; [Simic, Vladimir] Univ Belgrade, Dept Transport & Traff Engn, Fac Transport & Traff Engn, Belgrade, Serbia	University of Pardubice; University of Belgrade	Jovcic, S (corresponding author), Univ Pardubice, Dept Transport Management Mkt & Logist, Fac Transport Engn, Pardubice, Czech Republic.	stefan.jovcic@upce.cz		Jovcic, Stefan/0000-0002-9162-2133; Simic, Vladimir/0000-0001-5709-3744				Adali EA, 2021, INT J HEALTHCARE MAN, V14, P534, DOI 10.1080/20479700.2019.1674005; Akyurt IZ, 2021, IEEE T ENG MANAGE, DOI 10.1109/TEM.2021.3119659; Al Amin M., 2019, INT J SCI QUAL ANAL, V5, P43; Al Chami Z, 2019, ANN OPER RES, V273, P237, DOI 10.1007/s10479-017-2500-9; Ali A, 2021, SOFT COMPUT, V25, P563, DOI 10.1007/s00500-020-05169-z; Arrieta-Prieto M, 2022, NETWORKS, V79, P292, DOI 10.1002/net.22076; Awasthi A, 2011, MATH COMPUT MODEL, V53, P98, DOI 10.1016/j.mcm.2010.07.023; Badalpur M, 2021, INT J CONSTR MANAG, V21, P910, DOI 10.1080/15623599.2019.1595354; Barros Brito Thiago, 2012, International Journal of Logistics Systems and Management, V12, P247, DOI 10.1504/IJLSM.2012.047601; Bergmann FM, 2020, TRANSPORT RES B-METH, V131, P26, DOI 10.1016/j.trb.2019.09.013; Bettinelli A, 2019, EUR J OPER RES, V279, P824, DOI 10.1016/j.ejor.2019.06.032; Butrina P, 2017, TRANSPORT RES REC, P85, DOI 10.3141/2609-10; Catay B, 2010, EXPERT SYST APPL, V37, P6809, DOI 10.1016/j.eswa.2010.03.045; Cetin S, 2010, J FAC ENG ARCHIT GAZ, V25, P579; Chakraborty S, 2014, INFORMATICA-LITHUAN, V25, P1, DOI 10.15388/Informatica.2014.01; Chou CC, 2010, MATH COMPUT MODEL, V51, P791, DOI 10.1016/j.mcm.2009.10.015; Cinar N., 2009, WORLD ACAD SCI ENG T, V36; Cleophas C, 2014, BUS INFORM SYST ENG+, V6, P153, DOI 10.1007/s12599-014-0321-9; de Kervenoael R, 2020, J RETAIL CONSUM SERV, V54, DOI 10.1016/j.jretconser.2019.102016; Bandeira RAD, 2019, TRANSPORT RES D-TR E, V67, P491, DOI 10.1016/j.trd.2018.12.017; de Oliveira LK, 2019, URBE-CURITIBA, V11, DOI 10.1590/2175-3369.011.e20190048; Deveci M, 2022, STRUCT CHANGE ECON D, V61, P1, DOI 10.1016/j.strueco.2022.01.009; Deveci M, 2022, APPL SOFT COMPUT, V118, DOI 10.1016/j.asoc.2022.108465; Deveci M, 2022, CSEE J POWER ENERGY, V8, P1261, DOI [10.17775/CSEEJPES.2021.07700, 10.1017/S1047951122003699]; Deveci M, 2022, APPL SOFT COMPUT, V114, DOI 10.1016/j.asoc.2021.108076; DIAKOULAKI D, 1995, COMPUT OPER RES, V22, P763, DOI 10.1016/0305-0548(94)00059-H; Ding J., 2013, APPLYING INTEGRATED; Duleba S, 2021, EUR TRANSP RES REV, V13, DOI 10.1186/s12544-021-00489-z; Esra Aytac Adali AysegulTusIsik., 2017, EUROPEAN J MULTIDISC, V2; Faccio M, 2015, SUSTAINABILITY-BASEL, V7, P14873, DOI 10.3390/su71114873; Grzybowska H, 2012, PROCD SOC BEHV, V39, P712, DOI 10.1016/j.sbspro.2012.03.142; Guler D, 2020, ANN GIS, V26, P169, DOI 10.1080/19475683.2020.1737226; Guo XZ, 2019, J CLEAN PROD, V241, DOI 10.1016/j.jclepro.2019.118365; Gupta S, 2021, J STAT MANAG SYST, V24, P411, DOI 10.1080/09720510.2021.1879470; Haseli G, 2021, MATHEMATICS-BASEL, V9, DOI 10.3390/math9161881; Hruska R, 2021, PROMET-ZAGREB, V33, P905; Hruska R, 2014, TRANSPORT-VILNIUS, V29, P195, DOI 10.3846/16484142.2014.930928; Hwang C L., 1981, MULTIPLE ATTRIBUTE D; Ilbahar E, 2018, J INTELL FUZZY SYST, V35, P3835, DOI 10.3233/JIFS-18730; Janjevic M, 2016, TRANSP RES PROC, V12, P598, DOI 10.1016/j.trpro.2016.02.014; Jayant A., 2018, P INT C IND ENG OPER, P26; Kant P., 2020, SMART SUST SUPPL CHA, DOI [10.1007/978-3-030-61947-3_10, DOI 10.1007/978-3-030-61947-3_10]; Karabasevic Stanujkic D., 2016, BIZINFO J EC MANAGEM, p7. 1, DOI [10.5937/bizinfo1601001K, DOI 10.5937/BIZINFO1601001K]; Karasan A, 2020, NEURAL COMPUT APPL, V32, P4553, DOI 10.1007/s00521-018-3752-2; Keshavarz Ghorabaee M, 2018, ARCH CIV MECH ENG, V18, P32, DOI 10.1016/j.acme.2017.04.011; Keshavarz Ghorabaee M, 2017, ECON RES-EKON ISTRAZ, V30, P1073, DOI 10.1080/1331677X.2017.1314828; Keshavarz Ghorabaee M, 2017, TRANSPORT-VILNIUS, V32, P66, DOI 10.3846/16484142.2017.1282381; Kirschstein T, 2020, TRANSPORT RES D-TR E, V78, DOI 10.1016/j.trd.2019.102209; Klumpp M, 2014, ENVIRON SCI ENG, P201, DOI 10.1007/978-3-642-36011-4_17; Krishnan AR, 2021, SYMMETRY-BASEL, V13, DOI 10.3390/sym13060973; Lazarevic D., 2020, PERNERS CONTACTS, V15, DOI [10.46585/pc.2020.1.1547, DOI 10.46585/PC.2020.1.1547]; Leyerer M, 2019, EURO J DECIS PROCESS, V7, P267, DOI 10.1007/s40070-019-00105-5; Liaw CF, 2020, SYMMETRY-BASEL, V12, DOI 10.3390/sym12121962; Lu EHC, 2019, EXPERT SYST APPL, V118, P482, DOI 10.1016/j.eswa.2018.10.031; Ma Y., 2021, EVALUATE LOCATIONS S, P7199, DOI [10.3233/JIFS-211066, DOI 10.3233/JIFS-211066]; Macioszek E, 2018, ADV INTELL SYST, V631, P147, DOI 10.1007/978-3-319-62316-0_12; Mahmoudi A, 2020, INFORMATICA-LITHUAN, V31, P331, DOI 10.15388/20-INFOR409; Manier H, 2016, IFAC PAPERSONLINE, V49, P1880, DOI 10.1016/j.ifacol.2016.07.904; Mathew M., 2018, MANAGEMENT SCI LETT, V8, P139, DOI [10.5267/j.msl.2018.1.004, DOI 10.5267/J.MSL.2018.1.004]; McLeod FN, 2020, TRANSPORT RES D-TR E, V82, DOI 10.1016/j.trd.2020.102311; Mesran M., 2020, IJISTECH INT J INFOR, V3, DOI [10.30645/ijistech.v3i2.43, DOI 10.30645/IJISTECH.V3I2.43]; Mic P, 2021, SAGE OPEN, V11, DOI 10.1177/21582440211040115; Munoz-Villamizar A, 2021, LOGISTICS-BASEL, V5, DOI 10.3390/logistics5010017; Munoz-Villamizar A, 2015, PROC CIRP, V30, P263, DOI 10.1016/j.procir.2015.02.147; Ortega J, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su122310083; Ozmen M, 2020, ARTIF INTELL REV, V53, P725, DOI 10.1007/s10462-019-09763-y; Pamucar D, 2020, MATHEMATICS-BASEL, V8, DOI 10.3390/math8081342; Perboli G, 2019, TRANSPORT RES C-EMER, V99, P19, DOI 10.1016/j.trc.2019.01.006; Petersen HL, 2011, LECT NOTES COMPUT SC, V6971, P101, DOI 10.1007/978-3-642-24264-9_8; Petrovic G, 2019, FACTA UNIV-SER MECH, V17, P455, DOI 10.22190/FUME190420039P; Nguyen PK, 2017, ANN OPER RES, V253, P899, DOI 10.1007/s10479-015-2001-7; Pinar O, 2019, HEALTHCARE FACILITY, V16, DOI [10.31590/ejosat.584217, DOI 10.31590/EJOSAT.584217]; Rezaei J, 2015, OMEGA-INT J MANAGE S, V53, P49, DOI 10.1016/j.omega.2014.11.009; Rodriguez-Gutierrez P, 2021, J ENVIRON PLANN MAN, V64, P2618, DOI 10.1080/09640568.2021.1876003; Rosenberg LN, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13042067; Sarabi EP, 2021, APPL SOFT COMPUT, V98, DOI 10.1016/j.asoc.2020.106849; Sarbast M., 2020, SUSTAINABILITY-BASEL, V12, P1; Shi HT, 2021, MEAS CONTROL-UK, V54, P1097, DOI 10.1177/00202940211016092; Simic V, 2021, EUR TRANSP RES REV, V13, DOI 10.1186/s12544-021-00501-6; Souza CD, 2020, URBE-CURITIBA, V12, DOI 10.1590/2175-3369.012.e20190138; Stojic G, 2018, INFORMATION, V9, DOI 10.3390/info9050121; Tus A, 2019, OPSEARCH, V56, P528, DOI 10.1007/s12597-019-00371-6; Ugo P., 2015, INT J MANAGEMENT BUS, V5; Wang FX, 2019, IEEE NETWORK, V33, P23, DOI 10.1109/MNET.2019.1800228; Wang Y, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11123492; Wu HY, 2015, LECT NOTES ARTIF INT, V9077, P498, DOI 10.1007/978-3-319-18038-0_39; Xu Y L., 2017, 4 INT C MANAGEMENT I, P38; Yorukoglu M., 2020, INT J IND MANUFACTUR, V14, P444; Yu HY, 2022, J COMB OPTIM, V43, P974, DOI 10.1007/s10878-020-00615-y; Yuan XJ, 2022, ENG COMPUT-GERMANY, V38, P2389, DOI 10.1007/s00366-021-01377-9; Yucenur GN, 2021, RENEW ENERG, V163, P1287, DOI 10.1016/j.renene.2020.08.131; Zafar S, 2021, PEER PEER NETW APPL, V14, P3110, DOI 10.1007/s12083-021-01173-8; Zavadskas EK, 2012, ELEKTRON ELEKTROTECH, V122, P3, DOI 10.5755/j01.eee.122.6.1810; Zhou JL, 2020, ENERG CONVERS MANAGE, V205, DOI 10.1016/j.enconman.2019.112340	94	0	0	7	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2022	17	7							e0270926	10.1371/journal.pone.0270926	http://dx.doi.org/10.1371/journal.pone.0270926			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6G0CU	35789231	Green Published, gold			2022-12-26	WOS:000884428700003
J	Li, YP; Yu, JF; Zhang, J; Zhangid, ZJ; Wang, XQ				Li, Yapeng; Yu, Jiafeng; Zhang, Jun; Zhangid, Zhijie; Wang, Xueqiang			Quantifying the stiffness of lumbar erector spinae during different positions among participants with chronic low back pain	PLOS ONE			English	Article							SHEAR-WAVE ELASTOGRAPHY; MUSCLE-STIFFNESS; SURFACE ELECTROMYOGRAPHY; ASSOCIATIONS; THICKNESS; FORCE; YOUNG; MASS; SEX	Objective The purposes of this study were to (1) detect the intra- and inter-reliabilities of the lumbar erector spinae stiffness by MyotonPRO among participants with chronic lower back pain (CLBP); (2) compare the muscle stiffness between pain and non-pain sides during different positions; (3) explore the correlation between intensity of pain and muscle stiffness. Design Twenty participants with CLBP were recruited and the stiffness measurements were carried out by two experienced physiotherapists (operators. and.). Each participant was evaluated by the operator. in different postures (static prone and sitting). After a 5-day interval, the same participant was reassessed by the operator. in the static prone posture. For the interrater reliability test, each participant was quantified by both operators once, with 30 minutes between the measurements on the same day. The intensity of pain was evaluated using a 0-10 visual analog scale (VAS). Results The intra- and inter-rater reliabilities were excellent (ICC = 0.88-0.99). The MDC values ranged from 25.03 to 86.26 N/m. Examples of Bland-Altman plots showed good agreement. The erector spinae stiffness on the painful sides was higher with a marked increase in the sitting position (P <.05) when compared with the non-painful side. However, there was no significant difference in the prone position (P >.05). The intensity of pain among adults with CLBP was not associated with muscle stiffness of the lumbar erector spinae muscle. Conclusions Our findings indicated that the MyotonPRO is a feasible device in quantifying the stiffness of the lumbar erector spinae muscle in patients with CLBP. Meanwhile, the erector spinae stiffness on the painful sides was higher in the sitting when compared with the non-painful side.	[Li, Yapeng; Zhangid, Zhijie] Orthoped Hosp Henan Prov, Luoyang Orthoped Hosp Henan Prov, Rehabil Therapy Ctr, Luoyang, Peoples R China; [Yu, Jiafeng] Zhengzhou Univ, Affiliated Hosp 1, Dept Rehabil Med, Zhengzhou, Peoples R China; [Zhang, Jun] Hunan Tradit Chinese Med Coll, Inst Rehabil & Hlth Care, Dept Rehabil, Changsha, Hunan, Peoples R China; [Wang, Xueqiang] Shanghai Univ Sport, Dept Sport Rehabil, Shanghai, Peoples R China	Zhengzhou University; Hunan University of Chinese Medicine; Shanghai University of Sport	Zhangid, ZJ (corresponding author), Orthoped Hosp Henan Prov, Luoyang Orthoped Hosp Henan Prov, Rehabil Therapy Ctr, Luoyang, Peoples R China.	Sportspt@163.com			Project of Science Research of Traditional Chinese Medicine of Henan Province of China [2019ZY1028]	Project of Science Research of Traditional Chinese Medicine of Henan Province of China	This study was supported by Project of Science Research of Traditional Chinese Medicine of Henan Province of China. Award Number: 2019ZY1028; Recipient: Zhi Jie Zhang	Aird L, 2012, ARCH GERONTOL GERIAT, V55, pE31, DOI 10.1016/j.archger.2012.03.005; Alessa F, 2018, HUM MOVEMENT SCI, V57, P59, DOI 10.1016/j.humov.2017.11.006; Becker S, 2018, GAIT POSTURE, V66, P208, DOI 10.1016/j.gaitpost.2018.08.042; Buchbinder R, 2013, BEST PRACT RES CL RH, V27, P575, DOI 10.1016/j.berh.2013.10.007; Chen J, 2017, CLIN IMAG, V45, P26, DOI 10.1016/j.clinimag.2017.05.017; Chuang LL, 2013, ARCH PHYS MED REHAB, V94, P459, DOI 10.1016/j.apmr.2012.08.212; Coenen P, 2017, GAIT POSTURE, V58, P310, DOI 10.1016/j.gaitpost.2017.08.024; Disselhorst-Klug C, 2009, CLIN BIOMECH, V24, P225, DOI 10.1016/j.clinbiomech.2008.08.003; Domholdt E, 1993, PHYS THERAPY RES PRI, P153; Eby SF, 2015, CLIN BIOMECH, V30, P22, DOI 10.1016/j.clinbiomech.2014.11.011; Feng YN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34719-7; Goubert D, 2017, SPINE J, V17, P1285, DOI 10.1016/j.spinee.2017.04.025; Gsell KY, 2017, SPINE, V42, P1440, DOI 10.1097/BRS.0000000000002132; Hong SH, 2016, ACTA RADIOL, V57, P1099, DOI 10.1177/0284185115571987; Hu XQ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32418-x; Hug F, 2015, J ORTHOP SPORT PHYS, V45, P360, DOI 10.2519/jospt.2015.5905; Ikezoe T, 2012, GERIATR GERONTOL INT, V12, P86, DOI 10.1111/j.1447-0594.2011.00735.x; Kelly JP, 2018, J ELECTROMYOGR KINES, V38, P73, DOI 10.1016/j.jelekin.2017.11.001; Ko CY, 2018, J BIOMECH, V73, P60, DOI 10.1016/j.jbiomech.2018.03.026; Koppenhaver SL, 2019, CLIN BIOMECH, V62, P113, DOI 10.1016/j.clinbiomech.2019.01.010; Kuo WH, 2013, ULTRASOUND MED BIOL, V39, P1356, DOI 10.1016/j.ultrasmedbio.2012.11.015; Li YP, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000019519; Lin KC, 2009, NEUROREHAB NEURAL RE, V23, P429, DOI 10.1177/1545968308331144; Lo WLA, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/4294028; Lohr C, 2018, EUR J APPL PHYSIOL, V118, P1349, DOI 10.1007/s00421-018-3867-2; Masaki M, 2017, CLIN BIOMECH, V49, P128, DOI 10.1016/j.clinbiomech.2017.09.008; Merce BB, 2021, BMC MUSCULOSKEL DIS, V22, DOI 10.1186/s12891-021-04623-9; Nair K, 2016, J BODYW MOV THER, V20, P388, DOI 10.1016/j.jbmt.2015.12.005; Perez-Bellmunt A, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18083891; Ploumis A, 2011, BRIT J RADIOL, V84, P709, DOI 10.1259/bjr/58136533; Porter JM, 2002, OCCUP MED-OXFORD, V52, P4, DOI 10.1093/occmed/52.1.4; Sanchez-Infante J, 2021, MUSCULOSKEL SCI PRAC, V56, DOI 10.1016/j.msksp.2021.102456; Seyedhoseinpoor T, 2022, CLIN ANAT, V35, P762, DOI 10.1002/ca.23893; Shamsi M, 2016, PHYSIOTHER THEOR PR, V32, P277, DOI 10.3109/09593985.2016.1138559; Van Deun B, 2018, J GERIATR PHYS THER, V41, P194, DOI 10.1519/JPT.0000000000000119; Walter SD, 1998, STAT MED, V17, P101, DOI 10.1002/(SICI)1097-0258(19980115)17:1<101::AID-SIM727>3.3.CO;2-5; Wu AM, 2019, PAIN, V160, P237, DOI 10.1097/j.pain.0000000000001396; Zhang ZJ, 2017, SCAND J MED SCI SPOR, V27, P1099, DOI 10.1111/sms.12749; Zhang ZJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108337; 冯亚男, 2019, [中国康复医学杂志, Chinese Journal of Rehabilitation Medicine], V34, P465	40	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2022	17	6							e0270286	10.1371/journal.pone.0270286	http://dx.doi.org/10.1371/journal.pone.0270286			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6N2EB	35749429	Green Published, gold			2022-12-26	WOS:000889370600001
J	Klasson, CL; Sadhir, S; Pontzer, H				Klasson, Christopher L.; Sadhir, Srishti; Pontzer, Herman			Daily physical activity is negatively associated with thyroid hormone levels, inflammation, and immune system markers among men and women in the NHANES dataset	PLOS ONE			English	Article							TOTAL-ENERGY EXPENDITURE; EXERCISE; FITNESS; IMPACT	The acute effects of exercise on metabolic energy expenditure and inflammation are well studied, but the long-term effects of regular daily physical activity on metabolic and endocrine effects are less clear. Further, prior studies investigating the impact of daily physical activity in large cohorts have generally relied on self-reported activity. Here, we used the U.S. National Health and Nutrition Examination Survey (NHANES) to investigate the relationship between daily physical activity and both thyroid and immune activity. Daily physical activity was assessed through accelerometry or accelerometry-validated survey responses. Thyroid activity was assessed from circulating levels of thyroid stimulating hormone (TSH) and thyroxine (T4). Immune function was assessed from circulating cytokines (C-reactive protein [CRP], immunoglobulin E [IgE], fibrinogen) and blood cell counts. In general linear models including body mass index, age, gender, activity and TSH as factors, active adults had a lower levels of T4 and reduced slope of the TSH:T4 relationship. Similarly, greater physical activity was associated with lower CRP and fibrinogen levels (but not IgE) and lower white blood cell, basophil, monocyte, neutrophil, and eosinophil (but not lymphocyte) counts. Daily physical activity was also associated with lower prevalence of clinically elevated CRP, WBC, and lymphocytes in a dose-response manner. These results underscore the long-term impact of daily physical activity on both systemic metabolic activity (thyroid) and on specific physiological tasks (immune). The regulatory effects of physical activity on other bodily systems are clinically relevant and should be incorporated into public health strategies promoting exercise.	[Klasson, Christopher L.] Duke Univ, Trinity Coll, Durham, NC 27708 USA; [Sadhir, Srishti; Pontzer, Herman] Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27710 USA; [Pontzer, Herman] Duke Univ, Duke Global Hlth Inst, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Klasson, CL (corresponding author), Duke Univ, Trinity Coll, Durham, NC 27708 USA.; Pontzer, H (corresponding author), Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27710 USA.; Pontzer, H (corresponding author), Duke Univ, Duke Global Hlth Inst, Durham, NC 27710 USA.	chrisklasson98@gmail.com; herman.pontzer@duke.edu		Klasson, Christopher/0000-0003-1250-150X				Abramson JL, 2002, ARCH INTERN MED, V162, P1286, DOI 10.1001/archinte.162.11.1286; [Anonymous], 2005, Food Nutr Bull, V26, P166; Baylor LS, 2003, EUR J APPL PHYSIOL, V88, P480, DOI 10.1007/s00421-002-0737-7; Boule NG, 2005, DIABETES CARE, V28, P108, DOI 10.2337/diacare.28.1.108; Centers for Disease Control and Prevention, 2020, ADOLESCENT HEALTH; CREWS DJ, 1987, MED SCI SPORT EXER, V19, pS114; Dipla K, 2021, HORM-INT J ENDOCRINO, V20, P35, DOI 10.1007/s42000-020-00214-w; Gleeson M, 2011, NAT REV IMMUNOL, V11, P607, DOI 10.1038/nri3041; Goncalves CAM, 2020, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01602; Hackney AC, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00011; Hackney AC, 2018, HORM-INT J ENDOCRINO, V17, P137, DOI 10.1007/s42000-018-0010-z; Hall KS, 2020, INT J BEHAV NUTR PHY, V17, DOI 10.1186/s12966-020-00978-9; Kearney ML, 2016, CURR DIABETES REV, V12, P199, DOI 10.2174/1573399811666150615112441; Kraus WE, 2018, BMJ OPEN DIAB RES CA, V6, DOI 10.1136/bmjdrc-2018-000523; Krogh AKH, 2014, ACTA VET SCAND, V56, DOI 10.1186/1751-0147-56-11; Lesmana R, 2016, ENDOCR J, V63, P727, DOI 10.1507/endocrj.EJ16-0126; Uribe RM, 2014, ENDOCRINOLOGY, V155, P2020, DOI 10.1210/en.2013-1724; McDade TW, 2016, EVOL MED PUBLIC HLTH, P1, DOI 10.1093/emph/eov033; Morgan Julie A, 2015, J Mol Psychiatry, V3, P3, DOI 10.1186/s40303-015-0010-8; Nabkasorn C, 2006, EUR J PUBLIC HEALTH, V16, P179, DOI 10.1093/eurpub/cki159; Nicoll JX, 2018, EUR J APPL PHYSIOL, V118, P65, DOI 10.1007/s00421-017-3723-9; Padilla J, 2015, EXP PHYSIOL, V100, P759, DOI 10.1113/EP085107; PAKARINEN A, 1988, EUR J APPL PHYSIOL O, V57, P394, DOI 10.1007/BF00417982; Pontzer H., 2021, SCIENCE; Pontzer H, 2018, PHYSIOLOGY, V33, P384, DOI 10.1152/physiol.00027.2018; Pontzer H, 2017, EVOL ANTHROPOL, V26, P12, DOI 10.1002/evan.21513; Pontzer H, 2016, CURR BIOL, V26, P410, DOI 10.1016/j.cub.2015.12.046; Pontzer H, 2015, EXERC SPORT SCI REV, V43, P110, DOI 10.1249/JES.0000000000000048; R Core Team, 2020, R LANG ENV STAT COMP; Raichlen DA, 2017, TRENDS NEUROSCI, V40, P408, DOI 10.1016/j.tins.2017.05.001; Shaw DM, 2018, CYTOKINE, V104, P136, DOI 10.1016/j.cyto.2017.10.001; Siedlik JA, 2016, BRAIN BEHAV IMMUN, V56, P343, DOI 10.1016/j.bbi.2016.04.008; Silverman MN, 2014, INTERFACE FOCUS, V4, DOI 10.1098/rsfs.2014.0040; Smith MP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33288-z; Van Domelen DR, 2014, R J, V6, P52; Walsh NP, 2011, EXERC IMMUNOL REV, V17, P6; Wolff-Hughes DL, 2015, J PHYS ACT HEALTH, V12, P447, DOI 10.1123/jpah.2013-0464; Wolff-Hughes DL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115915; Wolowczuk I, 2008, CLIN DEV IMMUNOL, P1, DOI 10.1155/2008/639803	39	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7								10.1371/journal.pone.0270221	http://dx.doi.org/10.1371/journal.pone.0270221			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M3CI	35793317	gold, Green Published			2022-12-26	WOS:000835338100023
J	Mebratie, AE; Moges, NA; Meselu, BT; Melesse, MF				Mebratie, Andamlak Eskale; Moges, Nurilign Abebe; Meselu, Belsity Temesgen; Melesse, Misganaw Fikrie			Time to death from cervical cancer and predictors among cervical cancer patients in Felege Hiwot Comprehensive Specialized Hospital, North West Ethiopia: Facility-based retrospective follow-up study	PLOS ONE			English	Article							MORTALITY; SURVIVAL; TRENDS; BURDEN; CHINA	IntroductionA sexually transmitted virus called the Human Papillomavirus is responsible for more than 99% of cervical cancer cases and its precursors. In 2019, the median survival time of cervical cancer patients at 5 years was 37 months. The survival time and predictors of death from cervical cancer vary in different study settings. This study was aimed to assess the time to death and to identify the major predictors of death of cervical cancer patients in Felege Hiwot Comprehensive Specialized Hospital. MethodsA facility-based retrospective follow-up study was conducted among 422 randomly selected cervical cancer patients in Felege Hiwot Comprehensive Specialized Hospital from 25(th) June 2017 to 31(st) March 2021. Data were extracted from the sampled patient charts by using a structured checklist which was prepared in an English version. Data were coded and then entered, edited, and cleaned using EPI-data 3.1 and exported to STATA14.2 statistical software for analysis. Frequencies and proportions were used to describe the study population with relevant variables and were presented using tables, pie charts, and graphs. Kaplan Meier and life table were used to describe the restricted mean survival time and the overall survival rates. Differences in survival among different variables were compared using the log-rank test. The assumption of proportional hazard was checked using Schoenfeld residual test. Variables having a P-value > 0.05 were considered as fulfilling the assumption. Variables with a significance level below 0.2 in the bivariable Cox regression model were included in a multivariable Cox regression model analysis, where Variables with a p-value < 0.05 were considered to be statistically significant at a 95% confidence interval. Model fitness was checked by Cox-Snell residual. ResultsThe mean follow up time of this cohort was 27.66 (CI: 26.96, 28.36) months, and the restricted mean survival time of cervical cancer patients in this study was 40.21 (95% CI: 38.95, 41.47) months. Being FIGO stage IV [AHR = 6.10, 95% CI: 2.18, 16.90)], having adenocarcinoma [AHR = 3.12, 95% CI: 1.34, 7.28)], having co-morbidity [AHR = 2.57, 95% CI: 1.29, 5.11)], and being initiated with radiotherapy [AHR = 4.57, 95% CI: 1.60, 13.06)] were a significant predictors of death from cervical cancer. ConclusionThe restricted mean survival time of cervical cancer patients in this study was 40.21 months. Marital status, type of tumor histology, stage of disease, type of treatment initiated, and presence of co-morbidity were significant predictors of death for cervical cancer. Treatment of comorbidities in the early stage of cervical cancer plays a key role in maximizing the survival time of cervical cancer patients.	[Mebratie, Andamlak Eskale] Sidama Reg Hlth Bur, Dept Epidemiol, Awasa, Ethiopia; [Moges, Nurilign Abebe] Debre Markos Univ, Dept Publ Hlth, Debre Markos, Ethiopia; [Meselu, Belsity Temesgen; Melesse, Misganaw Fikrie] Debre Markos Univ, Dept Midwifery, Debre Markos, Ethiopia		Melesse, MF (corresponding author), Debre Markos Univ, Dept Midwifery, Debre Markos, Ethiopia.	misganawfikrie@gmail.com		Melesse, Misganaw/0000-0002-6343-7651				Alliance for Cervical Cancer Prevention (ACCP), 2004, PLANN IMPL CERV CANC; [Anonymous], 2016, J PHYSIOTHER, V62, P171, DOI 10.1016/j.jphys.2016.05.008; Anorlu RI, 2008, REPROD HEALTH MATTER, V16, P41, DOI 10.1016/S0968-8080(08)32415-X; Arbyn M, 2020, LANCET GLOB HEALTH, V8, pE191, DOI 10.1016/S2214-109X(19)30482-6; Asseffa NA., 2017, J GYNECOL WOMENS HLT, V5, P555660; Canfell K, 2020, LANCET, V395, P591, DOI 10.1016/S0140-6736(20)30157-4; Carneiro SR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187579; Charlson M, 2018, CHARLSON COMORBIDITY; Chen JG, 2018, J CANCER, V9, P851, DOI 10.7150/jca.23039; Chinemerem CN., 2017, INT J PUBLIC HLTH CL, V4, P10; Denny L, 2012, CANCER EPIDEM BIOMAR, V21, P1434, DOI 10.1158/1055-9965.EPI-12-0334; Diaz A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196764; Feuchtner J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219519; Forman D, 2012, VACCINE, V30, pF12, DOI 10.1016/j.vaccine.2012.07.055; Gizaw M, 2017, INFECT AGENTS CANCER, V12, DOI 10.1186/s13027-017-0171-4; Grjibovski AM, 2018, INT HEALTH, V10, P92, DOI 10.1093/inthealth/ihx068; Gultekin M., 2020, BMJ SPECIALIST J; Guo P, 2012, ANN ONCOL, V23, P2755, DOI 10.1093/annonc/mds069; Jemal A, 2012, CANCER-AM CANCER SOC, V118, P4372, DOI 10.1002/cncr.27410; Kantelhardt EJ, 2014, ONCOLOGIST, V19, P727, DOI 10.1634/theoncologist.2013-0326; Moelle U, 2018, ONCOLOGIST, V23, P1024, DOI 10.1634/theoncologist.2017-0271; Musa J, 2016, INFECT AGENTS CANCER, V11, DOI 10.1186/s13027-016-0062-0; Pecorelli S, 2009, INT J GYNECOL OBSTET, V105, P103, DOI 10.1016/j.ijgo.2009.02.012; Ryan TP, 2013, WILEY SER PROBAB ST, P1, DOI 10.1002/9781118439241; Sengayi-Muchengeti M, 2020, INT J CANCER, V147, P3037, DOI 10.1002/ijc.33120; Shimbre M. S., 2020, Journal of Public Health and Epidemiology, V12, P13, DOI 10.5897/JPHE2019.1129; Sun DQ, 2020, CHINESE J CANCER RES, V32, P129, DOI 10.21147/j.issn.1000-9604.2020.02.01; Vishma B., 2017, INT J COMMUN MED PUB, V3, P218; Wassie M, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-6447-x; Xie L, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.01353	30	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	6							e0269576	10.1371/journal.pone.0269576	http://dx.doi.org/10.1371/journal.pone.0269576			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3F0KH	35749539	gold, Green Published			2022-12-26	WOS:000830362700050
J	Mei, CE; Hu, JC; Li, JR; Chiu, KY; Wang, SS; Chen, CS				Mei, Cheng-En; Hu, Ju-Chuan; Li, Jian-Ri; Chiu, Kun-Yuan; Wang, Shian-Shiang; Chen, Chuan-Shu			Intraoperative calculus or hemorrhage in transurethral seminal vesiculoscopy as a risk factor for recurrent hemospermia	PLOS ONE			English	Article							INTRACTABLE HEMATOSPERMIA; MANAGEMENT	We have summarized our experience regarding transurethral seminal vesiculoscopy (TUSV) and analyzed both its recurrence status and the risk factors for recurrence. From January 2010 to December 2020, 48 patients with intractable hemospermia received successful TUSV at Taichung Invalids General Hospital. Upon analysis of the intraoperative findings, the five-year disease-free Survival rates (DFS) were 74.1% in the no calculus group compared to 37.1% in the calculus group with a significant difference (log-rank p = 0.015), 75.0% in the no hemorrhage or no blood clot group compared to 43.2% in the hemorrhage or blood clot group with significant difference (log-rank p = 0.032). Univariate analysis showed intraoperative calculus (p = 0.040; HR: 2.94, 95% CI: 1.05-8.21) to be significantly associated with recurrence (p < 0.05). Patients with intractable hemospermia who were diagnosed with stones or blood clots found during TUSV experienced a higher rate of hemospermia recurrence.	[Mei, Cheng-En] Taichung Vet Gen Hosp, Dept Emergency, Div Traumatol, Taichung, Taiwan; [Mei, Cheng-En; Hu, Ju-Chuan; Li, Jian-Ri; Chiu, Kun-Yuan; Wang, Shian-Shiang; Chen, Chuan-Shu] Taichung Vet Gen Hosp, Dept Surg, Div Urol, Taichung, Taiwan	Taichung Veterans General Hospital; Taichung Veterans General Hospital	Chen, CS (corresponding author), Taichung Vet Gen Hosp, Dept Surg, Div Urol, Taichung, Taiwan.	r2060d@gmail.com						Chen R, 2018, ASIAN J ANDROL, V20, P438, DOI 10.4103/aja.aja_76_17; Chen WK, 2021, BMC UROL, V21, DOI 10.1186/s12894-021-00817-4; Cui Bo, 2020, Transl Androl Urol, V9, P2493, DOI 10.21037/tau-20-870; Dong Qiang, 2016, Zhonghua Nan Ke Xue, V22, P291; Furuya S, 2016, INT J UROL, V23, P934, DOI 10.1111/iju.13176; Han H, 2021, ANDROLOGIA, V53, DOI 10.1111/and.14054; Han WK, 2009, UROLOGY, V73, P1377, DOI 10.1016/j.urology.2008.07.038; Hu JC, 2018, INT J UROL, V25, P589, DOI 10.1111/iju.13569; Jhan JH, 2018, UROL SCI, V29, P129, DOI 10.4103/UROS.UROS_18_18; Kang PM, 2016, WORLD J UROL, V34, P985, DOI 10.1007/s00345-015-1689-y; Kumar P, 2006, ANN ROY COLL SURG, V88, P339, DOI 10.1308/003588406X114749; Liao LG, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41123-2; Neto FTL, 2020, J BRAS REPROD ASSIST, V24, P382, DOI 10.5935/1518-0557.20190075; Pang K, 2020, ASIAN J ANDROL, V22, P227, DOI 10.4103/aja.aja_56_19; Ren ZJ, 2020, BMC UROL, V20, DOI 10.1186/s12894-020-00589-3; Song T, 2012, CHINESE MED J-PEKING, V125, P1475, DOI 10.3760/cma.j.issn.0366-6999.2012.08.021; Suh Y, 2017, TRANSL ANDROL UROL, V6, P959, DOI 10.21037/tau.2017.06.01; Tang S X, 2016, Zhonghua Yi Xue Za Zhi, V96, P2872, DOI 10.3760/cma.j.issn.0376-2491.2016.36.005; Wang H B, 2020, Beijing Da Xue Xue Bao Yi Xue Ban, V52, P642; Wang LJ, 2006, UROLOGY, V68, P938, DOI 10.1016/j.urology.2006.06.015; Wang XS, 2020, ASIAN J ANDROL, V22, P507, DOI 10.4103/aja.aja_134_19; Wu XJ, 2016, ASIAN J ANDROL, V18, P140, DOI 10.4103/1008-682X.151392; Xing CY, 2012, INT J UROL, V19, P437, DOI 10.1111/j.1442-2042.2011.02952.x; Yang SC, 2002, J ENDOUROL, V16, P343, DOI 10.1089/089277902760261347	24	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7								10.1371/journal.pone.0268314	http://dx.doi.org/10.1371/journal.pone.0268314			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M5FN	35789209	Green Published, gold, Green Submitted			2022-12-26	WOS:000835487000034
J	Thomas, M; Willis, S; Iii, JGJ; Fu, QJ				Thomas, Mathew; Willis, Shelby; Galvin III, John J.; Fu, Qian-Jie			Effects of tonotopic matching and spatial cues on segregation of competing speech in simulations of bilateral cochlear implants	PLOS ONE			English	Article							ENERGETIC MASKING; BINAURAL FUSION; RELEASE; RECOGNITION; SEPARATION; SENTENCES; MISMATCH; BENEFIT; PITCH	In the clinical fitting of cochlear implants (CIs), the lowest input acoustic frequency is typically much lower than the characteristic frequency associated with the most apical electrode position, due to the limited electrode insertion depth. For bilateral CI users, electrode positions may differ across ears. However, the same acoustic-to-electrode frequency allocation table (FAT) is typically assigned to both ears. As such, bilateral CI users may experience both intra-aural frequency mismatch within each ear and inter-aural mismatch across ears. This inter-aural mismatch may limit the ability of bilateral CI users to take advantage of spatial cues when attempting to segregate competing speech. Adjusting the FAT to tonotopically match the electrode position in each ear (i.e., increasing the low acoustic input frequency) is theorized to reduce this inter-aural mismatch. Unfortunately, this approach may also introduce the loss of acoustic information below the modified input acoustic frequency. The present study explored the trade-off between reduced inter-aural frequency mismatch and low-frequency information loss for segregation of competing speech. Normal-hearing participants were tested while listening to acoustic simulations of bilateral CIs. Speech reception thresholds (SRTs) were measured for target sentences produced by a male talker in the presence of two different male talkers. Masker speech was either co-located with or spatially separated from the target speech. The bilateral CI simulations were produced by 16-channel sinewave vocoders; the simulated insertion depth was fixed in one ear and varied in the other ear, resulting in an inter-aural mismatch of 0, 2, or 6 mm in terms of cochlear place. Two FAT conditions were compared: 1) clinical (200-8000 Hz in both ears), or 2) matched to the simulated insertion depth in each ear. Results showed that SRTs were significantly lower with the matched than with the clinical FAT, regardless of the insertion depth or spatial configuration of the masker speech. The largest improvement in SRTs with the matched FAT was observed when the inter-aural mismatch was largest (6 mm). These results suggest that minimizing inter-aural mismatch with tonotopically matched FATs may benefit bilateral CI users' ability to segregate competing speech despite substantial low-frequency information loss in ears with shallow insertion depths.	[Thomas, Mathew; Willis, Shelby; Fu, Qian-Jie] UCLA, David Geffen Sch Med, Dept Head & Neck Surg, Los Angeles, CA 90095 USA; [Galvin III, John J.] House Inst Fdn, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Fu, QJ (corresponding author), UCLA, David Geffen Sch Med, Dept Head & Neck Surg, Los Angeles, CA 90095 USA.	qfu@mednet.ucla.edu		Fu, Qian-Jie/0000-0003-3494-7633	National Institutes of Health [R01-DC017738, R01-DC016883]; NIH [R01-DC017738, R01-DC016883]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health [grant number R01-DC017738 and R01-DC016883 to Dr. Fu]. Drs. Galvin and Fu were supported by NIH grant R01-DC016883 and R01-DC017738. Dr. Fu also has a financial interest at Nurotron Biotechnology Co. Ltd., a medical device company that designs, develops, and markets CI systems. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baskent D, 2007, EAR HEARING, V28, P277; Bernstein JGW, 2018, TRENDS HEAR, V22, DOI 10.1177/2331216518765514; Brown DK, 2010, J AM ACAD AUDIOL, V21, P629, DOI 10.3766/jaaa.21.10.3; Brungart DS, 2001, J ACOUST SOC AM, V110, P2527, DOI 10.1121/1.1408946; Crew JD, 2016, TRENDS HEAR, V20, DOI 10.1177/2331216516669329; D'Onofrio K, 2020, J SPEECH LANG HEAR R, V63, P3816, DOI 10.1044/2020_JSLHR-20-00044; DePaolis RA, 1996, J SPEECH HEAR RES, V39, P714, DOI 10.1044/jshr.3904.714; Fu QJ, 2002, NEUROREPORT, V13, P1635, DOI 10.1097/00001756-200209160-00013; Fu QJ, 2002, J ACOUST SOC AM, V112, P1664, DOI 10.1121/1.1502901; Fu QJ, 1999, J ACOUST SOC AM, V105, P1889, DOI 10.1121/1.426725; Goupell MJ, 2018, EAR HEARING, V39, P895, DOI 10.1097/AUD.0000000000000541; GREENWOOD DD, 1990, J ACOUST SOC AM, V87, P2592, DOI 10.1121/1.399052; Hu HM, 2018, J ACOUST SOC AM, V143, P2128, DOI 10.1121/1.5030918; Kan A, 2015, EAR HEARING, V36, pE62, DOI 10.1097/AUD.0000000000000135; Kidd G, 2010, J ACOUST SOC AM, V128, P1965, DOI 10.1121/1.3478781; Landsberger DM, 2015, EAR HEARING, V36, pE207, DOI 10.1097/AUD.0000000000000163; Marrone N, 2008, J ACOUST SOC AM, V124, P3064, DOI 10.1121/1.2980441; Moore BCJ, 1996, J ACOUST SOC AM, V100, P2373, DOI 10.1121/1.417947; Oh Y, 2021, JASA EXPRESS LETT, V1, DOI 10.1121/10.0005831; Shannon RV, 2002, JARO, V3, P185, DOI 10.1007/s101620020021; Staisloff HE, 2016, HEARING RES, V337, P59, DOI 10.1016/j.heares.2016.05.002; Suneel D, 2017, J ACOUST SOC AM, V142, pEL276, DOI 10.1121/1.5001903; Svirsky MA, 2015, ACTA OTO-LARYNGOL, V135, P354, DOI 10.3109/00016489.2014.1002052; Vinay, 2007, J ACOUST SOC AM, V122, P542, DOI 10.1121/1.2722055; WIGHTMAN FL, 1989, J ACOUST SOC AM, V85, P868, DOI 10.1121/1.397558; Willis S, 2021, JASA EXPRESS LETT, V1, DOI 10.1121/10.0003049; Xu K, 2020, EAR HEARING, V41, P1362, DOI 10.1097/AUD.0000000000000865; Yoon YS, 2011, J ACOUST SOC AM, V130, pEL94, DOI 10.1121/1.3606460; Zhang J, 2020, J SPEECH LANG HEAR R, V63, P2801, DOI 10.1044/2020_JSLHR-19-00421	29	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	7								10.1371/journal.pone.0270759	http://dx.doi.org/10.1371/journal.pone.0270759			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M5FN	35788202	Green Published, gold			2022-12-26	WOS:000835487000028
J	Yang, ZC; Shi, C; Zheng, YL; Gu, SR				Yang, Zhengcai; Shi, Chuan; Zheng, Yinglin; Gu, Shirui			A study on a vehicle semi-active suspension control system based on road elevation identification	PLOS ONE			English	Article							PROFILE ESTIMATION	A semi-active suspension system can effectively improve vehicle ride comfort and handling stability, and the active detection of road information is key to achieving semi-active suspension. To improve the road elevation perception ability of vehicles, this study proposes a continuous multiple scanning recursive matching algorithm based on a single-line LIDAR sensor. Radar recursive scanning is used to obtain the multiple superposition data of echo signals, and coordinate matching is realized between historical scanning data and current scanning data. Simultaneously, the sensor height deviation and pitch angle deviation of the sensors are regressed to obtain an accurate pavement elevation. Considering the control effect of the active vehicle suspension, a vehicle suspension model with seven degrees of freedom is established. The semi-active suspension controller is constructed using a diagonal recursive neural network algorithm, and the neural network weight is trained using a genetic algorithm. In addition, a preview diagonal recursive neural network control strategy for semi-active suspension, based on the combination of road elevation information, is proposed. The results of a hardware-in-the-loop co-simulation, which was conducted based on the Simulink control model and dSPACE real-time simulation, revealed that the ride comfort and stability of the vehicle were improved owing to a preview of the elevation information of the road ahead and the active adjustment of the shock absorber of the suspension system.	[Yang, Zhengcai; Shi, Chuan; Gu, Shirui] Hubei Univ Automot Technol, Sch Automot Engn, Shiyan, Hubei, Peoples R China; [Yang, Zhengcai; Zheng, Yinglin] Jilin Univ, Coll Automot Engn, Changchun, Jilin, Peoples R China	Hubei University of Automotive Technology; Jilin University	Yang, ZC (corresponding author), Hubei Univ Automot Technol, Sch Automot Engn, Shiyan, Hubei, Peoples R China.; Yang, ZC (corresponding author), Jilin Univ, Coll Automot Engn, Changchun, Jilin, Peoples R China.	yang516516@163.com			Hubei Provincial Key Research and Development Project, China [2020BAB099]	Hubei Provincial Key Research and Development Project, China	This research was funded by the Hubei Provincial Key Research and Development Project, China(No.2020BAB099) 2) funder:Zheng-cai YANG,RMB:250000 3) https://kjt.hubei.gov.cn/ 4)The funder plays an important role in the study design, data collection and analysis.	American Society of Testing and Materials, 2008, STANDARD TEST METHOD; Bar Hillel A, 2014, MACH VISION APPL, V25, P727, DOI 10.1007/s00138-011-0404-2; Dawkins JJ, 2014, P AMER CONTR CONF, P2792, DOI 10.1109/ACC.2014.6859189; [段慧达 Duan Huida], 2004, [北京科技大学学报, Journal of University Science and Technology Beijing], V26, P103; Fauriat W, 2016, VEHICLE SYST DYN, V54, P585, DOI 10.1080/00423114.2016.1145243; Fergani S, 2013, IEEE DECIS CONTR P, P3511, DOI 10.1109/CDC.2013.6760422; Gohrle C, 2015, IEEE-ASME T MECH, V20, P2299, DOI 10.1109/TMECH.2014.2375336; Guo Xuexun., 2009, SINO FOREIGN HIGHWAY, V29, P47; Hamersma HA, 2021, VEHICLE SYST DYN, V59, P1616, DOI 10.1080/00423114.2020.1774067; Imine H, 2008, INT J VEHICLE DES, V47, P234, DOI 10.1504/IJVD.2008.020889; Imine H, 2005, IEEE INT CONF ROBOT, P4751; Imine H, 2005, VEHICLE SYST DYN, V43, P359, DOI 10.1080/00423110500108945; Imine H M., 2003, SAE INT J PASSENGER; Kang SW, 2019, VEHICLE SYST DYN, V57, P1530, DOI 10.1080/00423114.2018.1524151; Kim G, 2021, IEEE ACCESS, V9, P13878, DOI 10.1109/ACCESS.2021.3051619; Labayrade R, 2002, IV'2002: IEEE INTELLIGENT VEHICLE SYMPOSIUM, PROCEEDINGS, P646; Nemeth B, 2010, IFAC P VOLUMES, V15, P396; Oniga F, 2007, 2007 IEEE INTELLIGENT TRANSPORTATION SYSTEMS CONFERENCE, VOLS 1 AND 2, P861, DOI 10.1109/ITSC.2007.4357734; Qin YC, 2015, IEEE DECIS CONTR P, P1533, DOI 10.1109/CDC.2015.7402428; Qin YC, 2015, SHOCK VIB, V2015, DOI 10.1155/2015/636739; Shen T, 2014, 2014 IEEE 17TH INTERNATIONAL CONFERENCE ON INTELLIGENT TRANSPORTATION SYSTEMS (ITSC), P1843, DOI 10.1109/ITSC.2014.6957961; [宋刚 Song Gang], 2013, [农业机械学报, Transactions of the Chinese Society of Agricultural Machinery], V44, P1; Vazquez AGA, 2019, IEEE INT VEH SYM, P1809, DOI 10.1109/IVS.2019.8814242; Wang B, 2014, J TERRAMECHANICS, V56, P103, DOI 10.1016/j.jterra.2014.09.001; Wang Gang., 2019, RES DAMPING FORCE CO; Wang RC, 2022, VEHICLE SYST DYN, V60, P1972, DOI 10.1080/00423114.2021.1889621; Xue K, 2020, MECH SYST SIGNAL PR, V142, DOI 10.1016/j.ymssp.2020.106722; Yao M T., 2011, TRACTOR FARM TRANSPO, V38, P28; Zhao Jihai, 2000, MEASUREMENT ANAL APP, V5	29	1	1	16	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	6							e0269406	10.1371/journal.pone.0269406	http://dx.doi.org/10.1371/journal.pone.0269406			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3F0KH	35749570	Green Published, gold			2022-12-26	WOS:000830362700019
